data_5kpe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5kpe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.495 0.664 . . . . 73.22 109.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 96' ' ' VAL . 46.8 mm -71.37 -32.91 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.955 -1.02 . . . . 72.21 110.533 -174.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HA ' HG23 ' A' ' 71' ' ' VAL . 22.0 t -67.25 -46.55 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.458 0.703 . . . . 64.31 110.02 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -46.51 83.4 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.55 109.218 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.92 79.16 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.033 -0.985 . . . . 74.13 111.596 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.12 -36.32 74.73 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.05 0.54 . . . . 64.43 111.242 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 64' ' ' VAL . 81.3 tttt -60.44 -55.39 34.06 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 123.837 0.711 . . . . 73.04 109.58 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.8 -35.9 75.63 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.983 -1.008 . . . . 73.11 111.148 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 35' ' ' LEU . . . -65.11 -49.12 71.2 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 124.142 0.901 . . . . 74.41 110.693 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.464 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -60.68 -52.62 64.37 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 123.993 0.808 . . . . 75.42 110.854 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.437 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 59.2 mt -62.01 -39.95 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 123.965 0.791 . . . . 73.43 110.323 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.24 75.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.605 0.762 . . . . 71.55 112.142 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.37 -43.43 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.316 0.646 . . . . 74.33 109.866 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.16 -29.99 69.0 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.849 0.46 . . . . 74.23 111.303 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 78.2 mt-30 -66.93 -33.58 75.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.862 0.465 . . . . 75.22 110.47 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.3 mt -73.42 -35.71 65.86 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.235 0.335 . . . . 75.44 110.936 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -62.86 -31.04 71.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.691 0.397 . . . . 72.13 111.896 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -92.75 -30.6 15.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.022 0.529 . . . . 75.4 110.904 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.39 87.37 2.36 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 123.461 0.705 . . . . 74.11 109.787 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.07 -3.66 12.67 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.266 2.644 . . . . 74.32 113.959 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -95.83 7.5 46.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.112 0.965 . . . . 74.02 111.498 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.53 118.07 47.18 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.66 -0.686 . . . . 71.24 109.927 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.88 -39.33 20.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.831 2.354 . . . . 73.32 113.009 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.77 -47.61 58.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.049 0.54 . . . . 72.43 110.089 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.65 -56.28 23.9 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 114.723 -1.126 . . . . 55.42 111.304 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.24 -34.93 77.46 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.094 0.558 . . . . 75.43 111.418 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.36 -51.79 27.3 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.132 0.573 . . . . 75.11 110.748 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -63.11 -38.7 92.22 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.815 0.697 . . . . 73.21 109.827 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.81 -35.87 77.6 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.79 0.836 . . . . 73.31 111.265 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -73.08 -28.87 62.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.074 0.55 . . . . 72.12 110.75 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -81.86 -41.94 20.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 73.13 111.628 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 30' ' ' LEU . 9.8 pt -100.16 -38.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.04 0.536 . . . . 75.05 112.29 -169.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 11' ' ' ALA . 45.6 mt -98.45 178.24 5.09 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.092 -0.707 . . . . 74.13 109.092 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 39' ' ' VAL . 49.0 m -68.67 144.83 96.55 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.205 -0.452 . . . . 63.41 110.347 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.54 -22.79 68.25 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.698 2.265 . . . . 75.12 112.456 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.43 -37.16 86.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.452 1.101 . . . . 74.3 110.903 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 36' ' ' SER . 91.9 t -67.8 -49.97 64.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 123.475 0.71 . . . . 74.54 111.344 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.9 -33.76 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 120.832 0.348 . . . . 71.13 110.396 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 30.2 t70 -71.68 -51.62 22.08 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.042 -0.981 . . . . 71.14 110.167 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -62.94 -32.89 74.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.244 0.218 . . . . 73.05 111.348 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.43 -49.18 79.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 CA-C-O 118.982 -0.532 . . . . 74.35 110.401 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -67.1 -31.3 71.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.464 0.477 . . . . 75.33 111.843 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 16.5 mm-40 -62.5 -51.8 66.01 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.319 0.581 . . . . 74.43 110.104 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.409 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 44.1 m80 -72.97 -24.34 60.77 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.954 -1.021 . . . . 71.23 111.278 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.95 93.19 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.175 0.99 . . . . 74.43 110.926 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.2 -34.95 77.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.406 -0.816 . . . . 73.23 110.825 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.68 -39.26 62.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.732 0.813 . . . . 72.23 111.099 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 84.7 mt -74.5 -29.97 61.63 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.758 . . . . 72.45 110.654 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -69.49 -39.05 77.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.835 0.854 . . . . 72.3 109.912 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 5.2 ttpm? -75.18 -24.65 57.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.771 0.828 . . . . 74.42 110.876 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.88 -36.5 80.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.09 30.43 31.34 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.528 -0.76 . . . . 62.24 111.99 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.85 98.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 109.073 -0.714 . . . . 74.31 109.073 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -84.02 109.57 17.76 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.45 -1.315 . . . . 74.32 107.45 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.0 p90 -111.08 161.45 15.9 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.53 113.13 7.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.844 -1.169 . . . . 73.2 107.844 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.25 108.42 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.112 0.965 . . . . 74.52 110.133 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -91.59 -50.87 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.147 0.579 . . . . 75.23 111.189 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -137.35 134.56 36.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.892 . . . . 74.52 109.037 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -125.77 118.54 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.809 -1.182 . . . . 74.03 107.809 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.78 107.5 9.71 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.874 -0.788 . . . . 73.24 108.874 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 9' ' ' LYS . 7.4 p -103.61 134.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.995 0.518 . . . . 71.22 109.763 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -149.53 166.18 29.97 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.1 0.96 . . . . 65.24 109.085 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 p -96.67 151.78 19.29 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.325 0.583 . . . . 73.2 110.297 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.32 83.07 1.81 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 106.492 -1.67 . . . . 72.12 106.492 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.91 -115.05 7.12 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.493 -1.23 . . . . 61.54 111.377 -168.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -96.11 -14.66 22.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.101 0.561 . . . . 73.31 110.765 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 m -96.58 121.44 38.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.595 0.758 . . . . 73.1 109.642 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 94' ' ' PHE . 8.7 p -89.31 126.57 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 120.981 0.42 . . . . 73.21 110.187 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.64 130.6 54.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.467 0.707 . . . . 70.54 109.939 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 64' ' ' VAL . 21.7 t -112.05 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.999 -0.741 . . . . 70.02 108.999 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -89.39 104.59 17.13 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.646 -0.872 . . . . 75.03 108.646 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.32 120.33 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.837 0.855 . . . . 73.02 109.709 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -89.83 127.94 36.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.766 0.826 . . . . 74.42 108.992 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -127.63 140.5 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.216 0.606 . . . . 72.21 109.393 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -89.42 112.13 23.18 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.021 -1.103 . . . . 71.23 108.021 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.7 mt-10 -101.38 114.83 29.18 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.309 0.643 . . . . 72.42 109.44 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m -87.75 103.28 15.47 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.066 -1.087 . . . . 73.53 108.066 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -140.12 133.88 30.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.74 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.75 16.16 74.11 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.708 -0.678 . . . . 75.45 113.358 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.53 84.55 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.048 0.356 . . . . 73.44 113.185 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -108.4 121.75 45.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.585 0.754 . . . . 71.31 110.371 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.6 m -87.69 116.89 26.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.535 -0.913 . . . . 73.41 108.535 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.3 t -127.22 152.86 46.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.34 0.656 . . . . 73.03 109.749 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -80.06 133.11 36.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.56 -0.533 . . . . 61.13 109.56 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 m -142.59 111.13 6.18 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.779 -1.193 . . . . 72.03 107.779 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -91.02 121.78 33.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.218 0.607 . . . . 70.44 109.562 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.58 125.85 49.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -109.93 102.32 11.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.728 -1.212 . . . . 75.4 107.728 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 12' ' ' ALA . 5.1 mp -89.08 105.72 17.97 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.292 -1.373 . . . . 75.55 107.292 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 15.3 ttt180 -101.16 97.64 8.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.713 -1.217 . . . . 75.41 107.713 -170.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.518 ' HB3' HG22 ' A' ' 101' ' ' ILE . 99.1 m-85 -88.49 109.48 20.08 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.445 0.698 . . . . 74.21 109.596 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 6.5 tm-20 -86.86 119.37 27.01 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.449 -1.315 . . . . 74.41 107.449 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.527 HG13 HG12 ' A' ' 101' ' ' ILE . 3.0 m -97.08 150.93 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.091 0.956 . . . . 75.23 111.646 -168.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.12 99.93 4.41 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.385 1.074 . . . . 75.31 109.089 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.37 -99.47 0.73 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.662 -0.699 . . . . 74.13 112.734 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -107.76 -20.62 13.15 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.567 0.747 . . . . 75.31 110.849 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -128.04 153.31 46.92 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.654 0.782 . . . . 73.01 110.662 -170.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 HG13 ' A' ' 96' ' ' VAL . 72.6 mt -95.1 130.75 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.878 0.871 . . . . 72.32 109.588 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.427 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 9.5 mmt180 -102.62 -35.36 8.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.099 0.56 . . . . 74.33 111.288 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.558 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.9 mtt85 -127.51 145.18 50.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.794 -0.639 . . . . 74.43 109.592 -167.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.84 123.7 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.226 1.011 . . . . 74.24 108.952 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 12.6 m -109.25 103.22 12.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.255 -1.017 . . . . 73.24 108.255 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.12 106.53 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.413 -0.958 . . . . 74.01 108.413 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.1 m -100.26 105.03 16.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.375 0.67 . . . . 74.15 109.334 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -87.49 92.04 8.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.92 0.488 . . . . 62.42 109.734 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 124.214 1.006 . . . . 74.44 110.123 176.517 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 112.976 0.732 . . . . 73.34 112.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 HG21 HG12 ' A' ' 96' ' ' VAL . 47.2 mm -72.8 -29.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.638 1.175 . . . . 75.53 111.957 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.98 -56.56 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 71.12 110.703 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.97 -34.5 69.0 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.802 -0.636 . . . . 61.52 110.804 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -57.25 -50.65 72.23 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.549 0.531 . . . . 72.12 110.455 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.98 -32.07 68.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.505 0.722 . . . . 73.43 112.37 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.18 -58.37 8.62 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.719 0.637 . . . . 73.41 110.154 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.92 -30.27 71.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.997 0.919 . . . . 71.52 111.141 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 35' ' ' LEU . . . -62.61 -51.65 66.45 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 124.188 0.93 . . . . 74.13 110.531 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' A' ' 92' ' ' LEU . . . -59.43 -44.18 92.94 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 124.394 1.059 . . . . 72.44 112.357 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 62' ' ' VAL . 42.4 mt -66.73 -42.27 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.556 0.743 . . . . 73.24 109.965 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.3 -28.02 68.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.714 0.805 . . . . 75.33 112.051 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 11' ' ' ALA . 62.7 mt -60.89 -45.72 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.749 0.82 . . . . 74.44 109.909 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 42.3 m-85 -76.68 -29.43 56.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.276 -0.42 . . . . 73.35 112.011 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -60.59 -39.16 87.07 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.796 0.685 . . . . 74.21 110.054 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.6 -38.44 59.03 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.82 0.7 . . . . 65.1 111.176 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 28.2 m0 -62.88 -31.1 72.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.767 0.654 . . . . 74.23 112.767 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -95.97 -19.09 19.77 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.613 0.365 . . . . 75.03 111.204 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -158.04 88.33 2.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.412 0.685 . . . . 75.34 109.982 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.49 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.115 2.543 . . . . 73.21 113.242 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -91.56 10.66 27.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.271 1.028 . . . . 70.35 111.396 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.08 111.19 16.55 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 109.32 -0.622 . . . . 74.24 109.32 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 -44.85 7.03 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.651 2.234 . . . . 74.4 113.007 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.56 -27.72 58.71 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.274 0.472 . . . . 70.53 112.274 -171.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -62.85 -57.83 9.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.813 0.445 . . . . 74.51 110.532 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -66.66 -26.41 67.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.318 0.647 . . . . 71.2 111.937 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -67.09 -46.44 74.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.168 0.987 . . . . 74.42 110.987 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 4.2 pp -70.86 -34.27 71.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.796 -0.184 . . . . 73.31 110.719 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 93.1 mt -61.1 -28.93 69.44 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.667 0.787 . . . . 70.15 111.141 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.34 -24.95 63.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.932 0.893 . . . . 74.1 111.287 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -93.35 -44.81 8.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.666 0.786 . . . . 74.33 110.525 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.54 HG13 ' HG ' ' A' ' 35' ' ' LEU . 11.8 pt -94.67 -30.45 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.435 0.694 . . . . 74.34 112.321 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 11' ' ' ALA . 68.6 mt -110.21 175.14 5.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.324 0.65 . . . . 75.2 109.977 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB2' HG21 ' A' ' 39' ' ' VAL . 32.6 m -73.74 144.4 82.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.31 -0.859 . . . . 72.15 109.369 170.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 88.9 Cg_exo -52.16 -30.44 41.32 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 123.706 2.937 . . . . 74.31 114.285 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.9 -32.34 71.91 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.475 0.71 . . . . 73.11 111.482 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 36' ' ' SER . 40.4 t -70.29 -41.47 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.605 0.762 . . . . 63.33 110.987 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' PRO . 4.1 pp -72.57 -31.33 65.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.749 0.309 . . . . 74.41 110.76 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.6 t70 -65.28 -50.02 67.32 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.23 -0.896 . . . . 71.23 110.783 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.95 -32.52 72.96 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.286 0.366 . . . . 72.23 111.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 15' ' ' ILE . 47.0 t -63.38 -54.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.558 0.743 . . . . 75.44 111.219 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -67.14 -21.51 65.82 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.572 0.582 . . . . 75.44 112.572 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 12.1 mm-40 -80.35 -39.8 27.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.842 0.457 . . . . 72.33 111.344 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -73.92 -22.09 59.81 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.132 0.573 . . . . 75.24 110.698 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -59.72 -43.68 94.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.96 1.304 . . . . 74.1 111.791 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.19 -20.96 65.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.498 -1.228 . . . . 72.41 112.024 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.98 -59.27 4.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.637 0.375 . . . . 75.41 110.219 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.31 -29.89 70.96 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.053 0.941 . . . . 72.32 111.443 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -59.51 -51.14 71.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.622 1.169 . . . . 73.42 110.672 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.62 -26.9 55.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.517 0.727 . . . . 70.24 111.885 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -74.39 -24.08 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.338 0.655 . . . . 74.34 110.07 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.19 23.96 77.15 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.469 -0.787 . . . . 61.31 113.309 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.4 mt -71.84 103.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.459 -0.941 . . . . 75.43 108.459 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -79.68 124.13 28.28 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.855 -0.794 . . . . 71.31 108.855 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.53 168.2 20.29 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.583 -0.895 . . . . 73.52 108.583 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -148.77 139.26 22.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 74.21 109.187 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 p -70.43 108.6 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.951 0.901 . . . . 71.54 109.363 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -95.53 -39.54 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.437 0.695 . . . . 73.34 111.909 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -151.07 134.29 16.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.617 0.367 . . . . 64.42 110.242 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 13' ' ' ILE . 41.0 t -125.94 116.16 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.879 0.872 . . . . 74.52 109.453 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -127.49 110.45 12.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.243 -1.021 . . . . 72.44 108.243 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 p -96.55 114.45 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.251 0.62 . . . . 73.12 109.991 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.9 m -109.19 135.85 49.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.765 1.226 . . . . 71.33 110.064 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 p -91.92 113.2 25.41 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.195 -0.668 . . . . 62.14 109.195 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.29 87.3 2.51 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.527 -0.916 . . . . 72.24 108.527 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.84 -123.13 12.62 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.361 -0.836 . . . . 64.51 111.139 -172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.34 -16.46 31.01 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.171 0.588 . . . . 72.51 110.538 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 95' ' ' GLU . 9.8 m -96.3 125.61 40.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.444 0.698 . . . . 75.01 109.473 -172.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 94' ' ' PHE . 6.5 p -95.54 115.57 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.746 0.784 . . . . 74.52 110.792 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -102.38 104.63 15.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.911 0.884 . . . . 65.44 109.117 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.8 105.77 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.524 -0.547 . . . . 72.53 109.524 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.0 m -86.41 105.46 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.793 -0.817 . . . . 74.32 108.793 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.02 120.73 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.793 0.837 . . . . 75.01 110.759 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -86.42 129.31 34.9 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.913 0.885 . . . . 72.44 109.65 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.07 137.2 55.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.595 0.758 . . . . 75.13 109.02 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.46 105.49 17.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.183 -1.043 . . . . 74.41 108.183 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -97.36 115.16 27.19 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.428 0.691 . . . . 74.53 111.068 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -90.64 104.42 17.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.02 0.928 . . . . 63.4 108.673 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -124.57 122.22 36.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.263 1.025 . . . . 74.31 109.461 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.72 -88.18 0.36 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.19 0.424 . . . . 74.42 112.653 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.74 13.15 1.74 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.381 0.515 . . . . 73.31 112.256 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.6 p -116.67 139.66 50.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.826 0.851 . . . . 73.34 109.605 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -120.93 119.25 32.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.843 -1.169 . . . . 75.52 107.843 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.9 m -142.19 143.27 32.86 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.948 0.499 . . . . 74.22 110.151 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.64 102.96 8.27 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.723 0.809 . . . . 73.23 109.73 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.8 m -99.83 120.74 40.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.487 1.115 . . . . 74.02 108.743 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 m -89.41 127.52 35.84 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.448 -0.575 . . . . 70.25 109.448 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -107.44 126.5 52.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.653 -1.24 . . . . 75.42 107.653 170.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -108.56 103.28 12.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.509 -0.922 . . . . 71.12 108.509 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 12' ' ' ALA . 60.3 mt -90.0 104.71 17.25 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.373 1.069 . . . . 75.42 109.52 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 49.8 ttt85 -93.76 98.93 11.42 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.133 -0.691 . . . . 75.42 109.133 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.535 ' HB2' HG11 ' A' ' 71' ' ' VAL . 86.7 m-85 -87.52 116.49 25.67 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 9.2 tp10 -87.93 131.45 34.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 122.72 0.408 . . . . 55.04 110.114 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.49 HG11 HG12 ' A' ' 101' ' ' ILE . 5.9 m -103.82 149.66 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.952 0.901 . . . . 74.43 110.32 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.429 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 17.3 t70 -141.38 111.08 6.51 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.599 -1.259 . . . . 63.41 107.599 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.96 -110.5 3.06 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.697 -0.683 . . . . 72.35 112.446 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -113.12 -6.26 13.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.113 0.965 . . . . 63.2 112.263 -171.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -135.82 165.66 25.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.064 0.546 . . . . 75.42 110.754 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.49 HG12 HG11 ' A' ' 96' ' ' VAL . 71.0 mt -93.53 132.35 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.058 0.943 . . . . 72.22 109.3 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HE ' ' HB3' ' A' ' 97' ' ' ASP . 21.0 mmt180 -102.98 -28.43 12.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 73.51 111.182 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 48.9 ttt180 -145.53 154.12 41.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.69 0.396 . . . . 73.43 110.955 -166.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.95 138.18 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 71.33 108.579 167.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.2 m -113.86 112.47 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.446 -0.946 . . . . 70.03 108.446 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.92 104.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.045 -0.724 . . . . 73.33 109.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -103.84 105.84 16.17 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -81.22 95.62 6.99 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.179 -1.045 . . . . 72.44 108.179 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 . . . . . 0 CA--C 1.547 0.837 0 CA-C-N 114.982 -1.008 . . . . 64.14 109.41 -177.35 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 121.277 0.561 . . . . 63.14 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.136 1.374 . . . . 71.25 112.478 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 66' ' ' THR . 40.6 t -59.88 -57.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.663 0.785 . . . . 74.51 110.12 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.72 -37.04 83.89 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.825 -1.08 . . . . 74.12 111.203 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.07 81.82 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.56 0.538 . . . . 61.41 111.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.95 95.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.886 -0.597 . . . . 71.05 111.528 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.2 -47.01 72.16 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.926 0.491 . . . . 75.24 111.664 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.58 -34.03 77.29 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.348 1.059 . . . . 75.25 110.783 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.75 81.63 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.101 -0.954 . . . . 72.24 110.755 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.24 82.42 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.257 0.973 . . . . 72.4 110.785 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 70.3 mt -59.29 -44.13 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 O-C-N 124.39 1.056 . . . . 75.43 109.799 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.06 77.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.157 0.983 . . . . 70.2 113.077 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.84 -39.75 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 73.04 109.974 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -76.7 -28.2 55.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.985 0.514 . . . . 74.54 111.807 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 95.6 mt-30 -68.81 -27.43 65.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.064 0.546 . . . . 74.21 110.559 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 69.1 mt -79.99 -43.76 21.42 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.833 0.453 . . . . 54.51 110.252 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -62.23 -25.03 67.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.939 0.718 . . . . 72.02 112.939 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -82.87 -33.24 27.06 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.133 0.492 . . . . 73.55 110.747 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -158.02 93.04 2.11 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.331 1.052 . . . . 73.04 108.289 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 48' ' ' ARG . 19.1 Cg_endo -56.41 -27.12 66.35 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 123.559 2.84 . . . . 74.41 113.947 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -84.8 15.01 4.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.404 0.682 . . . . 74.32 111.85 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.55 111.05 8.23 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.94 -38.95 6.71 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.412 2.074 . . . . 74.21 112.593 -173.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.91 -41.41 95.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.61 0.764 . . . . 75.04 111.245 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.03 8.85 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.216 0.947 . . . . 74.02 111.76 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -70.62 -26.59 63.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.055 -0.521 . . . . 74.53 112.383 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.83 -40.25 63.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.922 0.489 . . . . 74.51 110.707 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 2.3 pp -70.68 -31.84 68.88 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 110.056 -0.35 . . . . 75.0 110.056 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.834 0.854 . . . . 73.23 111.524 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.98 -29.45 64.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.914 0.486 . . . . 64.15 110.647 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 26.3 mtpp -80.48 -42.84 21.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.973 0.909 . . . . 74.42 111.431 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.532 HG13 HD22 ' A' ' 35' ' ' LEU . 16.9 pt -107.22 -36.13 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.61 0.596 . . . . 73.42 112.61 -168.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 34' ' ' ILE . 2.3 mm? -99.43 179.23 4.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.996 0.918 . . . . 71.23 110.801 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -80.85 146.52 59.95 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 115.046 -0.979 . . . . 75.44 110.356 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -31.35 92.48 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.371 2.714 . . . . 65.24 114.031 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.62 -38.95 92.76 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.676 0.79 . . . . 74.21 111.153 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.97 -53.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.691 0.796 . . . . 72.35 111.437 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.51 -32.12 72.99 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.569 0.224 . . . . 74.2 111.035 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 18.2 t70 -71.27 -49.85 38.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 124.16 0.913 . . . . 74.33 110.893 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -65.59 -38.38 89.33 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.29 0.236 . . . . 72.1 111.449 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.2 -45.09 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.223 0.609 . . . . 71.53 111.477 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.0 ptm180 -72.57 -25.99 61.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.518 0.327 . . . . 75.22 111.228 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 53.8 mt-10 -69.8 -46.32 65.98 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.212 0.605 . . . . 75.55 110.933 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.37 -34.35 78.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.843 -0.617 . . . . 75.25 110.035 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.15 -31.44 72.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.493 1.117 . . . . 64.34 112.222 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.522 ' HA ' ' HG3' ' A' ' 22' ' ' PRO . 70.4 mtp180 -63.28 -36.68 84.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.369 0.668 . . . . 72.2 110.31 174.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -74.6 -34.44 62.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.759 -0.655 . . . . 71.23 110.69 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 55' ' ' ILE . 74.9 mt -74.26 -23.68 59.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.381 0.672 . . . . 71.24 110.707 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.44 -43.09 70.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.179 0.992 . . . . 75.42 109.898 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.26 -41.85 94.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.722 0.809 . . . . 73.35 110.855 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.401 ' NE2' HD21 ' A' ' 50' ' ' LEU . 48.3 mt-30 -73.14 -29.26 62.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.042 -0.981 . . . . 72.52 111.022 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.98 46.41 59.44 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.556 0.535 . . . . 74.24 112.766 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 50' ' ' LEU . 58.7 mt -79.56 109.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.191 0.597 . . . . 74.1 109.933 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -91.47 119.99 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.148 -1.056 . . . . 74.32 108.148 173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.7 158.64 39.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.107 0.963 . . . . 72.1 109.163 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.38 130.12 38.33 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.382 0.673 . . . . 73.24 109.978 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.82 121.56 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 109.573 -0.529 . . . . 63.31 109.573 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -94.38 -48.0 6.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.285 1.034 . . . . 73.12 109.711 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -138.72 139.82 38.51 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.943 -1.132 . . . . 74.12 107.943 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.33 107.53 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.299 -1.0 . . . . 71.12 108.299 171.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -118.93 151.28 38.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.445 1.098 . . . . 74.22 108.799 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.1 126.22 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 72.41 109.335 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -132.22 117.18 17.89 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.966 -0.753 . . . . 73.4 108.966 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.517 HG22 HG23 ' A' ' 5' ' ' VAL . 70.5 p -88.43 127.25 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.529 -0.545 . . . . 72.32 109.529 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -132.71 100.99 5.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.289 -1.004 . . . . 74.5 108.289 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.16 -110.55 3.56 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.933 0.771 . . . . 75.11 112.138 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -118.4 23.7 11.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.866 0.866 . . . . 74.54 110.351 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -133.18 122.09 23.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.277 0.631 . . . . 74.45 109.358 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -97.95 103.72 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.446 0.641 . . . . 73.21 110.15 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -84.04 100.86 11.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.618 1.167 . . . . 72.35 109.42 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 105.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 71.42 109.234 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -89.53 109.24 20.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.015 0.926 . . . . 73.42 109.108 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.12 116.69 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.441 0.696 . . . . 72.2 110.151 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -84.18 135.51 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.079 0.952 . . . . 74.43 109.114 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.52 141.3 41.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.424 0.69 . . . . 75.25 109.608 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.63 108.67 21.43 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.315 -0.624 . . . . 70.5 109.315 168.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.59 107.63 18.24 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.63 -0.878 . . . . 74.4 108.63 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 m -89.57 102.91 15.59 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.937 -1.505 . . . . 64.4 106.937 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 t -140.94 124.18 16.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.305 1.042 . . . . 61.03 108.797 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.48 75.32 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.688 -0.687 . . . . 74.13 112.969 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.82 -19.87 42.64 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.746 -0.474 . . . . 64.31 113.416 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.4 p -88.68 120.23 29.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.159 0.584 . . . . 74.23 110.648 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -90.88 110.26 21.49 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.358 -0.979 . . . . 75.11 108.358 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.1 m -119.49 128.74 54.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 73.4 110.519 -172.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -77.35 101.7 6.45 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.126 -0.694 . . . . 62.15 109.126 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 m -108.42 114.49 28.37 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.453 1.101 . . . . 64.5 108.319 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -88.36 122.04 31.42 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.57 -0.9 . . . . 72.32 108.57 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -102.45 129.77 49.04 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.781 -1.192 . . . . 74.22 107.781 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.45 102.07 11.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.77 104.54 16.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.779 -1.193 . . . . 73.2 107.779 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -101.56 100.74 11.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.102 -1.408 . . . . 75.21 108.225 -170.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.22 110.57 21.61 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.752 0.821 . . . . 73.45 111.559 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -79.49 99.88 7.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.506 HG12 HG21 ' A' ' 101' ' ' ILE . 4.2 m -97.73 141.14 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 65.33 110.163 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.9 116.38 9.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.217 0.607 . . . . 72.32 109.935 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.88 -114.22 5.45 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.969 0.793 . . . . 72.55 112.648 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.93 -3.09 26.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.9 0.88 . . . . 71.03 112.036 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.2 t -137.46 148.79 46.36 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.136 0.493 . . . . 74.22 110.943 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.506 HG21 HG12 ' A' ' 96' ' ' VAL . 34.8 mt -89.3 121.28 39.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.287 -1.005 . . . . 75.42 108.287 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -88.03 -41.86 12.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.992 0.917 . . . . 73.43 112.26 -167.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -142.37 163.89 31.62 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.809 0.338 . . . . 74.15 110.727 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.74 117.15 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.466 1.106 . . . . 74.41 108.831 168.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.1 m -93.45 104.28 16.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.649 -0.871 . . . . 74.41 108.649 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.12 104.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.719 0.771 . . . . 72.23 109.937 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 m -95.51 110.04 22.16 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.001 0.92 . . . . 73.42 109.428 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -81.68 94.38 6.96 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.485 0.714 . . . . 72.1 109.805 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.618 0.767 . . . . 75.24 109.485 178.124 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.504 -0.184 . . . . 73.14 110.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -49.92 -44.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.785 1.234 . . . . 74.13 112.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.78 -46.63 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.554 1.142 . . . . 72.44 111.031 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.0 -46.42 81.46 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.713 -0.676 . . . . 73.43 110.526 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.12 -30.25 70.21 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.241 1.016 . . . . 62.12 111.404 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.18 86.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.997 0.519 . . . . 74.31 110.062 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 13' ' ' ILE . 88.2 tttt -66.38 -45.18 80.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.329 -0.851 . . . . 71.4 110.135 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -57.52 -45.3 85.17 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.136 0.974 . . . . 71.31 110.475 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.21 91.73 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 124.594 1.184 . . . . 74.42 111.04 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.2 66.31 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.994 0.809 . . . . 64.13 111.583 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 9' ' ' LYS . 33.2 mt -60.94 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 123.853 0.721 . . . . 74.22 109.706 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.48 83.92 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.271 1.029 . . . . 71.35 112.276 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.71 -43.57 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 123.973 0.796 . . . . 75.52 110.206 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 75.6 m-85 -73.73 -31.86 63.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.068 0.396 . . . . 73.24 112.068 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.4 HE21 HG23 ' A' ' 13' ' ' ILE . 78.4 mt-30 -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.647 0.592 . . . . 72.31 109.964 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 28' ' ' GLN . 81.4 mt -67.72 -48.25 67.03 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 124.192 0.933 . . . . 75.24 110.317 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 20.9 m0 -54.07 -29.4 44.18 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.843 0.857 . . . . 73.25 113.144 -174.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 20.0 ptmt -101.97 -23.01 14.18 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.074 0.55 . . . . 75.21 112.065 174.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -149.95 83.15 6.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.403 0.681 . . . . 72.4 109.996 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 44.2 Cg_endo -71.73 -7.71 21.68 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.301 2.667 . . . . 73.41 114.597 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -78.97 -10.14 59.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 74.25 112.128 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.93 117.18 51.38 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.683 0.393 . . . . 74.41 110.276 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.49 -41.97 2.09 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.679 2.253 . . . . 73.13 113.446 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.81 -33.56 74.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.227 0.611 . . . . 74.32 112.226 -170.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.22 75.51 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.477 0.711 . . . . 62.24 110.667 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 18' ' ' LEU . 9.3 pt20 -79.2 -20.83 47.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.836 -0.62 . . . . 74.43 111.815 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -46.75 75.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.608 0.763 . . . . 72.45 110.572 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.2 pp -70.33 -31.7 69.11 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.487 0.492 . . . . 70.34 110.337 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.3 -28.89 70.32 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.663 0.785 . . . . 75.35 112.048 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -70.04 -33.87 72.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.144 0.497 . . . . 75.45 110.208 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.27 -33.92 23.91 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.859 0.863 . . . . 74.34 112.023 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 7' ' ' ALA . 10.1 pt -108.89 -33.67 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 122.954 0.502 . . . . 73.41 111.446 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 39' ' ' VAL . 3.5 mm? -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.443 1.097 . . . . 74.31 108.641 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.538 ' HB2' HG21 ' A' ' 39' ' ' VAL . 5.1 m -67.62 145.3 98.16 Favored Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 109.754 -0.461 . . . . 65.02 109.754 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.05 -18.12 56.0 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.486 2.124 . . . . 72.43 112.825 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.49 -33.86 62.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.002 0.921 . . . . 61.31 111.027 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG21 ' HB2' ' A' ' 36' ' ' SER . 63.3 t -63.96 -41.45 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.745 0.818 . . . . 74.03 111.5 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.55 -35.4 75.92 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 120.697 0.284 . . . . 71.22 111.056 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.7 t70 -72.6 -52.58 14.88 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.156 -0.929 . . . . 70.2 110.558 -175.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -61.34 -29.27 69.79 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.295 0.48 . . . . 75.34 112.295 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.9 t -71.7 -48.36 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.685 0.794 . . . . 74.33 110.868 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -73.14 -21.5 60.71 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.76 0.424 . . . . 74.41 111.926 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 mm-40 -82.73 -35.33 26.75 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 122.211 -0.305 . . . . 73.32 110.423 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -68.73 -26.58 65.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.762 0.791 . . . . 74.43 110.69 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -67.93 -38.35 82.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.601 -1.181 . . . . 63.5 111.568 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -65.22 -21.29 66.73 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.679 0.612 . . . . 73.11 111.338 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -72.03 -46.72 56.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.525 0.73 . . . . 74.55 110.628 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.85 -22.95 63.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.56 0.744 . . . . 74.31 111.176 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.63 -27.33 63.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.107 0.963 . . . . 75.23 111.338 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -78.61 -6.73 56.42 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.618 0.367 . . . . 64.21 111.034 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -116.69 172.56 7.15 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.117 0.967 . . . . 71.42 110.248 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.67 24.41 30.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.727 -0.67 . . . . 60.02 113.144 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 88.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-O 121.357 0.599 . . . . 74.41 109.464 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -101.46 110.36 22.35 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.185 -1.042 . . . . 73.54 108.185 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -117.34 135.56 53.76 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.486 0.715 . . . . 73.11 110.469 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.61 122.2 45.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.775 0.83 . . . . 74.41 109.882 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.67 101.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.686 -0.857 . . . . 72.23 108.686 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -77.68 -44.1 29.08 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.686 -0.688 . . . . 74.33 110.805 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 17.6 tpp85 -152.77 142.1 21.58 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.78 -1.1 . . . . 71.1 108.869 -177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.77 110.01 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.615 -0.884 . . . . 71.41 108.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG3' ' HD2' ' A' ' 61' ' ' ARG . 28.8 mt-10 -128.7 122.92 31.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.008 -0.738 . . . . 74.13 109.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.78 135.77 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.496 1.118 . . . . 71.21 110.135 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -138.55 137.63 37.22 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.176 0.99 . . . . 63.54 109.287 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -95.44 155.82 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.046 0.538 . . . . 74.41 111.368 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 95.62 2.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.32 -1.363 . . . . 75.34 107.32 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.63 -117.08 9.41 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 111.736 -0.546 . . . . 44.05 111.736 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.87 -12.93 21.58 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.01 0.524 . . . . 74.41 111.533 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.9 m -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.982 0.513 . . . . 60.33 110.087 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 94' ' ' PHE . 7.8 p -99.73 136.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.719 0.808 . . . . 71.15 110.568 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.95 115.97 22.81 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.058 1.343 . . . . 73.31 108.883 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.24 113.07 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 110.181 -0.303 . . . . 72.43 110.181 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.2 m -87.64 104.89 16.94 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.074 -1.084 . . . . 74.13 108.074 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.48 122.52 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.231 1.012 . . . . 74.33 109.015 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -94.96 132.93 39.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.937 0.895 . . . . 74.54 109.305 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.57 154.91 49.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.407 0.683 . . . . 72.5 109.808 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -110.07 104.48 13.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 72.23 109.289 171.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.52 106.65 17.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.567 0.747 . . . . 74.4 110.191 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -87.85 102.93 15.17 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.886 -1.153 . . . . 64.44 107.886 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.5 t -146.95 135.82 22.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.133 0.973 . . . . 60.13 109.485 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 22.45 71.08 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.732 -0.667 . . . . 73.0 112.843 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.3 80.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.938 -0.368 . . . . 72.5 114.004 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -126.97 123.43 37.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.376 0.67 . . . . 73.3 110.959 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.6 m -88.07 115.08 25.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.308 1.043 . . . . 74.01 110.005 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.6 m -119.08 133.51 55.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.013 0.925 . . . . 72.23 110.134 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -79.21 125.43 29.45 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.974 -0.75 . . . . 62.21 108.974 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.9 m -141.96 125.17 16.41 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.671 0.788 . . . . 73.22 110.234 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -90.75 129.88 36.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.648 -0.501 . . . . 72.34 109.648 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -108.96 146.84 33.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.554 0.742 . . . . 72.21 109.166 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.3 103.66 7.29 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.066 -1.087 . . . . 74.3 108.066 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.77 108.49 20.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 74.2 107.912 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -90.48 99.79 12.75 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.48 -0.782 . . . . 75.31 109.329 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.557 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.6 m-85 -89.3 110.3 21.1 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.987 -0.746 . . . . 73.55 108.987 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 26.6 tt0 -92.13 127.86 37.76 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.089 -1.078 . . . . 72.2 108.089 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -85.09 142.49 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.263 0.554 . . . . 73.2 110.979 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -120.96 97.41 5.52 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.915 -1.143 . . . . 75.41 107.915 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.92 -107.08 1.86 Allowed Glycine 0 C--N 1.343 0.929 0 O-C-N 123.822 0.701 . . . . 73.33 113.241 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.63 -19.05 22.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.047 0.939 . . . . 71.41 112.053 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -132.45 167.95 19.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.669 0.787 . . . . 74.12 110.614 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.557 HG21 ' HB3' ' A' ' 94' ' ' PHE . 50.0 mt -92.06 135.79 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.685 -0.857 . . . . 64.44 108.685 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -129.48 7.69 5.36 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.942 0.497 . . . . 74.1 111.828 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 31.2 mmt180 -144.45 146.58 32.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.999 0.519 . . . . 75.41 111.544 -175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 130.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.993 1.317 . . . . 72.14 109.333 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -127.03 105.8 8.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.417 -0.957 . . . . 74.13 108.417 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 t -86.61 106.81 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.045 -0.724 . . . . 72.2 109.045 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 m -95.57 152.12 18.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.624 -0.88 . . . . 72.11 108.624 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -129.03 138.58 51.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.351 0.66 . . . . 74.52 110.197 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 108.033 -1.099 . . . . 75.41 108.033 174.065 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.52 -0.178 . . . . 73.44 110.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.37 -39.92 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.576 1.55 . . . . 74.52 113.331 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.76 -50.31 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.545 0.738 . . . . 74.31 110.292 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.19 -30.47 64.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.547 -0.752 . . . . 73.35 110.92 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.55 69.98 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.497 0.719 . . . . 63.44 109.954 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.75 94.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.532 0.733 . . . . 70.13 111.495 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.3 -57.88 11.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.268 1.027 . . . . 75.4 111.397 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -66.96 -29.1 68.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 74.43 110.906 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.76 83.6 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 123.925 0.766 . . . . 72.5 110.934 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.08 69.8 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.373 1.046 . . . . 55.2 110.631 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 mt -61.69 -42.79 95.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 O-C-N 124.402 1.064 . . . . 71.1 110.413 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.64 74.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.803 0.841 . . . . 75.11 112.026 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.63 -40.97 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 73.24 109.508 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 60.2 m-85 -72.16 -31.13 65.67 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.472 0.309 . . . . 62.22 111.742 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.436 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 68.9 mt-30 -66.09 -35.57 80.86 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.494 0.496 . . . . 75.11 110.407 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 -42.85 65.74 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 123.888 0.742 . . . . 65.41 109.966 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 37.6 m0 -61.11 -26.06 67.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.166 0.802 . . . . 73.15 113.166 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 17' ' ' GLN . 64.3 pttt -100.22 -21.7 15.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.791 0.436 . . . . 75.52 110.948 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -152.99 89.5 3.69 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.35 0.66 . . . . 65.15 109.56 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.71 -19.21 66.87 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.095 2.53 . . . . 71.52 113.169 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.3 p -83.13 7.9 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.049 0.939 . . . . 72.52 112.469 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.77 108.59 6.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.03 0.532 . . . . 71.33 109.934 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.74 -29.68 15.42 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.573 2.182 . . . . 74.33 113.185 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.67 -41.6 62.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.247 0.619 . . . . 74.43 110.722 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.19 61.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.816 0.846 . . . . 55.13 111.144 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.91 -28.77 68.58 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.713 -0.676 . . . . 74.03 111.764 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.81 -52.35 44.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.881 0.472 . . . . 73.33 110.86 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.512 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.6 pp -66.89 -31.75 72.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.233 -0.44 . . . . 74.1 110.192 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.04 -12.58 61.81 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.959 0.903 . . . . 73.54 112.905 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 -27.02 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.419 0.628 . . . . 74.21 109.963 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -85.47 -30.49 23.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.97 0.908 . . . . 64.45 111.181 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.533 HG13 HD22 ' A' ' 35' ' ' LEU . 12.9 pt -117.77 -32.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.791 0.437 . . . . 71.31 111.538 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 39' ' ' VAL . 3.7 mm? -109.2 179.28 4.21 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.688 0.795 . . . . 73.12 109.253 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 39' ' ' VAL . 28.7 m -76.26 152.47 83.94 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 122.772 0.429 . . . . 75.13 111.347 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.61 -23.51 65.65 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.821 2.347 . . . . 74.33 112.366 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.6 -39.94 80.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.53 1.132 . . . . 71.11 111.133 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 35' ' ' LEU . 93.5 t -65.63 -57.42 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.306 0.643 . . . . 65.55 110.651 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -58.04 -27.04 63.23 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.34 0.496 . . . . 70.5 112.34 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.78 -41.02 24.1 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.77 0.828 . . . . 73.31 110.959 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -74.46 -27.91 60.79 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.303 -0.248 . . . . 74.52 110.626 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -40.83 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.161 0.985 . . . . 65.12 110.749 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.58 -30.73 69.55 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 120.268 0.08 . . . . 74.32 111.052 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.77 -26.32 27.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.844 0.458 . . . . 75.42 111.076 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -66.49 -27.11 67.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.978 0.511 . . . . 74.03 110.365 172.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.86 91.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.92 -1.036 . . . . 70.5 111.878 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -64.71 -31.76 73.13 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.119 0.887 . . . . 71.2 111.479 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.04 -44.19 97.22 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 123.824 0.702 . . . . 71.43 110.44 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -78.42 -36.16 46.02 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.327 1.051 . . . . 75.35 111.314 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.31 -30.15 63.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.924 0.89 . . . . 74.31 110.156 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.98 -36.25 80.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.649 1.18 . . . . 75.14 110.225 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.24 -20.92 29.39 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.974 -1.012 . . . . 65.42 111.013 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.57 20.91 70.5 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.922 -0.581 . . . . 74.32 113.208 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.1 mt -82.21 100.28 5.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 123.366 0.666 . . . . 74.22 110.123 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -92.96 112.98 25.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.219 -0.66 . . . . 74.35 109.219 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 5.7 p90 -105.81 159.45 16.0 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.12 -0.696 . . . . 75.04 109.12 168.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -133.0 133.54 43.27 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.988 -0.551 . . . . 65.43 110.034 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.43 101.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.512 1.132 . . . . 73.5 109.974 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.84 -54.89 3.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.93 0.395 . . . . 73.53 111.48 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -133.16 123.43 25.65 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 109.471 -0.566 . . . . 73.14 109.471 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.54 125.6 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.043 0.937 . . . . 73.43 109.398 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.65 109.12 9.5 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.481 -0.933 . . . . 73.34 108.481 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.6 p -95.41 108.27 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.484 0.659 . . . . 72.43 109.356 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.2 p -113.18 124.97 53.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.564 0.746 . . . . 75.13 109.632 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 71' ' ' VAL . 45.5 p -88.35 154.13 20.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.826 0.45 . . . . 74.42 109.948 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -148.48 92.93 2.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.017 -1.475 . . . . 74.11 107.017 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.65 -117.69 10.39 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.986 -0.846 . . . . 75.14 110.986 -169.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -94.56 -14.06 25.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.402 0.681 . . . . 64.11 110.503 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -93.84 121.62 35.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.642 0.777 . . . . 65.41 110.411 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 66' ' ' THR . 48.2 t -99.66 111.64 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.232 0.613 . . . . 72.44 110.85 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -94.74 107.31 19.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.334 1.054 . . . . 74.44 108.953 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.55 103.61 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.707 -0.479 . . . . 74.11 109.707 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.2 m -86.57 106.15 17.35 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.343 1.057 . . . . 64.45 109.03 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.87 124.85 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.06 0.944 . . . . 71.21 110.293 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -94.82 127.14 40.61 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.971 0.908 . . . . 74.21 109.051 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.99 157.07 30.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.582 0.753 . . . . 74.42 109.259 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' THR . 40.8 mt-10 -109.22 106.52 16.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.154 -0.475 . . . . 75.15 109.852 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.494 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 23.7 mt-10 -86.02 119.81 26.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.697 0.799 . . . . 75.35 110.616 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -89.51 100.44 13.24 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.743 -1.206 . . . . 71.14 107.743 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 t -149.44 128.46 12.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.123 0.969 . . . . 72.34 110.007 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.03 69.61 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 113.835 0.294 . . . . 72.35 113.835 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.45 13.22 83.61 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.901 -0.389 . . . . 71.43 113.989 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.9 p -121.56 149.39 43.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.412 0.685 . . . . 75.51 109.937 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 m -116.61 106.15 13.23 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.364 -0.976 . . . . 65.22 108.364 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 12.0 t -110.66 139.04 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.977 0.418 . . . . 65.3 110.97 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -80.45 102.71 9.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.097 -0.705 . . . . 65.21 109.097 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -114.62 128.15 56.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.227 0.611 . . . . 73.23 109.454 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.7 m -93.43 119.12 32.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.287 0.635 . . . . 72.35 110.186 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -104.3 130.34 52.12 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.241 -1.022 . . . . 64.14 108.241 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.77 104.74 11.96 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.039 -1.097 . . . . 72.45 108.039 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.2 mp -90.96 108.96 20.2 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.85 -1.167 . . . . 73.12 107.85 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.479 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 27.6 ttt180 -89.36 99.68 12.63 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.042 -0.981 . . . . 70.12 108.376 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.476 ' HB3' HG23 ' A' ' 101' ' ' ILE . 91.7 m-85 -87.82 107.65 18.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.253 -0.885 . . . . 64.51 109.053 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 108.15 20.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.471 -1.307 . . . . 74.11 107.471 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.537 HG13 HG12 ' A' ' 101' ' ' ILE . 3.8 m -86.68 151.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 114.871 -1.059 . . . . 73.15 112.407 -165.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.39 103.28 5.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.696 1.198 . . . . 72.33 108.631 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.13 -108.28 2.49 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.369 -0.378 . . . . 72.34 113.279 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.33 2.42 16.5 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.826 0.85 . . . . 64.51 111.74 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 164.63 26.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.691 0.796 . . . . 63.24 109.265 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 96' ' ' VAL . 24.9 mt -101.18 107.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.605 -1.257 . . . . 73.14 107.605 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -85.25 -29.12 24.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.472 0.309 . . . . 73.51 111.624 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -130.06 142.58 50.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.36 0.664 . . . . 74.44 109.757 -164.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.02 142.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.464 0.705 . . . . 75.24 110.615 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.1 m -119.48 141.65 48.98 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.241 1.017 . . . . 72.34 108.889 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 110.09 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.48 -0.563 . . . . 75.51 109.48 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.1 m -103.39 104.86 15.0 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.561 0.744 . . . . 72.24 109.64 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.51 96.11 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.248 0.547 . . . . 74.34 109.854 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 . . . . . 0 C--O 1.244 0.775 0 C-N-CA 124.158 0.983 . . . . 74.24 109.662 175.327 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.113 -0.699 . . . . 73.43 109.113 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.562 HG21 HG11 ' A' ' 96' ' ' VAL . 36.1 mm -48.01 -47.19 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.971 1.709 . . . . 75.11 113.19 -171.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 66' ' ' THR . 45.9 t -66.12 -56.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.497 0.719 . . . . 73.52 110.759 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -74.77 -29.17 61.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.181 -0.918 . . . . 74.22 111.768 -170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 34' ' ' ILE . . . -67.1 -45.31 77.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.411 0.684 . . . . 64.04 110.023 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 71' ' ' VAL . . . -68.64 -32.72 72.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.454 0.702 . . . . 63.21 111.881 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.0 -47.8 78.88 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.554 0.742 . . . . 75.44 110.482 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.761 0.824 . . . . 74.13 111.437 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.29 86.44 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.749 0.82 . . . . 75.25 110.806 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.86 79.56 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 124.202 0.939 . . . . 61.15 111.415 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.3 -40.41 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.147 -0.933 . . . . 73.02 110.449 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.92 82.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.678 0.791 . . . . 65.01 111.665 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.434 ' HA ' HG13 ' A' ' 43' ' ' VAL . 56.4 mt -60.87 -41.58 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.072 0.949 . . . . 74.35 110.35 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -76.38 -31.58 58.09 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.825 0.45 . . . . 73.04 111.819 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.86 -32.5 74.05 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.131 0.572 . . . . 73.34 110.563 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -49.11 26.39 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.502 0.501 . . . . 75.51 110.434 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -59.42 -26.09 64.88 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.39 -29.51 14.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.54 0.336 . . . . 75.25 111.008 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -147.45 85.55 6.7 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.433 0.693 . . . . 74.12 109.137 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.07 -12.16 33.51 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.977 2.451 . . . . 74.23 112.951 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -84.98 5.01 31.01 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.222 1.009 . . . . 73.11 111.584 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -77.33 110.78 13.48 Favored Pre-proline 0 C--N 1.357 0.921 0 N-CA-C 109.53 -0.544 . . . . 75.51 109.53 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.26 -26.09 9.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.408 2.072 . . . . 70.03 112.352 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -75.28 -44.3 46.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.936 0.895 . . . . 74.44 111.118 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.42 81.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 124.273 0.983 . . . . 62.04 111.094 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.488 ' HB2' HD12 ' A' ' 40' ' ' LEU . 11.3 pt20 -75.5 -24.61 56.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.735 -0.666 . . . . 70.24 111.881 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.22 -46.26 61.56 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.027 0.531 . . . . 74.1 110.983 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.4 pp -68.01 -29.34 68.32 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.357 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.2 mt -69.23 -14.76 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 74.21 112.335 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -81.29 -30.25 34.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.266 0.555 . . . . 73.34 109.503 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -82.73 -36.97 25.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.097 0.959 . . . . 70.34 111.05 -174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 7' ' ' ALA . 12.9 pt -105.16 -35.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.309 0.643 . . . . 74.31 111.637 -173.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.437 HD23 HG13 ' A' ' 34' ' ' ILE . 3.9 mm? -111.13 175.7 5.32 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.335 1.054 . . . . 75.31 109.373 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB2' HG22 ' A' ' 39' ' ' VAL . 17.8 m -74.11 146.23 84.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 116.036 -0.529 . . . . 75.13 110.609 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.38 -32.26 41.54 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.288 2.659 . . . . 75.53 114.031 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.49 -39.82 92.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.213 1.005 . . . . 73.3 111.457 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 36' ' ' SER . 96.0 t -70.47 -45.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.498 0.719 . . . . 74.33 111.113 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 28' ' ' GLN . 2.8 pp -64.14 -30.05 71.13 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.936 0.398 . . . . 71.0 110.556 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 23.8 t70 -68.23 -56.73 7.63 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.8 -1.091 . . . . 54.33 110.06 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.42 -31.64 69.45 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 111.898 0.333 . . . . 71.23 111.898 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 15' ' ' ILE . 54.5 t -66.25 -51.99 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.219 0.608 . . . . 70.21 110.415 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 40.4 ptt180 -69.42 -21.9 63.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 119.664 -0.208 . . . . 74.51 111.463 -176.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 18.6 mm-40 -71.02 -46.25 62.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.817 0.447 . . . . 74.15 111.068 175.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -66.32 -28.95 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.052 -0.522 . . . . 75.23 110.769 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.08 93.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.043 0.937 . . . . 75.45 112.049 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 79.3 mtp180 -68.13 -23.64 64.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.689 0.796 . . . . 74.51 111.777 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.26 -47.08 12.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.842 0.857 . . . . 75.2 110.152 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD21 ' NE2' ' A' ' 53' ' ' GLN . 89.8 mt -67.09 -20.17 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.918 0.887 . . . . 74.32 111.341 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.56 -35.04 79.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.435 1.094 . . . . 74.42 110.902 174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.73 -32.95 25.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.278 0.631 . . . . 72.22 110.875 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' NE2' HD21 ' A' ' 50' ' ' LEU . 47.8 mt-30 -80.84 147.34 30.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.402 0.681 . . . . 74.51 110.394 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.08 56.94 5.01 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.475 -0.33 . . . . 45.15 112.46 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.41 105.14 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.086 0.954 . . . . 73.03 108.658 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -104.72 110.37 22.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.665 -0.865 . . . . 75.31 108.665 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.71 162.3 16.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.353 0.661 . . . . 74.24 109.423 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.71 140.46 22.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.673 -0.491 . . . . 73.44 109.673 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.64 122.19 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.12 0.968 . . . . 61.55 109.436 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -106.27 -17.01 14.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.442 0.697 . . . . 72.41 111.202 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.629 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.7 ttt180 -163.45 132.97 4.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.289 0.635 . . . . 74.33 110.227 -169.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.4 t -125.26 135.29 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.293 1.037 . . . . 62.0 108.762 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.84 108.97 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.283 -1.006 . . . . 74.5 108.283 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.4 121.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 121.11 0.481 . . . . 71.01 110.11 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.7 m -141.12 135.24 30.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.972 0.909 . . . . 74.13 108.639 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.495 HG22 HG21 ' A' ' 5' ' ' VAL . 26.8 p -100.8 134.13 44.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.606 0.762 . . . . 71.04 111.218 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.87 107.79 15.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.059 1.343 . . . . 75.12 108.715 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.39 -108.35 2.58 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.448 -0.661 . . . . 72.45 111.448 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.62 -11.97 12.92 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.34 1.056 . . . . 62.04 109.453 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 95' ' ' GLU . 44.8 m -90.28 129.74 36.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.194 0.998 . . . . 74.32 109.9 -172.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.409 HG12 ' HB1' ' A' ' 8' ' ' ALA . 21.6 t -88.8 143.74 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.38 0.672 . . . . 73.01 110.12 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -124.34 112.53 17.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.078 -1.082 . . . . 65.34 108.078 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.5 103.71 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 109.265 -0.643 . . . . 73.13 109.265 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.7 m -87.78 104.43 16.56 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.227 -1.027 . . . . 71.02 108.227 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.28 121.08 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.784 0.834 . . . . 73.42 109.763 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.7 tp10 -83.53 114.94 21.85 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.691 -0.855 . . . . 71.43 108.691 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' A' ' 90' ' ' TYR . 6.2 mp -101.66 160.65 14.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.193 -1.04 . . . . 62.54 108.193 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.23 105.28 7.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -105.49 106.81 17.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.39 0.676 . . . . 74.43 110.638 -169.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -87.79 104.75 16.87 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.712 -1.218 . . . . 65.23 107.712 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 t -136.52 125.0 23.49 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.374 -0.973 . . . . 73.24 108.374 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.01 26.11 72.26 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.98 -0.554 . . . . 64.43 112.993 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.38 60.13 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.19 0.424 . . . . 64.03 113.476 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.3 m -93.28 112.31 24.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.568 0.747 . . . . 73.51 110.432 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.6 m -88.47 107.88 19.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.682 0.793 . . . . 74.54 109.21 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.9 m -126.61 125.49 42.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.448 0.699 . . . . 73.2 110.221 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -77.9 115.68 17.83 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.304 0.642 . . . . 74.33 110.122 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 m -118.58 119.72 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.627 1.171 . . . . 72.42 108.799 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 m -88.17 120.76 29.83 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.59 -0.522 . . . . 75.23 109.59 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.435 ' CD1' HD11 ' A' ' 77' ' ' LEU . 11.3 m-85 -103.58 134.71 46.46 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.297 -1.371 . . . . 73.31 107.297 174.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -118.13 102.46 9.03 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.223 -1.029 . . . . 61.12 108.223 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.8 104.92 16.87 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.039 -1.097 . . . . 75.54 108.039 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -95.64 102.24 14.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.81 -0.811 . . . . 71.03 108.81 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.409 ' HB3' HG22 ' A' ' 101' ' ' ILE . 91.8 m-85 -87.47 108.86 19.22 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.674 0.79 . . . . 74.23 109.562 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 30.6 tt0 -92.81 120.94 33.68 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.471 -0.786 . . . . 75.21 109.645 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 4' ' ' ILE . 4.3 m -98.11 148.09 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.35 -0.841 . . . . 74.24 110.697 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.443 ' HB2' ' HG3' ' A' ' 102' ' ' ARG . 6.7 m-20 -120.37 91.59 3.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.909 -1.145 . . . . 70.2 107.909 173.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.7 -128.19 8.36 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 114.861 -1.063 . . . . 32.03 111.946 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.4 8.8 36.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.493 0.717 . . . . 74.21 112.616 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -139.63 162.43 35.12 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.315 0.646 . . . . 74.14 110.282 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 10.2 mt -95.52 140.12 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.412 -0.958 . . . . 65.34 108.412 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 36.0 mmt180 -126.9 -31.3 2.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.712 0.634 . . . . 74.23 112.712 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.8 mtt180 -130.39 161.67 30.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.528 0.331 . . . . 75.03 110.404 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.39 139.23 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.212 1.005 . . . . 75.31 109.319 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.3 m -121.28 105.16 10.29 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.567 -0.901 . . . . 63.1 108.567 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -89.29 104.3 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.8 m -95.73 103.78 15.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.307 -0.627 . . . . 73.32 109.307 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -85.22 95.06 9.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.605 0.762 . . . . 72.44 109.74 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.243 0.716 0 N-CA-C 108.227 -1.027 . . . . 75.02 108.227 172.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 108.802 -0.814 . . . . 75.02 108.802 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.575 HG21 HG13 ' A' ' 96' ' ' VAL . 36.9 mm -47.69 -38.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.694 1.598 . . . . 64.41 113.842 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.2 -47.8 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.957 0.503 . . . . 64.25 110.022 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.23 -42.11 80.22 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.135 -0.939 . . . . 74.34 110.092 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -61.68 -37.96 86.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.01 0.924 . . . . 74.43 111.666 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.6 -32.61 60.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.926 0.89 . . . . 72.42 110.742 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HD2' HG12 ' A' ' 64' ' ' VAL . 63.8 tttm -67.72 -39.32 84.31 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.325 -0.852 . . . . 74.44 110.327 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.46 -40.82 85.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.357 0.663 . . . . 73.31 110.164 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.21 86.68 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.129 0.971 . . . . 64.23 111.633 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.81 66.58 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.962 0.789 . . . . 75.04 111.61 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -70.73 -32.12 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.2 -0.909 . . . . 73.34 110.8 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.5 -32.2 70.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.125 0.57 . . . . 70.43 112.182 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -60.78 -41.09 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.502 0.721 . . . . 73.2 109.398 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.29 -30.06 61.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.217 0.607 . . . . 72.52 111.771 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.29 -35.47 79.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.412 0.685 . . . . 74.33 110.271 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 73.4 mt -73.93 -40.4 63.12 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.81 -0.632 . . . . 71.55 110.867 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -60.71 -30.35 69.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.208 0.448 . . . . 74.32 112.208 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -96.65 -21.9 17.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.201 0.6 . . . . 75.32 111.024 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.66 89.14 2.69 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.538 0.735 . . . . 75.41 109.219 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.27 -17.53 44.74 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.905 2.403 . . . . 74.42 113.708 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.2 p -89.48 13.55 13.53 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.588 0.755 . . . . 74.52 111.425 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.39 112.27 12.28 Favored Pre-proline 0 C--N 1.358 0.978 0 C-N-CA 123.142 0.577 . . . . 75.12 110.035 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.72 -28.78 13.51 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.704 2.269 . . . . 73.33 113.02 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.1 -41.8 49.2 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.23 0.612 . . . . 71.1 110.949 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -55.72 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 62.44 110.667 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -66.95 -25.9 66.57 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.764 0.426 . . . . 74.43 111.993 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.37 -56.15 24.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.331 0.652 . . . . 74.3 110.196 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.57 -35.03 76.84 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.065 -0.516 . . . . 75.5 110.458 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.8 -29.32 70.63 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.716 0.806 . . . . 74.31 112.176 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -71.97 -35.52 69.56 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.194 0.521 . . . . 71.44 109.811 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -79.8 -39.07 31.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.834 -1.075 . . . . 74.12 111.55 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.513 HG13 ' HG ' ' A' ' 35' ' ' LEU . 7.5 pt -96.54 -40.57 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.858 0.463 . . . . 73.13 111.956 -172.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.513 ' HG ' HG13 ' A' ' 34' ' ' ILE . 47.3 mt -100.95 -175.2 2.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.737 0.815 . . . . 72.41 109.24 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.574 ' HB2' HG21 ' A' ' 39' ' ' VAL . 11.0 m -75.98 146.21 78.67 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 109.334 -0.617 . . . . 72.22 109.334 167.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.22 -19.99 62.52 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.83 2.354 . . . . 73.02 112.452 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.98 -31.71 71.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.501 1.121 . . . . 73.14 111.339 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -69.54 -49.05 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 122.951 0.5 . . . . 64.13 110.287 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.36 -30.22 71.27 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.35 -0.241 . . . . 72.23 110.35 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.58 -40.39 84.83 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.302 1.041 . . . . 61.14 111.495 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.9 -33.06 52.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.211 0.204 . . . . 74.3 110.833 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.84 -47.63 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.415 0.686 . . . . 62.13 110.985 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 5.9 ppt_? -62.8 -29.97 71.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.741 0.417 . . . . 75.03 112.114 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.42 -47.86 58.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.757 0.423 . . . . 75.33 112.072 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -66.2 -31.24 71.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.115 0.484 . . . . 73.41 110.332 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.4 -39.57 92.34 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.714 -1.13 . . . . 74.11 111.891 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 71.9 mtp180 -67.77 -30.58 70.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.266 0.626 . . . . 74.42 111.182 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -72.77 -31.7 65.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.374 0.27 . . . . 75.34 111.069 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.23 -32.04 62.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.152 0.581 . . . . 73.31 110.742 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -70.29 -37.01 74.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.408 0.683 . . . . 74.01 110.354 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.564 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 4.7 ttmp? -60.8 -38.07 84.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.03 0.932 . . . . 65.14 109.816 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -90.12 176.75 6.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.012 -0.995 . . . . 75.21 110.41 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.59 33.12 6.82 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mt -77.79 101.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.996 -0.742 . . . . 72.4 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -94.09 151.85 19.2 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.671 -0.863 . . . . 70.3 108.671 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 44.1 p90 -147.67 161.77 40.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.572 0.749 . . . . 72.0 109.025 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -141.02 136.47 32.12 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.739 -0.467 . . . . 73.32 109.739 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.02 122.07 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 109.368 -0.605 . . . . 75.34 109.368 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -112.01 -44.61 3.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.355 1.062 . . . . 74.1 110.186 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -140.53 135.25 31.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.091 -0.959 . . . . 75.54 109.167 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.48 115.36 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.035 -1.098 . . . . 75.11 108.035 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -127.87 131.97 49.4 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.439 HG12 ' HD2' ' A' ' 9' ' ' LYS . 7.6 p -120.07 109.79 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.886 -0.783 . . . . 74.41 108.886 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.3 p -111.0 164.12 13.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.531 0.732 . . . . 54.12 109.07 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -119.96 143.15 48.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.1 110.093 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB3' ' ND2' ' A' ' 72' ' ' ASN . 5.0 t70 -140.23 91.55 2.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.833 -1.543 . . . . 54.22 106.833 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.56 -124.9 11.13 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.855 -1.298 . . . . 72.33 109.855 -164.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -97.51 -7.7 30.84 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.344 0.657 . . . . 71.51 110.749 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.1 m -88.29 121.54 30.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.343 -0.614 . . . . 74.32 109.343 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.1 t -86.96 136.69 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.664 0.786 . . . . 74.25 109.318 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 67' ' ' ASP . 9.0 m-80 -119.5 99.91 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.244 -1.021 . . . . 73.32 108.244 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.22 104.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.19 -0.67 . . . . 73.4 109.19 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.2 m -87.16 103.36 15.34 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.913 -1.143 . . . . 75.52 107.913 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.59 115.35 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.969 0.908 . . . . 73.33 109.166 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 37.7 tt0 -84.36 124.3 31.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.829 0.852 . . . . 74.11 109.522 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.95 119.7 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.429 0.692 . . . . 74.44 109.347 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -87.59 102.72 14.87 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.214 -1.032 . . . . 72.12 108.214 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.6 mt-10 -89.15 110.42 21.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.14 0.976 . . . . 72.44 111.452 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 45.2 m -89.77 99.88 12.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.551 -1.277 . . . . 72.14 107.551 172.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -147.55 144.65 28.66 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.422 0.689 . . . . 64.32 110.101 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.08 15.63 72.17 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.837 -0.619 . . . . 53.24 113.265 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.38 3.88 81.21 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.1 -0.278 . . . . 72.2 113.474 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -124.59 148.72 47.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.002 0.521 . . . . 64.22 110.559 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 67.3 m -102.86 106.0 16.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.144 -0.687 . . . . 74.32 109.144 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.4 m -101.95 120.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.527 1.131 . . . . 73.32 109.532 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.1 103.8 9.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.652 -0.87 . . . . 71.15 108.652 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -111.06 154.0 24.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.364 1.066 . . . . 75.22 109.744 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 29.9 m -114.53 149.1 36.97 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.113 -0.699 . . . . 60.41 109.113 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.93 131.73 47.56 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.176 1.39 . . . . 72.24 107.691 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -113.83 105.77 13.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.999 . . . . 73.41 108.304 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 106' ' ' VAL . 7.1 mp -98.4 106.21 18.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.828 -0.804 . . . . 74.34 108.828 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -95.9 103.05 14.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.134 0.574 . . . . 72.02 109.843 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.415 ' HB3' HG23 ' A' ' 101' ' ' ILE . 96.5 m-85 -87.18 108.49 18.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.129 0.972 . . . . 75.03 109.637 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 24.8 tt0 -99.71 124.21 44.73 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.575 HG13 HG21 ' A' ' 4' ' ' ILE . 3.2 m -98.17 151.89 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.177 -0.92 . . . . 65.33 111.808 -165.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -137.98 99.23 3.84 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.525 1.13 . . . . 71.44 108.062 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.31 -107.76 2.46 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.185 -0.916 . . . . 71.11 113.023 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.25 -4.08 13.77 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.63 1.172 . . . . 64.32 110.908 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.515 HG21 ' HD3' ' A' ' 102' ' ' ARG . 5.2 t -127.98 154.1 45.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.733 0.813 . . . . 73.13 110.228 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 96' ' ' VAL . 52.3 mt -95.37 133.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.177 -1.045 . . . . 71.14 108.177 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.515 ' HD3' HG21 ' A' ' 100' ' ' THR . 22.2 mmm180 -118.19 -2.98 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.633 0.373 . . . . 75.22 111.324 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 21.9 tpt180 -143.76 133.99 24.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.508 0.723 . . . . 75.3 110.01 -172.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.74 118.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.656 -1.238 . . . . 74.24 107.656 166.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 m -97.46 103.08 14.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.877 -1.157 . . . . 74.54 107.877 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG21 ' HG ' ' A' ' 92' ' ' LEU . 44.6 t -93.87 105.24 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.408 -0.96 . . . . 74.21 108.408 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -110.54 122.09 46.9 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.56 -0.533 . . . . 71.31 109.56 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.77 97.15 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 108.255 -1.017 . . . . 72.31 108.255 176.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t0 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.33 0.586 . . . . 72.2 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -76.27 -39.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.372 1.069 . . . . 74.23 111.068 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.56 -48.38 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.016 0.526 . . . . 72.54 110.979 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.94 -40.47 93.38 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.908 0.755 . . . . 72.44 110.326 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.42 90.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.021 0.825 . . . . 74.05 111.136 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.26 80.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.441 0.696 . . . . 74.14 111.613 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -72.82 -48.78 34.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 72.05 110.549 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -61.15 -42.68 98.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.055 0.942 . . . . 71.32 110.937 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.72 91.65 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.111 -0.949 . . . . 73.32 111.26 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -55.31 -51.22 67.44 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.045 0.841 . . . . 72.4 111.416 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.56 -46.72 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.425 -0.807 . . . . 74.13 110.28 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.146 0.978 . . . . 74.31 113.057 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' HA ' HG13 ' A' ' 43' ' ' VAL . 57.6 mt -62.72 -43.19 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.802 0.841 . . . . 72.42 110.192 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -72.8 -33.16 66.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.553 0.341 . . . . 74.15 111.465 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.562 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 49.7 mt-30 -63.02 -37.85 88.83 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.639 0.587 . . . . 75.52 111.079 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 28' ' ' GLN . 95.6 mt -75.2 -37.24 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.768 0.667 . . . . 75.43 111.185 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.43 -29.32 70.63 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.747 0.647 . . . . 73.51 112.747 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -101.88 -15.11 16.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.825 0.45 . . . . 74.35 111.58 175.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.59 84.27 3.16 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 108.975 -0.75 . . . . 74.32 108.975 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 -12.93 36.76 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.142 2.562 . . . . 75.43 112.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -80.91 -5.58 57.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.446 1.098 . . . . 74.55 112.384 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.99 112.55 18.42 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 109.756 -0.461 . . . . 74.44 109.756 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.15 -34.11 5.23 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.599 2.199 . . . . 64.13 113.018 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.93 -30.83 56.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.867 0.467 . . . . 74.11 111.653 -171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.02 79.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.354 0.662 . . . . 62.44 110.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.53 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.0 pt20 -78.34 -23.94 46.76 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.09 -0.504 . . . . 72.41 111.616 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.67 -48.85 75.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 72.04 110.375 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.0 pp -66.48 -35.02 79.22 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.419 0.449 . . . . 74.04 109.951 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.15 -21.6 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.782 0.833 . . . . 72.54 112.191 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.1 -31.27 34.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.555 -0.535 . . . . 74.53 109.555 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.98 -35.09 38.0 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.22 1.008 . . . . 74.11 112.382 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.5 pt -111.26 -45.15 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.038 0.535 . . . . 74.32 111.854 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 39' ' ' VAL . 3.8 mm? -96.03 177.27 5.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.998 0.919 . . . . 71.31 108.869 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.453 ' HB2' HG21 ' A' ' 39' ' ' VAL . 19.4 m -71.65 147.01 91.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 116.321 -0.399 . . . . 64.45 110.061 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.63 -18.77 56.92 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.558 2.172 . . . . 75.51 113.21 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.07 -37.92 81.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.295 1.038 . . . . 61.42 111.18 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 35' ' ' LEU . 77.5 t -61.8 -55.57 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.749 0.656 . . . . 62.03 110.047 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.0 pp -59.73 -33.46 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.439 0.462 . . . . 74.12 111.038 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 27.5 t70 -67.55 -54.4 20.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 124.249 0.968 . . . . 75.11 110.44 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -67.28 -24.71 65.81 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.155 0.182 . . . . 74.45 111.404 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.476 HG13 ' HA ' ' A' ' 15' ' ' ILE . 31.8 t -68.91 -52.03 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.491 0.716 . . . . 75.03 110.64 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -65.91 -20.73 66.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.576 0.35 . . . . 74.44 111.389 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 44.8 mt-10 -81.93 -35.77 28.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.406 0.682 . . . . 72.13 110.642 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -67.34 -22.29 65.6 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.223 0.609 . . . . 74.41 110.498 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.14 64.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 70.1 111.431 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -59.11 -33.14 70.51 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 124.33 1.018 . . . . 73.04 111.563 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.63 -50.87 61.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.284 0.634 . . . . 72.33 110.633 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.39 -34.26 61.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.081 -0.963 . . . . 75.45 110.682 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.06 -29.04 54.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.166 0.986 . . . . 75.32 110.848 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.43 -40.28 85.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.475 0.71 . . . . 73.45 109.847 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.8 -29.56 62.24 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.002 -0.999 . . . . 73.41 110.315 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.47 29.14 30.86 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.902 0.751 . . . . 44.11 112.81 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.43 116.47 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.743 0.817 . . . . 74.43 109.957 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -91.48 112.18 23.99 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.794 -1.188 . . . . 64.43 107.794 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -130.17 132.59 46.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.629 0.772 . . . . 73.34 109.621 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.32 135.72 51.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.152 0.581 . . . . 71.43 110.427 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.54 119.83 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.285 1.034 . . . . 74.23 109.81 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -104.89 -55.22 2.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.085 0.554 . . . . 74.1 110.409 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -131.9 124.77 30.17 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.753 -0.832 . . . . 75.35 108.753 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.28 116.31 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.274 -1.01 . . . . 72.22 108.274 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -113.92 108.44 17.05 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.637 -0.875 . . . . 73.23 108.637 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.88 127.18 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.381 -0.97 . . . . 73.22 108.381 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -139.61 139.83 36.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.398 0.679 . . . . 74.24 109.2 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.521 HG22 HG23 ' A' ' 71' ' ' VAL . 47.3 p -97.56 116.23 29.38 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.046 0.538 . . . . 73.32 110.007 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.33 91.4 3.65 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.564 -1.273 . . . . 73.12 107.564 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.1 -119.98 7.0 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.017 -0.992 . . . . 73.55 110.905 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -101.13 -11.54 19.5 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.326 0.65 . . . . 74.33 111.082 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 m -94.39 121.51 36.0 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.516 0.726 . . . . 72.32 109.516 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 HG23 HG22 ' A' ' 66' ' ' THR . 68.3 t -87.62 139.14 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.937 -0.764 . . . . 72.33 108.937 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -120.91 110.49 16.36 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.123 . . . . 65.12 108.171 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.12 104.11 15.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.615 -0.883 . . . . 64.12 108.615 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 78.4 m -92.72 105.58 17.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.897 -1.149 . . . . 70.33 107.897 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.55 124.01 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.658 0.783 . . . . 74.52 110.412 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.88 121.91 30.01 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.28 -1.007 . . . . 71.31 108.28 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.419 HD11 ' CD1' ' A' ' 90' ' ' TYR . 6.6 mp -107.45 160.65 15.48 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.337 0.655 . . . . 71.15 109.328 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -116.63 104.64 11.59 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.541 1.137 . . . . 74.22 108.153 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -100.36 102.97 14.34 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.893 -0.41 . . . . 70.23 109.893 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -89.83 104.23 16.81 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.333 -1.358 . . . . 70.44 107.333 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 t -133.73 122.9 24.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.593 0.757 . . . . 74.53 110.25 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.65 0.25 58.36 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.639 -0.709 . . . . 75.2 114.02 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.28 -36.22 3.49 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.734 0.683 . . . . 54.1 111.531 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.3 p -84.87 124.82 32.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.554 0.742 . . . . 74.31 110.914 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -93.7 106.24 18.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.698 0.799 . . . . 74.44 109.796 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 m -114.33 123.61 49.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.117 0.967 . . . . 75.1 109.002 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.57 130.21 35.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.094 -0.706 . . . . 75.3 109.094 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -127.03 125.92 42.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.077 0.951 . . . . 72.01 109.335 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -89.01 121.0 30.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.275 -0.639 . . . . 63.24 109.275 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.419 ' CD1' HD11 ' A' ' 77' ' ' LEU . 10.2 m-85 -102.99 133.08 48.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.261 -1.385 . . . . 70.33 107.261 173.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.34 106.1 12.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.91 -0.774 . . . . 74.15 108.91 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.0 mp -97.34 106.23 18.51 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.26 1.024 . . . . 64.04 108.384 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.589 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 76.8 ttt-85 -96.2 99.97 11.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.706 -0.85 . . . . 71.4 108.706 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -85.87 107.88 17.88 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.68 -0.691 . . . . 74.55 109.418 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 38.5 tt0 -101.11 124.26 46.55 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.913 -1.04 . . . . 75.22 108.954 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 101' ' ' ILE . 29.9 m -87.27 147.46 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.562 -0.744 . . . . 74.32 111.534 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.82 99.44 6.28 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.648 -1.242 . . . . 74.5 107.648 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.67 -110.99 3.43 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.272 -0.876 . . . . 31.42 112.61 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -89.23 -16.23 31.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.924 0.89 . . . . 64.13 112.311 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -133.69 166.29 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.231 0.612 . . . . 74.44 111.156 -168.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.476 HG12 HG13 ' A' ' 96' ' ' VAL . 25.1 mt -94.73 120.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 107.934 -1.136 . . . . 61.02 107.934 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -106.75 -17.22 14.28 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.044 0.538 . . . . 70.13 111.2 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 84.4 mtt85 -128.63 146.98 50.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.405 0.682 . . . . 75.32 110.889 -170.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.8 p -146.31 112.23 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 114.963 -1.017 . . . . 74.3 108.755 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 92.8 m -91.8 103.54 16.08 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.634 -0.876 . . . . 73.43 108.634 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.76 112.39 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.075 -0.713 . . . . 72.33 109.075 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.0 m -106.89 118.64 37.22 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.034 0.534 . . . . 64.5 109.825 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.75 84.04 7.7 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.826 0.85 . . . . 72.32 109.103 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 . . . . . 0 N--CA 1.478 0.953 0 CA-C-N 115.996 -0.547 . . . . 72.21 109.715 -179.578 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--O 1.211 -0.971 0 CA-C-O 119.107 -0.473 . . . . 73.03 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.439 HG23 HG13 ' A' ' 96' ' ' VAL . 46.2 mm -46.4 -46.11 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.22 1.408 . . . . 73.02 113.934 -167.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.33 -52.18 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.41 0.684 . . . . 73.41 110.551 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.02 -33.92 72.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.512 -0.767 . . . . 74.14 111.35 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.02 68.72 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 124.237 1.015 . . . . 75.35 109.945 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.14 -32.64 73.05 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.719 0.637 . . . . 74.51 111.443 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.59 -51.49 59.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.581 0.752 . . . . 74.23 110.319 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.66 -33.82 76.83 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.611 0.765 . . . . 73.33 111.163 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.13 81.69 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 124.284 0.99 . . . . 71.15 110.752 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.47 71.1 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.399 1.062 . . . . 63.42 111.256 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 HG23 HE21 ' A' ' 17' ' ' GLN . 28.8 mt -66.31 -38.32 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 O-C-N 124.1 0.875 . . . . 74.55 110.072 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.1 74.37 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.814 0.845 . . . . 73.21 111.858 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 43' ' ' VAL . 60.1 mt -61.65 -40.97 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.774 0.83 . . . . 65.51 109.747 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.476 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 43.4 m-85 -75.36 -29.11 59.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.774 0.43 . . . . 75.45 112.084 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.405 HE21 HG23 ' A' ' 13' ' ' ILE . 72.7 mt-30 -63.13 -38.2 90.25 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.468 0.48 . . . . 73.34 110.148 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.09 -38.78 63.78 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.691 0.619 . . . . 74.44 110.707 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.1 m0 -68.58 -22.04 64.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.825 0.676 . . . . 73.42 112.825 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -99.68 -20.86 16.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.053 0.541 . . . . 73.33 110.883 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -158.72 91.75 2.02 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 123.928 0.891 . . . . 74.55 109.96 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.11 -9.14 24.84 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.268 2.645 . . . . 75.11 113.965 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 p -90.25 0.64 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.818 0.847 . . . . 75.51 111.868 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.04 114.73 22.45 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 122.866 0.466 . . . . 74.44 110.541 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 98.2 Cg_endo -75.21 -27.38 9.74 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.51 2.14 . . . . 75.41 114.005 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.9 -34.39 24.55 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.864 0.465 . . . . 61.32 112.06 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -52.34 57.12 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.483 0.713 . . . . 62.21 110.223 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -66.39 -28.53 68.7 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.203 -0.908 . . . . 74.55 111.31 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 6.8 tm-20 -58.49 -59.04 5.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.018 0.927 . . . . 73.21 109.93 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -63.97 -33.99 76.96 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.08 0.862 . . . . 72.21 111.034 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.12 -30.1 71.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.912 0.885 . . . . 72.1 112.471 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -65.42 -27.11 68.3 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.07 0.396 . . . . 74.3 111.866 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -94.16 -36.29 12.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.987 0.915 . . . . 72.33 112.286 -171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HG13 HD22 ' A' ' 35' ' ' LEU . 22.0 pt -103.74 -29.08 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 122.859 0.464 . . . . 74.23 112.225 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.476 HD11 HG23 ' A' ' 39' ' ' VAL . 4.1 mm? -106.05 178.38 4.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.035 0.934 . . . . 73.23 108.592 172.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 m -84.78 149.88 54.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.049 -0.523 . . . . 74.54 109.952 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HA ' HD21 ' A' ' 40' ' ' LEU . 83.0 Cg_exo -50.55 -26.25 16.28 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.565 2.843 . . . . 74.15 114.668 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.93 -42.07 95.0 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.084 0.954 . . . . 72.12 111.559 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 35' ' ' LEU . 88.6 t -60.83 -60.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.555 0.742 . . . . 75.11 112.056 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -61.05 -22.55 64.68 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.073 0.397 . . . . 75.44 112.073 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.29 -42.68 30.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 71.01 111.234 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -71.56 -27.11 62.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 110.298 -0.26 . . . . 72.53 110.298 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.414 HG21 HG12 ' A' ' 15' ' ' ILE . 37.7 t -65.92 -53.8 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.69 0.796 . . . . 73.44 110.151 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -63.11 -22.47 66.88 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.229 0.212 . . . . 73.21 111.03 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -74.93 -45.27 43.62 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.452 0.701 . . . . 73.13 110.484 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -71.19 -22.67 62.0 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.895 -0.593 . . . . 73.12 110.701 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.49 98.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.187 0.995 . . . . 73.22 110.898 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -66.06 -34.14 77.4 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.912 -1.04 . . . . 75.25 110.837 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.53 -48.33 79.98 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.804 0.69 . . . . 63.43 110.867 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.67 -51.8 60.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.613 -0.722 . . . . 72.31 110.752 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.77 -35.29 79.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.351 -1.295 . . . . 71.22 111.405 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -61.01 -43.08 99.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.668 1.187 . . . . 75.24 111.356 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -83.65 -15.12 50.12 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.23 -0.896 . . . . 73.11 111.256 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.32 60.19 Favored Glycine 0 C--N 1.345 1.032 0 O-C-N 123.268 0.355 . . . . 74.44 112.878 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.95 91.49 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.821 -0.807 . . . . 75.02 108.821 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -92.53 153.15 19.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.398 -0.819 . . . . 71.55 108.876 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -149.84 170.17 19.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.339 0.655 . . . . 74.44 110.49 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -141.04 138.12 33.41 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.527 -0.916 . . . . 62.13 108.527 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.92 138.22 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 123.528 0.517 . . . . 74.44 109.86 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -115.98 -42.26 3.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.776 0.83 . . . . 73.14 111.559 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttm105 -157.82 123.87 4.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.805 -0.634 . . . . 72.44 109.998 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.89 107.62 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.264 -1.013 . . . . 72.43 108.264 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.71 123.75 43.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 63.33 108.945 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.81 128.75 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.83 -0.804 . . . . 71.43 108.83 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -137.91 117.85 13.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.171 -0.677 . . . . 71.41 109.171 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.468 HG23 HG23 ' A' ' 71' ' ' VAL . 22.1 p -89.79 114.83 26.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.879 0.871 . . . . 75.31 109.856 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -113.99 90.92 3.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.448 1.099 . . . . 75.22 109.096 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.76 -105.13 1.45 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.513 -0.767 . . . . 75.31 112.43 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -114.89 14.65 17.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.241 1.016 . . . . 73.24 110.346 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.4 m -132.01 122.61 25.79 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.348 0.659 . . . . 64.12 110.227 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.468 HG23 HG23 ' A' ' 66' ' ' THR . 58.7 t -90.03 115.35 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 122.939 0.495 . . . . 70.44 109.792 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -102.31 106.82 17.67 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.617 1.167 . . . . 73.51 108.872 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.22 110.53 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.533 0.733 . . . . 73.51 109.706 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -98.4 105.3 17.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.195 -1.039 . . . . 73.32 108.195 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG13 ' HE2' ' A' ' 16' ' ' PHE . 2.4 p -124.3 127.88 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.071 0.548 . . . . 74.0 110.065 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.27 136.98 32.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.937 0.495 . . . . 72.31 109.876 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.5 141.78 48.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.852 0.861 . . . . 73.4 109.927 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.32 104.32 16.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.728 0.811 . . . . 71.03 109.905 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -86.18 107.05 17.71 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.298 0.639 . . . . 75.15 109.557 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.3 m -88.34 104.55 16.86 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.12 -1.067 . . . . 74.1 108.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -144.02 131.81 21.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.437 1.095 . . . . 74.25 108.959 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.33 26.66 73.49 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.844 -0.162 . . . . 73.13 112.863 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.84 85.71 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.49 -0.616 . . . . 71.34 114.359 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.2 t -127.47 146.02 50.64 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.643 0.721 . . . . 61.34 111.259 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 149.97 22.08 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.12 0.968 . . . . 75.03 111.104 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.2 m -137.6 122.03 18.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.269 1.027 . . . . 74.5 109.219 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.41 100.31 5.15 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.03 -1.1 . . . . 74.14 108.03 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -114.72 122.76 47.4 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.359 -0.837 . . . . 72.22 109.046 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.8 m -89.99 124.68 34.96 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.75 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -104.52 127.57 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.818 0.847 . . . . 74.23 109.024 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.63 113.62 27.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.644 -0.873 . . . . 75.5 108.644 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.31 107.36 18.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.719 -0.845 . . . . 71.02 108.719 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -91.6 100.36 13.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.255 1.022 . . . . 73.45 109.484 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.26 106.9 18.52 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.367 0.667 . . . . 75.32 109.47 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 44.0 tt0 -97.54 116.95 30.72 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.736 0.814 . . . . 74.35 108.858 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 101' ' ' ILE . 4.5 m -89.69 149.32 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.444 0.697 . . . . 75.41 110.629 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.46 119.48 15.42 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.444 -1.317 . . . . 75.22 107.444 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.14 -97.99 0.97 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.017 -0.433 . . . . 54.44 112.017 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -121.72 -17.49 7.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.885 0.874 . . . . 73.12 111.91 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.7 t -124.94 160.03 29.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.93 0.492 . . . . 73.1 111.152 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.537 HG12 HG12 ' A' ' 96' ' ' VAL . 27.3 mt -86.03 126.78 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.772 -0.825 . . . . 71.52 108.772 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -102.36 -29.96 11.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.531 0.733 . . . . 74.14 111.715 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -130.95 146.89 52.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.624 0.25 . . . . 62.24 111.086 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.61 107.81 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.263 1.025 . . . . 64.43 109.36 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -95.12 106.57 18.59 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.949 -0.76 . . . . 74.24 108.949 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.49 136.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 109.61 -0.515 . . . . 74.43 109.61 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -129.46 113.0 14.35 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.59 0.756 . . . . 74.03 109.796 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.31 101.79 7.36 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.316 0.647 . . . . 73.42 109.902 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 . . . . . 0 N--CA 1.47 0.543 0 C-N-CA 124.124 0.97 . . . . 65.25 108.887 177.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 109.692 -0.484 . . . . 72.23 109.692 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.25 -39.74 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.583 0.753 . . . . 74.41 111.725 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.27 -52.93 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.682 0.793 . . . . 63.24 111.891 -171.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -67.62 -35.7 79.43 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.686 -0.688 . . . . 72.02 110.523 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -62.8 -41.84 99.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.325 0.65 . . . . 72.52 111.293 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.65 66.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 73.41 111.008 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.58 -54.63 44.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.553 1.141 . . . . 74.22 111.054 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -64.43 -33.94 77.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.509 0.723 . . . . 75.52 110.977 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -49.42 76.11 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.008 0.818 . . . . 61.0 111.025 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.75 68.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.315 1.01 . . . . 71.34 111.504 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.407 HG22 HE21 ' A' ' 17' ' ' GLN . 51.1 mt -63.4 -40.46 89.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 124.175 0.922 . . . . 73.4 110.324 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.348 0.659 . . . . 73.53 111.334 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.3 mt -56.13 -39.32 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 72.24 110.304 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -71.12 -32.67 69.3 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.249 0.62 . . . . 74.42 111.759 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.407 HE21 HG22 ' A' ' 13' ' ' ILE . 71.8 mt-30 -63.04 -38.37 90.92 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.099 0.56 . . . . 72.24 110.519 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 3.4 mm? -66.59 -48.87 68.2 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 123.543 0.527 . . . . 75.22 109.945 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.445 ' HH2' HG13 ' A' ' 106' ' ' VAL . 32.4 m0 -51.52 -34.33 35.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.485 0.92 . . . . 74.05 113.485 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.46 -32.24 12.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.7 0.4 . . . . 73.31 111.686 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -143.95 86.99 8.22 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 108.983 -0.747 . . . . 74.15 108.983 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.89 -15.69 50.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.979 2.453 . . . . 74.23 113.03 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.2 p -89.45 13.34 13.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.42 1.088 . . . . 75.51 112.283 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.21 110.81 26.19 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.281 -0.636 . . . . 74.52 109.281 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.16 -21.61 17.71 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.461 2.107 . . . . 53.23 113.624 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.69 -39.55 26.97 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.359 0.664 . . . . 71.54 111.444 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.19 -50.02 65.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.464 0.706 . . . . 74.21 110.748 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 40' ' ' LEU . 11.6 pt20 -72.41 -19.63 61.56 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.429 -0.805 . . . . 71.3 111.505 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.49 -54.97 24.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.13 0.572 . . . . 74.55 110.592 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.26 -30.3 70.15 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.262 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.18 -28.4 69.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.908 0.755 . . . . 74.41 112.034 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -75.11 -26.96 59.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.317 0.58 . . . . 71.01 109.891 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -78.8 -41.26 30.84 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.915 0.886 . . . . 72.22 110.748 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 HD22 ' A' ' 35' ' ' LEU . 9.9 pt -103.27 -36.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.081 0.552 . . . . 74.43 112.294 -170.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD22 HG13 ' A' ' 34' ' ' ILE . 3.8 mm? -103.28 -176.88 3.21 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.26 1.024 . . . . 75.24 109.477 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 m -81.29 145.89 56.84 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.421 -0.809 . . . . 71.22 109.878 170.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.22 -27.98 59.47 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.854 2.369 . . . . 63.05 112.484 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.62 -48.33 77.71 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.537 1.135 . . . . 75.22 111.479 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.429 HG23 HD13 ' A' ' 35' ' ' LEU . 98.7 t -66.33 -51.97 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.81 0.844 . . . . 70.14 111.391 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 28' ' ' GLN . 4.0 pp -65.13 -28.66 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 120.769 0.318 . . . . 75.43 111.539 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.79 -33.21 60.13 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.511 -0.768 . . . . 72.02 110.54 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -77.62 -32.63 53.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.696 -0.483 . . . . 73.01 109.696 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.3 t -59.94 -42.73 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.442 0.697 . . . . 73.25 111.028 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -73.36 -21.49 60.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.834 0.454 . . . . 62.21 111.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.26 -50.73 13.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.295 0.638 . . . . 74.55 110.829 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -71.01 -21.3 62.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.712 0.805 . . . . 70.32 111.02 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -58.25 -44.86 88.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.725 1.21 . . . . 72.12 111.613 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 99.4 mtt180 -60.43 -35.55 76.08 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.408 -1.269 . . . . 74.23 110.689 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.69 -43.97 74.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.908 0.755 . . . . 74.33 110.3 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.97 -27.96 68.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.755 0.822 . . . . 73.21 111.207 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -79.4 -33.34 42.82 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.991 0.917 . . . . 72.54 110.089 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 94.0 mttt -67.63 -39.37 84.65 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.574 0.749 . . . . 74.5 110.315 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.18 -44.51 88.23 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.085 -0.962 . . . . 73.43 109.219 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.92 44.79 5.91 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.251 -0.886 . . . . 72.21 112.137 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -79.37 106.23 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.781 -0.822 . . . . 73.53 108.781 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -85.81 108.97 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.896 -1.15 . . . . 75.04 107.896 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.53 142.09 50.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.409 -0.589 . . . . 74.14 109.409 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.89 135.72 54.78 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.797 -0.816 . . . . 72.54 108.797 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.37 100.12 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.202 -1.036 . . . . 75.03 108.202 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.37 -49.98 8.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.47 -0.786 . . . . 74.53 110.816 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -144.5 122.65 12.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.308 -0.86 . . . . 73.25 109.682 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.65 124.76 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.623 0.769 . . . . 73.14 109.275 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.1 108.2 10.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.27 -1.011 . . . . 74.11 108.27 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 HG22 ' A' ' 73' ' ' VAL . 7.7 p -96.17 121.23 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.276 0.56 . . . . 73.44 109.541 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.1 m -129.4 141.46 51.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.165 0.986 . . . . 75.15 109.711 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -88.89 163.33 15.67 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.037 0.535 . . . . 74.43 110.939 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -158.57 74.76 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.767 -1.197 . . . . 72.01 107.767 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.84 -117.83 11.21 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.861 -0.495 . . . . 72.41 111.861 -171.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -88.31 -11.68 45.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.114 0.565 . . . . 70.03 111.023 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -97.93 156.05 16.79 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.706 1.202 . . . . 73.35 109.693 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.32 123.5 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.281 0.633 . . . . 73.12 110.296 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -99.34 112.64 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.855 0.862 . . . . 74.03 109.686 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.477 HG22 HG23 ' A' ' 64' ' ' VAL . 61.5 t -91.1 105.02 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.901 -0.777 . . . . 71.11 108.901 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -86.07 104.95 16.14 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.367 -0.975 . . . . 74.42 108.367 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.16 126.82 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.995 0.518 . . . . 65.33 110.461 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.65 123.75 32.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.809 0.844 . . . . 74.14 109.381 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.69 123.15 45.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.316 -0.994 . . . . 73.44 108.316 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 34.9 tt0 -88.86 107.82 19.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.461 -0.941 . . . . 73.13 108.461 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.89 130.61 48.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.731 0.813 . . . . 74.25 110.652 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.2 m -119.52 117.68 29.04 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.158 1.383 . . . . 72.45 107.926 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -144.27 134.29 24.06 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.542 -0.91 . . . . 75.4 108.542 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.51 28.64 62.61 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.355 0.409 . . . . 73.32 113.619 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.67 -34.34 4.25 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 74.33 113.03 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -82.05 133.99 35.32 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.236 0.614 . . . . 72.15 110.612 -170.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -118.51 129.85 55.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.601 0.761 . . . . 64.22 110.334 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.1 m -143.64 136.27 27.24 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.918 0.887 . . . . 73.22 109.669 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 16.5 m120 -79.79 105.39 11.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.684 0.793 . . . . 75.5 109.956 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 m -101.03 126.53 47.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.625 1.17 . . . . 72.42 110.385 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -93.78 122.52 36.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.876 0.47 . . . . 72.22 110.795 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.8 127.54 53.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.398 0.679 . . . . 73.21 109.485 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.03 106.69 18.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.909 -1.145 . . . . 72.13 107.909 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 106' ' ' VAL . 6.7 mp -95.34 106.84 18.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.09 -1.078 . . . . 74.5 108.09 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 34.1 ttt180 -98.44 99.91 11.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.942 0.897 . . . . 74.32 109.41 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.81 112.46 22.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.525 1.13 . . . . 72.32 111.007 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 31.2 tt0 -90.91 134.36 34.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.088 -0.708 . . . . 73.31 109.088 174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.44 151.42 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.304 1.042 . . . . 72.23 111.712 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.37 103.41 6.9 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.705 -1.221 . . . . 64.04 107.705 162.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.33 -105.32 2.06 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.719 -0.673 . . . . 75.11 112.072 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.64 -9.9 10.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.24 1.016 . . . . 73.21 110.912 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -110.4 148.08 32.73 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.598 0.759 . . . . 74.32 109.214 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.09 144.73 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.865 -0.791 . . . . 74.31 108.865 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -125.06 -25.57 3.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.498 0.719 . . . . 72.43 112.443 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.577 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 3.0 mpt_? -129.72 156.44 44.27 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.755 0.422 . . . . 74.43 110.299 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 109.92 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.359 1.064 . . . . 74.33 109.091 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 40.7 m -92.05 105.12 17.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.762 -0.829 . . . . 61.44 108.762 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG21 ' HG ' ' A' ' 92' ' ' LEU . 48.0 t -93.36 105.84 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 122.927 0.491 . . . . 74.23 109.742 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.6 m -100.64 113.8 26.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.524 0.729 . . . . 74.33 109.849 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -79.62 126.67 31.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.027 -0.731 . . . . 75.45 109.027 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.66 0.784 . . . . 65.42 109.589 -176.426 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.974 -0.38 . . . . 63.43 109.974 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.76 -43.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.431 1.082 . . . . 75.52 111.489 -175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.5 -46.18 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.945 0.898 . . . . 70.52 110.199 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -67.23 -33.93 76.4 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.576 -0.738 . . . . 65.44 110.521 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.75 81.35 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.304 0.642 . . . . 75.04 110.513 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.26 98.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.575 0.75 . . . . 73.34 110.969 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -59.02 -56.54 20.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.258 1.023 . . . . 75.21 111.019 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.77 0.828 . . . . 73.14 111.444 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB3' HD13 ' A' ' 35' ' ' LEU . . . -66.44 -45.13 80.87 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 124.151 0.907 . . . . 53.1 110.628 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.12 75.16 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 124.112 0.883 . . . . 70.51 110.816 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.49 -44.85 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 124.263 0.977 . . . . 74.45 110.163 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.63 71.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.107 0.963 . . . . 73.52 112.7 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.401 ' HA ' HG13 ' A' ' 43' ' ' VAL . 62.7 mt -65.07 -41.45 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.26 0.624 . . . . 75.1 110.338 175.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -74.55 -31.51 62.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.71 0.404 . . . . 74.23 111.28 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.93 -37.41 85.98 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.111 0.564 . . . . 75.05 110.341 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.79 -38.86 67.11 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 119.199 -0.429 . . . . 74.42 110.71 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.429 ' HB3' ' HZ ' ' A' ' 57' ' ' PHE . 19.6 m0 -63.61 -21.33 66.3 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.364 0.876 . . . . 75.01 113.364 -176.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -102.32 -25.21 13.74 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.676 0.39 . . . . 71.21 111.156 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -146.04 96.0 4.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 123.273 0.629 . . . . 74.14 109.966 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.88 -28.51 75.59 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.251 2.634 . . . . 74.14 112.925 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 p -92.55 22.08 4.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.901 0.88 . . . . 73.44 111.945 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.25 112.15 23.75 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.055 -0.72 . . . . 74.3 109.055 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.37 -34.45 20.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.79 2.327 . . . . 72.3 112.898 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.71 -49.1 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 74.21 110.973 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.11 -52.67 64.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 124.225 0.953 . . . . 71.54 111.105 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HB2' HD12 ' A' ' 40' ' ' LEU . 2.9 pt20 -68.15 -32.8 73.32 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 116.061 -0.518 . . . . 71.41 111.608 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.2 tt0 -69.87 -43.5 71.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.469 0.307 . . . . 74.15 111.098 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.6 pp -67.35 -34.01 76.42 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.826 -0.435 . . . . 75.34 109.826 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.42 HD22 HD12 ' A' ' 35' ' ' LEU . 85.8 mt -65.34 -30.6 71.45 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.56 0.744 . . . . 75.23 111.517 174.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -67.53 -33.85 75.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.194 0.598 . . . . 72.23 110.355 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 27.4 mtpp -80.89 -46.35 15.37 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.161 -0.927 . . . . 73.31 111.376 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 30' ' ' LEU . 13.0 pt -99.07 -35.18 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.654 0.382 . . . . 75.53 111.732 -168.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 11' ' ' ALA . 28.3 mt -101.95 -170.52 1.83 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.397 -0.594 . . . . 74.21 109.397 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.555 ' HB2' HG21 ' A' ' 39' ' ' VAL . 8.9 m -73.36 138.35 78.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 115.623 -0.717 . . . . 70.32 109.504 169.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.93 -19.68 33.14 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.793 2.329 . . . . 64.13 113.501 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.78 -33.39 70.71 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.513 1.125 . . . . 75.34 111.755 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 36' ' ' SER . 53.0 t -67.07 -49.67 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.435 0.694 . . . . 74.32 111.42 -175.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 28' ' ' GLN . 3.5 pp -58.78 -30.8 67.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.396 0.278 . . . . 72.34 111.212 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.45 -58.93 5.05 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.714 1.206 . . . . 70.34 110.986 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.31 -30.47 71.6 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.823 0.449 . . . . 63.41 111.654 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 15' ' ' ILE . 48.9 t -67.08 -50.5 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.897 0.879 . . . . 74.31 110.651 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -73.68 -20.42 60.55 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.124 0.416 . . . . 73.25 112.124 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -85.61 -26.59 25.98 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 122.22 -0.3 . . . . 74.41 110.543 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.7 -25.31 60.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.885 0.874 . . . . 72.11 109.936 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.25 90.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.185 1.394 . . . . 75.12 112.066 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -59.89 -38.65 82.85 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.836 1.335 . . . . 75.14 111.005 -173.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -57.19 -58.84 6.46 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.233 0.958 . . . . 75.53 110.659 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.8 -34.02 76.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.509 1.124 . . . . 73.3 111.983 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -66.11 -45.11 82.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.014 0.925 . . . . 71.14 110.339 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.6 -32.56 66.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.48 0.712 . . . . 72.55 111.157 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -69.45 -18.29 63.71 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.486 0.714 . . . . 75.33 111.427 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.75 42.0 40.46 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.557 0.536 . . . . 73.24 112.203 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -111.15 96.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.211 -0.663 . . . . 74.32 109.211 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -92.05 108.11 19.7 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.192 -0.669 . . . . 70.31 109.192 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 8.7 p90 -106.3 135.49 47.7 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.174 -1.417 . . . . 73.44 107.174 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.56 135.6 47.15 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 110.007 -0.368 . . . . 73.21 110.007 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.68 125.18 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.902 1.376 . . . . 74.04 110.626 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.39 -37.93 3.91 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.731 0.813 . . . . 73.03 111.064 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 27.2 ttp85 -143.81 129.5 19.24 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.338 0.655 . . . . 75.01 109.349 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.65 128.66 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.878 0.871 . . . . 72.14 108.759 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.38 106.62 9.33 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.737 -1.208 . . . . 62.42 107.737 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 73' ' ' VAL . 7.3 p -103.26 113.97 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.772 -0.825 . . . . 74.53 108.772 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.5 t -137.55 153.63 49.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 74.5 109.97 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.544 HG21 HG21 ' A' ' 71' ' ' VAL . 34.2 p -100.75 130.16 46.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.145 0.578 . . . . 73.43 111.676 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.88 81.08 1.38 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.503 1.921 . . . . 71.33 108.437 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.44 -120.47 8.35 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.41 -0.814 . . . . 64.24 111.207 -173.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -87.38 -11.33 49.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.441 0.697 . . . . 73.15 110.639 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.4 m -89.96 156.73 18.22 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.272 1.029 . . . . 75.3 108.845 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.544 HG21 HG21 ' A' ' 66' ' ' THR . 43.7 t -122.4 133.0 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.04 0.936 . . . . 74.25 109.331 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -110.56 125.83 53.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.722 0.809 . . . . 75.12 109.203 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 64' ' ' VAL . 48.7 t -97.38 104.1 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.378 -0.971 . . . . 73.33 108.378 169.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -86.75 102.22 14.05 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.515 -1.291 . . . . 73.15 107.515 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.21 123.1 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 75.3 109.89 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.0 tt0 -90.13 127.81 36.19 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.353 1.061 . . . . 75.11 109.444 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.49 143.68 51.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.288 0.635 . . . . 75.33 109.847 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -91.61 108.75 20.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.178 -0.675 . . . . 74.51 109.178 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 24.9 mt-10 -87.25 103.18 15.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.075 0.55 . . . . 75.34 109.666 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.7 m -93.96 106.14 18.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 74.42 109.465 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -145.59 118.55 8.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.346 1.058 . . . . 75.54 109.24 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.73 23.14 62.8 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.514 0.565 . . . . 53.34 114.514 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.03 -22.64 34.48 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.964 0.316 . . . . 75.1 112.901 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.2 m -83.69 124.52 30.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.561 0.745 . . . . 71.14 109.833 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 m -126.92 110.37 12.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.445 -0.946 . . . . 61.34 108.445 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.9 m -125.9 136.11 52.68 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.955 0.902 . . . . 64.32 109.976 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.93 100.58 6.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.833 -1.173 . . . . 55.32 107.833 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.2 m -105.29 132.63 51.24 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.927 -1.033 . . . . 74.4 108.985 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -89.39 122.89 33.04 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.427 -0.583 . . . . 75.22 109.427 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -104.8 126.77 52.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.164 -1.05 . . . . 72.31 108.164 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -113.79 103.9 11.66 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.103 -1.073 . . . . 74.32 108.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HG ' HG23 ' A' ' 106' ' ' VAL . 5.7 mp -98.38 107.07 19.44 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.117 -1.068 . . . . 75.23 108.117 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -90.45 98.74 11.95 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.075 -0.713 . . . . 73.44 109.075 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.578 ' HB3' HG23 ' A' ' 101' ' ' ILE . 93.4 m-85 -89.54 109.92 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.492 1.117 . . . . 73.11 109.284 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 28.2 tt0 -107.63 131.59 54.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.616 -0.513 . . . . 72.34 109.616 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 101' ' ' ILE . 11.0 m -84.35 151.84 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.83 1.252 . . . . 63.44 111.115 -168.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.8 98.38 3.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.215 -1.032 . . . . 72.41 108.215 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.82 2.18 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.021 -0.831 . . . . 65.34 111.021 -174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.68 -5.25 12.71 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.977 0.911 . . . . 73.44 111.17 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 102' ' ' ARG . 4.6 t -127.44 143.86 51.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.68 . . . . 74.42 110.282 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' A' ' 94' ' ' PHE . 73.4 mt -87.9 109.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.671 0.788 . . . . 73.22 109.361 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HD3' HG23 ' A' ' 100' ' ' THR . 15.9 mmm180 -103.27 6.16 37.93 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.209 0.448 . . . . 75.13 112.209 -173.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 90.0 mtt180 -133.21 141.91 48.31 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.349 0.66 . . . . 73.4 110.903 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.96 134.68 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 72.24 108.504 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.4 m -132.02 106.56 8.1 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.444 HG23 ' HG ' ' A' ' 92' ' ' LEU . 37.6 t -90.04 119.03 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.924 0.49 . . . . 73.01 109.798 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.6 m -113.31 106.88 15.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.504 0.722 . . . . 73.23 110.374 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -77.93 103.83 8.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.39 -0.967 . . . . 65.13 108.39 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 . . . . . 0 N--CA 1.473 0.693 0 C-N-CA 123.539 0.735 . . . . 64.3 109.588 -178.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 119.722 -0.18 . . . . 73.34 110.97 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -51.59 -41.1 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 125.401 1.481 . . . . 61.22 114.111 -166.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.34 -51.9 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.457 0.703 . . . . 73.3 110.678 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.71 -30.1 71.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.437 0.695 . . . . 74.1 110.344 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.68 71.18 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.848 1.259 . . . . 65.34 109.87 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.78 82.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.528 0.731 . . . . 71.34 111.495 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HG3' HG11 ' A' ' 62' ' ' VAL . 39.6 tttm -63.68 -51.66 64.13 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.028 -0.987 . . . . 75.11 111.796 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.64 -24.7 61.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.348 0.259 . . . . 64.45 111.317 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.04 -45.12 86.7 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 123.533 0.733 . . . . 75.02 110.237 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -56.64 -54.37 46.9 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.475 1.109 . . . . 74.23 110.746 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.44 HG12 HG12 ' A' ' 59' ' ' VAL . 57.0 mt -59.89 -41.67 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.086 0.866 . . . . 72.35 110.854 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.71 88.52 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.959 0.904 . . . . 63.13 111.58 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.483 ' HA ' HG11 ' A' ' 43' ' ' VAL . 45.6 mt -61.22 -37.23 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 124.064 0.853 . . . . 74.51 110.496 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.27 -29.9 34.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.792 0.437 . . . . 74.45 111.497 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -66.73 -35.2 79.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.355 0.662 . . . . 74.33 110.276 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.15 -47.22 59.07 Favored 'General case' 0 C--O 1.213 -0.816 0 O-C-N 123.669 0.606 . . . . 74.05 110.17 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.487 ' HB3' HD12 ' A' ' 50' ' ' LEU . 29.1 m0 -57.1 -26.67 60.85 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.105 0.78 . . . . 72.54 113.105 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -101.36 -16.18 16.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.807 0.443 . . . . 74.42 111.963 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.419 HD21 ' HB2' ' A' ' 24' ' ' ASP . 7.8 t30 -156.17 89.54 2.79 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 123.996 0.918 . . . . 75.54 109.352 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 23.6 Cg_endo -59.77 -23.1 70.71 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.883 3.055 . . . . 74.13 113.633 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.4 p -81.17 -2.22 47.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.15 0.98 . . . . 62.54 112.341 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' HD21 ' A' ' 21' ' ' ASN . 10.2 t70 -66.95 113.49 13.54 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 122.919 0.487 . . . . 73.23 109.873 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.51 -28.26 4.54 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.363 2.042 . . . . 72.42 112.766 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -70.03 -41.02 74.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.47 0.708 . . . . 73.13 111.183 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -51.41 49.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.897 -1.047 . . . . 75.35 111.116 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -68.41 -28.37 67.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.118 -0.492 . . . . 74.32 112.056 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.28 -47.26 62.02 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.254 0.346 . . . . 62.3 110.874 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -65.76 -33.34 75.65 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 110.175 -0.306 . . . . 74.53 110.175 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.96 -28.88 70.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.731 0.813 . . . . 73.03 111.722 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -69.39 -41.63 76.21 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.435 0.636 . . . . 70.31 109.613 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -73.98 -22.62 59.55 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.606 -1.179 . . . . 74.35 112.215 -171.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.0 pt -118.09 -51.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.315 0.507 . . . . 75.25 112.337 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.438 HD21 HG13 ' A' ' 34' ' ' ILE . 3.1 mm? -82.14 166.43 19.68 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 65.31 108.206 173.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -61.79 142.7 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 109.77 -0.456 . . . . 75.4 109.77 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.84 -11.42 14.85 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.746 2.297 . . . . 72.14 113.444 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.86 -37.12 73.07 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.735 0.814 . . . . 53.54 110.816 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.0 -37.54 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.253 1.021 . . . . 61.51 112.202 -171.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.35 -31.54 72.19 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.784 0.265 . . . . 71.52 110.905 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.22 -57.34 6.9 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 124.457 1.098 . . . . 73.03 109.991 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 12.1 pt20 -58.79 -30.44 67.59 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.035 0.534 . . . . 75.45 111.993 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 15' ' ' ILE . 67.6 t -75.44 -49.8 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.127 0.971 . . . . 72.14 111.913 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -67.67 -24.96 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.745 0.307 . . . . 74.33 111.344 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -86.14 -25.57 25.67 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.825 0.45 . . . . 73.12 110.984 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 5.5 t60 -67.0 -29.29 69.09 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.913 0.885 . . . . 73.4 109.544 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 22' ' ' PRO . . . -59.03 -39.6 82.44 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.107 1.363 . . . . 63.21 112.667 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 75.3 mtp180 -58.43 -32.04 68.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.031 0.932 . . . . 73.22 111.293 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.22 -51.66 62.59 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.166 0.986 . . . . 74.52 110.907 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 55' ' ' ILE . 53.0 mt -73.6 -17.69 61.14 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.307 -0.86 . . . . 75.33 111.317 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -72.61 -42.73 64.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.177 0.991 . . . . 74.41 109.625 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 73.6 mmtt -61.62 -42.62 99.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 123.739 0.649 . . . . 74.44 109.611 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.418 ' NE2' HD23 ' A' ' 50' ' ' LEU . 50.9 mt-30 -72.53 -28.52 62.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.231 -1.349 . . . . 73.32 111.732 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.12 40.71 95.13 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.729 0.643 . . . . 54.2 113.087 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.495 HD12 HD21 ' A' ' 50' ' ' LEU . 59.3 mt -78.62 114.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.883 0.473 . . . . 72.12 109.865 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -90.64 112.92 24.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.485 -0.931 . . . . 72.11 108.485 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.2 134.38 20.51 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.428 0.558 . . . . 73.12 111.164 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.875 0.87 . . . . 72.02 109.645 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 13' ' ' ILE . 49.4 t -77.18 120.62 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.394 1.077 . . . . 72.51 109.755 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.19 -54.5 2.6 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.431 0.692 . . . . 72.15 111.376 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 8.6 tpp85 -132.59 127.27 34.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.442 -0.948 . . . . 70.14 108.442 -173.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.48 HG11 ' HG3' ' A' ' 9' ' ' LYS . 38.3 t -123.0 109.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.723 -0.843 . . . . 73.42 108.723 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -119.79 108.39 14.33 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.632 -0.877 . . . . 73.3 108.632 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -105.34 109.95 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.085 0.954 . . . . 71.04 109.687 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -123.83 142.55 51.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.913 0.885 . . . . 75.33 109.742 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.1 p -93.42 124.05 37.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.657 0.383 . . . . 75.2 110.369 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -113.51 98.24 6.95 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.228 -1.027 . . . . 72.35 108.228 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.191 -1.164 . . . . 73.42 110.191 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.45 -15.21 15.08 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.358 0.663 . . . . 74.44 110.332 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.0 m -93.35 117.06 29.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.922 0.489 . . . . 75.22 109.761 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 94' ' ' PHE . 8.0 p -88.68 128.9 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.189 0.596 . . . . 75.43 110.377 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.63 113.35 25.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.782 1.233 . . . . 74.22 109.363 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.57 104.48 15.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.292 -0.632 . . . . 75.42 109.292 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.404 ' HG1' ' HG3' ' A' ' 91' ' ' GLU . 56.9 m -86.29 104.8 16.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.019 -1.104 . . . . 72.51 108.019 173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.1 p -127.61 115.35 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.337 0.655 . . . . 74.34 111.391 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.59 132.43 35.3 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.206 -0.906 . . . . 72.33 109.573 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.24 135.17 54.43 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.001 0.92 . . . . 74.41 108.679 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 85' ' ' THR . 33.4 tt0 -93.96 102.14 14.22 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -95.35 112.88 24.52 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.482 1.113 . . . . 74.12 109.593 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -87.67 102.97 15.15 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.766 -1.198 . . . . 75.0 107.766 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -134.83 134.98 41.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.952 -1.129 . . . . 72.12 107.952 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.11 65.57 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.091 0.245 . . . . 71.3 112.553 -172.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.27 59.53 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 123.206 0.431 . . . . 72.41 113.5 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.2 p -96.66 151.01 20.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.905 0.882 . . . . 71.54 111.093 -173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 78' ' ' GLU . 89.4 m -85.38 115.85 23.36 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.093 0.957 . . . . 74.44 109.125 177.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.6 m -121.42 111.02 16.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.714 -0.847 . . . . 72.34 108.714 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -90.37 102.7 15.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.487 -0.931 . . . . 71.55 108.487 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.6 m -111.46 126.11 54.6 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.627 0.771 . . . . 74.22 109.261 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -91.73 120.89 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.456 -0.572 . . . . 74.14 109.456 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.2 127.69 49.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.768 -1.567 . . . . 75.14 106.768 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.404 ' HG3' ' HG1' ' A' ' 74' ' ' THR . 37.0 tt0 -111.26 102.08 10.52 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.987 -1.116 . . . . 70.35 107.987 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.4 mp -90.74 106.58 18.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.504 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 50.6 ttp180 -91.67 98.46 11.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.731 -1.122 . . . . 74.41 108.175 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.525 ' HB3' HG22 ' A' ' 101' ' ' ILE . 98.7 m-85 -88.53 107.75 19.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.999 -0.741 . . . . 74.02 108.999 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.572 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 1.6 tm-20 -90.89 125.95 35.9 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.882 -1.525 . . . . 74.33 106.882 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.13 148.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.177 0.991 . . . . 75.12 111.676 -163.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.7 92.45 2.75 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.691 1.196 . . . . 75.01 109.007 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.62 -102.42 1.29 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.468 -0.787 . . . . 74.14 111.53 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.5 -10.06 13.75 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.078 0.951 . . . . 73.4 111.037 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -108.17 166.73 10.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.274 0.63 . . . . 71.25 109.565 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 94' ' ' PHE . 54.1 mt -115.52 120.29 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 107.637 -1.245 . . . . 73.12 107.637 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -88.26 -30.92 19.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.176 0.19 . . . . 74.35 111.153 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 65.2 mtt180 -129.42 147.73 51.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.904 0.481 . . . . 75.33 110.904 -164.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.67 110.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 74.34 109.051 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 25.9 m -95.39 104.67 16.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.667 -0.864 . . . . 73.35 108.667 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.505 HG22 ' HG ' ' A' ' 92' ' ' LEU . 40.9 t -85.55 102.41 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.669 -1.234 . . . . 72.15 107.669 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 m -99.26 109.31 21.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.096 -0.705 . . . . 74.02 109.096 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.37 106.56 12.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.593 0.757 . . . . 74.4 110.374 -174.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.611 1.164 . . . . 62.32 108.54 176.666 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.623 -0.51 . . . . 74.43 109.623 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.31 -50.15 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.884 0.874 . . . . 73.41 110.999 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.39 -36.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.205 -0.907 . . . . 65.03 110.295 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.14 -35.57 80.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.919 -0.582 . . . . 75.41 110.869 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . . . -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.731 0.412 . . . . 75.15 110.211 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.38 90.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.702 -0.681 . . . . 73.21 111.699 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.29 -46.79 69.39 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.471 -0.786 . . . . 74.31 111.285 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -63.83 -41.77 97.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.448 0.699 . . . . 73.11 110.666 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.34 97.86 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 123.666 0.604 . . . . 72.25 111.29 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -56.51 -53.71 54.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.032 0.833 . . . . 72.34 111.156 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 70.1 mt -61.96 -43.68 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.363 -0.835 . . . . 74.13 110.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 30' ' ' LEU . . . -63.96 -37.56 87.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.588 0.755 . . . . 72.13 112.454 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.14 -37.59 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.841 0.856 . . . . 73.42 109.985 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -74.52 -35.01 63.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.257 0.623 . . . . 73.4 111.818 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 8.3 mm-40 -63.35 -37.29 86.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.526 -0.546 . . . . 74.03 109.526 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 81.7 mt -71.48 -41.84 68.82 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.36 -0.836 . . . . 74.11 110.891 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -59.29 -34.57 72.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.87 0.693 . . . . 74.02 112.87 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -96.91 -15.99 20.9 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.606 0.362 . . . . 75.05 111.547 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.82 84.36 2.76 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.579 0.752 . . . . 74.45 109.145 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.18 -13.51 32.43 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.275 2.65 . . . . 72.42 114.135 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 p -89.43 9.68 25.44 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.717 0.807 . . . . 62.34 112.284 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.1 109.79 4.99 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.166 0.586 . . . . 74.12 110.056 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.67 -37.62 16.0 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.555 2.17 . . . . 74.32 112.979 -171.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.06 -42.73 69.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.791 0.836 . . . . 73.31 111.697 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.11 -54.97 29.59 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.548 0.739 . . . . 64.12 111.564 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -62.81 -32.87 74.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.756 -0.657 . . . . 74.12 111.6 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.9 -46.28 72.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.106 0.563 . . . . 73.24 112.129 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 14' ' ' ALA . 4.2 pp -69.64 -27.31 64.94 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 120.842 0.353 . . . . 73.34 110.422 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 mt -69.18 -18.63 63.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.011 0.925 . . . . 72.24 112.61 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -73.96 -29.05 61.79 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.082 0.401 . . . . 73.04 110.483 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.08 -42.21 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 75.04 111.654 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 20.0 pt -103.97 -31.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 112.326 0.491 . . . . 73.23 112.326 -172.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.78 -179.35 3.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.111 0.964 . . . . 72.33 109.208 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 39' ' ' VAL . 50.7 m -84.67 143.29 40.69 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 73.42 109.941 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.94 -32.22 37.19 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.298 2.665 . . . . 75.12 113.185 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.43 -47.99 77.93 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.115 0.966 . . . . 53.22 111.856 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.1 t -63.02 -52.32 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.199 -0.91 . . . . 71.33 111.259 -173.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.97 -28.18 69.91 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.187 0.44 . . . . 75.33 112.187 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -58.81 5.08 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 124.156 0.91 . . . . 64.05 110.073 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 39' ' ' VAL . 26.8 pt20 -69.16 -21.11 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.039 -0.528 . . . . 74.45 111.414 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.36 -50.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.725 0.41 . . . . 74.14 110.071 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 4.7 ppt_? -71.06 -21.0 62.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.757 0.281 . . . . 74.41 111.757 -177.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -73.22 -49.21 29.16 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.704 0.401 . . . . 75.31 111.498 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -67.89 -21.84 65.13 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.045 0.538 . . . . 63.13 111.111 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 18' ' ' LEU . . . -65.0 -37.7 88.52 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.234 1.013 . . . . 64.41 111.853 174.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 61.9 mtp180 -62.86 -27.38 69.3 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.57 0.748 . . . . 74.14 110.555 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -47.62 60.61 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.897 -0.592 . . . . 72.43 110.253 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD22 ' NE2' ' A' ' 53' ' ' GLN . 92.8 mt -65.86 -33.23 75.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.628 0.771 . . . . 70.22 111.361 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.82 -44.71 95.43 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.019 0.928 . . . . 74.52 109.702 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.82 -31.59 69.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.994 -1.003 . . . . 75.12 111.056 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' NE2' HD22 ' A' ' 50' ' ' LEU . 49.8 mt-30 -77.48 -15.59 59.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.445 0.698 . . . . 75.54 111.198 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.38 30.1 74.91 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.59 0.556 . . . . 45.01 113.469 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.62 99.18 4.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 109.588 -0.523 . . . . 74.53 109.588 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -81.33 109.62 16.01 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 107.591 -1.263 . . . . 74.34 107.591 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.66 162.88 14.72 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.596 -0.89 . . . . 74.51 108.596 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.12 130.33 20.85 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.781 -0.452 . . . . 71.43 109.781 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.6 t -68.04 135.58 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 123.967 0.792 . . . . 74.32 109.81 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -117.62 -51.97 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.582 1.153 . . . . 75.33 110.345 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -142.07 123.83 15.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.157 -0.929 . . . . 74.34 108.913 -173.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.25 112.81 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.231 -0.655 . . . . 75.24 109.231 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.05 146.64 44.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.951 -1.129 . . . . 72.42 107.951 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG21 HG22 ' A' ' 73' ' ' VAL . 5.7 p -135.45 108.81 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.052 -0.721 . . . . 74.12 109.052 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.8 m -118.38 128.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.328 1.051 . . . . 72.41 109.399 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.4 p -88.64 162.6 16.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.116 0.566 . . . . 74.31 110.478 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -160.6 92.15 0.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.335 1.054 . . . . 73.54 108.218 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.95 9.95 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.609 -0.55 . . . . 71.3 111.827 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -91.76 -10.88 38.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 74.21 111.224 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.2 m -101.6 140.54 35.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.571 0.749 . . . . 72.41 110.605 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 94' ' ' PHE . 2.9 p -121.76 116.67 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.561 0.696 . . . . 70.13 110.142 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -96.26 108.4 20.88 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.448 1.099 . . . . 73.23 109.154 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 64' ' ' VAL . 59.2 t -88.52 107.12 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.667 -0.864 . . . . 75.21 108.667 177.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -95.89 105.25 17.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.96 -1.126 . . . . 70.21 107.96 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.52 125.49 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.517 0.727 . . . . 75.43 110.45 -170.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.7 123.66 31.34 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.257 0.623 . . . . 73.4 110.061 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.15 122.41 37.0 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.285 -1.006 . . . . 72.2 108.285 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.3 116.73 27.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.293 0.568 . . . . 74.23 109.78 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.89 105.0 17.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.154 0.982 . . . . 72.41 111.416 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -90.78 103.13 15.87 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.651 1.181 . . . . 63.12 108.744 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.0 t -138.53 137.22 36.87 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.34 0.656 . . . . 64.44 109.557 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.77 22.12 67.95 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.918 -0.583 . . . . 60.24 113.018 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.9 -33.72 5.06 Favored Glycine 0 C--N 1.354 1.569 0 C-N-CA 122.848 0.261 . . . . 63.33 112.988 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -84.57 135.6 34.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.532 0.733 . . . . 75.11 111.486 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -107.88 145.95 33.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.706 0.802 . . . . 71.15 110.034 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.8 m -143.63 123.87 13.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.489 0.715 . . . . 74.13 109.082 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.97 102.13 6.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.077 -0.712 . . . . 73.03 109.077 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.9 m -107.68 131.63 54.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.967 0.907 . . . . 72.23 110.118 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -95.47 120.14 35.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.311 0.644 . . . . 63.45 109.435 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -102.9 126.37 50.03 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.989 0.915 . . . . 72.34 108.822 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.53 104.27 13.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.723 -0.843 . . . . 73.33 108.723 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 12' ' ' ALA . 5.7 mp -91.83 107.38 19.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.285 -1.006 . . . . 74.24 108.285 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -91.74 97.43 11.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.481 -0.781 . . . . 71.41 109.583 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.549 ' HB2' HG11 ' A' ' 71' ' ' VAL . 97.5 m-85 -91.14 117.4 29.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.517 0.727 . . . . 74.45 110.16 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 28.3 tt0 -101.48 121.19 41.5 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.682 -0.858 . . . . 74.24 108.682 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 101' ' ' ILE . 10.0 m -86.37 140.17 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.913 -0.403 . . . . 74.53 109.913 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -134.56 117.45 16.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.237 -1.394 . . . . 63.01 107.237 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -114.32 3.99 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.691 -0.964 . . . . 71.22 110.691 -168.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -113.95 -19.15 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.236 0.614 . . . . 75.24 112.097 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -112.14 161.86 16.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.227 0.611 . . . . 73.35 110.675 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 96' ' ' VAL . 52.4 mt -82.31 128.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.797 -0.816 . . . . 72.14 108.797 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -114.56 -14.52 12.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.409 0.684 . . . . 74.35 112.32 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 9.8 tpt180 -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.474 0.309 . . . . 75.0 110.505 -172.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.82 139.95 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.986 0.914 . . . . 64.34 109.162 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -134.62 104.62 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.581 -0.896 . . . . 74.43 108.581 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.72 132.02 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.014 0.526 . . . . 72.52 109.722 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.4 m -120.47 116.22 25.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.652 0.781 . . . . 64.34 109.212 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -80.3 105.26 11.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.774 0.83 . . . . 73.2 109.467 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 124.441 1.096 . . . . 73.33 110.566 -175.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 109.713 -0.477 . . . . 74.3 109.713 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 HG13 ' A' ' 96' ' ' VAL . 34.3 mm -64.33 -43.65 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.423 1.089 . . . . 71.44 112.84 -169.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.5 -52.43 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.563 0.745 . . . . 74.12 109.554 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -69.93 -26.48 64.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.053 -1.43 . . . . 75.24 111.583 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.81 -57.39 8.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.619 0.767 . . . . 74.11 109.667 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.31 76.75 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.28 0.988 . . . . 74.22 111.883 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.75 -58.8 7.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.953 0.901 . . . . 65.24 110.694 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -69.82 -22.26 63.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.709 0.804 . . . . 75.31 111.67 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.3 -45.38 69.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.039 0.935 . . . . 71.01 110.571 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.521 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.18 -46.72 87.66 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.294 0.996 . . . . 74.45 110.672 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.592 HG12 HG21 ' A' ' 62' ' ' VAL . 41.7 mt -61.39 -42.31 93.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 O-C-N 124.404 1.065 . . . . 73.4 110.165 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.87 68.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.165 0.986 . . . . 72.54 112.62 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.5 mt -63.21 -42.52 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.595 0.758 . . . . 70.04 109.826 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 92' ' ' LEU . 30.4 m-85 -69.96 -37.27 75.77 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.728 -0.669 . . . . 74.31 111.547 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -61.67 -38.49 87.94 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.759 0.662 . . . . 75.12 110.909 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 44' ' ' ARG . 75.6 mt -70.0 -40.45 75.28 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.582 0.552 . . . . 75.33 110.487 174.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.477 ' HB3' HD13 ' A' ' 50' ' ' LEU . 39.5 m0 -64.87 -31.03 72.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 112.906 0.706 . . . . 74.42 112.906 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -98.52 -20.69 16.92 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.045 0.538 . . . . 74.14 111.537 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -156.27 85.14 3.17 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 123.786 0.835 . . . . 72.41 108.808 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.84 -19.87 69.8 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.45 2.1 . . . . 70.12 113.289 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -81.04 2.41 27.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.689 0.796 . . . . 75.3 112.635 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.86 111.48 6.5 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 122.878 0.471 . . . . 73.05 109.764 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.7 -31.58 8.4 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.347 2.032 . . . . 73.22 112.733 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.12 -39.42 65.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.343 0.657 . . . . 74.41 110.958 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -56.4 18.75 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 124.118 0.967 . . . . 74.12 110.937 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.44 -32.61 74.32 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.779 -0.646 . . . . 71.13 111.306 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.09 -56.71 16.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.515 0.726 . . . . 74.45 111.296 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -62.82 -31.73 72.78 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 123.759 0.662 . . . . 74.32 110.606 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -66.95 -26.03 66.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.552 0.741 . . . . 73.14 112.073 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.854 0.752 . . . . 72.24 110.516 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.77 -16.03 31.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.028 0.931 . . . . 74.3 111.501 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 30' ' ' LEU . 16.2 pt -124.56 -45.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.405 0.52 . . . . 70.54 112.405 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 39' ' ' VAL . 3.8 mm? -95.15 172.46 8.11 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.037 0.935 . . . . 73.41 109.26 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB2' HG23 ' A' ' 39' ' ' VAL . 21.0 m -83.25 143.52 45.28 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.464 -0.789 . . . . 71.13 110.041 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.71 -31.88 52.62 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.046 3.164 . . . . 72.44 114.049 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.34 -48.03 77.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.779 0.832 . . . . 75.04 111.619 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 35' ' ' LEU . 42.2 t -63.19 -39.48 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 72.24 111.516 -171.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.07 -27.57 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.472 0.177 . . . . 74.51 111.064 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 17.5 t70 -73.68 -44.81 55.62 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.71 0.631 . . . . 75.05 110.405 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.88 -32.71 74.03 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.593 0.357 . . . . 75.42 110.892 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.52 -51.56 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 74.3 111.263 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 18' ' ' LEU . 3.3 ptm180 -69.29 -17.27 63.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.058 0.543 . . . . 73.14 111.914 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 51.3 mt-10 -84.26 -35.26 23.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.433 0.693 . . . . 75.22 111.511 171.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -73.34 -17.76 61.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.476 0.711 . . . . 74.43 110.801 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.79 67.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.595 1.158 . . . . 74.24 111.673 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -56.1 -34.82 66.39 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 124.348 1.03 . . . . 72.4 111.507 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -65.19 -55.04 20.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.969 0.507 . . . . 73.35 111.04 -175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 19' ' ' TRP . 88.4 mt -71.39 -34.39 70.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.255 0.622 . . . . 75.34 111.35 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.46 -45.63 68.59 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.725 0.81 . . . . 74.11 111.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.01 -40.79 97.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.116 0.967 . . . . 65.03 111.134 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -75.72 -19.72 58.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.735 -0.666 . . . . 73.31 111.938 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.43 28.76 57.15 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.293 0.371 . . . . 51.02 113.44 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.62 104.97 9.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.602 0.761 . . . . 75.34 109.76 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -82.66 111.25 18.44 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.645 -0.872 . . . . 73.44 108.645 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 43.4 p90 -108.53 144.77 35.75 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.487 -1.301 . . . . 74.13 107.487 168.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -121.56 121.02 36.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.995 -0.743 . . . . 64.41 108.995 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.27 100.44 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.753 -0.832 . . . . 73.5 108.753 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -86.45 -45.19 11.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.824 0.849 . . . . 65.55 111.504 -171.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -144.87 142.29 29.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.265 -0.643 . . . . 74.41 109.265 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.592 HG21 HG12 ' A' ' 13' ' ' ILE . 93.1 t -125.18 128.73 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.264 -1.013 . . . . 72.31 108.264 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.2 123.73 40.91 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.933 -1.136 . . . . 64.14 107.933 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.31 126.42 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 109.467 -0.568 . . . . 74.14 109.467 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.7 m -132.56 122.3 24.59 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.554 0.742 . . . . 73.2 109.544 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -88.57 121.52 31.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.449 0.7 . . . . 61.42 109.983 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -125.96 89.28 3.0 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.176 0.991 . . . . 73.31 108.337 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.81 -121.46 7.85 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.022 -0.831 . . . . 44.42 111.022 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -98.54 -9.94 24.21 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.127 0.571 . . . . 74.52 110.294 170.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.6 m -96.49 111.16 23.37 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.334 0.654 . . . . 75.45 109.698 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.07 109.31 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.247 0.546 . . . . 71.51 110.225 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.471 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -84.22 103.93 13.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.601 1.16 . . . . 73.22 108.616 177.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.94 105.34 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.121 0.486 . . . . 73.32 109.85 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.407 ' HG1' ' HG3' ' A' ' 91' ' ' GLU . 17.1 m -86.04 105.13 16.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.28 1.032 . . . . 71.22 109.691 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.75 123.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.721 0.809 . . . . 72.4 109.878 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -85.61 117.68 24.66 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.282 0.633 . . . . 73.23 109.304 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.68 163.06 13.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.783 -0.821 . . . . 73.41 108.783 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -136.52 102.55 4.98 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.938 -1.504 . . . . 72.33 106.938 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.2 mt-10 -94.14 106.51 18.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.963 0.905 . . . . 75.41 110.46 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -93.92 106.41 18.39 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.737 0.815 . . . . 74.14 109.173 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -132.95 132.48 42.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.805 0.842 . . . . 75.24 109.621 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.16 13.26 61.9 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.089 0.396 . . . . 74.24 114.089 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.07 -32.97 6.83 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.78 -0.455 . . . . 72.43 112.881 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -84.09 150.18 25.73 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.216 0.508 . . . . 75.31 110.862 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.9 m -118.28 134.02 55.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.881 0.872 . . . . 63.34 109.959 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 m -138.52 122.11 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.475 1.11 . . . . 72.23 109.257 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -76.6 119.65 20.71 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.097 -0.705 . . . . 73.32 109.097 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.9 m -129.86 123.26 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.88 0.872 . . . . 72.3 109.5 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.0 m -87.67 128.86 35.29 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.534 -0.543 . . . . 75.22 109.534 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -109.75 125.38 52.63 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.32 -1.363 . . . . 73.43 107.32 168.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HG3' ' HG1' ' A' ' 74' ' ' THR . 2.9 tt0 -106.57 104.69 14.44 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.061 -1.088 . . . . 72.25 108.061 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 12' ' ' ALA . 4.3 mp -90.88 105.29 17.73 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.565 -1.272 . . . . 73.43 107.565 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -93.71 99.13 11.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.883 0.873 . . . . 74.43 108.846 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.96 108.16 19.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.189 0.996 . . . . 74.25 110.136 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 29.2 tt0 -90.92 113.99 26.35 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.902 -0.777 . . . . 61.22 108.902 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.592 HG12 HG12 ' A' ' 101' ' ' ILE . 4.1 m -83.48 148.82 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.095 -0.705 . . . . 65.22 109.095 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -141.97 96.53 2.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.117 -1.068 . . . . 74.2 108.117 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 -124.07 6.7 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.402 -0.679 . . . . 73.43 111.402 -173.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -89.87 -21.31 22.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.491 0.717 . . . . 74.3 111.689 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -121.87 157.59 30.82 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.33 0.652 . . . . 75.53 110.795 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.592 HG12 HG12 ' A' ' 96' ' ' VAL . 28.6 mt -90.55 115.47 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 75.21 108.689 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HD3' ' OG ' ' A' ' 36' ' ' SER . 28.6 mmt180 -89.35 -28.21 19.96 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.534 0.734 . . . . 75.44 111.104 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 29.5 mtt180 -130.85 135.9 48.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.929 0.492 . . . . 75.52 110.948 -163.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.95 142.94 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.263 1.025 . . . . 73.15 109.01 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -127.8 105.43 8.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.254 -1.017 . . . . 75.21 108.254 172.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.35 104.17 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.896 -1.15 . . . . 75.32 107.896 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -104.36 104.51 14.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.894 0.477 . . . . 52.35 109.952 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.76 98.48 2.41 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.542 -0.91 . . . . 74.41 108.542 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 62.32 112.037 -174.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.147 -0.316 . . . . 74.14 110.147 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -74.67 -31.67 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.846 0.859 . . . . 71.11 112.096 -174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -59.05 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.423 0.689 . . . . 73.45 110.754 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.31 -19.1 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.294 -0.412 . . . . 73.02 111.099 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -48.15 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.271 -0.64 . . . . 75.12 109.271 170.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.24 78.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.08 -0.964 . . . . 71.52 112.066 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.64 -53.25 57.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.681 0.792 . . . . 74.42 110.829 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.37 -30.55 70.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 75.51 111.053 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -61.88 -51.18 69.22 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 123.801 0.688 . . . . 74.35 110.693 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.51 57.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 124.068 0.855 . . . . 61.03 110.91 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.0 mt -57.61 -43.03 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.089 0.956 . . . . 74.54 110.987 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.43 72.9 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.253 0.621 . . . . 75.12 112.229 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.26 -40.91 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.843 0.857 . . . . 74.21 109.896 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 66.3 m-85 -79.55 -25.65 41.6 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.851 0.46 . . . . 75.45 112.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -67.85 -34.65 77.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.134 0.573 . . . . 73.32 109.858 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.3 mt -74.59 -46.02 41.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.005 -0.543 . . . . 72.33 110.179 172.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.0 m0 -61.48 -17.96 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.865 0.691 . . . . 73.21 112.865 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -102.4 -24.56 13.84 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 122.904 0.482 . . . . 74.51 111.599 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 24' ' ' ASP . 8.1 t30 -157.55 87.36 2.59 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.724 0.81 . . . . 74.44 109.693 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.54 -17.56 53.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.226 2.617 . . . . 73.34 113.348 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -79.69 -4.39 51.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.823 0.849 . . . . 65.14 112.693 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 21' ' ' ASN . 12.4 t70 -71.48 120.42 79.72 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 109.475 -0.565 . . . . 73.44 109.475 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.98 -30.39 7.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.234 1.956 . . . . 64.31 113.301 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.05 -26.31 27.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.198 0.599 . . . . 75.22 112.305 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.91 -48.01 55.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.36 0.664 . . . . 71.32 109.483 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.16 -27.36 63.49 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.73 -0.668 . . . . 71.41 111.895 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.27 -55.31 36.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.791 0.837 . . . . 74.52 111.733 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.547 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 4.1 pp -64.13 -28.18 69.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.929 0.768 . . . . 71.1 111.282 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.56 -28.29 67.66 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.923 0.889 . . . . 71.24 112.258 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -65.88 -37.99 87.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.327 0.584 . . . . 75.34 110.517 173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 50.0 mtpt -77.02 -39.35 50.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.686 -1.143 . . . . 71.43 111.281 -170.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 35' ' ' LEU . 16.2 pt -102.41 -32.77 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.365 0.666 . . . . 74.22 112.325 -171.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 34' ' ' ILE . 75.3 mt -116.34 -179.36 3.65 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.897 0.879 . . . . 75.41 110.453 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -74.27 152.85 88.18 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 115.349 -0.841 . . . . 75.32 111.371 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.76 -30.65 93.2 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.022 2.482 . . . . 74.25 112.588 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.1 -38.16 78.88 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.967 1.307 . . . . 55.34 112.49 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.492 HG11 HD11 ' A' ' 35' ' ' LEU . 57.5 t -68.24 -56.15 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.489 -0.778 . . . . 71.01 110.163 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -25.55 67.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.53 0.332 . . . . 72.52 111.528 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.55 -49.28 66.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.068 . . . . 71.42 110.488 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -73.06 -32.25 64.92 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.208 -0.451 . . . . 75.35 111.366 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.17 -47.48 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.067 0.947 . . . . 53.23 111.2 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -70.74 -23.31 62.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.153 0.427 . . . . 72.12 112.153 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.81 -51.51 12.43 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.435 0.694 . . . . 71.42 110.504 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 83.0 t60 -63.22 -27.25 69.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.019 -0.991 . . . . 73.41 110.836 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -61.87 -45.67 92.77 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.747 1.219 . . . . 74.35 111.495 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 96.5 mtt180 -61.51 -38.43 87.35 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.816 -1.084 . . . . 72.42 110.581 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.31 -46.76 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.147 0.579 . . . . 64.0 111.607 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 71.5 mt -64.03 -35.42 80.66 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.354 0.662 . . . . 73.24 110.479 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -62.56 -46.3 89.01 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.226 -0.897 . . . . 74.23 110.695 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 7.6 mtpm? -62.17 -41.03 97.93 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.331 0.652 . . . . 74.0 110.769 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -75.43 -19.76 59.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.3 -0.864 . . . . 74.31 111.4 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.25 38.14 19.22 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.188 0.305 . . . . 63.44 112.963 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.2 mt -90.55 89.56 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.06 0.944 . . . . 74.43 108.453 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -92.84 111.54 23.18 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 53.7 p90 -134.69 152.35 51.7 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.864 0.465 . . . . 75.3 110.327 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.79 142.06 51.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.173 0.589 . . . . 75.42 109.577 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.69 110.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.801 1.241 . . . . 73.14 109.077 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.56 -29.38 12.74 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.743 0.417 . . . . 72.21 112.022 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.03 131.72 33.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.198 0.599 . . . . 75.31 109.806 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.63 117.3 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.262 -1.014 . . . . 74.21 108.262 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.4 108.01 8.89 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.782 -0.821 . . . . 74.42 108.782 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.07 115.54 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.158 0.583 . . . . 71.03 109.557 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -130.19 128.3 41.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.78 0.832 . . . . 74.31 108.831 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -88.07 144.66 26.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.14 0.576 . . . . 70.43 109.642 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -131.9 90.09 2.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.517 -1.29 . . . . 72.13 107.517 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.93 -122.4 19.25 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.013 -0.994 . . . . 54.42 111.231 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -91.45 -7.73 49.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.506 0.723 . . . . 75.44 111.858 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.1 m -111.43 115.81 29.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.02 0.528 . . . . 74.42 109.835 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -92.74 131.02 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.599 0.76 . . . . 73.11 111.121 -175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -103.79 110.47 22.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.993 1.317 . . . . 74.21 109.448 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.11 104.53 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.67 -0.863 . . . . 75.35 108.67 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -86.68 105.42 16.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.263 -1.014 . . . . 74.52 108.263 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 16' ' ' PHE . 7.6 p -114.59 134.55 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.327 1.051 . . . . 72.41 108.603 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.4 123.78 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.774 -0.824 . . . . 72.34 108.774 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.82 161.78 24.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.082 0.953 . . . . 73.5 109.865 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.0 10.95 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 27.6 mt-10 -87.25 104.13 16.09 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.685 0.794 . . . . 63.23 110.685 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -89.17 102.99 15.64 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.498 -0.927 . . . . 73.11 108.498 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -141.54 136.45 31.15 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.314 1.046 . . . . 64.21 109.14 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.64 12.26 80.53 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.817 -0.629 . . . . 53.14 111.968 -170.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.22 -22.89 27.24 Favored Glycine 0 C--N 1.356 1.64 0 C-N-CA 123.496 0.569 . . . . 61.22 112.914 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 p -94.11 134.51 36.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.811 0.844 . . . . 65.42 111.269 -175.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.6 m -87.99 124.17 33.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.163 0.985 . . . . 74.22 110.118 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -120.97 116.42 25.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.456 1.102 . . . . 73.2 108.821 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -78.28 116.85 19.01 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.203 -0.665 . . . . 72.23 109.203 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -131.63 134.69 46.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.709 1.204 . . . . 74.33 109.883 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 m -97.67 145.6 26.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.273 0.629 . . . . 73.33 109.774 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -126.89 128.48 46.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.672 1.189 . . . . 73.51 108.007 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.95 104.25 16.26 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 71.35 108.252 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.19 106.04 18.23 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.226 -1.398 . . . . 64.33 107.226 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -102.1 97.91 8.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.678 0.791 . . . . 74.11 109.206 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 101' ' ' ILE . 90.8 m-85 -89.25 111.29 22.06 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.853 0.861 . . . . 74.31 109.899 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 38.5 tt0 -96.01 132.58 41.21 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.224 -0.658 . . . . 72.13 109.224 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.75 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.813 0.845 . . . . 74.34 111.343 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 102' ' ' ARG . 31.4 t70 -132.15 101.4 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.335 -1.358 . . . . 73.52 107.335 171.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.98 -99.42 0.94 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.328 -0.709 . . . . 75.2 111.328 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.17 -17.51 8.9 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.563 0.745 . . . . 74.33 111.123 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.0 m -113.91 133.96 55.12 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.24 0.616 . . . . 74.41 110.266 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 94' ' ' PHE . 74.2 mt -73.6 116.83 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.784 0.834 . . . . 75.32 109.12 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 97' ' ' ASP . 32.0 mmt180 -105.72 -7.68 18.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.242 0.617 . . . . 73.42 111.369 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.9 ttt180 -136.0 139.07 42.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.766 0.426 . . . . 75.34 110.658 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.27 130.69 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.219 1.008 . . . . 75.12 109.187 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.7 m -110.34 104.52 13.32 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.044 -1.095 . . . . 75.31 108.044 172.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.91 104.61 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.249 -1.019 . . . . 73.31 108.249 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 m -103.84 112.92 26.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.361 0.664 . . . . 74.52 109.617 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -74.13 103.43 4.57 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.808 -1.182 . . . . 72.41 107.808 171.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.242 0.66 0 C-N-CA 123.846 0.859 . . . . 65.34 110.832 -177.229 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.156 0.503 . . . . 62.02 109.646 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 96' ' ' VAL . 47.4 mm -74.51 -22.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.263 1.025 . . . . 75.4 111.709 -172.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.31 -55.84 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.466 -0.568 . . . . 72.31 109.466 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.97 -32.56 65.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.061 -0.972 . . . . 73.21 111.884 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.73 -52.33 63.67 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.529 0.518 . . . . 72.24 110.404 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.72 67.49 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.549 0.74 . . . . 74.12 111.839 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.67 -55.68 21.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.396 0.678 . . . . 73.13 110.45 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -63.91 -32.59 74.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.864 0.866 . . . . 74.3 111.239 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.39 86.26 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 124.014 0.821 . . . . 71.33 111.143 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.77 92.47 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.97 0.793 . . . . 45.43 111.179 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 69.4 mt -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 124.291 0.994 . . . . 74.33 109.692 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.91 -29.99 71.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.041 0.936 . . . . 74.15 112.432 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.93 -41.15 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.538 0.735 . . . . 72.14 109.81 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -72.4 -35.21 68.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.73 0.412 . . . . 74.42 111.332 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 20.3 mm-40 -61.31 -37.43 83.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.868 0.73 . . . . 74.31 110.15 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.45 -45.13 32.69 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 123.634 0.584 . . . . 73.42 110.926 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -54.21 -31.62 53.61 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.387 0.675 . . . . 74.54 112.731 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -101.89 -19.05 15.43 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.889 0.475 . . . . 74.34 112.103 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.401 HD21 ' HB2' ' A' ' 24' ' ' ASP . 4.8 t30 -150.66 81.91 6.32 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.254 -0.647 . . . . 72.1 109.254 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.43 -11.89 33.42 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.135 2.557 . . . . 72.33 112.948 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -80.94 -2.29 47.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.591 1.156 . . . . 72.14 112.687 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' HB2' HD21 ' A' ' 21' ' ' ASN . 9.3 t70 -76.31 107.68 4.96 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 119.183 -0.437 . . . . 75.22 110.09 -177.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -31.14 24.68 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.764 2.31 . . . . 75.4 113.359 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -77.64 -34.83 53.1 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.187 0.595 . . . . 75.34 111.592 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.95 -45.69 73.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.299 0.64 . . . . 65.1 110.401 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -75.36 -20.92 58.72 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.66 -0.7 . . . . 74.1 111.628 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.05 -51.35 39.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.356 0.662 . . . . 75.33 110.896 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.526 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.7 pp -65.67 -37.68 87.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.668 -0.493 . . . . 74.02 109.668 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.96 -28.59 69.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.488 0.715 . . . . 75.14 111.571 173.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.31 -24.32 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.932 0.493 . . . . 74.4 111.209 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -97.18 -24.68 15.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.047 0.939 . . . . 73.15 112.254 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 30' ' ' LEU . 8.2 pt -121.82 -26.58 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 112.898 0.703 . . . . 74.22 112.898 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.5 mm? -102.65 172.34 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.265 0.626 . . . . 71.33 110.389 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.5 m -79.31 143.79 60.93 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 114.854 -1.066 . . . . 72.25 110.238 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.71 -31.03 18.1 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.657 2.905 . . . . 64.23 114.632 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -66.56 -36.97 83.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.148 0.579 . . . . 75.32 111.382 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 93.5 t -67.51 -57.35 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.656 0.782 . . . . 75.32 110.696 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.89 -28.44 66.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.667 0.387 . . . . 75.32 111.301 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.98 -54.96 10.91 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 124.527 1.142 . . . . 74.21 110.559 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 1.1 pp0? -61.64 -25.92 67.67 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.308 0.243 . . . . 73.42 111.604 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.48 -53.08 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.7 0.8 . . . . 75.42 111.02 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -67.34 -22.49 65.59 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.025 0.38 . . . . 75.23 112.025 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -81.07 -45.26 16.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.853 0.461 . . . . 71.42 110.455 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.96 -26.01 68.39 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.396 0.678 . . . . 72.31 111.052 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.63 97.1 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.795 1.238 . . . . 75.42 112.333 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -65.8 -28.43 69.0 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.945 0.778 . . . . 73.54 111.439 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.84 -41.81 67.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.966 0.907 . . . . 73.33 110.867 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -76.81 -28.16 55.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.454 0.701 . . . . 73.0 110.989 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.85 -35.17 67.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.462 1.105 . . . . 74.32 110.422 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.62 -40.91 98.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 75.23 109.785 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -84.87 178.01 7.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.167 -0.924 . . . . 71.04 110.643 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.24 33.42 6.59 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.699 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.96 89.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 109.127 -0.694 . . . . 73.1 109.127 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -83.3 136.31 34.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.829 -1.078 . . . . 74.25 108.177 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 140.3 24.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.503 -0.555 . . . . 71.42 109.503 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.13 130.96 39.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.227 1.011 . . . . 72.41 109.618 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.49 102.34 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 74.5 109.686 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -84.27 -35.19 23.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.654 0.782 . . . . 74.14 110.886 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 58.5 ttt180 -155.56 125.41 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.913 -0.773 . . . . 74.45 108.913 -173.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.92 125.94 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 74.33 109.856 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.03 125.36 24.83 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.518 1.127 . . . . 71.42 108.953 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.33 134.99 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.328 0.651 . . . . 75.4 110.687 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.6 m -145.67 130.67 18.28 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.084 0.954 . . . . 71.41 108.969 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 71' ' ' VAL . 71.8 p -88.31 149.17 23.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.6 0.36 . . . . 71.24 110.425 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -129.97 96.11 4.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.444 -1.317 . . . . 73.25 107.444 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.05 -102.08 0.95 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.992 -0.843 . . . . 72.02 110.992 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -115.49 -13.48 11.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.972 0.909 . . . . 73.45 110.373 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.9 m -97.15 119.33 35.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.606 0.763 . . . . 75.45 109.568 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 66' ' ' THR . 23.4 t -87.93 144.48 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.676 0.79 . . . . 73.4 110.456 -170.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -124.31 102.48 7.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.59 1.156 . . . . 73.14 108.903 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.13 103.21 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.079 -0.711 . . . . 72.23 109.079 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.3 m -89.53 112.38 23.54 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.322 1.049 . . . . 73.01 109.026 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.91 119.26 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.367 0.667 . . . . 75.12 110.771 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.5 tp10 -80.2 129.91 34.84 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.323 1.049 . . . . 75.21 109.143 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.1 142.01 51.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.236 0.614 . . . . 73.43 109.686 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.96 108.64 21.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.439 -1.319 . . . . 74.31 107.439 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -104.54 105.74 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.173 0.589 . . . . 75.31 111.162 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -93.25 111.24 22.83 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.783 -0.821 . . . . 71.12 108.783 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -134.99 123.6 23.57 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.176 0.99 . . . . 74.31 109.732 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.33 13.66 70.85 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.171 0.415 . . . . 71.11 113.491 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.13 -28.31 15.25 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 112.027 -0.429 . . . . 63.4 112.027 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.5 p -85.01 120.13 26.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.246 0.618 . . . . 74.11 110.615 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -94.31 142.04 27.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.522 0.729 . . . . 73.43 110.25 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.1 m -144.68 123.26 12.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.327 1.051 . . . . 75.42 109.326 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -77.93 109.67 12.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.907 -0.775 . . . . 71.24 108.907 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 m -114.78 122.12 45.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.415 1.086 . . . . 73.12 109.53 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 10.6 m -88.95 120.09 30.05 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -104.78 136.5 44.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.562 -0.903 . . . . 74.01 108.562 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -115.27 103.06 10.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.144 -1.058 . . . . 51.12 108.144 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 106' ' ' VAL . 6.1 mp -87.71 104.39 16.5 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.249 -1.389 . . . . 74.3 107.249 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -96.66 108.0 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.359 -0.837 . . . . 74.24 109.35 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -88.82 109.09 19.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.692 0.797 . . . . 75.41 110.293 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.54 114.71 26.99 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.818 0.847 . . . . 65.4 109.268 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG23 ' A' ' 4' ' ' ILE . 3.9 m -100.58 149.62 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.694 0.798 . . . . 64.25 110.275 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.72 119.36 16.04 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.73 -1.211 . . . . 71.41 107.73 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.54 -100.58 1.82 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.946 -0.462 . . . . 71.11 111.946 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.93 -21.78 5.43 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.094 0.558 . . . . 73.54 112.165 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -114.04 158.65 20.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.058 0.456 . . . . 73.2 110.989 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 35' ' ' LEU . 16.6 mt -84.55 125.19 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.038 -0.983 . . . . 73.1 108.878 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -96.11 -43.18 7.87 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.268 0.627 . . . . 74.35 111.264 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -132.77 160.93 35.42 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.714 0.806 . . . . 74.42 110.591 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.48 120.14 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.394 -0.965 . . . . 62.44 108.394 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.7 m -100.68 104.83 16.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.259 -1.015 . . . . 74.53 108.259 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.448 HG21 ' HG ' ' A' ' 92' ' ' LEU . 46.5 t -87.29 103.99 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.631 -0.878 . . . . 72.44 108.631 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -94.5 106.38 18.36 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.593 0.757 . . . . 64.5 109.453 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -82.06 97.45 8.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.493 -0.776 . . . . 74.13 109.9 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.434 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.3 m-80 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 107.53 -1.285 . . . . 75.24 107.53 170.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.701 -0.481 . . . . 71.52 109.701 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.27 -32.87 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.578 1.151 . . . . 71.31 112.017 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.44 -51.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.236 0.614 . . . . 65.14 109.769 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -28.33 65.44 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.447 -0.797 . . . . 64.42 111.129 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -59.04 -48.75 80.47 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.933 0.397 . . . . 73.44 110.208 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.79 83.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.543 -0.753 . . . . 71.05 111.728 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.79 -52.25 64.97 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.581 0.752 . . . . 73.44 111.475 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.55 -37.1 82.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 73.13 110.665 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.93 80.95 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.405 -1.27 . . . . 73.03 111.498 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.56 82.22 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.911 0.757 . . . . 71.03 111.891 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.85 -40.05 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.939 -1.028 . . . . 75.44 110.204 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.03 72.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.791 0.836 . . . . 64.11 112.852 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.5 mt -63.1 -40.3 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.531 0.732 . . . . 75.23 110.028 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -71.14 -33.54 70.17 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.143 0.577 . . . . 74.24 111.521 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -62.07 -40.98 97.64 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.857 0.863 . . . . 72.44 110.997 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.23 -37.52 66.37 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.972 -0.558 . . . . 75.34 110.863 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -63.13 -32.85 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.45 0.537 . . . . 74.42 112.45 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.57 -23.31 22.01 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.394 0.278 . . . . 73.41 111.234 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.14 88.27 2.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.477 0.711 . . . . 74.43 109.242 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.19 -22.53 70.59 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.337 2.691 . . . . 73.35 114.312 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -88.46 11.23 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.578 0.751 . . . . 64.43 112.722 -174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.97 114.14 26.37 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.89 -32.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.551 2.167 . . . . 73.33 113.354 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.76 -40.26 55.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.212 0.605 . . . . 65.35 111.387 -171.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.99 67.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.727 0.811 . . . . 71.23 110.993 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.19 -26.25 63.81 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.533 -0.758 . . . . 73.2 111.864 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.21 -43.17 71.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 74.53 111.323 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.3 pp -71.08 -35.4 71.84 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.583 -0.525 . . . . 72.13 109.583 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.93 -22.34 66.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.75 0.82 . . . . 74.51 112.112 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -73.46 -30.62 63.3 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.278 0.631 . . . . 64.14 110.96 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.53 -46.28 9.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.33 -0.85 . . . . 75.22 111.538 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.7 pt -101.88 -28.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 116.092 -0.504 . . . . 73.24 111.513 -169.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.491 HD13 HG22 ' A' ' 39' ' ' VAL . 3.4 mm? -108.9 -173.94 2.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.384 1.074 . . . . 71.42 109.378 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.0 m -77.77 149.15 77.14 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 122.915 0.486 . . . . 72.42 111.091 176.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.79 -25.75 81.73 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.488 2.125 . . . . 73.11 111.804 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.83 -43.64 95.59 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.222 -1.354 . . . . 74.44 110.805 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.9 t -64.39 -52.51 54.53 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 123.531 0.732 . . . . 75.21 111.131 -175.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.22 -35.86 74.38 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 120.829 0.347 . . . . 72.43 111.528 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.88 -43.49 68.3 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.216 1.006 . . . . 74.23 111.431 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -74.25 -27.31 60.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.221 0.209 . . . . 71.23 110.952 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 t -72.62 -41.76 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.028 0.531 . . . . 75.34 110.564 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -21.49 61.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.65 0.205 . . . . 75.31 111.537 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.45 -49.26 12.58 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.922 0.392 . . . . 74.12 110.077 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.7 -24.04 67.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.98 0.912 . . . . 75.21 110.63 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.25 76.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.109 1.364 . . . . 74.32 112.471 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -61.68 -22.94 65.75 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.218 -0.901 . . . . 74.42 112.625 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.38 -46.46 66.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.583 0.753 . . . . 73.24 110.581 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.35 -31.77 60.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.819 0.848 . . . . 73.12 111.347 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.25 -39.01 78.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 73.12 110.166 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -59.74 -43.3 94.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.586 0.754 . . . . 73.32 110.266 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -75.71 -29.63 59.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.073 -0.967 . . . . 73.33 111.4 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.31 35.52 76.76 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.456 0.472 . . . . 63.11 113.427 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.35 107.9 12.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.704 -0.851 . . . . 74.45 108.704 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -84.13 111.14 19.07 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 108.728 -0.842 . . . . 74.24 108.728 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.474 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 15.5 p90 -110.37 142.67 41.72 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.009 -1.478 . . . . 72.44 107.009 168.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -134.42 126.94 30.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.152 0.283 . . . . 53.34 110.252 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.23 134.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.116 0.966 . . . . 74.34 110.047 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -117.12 -54.31 2.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.526 1.13 . . . . 74.43 109.522 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -140.78 123.72 16.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 114.658 -1.155 . . . . 72.41 108.673 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.27 124.04 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.139 -1.06 . . . . 74.44 108.139 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.08 107.6 9.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.515 HG21 HG23 ' A' ' 73' ' ' VAL . 14.7 p -99.0 140.16 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.722 0.409 . . . . 74.01 110.14 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -144.27 170.74 15.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.749 0.82 . . . . 64.24 109.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.425 HG23 HG21 ' A' ' 71' ' ' VAL . 40.1 p -126.66 149.72 49.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.209 0.604 . . . . 74.05 110.756 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -135.95 95.6 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.46 -1.311 . . . . 70.0 107.46 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.91 -101.34 1.1 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.207 -1.157 . . . . 54.0 110.207 -166.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -119.02 -7.67 10.34 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.777 0.831 . . . . 74.44 110.594 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 95' ' ' GLU . 22.1 m -87.88 114.79 24.84 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.24 -0.652 . . . . 75.53 109.24 -174.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 66' ' ' THR . 24.3 t -87.03 132.24 32.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 115.674 -0.693 . . . . 74.34 109.422 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -118.79 117.52 29.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.192 0.997 . . . . 71.21 108.634 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.515 HG23 HG21 ' A' ' 64' ' ' VAL . 46.3 t -100.35 103.18 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 73.14 109.647 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.9 m -90.65 105.42 17.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.679 -0.859 . . . . 72.24 108.679 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.54 126.51 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.679 0.792 . . . . 72.31 110.694 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.03 120.48 23.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.179 0.991 . . . . 73.05 109.783 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.39 119.1 35.14 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.374 -0.972 . . . . 75.13 108.374 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -88.46 103.41 15.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.211 -1.033 . . . . 74.22 108.211 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 30.3 mt-10 -88.2 126.06 34.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.32 1.048 . . . . 74.33 110.067 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.499 ' HG1' HG22 ' A' ' 85' ' ' THR . 25.3 m -115.64 107.72 15.48 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.218 -1.03 . . . . 73.44 108.218 173.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -147.51 138.14 23.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.908 0.883 . . . . 75.33 109.351 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.94 12.24 64.66 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.368 0.418 . . . . 24.53 113.846 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.94 -32.9 6.56 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 117.127 0.464 . . . . 74.44 112.421 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -84.09 144.78 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.482 0.713 . . . . 73.31 111.688 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.499 HG22 ' HG1' ' A' ' 80' ' ' THR . 23.4 m -121.47 129.98 53.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.014 0.926 . . . . 73.54 110.603 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.3 m -143.54 133.12 23.61 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.724 0.809 . . . . 53.42 110.1 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -81.25 101.52 9.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.386 -0.598 . . . . 74.23 109.386 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.1 m -101.54 122.44 43.83 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.198 0.999 . . . . 75.41 109.226 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -88.52 125.82 34.96 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.588 . . . . 65.42 109.414 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -104.65 126.08 51.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.765 -1.198 . . . . 74.4 107.765 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.22 103.59 12.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.145 -1.057 . . . . 75.45 108.145 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.98 110.48 22.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.893 -0.78 . . . . 73.15 108.893 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.41 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 59.7 ttp180 -88.89 99.76 12.65 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.94 -0.763 . . . . 74.01 108.94 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.534 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.9 m-85 -86.17 107.82 18.05 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.914 0.864 . . . . 75.44 108.687 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . 19.2 mt-10 -90.09 116.49 28.15 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.984 -1.462 . . . . 74.2 108.053 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 101' ' ' ILE . 11.3 m -85.45 144.92 8.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.358 -0.837 . . . . 72.53 110.907 -169.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.7 79.49 1.9 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.34 18.07 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.426 -0.806 . . . . 64.1 111.736 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -80.15 -4.87 54.74 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.95 0.722 . . . . 72.01 112.95 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.3 m -134.68 134.65 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.591 0.356 . . . . 73.23 110.217 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 94' ' ' PHE . 45.4 mt -77.46 132.02 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.169 -1.049 . . . . 74.35 108.169 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -119.4 -10.07 9.76 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.372 0.533 . . . . 75.1 111.617 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 14.4 mmt180 -130.02 150.4 51.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.224 0.61 . . . . 74.43 111.527 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.16 124.9 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.474 1.11 . . . . 72.02 109.466 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 87.7 m -111.92 105.07 13.4 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.651 0.78 . . . . 63.2 108.941 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.0 105.14 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.531 -0.914 . . . . 73.25 108.531 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.9 m -99.94 105.7 17.43 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.468 0.707 . . . . 75.44 109.384 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -84.03 123.63 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.65 -0.5 . . . . 74.05 109.65 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 123.384 0.673 . . . . 65.24 111.0 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 110.393 -0.225 . . . . 61.4 110.393 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.3 -39.82 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 126.061 1.745 . . . . 73.22 113.938 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 66' ' ' THR . 19.0 t -70.7 -54.24 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.021 0.529 . . . . 71.24 110.461 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 8.5 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.197 0.935 . . . . 73.0 111.021 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . . . -65.96 -47.43 74.65 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.232 -0.894 . . . . 72.34 110.716 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.8 78.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 72.21 111.572 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -64.75 -48.84 73.1 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.36 1.064 . . . . 74.44 110.85 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 23.1 mt-30 -67.68 -37.55 82.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.521 0.729 . . . . 73.11 110.352 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.25 97.01 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.03 0.932 . . . . 73.0 111.029 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.46 11.69 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.345 1.028 . . . . 74.43 110.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -60.33 -39.74 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 124.222 0.951 . . . . 72.3 110.597 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.18 93.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.975 0.91 . . . . 75.14 112.305 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.76 -45.8 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.881 0.873 . . . . 72.54 110.161 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.66 -34.46 75.75 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.985 0.514 . . . . 73.32 112.01 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.69 -38.07 89.76 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.551 0.532 . . . . 75.22 110.055 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.8 -38.49 76.66 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.754 0.659 . . . . 74.25 110.766 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -58.4 -36.78 74.08 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.52 0.728 . . . . 72.5 112.717 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -102.14 -16.28 16.43 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.863 0.465 . . . . 74.14 112.115 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.19 78.54 5.26 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.351 0.661 . . . . 71.31 109.354 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.54 -4.64 15.72 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.699 2.266 . . . . 74.24 112.733 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 p -77.2 -12.9 60.0 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.834 1.254 . . . . 74.35 112.062 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.78 113.12 19.91 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 122.622 0.369 . . . . 64.42 111.031 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.17 -18.11 18.64 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.845 2.363 . . . . 75.15 113.396 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.29 -44.89 24.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.152 0.581 . . . . 75.44 110.329 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.39 -50.1 74.95 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.114 -0.948 . . . . 64.1 110.841 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.411 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.4 pt20 -72.9 -23.61 60.73 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.673 -0.694 . . . . 62.42 112.129 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.19 -44.35 53.73 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.68 0.392 . . . . 75.44 111.319 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.21 -31.99 72.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.775 -0.454 . . . . 72.53 109.775 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 35' ' ' LEU . 97.7 mt -66.12 -29.36 69.65 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.814 0.845 . . . . 74.41 111.852 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.46 -31.95 71.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.709 0.804 . . . . 72.43 110.674 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -84.68 -43.27 14.5 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.282 -0.872 . . . . 72.4 111.137 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 8.8 pt -96.84 -37.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.96 0.504 . . . . 75.41 112.302 -168.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.434 HD11 HD21 ' A' ' 31' ' ' LEU . 73.6 mt -104.52 174.04 6.05 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.962 0.905 . . . . 74.01 108.912 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 102' ' ' ARG . 9.0 p -68.78 136.67 90.1 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.337 -0.616 . . . . 74.4 109.337 169.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.07 -22.64 19.57 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.143 2.562 . . . . 74.02 114.735 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -60.6 -40.4 91.68 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.193 0.997 . . . . 71.05 111.289 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.66 -54.56 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 72.33 111.268 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 28' ' ' GLN . 2.8 pp -64.06 -32.46 74.02 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.558 0.218 . . . . 74.13 111.05 -176.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.96 -34.03 75.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.14 0.976 . . . . 74.2 111.714 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -85.38 -36.56 20.64 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.801 0.44 . . . . 73.15 110.998 174.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.4 -39.88 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.458 0.703 . . . . 75.14 111.49 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -67.77 -21.93 65.23 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.335 0.654 . . . . 75.41 111.945 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -86.83 -44.8 11.44 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.059 0.943 . . . . 74.45 110.664 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -68.79 -24.39 64.41 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.224 0.609 . . . . 74.31 110.984 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.43 80.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.291 1.436 . . . . 75.22 111.557 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 97.2 mtt180 -62.25 -27.38 68.97 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.871 -1.513 . . . . 74.53 111.627 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.1 -40.49 74.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.146 0.578 . . . . 72.44 110.984 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.411 ' HA ' HE21 ' A' ' 53' ' ' GLN . 91.3 mt -74.92 -31.87 61.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.64 0.776 . . . . 71.1 110.738 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -65.38 -40.6 93.68 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.109 -0.951 . . . . 73.21 111.087 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 55.8 mttp -59.05 -40.87 86.42 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.437 0.695 . . . . 75.5 111.049 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 50' ' ' LEU . 46.1 mt-30 -72.3 -12.02 60.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.952 -1.022 . . . . 71.14 111.54 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.45 30.65 78.05 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.882 0.739 . . . . 75.14 113.336 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.3 mt -74.95 109.24 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.626 -0.879 . . . . 74.01 108.626 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -84.31 109.33 17.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 73.54 108.003 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.71 140.29 44.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.18 -0.674 . . . . 73.42 109.18 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -133.13 146.4 51.56 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.365 0.666 . . . . 74.23 109.775 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.32 116.03 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.724 1.265 . . . . 70.14 110.05 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -88.73 -54.92 3.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.518 0.675 . . . . 71.53 109.639 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tpm_? -139.08 127.06 22.32 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.847 -1.069 . . . . 74.14 109.13 -166.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.48 116.31 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.845 -1.169 . . . . 75.24 107.845 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.69 107.73 9.38 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.504 -0.925 . . . . 75.14 108.504 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -97.34 121.76 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.162 0.985 . . . . 74.31 109.89 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.6 m -130.23 127.79 40.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 73.35 108.563 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.476 HG21 HG22 ' A' ' 5' ' ' VAL . 32.8 p -88.4 154.44 20.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.229 0.612 . . . . 73.24 110.847 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -137.56 86.69 2.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.524 -1.287 . . . . 65.44 107.524 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.38 -101.08 0.79 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.857 -1.065 . . . . 52.42 111.918 -174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.74 -11.99 14.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.105 0.962 . . . . 72.1 111.319 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 HH11 ' A' ' 93' ' ' ARG . 44.8 m -100.98 118.95 38.0 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.618 -0.512 . . . . 62.44 109.618 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 66' ' ' THR . 46.1 t -87.5 140.91 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.808 0.843 . . . . 75.33 109.935 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -123.96 100.95 6.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.923 0.889 . . . . 75.11 108.742 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.98 106.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.449 0.7 . . . . 71.42 109.355 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -86.06 106.22 17.06 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.723 -0.843 . . . . 74.11 108.723 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.4 p -129.63 116.52 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.835 0.854 . . . . 73.12 110.602 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -97.08 139.96 32.3 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.238 1.015 . . . . 72.1 109.32 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -135.02 142.61 46.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.796 0.838 . . . . 74.42 109.085 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.0 105.8 17.85 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.269 1.033 . . . . 75.23 109.351 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.09 105.39 15.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.495 -0.775 . . . . 63.24 110.091 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.7 m -102.19 106.7 17.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.502 1.121 . . . . 74.24 108.331 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 t -148.38 140.34 23.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.111 0.965 . . . . 72.41 109.591 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.3 25.66 73.58 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.106 0.402 . . . . 75.03 114.106 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.9 83.51 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.897 -0.391 . . . . 63.45 114.026 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -116.91 139.05 51.1 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.43 0.615 . . . . 71.3 111.052 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.5 m -100.73 144.31 29.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.357 1.063 . . . . 72.32 109.522 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.4 m -143.92 114.54 7.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.78 0.832 . . . . 75.12 109.575 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.85 101.03 5.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.757 -0.831 . . . . 73.32 108.757 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.5 m -102.92 124.88 49.27 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.547 1.139 . . . . 65.41 110.098 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.9 m -94.05 116.9 29.38 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.316 0.646 . . . . 73.53 110.242 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.34 127.84 53.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.164 -1.05 . . . . 73.43 108.164 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -110.06 100.47 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.552 -1.277 . . . . 74.31 107.552 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.76 105.88 17.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.07 -1.085 . . . . 73.14 108.07 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.424 HH11 HG23 ' A' ' 70' ' ' THR . 59.1 ttp85 -91.35 99.02 12.06 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.547 -1.206 . . . . 75.45 107.989 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.2 m-85 -87.51 108.02 18.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.935 -0.765 . . . . 70.51 108.935 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 34.9 tt0 -98.16 133.15 42.99 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.442 -0.947 . . . . 73.12 108.442 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 25.6 m -84.06 142.66 13.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.166 0.508 . . . . 75.0 109.918 176.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.32 104.62 14.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.343 -1.725 . . . . 75.25 106.343 167.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.07 -100.68 1.51 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.399 -0.819 . . . . 33.15 111.293 -172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -123.88 -0.55 8.47 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.936 0.894 . . . . 60.01 112.54 -171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -139.71 150.03 44.36 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.514 0.725 . . . . 72.35 110.314 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 18.3 mt -75.52 119.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.054 0.542 . . . . 72.41 110.176 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 36' ' ' SER . 44.3 mmt-85 -131.18 14.98 5.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.042 0.937 . . . . 74.21 110.627 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 39.0 ttm105 -150.53 137.98 19.64 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 122.649 0.38 . . . . 75.53 110.114 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.96 119.7 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.271 1.028 . . . . 44.52 108.605 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 m -112.26 104.26 12.44 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.912 -1.144 . . . . 71.2 107.912 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.78 107.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.17 -0.678 . . . . 75.42 109.17 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 m -94.31 104.21 16.21 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.51 -0.922 . . . . 75.12 108.51 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -86.97 123.57 32.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.112 -1.07 . . . . 65.13 108.112 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 123.414 0.685 . . . . 70.05 111.108 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 110.192 -0.299 . . . . 73.11 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.544 HG22 HG12 ' A' ' 96' ' ' VAL . 44.5 mm -86.21 -52.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.806 1.242 . . . . 72.31 111.047 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.43 -40.93 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.835 0.854 . . . . 72.43 110.508 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.06 -56.21 23.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.157 . . . . 75.5 110.984 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.4 70.05 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.061 0.851 . . . . 72.04 111.432 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -48.28 42.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.585 0.754 . . . . 73.11 111.694 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.43 -46.32 70.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.431 -0.804 . . . . 75.21 111.093 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.94 -39.78 93.28 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.638 0.775 . . . . 72.33 110.559 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HB2' HD11 ' A' ' 35' ' ' LEU . . . -58.78 -50.44 73.93 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 123.807 0.692 . . . . 63.02 111.317 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -54.72 42.74 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 124.218 0.949 . . . . 72.35 112.167 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.05 -39.78 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.88 0.872 . . . . 73.21 110.943 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.98 70.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.526 0.73 . . . . 71.12 112.617 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' HG13 ' A' ' 43' ' ' VAL . 63.6 mt -61.73 -38.39 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.501 0.72 . . . . 74.54 110.28 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.05 -34.03 61.79 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.002 0.521 . . . . 74.55 111.254 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.07 -21.39 64.08 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.249 0.62 . . . . 74.33 111.38 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.13 -36.28 21.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.386 0.274 . . . . 71.34 110.59 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.602 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 41.0 m0 -63.46 -27.32 69.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.64 -27.5 21.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.099 0.56 . . . . 71.43 111.467 173.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -158.43 93.41 1.99 Allowed Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.398 0.679 . . . . 73.44 109.75 -177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -16.83 56.12 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.543 2.829 . . . . 71.5 113.857 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 p -97.04 11.71 35.18 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.908 0.883 . . . . 74.35 111.454 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.45 114.59 29.29 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 109.177 -0.675 . . . . 65.33 109.177 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.25 -33.24 11.62 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.411 2.074 . . . . 74.55 112.531 -168.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.86 -48.28 59.44 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.482 0.713 . . . . 71.53 111.114 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -58.76 -50.84 72.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.631 0.772 . . . . 73.33 111.587 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.51 -29.98 62.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.412 0.523 . . . . 72.1 112.412 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.44 -36.64 71.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.813 0.279 . . . . 75.55 111.313 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.5 pp -70.61 -34.53 72.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 75.22 109.602 175.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 85.6 mt -66.67 -22.51 66.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.751 0.821 . . . . 74.54 111.716 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.29 -29.87 61.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.964 0.506 . . . . 71.12 110.477 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.27 -42.84 9.11 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.769 0.828 . . . . 75.52 111.803 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 30' ' ' LEU . 19.8 pt -95.12 -21.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.843 0.457 . . . . 75.42 111.519 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 11' ' ' ALA . 44.3 mt -122.84 -176.63 3.45 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.933 -0.766 . . . . 74.51 108.933 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -75.97 148.08 81.25 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.319 0.648 . . . . 73.11 110.514 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.26 -20.27 46.47 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.97 2.447 . . . . 73.05 113.044 171.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.26 -40.05 89.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.398 1.079 . . . . 73.5 111.237 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG11 HD12 ' A' ' 35' ' ' LEU . 57.3 t -64.05 -51.45 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.798 0.439 . . . . 74.02 111.065 -173.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.64 -27.88 69.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.77 0.319 . . . . 72.02 111.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.81 -28.76 55.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.16 0.984 . . . . 73.34 112.252 -175.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 39' ' ' VAL . 29.3 pt20 -85.45 -33.06 21.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 110.088 -0.338 . . . . 65.11 110.088 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 15' ' ' ILE . 55.1 t -65.75 -41.95 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.834 0.854 . . . . 75.53 111.209 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -63.47 -22.61 66.98 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.037 0.535 . . . . 74.44 111.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -80.33 -48.41 13.02 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.549 0.74 . . . . 73.31 110.398 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.74 -19.85 64.36 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.046 0.939 . . . . 74.32 111.805 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -53.72 -56.72 14.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.554 1.142 . . . . 64.41 112.824 173.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -18.28 65.24 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.641 0.588 . . . . 74.44 112.379 -173.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.67 -51.94 50.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.721 -0.474 . . . . 70.41 109.721 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -78.4 -33.52 48.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.669 0.787 . . . . 73.33 110.954 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.43 -38.19 84.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.228 1.011 . . . . 75.32 111.091 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.53 -42.49 95.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.4 0.68 . . . . 73.51 110.221 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -65.79 -24.2 66.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.241 -0.89 . . . . 75.03 110.703 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.77 33.73 45.69 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.958 -0.564 . . . . 74.02 111.995 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 80' ' ' THR . 65.8 mt -73.49 110.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.678 0.791 . . . . 72.02 109.668 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -89.88 107.67 19.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.525 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 18.5 p90 -112.24 123.96 51.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.581 -0.896 . . . . 73.11 108.581 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -111.47 130.39 55.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.246 0.618 . . . . 74.44 109.364 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.25 108.53 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.043 -0.725 . . . . 75.25 109.043 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HD3' ' HB2' ' A' ' 78' ' ' GLU . 31.3 mmmt -78.03 -45.74 22.86 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.873 0.869 . . . . 71.5 109.775 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -167.48 125.34 1.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.812 0.845 . . . . 74.21 109.768 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.07 109.82 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.736 0.814 . . . . 62.13 110.173 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -104.86 143.01 33.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 74.32 108.852 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -140.92 125.74 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.02 0.928 . . . . 72.45 109.881 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -140.24 139.2 35.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.058 0.943 . . . . 71.35 109.459 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.8 p -89.51 157.74 17.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.357 0.663 . . . . 64.25 111.547 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -160.84 84.78 0.68 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.403 1.081 . . . . 74.3 109.282 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.36 -116.49 8.84 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.831 -0.622 . . . . 70.21 113.445 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.22 11.88 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.276 0.63 . . . . 73.02 111.247 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.91 155.29 50.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.446 0.698 . . . . 74.25 109.773 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -137.33 120.25 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.699 0.799 . . . . 74.31 109.319 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.04 109.57 21.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.276 1.03 . . . . 75.32 109.648 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.22 105.73 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.998 -0.742 . . . . 73.1 108.998 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.6 m -96.28 102.32 14.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.871 -1.159 . . . . 71.44 107.871 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.73 113.82 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.966 0.907 . . . . 71.34 109.159 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.24 126.17 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.894 0.877 . . . . 73.31 108.923 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.84 163.24 16.48 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.886 0.874 . . . . 71.53 108.783 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 32.6 tt0 -122.65 101.69 7.62 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.701 -1.222 . . . . 74.35 107.701 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 31.6 mt-10 -86.66 139.98 30.25 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.281 1.032 . . . . 73.42 110.15 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 11.9 m -119.62 102.94 8.98 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.31 108.55 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 t -118.2 120.39 37.54 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.998 0.919 . . . . 73.13 110.079 -173.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.52 -93.46 0.46 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.769 -0.651 . . . . 62.25 112.602 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -141.44 19.16 2.63 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.24 0.447 . . . . 64.24 112.072 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.9 p -124.01 145.37 49.24 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.183 0.993 . . . . 64.13 108.99 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 m -116.39 104.27 11.29 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.181 -1.044 . . . . 73.24 108.181 177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.0 m -102.02 119.19 38.39 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.48 1.112 . . . . 75.21 109.399 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 28.5 t-20 -77.68 101.2 6.51 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.296 -1.002 . . . . 73.42 108.296 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.0 m -113.05 124.25 52.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.241 1.016 . . . . 74.55 109.884 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 109' ' ' ASN . 27.5 m -87.01 141.02 28.97 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.276 -0.639 . . . . 74.23 109.276 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -119.28 127.13 52.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.554 1.142 . . . . 74.35 108.72 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -105.7 103.21 12.67 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.232 -1.025 . . . . 71.51 108.232 176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.46 105.2 17.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 70.25 108.015 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 36.3 ttm-85 -100.0 108.64 20.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.188 -0.914 . . . . 64.1 108.659 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.465 ' HB3' HG12 ' A' ' 101' ' ' ILE . 94.8 m-85 -99.85 111.73 24.03 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.925 0.89 . . . . 71.2 110.943 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 103' ' ' ARG . 7.3 mp0 -80.14 112.21 17.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.742 -0.836 . . . . 72.13 108.742 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 2.0 m -83.19 141.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.752 0.821 . . . . 74.44 109.69 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -140.82 117.0 10.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.411 -0.959 . . . . 71.44 108.411 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.34 -99.21 1.43 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.632 -0.587 . . . . 72.34 111.632 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -122.26 -16.96 7.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.089 0.955 . . . . 73.11 110.997 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -140.38 165.22 28.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.706 0.402 . . . . 74.42 110.573 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 2.6 mp -76.98 134.12 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.101 0.56 . . . . 70.11 109.81 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -123.47 5.57 8.99 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.35 1.06 . . . . 74.21 111.602 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 21.3 tpt180 -154.67 129.79 9.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.772 -0.455 . . . . 73.42 109.772 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.92 149.3 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.072 0.949 . . . . 74.41 109.322 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.8 m -131.17 106.79 8.57 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.351 -0.981 . . . . 74.01 108.351 171.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.77 105.04 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.725 -0.843 . . . . 75.35 108.725 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -116.17 105.78 12.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.54 0.736 . . . . 72.31 109.068 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -73.1 105.06 4.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.637 -0.875 . . . . 70.02 108.637 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 24.7 t-20 . . . . . 0 CA--C 1.55 0.955 0 C-N-CA 123.686 0.794 . . . . 70.04 110.292 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 108.394 -0.965 . . . . 62.4 108.394 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -74.02 -34.19 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.117 0.967 . . . . 70.32 112.121 -168.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.26 -42.24 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.454 0.702 . . . . 72.53 109.537 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.49 -35.94 70.95 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.026 -0.988 . . . . 74.33 110.412 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 34' ' ' ILE . . . -64.27 -40.67 96.44 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.244 0.618 . . . . 75.45 110.447 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.66 76.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.747 0.819 . . . . 64.23 110.956 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HG3' HG22 ' A' ' 64' ' ' VAL . 87.2 tttt -63.13 -56.88 13.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.455 -0.793 . . . . 70.35 110.504 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -67.41 -23.2 65.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.047 0.539 . . . . 75.11 111.077 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -49.4 64.58 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 123.721 0.638 . . . . 60.3 110.115 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.11 83.25 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.173 0.921 . . . . 73.43 110.906 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.402 HG22 HE21 ' A' ' 17' ' ' GLN . 74.1 mt -61.51 -40.24 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.327 1.051 . . . . 72.23 111.085 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.7 61.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.403 0.681 . . . . 74.44 111.983 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.02 -37.47 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.485 0.714 . . . . 75.21 109.239 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -73.11 -35.16 66.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.09 0.556 . . . . 73.3 111.054 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.402 HE21 HG22 ' A' ' 13' ' ' ILE . 77.1 mt-30 -61.43 -37.39 83.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.354 0.662 . . . . 74.23 110.464 174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 70.0 mt -73.26 -40.82 64.3 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 123.759 0.662 . . . . 75.13 110.532 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -59.69 -27.8 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.421 0.526 . . . . 71.23 112.421 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HB2' ' HZ1' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.08 -14.33 17.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.169 0.588 . . . . 73.14 111.815 175.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -159.58 89.9 1.93 Allowed Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 123.42 0.688 . . . . 73.14 110.381 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' HE21 ' A' ' 51' ' ' GLN . 37.6 Cg_endo -62.32 -22.33 73.95 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.374 2.716 . . . . 64.41 113.193 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -92.16 11.48 25.4 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.66 0.784 . . . . 74.2 111.809 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.11 110.73 8.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.048 -0.723 . . . . 75.0 109.048 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.78 -38.54 23.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.468 2.112 . . . . 71.34 113.104 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.61 -40.16 73.32 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.31 0.644 . . . . 74.52 111.644 -172.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -61.74 -56.85 15.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.025 0.828 . . . . 74.21 110.783 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.9 -24.64 66.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.507 0.723 . . . . 75.3 111.661 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.45 -46.83 65.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.809 0.443 . . . . 63.41 111.254 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.93 -30.56 67.99 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 110.288 -0.264 . . . . 72.21 110.288 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.477 HD22 HD12 ' A' ' 35' ' ' LEU . 83.2 mt -66.99 -28.19 68.05 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.424 0.69 . . . . 75.4 111.571 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -71.52 -25.39 62.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.999 0.428 . . . . 74.31 110.109 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -85.62 -41.3 15.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.636 0.774 . . . . 74.45 111.598 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 7' ' ' ALA . 9.4 pt -103.64 -17.32 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.123 0.569 . . . . 75.54 112.23 -170.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.477 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -123.43 174.61 7.26 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.026 0.93 . . . . 73.01 108.681 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.533 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.8 m -68.98 141.89 92.65 Favored Pre-proline 0 CA--C 1.561 1.404 0 N-CA-C 109.949 -0.389 . . . . 41.2 109.949 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.36 -20.01 14.29 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.997 2.464 . . . . 73.41 114.514 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.08 -37.23 66.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 74.42 111.796 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -64.03 -41.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.843 0.857 . . . . 64.42 111.386 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.59 -28.02 60.73 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.943 0.402 . . . . 74.12 111.358 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.32 -27.89 62.72 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.872 -1.058 . . . . 62.43 111.224 -172.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.65 -32.72 23.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.746 0.418 . . . . 74.41 111.077 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.21 -40.21 88.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 123.337 0.655 . . . . 72.22 110.758 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -67.59 -24.89 65.54 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.597 0.56 . . . . 74.53 111.535 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.29 -48.44 14.13 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.487 0.715 . . . . 73.34 110.255 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -62.63 -28.06 69.65 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.507 1.123 . . . . 71.35 110.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.05 -35.29 80.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.302 -1.317 . . . . 75.4 112.65 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -65.62 -27.46 68.41 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.665 0.786 . . . . 75.04 111.469 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.3 -48.67 32.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.678 0.791 . . . . 72.44 109.894 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.03 -30.3 69.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.839 0.856 . . . . 72.03 110.859 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.402 HE21 ' HD2' ' A' ' 22' ' ' PRO . 4.8 tp-100 -66.61 -47.35 72.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.03 1.332 . . . . 75.34 109.677 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.69 -31.58 72.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.241 -0.89 . . . . 72.4 110.845 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 -25.62 39.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.512 0.725 . . . . 73.12 110.877 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.34 40.31 80.59 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.377 0.423 . . . . 70.41 113.179 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.13 110.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.266 0.626 . . . . 75.21 109.396 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -94.55 106.63 18.62 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 7.3 p90 -112.38 143.07 44.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.534 0.734 . . . . 74.13 109.253 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -130.23 129.03 42.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.978 0.511 . . . . 71.33 109.767 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.94 101.37 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.551 0.741 . . . . 65.44 109.245 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.53 -27.27 19.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.971 0.908 . . . . 75.31 110.332 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.8 tpp180 -145.29 146.79 31.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.164 -1.05 . . . . 75.42 108.164 176.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.58 118.62 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.598 0.759 . . . . 74.32 109.013 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.97 105.76 10.6 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.96 -1.126 . . . . 71.4 107.96 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 73' ' ' VAL . 84.6 t -99.9 108.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.567 -1.272 . . . . 70.51 107.567 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -124.37 126.1 45.42 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.337 -0.616 . . . . 65.35 109.337 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.555 HG23 HG22 ' A' ' 71' ' ' VAL . 1.4 m -89.45 113.18 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.587 -0.894 . . . . 71.34 108.587 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -110.02 91.59 3.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.781 1.232 . . . . 54.54 107.812 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.7 -110.06 3.17 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 114.869 -1.06 . . . . 73.11 112.101 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.76 23.75 13.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.585 0.754 . . . . 65.24 110.379 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.6 m -134.88 122.6 22.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.157 0.583 . . . . 75.44 110.285 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 66' ' ' THR . 30.0 t -88.68 111.1 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.046 0.538 . . . . 71.33 109.606 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -97.94 104.59 16.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.704 0.802 . . . . 70.32 109.427 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 64' ' ' VAL . 78.0 t -89.29 103.68 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.203 -0.666 . . . . 70.31 109.203 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.9 m -99.02 103.3 15.23 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.0 -1.111 . . . . 63.24 108.0 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.05 128.9 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.441 0.696 . . . . 72.44 110.214 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 6.9 tp10 -92.77 111.96 23.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.08 1.352 . . . . 73.15 109.548 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 4.9 mp -109.51 118.81 37.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.605 -0.887 . . . . 73.22 108.605 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 26.1 tt0 -88.24 101.61 14.01 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.173 -1.418 . . . . 64.23 107.173 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 28.0 mt-10 -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.344 1.058 . . . . 73.34 110.588 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.3 m -125.05 111.09 14.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.861 -1.162 . . . . 70.3 107.861 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.9 t -132.36 131.25 41.69 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.483 -0.932 . . . . 73.52 108.483 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.6 -78.56 0.47 Allowed Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.48 -0.648 . . . . 65.3 111.48 -172.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.91 10.68 0.11 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 123.529 0.585 . . . . 72.14 111.959 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.4 p -98.67 126.91 44.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.077 0.951 . . . . 64.32 109.636 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.4 m -116.44 108.33 15.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.74 0.816 . . . . 73.03 110.181 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.0 m -131.74 139.53 48.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.012 0.925 . . . . 70.21 110.395 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 18.2 m120 -77.69 115.72 17.67 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.128 0.571 . . . . 72.12 109.597 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -116.65 121.39 41.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.304 1.042 . . . . 55.22 108.644 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -88.99 122.76 32.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.976 -0.379 . . . . 75.05 109.976 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -106.84 126.07 51.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.895 -0.779 . . . . 75.12 108.895 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.8 103.4 12.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.987 -1.116 . . . . 64.54 107.987 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.13 106.68 18.71 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.701 -1.222 . . . . 71.21 107.701 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 39.5 ttm180 -93.3 99.93 12.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.26 1.024 . . . . 74.22 110.113 -175.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.42 109.67 20.96 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.746 0.819 . . . . 72.44 110.157 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 40.5 tt0 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.248 -0.649 . . . . 74.3 109.248 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.94 149.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.461 0.704 . . . . 74.33 110.134 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -154.58 103.3 2.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 53.12 108.81 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 -118.39 5.04 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.748 -0.541 . . . . 60.44 111.748 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.37 20.37 13.65 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 71.34 109.832 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -139.22 168.44 19.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.305 1.042 . . . . 75.54 109.199 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.469 ' HB ' HD21 ' A' ' 35' ' ' LEU . 65.1 mt -108.17 127.78 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.979 0.912 . . . . 72.42 108.726 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -115.06 5.46 14.94 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.257 0.623 . . . . 74.14 112.435 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.8 ttp85 -153.53 134.91 14.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 110.576 -0.157 . . . . 73.53 110.576 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 129.68 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.289 1.036 . . . . 73.32 109.056 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.3 m -116.68 104.61 11.55 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.522 -0.918 . . . . 74.22 108.522 176.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.37 117.28 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.773 -0.825 . . . . 64.31 108.773 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 m -117.66 106.3 12.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.911 0.484 . . . . 75.54 109.812 -171.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.12 122.46 25.65 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.131 0.572 . . . . 74.11 109.536 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.041 . . . . 75.04 109.21 -177.377 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HE3' ' HB ' ' A' ' 34' ' ' ILE . 25.0 ptt? . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.937 0.399 . . . . 61.24 110.754 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -99.1 -6.1 28.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.58 0.752 . . . . 74.12 109.232 164.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.41 57.58 4.36 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.023 1.329 . . . . 73.22 109.877 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 96' ' ' VAL . 46.8 mm -71.37 -32.91 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.955 -1.02 . . . . 72.21 110.533 -174.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HA ' HG23 ' A' ' 71' ' ' VAL . 22.0 t -67.25 -46.55 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.458 0.703 . . . . 64.31 110.02 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -46.51 83.4 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.55 109.218 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.92 79.16 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.033 -0.985 . . . . 74.13 111.596 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.12 -36.32 74.73 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.05 0.54 . . . . 64.43 111.242 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 64' ' ' VAL . 81.3 tttt -60.44 -55.39 34.06 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 123.837 0.711 . . . . 73.04 109.58 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.8 -35.9 75.63 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.983 -1.008 . . . . 73.11 111.148 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 35' ' ' LEU . . . -65.11 -49.12 71.2 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 124.142 0.901 . . . . 74.41 110.693 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.464 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -60.68 -52.62 64.37 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 123.993 0.808 . . . . 75.42 110.854 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.437 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 59.2 mt -62.01 -39.95 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 123.965 0.791 . . . . 73.43 110.323 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.24 75.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.605 0.762 . . . . 71.55 112.142 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.37 -43.43 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.316 0.646 . . . . 74.33 109.866 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.16 -29.99 69.0 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.849 0.46 . . . . 74.23 111.303 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 78.2 mt-30 -66.93 -33.58 75.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.862 0.465 . . . . 75.22 110.47 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.3 mt -73.42 -35.71 65.86 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.235 0.335 . . . . 75.44 110.936 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -62.86 -31.04 71.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.691 0.397 . . . . 72.13 111.896 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -92.75 -30.6 15.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.022 0.529 . . . . 75.4 110.904 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.39 87.37 2.36 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 123.461 0.705 . . . . 74.11 109.787 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.07 -3.66 12.67 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.266 2.644 . . . . 74.32 113.959 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -95.83 7.5 46.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.112 0.965 . . . . 74.02 111.498 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.53 118.07 47.18 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.66 -0.686 . . . . 71.24 109.927 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.88 -39.33 20.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.831 2.354 . . . . 73.32 113.009 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.77 -47.61 58.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.049 0.54 . . . . 72.43 110.089 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.65 -56.28 23.9 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 114.723 -1.126 . . . . 55.42 111.304 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.24 -34.93 77.46 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.094 0.558 . . . . 75.43 111.418 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.36 -51.79 27.3 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.132 0.573 . . . . 75.11 110.748 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -63.11 -38.7 92.22 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.815 0.697 . . . . 73.21 109.827 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.81 -35.87 77.6 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.79 0.836 . . . . 73.31 111.265 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -73.08 -28.87 62.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.074 0.55 . . . . 72.12 110.75 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -81.86 -41.94 20.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 73.13 111.628 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 30' ' ' LEU . 9.8 pt -100.16 -38.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.04 0.536 . . . . 75.05 112.29 -169.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 11' ' ' ALA . 45.6 mt -98.45 178.24 5.09 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.092 -0.707 . . . . 74.13 109.092 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 39' ' ' VAL . 49.0 m -68.67 144.83 96.55 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.205 -0.452 . . . . 63.41 110.347 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.54 -22.79 68.25 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.698 2.265 . . . . 75.12 112.456 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.43 -37.16 86.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.452 1.101 . . . . 74.3 110.903 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 36' ' ' SER . 91.9 t -67.8 -49.97 64.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 123.475 0.71 . . . . 74.54 111.344 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.9 -33.76 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 120.832 0.348 . . . . 71.13 110.396 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 30.2 t70 -71.68 -51.62 22.08 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.042 -0.981 . . . . 71.14 110.167 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -62.94 -32.89 74.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.244 0.218 . . . . 73.05 111.348 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.43 -49.18 79.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 CA-C-O 118.982 -0.532 . . . . 74.35 110.401 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -67.1 -31.3 71.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.464 0.477 . . . . 75.33 111.843 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 16.5 mm-40 -62.5 -51.8 66.01 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.319 0.581 . . . . 74.43 110.104 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.409 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 44.1 m80 -72.97 -24.34 60.77 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.954 -1.021 . . . . 71.23 111.278 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.95 93.19 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.175 0.99 . . . . 74.43 110.926 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.2 -34.95 77.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.406 -0.816 . . . . 73.23 110.825 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.68 -39.26 62.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.732 0.813 . . . . 72.23 111.099 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 84.7 mt -74.5 -29.97 61.63 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.758 . . . . 72.45 110.654 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -69.49 -39.05 77.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.835 0.854 . . . . 72.3 109.912 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 5.2 ttpm? -75.18 -24.65 57.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.771 0.828 . . . . 74.42 110.876 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.88 -36.5 80.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.09 30.43 31.34 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.528 -0.76 . . . . 62.24 111.99 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.85 98.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 109.073 -0.714 . . . . 74.31 109.073 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -84.02 109.57 17.76 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.45 -1.315 . . . . 74.32 107.45 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.0 p90 -111.08 161.45 15.9 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.53 113.13 7.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.844 -1.169 . . . . 73.2 107.844 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.25 108.42 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.112 0.965 . . . . 74.52 110.133 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -91.59 -50.87 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.147 0.579 . . . . 75.23 111.189 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -137.35 134.56 36.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.892 . . . . 74.52 109.037 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -125.77 118.54 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.809 -1.182 . . . . 74.03 107.809 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.78 107.5 9.71 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.874 -0.788 . . . . 73.24 108.874 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 9' ' ' LYS . 7.4 p -103.61 134.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.995 0.518 . . . . 71.22 109.763 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -149.53 166.18 29.97 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.1 0.96 . . . . 65.24 109.085 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 p -96.67 151.78 19.29 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.325 0.583 . . . . 73.2 110.297 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.32 83.07 1.81 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 106.492 -1.67 . . . . 72.12 106.492 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.91 -115.05 7.12 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.493 -1.23 . . . . 61.54 111.377 -168.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -96.11 -14.66 22.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.101 0.561 . . . . 73.31 110.765 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 m -96.58 121.44 38.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.595 0.758 . . . . 73.1 109.642 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 94' ' ' PHE . 8.7 p -89.31 126.57 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 120.981 0.42 . . . . 73.21 110.187 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.64 130.6 54.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.467 0.707 . . . . 70.54 109.939 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 64' ' ' VAL . 21.7 t -112.05 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.999 -0.741 . . . . 70.02 108.999 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -89.39 104.59 17.13 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.646 -0.872 . . . . 75.03 108.646 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.32 120.33 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.837 0.855 . . . . 73.02 109.709 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -89.83 127.94 36.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.766 0.826 . . . . 74.42 108.992 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -127.63 140.5 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.216 0.606 . . . . 72.21 109.393 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -89.42 112.13 23.18 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.021 -1.103 . . . . 71.23 108.021 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.7 mt-10 -101.38 114.83 29.18 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.309 0.643 . . . . 72.42 109.44 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m -87.75 103.28 15.47 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.066 -1.087 . . . . 73.53 108.066 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -140.12 133.88 30.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.74 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.75 16.16 74.11 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.708 -0.678 . . . . 75.45 113.358 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.53 84.55 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.048 0.356 . . . . 73.44 113.185 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -108.4 121.75 45.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.585 0.754 . . . . 71.31 110.371 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.6 m -87.69 116.89 26.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.535 -0.913 . . . . 73.41 108.535 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.3 t -127.22 152.86 46.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.34 0.656 . . . . 73.03 109.749 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -80.06 133.11 36.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.56 -0.533 . . . . 61.13 109.56 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 m -142.59 111.13 6.18 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.779 -1.193 . . . . 72.03 107.779 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -91.02 121.78 33.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.218 0.607 . . . . 70.44 109.562 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.58 125.85 49.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -109.93 102.32 11.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.728 -1.212 . . . . 75.4 107.728 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 12' ' ' ALA . 5.1 mp -89.08 105.72 17.97 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.292 -1.373 . . . . 75.55 107.292 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 15.3 ttt180 -101.16 97.64 8.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.713 -1.217 . . . . 75.41 107.713 -170.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.518 ' HB3' HG22 ' A' ' 101' ' ' ILE . 99.1 m-85 -88.49 109.48 20.08 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.445 0.698 . . . . 74.21 109.596 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 6.5 tm-20 -86.86 119.37 27.01 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.449 -1.315 . . . . 74.41 107.449 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.527 HG13 HG12 ' A' ' 101' ' ' ILE . 3.0 m -97.08 150.93 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.091 0.956 . . . . 75.23 111.646 -168.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.12 99.93 4.41 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.385 1.074 . . . . 75.31 109.089 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.37 -99.47 0.73 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.662 -0.699 . . . . 74.13 112.734 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -107.76 -20.62 13.15 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.567 0.747 . . . . 75.31 110.849 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -128.04 153.31 46.92 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.654 0.782 . . . . 73.01 110.662 -170.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 HG13 ' A' ' 96' ' ' VAL . 72.6 mt -95.1 130.75 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.878 0.871 . . . . 72.32 109.588 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.427 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 9.5 mmt180 -102.62 -35.36 8.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.099 0.56 . . . . 74.33 111.288 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.558 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.9 mtt85 -127.51 145.18 50.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.794 -0.639 . . . . 74.43 109.592 -167.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.84 123.7 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.226 1.011 . . . . 74.24 108.952 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 12.6 m -109.25 103.22 12.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.255 -1.017 . . . . 73.24 108.255 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.12 106.53 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.413 -0.958 . . . . 74.01 108.413 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.1 m -100.26 105.03 16.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.375 0.67 . . . . 74.15 109.334 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -87.49 92.04 8.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.92 0.488 . . . . 62.42 109.734 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -96.38 163.12 13.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.214 1.006 . . . . 74.44 110.123 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.49 101.05 0.18 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.238 -1.145 . . . . 44.43 110.238 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.49 167.49 35.13 Favored Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.868 -0.493 . . . . 75.41 111.868 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.0 m -90.52 82.08 5.89 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.469 0.652 . . . . 75.3 111.077 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.66 -16.43 14.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.947 0.899 . . . . 75.22 109.432 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -167.09 1.27 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.818 1.247 . . . . 74.31 112.283 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -128.62 97.51 4.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.849 0.86 . . . . 74.1 109.862 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 46.28 65.08 1.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.357 1.863 . . . . 72.42 112.584 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -70.52 117.66 12.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.611 -0.722 . . . . 75.21 109.918 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -64.09 113.24 3.39 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.431 -0.952 . . . . 70.35 108.431 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.31 -87.08 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.652 0.381 . . . . 73.15 110.572 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 -168.728 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 108.481 -0.933 . . . . 75.41 108.481 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -168.1 -177.24 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.067 -1.086 . . . . 74.43 108.067 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -42.64 119.03 1.34 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.247 1.419 . . . . 73.34 112.976 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG21 HG12 ' A' ' 96' ' ' VAL . 47.2 mm -72.8 -29.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.638 1.175 . . . . 75.53 111.957 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.98 -56.56 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 71.12 110.703 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.97 -34.5 69.0 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.802 -0.636 . . . . 61.52 110.804 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -57.25 -50.65 72.23 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.549 0.531 . . . . 72.12 110.455 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.98 -32.07 68.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.505 0.722 . . . . 73.43 112.37 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.18 -58.37 8.62 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.719 0.637 . . . . 73.41 110.154 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.92 -30.27 71.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.997 0.919 . . . . 71.52 111.141 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 35' ' ' LEU . . . -62.61 -51.65 66.45 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 124.188 0.93 . . . . 74.13 110.531 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' A' ' 92' ' ' LEU . . . -59.43 -44.18 92.94 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 124.394 1.059 . . . . 72.44 112.357 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 62' ' ' VAL . 42.4 mt -66.73 -42.27 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.556 0.743 . . . . 73.24 109.965 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.3 -28.02 68.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.714 0.805 . . . . 75.33 112.051 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 11' ' ' ALA . 62.7 mt -60.89 -45.72 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.749 0.82 . . . . 74.44 109.909 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 42.3 m-85 -76.68 -29.43 56.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.276 -0.42 . . . . 73.35 112.011 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -60.59 -39.16 87.07 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.796 0.685 . . . . 74.21 110.054 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.6 -38.44 59.03 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.82 0.7 . . . . 65.1 111.176 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 28.2 m0 -62.88 -31.1 72.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.767 0.654 . . . . 74.23 112.767 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -95.97 -19.09 19.77 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.613 0.365 . . . . 75.03 111.204 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -158.04 88.33 2.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.412 0.685 . . . . 75.34 109.982 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.49 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.115 2.543 . . . . 73.21 113.242 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -91.56 10.66 27.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.271 1.028 . . . . 70.35 111.396 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.08 111.19 16.55 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 109.32 -0.622 . . . . 74.24 109.32 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 -44.85 7.03 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.651 2.234 . . . . 74.4 113.007 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.56 -27.72 58.71 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.274 0.472 . . . . 70.53 112.274 -171.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -62.85 -57.83 9.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.813 0.445 . . . . 74.51 110.532 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -66.66 -26.41 67.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.318 0.647 . . . . 71.2 111.937 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -67.09 -46.44 74.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.168 0.987 . . . . 74.42 110.987 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 4.2 pp -70.86 -34.27 71.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.796 -0.184 . . . . 73.31 110.719 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 93.1 mt -61.1 -28.93 69.44 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.667 0.787 . . . . 70.15 111.141 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.34 -24.95 63.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.932 0.893 . . . . 74.1 111.287 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -93.35 -44.81 8.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.666 0.786 . . . . 74.33 110.525 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.54 HG13 ' HG ' ' A' ' 35' ' ' LEU . 11.8 pt -94.67 -30.45 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.435 0.694 . . . . 74.34 112.321 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 11' ' ' ALA . 68.6 mt -110.21 175.14 5.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.324 0.65 . . . . 75.2 109.977 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB2' HG21 ' A' ' 39' ' ' VAL . 32.6 m -73.74 144.4 82.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.31 -0.859 . . . . 72.15 109.369 170.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 88.9 Cg_exo -52.16 -30.44 41.32 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 123.706 2.937 . . . . 74.31 114.285 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.9 -32.34 71.91 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.475 0.71 . . . . 73.11 111.482 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 36' ' ' SER . 40.4 t -70.29 -41.47 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.605 0.762 . . . . 63.33 110.987 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' PRO . 4.1 pp -72.57 -31.33 65.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.749 0.309 . . . . 74.41 110.76 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.6 t70 -65.28 -50.02 67.32 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.23 -0.896 . . . . 71.23 110.783 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.95 -32.52 72.96 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.286 0.366 . . . . 72.23 111.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 15' ' ' ILE . 47.0 t -63.38 -54.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.558 0.743 . . . . 75.44 111.219 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -67.14 -21.51 65.82 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.572 0.582 . . . . 75.44 112.572 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 12.1 mm-40 -80.35 -39.8 27.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.842 0.457 . . . . 72.33 111.344 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -73.92 -22.09 59.81 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.132 0.573 . . . . 75.24 110.698 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -59.72 -43.68 94.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.96 1.304 . . . . 74.1 111.791 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.19 -20.96 65.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.498 -1.228 . . . . 72.41 112.024 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.98 -59.27 4.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.637 0.375 . . . . 75.41 110.219 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.31 -29.89 70.96 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.053 0.941 . . . . 72.32 111.443 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -59.51 -51.14 71.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.622 1.169 . . . . 73.42 110.672 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.62 -26.9 55.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.517 0.727 . . . . 70.24 111.885 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -74.39 -24.08 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.338 0.655 . . . . 74.34 110.07 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.19 23.96 77.15 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.469 -0.787 . . . . 61.31 113.309 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.4 mt -71.84 103.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.459 -0.941 . . . . 75.43 108.459 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -79.68 124.13 28.28 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.855 -0.794 . . . . 71.31 108.855 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.53 168.2 20.29 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.583 -0.895 . . . . 73.52 108.583 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -148.77 139.26 22.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 74.21 109.187 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 p -70.43 108.6 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.951 0.901 . . . . 71.54 109.363 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -95.53 -39.54 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.437 0.695 . . . . 73.34 111.909 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -151.07 134.29 16.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.617 0.367 . . . . 64.42 110.242 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 13' ' ' ILE . 41.0 t -125.94 116.16 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.879 0.872 . . . . 74.52 109.453 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -127.49 110.45 12.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.243 -1.021 . . . . 72.44 108.243 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 p -96.55 114.45 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.251 0.62 . . . . 73.12 109.991 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.9 m -109.19 135.85 49.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.765 1.226 . . . . 71.33 110.064 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 p -91.92 113.2 25.41 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.195 -0.668 . . . . 62.14 109.195 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.29 87.3 2.51 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.527 -0.916 . . . . 72.24 108.527 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.84 -123.13 12.62 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.361 -0.836 . . . . 64.51 111.139 -172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.34 -16.46 31.01 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.171 0.588 . . . . 72.51 110.538 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 95' ' ' GLU . 9.8 m -96.3 125.61 40.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.444 0.698 . . . . 75.01 109.473 -172.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 94' ' ' PHE . 6.5 p -95.54 115.57 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.746 0.784 . . . . 74.52 110.792 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -102.38 104.63 15.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.911 0.884 . . . . 65.44 109.117 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.8 105.77 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.524 -0.547 . . . . 72.53 109.524 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.0 m -86.41 105.46 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.793 -0.817 . . . . 74.32 108.793 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.02 120.73 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.793 0.837 . . . . 75.01 110.759 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -86.42 129.31 34.9 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.913 0.885 . . . . 72.44 109.65 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.07 137.2 55.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.595 0.758 . . . . 75.13 109.02 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.46 105.49 17.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.183 -1.043 . . . . 74.41 108.183 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -97.36 115.16 27.19 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.428 0.691 . . . . 74.53 111.068 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -90.64 104.42 17.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.02 0.928 . . . . 63.4 108.673 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -124.57 122.22 36.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.263 1.025 . . . . 74.31 109.461 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.72 -88.18 0.36 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.19 0.424 . . . . 74.42 112.653 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.74 13.15 1.74 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.381 0.515 . . . . 73.31 112.256 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.6 p -116.67 139.66 50.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.826 0.851 . . . . 73.34 109.605 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -120.93 119.25 32.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.843 -1.169 . . . . 75.52 107.843 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.9 m -142.19 143.27 32.86 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.948 0.499 . . . . 74.22 110.151 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.64 102.96 8.27 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.723 0.809 . . . . 73.23 109.73 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.8 m -99.83 120.74 40.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.487 1.115 . . . . 74.02 108.743 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 m -89.41 127.52 35.84 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.448 -0.575 . . . . 70.25 109.448 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -107.44 126.5 52.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.653 -1.24 . . . . 75.42 107.653 170.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -108.56 103.28 12.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.509 -0.922 . . . . 71.12 108.509 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 12' ' ' ALA . 60.3 mt -90.0 104.71 17.25 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.373 1.069 . . . . 75.42 109.52 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 49.8 ttt85 -93.76 98.93 11.42 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.133 -0.691 . . . . 75.42 109.133 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.535 ' HB2' HG11 ' A' ' 71' ' ' VAL . 86.7 m-85 -87.52 116.49 25.67 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 9.2 tp10 -87.93 131.45 34.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 122.72 0.408 . . . . 55.04 110.114 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.49 HG11 HG12 ' A' ' 101' ' ' ILE . 5.9 m -103.82 149.66 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.952 0.901 . . . . 74.43 110.32 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.429 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 17.3 t70 -141.38 111.08 6.51 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.599 -1.259 . . . . 63.41 107.599 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.96 -110.5 3.06 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.697 -0.683 . . . . 72.35 112.446 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -113.12 -6.26 13.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.113 0.965 . . . . 63.2 112.263 -171.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -135.82 165.66 25.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.064 0.546 . . . . 75.42 110.754 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.49 HG12 HG11 ' A' ' 96' ' ' VAL . 71.0 mt -93.53 132.35 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.058 0.943 . . . . 72.22 109.3 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HE ' ' HB3' ' A' ' 97' ' ' ASP . 21.0 mmt180 -102.98 -28.43 12.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 73.51 111.182 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 48.9 ttt180 -145.53 154.12 41.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.69 0.396 . . . . 73.43 110.955 -166.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.95 138.18 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 71.33 108.579 167.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.2 m -113.86 112.47 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.446 -0.946 . . . . 70.03 108.446 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.92 104.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.045 -0.724 . . . . 73.33 109.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -103.84 105.84 16.17 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -81.22 95.62 6.99 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.179 -1.045 . . . . 72.44 108.179 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -69.7 113.77 7.28 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.982 -1.008 . . . . 64.14 109.41 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.21 -46.33 0.2 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.161 -0.775 . . . . 60.44 111.161 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.13 138.44 22.72 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.188 -0.765 . . . . 74.43 111.188 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -63.86 115.82 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.358 0.663 . . . . 61.4 110.689 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.34 -30.78 71.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.2 1.0 . . . . 74.41 110.548 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.45 155.79 20.87 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.047 0.939 . . . . 75.13 110.239 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -134.28 113.32 11.84 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.375 1.07 . . . . 55.45 108.248 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -132.64 144.38 50.31 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.056 0.542 . . . . 73.44 111.374 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -165.67 141.53 5.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.89 1.276 . . . . 75.4 108.678 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -84.0 -4.54 58.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.066 0.765 . . . . 75.41 113.066 -166.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.9 m170 74.69 -65.37 0.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.091 1.356 . . . . 73.33 110.674 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.892 -0.781 . . . . 70.43 108.892 173.372 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tpt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.404 -0.591 . . . . 75.34 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.85 -21.05 55.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.131 0.572 . . . . 73.51 111.501 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.3 73.01 5.93 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.66 0.784 . . . . 63.14 109.515 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.136 1.374 . . . . 71.25 112.478 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 66' ' ' THR . 40.6 t -59.88 -57.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.663 0.785 . . . . 74.51 110.12 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.72 -37.04 83.89 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.825 -1.08 . . . . 74.12 111.203 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.07 81.82 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.56 0.538 . . . . 61.41 111.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.95 95.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.886 -0.597 . . . . 71.05 111.528 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.2 -47.01 72.16 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.926 0.491 . . . . 75.24 111.664 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.58 -34.03 77.29 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.348 1.059 . . . . 75.25 110.783 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.75 81.63 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.101 -0.954 . . . . 72.24 110.755 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.24 82.42 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.257 0.973 . . . . 72.4 110.785 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 70.3 mt -59.29 -44.13 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 O-C-N 124.39 1.056 . . . . 75.43 109.799 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.06 77.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.157 0.983 . . . . 70.2 113.077 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.84 -39.75 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 73.04 109.974 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -76.7 -28.2 55.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.985 0.514 . . . . 74.54 111.807 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 95.6 mt-30 -68.81 -27.43 65.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.064 0.546 . . . . 74.21 110.559 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 69.1 mt -79.99 -43.76 21.42 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.833 0.453 . . . . 54.51 110.252 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -62.23 -25.03 67.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.939 0.718 . . . . 72.02 112.939 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -82.87 -33.24 27.06 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.133 0.492 . . . . 73.55 110.747 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -158.02 93.04 2.11 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.331 1.052 . . . . 73.04 108.289 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 48' ' ' ARG . 19.1 Cg_endo -56.41 -27.12 66.35 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 123.559 2.84 . . . . 74.41 113.947 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -84.8 15.01 4.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.404 0.682 . . . . 74.32 111.85 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.55 111.05 8.23 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.94 -38.95 6.71 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.412 2.074 . . . . 74.21 112.593 -173.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.91 -41.41 95.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.61 0.764 . . . . 75.04 111.245 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.03 8.85 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.216 0.947 . . . . 74.02 111.76 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -70.62 -26.59 63.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.055 -0.521 . . . . 74.53 112.383 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.83 -40.25 63.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.922 0.489 . . . . 74.51 110.707 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 2.3 pp -70.68 -31.84 68.88 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 110.056 -0.35 . . . . 75.0 110.056 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.834 0.854 . . . . 73.23 111.524 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.98 -29.45 64.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.914 0.486 . . . . 64.15 110.647 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 26.3 mtpp -80.48 -42.84 21.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.973 0.909 . . . . 74.42 111.431 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.532 HG13 HD22 ' A' ' 35' ' ' LEU . 16.9 pt -107.22 -36.13 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.61 0.596 . . . . 73.42 112.61 -168.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 34' ' ' ILE . 2.3 mm? -99.43 179.23 4.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.996 0.918 . . . . 71.23 110.801 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -80.85 146.52 59.95 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 115.046 -0.979 . . . . 75.44 110.356 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -31.35 92.48 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.371 2.714 . . . . 65.24 114.031 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.62 -38.95 92.76 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.676 0.79 . . . . 74.21 111.153 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.97 -53.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.691 0.796 . . . . 72.35 111.437 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.51 -32.12 72.99 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.569 0.224 . . . . 74.2 111.035 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 18.2 t70 -71.27 -49.85 38.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 124.16 0.913 . . . . 74.33 110.893 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -65.59 -38.38 89.33 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.29 0.236 . . . . 72.1 111.449 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.2 -45.09 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.223 0.609 . . . . 71.53 111.477 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.0 ptm180 -72.57 -25.99 61.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.518 0.327 . . . . 75.22 111.228 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 53.8 mt-10 -69.8 -46.32 65.98 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.212 0.605 . . . . 75.55 110.933 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.37 -34.35 78.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.843 -0.617 . . . . 75.25 110.035 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.15 -31.44 72.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.493 1.117 . . . . 64.34 112.222 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.522 ' HA ' ' HG3' ' A' ' 22' ' ' PRO . 70.4 mtp180 -63.28 -36.68 84.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.369 0.668 . . . . 72.2 110.31 174.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -74.6 -34.44 62.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.759 -0.655 . . . . 71.23 110.69 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 55' ' ' ILE . 74.9 mt -74.26 -23.68 59.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.381 0.672 . . . . 71.24 110.707 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.44 -43.09 70.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.179 0.992 . . . . 75.42 109.898 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.26 -41.85 94.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.722 0.809 . . . . 73.35 110.855 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.401 ' NE2' HD21 ' A' ' 50' ' ' LEU . 48.3 mt-30 -73.14 -29.26 62.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.042 -0.981 . . . . 72.52 111.022 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.98 46.41 59.44 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.556 0.535 . . . . 74.24 112.766 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 50' ' ' LEU . 58.7 mt -79.56 109.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.191 0.597 . . . . 74.1 109.933 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -91.47 119.99 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.148 -1.056 . . . . 74.32 108.148 173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.7 158.64 39.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.107 0.963 . . . . 72.1 109.163 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.38 130.12 38.33 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.382 0.673 . . . . 73.24 109.978 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.82 121.56 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 109.573 -0.529 . . . . 63.31 109.573 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -94.38 -48.0 6.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.285 1.034 . . . . 73.12 109.711 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -138.72 139.82 38.51 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.943 -1.132 . . . . 74.12 107.943 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.33 107.53 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.299 -1.0 . . . . 71.12 108.299 171.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -118.93 151.28 38.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.445 1.098 . . . . 74.22 108.799 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.1 126.22 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 72.41 109.335 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -132.22 117.18 17.89 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.966 -0.753 . . . . 73.4 108.966 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.517 HG22 HG23 ' A' ' 5' ' ' VAL . 70.5 p -88.43 127.25 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.529 -0.545 . . . . 72.32 109.529 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -132.71 100.99 5.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.289 -1.004 . . . . 74.5 108.289 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.16 -110.55 3.56 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.933 0.771 . . . . 75.11 112.138 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -118.4 23.7 11.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.866 0.866 . . . . 74.54 110.351 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -133.18 122.09 23.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.277 0.631 . . . . 74.45 109.358 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -97.95 103.72 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.446 0.641 . . . . 73.21 110.15 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -84.04 100.86 11.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.618 1.167 . . . . 72.35 109.42 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 105.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 71.42 109.234 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -89.53 109.24 20.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.015 0.926 . . . . 73.42 109.108 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.12 116.69 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.441 0.696 . . . . 72.2 110.151 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -84.18 135.51 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.079 0.952 . . . . 74.43 109.114 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.52 141.3 41.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.424 0.69 . . . . 75.25 109.608 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.63 108.67 21.43 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.315 -0.624 . . . . 70.5 109.315 168.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.59 107.63 18.24 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.63 -0.878 . . . . 74.4 108.63 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 m -89.57 102.91 15.59 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.937 -1.505 . . . . 64.4 106.937 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 t -140.94 124.18 16.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.305 1.042 . . . . 61.03 108.797 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.48 75.32 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.688 -0.687 . . . . 74.13 112.969 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.82 -19.87 42.64 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.746 -0.474 . . . . 64.31 113.416 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.4 p -88.68 120.23 29.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.159 0.584 . . . . 74.23 110.648 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -90.88 110.26 21.49 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.358 -0.979 . . . . 75.11 108.358 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.1 m -119.49 128.74 54.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 73.4 110.519 -172.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -77.35 101.7 6.45 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.126 -0.694 . . . . 62.15 109.126 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 m -108.42 114.49 28.37 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.453 1.101 . . . . 64.5 108.319 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -88.36 122.04 31.42 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.57 -0.9 . . . . 72.32 108.57 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -102.45 129.77 49.04 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.781 -1.192 . . . . 74.22 107.781 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.45 102.07 11.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.77 104.54 16.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.779 -1.193 . . . . 73.2 107.779 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -101.56 100.74 11.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.102 -1.408 . . . . 75.21 108.225 -170.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.22 110.57 21.61 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.752 0.821 . . . . 73.45 111.559 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -79.49 99.88 7.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.506 HG12 HG21 ' A' ' 101' ' ' ILE . 4.2 m -97.73 141.14 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 65.33 110.163 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.9 116.38 9.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.217 0.607 . . . . 72.32 109.935 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.88 -114.22 5.45 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.969 0.793 . . . . 72.55 112.648 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.93 -3.09 26.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.9 0.88 . . . . 71.03 112.036 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.2 t -137.46 148.79 46.36 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.136 0.493 . . . . 74.22 110.943 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.506 HG21 HG12 ' A' ' 96' ' ' VAL . 34.8 mt -89.3 121.28 39.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.287 -1.005 . . . . 75.42 108.287 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -88.03 -41.86 12.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.992 0.917 . . . . 73.43 112.26 -167.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -142.37 163.89 31.62 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.809 0.338 . . . . 74.15 110.727 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.74 117.15 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.466 1.106 . . . . 74.41 108.831 168.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.1 m -93.45 104.28 16.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.649 -0.871 . . . . 74.41 108.649 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.12 104.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.719 0.771 . . . . 72.23 109.937 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 m -95.51 110.04 22.16 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.001 0.92 . . . . 73.42 109.428 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -81.68 94.38 6.96 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.485 0.714 . . . . 72.1 109.805 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -92.29 95.97 10.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.618 0.767 . . . . 75.24 109.485 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.34 15.21 60.43 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 115.962 -0.563 . . . . 73.43 113.035 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.03 -147.14 11.5 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.476 -0.65 . . . . 54.21 111.476 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.0 m -151.49 142.14 22.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.392 0.677 . . . . 62.14 110.01 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -102.76 -9.32 20.09 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.022 0.929 . . . . 74.31 110.739 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.12 135.17 51.73 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.47 0.708 . . . . 75.24 111.355 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -103.6 18.36 22.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.147 0.979 . . . . 65.1 109.521 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -61.53 -54.92 36.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.714 1.206 . . . . 71.13 110.766 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -67.82 -38.91 83.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.012 0.525 . . . . 65.12 111.15 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.37 -3.83 51.16 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.64 0.776 . . . . 74.45 111.653 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.1 t60 72.01 -67.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.938 1.295 . . . . 74.24 110.394 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.82 -1.178 . . . . 64.13 107.82 174.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 107.822 -1.177 . . . . 74.21 107.822 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -111.95 17.04 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.39 1.076 . . . . 74.2 111.019 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.39 32.41 4.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.029 0.532 . . . . 73.14 110.504 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -49.92 -44.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.785 1.234 . . . . 74.13 112.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.78 -46.63 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.554 1.142 . . . . 72.44 111.031 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.0 -46.42 81.46 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.713 -0.676 . . . . 73.43 110.526 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.12 -30.25 70.21 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.241 1.016 . . . . 62.12 111.404 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.18 86.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.997 0.519 . . . . 74.31 110.062 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 13' ' ' ILE . 88.2 tttt -66.38 -45.18 80.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.329 -0.851 . . . . 71.4 110.135 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -57.52 -45.3 85.17 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.136 0.974 . . . . 71.31 110.475 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.21 91.73 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 124.594 1.184 . . . . 74.42 111.04 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.2 66.31 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.994 0.809 . . . . 64.13 111.583 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 9' ' ' LYS . 33.2 mt -60.94 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 123.853 0.721 . . . . 74.22 109.706 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.48 83.92 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.271 1.029 . . . . 71.35 112.276 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.71 -43.57 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 123.973 0.796 . . . . 75.52 110.206 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 75.6 m-85 -73.73 -31.86 63.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.068 0.396 . . . . 73.24 112.068 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.4 HE21 HG23 ' A' ' 13' ' ' ILE . 78.4 mt-30 -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.647 0.592 . . . . 72.31 109.964 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 28' ' ' GLN . 81.4 mt -67.72 -48.25 67.03 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 124.192 0.933 . . . . 75.24 110.317 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 20.9 m0 -54.07 -29.4 44.18 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.843 0.857 . . . . 73.25 113.144 -174.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 20.0 ptmt -101.97 -23.01 14.18 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.074 0.55 . . . . 75.21 112.065 174.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -149.95 83.15 6.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.403 0.681 . . . . 72.4 109.996 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 44.2 Cg_endo -71.73 -7.71 21.68 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.301 2.667 . . . . 73.41 114.597 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -78.97 -10.14 59.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 74.25 112.128 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.93 117.18 51.38 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.683 0.393 . . . . 74.41 110.276 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.49 -41.97 2.09 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.679 2.253 . . . . 73.13 113.446 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.81 -33.56 74.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.227 0.611 . . . . 74.32 112.226 -170.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.22 75.51 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.477 0.711 . . . . 62.24 110.667 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 18' ' ' LEU . 9.3 pt20 -79.2 -20.83 47.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.836 -0.62 . . . . 74.43 111.815 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -46.75 75.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.608 0.763 . . . . 72.45 110.572 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.406 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.2 pp -70.33 -31.7 69.11 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.487 0.492 . . . . 70.34 110.337 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.3 -28.89 70.32 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.663 0.785 . . . . 75.35 112.048 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -70.04 -33.87 72.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.144 0.497 . . . . 75.45 110.208 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.27 -33.92 23.91 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.859 0.863 . . . . 74.34 112.023 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 7' ' ' ALA . 10.1 pt -108.89 -33.67 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 122.954 0.502 . . . . 73.41 111.446 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 39' ' ' VAL . 3.5 mm? -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.443 1.097 . . . . 74.31 108.641 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.538 ' HB2' HG21 ' A' ' 39' ' ' VAL . 5.1 m -67.62 145.3 98.16 Favored Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 109.754 -0.461 . . . . 65.02 109.754 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.05 -18.12 56.0 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.486 2.124 . . . . 72.43 112.825 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.49 -33.86 62.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.002 0.921 . . . . 61.31 111.027 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 HG21 ' HB2' ' A' ' 36' ' ' SER . 63.3 t -63.96 -41.45 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.745 0.818 . . . . 74.03 111.5 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.55 -35.4 75.92 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 120.697 0.284 . . . . 71.22 111.056 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.7 t70 -72.6 -52.58 14.88 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.156 -0.929 . . . . 70.2 110.558 -175.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -61.34 -29.27 69.79 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.295 0.48 . . . . 75.34 112.295 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.9 t -71.7 -48.36 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.685 0.794 . . . . 74.33 110.868 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -73.14 -21.5 60.71 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.76 0.424 . . . . 74.41 111.926 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 mm-40 -82.73 -35.33 26.75 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 122.211 -0.305 . . . . 73.32 110.423 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -68.73 -26.58 65.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.762 0.791 . . . . 74.43 110.69 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -67.93 -38.35 82.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.601 -1.181 . . . . 63.5 111.568 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -65.22 -21.29 66.73 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.679 0.612 . . . . 73.11 111.338 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -72.03 -46.72 56.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.525 0.73 . . . . 74.55 110.628 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.85 -22.95 63.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.56 0.744 . . . . 74.31 111.176 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.63 -27.33 63.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.107 0.963 . . . . 75.23 111.338 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -78.61 -6.73 56.42 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.618 0.367 . . . . 64.21 111.034 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -116.69 172.56 7.15 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.117 0.967 . . . . 71.42 110.248 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.67 24.41 30.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.727 -0.67 . . . . 60.02 113.144 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 88.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-O 121.357 0.599 . . . . 74.41 109.464 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -101.46 110.36 22.35 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.185 -1.042 . . . . 73.54 108.185 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -117.34 135.56 53.76 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.486 0.715 . . . . 73.11 110.469 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.61 122.2 45.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.775 0.83 . . . . 74.41 109.882 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.67 101.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.686 -0.857 . . . . 72.23 108.686 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -77.68 -44.1 29.08 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.686 -0.688 . . . . 74.33 110.805 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 17.6 tpp85 -152.77 142.1 21.58 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.78 -1.1 . . . . 71.1 108.869 -177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.77 110.01 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.615 -0.884 . . . . 71.41 108.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG3' ' HD2' ' A' ' 61' ' ' ARG . 28.8 mt-10 -128.7 122.92 31.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.008 -0.738 . . . . 74.13 109.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.78 135.77 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.496 1.118 . . . . 71.21 110.135 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -138.55 137.63 37.22 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.176 0.99 . . . . 63.54 109.287 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -95.44 155.82 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.046 0.538 . . . . 74.41 111.368 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 95.62 2.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.32 -1.363 . . . . 75.34 107.32 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.63 -117.08 9.41 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 111.736 -0.546 . . . . 44.05 111.736 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.87 -12.93 21.58 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.01 0.524 . . . . 74.41 111.533 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.9 m -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.982 0.513 . . . . 60.33 110.087 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 94' ' ' PHE . 7.8 p -99.73 136.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.719 0.808 . . . . 71.15 110.568 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.95 115.97 22.81 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.058 1.343 . . . . 73.31 108.883 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.24 113.07 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 110.181 -0.303 . . . . 72.43 110.181 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.2 m -87.64 104.89 16.94 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.074 -1.084 . . . . 74.13 108.074 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.48 122.52 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.231 1.012 . . . . 74.33 109.015 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -94.96 132.93 39.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.937 0.895 . . . . 74.54 109.305 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.57 154.91 49.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.407 0.683 . . . . 72.5 109.808 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -110.07 104.48 13.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 72.23 109.289 171.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.52 106.65 17.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.567 0.747 . . . . 74.4 110.191 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -87.85 102.93 15.17 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.886 -1.153 . . . . 64.44 107.886 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.5 t -146.95 135.82 22.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.133 0.973 . . . . 60.13 109.485 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 22.45 71.08 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.732 -0.667 . . . . 73.0 112.843 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.3 80.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.938 -0.368 . . . . 72.5 114.004 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -126.97 123.43 37.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.376 0.67 . . . . 73.3 110.959 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.6 m -88.07 115.08 25.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.308 1.043 . . . . 74.01 110.005 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.6 m -119.08 133.51 55.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.013 0.925 . . . . 72.23 110.134 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -79.21 125.43 29.45 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.974 -0.75 . . . . 62.21 108.974 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.9 m -141.96 125.17 16.41 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.671 0.788 . . . . 73.22 110.234 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -90.75 129.88 36.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.648 -0.501 . . . . 72.34 109.648 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -108.96 146.84 33.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.554 0.742 . . . . 72.21 109.166 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.3 103.66 7.29 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.066 -1.087 . . . . 74.3 108.066 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.77 108.49 20.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 74.2 107.912 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -90.48 99.79 12.75 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.48 -0.782 . . . . 75.31 109.329 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.557 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.6 m-85 -89.3 110.3 21.1 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.987 -0.746 . . . . 73.55 108.987 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 26.6 tt0 -92.13 127.86 37.76 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.089 -1.078 . . . . 72.2 108.089 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -85.09 142.49 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.263 0.554 . . . . 73.2 110.979 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -120.96 97.41 5.52 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.915 -1.143 . . . . 75.41 107.915 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.92 -107.08 1.86 Allowed Glycine 0 C--N 1.343 0.929 0 O-C-N 123.822 0.701 . . . . 73.33 113.241 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.63 -19.05 22.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.047 0.939 . . . . 71.41 112.053 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -132.45 167.95 19.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.669 0.787 . . . . 74.12 110.614 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.557 HG21 ' HB3' ' A' ' 94' ' ' PHE . 50.0 mt -92.06 135.79 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.685 -0.857 . . . . 64.44 108.685 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -129.48 7.69 5.36 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.942 0.497 . . . . 74.1 111.828 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 31.2 mmt180 -144.45 146.58 32.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.999 0.519 . . . . 75.41 111.544 -175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 130.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.993 1.317 . . . . 72.14 109.333 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -127.03 105.8 8.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.417 -0.957 . . . . 74.13 108.417 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 t -86.61 106.81 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.045 -0.724 . . . . 72.2 109.045 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 m -95.57 152.12 18.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.624 -0.88 . . . . 72.11 108.624 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -129.03 138.58 51.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.351 0.66 . . . . 74.52 110.197 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.55 83.09 2.24 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.033 -1.099 . . . . 75.41 108.033 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.9 56.9 3.33 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.636 -0.711 . . . . 14.31 111.518 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.3 157.47 9.51 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.683 -0.567 . . . . 74.33 111.683 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 51.0 m -151.29 131.84 13.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.054 0.942 . . . . 73.42 109.356 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.19 -40.85 51.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.274 0.629 . . . . 75.41 109.517 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.28 134.23 54.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.039 0.936 . . . . 71.21 109.314 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -167.81 139.0 2.91 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.172 -1.048 . . . . 73.52 108.172 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -58.32 112.64 1.63 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 54.52 109.307 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.17 68.79 3.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.087 0.955 . . . . 44.32 111.547 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -94.35 -34.42 12.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.008 0.923 . . . . 74.42 109.047 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -86.95 23.15 1.82 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.554 1.142 . . . . 73.22 110.49 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 124.768 1.227 . . . . 70.23 108.948 -165.463 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HE3' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 107.756 -1.202 . . . . 73.33 107.756 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 19.7 19.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.885 0.874 . . . . 75.44 111.365 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -91.83 26.72 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.885 0.474 . . . . 73.44 110.52 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.37 -39.92 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.576 1.55 . . . . 74.52 113.331 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.76 -50.31 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.545 0.738 . . . . 74.31 110.292 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.19 -30.47 64.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.547 -0.752 . . . . 73.35 110.92 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HE3' ' A' ' 1' ' ' MET . . . -66.31 -48.55 69.98 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.497 0.719 . . . . 63.44 109.954 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.75 94.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.532 0.733 . . . . 70.13 111.495 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.3 -57.88 11.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.268 1.027 . . . . 75.4 111.397 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -66.96 -29.1 68.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 74.43 110.906 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.76 83.6 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 123.925 0.766 . . . . 72.5 110.934 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.08 69.8 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.373 1.046 . . . . 55.2 110.631 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 mt -61.69 -42.79 95.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 O-C-N 124.402 1.064 . . . . 71.1 110.413 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.64 74.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.803 0.841 . . . . 75.11 112.026 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.63 -40.97 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 73.24 109.508 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 60.2 m-85 -72.16 -31.13 65.67 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.472 0.309 . . . . 62.22 111.742 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.436 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 68.9 mt-30 -66.09 -35.57 80.86 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.494 0.496 . . . . 75.11 110.407 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 -42.85 65.74 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 123.888 0.742 . . . . 65.41 109.966 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 37.6 m0 -61.11 -26.06 67.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.166 0.802 . . . . 73.15 113.166 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 17' ' ' GLN . 64.3 pttt -100.22 -21.7 15.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.791 0.436 . . . . 75.52 110.948 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -152.99 89.5 3.69 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.35 0.66 . . . . 65.15 109.56 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.71 -19.21 66.87 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.095 2.53 . . . . 71.52 113.169 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.3 p -83.13 7.9 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.049 0.939 . . . . 72.52 112.469 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.77 108.59 6.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.03 0.532 . . . . 71.33 109.934 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.74 -29.68 15.42 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.573 2.182 . . . . 74.33 113.185 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.67 -41.6 62.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.247 0.619 . . . . 74.43 110.722 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.19 61.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.816 0.846 . . . . 55.13 111.144 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.91 -28.77 68.58 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.713 -0.676 . . . . 74.03 111.764 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.81 -52.35 44.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.881 0.472 . . . . 73.33 110.86 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.512 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.6 pp -66.89 -31.75 72.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.233 -0.44 . . . . 74.1 110.192 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.04 -12.58 61.81 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.959 0.903 . . . . 73.54 112.905 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 -27.02 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.419 0.628 . . . . 74.21 109.963 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -85.47 -30.49 23.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.97 0.908 . . . . 64.45 111.181 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.533 HG13 HD22 ' A' ' 35' ' ' LEU . 12.9 pt -117.77 -32.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.791 0.437 . . . . 71.31 111.538 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 39' ' ' VAL . 3.7 mm? -109.2 179.28 4.21 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.688 0.795 . . . . 73.12 109.253 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 39' ' ' VAL . 28.7 m -76.26 152.47 83.94 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 122.772 0.429 . . . . 75.13 111.347 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.61 -23.51 65.65 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.821 2.347 . . . . 74.33 112.366 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.6 -39.94 80.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.53 1.132 . . . . 71.11 111.133 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 35' ' ' LEU . 93.5 t -65.63 -57.42 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.306 0.643 . . . . 65.55 110.651 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -58.04 -27.04 63.23 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.34 0.496 . . . . 70.5 112.34 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.78 -41.02 24.1 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.77 0.828 . . . . 73.31 110.959 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -74.46 -27.91 60.79 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.303 -0.248 . . . . 74.52 110.626 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -40.83 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.161 0.985 . . . . 65.12 110.749 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.58 -30.73 69.55 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 120.268 0.08 . . . . 74.32 111.052 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.77 -26.32 27.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.844 0.458 . . . . 75.42 111.076 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -66.49 -27.11 67.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.978 0.511 . . . . 74.03 110.365 172.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.86 91.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.92 -1.036 . . . . 70.5 111.878 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -64.71 -31.76 73.13 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.119 0.887 . . . . 71.2 111.479 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.04 -44.19 97.22 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 123.824 0.702 . . . . 71.43 110.44 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -78.42 -36.16 46.02 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.327 1.051 . . . . 75.35 111.314 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.31 -30.15 63.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.924 0.89 . . . . 74.31 110.156 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.98 -36.25 80.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.649 1.18 . . . . 75.14 110.225 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.24 -20.92 29.39 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.974 -1.012 . . . . 65.42 111.013 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.57 20.91 70.5 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.922 -0.581 . . . . 74.32 113.208 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.1 mt -82.21 100.28 5.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 123.366 0.666 . . . . 74.22 110.123 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -92.96 112.98 25.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.219 -0.66 . . . . 74.35 109.219 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 5.7 p90 -105.81 159.45 16.0 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.12 -0.696 . . . . 75.04 109.12 168.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -133.0 133.54 43.27 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.988 -0.551 . . . . 65.43 110.034 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.43 101.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.512 1.132 . . . . 73.5 109.974 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.84 -54.89 3.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.93 0.395 . . . . 73.53 111.48 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -133.16 123.43 25.65 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 109.471 -0.566 . . . . 73.14 109.471 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.54 125.6 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.043 0.937 . . . . 73.43 109.398 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.65 109.12 9.5 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.481 -0.933 . . . . 73.34 108.481 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.6 p -95.41 108.27 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.484 0.659 . . . . 72.43 109.356 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.2 p -113.18 124.97 53.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.564 0.746 . . . . 75.13 109.632 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 71' ' ' VAL . 45.5 p -88.35 154.13 20.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.826 0.45 . . . . 74.42 109.948 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -148.48 92.93 2.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.017 -1.475 . . . . 74.11 107.017 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.65 -117.69 10.39 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.986 -0.846 . . . . 75.14 110.986 -169.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -94.56 -14.06 25.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.402 0.681 . . . . 64.11 110.503 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -93.84 121.62 35.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.642 0.777 . . . . 65.41 110.411 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 66' ' ' THR . 48.2 t -99.66 111.64 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.232 0.613 . . . . 72.44 110.85 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -94.74 107.31 19.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.334 1.054 . . . . 74.44 108.953 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.55 103.61 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.707 -0.479 . . . . 74.11 109.707 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.2 m -86.57 106.15 17.35 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.343 1.057 . . . . 64.45 109.03 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.87 124.85 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.06 0.944 . . . . 71.21 110.293 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -94.82 127.14 40.61 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.971 0.908 . . . . 74.21 109.051 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.99 157.07 30.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.582 0.753 . . . . 74.42 109.259 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' THR . 40.8 mt-10 -109.22 106.52 16.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.154 -0.475 . . . . 75.15 109.852 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.494 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 23.7 mt-10 -86.02 119.81 26.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.697 0.799 . . . . 75.35 110.616 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -89.51 100.44 13.24 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.743 -1.206 . . . . 71.14 107.743 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 t -149.44 128.46 12.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.123 0.969 . . . . 72.34 110.007 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.03 69.61 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 113.835 0.294 . . . . 72.35 113.835 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.45 13.22 83.61 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.901 -0.389 . . . . 71.43 113.989 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.9 p -121.56 149.39 43.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.412 0.685 . . . . 75.51 109.937 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 m -116.61 106.15 13.23 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.364 -0.976 . . . . 65.22 108.364 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 12.0 t -110.66 139.04 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.977 0.418 . . . . 65.3 110.97 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -80.45 102.71 9.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.097 -0.705 . . . . 65.21 109.097 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -114.62 128.15 56.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.227 0.611 . . . . 73.23 109.454 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.7 m -93.43 119.12 32.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.287 0.635 . . . . 72.35 110.186 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -104.3 130.34 52.12 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.241 -1.022 . . . . 64.14 108.241 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.77 104.74 11.96 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.039 -1.097 . . . . 72.45 108.039 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.2 mp -90.96 108.96 20.2 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.85 -1.167 . . . . 73.12 107.85 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.479 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 27.6 ttt180 -89.36 99.68 12.63 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.042 -0.981 . . . . 70.12 108.376 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.476 ' HB3' HG23 ' A' ' 101' ' ' ILE . 91.7 m-85 -87.82 107.65 18.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.253 -0.885 . . . . 64.51 109.053 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 108.15 20.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.471 -1.307 . . . . 74.11 107.471 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.537 HG13 HG12 ' A' ' 101' ' ' ILE . 3.8 m -86.68 151.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 114.871 -1.059 . . . . 73.15 112.407 -165.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.39 103.28 5.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.696 1.198 . . . . 72.33 108.631 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.13 -108.28 2.49 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.369 -0.378 . . . . 72.34 113.279 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.33 2.42 16.5 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.826 0.85 . . . . 64.51 111.74 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 164.63 26.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.691 0.796 . . . . 63.24 109.265 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 96' ' ' VAL . 24.9 mt -101.18 107.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.605 -1.257 . . . . 73.14 107.605 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -85.25 -29.12 24.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.472 0.309 . . . . 73.51 111.624 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -130.06 142.58 50.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.36 0.664 . . . . 74.44 109.757 -164.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.02 142.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.464 0.705 . . . . 75.24 110.615 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.1 m -119.48 141.65 48.98 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.241 1.017 . . . . 72.34 108.889 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 110.09 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.48 -0.563 . . . . 75.51 109.48 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.1 m -103.39 104.86 15.0 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.561 0.744 . . . . 72.24 109.64 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.51 96.11 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.248 0.547 . . . . 74.34 109.854 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -81.37 86.61 6.25 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.158 0.983 . . . . 74.24 109.662 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.71 -22.6 28.08 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.558 -0.746 . . . . 52.24 111.509 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.66 90.25 0.53 Allowed Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.357 -0.697 . . . . 71.31 111.357 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.6 m -89.05 31.16 0.88 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.711 0.804 . . . . 75.34 111.652 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.82 -2.55 54.93 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.605 0.762 . . . . 75.12 112.057 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -80.71 -175.01 5.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.682 0.793 . . . . 71.24 111.261 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -124.27 92.43 3.66 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.082 0.953 . . . . 74.43 108.639 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -66.3 -58.9 4.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.101 0.561 . . . . 73.23 109.555 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -86.65 77.63 9.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.824 -1.176 . . . . 63.23 107.824 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -76.14 94.13 3.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.37 0.668 . . . . 70.11 110.321 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -73.8 140.46 45.85 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.394 -0.821 . . . . 72.03 110.956 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 . . . . . 0 C--O 1.251 1.136 0 N-CA-C 108.117 -1.068 . . . . 72.41 108.117 171.713 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.472 0.653 . . . . 73.12 111.036 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -130.96 0.55 4.25 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.631 1.173 . . . . 74.44 108.249 167.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.72 70.2 10.3 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 124.536 1.135 . . . . 73.43 109.113 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.562 HG21 HG11 ' A' ' 96' ' ' VAL . 36.1 mm -48.01 -47.19 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.971 1.709 . . . . 75.11 113.19 -171.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 66' ' ' THR . 45.9 t -66.12 -56.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.497 0.719 . . . . 73.52 110.759 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -74.77 -29.17 61.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.181 -0.918 . . . . 74.22 111.768 -170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 34' ' ' ILE . . . -67.1 -45.31 77.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.411 0.684 . . . . 64.04 110.023 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 71' ' ' VAL . . . -68.64 -32.72 72.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.454 0.702 . . . . 63.21 111.881 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.0 -47.8 78.88 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.554 0.742 . . . . 75.44 110.482 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.761 0.824 . . . . 74.13 111.437 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.29 86.44 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.749 0.82 . . . . 75.25 110.806 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.86 79.56 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 124.202 0.939 . . . . 61.15 111.415 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.3 -40.41 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.147 -0.933 . . . . 73.02 110.449 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.92 82.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.678 0.791 . . . . 65.01 111.665 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.434 ' HA ' HG13 ' A' ' 43' ' ' VAL . 56.4 mt -60.87 -41.58 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.072 0.949 . . . . 74.35 110.35 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -76.38 -31.58 58.09 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.825 0.45 . . . . 73.04 111.819 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.86 -32.5 74.05 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.131 0.572 . . . . 73.34 110.563 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -49.11 26.39 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.502 0.501 . . . . 75.51 110.434 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -59.42 -26.09 64.88 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.39 -29.51 14.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.54 0.336 . . . . 75.25 111.008 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -147.45 85.55 6.7 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.433 0.693 . . . . 74.12 109.137 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.07 -12.16 33.51 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.977 2.451 . . . . 74.23 112.951 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -84.98 5.01 31.01 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.222 1.009 . . . . 73.11 111.584 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -77.33 110.78 13.48 Favored Pre-proline 0 C--N 1.357 0.921 0 N-CA-C 109.53 -0.544 . . . . 75.51 109.53 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.26 -26.09 9.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.408 2.072 . . . . 70.03 112.352 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -75.28 -44.3 46.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.936 0.895 . . . . 74.44 111.118 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.42 81.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 124.273 0.983 . . . . 62.04 111.094 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.488 ' HB2' HD12 ' A' ' 40' ' ' LEU . 11.3 pt20 -75.5 -24.61 56.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.735 -0.666 . . . . 70.24 111.881 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.22 -46.26 61.56 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.027 0.531 . . . . 74.1 110.983 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.4 pp -68.01 -29.34 68.32 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.357 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.2 mt -69.23 -14.76 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 74.21 112.335 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -81.29 -30.25 34.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.266 0.555 . . . . 73.34 109.503 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -82.73 -36.97 25.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.097 0.959 . . . . 70.34 111.05 -174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 7' ' ' ALA . 12.9 pt -105.16 -35.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.309 0.643 . . . . 74.31 111.637 -173.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.437 HD23 HG13 ' A' ' 34' ' ' ILE . 3.9 mm? -111.13 175.7 5.32 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.335 1.054 . . . . 75.31 109.373 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB2' HG22 ' A' ' 39' ' ' VAL . 17.8 m -74.11 146.23 84.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 116.036 -0.529 . . . . 75.13 110.609 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.38 -32.26 41.54 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.288 2.659 . . . . 75.53 114.031 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.49 -39.82 92.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.213 1.005 . . . . 73.3 111.457 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 36' ' ' SER . 96.0 t -70.47 -45.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.498 0.719 . . . . 74.33 111.113 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 28' ' ' GLN . 2.8 pp -64.14 -30.05 71.13 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.936 0.398 . . . . 71.0 110.556 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 23.8 t70 -68.23 -56.73 7.63 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.8 -1.091 . . . . 54.33 110.06 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.42 -31.64 69.45 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 111.898 0.333 . . . . 71.23 111.898 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 15' ' ' ILE . 54.5 t -66.25 -51.99 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.219 0.608 . . . . 70.21 110.415 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 40.4 ptt180 -69.42 -21.9 63.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 119.664 -0.208 . . . . 74.51 111.463 -176.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 18.6 mm-40 -71.02 -46.25 62.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.817 0.447 . . . . 74.15 111.068 175.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -66.32 -28.95 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.052 -0.522 . . . . 75.23 110.769 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.08 93.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.043 0.937 . . . . 75.45 112.049 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 79.3 mtp180 -68.13 -23.64 64.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.689 0.796 . . . . 74.51 111.777 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.26 -47.08 12.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.842 0.857 . . . . 75.2 110.152 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD21 ' NE2' ' A' ' 53' ' ' GLN . 89.8 mt -67.09 -20.17 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.918 0.887 . . . . 74.32 111.341 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.56 -35.04 79.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.435 1.094 . . . . 74.42 110.902 174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.73 -32.95 25.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.278 0.631 . . . . 72.22 110.875 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' NE2' HD21 ' A' ' 50' ' ' LEU . 47.8 mt-30 -80.84 147.34 30.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.402 0.681 . . . . 74.51 110.394 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.08 56.94 5.01 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.475 -0.33 . . . . 45.15 112.46 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.41 105.14 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.086 0.954 . . . . 73.03 108.658 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -104.72 110.37 22.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.665 -0.865 . . . . 75.31 108.665 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.71 162.3 16.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.353 0.661 . . . . 74.24 109.423 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.71 140.46 22.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.673 -0.491 . . . . 73.44 109.673 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.64 122.19 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.12 0.968 . . . . 61.55 109.436 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -106.27 -17.01 14.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.442 0.697 . . . . 72.41 111.202 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.629 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.7 ttt180 -163.45 132.97 4.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.289 0.635 . . . . 74.33 110.227 -169.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.4 t -125.26 135.29 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.293 1.037 . . . . 62.0 108.762 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.84 108.97 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.283 -1.006 . . . . 74.5 108.283 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.4 121.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 121.11 0.481 . . . . 71.01 110.11 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.7 m -141.12 135.24 30.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.972 0.909 . . . . 74.13 108.639 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.495 HG22 HG21 ' A' ' 5' ' ' VAL . 26.8 p -100.8 134.13 44.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.606 0.762 . . . . 71.04 111.218 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.87 107.79 15.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.059 1.343 . . . . 75.12 108.715 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.39 -108.35 2.58 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.448 -0.661 . . . . 72.45 111.448 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.62 -11.97 12.92 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.34 1.056 . . . . 62.04 109.453 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 95' ' ' GLU . 44.8 m -90.28 129.74 36.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.194 0.998 . . . . 74.32 109.9 -172.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.409 HG12 ' HB1' ' A' ' 8' ' ' ALA . 21.6 t -88.8 143.74 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.38 0.672 . . . . 73.01 110.12 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -124.34 112.53 17.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.078 -1.082 . . . . 65.34 108.078 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.5 103.71 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 109.265 -0.643 . . . . 73.13 109.265 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.7 m -87.78 104.43 16.56 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.227 -1.027 . . . . 71.02 108.227 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.28 121.08 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.784 0.834 . . . . 73.42 109.763 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.7 tp10 -83.53 114.94 21.85 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.691 -0.855 . . . . 71.43 108.691 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' A' ' 90' ' ' TYR . 6.2 mp -101.66 160.65 14.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.193 -1.04 . . . . 62.54 108.193 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.23 105.28 7.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -105.49 106.81 17.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.39 0.676 . . . . 74.43 110.638 -169.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -87.79 104.75 16.87 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.712 -1.218 . . . . 65.23 107.712 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 t -136.52 125.0 23.49 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.374 -0.973 . . . . 73.24 108.374 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.01 26.11 72.26 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.98 -0.554 . . . . 64.43 112.993 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.38 60.13 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.19 0.424 . . . . 64.03 113.476 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.3 m -93.28 112.31 24.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.568 0.747 . . . . 73.51 110.432 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.6 m -88.47 107.88 19.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.682 0.793 . . . . 74.54 109.21 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.9 m -126.61 125.49 42.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.448 0.699 . . . . 73.2 110.221 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -77.9 115.68 17.83 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.304 0.642 . . . . 74.33 110.122 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.522 HG21 ' HA2' ' A' ' 110' ' ' GLY . 39.6 m -118.58 119.72 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.627 1.171 . . . . 72.42 108.799 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 m -88.17 120.76 29.83 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.59 -0.522 . . . . 75.23 109.59 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.435 ' CD1' HD11 ' A' ' 77' ' ' LEU . 11.3 m-85 -103.58 134.71 46.46 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.297 -1.371 . . . . 73.31 107.297 174.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -118.13 102.46 9.03 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.223 -1.029 . . . . 61.12 108.223 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.8 104.92 16.87 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.039 -1.097 . . . . 75.54 108.039 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -95.64 102.24 14.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.81 -0.811 . . . . 71.03 108.81 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.409 ' HB3' HG22 ' A' ' 101' ' ' ILE . 91.8 m-85 -87.47 108.86 19.22 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.674 0.79 . . . . 74.23 109.562 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 30.6 tt0 -92.81 120.94 33.68 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.471 -0.786 . . . . 75.21 109.645 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 4' ' ' ILE . 4.3 m -98.11 148.09 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.35 -0.841 . . . . 74.24 110.697 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.443 ' HB2' ' HG3' ' A' ' 102' ' ' ARG . 6.7 m-20 -120.37 91.59 3.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.909 -1.145 . . . . 70.2 107.909 173.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.7 -128.19 8.36 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 114.861 -1.063 . . . . 32.03 111.946 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.4 8.8 36.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.493 0.717 . . . . 74.21 112.616 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -139.63 162.43 35.12 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.315 0.646 . . . . 74.14 110.282 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 10.2 mt -95.52 140.12 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.412 -0.958 . . . . 65.34 108.412 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 36.0 mmt180 -126.9 -31.3 2.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.712 0.634 . . . . 74.23 112.712 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.8 mtt180 -130.39 161.67 30.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.528 0.331 . . . . 75.03 110.404 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.39 139.23 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.212 1.005 . . . . 75.31 109.319 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.3 m -121.28 105.16 10.29 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.567 -0.901 . . . . 63.1 108.567 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -89.29 104.3 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.8 m -95.73 103.78 15.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.307 -0.627 . . . . 73.32 109.307 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -85.22 95.06 9.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.605 0.762 . . . . 72.44 109.74 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.7 OUTLIER -77.79 93.61 4.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.227 -1.027 . . . . 75.02 108.227 172.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -79.94 57.97 4.56 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.724 -0.671 . . . . 71.34 111.915 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.81 145.28 4.13 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.513 -1.035 . . . . 64.13 110.513 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 t -107.35 170.75 7.78 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.56 0.744 . . . . 71.34 110.407 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -76.72 -14.01 59.98 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.712 -0.677 . . . . 74.12 110.515 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.67 109.58 2.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.345 1.058 . . . . 73.43 110.172 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -138.57 160.93 38.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.392 0.677 . . . . 74.2 109.801 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -104.34 -71.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.832 -0.803 . . . . 74.34 108.832 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -148.97 -167.26 2.78 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.334 1.053 . . . . 74.53 109.672 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.3 m80 66.08 43.49 2.9 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 124.183 0.993 . . . . 73.32 110.116 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -60.49 -31.33 70.37 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.095 0.958 . . . . 72.33 111.351 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.0 p80 . . . . . 0 C--O 1.251 1.141 0 N-CA-C 108.852 -0.796 . . . . 75.31 108.852 172.483 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 34' ' ' ILE . 8.6 ptm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.919 -0.4 . . . . 74.41 109.919 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -77.35 74.12 3.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.481 1.112 . . . . 73.34 110.755 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -172.47 35.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.332 1.453 . . . . 75.02 108.802 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.575 HG21 HG13 ' A' ' 96' ' ' VAL . 36.9 mm -47.69 -38.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.694 1.598 . . . . 64.41 113.842 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.2 -47.8 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.957 0.503 . . . . 64.25 110.022 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.23 -42.11 80.22 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.135 -0.939 . . . . 74.34 110.092 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -61.68 -37.96 86.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.01 0.924 . . . . 74.43 111.666 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.6 -32.61 60.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.926 0.89 . . . . 72.42 110.742 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HD2' HG12 ' A' ' 64' ' ' VAL . 63.8 tttm -67.72 -39.32 84.31 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.325 -0.852 . . . . 74.44 110.327 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.46 -40.82 85.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.357 0.663 . . . . 73.31 110.164 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.21 86.68 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.129 0.971 . . . . 64.23 111.633 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.81 66.58 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.962 0.789 . . . . 75.04 111.61 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -70.73 -32.12 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.2 -0.909 . . . . 73.34 110.8 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.5 -32.2 70.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.125 0.57 . . . . 70.43 112.182 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -60.78 -41.09 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.502 0.721 . . . . 73.2 109.398 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.29 -30.06 61.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.217 0.607 . . . . 72.52 111.771 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.29 -35.47 79.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.412 0.685 . . . . 74.33 110.271 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 73.4 mt -73.93 -40.4 63.12 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.81 -0.632 . . . . 71.55 110.867 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -60.71 -30.35 69.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.208 0.448 . . . . 74.32 112.208 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -96.65 -21.9 17.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.201 0.6 . . . . 75.32 111.024 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.66 89.14 2.69 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.538 0.735 . . . . 75.41 109.219 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.27 -17.53 44.74 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.905 2.403 . . . . 74.42 113.708 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.2 p -89.48 13.55 13.53 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.588 0.755 . . . . 74.52 111.425 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.39 112.27 12.28 Favored Pre-proline 0 C--N 1.358 0.978 0 C-N-CA 123.142 0.577 . . . . 75.12 110.035 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.72 -28.78 13.51 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.704 2.269 . . . . 73.33 113.02 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.1 -41.8 49.2 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.23 0.612 . . . . 71.1 110.949 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -55.72 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 62.44 110.667 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -66.95 -25.9 66.57 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.764 0.426 . . . . 74.43 111.993 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.37 -56.15 24.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.331 0.652 . . . . 74.3 110.196 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.57 -35.03 76.84 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.065 -0.516 . . . . 75.5 110.458 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.8 -29.32 70.63 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.716 0.806 . . . . 74.31 112.176 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -71.97 -35.52 69.56 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.194 0.521 . . . . 71.44 109.811 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -79.8 -39.07 31.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.834 -1.075 . . . . 74.12 111.55 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 ' SD ' ' A' ' 1' ' ' MET . 7.5 pt -96.54 -40.57 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.858 0.463 . . . . 73.13 111.956 -172.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.513 ' HG ' HG13 ' A' ' 34' ' ' ILE . 47.3 mt -100.95 -175.2 2.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.737 0.815 . . . . 72.41 109.24 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.574 ' HB2' HG21 ' A' ' 39' ' ' VAL . 11.0 m -75.98 146.21 78.67 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 109.334 -0.617 . . . . 72.22 109.334 167.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.22 -19.99 62.52 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.83 2.354 . . . . 73.02 112.452 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.98 -31.71 71.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.501 1.121 . . . . 73.14 111.339 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -69.54 -49.05 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 122.951 0.5 . . . . 64.13 110.287 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.36 -30.22 71.27 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.35 -0.241 . . . . 72.23 110.35 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.58 -40.39 84.83 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.302 1.041 . . . . 61.14 111.495 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.9 -33.06 52.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.211 0.204 . . . . 74.3 110.833 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.84 -47.63 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.415 0.686 . . . . 62.13 110.985 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 5.9 ppt_? -62.8 -29.97 71.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.741 0.417 . . . . 75.03 112.114 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.42 -47.86 58.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.757 0.423 . . . . 75.33 112.072 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -66.2 -31.24 71.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.115 0.484 . . . . 73.41 110.332 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.4 -39.57 92.34 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.714 -1.13 . . . . 74.11 111.891 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 71.9 mtp180 -67.77 -30.58 70.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.266 0.626 . . . . 74.42 111.182 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -72.77 -31.7 65.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.374 0.27 . . . . 75.34 111.069 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.23 -32.04 62.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.152 0.581 . . . . 73.31 110.742 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -70.29 -37.01 74.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.408 0.683 . . . . 74.01 110.354 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.564 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 4.7 ttmp? -60.8 -38.07 84.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.03 0.932 . . . . 65.14 109.816 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -90.12 176.75 6.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.012 -0.995 . . . . 75.21 110.41 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.59 33.12 6.82 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mt -77.79 101.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.996 -0.742 . . . . 72.4 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -94.09 151.85 19.2 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.671 -0.863 . . . . 70.3 108.671 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 44.1 p90 -147.67 161.77 40.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.572 0.749 . . . . 72.0 109.025 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -141.02 136.47 32.12 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.739 -0.467 . . . . 73.32 109.739 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.02 122.07 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 109.368 -0.605 . . . . 75.34 109.368 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -112.01 -44.61 3.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.355 1.062 . . . . 74.1 110.186 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -140.53 135.25 31.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.091 -0.959 . . . . 75.54 109.167 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.48 115.36 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.035 -1.098 . . . . 75.11 108.035 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -127.87 131.97 49.4 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.439 HG12 ' HD2' ' A' ' 9' ' ' LYS . 7.6 p -120.07 109.79 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.886 -0.783 . . . . 74.41 108.886 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.3 p -111.0 164.12 13.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.531 0.732 . . . . 54.12 109.07 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -119.96 143.15 48.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.1 110.093 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB3' ' ND2' ' A' ' 72' ' ' ASN . 5.0 t70 -140.23 91.55 2.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.833 -1.543 . . . . 54.22 106.833 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.56 -124.9 11.13 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.855 -1.298 . . . . 72.33 109.855 -164.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -97.51 -7.7 30.84 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.344 0.657 . . . . 71.51 110.749 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.1 m -88.29 121.54 30.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.343 -0.614 . . . . 74.32 109.343 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.1 t -86.96 136.69 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.664 0.786 . . . . 74.25 109.318 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 67' ' ' ASP . 9.0 m-80 -119.5 99.91 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.244 -1.021 . . . . 73.32 108.244 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.22 104.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.19 -0.67 . . . . 73.4 109.19 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.2 m -87.16 103.36 15.34 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.913 -1.143 . . . . 75.52 107.913 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.59 115.35 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.969 0.908 . . . . 73.33 109.166 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 37.7 tt0 -84.36 124.3 31.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.829 0.852 . . . . 74.11 109.522 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.95 119.7 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.429 0.692 . . . . 74.44 109.347 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -87.59 102.72 14.87 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.214 -1.032 . . . . 72.12 108.214 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.6 mt-10 -89.15 110.42 21.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.14 0.976 . . . . 72.44 111.452 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 45.2 m -89.77 99.88 12.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.551 -1.277 . . . . 72.14 107.551 172.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -147.55 144.65 28.66 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.422 0.689 . . . . 64.32 110.101 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.08 15.63 72.17 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.837 -0.619 . . . . 53.24 113.265 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.38 3.88 81.21 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.1 -0.278 . . . . 72.2 113.474 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -124.59 148.72 47.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.002 0.521 . . . . 64.22 110.559 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 67.3 m -102.86 106.0 16.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.144 -0.687 . . . . 74.32 109.144 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.4 m -101.95 120.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.527 1.131 . . . . 73.32 109.532 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.1 103.8 9.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.652 -0.87 . . . . 71.15 108.652 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -111.06 154.0 24.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.364 1.066 . . . . 75.22 109.744 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 29.9 m -114.53 149.1 36.97 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.113 -0.699 . . . . 60.41 109.113 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.93 131.73 47.56 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.176 1.39 . . . . 72.24 107.691 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -113.83 105.77 13.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.999 . . . . 73.41 108.304 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 106' ' ' VAL . 7.1 mp -98.4 106.21 18.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.828 -0.804 . . . . 74.34 108.828 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -95.9 103.05 14.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.134 0.574 . . . . 72.02 109.843 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' HB3' HG23 ' A' ' 101' ' ' ILE . 96.5 m-85 -87.18 108.49 18.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.129 0.972 . . . . 75.03 109.637 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 24.8 tt0 -99.71 124.21 44.73 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.575 HG13 HG21 ' A' ' 4' ' ' ILE . 3.2 m -98.17 151.89 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.177 -0.92 . . . . 65.33 111.808 -165.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -137.98 99.23 3.84 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.525 1.13 . . . . 71.44 108.062 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.31 -107.76 2.46 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.185 -0.916 . . . . 71.11 113.023 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.25 -4.08 13.77 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.63 1.172 . . . . 64.32 110.908 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.515 HG21 ' HD3' ' A' ' 102' ' ' ARG . 5.2 t -127.98 154.1 45.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.733 0.813 . . . . 73.13 110.228 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 96' ' ' VAL . 52.3 mt -95.37 133.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.177 -1.045 . . . . 71.14 108.177 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.515 ' HD3' HG21 ' A' ' 100' ' ' THR . 22.2 mmm180 -118.19 -2.98 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.633 0.373 . . . . 75.22 111.324 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 21.9 tpt180 -143.76 133.99 24.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.508 0.723 . . . . 75.3 110.01 -172.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.74 118.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.656 -1.238 . . . . 74.24 107.656 166.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 m -97.46 103.08 14.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.877 -1.157 . . . . 74.54 107.877 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG21 ' HG ' ' A' ' 92' ' ' LEU . 44.6 t -93.87 105.24 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.408 -0.96 . . . . 74.21 108.408 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -110.54 122.09 46.9 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.56 -0.533 . . . . 71.31 109.56 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.77 97.15 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.29 78.16 8.1 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.255 -1.017 . . . . 72.31 108.255 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.77 39.51 2.87 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.822 -1.081 . . . . 71.41 111.376 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.68 63.89 0.09 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.568 -0.613 . . . . 73.24 111.568 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.8 m -73.02 114.53 11.28 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.425 0.69 . . . . 74.23 110.449 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.42 1.64 27.93 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.462 0.705 . . . . 74.51 112.357 -176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.98 87.66 1.84 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.008 0.523 . . . . 73.44 111.463 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -116.9 107.85 15.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.39 -1.337 . . . . 75.23 107.39 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 52.7 t60 64.37 4.91 2.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.288 1.035 . . . . 74.04 111.143 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -81.6 70.06 8.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.894 0.878 . . . . 70.33 111.02 -170.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 168.72 127.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.53 2.332 . . . . 74.21 106.865 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -79.47 79.86 5.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.195 -0.668 . . . . 74.43 109.195 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.3 t60 . . . . . 0 C--O 1.257 1.467 0 N-CA-C 107.413 -1.328 . . . . 74.21 107.413 179.657 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HG3' ' HA ' ' A' ' 34' ' ' ILE . 13.2 tmm? . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 108.025 -1.102 . . . . 73.11 108.025 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.2 139.28 50.07 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.406 0.682 . . . . 54.0 110.323 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t0 65.59 101.88 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.314 1.446 . . . . 72.2 110.839 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -76.27 -39.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.372 1.069 . . . . 74.23 111.068 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.56 -48.38 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.016 0.526 . . . . 72.54 110.979 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.94 -40.47 93.38 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.908 0.755 . . . . 72.44 110.326 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.42 90.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.021 0.825 . . . . 74.05 111.136 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.26 80.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.441 0.696 . . . . 74.14 111.613 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -72.82 -48.78 34.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 72.05 110.549 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -61.15 -42.68 98.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.055 0.942 . . . . 71.32 110.937 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.72 91.65 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.111 -0.949 . . . . 73.32 111.26 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -55.31 -51.22 67.44 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.045 0.841 . . . . 72.4 111.416 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.56 -46.72 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.425 -0.807 . . . . 74.13 110.28 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.146 0.978 . . . . 74.31 113.057 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' HA ' HG13 ' A' ' 43' ' ' VAL . 57.6 mt -62.72 -43.19 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.802 0.841 . . . . 72.42 110.192 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -72.8 -33.16 66.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.553 0.341 . . . . 74.15 111.465 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.562 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 49.7 mt-30 -63.02 -37.85 88.83 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.639 0.587 . . . . 75.52 111.079 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 28' ' ' GLN . 95.6 mt -75.2 -37.24 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.768 0.667 . . . . 75.43 111.185 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.43 -29.32 70.63 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.747 0.647 . . . . 73.51 112.747 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -101.88 -15.11 16.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.825 0.45 . . . . 74.35 111.58 175.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.59 84.27 3.16 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 108.975 -0.75 . . . . 74.32 108.975 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 -12.93 36.76 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.142 2.562 . . . . 75.43 112.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -80.91 -5.58 57.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.446 1.098 . . . . 74.55 112.384 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.99 112.55 18.42 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 109.756 -0.461 . . . . 74.44 109.756 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.15 -34.11 5.23 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.599 2.199 . . . . 64.13 113.018 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.93 -30.83 56.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.867 0.467 . . . . 74.11 111.653 -171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.02 79.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.354 0.662 . . . . 62.44 110.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.53 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.0 pt20 -78.34 -23.94 46.76 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.09 -0.504 . . . . 72.41 111.616 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.67 -48.85 75.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 72.04 110.375 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.0 pp -66.48 -35.02 79.22 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.419 0.449 . . . . 74.04 109.951 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.15 -21.6 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.782 0.833 . . . . 72.54 112.191 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.1 -31.27 34.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.555 -0.535 . . . . 74.53 109.555 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.98 -35.09 38.0 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.22 1.008 . . . . 74.11 112.382 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.5 pt -111.26 -45.15 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.038 0.535 . . . . 74.32 111.854 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 39' ' ' VAL . 3.8 mm? -96.03 177.27 5.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.998 0.919 . . . . 71.31 108.869 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.453 ' HB2' HG21 ' A' ' 39' ' ' VAL . 19.4 m -71.65 147.01 91.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 116.321 -0.399 . . . . 64.45 110.061 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.63 -18.77 56.92 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.558 2.172 . . . . 75.51 113.21 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.07 -37.92 81.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.295 1.038 . . . . 61.42 111.18 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 35' ' ' LEU . 77.5 t -61.8 -55.57 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.749 0.656 . . . . 62.03 110.047 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.0 pp -59.73 -33.46 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.439 0.462 . . . . 74.12 111.038 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 27.5 t70 -67.55 -54.4 20.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 124.249 0.968 . . . . 75.11 110.44 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -67.28 -24.71 65.81 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.155 0.182 . . . . 74.45 111.404 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG13 ' HA ' ' A' ' 15' ' ' ILE . 31.8 t -68.91 -52.03 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.491 0.716 . . . . 75.03 110.64 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -65.91 -20.73 66.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.576 0.35 . . . . 74.44 111.389 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 44.8 mt-10 -81.93 -35.77 28.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.406 0.682 . . . . 72.13 110.642 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -67.34 -22.29 65.6 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.223 0.609 . . . . 74.41 110.498 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.14 64.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 70.1 111.431 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -59.11 -33.14 70.51 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 124.33 1.018 . . . . 73.04 111.563 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.63 -50.87 61.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.284 0.634 . . . . 72.33 110.633 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.39 -34.26 61.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.081 -0.963 . . . . 75.45 110.682 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.06 -29.04 54.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.166 0.986 . . . . 75.32 110.848 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.43 -40.28 85.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.475 0.71 . . . . 73.45 109.847 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.8 -29.56 62.24 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.002 -0.999 . . . . 73.41 110.315 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.47 29.14 30.86 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.902 0.751 . . . . 44.11 112.81 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.43 116.47 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.743 0.817 . . . . 74.43 109.957 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -91.48 112.18 23.99 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.794 -1.188 . . . . 64.43 107.794 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -130.17 132.59 46.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.629 0.772 . . . . 73.34 109.621 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.32 135.72 51.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.152 0.581 . . . . 71.43 110.427 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.54 119.83 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.285 1.034 . . . . 74.23 109.81 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -104.89 -55.22 2.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.085 0.554 . . . . 74.1 110.409 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -131.9 124.77 30.17 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.753 -0.832 . . . . 75.35 108.753 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.28 116.31 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.274 -1.01 . . . . 72.22 108.274 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -113.92 108.44 17.05 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.637 -0.875 . . . . 73.23 108.637 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.88 127.18 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.381 -0.97 . . . . 73.22 108.381 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -139.61 139.83 36.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.398 0.679 . . . . 74.24 109.2 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.521 HG22 HG23 ' A' ' 71' ' ' VAL . 47.3 p -97.56 116.23 29.38 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.046 0.538 . . . . 73.32 110.007 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.33 91.4 3.65 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.564 -1.273 . . . . 73.12 107.564 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.1 -119.98 7.0 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.017 -0.992 . . . . 73.55 110.905 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -101.13 -11.54 19.5 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.326 0.65 . . . . 74.33 111.082 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 m -94.39 121.51 36.0 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.516 0.726 . . . . 72.32 109.516 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 HG23 HG22 ' A' ' 66' ' ' THR . 68.3 t -87.62 139.14 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.937 -0.764 . . . . 72.33 108.937 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -120.91 110.49 16.36 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.123 . . . . 65.12 108.171 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.12 104.11 15.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.615 -0.883 . . . . 64.12 108.615 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 78.4 m -92.72 105.58 17.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.897 -1.149 . . . . 70.33 107.897 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.55 124.01 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.658 0.783 . . . . 74.52 110.412 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.88 121.91 30.01 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.28 -1.007 . . . . 71.31 108.28 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.419 HD11 ' CD1' ' A' ' 90' ' ' TYR . 6.6 mp -107.45 160.65 15.48 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.337 0.655 . . . . 71.15 109.328 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -116.63 104.64 11.59 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.541 1.137 . . . . 74.22 108.153 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -100.36 102.97 14.34 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.893 -0.41 . . . . 70.23 109.893 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -89.83 104.23 16.81 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.333 -1.358 . . . . 70.44 107.333 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 t -133.73 122.9 24.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.593 0.757 . . . . 74.53 110.25 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.65 0.25 58.36 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.639 -0.709 . . . . 75.2 114.02 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.28 -36.22 3.49 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.734 0.683 . . . . 54.1 111.531 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.3 p -84.87 124.82 32.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.554 0.742 . . . . 74.31 110.914 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -93.7 106.24 18.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.698 0.799 . . . . 74.44 109.796 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 m -114.33 123.61 49.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.117 0.967 . . . . 75.1 109.002 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.57 130.21 35.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.094 -0.706 . . . . 75.3 109.094 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -127.03 125.92 42.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.077 0.951 . . . . 72.01 109.335 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -89.01 121.0 30.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.275 -0.639 . . . . 63.24 109.275 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.419 ' CD1' HD11 ' A' ' 77' ' ' LEU . 10.2 m-85 -102.99 133.08 48.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.261 -1.385 . . . . 70.33 107.261 173.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.34 106.1 12.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.91 -0.774 . . . . 74.15 108.91 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.0 mp -97.34 106.23 18.51 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.26 1.024 . . . . 64.04 108.384 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.589 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 76.8 ttt-85 -96.2 99.97 11.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.706 -0.85 . . . . 71.4 108.706 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -85.87 107.88 17.88 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.68 -0.691 . . . . 74.55 109.418 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 38.5 tt0 -101.11 124.26 46.55 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.913 -1.04 . . . . 75.22 108.954 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 101' ' ' ILE . 29.9 m -87.27 147.46 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.562 -0.744 . . . . 74.32 111.534 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.82 99.44 6.28 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.648 -1.242 . . . . 74.5 107.648 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.67 -110.99 3.43 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.272 -0.876 . . . . 31.42 112.61 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -89.23 -16.23 31.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.924 0.89 . . . . 64.13 112.311 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -133.69 166.29 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.231 0.612 . . . . 74.44 111.156 -168.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.476 HG12 HG13 ' A' ' 96' ' ' VAL . 25.1 mt -94.73 120.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 107.934 -1.136 . . . . 61.02 107.934 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -106.75 -17.22 14.28 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.044 0.538 . . . . 70.13 111.2 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 84.4 mtt85 -128.63 146.98 50.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.405 0.682 . . . . 75.32 110.889 -170.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.8 p -146.31 112.23 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 114.963 -1.017 . . . . 74.3 108.755 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 92.8 m -91.8 103.54 16.08 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.634 -0.876 . . . . 73.43 108.634 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.76 112.39 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.075 -0.713 . . . . 72.33 109.075 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.0 m -106.89 118.64 37.22 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.034 0.534 . . . . 64.5 109.825 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.75 84.04 7.7 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.826 0.85 . . . . 72.32 109.103 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -77.25 95.2 4.27 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.996 -0.547 . . . . 72.21 109.715 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.82 92.18 0.1 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.276 -0.875 . . . . 65.5 110.928 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.36 -127.64 5.54 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.209 -0.756 . . . . 60.33 111.209 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -86.94 32.02 0.69 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.77 0.828 . . . . 63.12 111.748 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.7 29.05 1.05 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.952 0.901 . . . . 62.31 111.354 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -60.31 130.7 47.92 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.456 -0.942 . . . . 64.12 108.456 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -80.72 80.76 7.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.629 0.728 . . . . 72.44 110.566 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -86.93 40.68 0.92 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.975 -1.012 . . . . 73.11 110.953 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -138.44 90.5 2.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.07 -1.455 . . . . 63.55 107.07 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -144.49 162.78 35.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.562 0.745 . . . . 74.11 109.664 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -78.42 171.54 14.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.709 0.803 . . . . 75.22 111.352 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--O 1.25 1.11 0 N-CA-C 108.826 -0.805 . . . . 75.4 108.826 177.577 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.967 0.413 . . . . 72.51 110.678 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -139.95 10.0 2.38 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.903 0.881 . . . . 74.31 110.224 -175.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.24 105.42 1.73 Allowed 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 124.687 1.195 . . . . 73.03 109.825 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.439 HG23 HG13 ' A' ' 96' ' ' VAL . 46.2 mm -46.4 -46.11 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.22 1.408 . . . . 73.02 113.934 -167.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.33 -52.18 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.41 0.684 . . . . 73.41 110.551 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.02 -33.92 72.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.512 -0.767 . . . . 74.14 111.35 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.02 68.72 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 124.237 1.015 . . . . 75.35 109.945 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.14 -32.64 73.05 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.719 0.637 . . . . 74.51 111.443 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.59 -51.49 59.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.581 0.752 . . . . 74.23 110.319 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.66 -33.82 76.83 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.611 0.765 . . . . 73.33 111.163 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.13 81.69 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 124.284 0.99 . . . . 71.15 110.752 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.47 71.1 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.399 1.062 . . . . 63.42 111.256 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 HG23 HE21 ' A' ' 17' ' ' GLN . 28.8 mt -66.31 -38.32 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 O-C-N 124.1 0.875 . . . . 74.55 110.072 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.1 74.37 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.814 0.845 . . . . 73.21 111.858 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 43' ' ' VAL . 60.1 mt -61.65 -40.97 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.774 0.83 . . . . 65.51 109.747 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.476 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 43.4 m-85 -75.36 -29.11 59.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.774 0.43 . . . . 75.45 112.084 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.405 HE21 HG23 ' A' ' 13' ' ' ILE . 72.7 mt-30 -63.13 -38.2 90.25 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.468 0.48 . . . . 73.34 110.148 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.09 -38.78 63.78 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.691 0.619 . . . . 74.44 110.707 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.1 m0 -68.58 -22.04 64.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.825 0.676 . . . . 73.42 112.825 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -99.68 -20.86 16.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.053 0.541 . . . . 73.33 110.883 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -158.72 91.75 2.02 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 123.928 0.891 . . . . 74.55 109.96 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.11 -9.14 24.84 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.268 2.645 . . . . 75.11 113.965 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 p -90.25 0.64 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.818 0.847 . . . . 75.51 111.868 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.04 114.73 22.45 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 122.866 0.466 . . . . 74.44 110.541 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 98.2 Cg_endo -75.21 -27.38 9.74 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.51 2.14 . . . . 75.41 114.005 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.9 -34.39 24.55 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.864 0.465 . . . . 61.32 112.06 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -52.34 57.12 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.483 0.713 . . . . 62.21 110.223 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -66.39 -28.53 68.7 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.203 -0.908 . . . . 74.55 111.31 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 6.8 tm-20 -58.49 -59.04 5.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.018 0.927 . . . . 73.21 109.93 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -63.97 -33.99 76.96 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.08 0.862 . . . . 72.21 111.034 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.12 -30.1 71.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.912 0.885 . . . . 72.1 112.471 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -65.42 -27.11 68.3 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.07 0.396 . . . . 74.3 111.866 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -94.16 -36.29 12.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.987 0.915 . . . . 72.33 112.286 -171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HG13 HD22 ' A' ' 35' ' ' LEU . 22.0 pt -103.74 -29.08 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 122.859 0.464 . . . . 74.23 112.225 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.476 HD11 HG23 ' A' ' 39' ' ' VAL . 4.1 mm? -106.05 178.38 4.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.035 0.934 . . . . 73.23 108.592 172.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 m -84.78 149.88 54.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.049 -0.523 . . . . 74.54 109.952 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HA ' HD21 ' A' ' 40' ' ' LEU . 83.0 Cg_exo -50.55 -26.25 16.28 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.565 2.843 . . . . 74.15 114.668 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.93 -42.07 95.0 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.084 0.954 . . . . 72.12 111.559 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 35' ' ' LEU . 88.6 t -60.83 -60.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.555 0.742 . . . . 75.11 112.056 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -61.05 -22.55 64.68 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.073 0.397 . . . . 75.44 112.073 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.29 -42.68 30.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 71.01 111.234 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -71.56 -27.11 62.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 110.298 -0.26 . . . . 72.53 110.298 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.414 HG21 HG12 ' A' ' 15' ' ' ILE . 37.7 t -65.92 -53.8 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.69 0.796 . . . . 73.44 110.151 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -63.11 -22.47 66.88 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.229 0.212 . . . . 73.21 111.03 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -74.93 -45.27 43.62 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.452 0.701 . . . . 73.13 110.484 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -71.19 -22.67 62.0 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.895 -0.593 . . . . 73.12 110.701 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.49 98.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.187 0.995 . . . . 73.22 110.898 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -66.06 -34.14 77.4 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.912 -1.04 . . . . 75.25 110.837 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.53 -48.33 79.98 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.804 0.69 . . . . 63.43 110.867 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.67 -51.8 60.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.613 -0.722 . . . . 72.31 110.752 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.77 -35.29 79.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.351 -1.295 . . . . 71.22 111.405 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -61.01 -43.08 99.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.668 1.187 . . . . 75.24 111.356 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -83.65 -15.12 50.12 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.23 -0.896 . . . . 73.11 111.256 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.32 60.19 Favored Glycine 0 C--N 1.345 1.032 0 O-C-N 123.268 0.355 . . . . 74.44 112.878 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.95 91.49 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.821 -0.807 . . . . 75.02 108.821 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -92.53 153.15 19.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.398 -0.819 . . . . 71.55 108.876 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -149.84 170.17 19.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.339 0.655 . . . . 74.44 110.49 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -141.04 138.12 33.41 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.527 -0.916 . . . . 62.13 108.527 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.92 138.22 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 123.528 0.517 . . . . 74.44 109.86 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -115.98 -42.26 3.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.776 0.83 . . . . 73.14 111.559 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttm105 -157.82 123.87 4.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.805 -0.634 . . . . 72.44 109.998 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.89 107.62 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.264 -1.013 . . . . 72.43 108.264 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.71 123.75 43.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 63.33 108.945 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.81 128.75 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.83 -0.804 . . . . 71.43 108.83 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -137.91 117.85 13.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.171 -0.677 . . . . 71.41 109.171 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.468 HG23 HG23 ' A' ' 71' ' ' VAL . 22.1 p -89.79 114.83 26.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.879 0.871 . . . . 75.31 109.856 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -113.99 90.92 3.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.448 1.099 . . . . 75.22 109.096 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.76 -105.13 1.45 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.513 -0.767 . . . . 75.31 112.43 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -114.89 14.65 17.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.241 1.016 . . . . 73.24 110.346 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.4 m -132.01 122.61 25.79 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.348 0.659 . . . . 64.12 110.227 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.468 HG23 HG23 ' A' ' 66' ' ' THR . 58.7 t -90.03 115.35 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 122.939 0.495 . . . . 70.44 109.792 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -102.31 106.82 17.67 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.617 1.167 . . . . 73.51 108.872 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.22 110.53 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.533 0.733 . . . . 73.51 109.706 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -98.4 105.3 17.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.195 -1.039 . . . . 73.32 108.195 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG13 ' HE2' ' A' ' 16' ' ' PHE . 2.4 p -124.3 127.88 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.071 0.548 . . . . 74.0 110.065 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.27 136.98 32.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.937 0.495 . . . . 72.31 109.876 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.5 141.78 48.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.852 0.861 . . . . 73.4 109.927 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.32 104.32 16.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.728 0.811 . . . . 71.03 109.905 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -86.18 107.05 17.71 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.298 0.639 . . . . 75.15 109.557 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.3 m -88.34 104.55 16.86 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.12 -1.067 . . . . 74.1 108.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -144.02 131.81 21.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.437 1.095 . . . . 74.25 108.959 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.33 26.66 73.49 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.844 -0.162 . . . . 73.13 112.863 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.84 85.71 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.49 -0.616 . . . . 71.34 114.359 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.2 t -127.47 146.02 50.64 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.643 0.721 . . . . 61.34 111.259 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 149.97 22.08 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.12 0.968 . . . . 75.03 111.104 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.2 m -137.6 122.03 18.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.269 1.027 . . . . 74.5 109.219 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.41 100.31 5.15 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.03 -1.1 . . . . 74.14 108.03 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -114.72 122.76 47.4 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.359 -0.837 . . . . 72.22 109.046 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.8 m -89.99 124.68 34.96 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.75 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -104.52 127.57 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.818 0.847 . . . . 74.23 109.024 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.63 113.62 27.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.644 -0.873 . . . . 75.5 108.644 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.31 107.36 18.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.719 -0.845 . . . . 71.02 108.719 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -91.6 100.36 13.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.255 1.022 . . . . 73.45 109.484 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.26 106.9 18.52 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.367 0.667 . . . . 75.32 109.47 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 44.0 tt0 -97.54 116.95 30.72 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.736 0.814 . . . . 74.35 108.858 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 101' ' ' ILE . 4.5 m -89.69 149.32 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.444 0.697 . . . . 75.41 110.629 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.46 119.48 15.42 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.444 -1.317 . . . . 75.22 107.444 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.14 -97.99 0.97 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.017 -0.433 . . . . 54.44 112.017 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -121.72 -17.49 7.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.885 0.874 . . . . 73.12 111.91 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.7 t -124.94 160.03 29.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.93 0.492 . . . . 73.1 111.152 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.537 HG12 HG12 ' A' ' 96' ' ' VAL . 27.3 mt -86.03 126.78 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.772 -0.825 . . . . 71.52 108.772 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -102.36 -29.96 11.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.531 0.733 . . . . 74.14 111.715 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -130.95 146.89 52.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.624 0.25 . . . . 62.24 111.086 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.61 107.81 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.263 1.025 . . . . 64.43 109.36 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -95.12 106.57 18.59 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.949 -0.76 . . . . 74.24 108.949 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.49 136.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 109.61 -0.515 . . . . 74.43 109.61 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -129.46 113.0 14.35 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.59 0.756 . . . . 74.03 109.796 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.31 101.79 7.36 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.316 0.647 . . . . 73.42 109.902 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -90.47 90.16 7.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.124 0.97 . . . . 65.25 108.887 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 47.25 0.11 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.128 -1.189 . . . . 63.35 110.128 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.94 78.76 0.24 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.05 -0.575 . . . . 64.23 111.719 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 m -64.46 94.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.91 0.884 . . . . 74.04 110.634 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -106.63 109.24 21.1 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.062 -0.718 . . . . 75.44 109.062 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.02 167.91 24.54 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.614 1.166 . . . . 72.51 109.783 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -154.88 102.92 2.38 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.786 -1.19 . . . . 72.2 107.786 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -114.12 122.68 47.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.374 0.67 . . . . 73.22 110.204 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -86.99 138.13 31.76 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.248 0.619 . . . . 73.45 109.592 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -75.63 104.8 6.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.849 0.46 . . . . 75.41 110.099 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -68.82 147.32 51.92 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.471 -0.786 . . . . 75.05 108.967 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 108.311 -0.996 . . . . 73.53 108.311 -178.388 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 94.8 mmm . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.509 -0.552 . . . . 75.24 109.509 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -129.39 15.9 6.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.453 0.701 . . . . 73.23 109.844 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.48 162.9 12.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.15 0.98 . . . . 72.23 109.692 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.25 -39.74 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.583 0.753 . . . . 74.41 111.725 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.27 -52.93 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.682 0.793 . . . . 63.24 111.891 -171.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -67.62 -35.7 79.43 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.686 -0.688 . . . . 72.02 110.523 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -62.8 -41.84 99.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.325 0.65 . . . . 72.52 111.293 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.65 66.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 73.41 111.008 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.58 -54.63 44.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.553 1.141 . . . . 74.22 111.054 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -64.43 -33.94 77.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.509 0.723 . . . . 75.52 110.977 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -49.42 76.11 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.008 0.818 . . . . 61.0 111.025 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.75 68.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.315 1.01 . . . . 71.34 111.504 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.407 HG22 HE21 ' A' ' 17' ' ' GLN . 51.1 mt -63.4 -40.46 89.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 124.175 0.922 . . . . 73.4 110.324 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.348 0.659 . . . . 73.53 111.334 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.3 mt -56.13 -39.32 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 72.24 110.304 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -71.12 -32.67 69.3 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.249 0.62 . . . . 74.42 111.759 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.407 HE21 HG22 ' A' ' 13' ' ' ILE . 71.8 mt-30 -63.04 -38.37 90.92 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.099 0.56 . . . . 72.24 110.519 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 3.4 mm? -66.59 -48.87 68.2 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 123.543 0.527 . . . . 75.22 109.945 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.445 ' HH2' HG13 ' A' ' 106' ' ' VAL . 32.4 m0 -51.52 -34.33 35.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.485 0.92 . . . . 74.05 113.485 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.46 -32.24 12.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.7 0.4 . . . . 73.31 111.686 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -143.95 86.99 8.22 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 108.983 -0.747 . . . . 74.15 108.983 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.89 -15.69 50.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.979 2.453 . . . . 74.23 113.03 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.2 p -89.45 13.34 13.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.42 1.088 . . . . 75.51 112.283 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.21 110.81 26.19 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.281 -0.636 . . . . 74.52 109.281 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.16 -21.61 17.71 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.461 2.107 . . . . 53.23 113.624 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.69 -39.55 26.97 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.359 0.664 . . . . 71.54 111.444 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.19 -50.02 65.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.464 0.706 . . . . 74.21 110.748 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 40' ' ' LEU . 11.6 pt20 -72.41 -19.63 61.56 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.429 -0.805 . . . . 71.3 111.505 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.49 -54.97 24.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.13 0.572 . . . . 74.55 110.592 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.26 -30.3 70.15 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.262 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.18 -28.4 69.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.908 0.755 . . . . 74.41 112.034 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -75.11 -26.96 59.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.317 0.58 . . . . 71.01 109.891 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -78.8 -41.26 30.84 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.915 0.886 . . . . 72.22 110.748 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 HD22 ' A' ' 35' ' ' LEU . 9.9 pt -103.27 -36.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.081 0.552 . . . . 74.43 112.294 -170.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD22 HG13 ' A' ' 34' ' ' ILE . 3.8 mm? -103.28 -176.88 3.21 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.26 1.024 . . . . 75.24 109.477 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 m -81.29 145.89 56.84 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.421 -0.809 . . . . 71.22 109.878 170.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.22 -27.98 59.47 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.854 2.369 . . . . 63.05 112.484 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.62 -48.33 77.71 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.537 1.135 . . . . 75.22 111.479 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG23 HD13 ' A' ' 35' ' ' LEU . 98.7 t -66.33 -51.97 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.81 0.844 . . . . 70.14 111.391 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 28' ' ' GLN . 4.0 pp -65.13 -28.66 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 120.769 0.318 . . . . 75.43 111.539 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.79 -33.21 60.13 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.511 -0.768 . . . . 72.02 110.54 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -77.62 -32.63 53.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.696 -0.483 . . . . 73.01 109.696 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.3 t -59.94 -42.73 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.442 0.697 . . . . 73.25 111.028 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -73.36 -21.49 60.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.834 0.454 . . . . 62.21 111.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.26 -50.73 13.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.295 0.638 . . . . 74.55 110.829 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -71.01 -21.3 62.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.712 0.805 . . . . 70.32 111.02 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -58.25 -44.86 88.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.725 1.21 . . . . 72.12 111.613 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 99.4 mtt180 -60.43 -35.55 76.08 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.408 -1.269 . . . . 74.23 110.689 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.69 -43.97 74.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.908 0.755 . . . . 74.33 110.3 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.97 -27.96 68.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.755 0.822 . . . . 73.21 111.207 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -79.4 -33.34 42.82 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.991 0.917 . . . . 72.54 110.089 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 94.0 mttt -67.63 -39.37 84.65 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.574 0.749 . . . . 74.5 110.315 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.18 -44.51 88.23 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.085 -0.962 . . . . 73.43 109.219 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.92 44.79 5.91 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.251 -0.886 . . . . 72.21 112.137 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -79.37 106.23 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.781 -0.822 . . . . 73.53 108.781 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -85.81 108.97 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.896 -1.15 . . . . 75.04 107.896 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.53 142.09 50.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.409 -0.589 . . . . 74.14 109.409 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.89 135.72 54.78 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.797 -0.816 . . . . 72.54 108.797 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.37 100.12 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.202 -1.036 . . . . 75.03 108.202 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.37 -49.98 8.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.47 -0.786 . . . . 74.53 110.816 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -144.5 122.65 12.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.308 -0.86 . . . . 73.25 109.682 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.65 124.76 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.623 0.769 . . . . 73.14 109.275 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.1 108.2 10.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.27 -1.011 . . . . 74.11 108.27 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 HG22 ' A' ' 73' ' ' VAL . 7.7 p -96.17 121.23 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.276 0.56 . . . . 73.44 109.541 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.1 m -129.4 141.46 51.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.165 0.986 . . . . 75.15 109.711 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -88.89 163.33 15.67 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.037 0.535 . . . . 74.43 110.939 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -158.57 74.76 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.767 -1.197 . . . . 72.01 107.767 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.84 -117.83 11.21 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.861 -0.495 . . . . 72.41 111.861 -171.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -88.31 -11.68 45.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.114 0.565 . . . . 70.03 111.023 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -97.93 156.05 16.79 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.706 1.202 . . . . 73.35 109.693 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.32 123.5 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.281 0.633 . . . . 73.12 110.296 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -99.34 112.64 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.855 0.862 . . . . 74.03 109.686 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.477 HG22 HG23 ' A' ' 64' ' ' VAL . 61.5 t -91.1 105.02 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.901 -0.777 . . . . 71.11 108.901 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -86.07 104.95 16.14 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.367 -0.975 . . . . 74.42 108.367 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.16 126.82 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.995 0.518 . . . . 65.33 110.461 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.65 123.75 32.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.809 0.844 . . . . 74.14 109.381 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.69 123.15 45.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.316 -0.994 . . . . 73.44 108.316 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 34.9 tt0 -88.86 107.82 19.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.461 -0.941 . . . . 73.13 108.461 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.89 130.61 48.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.731 0.813 . . . . 74.25 110.652 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.2 m -119.52 117.68 29.04 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.158 1.383 . . . . 72.45 107.926 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -144.27 134.29 24.06 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.542 -0.91 . . . . 75.4 108.542 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.51 28.64 62.61 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.355 0.409 . . . . 73.32 113.619 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.67 -34.34 4.25 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 74.33 113.03 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -82.05 133.99 35.32 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.236 0.614 . . . . 72.15 110.612 -170.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -118.51 129.85 55.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.601 0.761 . . . . 64.22 110.334 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.1 m -143.64 136.27 27.24 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.918 0.887 . . . . 73.22 109.669 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 16.5 m120 -79.79 105.39 11.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.684 0.793 . . . . 75.5 109.956 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 m -101.03 126.53 47.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.625 1.17 . . . . 72.42 110.385 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -93.78 122.52 36.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.876 0.47 . . . . 72.22 110.795 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.8 127.54 53.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.398 0.679 . . . . 73.21 109.485 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.03 106.69 18.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.909 -1.145 . . . . 72.13 107.909 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 106' ' ' VAL . 6.7 mp -95.34 106.84 18.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.09 -1.078 . . . . 74.5 108.09 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 34.1 ttt180 -98.44 99.91 11.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.942 0.897 . . . . 74.32 109.41 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.81 112.46 22.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.525 1.13 . . . . 72.32 111.007 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 31.2 tt0 -90.91 134.36 34.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.088 -0.708 . . . . 73.31 109.088 174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.44 151.42 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.304 1.042 . . . . 72.23 111.712 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.37 103.41 6.9 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.705 -1.221 . . . . 64.04 107.705 162.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.33 -105.32 2.06 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.719 -0.673 . . . . 75.11 112.072 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.64 -9.9 10.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.24 1.016 . . . . 73.21 110.912 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -110.4 148.08 32.73 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.598 0.759 . . . . 74.32 109.214 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.09 144.73 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.865 -0.791 . . . . 74.31 108.865 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -125.06 -25.57 3.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.498 0.719 . . . . 72.43 112.443 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.577 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 3.0 mpt_? -129.72 156.44 44.27 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.755 0.422 . . . . 74.43 110.299 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 109.92 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.359 1.064 . . . . 74.33 109.091 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 40.7 m -92.05 105.12 17.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.762 -0.829 . . . . 61.44 108.762 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.478 HG21 ' HG ' ' A' ' 92' ' ' LEU . 48.0 t -93.36 105.84 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 122.927 0.491 . . . . 74.23 109.742 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.6 m -100.64 113.8 26.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.524 0.729 . . . . 74.33 109.849 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -79.62 126.67 31.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.027 -0.731 . . . . 75.45 109.027 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -128.95 146.93 50.83 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.66 0.784 . . . . 65.42 109.589 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.77 -12.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.423 -0.808 . . . . 73.42 111.93 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.62 151.42 19.16 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.343 -0.303 . . . . 74.5 112.343 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -93.06 85.92 5.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.528 0.68 . . . . 75.24 110.061 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.87 4.07 53.74 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.319 0.648 . . . . 74.42 111.448 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.02 95.61 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.15 109.963 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -178.14 159.3 1.27 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.871 1.268 . . . . 73.23 109.267 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -118.38 -74.47 0.6 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.097 -0.705 . . . . 72.11 109.097 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -97.05 43.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.438 0.695 . . . . 70.23 110.437 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.1 t60 67.08 62.2 0.48 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.232 1.413 . . . . 73.51 111.88 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -80.52 -15.24 57.17 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.297 0.57 . . . . 75.4 109.867 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.07 1.348 . . . . 73.13 107.918 174.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.766 -0.457 . . . . 74.55 109.766 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.6 8.66 33.31 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.32 0.648 . . . . 74.43 110.079 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -60.01 112.0 1.71 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 123.701 0.8 . . . . 63.43 109.974 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.76 -43.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.431 1.082 . . . . 75.52 111.489 -175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.5 -46.18 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.945 0.898 . . . . 70.52 110.199 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -67.23 -33.93 76.4 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.576 -0.738 . . . . 65.44 110.521 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.75 81.35 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.304 0.642 . . . . 75.04 110.513 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.26 98.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.575 0.75 . . . . 73.34 110.969 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -59.02 -56.54 20.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.258 1.023 . . . . 75.21 111.019 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.77 0.828 . . . . 73.14 111.444 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB3' HD13 ' A' ' 35' ' ' LEU . . . -66.44 -45.13 80.87 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 124.151 0.907 . . . . 53.1 110.628 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.12 75.16 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 124.112 0.883 . . . . 70.51 110.816 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.49 -44.85 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 124.263 0.977 . . . . 74.45 110.163 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.63 71.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.107 0.963 . . . . 73.52 112.7 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.401 ' HA ' HG13 ' A' ' 43' ' ' VAL . 62.7 mt -65.07 -41.45 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.26 0.624 . . . . 75.1 110.338 175.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -74.55 -31.51 62.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.71 0.404 . . . . 74.23 111.28 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.93 -37.41 85.98 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.111 0.564 . . . . 75.05 110.341 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.79 -38.86 67.11 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 119.199 -0.429 . . . . 74.42 110.71 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.429 ' HB3' ' HZ ' ' A' ' 57' ' ' PHE . 19.6 m0 -63.61 -21.33 66.3 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.364 0.876 . . . . 75.01 113.364 -176.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -102.32 -25.21 13.74 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.676 0.39 . . . . 71.21 111.156 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -146.04 96.0 4.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 123.273 0.629 . . . . 74.14 109.966 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.88 -28.51 75.59 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.251 2.634 . . . . 74.14 112.925 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 p -92.55 22.08 4.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.901 0.88 . . . . 73.44 111.945 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.25 112.15 23.75 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.055 -0.72 . . . . 74.3 109.055 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.37 -34.45 20.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.79 2.327 . . . . 72.3 112.898 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.71 -49.1 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 74.21 110.973 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.11 -52.67 64.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 124.225 0.953 . . . . 71.54 111.105 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HB2' HD12 ' A' ' 40' ' ' LEU . 2.9 pt20 -68.15 -32.8 73.32 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 116.061 -0.518 . . . . 71.41 111.608 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.2 tt0 -69.87 -43.5 71.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.469 0.307 . . . . 74.15 111.098 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.6 pp -67.35 -34.01 76.42 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.826 -0.435 . . . . 75.34 109.826 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.42 HD22 HD12 ' A' ' 35' ' ' LEU . 85.8 mt -65.34 -30.6 71.45 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.56 0.744 . . . . 75.23 111.517 174.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -67.53 -33.85 75.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.194 0.598 . . . . 72.23 110.355 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 27.4 mtpp -80.89 -46.35 15.37 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.161 -0.927 . . . . 73.31 111.376 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 30' ' ' LEU . 13.0 pt -99.07 -35.18 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.654 0.382 . . . . 75.53 111.732 -168.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 11' ' ' ALA . 28.3 mt -101.95 -170.52 1.83 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.397 -0.594 . . . . 74.21 109.397 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.555 ' HB2' HG21 ' A' ' 39' ' ' VAL . 8.9 m -73.36 138.35 78.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 115.623 -0.717 . . . . 70.32 109.504 169.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.93 -19.68 33.14 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.793 2.329 . . . . 64.13 113.501 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.78 -33.39 70.71 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.513 1.125 . . . . 75.34 111.755 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 36' ' ' SER . 53.0 t -67.07 -49.67 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.435 0.694 . . . . 74.32 111.42 -175.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 28' ' ' GLN . 3.5 pp -58.78 -30.8 67.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.396 0.278 . . . . 72.34 111.212 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.45 -58.93 5.05 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.714 1.206 . . . . 70.34 110.986 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.31 -30.47 71.6 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.823 0.449 . . . . 63.41 111.654 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 15' ' ' ILE . 48.9 t -67.08 -50.5 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.897 0.879 . . . . 74.31 110.651 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -73.68 -20.42 60.55 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.124 0.416 . . . . 73.25 112.124 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -85.61 -26.59 25.98 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 122.22 -0.3 . . . . 74.41 110.543 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.7 -25.31 60.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.885 0.874 . . . . 72.11 109.936 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.25 90.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.185 1.394 . . . . 75.12 112.066 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -59.89 -38.65 82.85 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.836 1.335 . . . . 75.14 111.005 -173.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -57.19 -58.84 6.46 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.233 0.958 . . . . 75.53 110.659 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.8 -34.02 76.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.509 1.124 . . . . 73.3 111.983 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -66.11 -45.11 82.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.014 0.925 . . . . 71.14 110.339 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.6 -32.56 66.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.48 0.712 . . . . 72.55 111.157 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -69.45 -18.29 63.71 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.486 0.714 . . . . 75.33 111.427 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.75 42.0 40.46 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.557 0.536 . . . . 73.24 112.203 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -111.15 96.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.211 -0.663 . . . . 74.32 109.211 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -92.05 108.11 19.7 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.192 -0.669 . . . . 70.31 109.192 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 8.7 p90 -106.3 135.49 47.7 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.174 -1.417 . . . . 73.44 107.174 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.56 135.6 47.15 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 110.007 -0.368 . . . . 73.21 110.007 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.68 125.18 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.902 1.376 . . . . 74.04 110.626 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.39 -37.93 3.91 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.731 0.813 . . . . 73.03 111.064 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 27.2 ttp85 -143.81 129.5 19.24 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.338 0.655 . . . . 75.01 109.349 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.65 128.66 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.878 0.871 . . . . 72.14 108.759 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.38 106.62 9.33 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.737 -1.208 . . . . 62.42 107.737 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 73' ' ' VAL . 7.3 p -103.26 113.97 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.772 -0.825 . . . . 74.53 108.772 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.5 t -137.55 153.63 49.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 74.5 109.97 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.544 HG21 HG21 ' A' ' 71' ' ' VAL . 34.2 p -100.75 130.16 46.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.145 0.578 . . . . 73.43 111.676 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.88 81.08 1.38 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.503 1.921 . . . . 71.33 108.437 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.44 -120.47 8.35 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.41 -0.814 . . . . 64.24 111.207 -173.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -87.38 -11.33 49.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.441 0.697 . . . . 73.15 110.639 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.4 m -89.96 156.73 18.22 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.272 1.029 . . . . 75.3 108.845 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.544 HG21 HG21 ' A' ' 66' ' ' THR . 43.7 t -122.4 133.0 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.04 0.936 . . . . 74.25 109.331 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -110.56 125.83 53.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.722 0.809 . . . . 75.12 109.203 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 64' ' ' VAL . 48.7 t -97.38 104.1 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.378 -0.971 . . . . 73.33 108.378 169.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -86.75 102.22 14.05 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.515 -1.291 . . . . 73.15 107.515 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.21 123.1 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 75.3 109.89 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.0 tt0 -90.13 127.81 36.19 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.353 1.061 . . . . 75.11 109.444 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.49 143.68 51.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.288 0.635 . . . . 75.33 109.847 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -91.61 108.75 20.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.178 -0.675 . . . . 74.51 109.178 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 24.9 mt-10 -87.25 103.18 15.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.075 0.55 . . . . 75.34 109.666 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.7 m -93.96 106.14 18.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 74.42 109.465 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -145.59 118.55 8.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.346 1.058 . . . . 75.54 109.24 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.73 23.14 62.8 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.514 0.565 . . . . 53.34 114.514 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.03 -22.64 34.48 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.964 0.316 . . . . 75.1 112.901 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.2 m -83.69 124.52 30.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.561 0.745 . . . . 71.14 109.833 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 m -126.92 110.37 12.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.445 -0.946 . . . . 61.34 108.445 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.9 m -125.9 136.11 52.68 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.955 0.902 . . . . 64.32 109.976 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.93 100.58 6.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.833 -1.173 . . . . 55.32 107.833 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.2 m -105.29 132.63 51.24 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.927 -1.033 . . . . 74.4 108.985 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -89.39 122.89 33.04 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.427 -0.583 . . . . 75.22 109.427 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -104.8 126.77 52.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.164 -1.05 . . . . 72.31 108.164 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -113.79 103.9 11.66 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.103 -1.073 . . . . 74.32 108.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HG ' HG23 ' A' ' 106' ' ' VAL . 5.7 mp -98.38 107.07 19.44 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.117 -1.068 . . . . 75.23 108.117 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -90.45 98.74 11.95 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.075 -0.713 . . . . 73.44 109.075 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.578 ' HB3' HG23 ' A' ' 101' ' ' ILE . 93.4 m-85 -89.54 109.92 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.492 1.117 . . . . 73.11 109.284 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 28.2 tt0 -107.63 131.59 54.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.616 -0.513 . . . . 72.34 109.616 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 101' ' ' ILE . 11.0 m -84.35 151.84 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.83 1.252 . . . . 63.44 111.115 -168.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.8 98.38 3.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.215 -1.032 . . . . 72.41 108.215 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.82 2.18 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.021 -0.831 . . . . 65.34 111.021 -174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.68 -5.25 12.71 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.977 0.911 . . . . 73.44 111.17 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 102' ' ' ARG . 4.6 t -127.44 143.86 51.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.68 . . . . 74.42 110.282 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' A' ' 94' ' ' PHE . 73.4 mt -87.9 109.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.671 0.788 . . . . 73.22 109.361 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HD3' HG23 ' A' ' 100' ' ' THR . 15.9 mmm180 -103.27 6.16 37.93 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.209 0.448 . . . . 75.13 112.209 -173.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 90.0 mtt180 -133.21 141.91 48.31 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.349 0.66 . . . . 73.4 110.903 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.96 134.68 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 72.24 108.504 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.4 m -132.02 106.56 8.1 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.444 HG23 ' HG ' ' A' ' 92' ' ' LEU . 37.6 t -90.04 119.03 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.924 0.49 . . . . 73.01 109.798 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.6 m -113.31 106.88 15.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.504 0.722 . . . . 73.23 110.374 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -77.93 103.83 8.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.39 -0.967 . . . . 65.13 108.39 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.97 79.94 9.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.539 0.735 . . . . 64.3 109.588 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.93 -17.75 15.66 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.461 -1.245 . . . . 71.25 111.687 172.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.86 120.22 0.58 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.299 -0.72 . . . . 70.22 111.299 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 m -72.98 159.57 33.46 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.253 0.621 . . . . 74.52 110.34 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.73 -60.08 4.23 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.831 0.852 . . . . 72.53 110.217 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.68 98.89 2.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.75 0.82 . . . . 74.35 109.385 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -81.7 178.38 8.36 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.302 0.641 . . . . 75.13 110.954 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -84.93 51.75 2.24 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.036 0.922 . . . . 72.41 110.331 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -143.41 97.06 3.01 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.998 0.919 . . . . 72.52 109.385 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -89.89 113.5 25.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.879 -0.786 . . . . 74.23 108.879 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 m80 63.91 97.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.805 1.242 . . . . 63.43 111.507 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.015 -1.105 . . . . 74.41 108.015 177.471 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.633 0.254 . . . . 74.44 110.38 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -88.48 -6.61 57.51 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.018 0.927 . . . . 75.53 110.801 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.99 41.62 0.98 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.519 1.128 . . . . 73.34 110.97 -170.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -51.59 -41.1 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 125.401 1.481 . . . . 61.22 114.111 -166.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.34 -51.9 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.457 0.703 . . . . 73.3 110.678 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.71 -30.1 71.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.437 0.695 . . . . 74.1 110.344 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.68 71.18 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.848 1.259 . . . . 65.34 109.87 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.78 82.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.528 0.731 . . . . 71.34 111.495 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HG3' HG11 ' A' ' 62' ' ' VAL . 39.6 tttm -63.68 -51.66 64.13 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.028 -0.987 . . . . 75.11 111.796 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.64 -24.7 61.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.348 0.259 . . . . 64.45 111.317 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.04 -45.12 86.7 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 123.533 0.733 . . . . 75.02 110.237 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -56.64 -54.37 46.9 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.475 1.109 . . . . 74.23 110.746 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.44 HG12 HG12 ' A' ' 59' ' ' VAL . 57.0 mt -59.89 -41.67 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.086 0.866 . . . . 72.35 110.854 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.71 88.52 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.959 0.904 . . . . 63.13 111.58 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.483 ' HA ' HG11 ' A' ' 43' ' ' VAL . 45.6 mt -61.22 -37.23 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 124.064 0.853 . . . . 74.51 110.496 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.27 -29.9 34.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.792 0.437 . . . . 74.45 111.497 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -66.73 -35.2 79.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.355 0.662 . . . . 74.33 110.276 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.15 -47.22 59.07 Favored 'General case' 0 C--O 1.213 -0.816 0 O-C-N 123.669 0.606 . . . . 74.05 110.17 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.487 ' HB3' HD12 ' A' ' 50' ' ' LEU . 29.1 m0 -57.1 -26.67 60.85 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.105 0.78 . . . . 72.54 113.105 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -101.36 -16.18 16.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.807 0.443 . . . . 74.42 111.963 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.419 HD21 ' HB2' ' A' ' 24' ' ' ASP . 7.8 t30 -156.17 89.54 2.79 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 123.996 0.918 . . . . 75.54 109.352 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 23.6 Cg_endo -59.77 -23.1 70.71 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.883 3.055 . . . . 74.13 113.633 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.4 p -81.17 -2.22 47.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.15 0.98 . . . . 62.54 112.341 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' HD21 ' A' ' 21' ' ' ASN . 10.2 t70 -66.95 113.49 13.54 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 122.919 0.487 . . . . 73.23 109.873 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.51 -28.26 4.54 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.363 2.042 . . . . 72.42 112.766 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -70.03 -41.02 74.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.47 0.708 . . . . 73.13 111.183 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -51.41 49.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.897 -1.047 . . . . 75.35 111.116 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -68.41 -28.37 67.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.118 -0.492 . . . . 74.32 112.056 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.28 -47.26 62.02 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.254 0.346 . . . . 62.3 110.874 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -65.76 -33.34 75.65 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 110.175 -0.306 . . . . 74.53 110.175 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.96 -28.88 70.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.731 0.813 . . . . 73.03 111.722 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -69.39 -41.63 76.21 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.435 0.636 . . . . 70.31 109.613 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -73.98 -22.62 59.55 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.606 -1.179 . . . . 74.35 112.215 -171.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.0 pt -118.09 -51.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.315 0.507 . . . . 75.25 112.337 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.438 HD21 HG13 ' A' ' 34' ' ' ILE . 3.1 mm? -82.14 166.43 19.68 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 65.31 108.206 173.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -61.79 142.7 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 109.77 -0.456 . . . . 75.4 109.77 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.84 -11.42 14.85 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.746 2.297 . . . . 72.14 113.444 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.86 -37.12 73.07 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.735 0.814 . . . . 53.54 110.816 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.0 -37.54 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.253 1.021 . . . . 61.51 112.202 -171.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.35 -31.54 72.19 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.784 0.265 . . . . 71.52 110.905 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.22 -57.34 6.9 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 124.457 1.098 . . . . 73.03 109.991 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 12.1 pt20 -58.79 -30.44 67.59 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.035 0.534 . . . . 75.45 111.993 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 15' ' ' ILE . 67.6 t -75.44 -49.8 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.127 0.971 . . . . 72.14 111.913 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -67.67 -24.96 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.745 0.307 . . . . 74.33 111.344 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -86.14 -25.57 25.67 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.825 0.45 . . . . 73.12 110.984 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 5.5 t60 -67.0 -29.29 69.09 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.913 0.885 . . . . 73.4 109.544 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 22' ' ' PRO . . . -59.03 -39.6 82.44 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.107 1.363 . . . . 63.21 112.667 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 75.3 mtp180 -58.43 -32.04 68.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.031 0.932 . . . . 73.22 111.293 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.22 -51.66 62.59 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.166 0.986 . . . . 74.52 110.907 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 55' ' ' ILE . 53.0 mt -73.6 -17.69 61.14 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.307 -0.86 . . . . 75.33 111.317 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -72.61 -42.73 64.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.177 0.991 . . . . 74.41 109.625 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 73.6 mmtt -61.62 -42.62 99.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 123.739 0.649 . . . . 74.44 109.611 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.418 ' NE2' HD23 ' A' ' 50' ' ' LEU . 50.9 mt-30 -72.53 -28.52 62.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.231 -1.349 . . . . 73.32 111.732 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.12 40.71 95.13 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.729 0.643 . . . . 54.2 113.087 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.495 HD12 HD21 ' A' ' 50' ' ' LEU . 59.3 mt -78.62 114.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.883 0.473 . . . . 72.12 109.865 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -90.64 112.92 24.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.485 -0.931 . . . . 72.11 108.485 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.2 134.38 20.51 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.428 0.558 . . . . 73.12 111.164 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.875 0.87 . . . . 72.02 109.645 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 13' ' ' ILE . 49.4 t -77.18 120.62 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.394 1.077 . . . . 72.51 109.755 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.19 -54.5 2.6 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.431 0.692 . . . . 72.15 111.376 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 8.6 tpp85 -132.59 127.27 34.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.442 -0.948 . . . . 70.14 108.442 -173.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.48 HG11 ' HG3' ' A' ' 9' ' ' LYS . 38.3 t -123.0 109.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.723 -0.843 . . . . 73.42 108.723 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -119.79 108.39 14.33 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.632 -0.877 . . . . 73.3 108.632 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -105.34 109.95 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.085 0.954 . . . . 71.04 109.687 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -123.83 142.55 51.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.913 0.885 . . . . 75.33 109.742 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.1 p -93.42 124.05 37.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.657 0.383 . . . . 75.2 110.369 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -113.51 98.24 6.95 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.228 -1.027 . . . . 72.35 108.228 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.191 -1.164 . . . . 73.42 110.191 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.45 -15.21 15.08 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.358 0.663 . . . . 74.44 110.332 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.0 m -93.35 117.06 29.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.922 0.489 . . . . 75.22 109.761 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 94' ' ' PHE . 8.0 p -88.68 128.9 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.189 0.596 . . . . 75.43 110.377 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.63 113.35 25.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.782 1.233 . . . . 74.22 109.363 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.57 104.48 15.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.292 -0.632 . . . . 75.42 109.292 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.404 ' HG1' ' HG3' ' A' ' 91' ' ' GLU . 56.9 m -86.29 104.8 16.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.019 -1.104 . . . . 72.51 108.019 173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.1 p -127.61 115.35 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.337 0.655 . . . . 74.34 111.391 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.59 132.43 35.3 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.206 -0.906 . . . . 72.33 109.573 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.24 135.17 54.43 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.001 0.92 . . . . 74.41 108.679 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 85' ' ' THR . 33.4 tt0 -93.96 102.14 14.22 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -95.35 112.88 24.52 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.482 1.113 . . . . 74.12 109.593 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -87.67 102.97 15.15 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.766 -1.198 . . . . 75.0 107.766 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -134.83 134.98 41.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.952 -1.129 . . . . 72.12 107.952 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.11 65.57 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.091 0.245 . . . . 71.3 112.553 -172.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.27 59.53 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 123.206 0.431 . . . . 72.41 113.5 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.2 p -96.66 151.01 20.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.905 0.882 . . . . 71.54 111.093 -173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 78' ' ' GLU . 89.4 m -85.38 115.85 23.36 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.093 0.957 . . . . 74.44 109.125 177.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.6 m -121.42 111.02 16.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.714 -0.847 . . . . 72.34 108.714 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -90.37 102.7 15.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.487 -0.931 . . . . 71.55 108.487 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.6 m -111.46 126.11 54.6 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.627 0.771 . . . . 74.22 109.261 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -91.73 120.89 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.456 -0.572 . . . . 74.14 109.456 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.2 127.69 49.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.768 -1.567 . . . . 75.14 106.768 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' HG3' ' HG1' ' A' ' 74' ' ' THR . 37.0 tt0 -111.26 102.08 10.52 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.987 -1.116 . . . . 70.35 107.987 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.4 mp -90.74 106.58 18.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.504 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 50.6 ttp180 -91.67 98.46 11.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.731 -1.122 . . . . 74.41 108.175 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.525 ' HB3' HG22 ' A' ' 101' ' ' ILE . 98.7 m-85 -88.53 107.75 19.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.999 -0.741 . . . . 74.02 108.999 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.572 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 1.6 tm-20 -90.89 125.95 35.9 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.882 -1.525 . . . . 74.33 106.882 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.13 148.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.177 0.991 . . . . 75.12 111.676 -163.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.7 92.45 2.75 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.691 1.196 . . . . 75.01 109.007 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.62 -102.42 1.29 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.468 -0.787 . . . . 74.14 111.53 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.5 -10.06 13.75 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.078 0.951 . . . . 73.4 111.037 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -108.17 166.73 10.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.274 0.63 . . . . 71.25 109.565 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 94' ' ' PHE . 54.1 mt -115.52 120.29 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 107.637 -1.245 . . . . 73.12 107.637 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -88.26 -30.92 19.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.176 0.19 . . . . 74.35 111.153 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 65.2 mtt180 -129.42 147.73 51.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.904 0.481 . . . . 75.33 110.904 -164.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.67 110.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 74.34 109.051 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 25.9 m -95.39 104.67 16.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.667 -0.864 . . . . 73.35 108.667 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.505 HG22 ' HG ' ' A' ' 92' ' ' LEU . 40.9 t -85.55 102.41 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.669 -1.234 . . . . 72.15 107.669 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 m -99.26 109.31 21.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.096 -0.705 . . . . 74.02 109.096 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.37 106.56 12.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.593 0.757 . . . . 74.4 110.374 -174.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -107.23 104.56 14.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.611 1.164 . . . . 62.32 108.54 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.32 -163.9 25.13 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-O 119.854 -0.414 . . . . 45.33 112.674 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.73 57.45 14.36 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.75 0.323 . . . . 74.52 112.855 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -87.52 97.67 10.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.85 0.46 . . . . 53.03 110.492 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.03 -55.1 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.244 0.545 . . . . 75.31 110.153 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 -167.95 2.14 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.574 1.15 . . . . 73.12 109.314 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -136.38 121.17 18.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.411 1.084 . . . . 74.14 108.782 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -67.54 -17.14 64.55 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.563 0.745 . . . . 73.54 112.292 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -129.36 145.14 51.44 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.442 -0.948 . . . . 75.13 108.442 165.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -52.62 143.55 15.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.998 0.919 . . . . 72.54 112.158 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -67.77 120.46 14.15 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.41 0.444 . . . . 72.11 110.958 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.411 -0.959 . . . . 73.31 108.411 171.381 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE1' ' HA ' ' A' ' 100' ' ' THR . 28.2 ttt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.205 -0.665 . . . . 73.11 109.205 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -58.46 -56.57 20.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.162 0.985 . . . . 71.53 112.193 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -160.54 163.01 33.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.536 0.734 . . . . 74.43 109.623 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.31 -50.15 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.884 0.874 . . . . 73.41 110.999 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.39 -36.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.205 -0.907 . . . . 65.03 110.295 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.14 -35.57 80.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.919 -0.582 . . . . 75.41 110.869 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . . . -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.731 0.412 . . . . 75.15 110.211 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.38 90.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.702 -0.681 . . . . 73.21 111.699 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.29 -46.79 69.39 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.471 -0.786 . . . . 74.31 111.285 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -63.83 -41.77 97.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.448 0.699 . . . . 73.11 110.666 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.34 97.86 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 123.666 0.604 . . . . 72.25 111.29 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -56.51 -53.71 54.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.032 0.833 . . . . 72.34 111.156 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 70.1 mt -61.96 -43.68 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.363 -0.835 . . . . 74.13 110.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 30' ' ' LEU . . . -63.96 -37.56 87.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.588 0.755 . . . . 72.13 112.454 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.14 -37.59 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.841 0.856 . . . . 73.42 109.985 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -74.52 -35.01 63.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.257 0.623 . . . . 73.4 111.818 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 8.3 mm-40 -63.35 -37.29 86.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.526 -0.546 . . . . 74.03 109.526 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 81.7 mt -71.48 -41.84 68.82 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.36 -0.836 . . . . 74.11 110.891 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -59.29 -34.57 72.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.87 0.693 . . . . 74.02 112.87 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -96.91 -15.99 20.9 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.606 0.362 . . . . 75.05 111.547 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.82 84.36 2.76 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.579 0.752 . . . . 74.45 109.145 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.18 -13.51 32.43 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.275 2.65 . . . . 72.42 114.135 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 p -89.43 9.68 25.44 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.717 0.807 . . . . 62.34 112.284 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.1 109.79 4.99 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.166 0.586 . . . . 74.12 110.056 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.67 -37.62 16.0 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.555 2.17 . . . . 74.32 112.979 -171.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.06 -42.73 69.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.791 0.836 . . . . 73.31 111.697 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.11 -54.97 29.59 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.548 0.739 . . . . 64.12 111.564 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -62.81 -32.87 74.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.756 -0.657 . . . . 74.12 111.6 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.9 -46.28 72.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.106 0.563 . . . . 73.24 112.129 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 14' ' ' ALA . 4.2 pp -69.64 -27.31 64.94 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 120.842 0.353 . . . . 73.34 110.422 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 mt -69.18 -18.63 63.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.011 0.925 . . . . 72.24 112.61 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -73.96 -29.05 61.79 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.082 0.401 . . . . 73.04 110.483 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.08 -42.21 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 75.04 111.654 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 20.0 pt -103.97 -31.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 112.326 0.491 . . . . 73.23 112.326 -172.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.78 -179.35 3.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.111 0.964 . . . . 72.33 109.208 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 39' ' ' VAL . 50.7 m -84.67 143.29 40.69 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 73.42 109.941 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.94 -32.22 37.19 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.298 2.665 . . . . 75.12 113.185 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.43 -47.99 77.93 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.115 0.966 . . . . 53.22 111.856 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.1 t -63.02 -52.32 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.199 -0.91 . . . . 71.33 111.259 -173.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.97 -28.18 69.91 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.187 0.44 . . . . 75.33 112.187 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -58.81 5.08 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 124.156 0.91 . . . . 64.05 110.073 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 39' ' ' VAL . 26.8 pt20 -69.16 -21.11 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.039 -0.528 . . . . 74.45 111.414 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.36 -50.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.725 0.41 . . . . 74.14 110.071 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 4.7 ppt_? -71.06 -21.0 62.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.757 0.281 . . . . 74.41 111.757 -177.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -73.22 -49.21 29.16 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.704 0.401 . . . . 75.31 111.498 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -67.89 -21.84 65.13 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.045 0.538 . . . . 63.13 111.111 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 18' ' ' LEU . . . -65.0 -37.7 88.52 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.234 1.013 . . . . 64.41 111.853 174.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 61.9 mtp180 -62.86 -27.38 69.3 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.57 0.748 . . . . 74.14 110.555 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -47.62 60.61 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.897 -0.592 . . . . 72.43 110.253 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD22 ' NE2' ' A' ' 53' ' ' GLN . 92.8 mt -65.86 -33.23 75.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.628 0.771 . . . . 70.22 111.361 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.82 -44.71 95.43 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.019 0.928 . . . . 74.52 109.702 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.82 -31.59 69.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.994 -1.003 . . . . 75.12 111.056 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' NE2' HD22 ' A' ' 50' ' ' LEU . 49.8 mt-30 -77.48 -15.59 59.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.445 0.698 . . . . 75.54 111.198 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.38 30.1 74.91 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.59 0.556 . . . . 45.01 113.469 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.62 99.18 4.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 109.588 -0.523 . . . . 74.53 109.588 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -81.33 109.62 16.01 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 107.591 -1.263 . . . . 74.34 107.591 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.66 162.88 14.72 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.596 -0.89 . . . . 74.51 108.596 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.12 130.33 20.85 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.781 -0.452 . . . . 71.43 109.781 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.6 t -68.04 135.58 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 123.967 0.792 . . . . 74.32 109.81 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -117.62 -51.97 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.582 1.153 . . . . 75.33 110.345 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -142.07 123.83 15.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.157 -0.929 . . . . 74.34 108.913 -173.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.25 112.81 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.231 -0.655 . . . . 75.24 109.231 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.05 146.64 44.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.951 -1.129 . . . . 72.42 107.951 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG21 HG22 ' A' ' 73' ' ' VAL . 5.7 p -135.45 108.81 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.052 -0.721 . . . . 74.12 109.052 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.8 m -118.38 128.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.328 1.051 . . . . 72.41 109.399 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.4 p -88.64 162.6 16.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.116 0.566 . . . . 74.31 110.478 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -160.6 92.15 0.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.335 1.054 . . . . 73.54 108.218 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.95 9.95 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.609 -0.55 . . . . 71.3 111.827 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -91.76 -10.88 38.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 74.21 111.224 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.2 m -101.6 140.54 35.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.571 0.749 . . . . 72.41 110.605 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 94' ' ' PHE . 2.9 p -121.76 116.67 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.561 0.696 . . . . 70.13 110.142 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -96.26 108.4 20.88 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.448 1.099 . . . . 73.23 109.154 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 64' ' ' VAL . 59.2 t -88.52 107.12 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.667 -0.864 . . . . 75.21 108.667 177.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -95.89 105.25 17.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.96 -1.126 . . . . 70.21 107.96 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.52 125.49 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.517 0.727 . . . . 75.43 110.45 -170.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.7 123.66 31.34 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.257 0.623 . . . . 73.4 110.061 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.15 122.41 37.0 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.285 -1.006 . . . . 72.2 108.285 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.3 116.73 27.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.293 0.568 . . . . 74.23 109.78 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.89 105.0 17.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.154 0.982 . . . . 72.41 111.416 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -90.78 103.13 15.87 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.651 1.181 . . . . 63.12 108.744 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.0 t -138.53 137.22 36.87 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.34 0.656 . . . . 64.44 109.557 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.77 22.12 67.95 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.918 -0.583 . . . . 60.24 113.018 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.9 -33.72 5.06 Favored Glycine 0 C--N 1.354 1.569 0 C-N-CA 122.848 0.261 . . . . 63.33 112.988 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -84.57 135.6 34.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.532 0.733 . . . . 75.11 111.486 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -107.88 145.95 33.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.706 0.802 . . . . 71.15 110.034 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.8 m -143.63 123.87 13.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.489 0.715 . . . . 74.13 109.082 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.97 102.13 6.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.077 -0.712 . . . . 73.03 109.077 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.9 m -107.68 131.63 54.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.967 0.907 . . . . 72.23 110.118 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -95.47 120.14 35.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.311 0.644 . . . . 63.45 109.435 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -102.9 126.37 50.03 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.989 0.915 . . . . 72.34 108.822 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.53 104.27 13.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.723 -0.843 . . . . 73.33 108.723 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 12' ' ' ALA . 5.7 mp -91.83 107.38 19.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.285 -1.006 . . . . 74.24 108.285 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -91.74 97.43 11.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.481 -0.781 . . . . 71.41 109.583 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.549 ' HB2' HG11 ' A' ' 71' ' ' VAL . 97.5 m-85 -91.14 117.4 29.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.517 0.727 . . . . 74.45 110.16 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 28.3 tt0 -101.48 121.19 41.5 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.682 -0.858 . . . . 74.24 108.682 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 101' ' ' ILE . 10.0 m -86.37 140.17 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.913 -0.403 . . . . 74.53 109.913 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -134.56 117.45 16.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.237 -1.394 . . . . 63.01 107.237 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -114.32 3.99 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.691 -0.964 . . . . 71.22 110.691 -168.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -113.95 -19.15 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.236 0.614 . . . . 75.24 112.097 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.489 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 8.9 t -112.14 161.86 16.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.227 0.611 . . . . 73.35 110.675 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 96' ' ' VAL . 52.4 mt -82.31 128.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.797 -0.816 . . . . 72.14 108.797 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -114.56 -14.52 12.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.409 0.684 . . . . 74.35 112.32 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 9.8 tpt180 -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.474 0.309 . . . . 75.0 110.505 -172.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.82 139.95 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.986 0.914 . . . . 64.34 109.162 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -134.62 104.62 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.581 -0.896 . . . . 74.43 108.581 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.72 132.02 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.014 0.526 . . . . 72.52 109.722 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.4 m -120.47 116.22 25.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.652 0.781 . . . . 64.34 109.212 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -80.3 105.26 11.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.774 0.83 . . . . 73.2 109.467 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -115.12 109.45 18.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.441 1.096 . . . . 73.33 110.566 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.41 63.56 4.45 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 112.087 -0.405 . . . . 72.45 112.087 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.51 31.76 56.04 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 112.129 -0.388 . . . . 73.33 112.129 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 m -77.56 117.4 18.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.511 0.724 . . . . 73.12 110.221 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt 59.74 33.23 21.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.39 1.076 . . . . 74.14 111.431 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.11 139.18 58.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.677 -1.147 . . . . 63.24 108.594 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -67.29 -41.94 84.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 74.2 112.964 -163.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -97.56 123.43 41.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.362 0.601 . . . . 71.12 110.942 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -69.36 91.93 0.57 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.914 -0.773 . . . . 74.03 108.914 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -81.22 23.53 0.59 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.438 0.903 . . . . 74.32 113.438 -170.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -159.05 129.36 5.84 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.113 -0.699 . . . . 74.0 109.113 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 124.7 1.2 . . . . 70.51 108.835 175.066 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.629 ' HB2' HG22 ' A' ' 34' ' ' ILE . 60.6 mtp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.344 -0.613 . . . . 74.02 109.344 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.29 -19.38 61.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.261 1.024 . . . . 73.02 111.789 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.67 85.36 0.64 Allowed 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.452 1.101 . . . . 74.3 109.713 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 HG13 ' A' ' 96' ' ' VAL . 34.3 mm -64.33 -43.65 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.423 1.089 . . . . 71.44 112.84 -169.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.5 -52.43 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.563 0.745 . . . . 74.12 109.554 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -69.93 -26.48 64.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.053 -1.43 . . . . 75.24 111.583 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.81 -57.39 8.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.619 0.767 . . . . 74.11 109.667 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.31 76.75 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.28 0.988 . . . . 74.22 111.883 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.75 -58.8 7.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.953 0.901 . . . . 65.24 110.694 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -69.82 -22.26 63.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.709 0.804 . . . . 75.31 111.67 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.3 -45.38 69.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.039 0.935 . . . . 71.01 110.571 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.18 -46.72 87.66 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.294 0.996 . . . . 74.45 110.672 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.592 HG12 HG21 ' A' ' 62' ' ' VAL . 41.7 mt -61.39 -42.31 93.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 O-C-N 124.404 1.065 . . . . 73.4 110.165 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.87 68.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.165 0.986 . . . . 72.54 112.62 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.5 mt -63.21 -42.52 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.595 0.758 . . . . 70.04 109.826 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 92' ' ' LEU . 30.4 m-85 -69.96 -37.27 75.77 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.728 -0.669 . . . . 74.31 111.547 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -61.67 -38.49 87.94 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.759 0.662 . . . . 75.12 110.909 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 44' ' ' ARG . 75.6 mt -70.0 -40.45 75.28 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.582 0.552 . . . . 75.33 110.487 174.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.477 ' HB3' HD13 ' A' ' 50' ' ' LEU . 39.5 m0 -64.87 -31.03 72.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 112.906 0.706 . . . . 74.42 112.906 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -98.52 -20.69 16.92 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.045 0.538 . . . . 74.14 111.537 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -156.27 85.14 3.17 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 123.786 0.835 . . . . 72.41 108.808 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.84 -19.87 69.8 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.45 2.1 . . . . 70.12 113.289 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -81.04 2.41 27.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.689 0.796 . . . . 75.3 112.635 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.86 111.48 6.5 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 122.878 0.471 . . . . 73.05 109.764 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.7 -31.58 8.4 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.347 2.032 . . . . 73.22 112.733 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.12 -39.42 65.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.343 0.657 . . . . 74.41 110.958 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -56.4 18.75 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 124.118 0.967 . . . . 74.12 110.937 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.44 -32.61 74.32 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.779 -0.646 . . . . 71.13 111.306 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.09 -56.71 16.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.515 0.726 . . . . 74.45 111.296 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -62.82 -31.73 72.78 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 123.759 0.662 . . . . 74.32 110.606 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -66.95 -26.03 66.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.552 0.741 . . . . 73.14 112.073 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.854 0.752 . . . . 72.24 110.516 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.77 -16.03 31.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.028 0.931 . . . . 74.3 111.501 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.629 HG22 ' HB2' ' A' ' 1' ' ' MET . 16.2 pt -124.56 -45.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.405 0.52 . . . . 70.54 112.405 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 39' ' ' VAL . 3.8 mm? -95.15 172.46 8.11 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.037 0.935 . . . . 73.41 109.26 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB2' HG23 ' A' ' 39' ' ' VAL . 21.0 m -83.25 143.52 45.28 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.464 -0.789 . . . . 71.13 110.041 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.71 -31.88 52.62 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.046 3.164 . . . . 72.44 114.049 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.34 -48.03 77.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.779 0.832 . . . . 75.04 111.619 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 35' ' ' LEU . 42.2 t -63.19 -39.48 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 72.24 111.516 -171.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.07 -27.57 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.472 0.177 . . . . 74.51 111.064 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 17.5 t70 -73.68 -44.81 55.62 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.71 0.631 . . . . 75.05 110.405 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.88 -32.71 74.03 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.593 0.357 . . . . 75.42 110.892 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.52 -51.56 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 74.3 111.263 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 18' ' ' LEU . 3.3 ptm180 -69.29 -17.27 63.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.058 0.543 . . . . 73.14 111.914 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 51.3 mt-10 -84.26 -35.26 23.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.433 0.693 . . . . 75.22 111.511 171.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -73.34 -17.76 61.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.476 0.711 . . . . 74.43 110.801 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.79 67.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.595 1.158 . . . . 74.24 111.673 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -56.1 -34.82 66.39 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 124.348 1.03 . . . . 72.4 111.507 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -65.19 -55.04 20.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.969 0.507 . . . . 73.35 111.04 -175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 19' ' ' TRP . 88.4 mt -71.39 -34.39 70.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.255 0.622 . . . . 75.34 111.35 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.46 -45.63 68.59 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.725 0.81 . . . . 74.11 111.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.01 -40.79 97.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.116 0.967 . . . . 65.03 111.134 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -75.72 -19.72 58.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.735 -0.666 . . . . 73.31 111.938 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.43 28.76 57.15 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.293 0.371 . . . . 51.02 113.44 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.62 104.97 9.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.602 0.761 . . . . 75.34 109.76 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -82.66 111.25 18.44 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.645 -0.872 . . . . 73.44 108.645 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 43.4 p90 -108.53 144.77 35.75 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.487 -1.301 . . . . 74.13 107.487 168.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -121.56 121.02 36.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.995 -0.743 . . . . 64.41 108.995 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.27 100.44 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.753 -0.832 . . . . 73.5 108.753 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -86.45 -45.19 11.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.824 0.849 . . . . 65.55 111.504 -171.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -144.87 142.29 29.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.265 -0.643 . . . . 74.41 109.265 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.592 HG21 HG12 ' A' ' 13' ' ' ILE . 93.1 t -125.18 128.73 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.264 -1.013 . . . . 72.31 108.264 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.2 123.73 40.91 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.933 -1.136 . . . . 64.14 107.933 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.31 126.42 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 109.467 -0.568 . . . . 74.14 109.467 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.7 m -132.56 122.3 24.59 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.554 0.742 . . . . 73.2 109.544 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -88.57 121.52 31.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.449 0.7 . . . . 61.42 109.983 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -125.96 89.28 3.0 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.176 0.991 . . . . 73.31 108.337 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.81 -121.46 7.85 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.022 -0.831 . . . . 44.42 111.022 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -98.54 -9.94 24.21 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.127 0.571 . . . . 74.52 110.294 170.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.6 m -96.49 111.16 23.37 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.334 0.654 . . . . 75.45 109.698 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.07 109.31 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.247 0.546 . . . . 71.51 110.225 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.471 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -84.22 103.93 13.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.601 1.16 . . . . 73.22 108.616 177.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.94 105.34 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.121 0.486 . . . . 73.32 109.85 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.407 ' HG1' ' HG3' ' A' ' 91' ' ' GLU . 17.1 m -86.04 105.13 16.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.28 1.032 . . . . 71.22 109.691 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.75 123.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.721 0.809 . . . . 72.4 109.878 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -85.61 117.68 24.66 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.282 0.633 . . . . 73.23 109.304 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.68 163.06 13.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.783 -0.821 . . . . 73.41 108.783 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -136.52 102.55 4.98 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.938 -1.504 . . . . 72.33 106.938 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.2 mt-10 -94.14 106.51 18.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.963 0.905 . . . . 75.41 110.46 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -93.92 106.41 18.39 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.737 0.815 . . . . 74.14 109.173 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -132.95 132.48 42.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.805 0.842 . . . . 75.24 109.621 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.16 13.26 61.9 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.089 0.396 . . . . 74.24 114.089 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.07 -32.97 6.83 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.78 -0.455 . . . . 72.43 112.881 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -84.09 150.18 25.73 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.216 0.508 . . . . 75.31 110.862 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.9 m -118.28 134.02 55.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.881 0.872 . . . . 63.34 109.959 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 m -138.52 122.11 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.475 1.11 . . . . 72.23 109.257 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -76.6 119.65 20.71 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.097 -0.705 . . . . 73.32 109.097 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.9 m -129.86 123.26 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.88 0.872 . . . . 72.3 109.5 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.0 m -87.67 128.86 35.29 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.534 -0.543 . . . . 75.22 109.534 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -109.75 125.38 52.63 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.32 -1.363 . . . . 73.43 107.32 168.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HG3' ' HG1' ' A' ' 74' ' ' THR . 2.9 tt0 -106.57 104.69 14.44 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.061 -1.088 . . . . 72.25 108.061 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 12' ' ' ALA . 4.3 mp -90.88 105.29 17.73 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.565 -1.272 . . . . 73.43 107.565 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -93.71 99.13 11.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.883 0.873 . . . . 74.43 108.846 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.96 108.16 19.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.189 0.996 . . . . 74.25 110.136 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 29.2 tt0 -90.92 113.99 26.35 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.902 -0.777 . . . . 61.22 108.902 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.592 HG12 HG12 ' A' ' 101' ' ' ILE . 4.1 m -83.48 148.82 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.095 -0.705 . . . . 65.22 109.095 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -141.97 96.53 2.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.117 -1.068 . . . . 74.2 108.117 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 -124.07 6.7 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.402 -0.679 . . . . 73.43 111.402 -173.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -89.87 -21.31 22.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.491 0.717 . . . . 74.3 111.689 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -121.87 157.59 30.82 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.33 0.652 . . . . 75.53 110.795 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.592 HG12 HG12 ' A' ' 96' ' ' VAL . 28.6 mt -90.55 115.47 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 75.21 108.689 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HD3' ' OG ' ' A' ' 36' ' ' SER . 28.6 mmt180 -89.35 -28.21 19.96 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.534 0.734 . . . . 75.44 111.104 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 29.5 mtt180 -130.85 135.9 48.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.929 0.492 . . . . 75.52 110.948 -163.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.95 142.94 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.263 1.025 . . . . 73.15 109.01 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -127.8 105.43 8.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.254 -1.017 . . . . 75.21 108.254 172.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.35 104.17 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.896 -1.15 . . . . 75.32 107.896 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -104.36 104.51 14.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.894 0.477 . . . . 52.35 109.952 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.76 98.48 2.41 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.542 -0.91 . . . . 74.41 108.542 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -60.42 133.68 56.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 62.32 112.037 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.44 -139.01 5.59 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.694 -1.362 . . . . 73.43 109.694 -173.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.37 -62.92 4.51 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 117.459 0.63 . . . . 74.4 112.341 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 t -137.1 143.86 42.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.117 0.967 . . . . 75.25 109.919 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.2 -11.0 39.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.847 0.859 . . . . 71.13 110.729 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.01 144.05 41.99 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.266 -1.013 . . . . 75.34 108.266 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -109.92 120.39 42.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.092 0.957 . . . . 74.24 108.602 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -65.42 89.98 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.911 0.862 . . . . 75.1 111.057 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -70.43 118.38 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.955 -1.021 . . . . 72.23 108.861 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -81.78 127.23 32.75 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.447 0.699 . . . . 73.44 110.002 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -59.01 107.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.141 0.977 . . . . 73.0 110.087 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.788 0.835 . . . . 74.45 108.825 178.222 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 107.814 -1.18 . . . . 74.52 107.814 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -58.36 -50.3 74.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.926 0.891 . . . . 70.21 111.989 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.47 104.0 16.0 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.227 0.611 . . . . 74.14 110.147 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -74.67 -31.67 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.846 0.859 . . . . 71.11 112.096 -174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -59.05 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.423 0.689 . . . . 73.45 110.754 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.31 -19.1 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.294 -0.412 . . . . 73.02 111.099 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -48.15 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.271 -0.64 . . . . 75.12 109.271 170.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.24 78.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.08 -0.964 . . . . 71.52 112.066 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.64 -53.25 57.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.681 0.792 . . . . 74.42 110.829 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.37 -30.55 70.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 75.51 111.053 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -61.88 -51.18 69.22 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 123.801 0.688 . . . . 74.35 110.693 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.51 57.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 124.068 0.855 . . . . 61.03 110.91 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.0 mt -57.61 -43.03 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.089 0.956 . . . . 74.54 110.987 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.43 72.9 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.253 0.621 . . . . 75.12 112.229 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.26 -40.91 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.843 0.857 . . . . 74.21 109.896 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 66.3 m-85 -79.55 -25.65 41.6 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.851 0.46 . . . . 75.45 112.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -67.85 -34.65 77.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.134 0.573 . . . . 73.32 109.858 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.3 mt -74.59 -46.02 41.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.005 -0.543 . . . . 72.33 110.179 172.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.0 m0 -61.48 -17.96 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.865 0.691 . . . . 73.21 112.865 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -102.4 -24.56 13.84 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 122.904 0.482 . . . . 74.51 111.599 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 24' ' ' ASP . 8.1 t30 -157.55 87.36 2.59 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.724 0.81 . . . . 74.44 109.693 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.54 -17.56 53.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.226 2.617 . . . . 73.34 113.348 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -79.69 -4.39 51.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.823 0.849 . . . . 65.14 112.693 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 21' ' ' ASN . 12.4 t70 -71.48 120.42 79.72 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 109.475 -0.565 . . . . 73.44 109.475 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.98 -30.39 7.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.234 1.956 . . . . 64.31 113.301 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.05 -26.31 27.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.198 0.599 . . . . 75.22 112.305 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.91 -48.01 55.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.36 0.664 . . . . 71.32 109.483 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.16 -27.36 63.49 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.73 -0.668 . . . . 71.41 111.895 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.27 -55.31 36.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.791 0.837 . . . . 74.52 111.733 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 4.1 pp -64.13 -28.18 69.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.929 0.768 . . . . 71.1 111.282 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.56 -28.29 67.66 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.923 0.889 . . . . 71.24 112.258 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -65.88 -37.99 87.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.327 0.584 . . . . 75.34 110.517 173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 50.0 mtpt -77.02 -39.35 50.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.686 -1.143 . . . . 71.43 111.281 -170.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 35' ' ' LEU . 16.2 pt -102.41 -32.77 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.365 0.666 . . . . 74.22 112.325 -171.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 34' ' ' ILE . 75.3 mt -116.34 -179.36 3.65 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.897 0.879 . . . . 75.41 110.453 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -74.27 152.85 88.18 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 115.349 -0.841 . . . . 75.32 111.371 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.76 -30.65 93.2 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.022 2.482 . . . . 74.25 112.588 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.1 -38.16 78.88 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.967 1.307 . . . . 55.34 112.49 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 HG11 HD11 ' A' ' 35' ' ' LEU . 57.5 t -68.24 -56.15 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.489 -0.778 . . . . 71.01 110.163 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -25.55 67.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.53 0.332 . . . . 72.52 111.528 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.55 -49.28 66.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.068 . . . . 71.42 110.488 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -73.06 -32.25 64.92 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.208 -0.451 . . . . 75.35 111.366 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.17 -47.48 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.067 0.947 . . . . 53.23 111.2 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -70.74 -23.31 62.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.153 0.427 . . . . 72.12 112.153 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.81 -51.51 12.43 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.435 0.694 . . . . 71.42 110.504 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 83.0 t60 -63.22 -27.25 69.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.019 -0.991 . . . . 73.41 110.836 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -61.87 -45.67 92.77 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.747 1.219 . . . . 74.35 111.495 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 96.5 mtt180 -61.51 -38.43 87.35 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.816 -1.084 . . . . 72.42 110.581 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.31 -46.76 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.147 0.579 . . . . 64.0 111.607 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 71.5 mt -64.03 -35.42 80.66 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.354 0.662 . . . . 73.24 110.479 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -62.56 -46.3 89.01 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.226 -0.897 . . . . 74.23 110.695 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 7.6 mtpm? -62.17 -41.03 97.93 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.331 0.652 . . . . 74.0 110.769 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -75.43 -19.76 59.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.3 -0.864 . . . . 74.31 111.4 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.25 38.14 19.22 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.188 0.305 . . . . 63.44 112.963 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.2 mt -90.55 89.56 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.06 0.944 . . . . 74.43 108.453 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -92.84 111.54 23.18 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 53.7 p90 -134.69 152.35 51.7 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.864 0.465 . . . . 75.3 110.327 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.79 142.06 51.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.173 0.589 . . . . 75.42 109.577 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.69 110.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.801 1.241 . . . . 73.14 109.077 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.56 -29.38 12.74 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.743 0.417 . . . . 72.21 112.022 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.03 131.72 33.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.198 0.599 . . . . 75.31 109.806 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.63 117.3 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.262 -1.014 . . . . 74.21 108.262 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.4 108.01 8.89 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.782 -0.821 . . . . 74.42 108.782 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.07 115.54 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.158 0.583 . . . . 71.03 109.557 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -130.19 128.3 41.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.78 0.832 . . . . 74.31 108.831 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -88.07 144.66 26.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.14 0.576 . . . . 70.43 109.642 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -131.9 90.09 2.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.517 -1.29 . . . . 72.13 107.517 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.93 -122.4 19.25 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.013 -0.994 . . . . 54.42 111.231 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -91.45 -7.73 49.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.506 0.723 . . . . 75.44 111.858 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.1 m -111.43 115.81 29.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.02 0.528 . . . . 74.42 109.835 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -92.74 131.02 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.599 0.76 . . . . 73.11 111.121 -175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -103.79 110.47 22.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.993 1.317 . . . . 74.21 109.448 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.11 104.53 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.67 -0.863 . . . . 75.35 108.67 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -86.68 105.42 16.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.263 -1.014 . . . . 74.52 108.263 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 16' ' ' PHE . 7.6 p -114.59 134.55 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.327 1.051 . . . . 72.41 108.603 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.4 123.78 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.774 -0.824 . . . . 72.34 108.774 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.82 161.78 24.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.082 0.953 . . . . 73.5 109.865 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.0 10.95 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 27.6 mt-10 -87.25 104.13 16.09 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.685 0.794 . . . . 63.23 110.685 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -89.17 102.99 15.64 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.498 -0.927 . . . . 73.11 108.498 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -141.54 136.45 31.15 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.314 1.046 . . . . 64.21 109.14 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.64 12.26 80.53 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.817 -0.629 . . . . 53.14 111.968 -170.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.22 -22.89 27.24 Favored Glycine 0 C--N 1.356 1.64 0 C-N-CA 123.496 0.569 . . . . 61.22 112.914 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 p -94.11 134.51 36.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.811 0.844 . . . . 65.42 111.269 -175.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.6 m -87.99 124.17 33.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.163 0.985 . . . . 74.22 110.118 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -120.97 116.42 25.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.456 1.102 . . . . 73.2 108.821 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -78.28 116.85 19.01 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.203 -0.665 . . . . 72.23 109.203 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -131.63 134.69 46.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.709 1.204 . . . . 74.33 109.883 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 m -97.67 145.6 26.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.273 0.629 . . . . 73.33 109.774 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -126.89 128.48 46.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.672 1.189 . . . . 73.51 108.007 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.95 104.25 16.26 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 71.35 108.252 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.19 106.04 18.23 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.226 -1.398 . . . . 64.33 107.226 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -102.1 97.91 8.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.678 0.791 . . . . 74.11 109.206 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 101' ' ' ILE . 90.8 m-85 -89.25 111.29 22.06 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.853 0.861 . . . . 74.31 109.899 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 38.5 tt0 -96.01 132.58 41.21 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.224 -0.658 . . . . 72.13 109.224 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.75 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.813 0.845 . . . . 74.34 111.343 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 102' ' ' ARG . 31.4 t70 -132.15 101.4 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.335 -1.358 . . . . 73.52 107.335 171.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.98 -99.42 0.94 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.328 -0.709 . . . . 75.2 111.328 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.17 -17.51 8.9 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.563 0.745 . . . . 74.33 111.123 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.0 m -113.91 133.96 55.12 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.24 0.616 . . . . 74.41 110.266 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 94' ' ' PHE . 74.2 mt -73.6 116.83 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.784 0.834 . . . . 75.32 109.12 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 97' ' ' ASP . 32.0 mmt180 -105.72 -7.68 18.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.242 0.617 . . . . 73.42 111.369 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.9 ttt180 -136.0 139.07 42.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.766 0.426 . . . . 75.34 110.658 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.27 130.69 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.219 1.008 . . . . 75.12 109.187 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.7 m -110.34 104.52 13.32 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.044 -1.095 . . . . 75.31 108.044 172.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.91 104.61 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.249 -1.019 . . . . 73.31 108.249 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 m -103.84 112.92 26.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.361 0.664 . . . . 74.52 109.617 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -74.13 103.43 4.57 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.808 -1.182 . . . . 72.41 107.808 171.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -68.73 131.47 45.22 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.846 0.859 . . . . 65.34 110.832 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.28 -64.99 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.951 -0.86 . . . . 75.42 110.951 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.58 162.28 11.17 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.04 0.352 . . . . 60.2 112.455 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 t -75.97 133.14 40.53 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.253 1.021 . . . . 63.31 109.88 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.12 -27.12 48.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.607 0.763 . . . . 72.23 110.197 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.75 167.18 19.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.303 1.041 . . . . 53.33 110.39 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -133.18 124.48 27.54 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.988 0.915 . . . . 72.21 108.645 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -138.4 6.32 2.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.659 0.784 . . . . 62.43 111.533 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -70.84 -20.48 62.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.098 0.559 . . . . 65.02 111.221 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -117.77 135.57 53.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.066 -1.087 . . . . 74.02 108.066 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -68.31 99.44 0.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.99 0.516 . . . . 72.03 109.772 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.7 p80 . . . . . 0 CA--C 1.553 1.094 0 C-N-CA 123.288 0.635 . . . . 74.53 109.377 177.234 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.432 0.158 . . . . 72.04 110.651 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.29 -6.41 58.86 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 74.24 111.151 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.7 71.39 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.228 1.011 . . . . 62.02 109.646 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 96' ' ' VAL . 47.4 mm -74.51 -22.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.263 1.025 . . . . 75.4 111.709 -172.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.31 -55.84 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.466 -0.568 . . . . 72.31 109.466 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.97 -32.56 65.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.061 -0.972 . . . . 73.21 111.884 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.73 -52.33 63.67 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.529 0.518 . . . . 72.24 110.404 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.72 67.49 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.549 0.74 . . . . 74.12 111.839 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.67 -55.68 21.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.396 0.678 . . . . 73.13 110.45 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -63.91 -32.59 74.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.864 0.866 . . . . 74.3 111.239 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.39 86.26 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 124.014 0.821 . . . . 71.33 111.143 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.77 92.47 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.97 0.793 . . . . 45.43 111.179 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 69.4 mt -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 124.291 0.994 . . . . 74.33 109.692 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.91 -29.99 71.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.041 0.936 . . . . 74.15 112.432 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.93 -41.15 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.538 0.735 . . . . 72.14 109.81 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -72.4 -35.21 68.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.73 0.412 . . . . 74.42 111.332 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 20.3 mm-40 -61.31 -37.43 83.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.868 0.73 . . . . 74.31 110.15 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.45 -45.13 32.69 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 123.634 0.584 . . . . 73.42 110.926 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -54.21 -31.62 53.61 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.387 0.675 . . . . 74.54 112.731 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -101.89 -19.05 15.43 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.889 0.475 . . . . 74.34 112.103 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.401 HD21 ' HB2' ' A' ' 24' ' ' ASP . 4.8 t30 -150.66 81.91 6.32 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.254 -0.647 . . . . 72.1 109.254 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.43 -11.89 33.42 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.135 2.557 . . . . 72.33 112.948 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -80.94 -2.29 47.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.591 1.156 . . . . 72.14 112.687 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' HB2' HD21 ' A' ' 21' ' ' ASN . 9.3 t70 -76.31 107.68 4.96 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 119.183 -0.437 . . . . 75.22 110.09 -177.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -31.14 24.68 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.764 2.31 . . . . 75.4 113.359 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -77.64 -34.83 53.1 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.187 0.595 . . . . 75.34 111.592 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.95 -45.69 73.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.299 0.64 . . . . 65.1 110.401 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -75.36 -20.92 58.72 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.66 -0.7 . . . . 74.1 111.628 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.05 -51.35 39.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.356 0.662 . . . . 75.33 110.896 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.526 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.7 pp -65.67 -37.68 87.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.668 -0.493 . . . . 74.02 109.668 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.96 -28.59 69.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.488 0.715 . . . . 75.14 111.571 173.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.31 -24.32 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.932 0.493 . . . . 74.4 111.209 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -97.18 -24.68 15.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.047 0.939 . . . . 73.15 112.254 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 30' ' ' LEU . 8.2 pt -121.82 -26.58 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 112.898 0.703 . . . . 74.22 112.898 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.5 mm? -102.65 172.34 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.265 0.626 . . . . 71.33 110.389 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.5 m -79.31 143.79 60.93 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 114.854 -1.066 . . . . 72.25 110.238 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.71 -31.03 18.1 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.657 2.905 . . . . 64.23 114.632 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -66.56 -36.97 83.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.148 0.579 . . . . 75.32 111.382 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 93.5 t -67.51 -57.35 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.656 0.782 . . . . 75.32 110.696 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.89 -28.44 66.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.667 0.387 . . . . 75.32 111.301 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.98 -54.96 10.91 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 124.527 1.142 . . . . 74.21 110.559 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 1.1 pp0? -61.64 -25.92 67.67 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.308 0.243 . . . . 73.42 111.604 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.48 -53.08 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.7 0.8 . . . . 75.42 111.02 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -67.34 -22.49 65.59 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.025 0.38 . . . . 75.23 112.025 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -81.07 -45.26 16.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.853 0.461 . . . . 71.42 110.455 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.96 -26.01 68.39 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.396 0.678 . . . . 72.31 111.052 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.63 97.1 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.795 1.238 . . . . 75.42 112.333 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -65.8 -28.43 69.0 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.945 0.778 . . . . 73.54 111.439 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.84 -41.81 67.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.966 0.907 . . . . 73.33 110.867 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -76.81 -28.16 55.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.454 0.701 . . . . 73.0 110.989 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.85 -35.17 67.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.462 1.105 . . . . 74.32 110.422 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.62 -40.91 98.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 75.23 109.785 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -84.87 178.01 7.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.167 -0.924 . . . . 71.04 110.643 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.24 33.42 6.59 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.699 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.96 89.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 109.127 -0.694 . . . . 73.1 109.127 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -83.3 136.31 34.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.829 -1.078 . . . . 74.25 108.177 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 140.3 24.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.503 -0.555 . . . . 71.42 109.503 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.13 130.96 39.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.227 1.011 . . . . 72.41 109.618 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.49 102.34 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 74.5 109.686 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -84.27 -35.19 23.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.654 0.782 . . . . 74.14 110.886 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 58.5 ttt180 -155.56 125.41 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.913 -0.773 . . . . 74.45 108.913 -173.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.92 125.94 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 74.33 109.856 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.03 125.36 24.83 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.518 1.127 . . . . 71.42 108.953 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.33 134.99 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.328 0.651 . . . . 75.4 110.687 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.6 m -145.67 130.67 18.28 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.084 0.954 . . . . 71.41 108.969 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 71' ' ' VAL . 71.8 p -88.31 149.17 23.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.6 0.36 . . . . 71.24 110.425 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -129.97 96.11 4.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.444 -1.317 . . . . 73.25 107.444 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.05 -102.08 0.95 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.992 -0.843 . . . . 72.02 110.992 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -115.49 -13.48 11.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.972 0.909 . . . . 73.45 110.373 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.9 m -97.15 119.33 35.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.606 0.763 . . . . 75.45 109.568 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 66' ' ' THR . 23.4 t -87.93 144.48 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.676 0.79 . . . . 73.4 110.456 -170.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -124.31 102.48 7.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.59 1.156 . . . . 73.14 108.903 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.13 103.21 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.079 -0.711 . . . . 72.23 109.079 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.3 m -89.53 112.38 23.54 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.322 1.049 . . . . 73.01 109.026 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.91 119.26 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.367 0.667 . . . . 75.12 110.771 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.5 tp10 -80.2 129.91 34.84 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.323 1.049 . . . . 75.21 109.143 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.1 142.01 51.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.236 0.614 . . . . 73.43 109.686 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.96 108.64 21.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.439 -1.319 . . . . 74.31 107.439 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -104.54 105.74 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.173 0.589 . . . . 75.31 111.162 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -93.25 111.24 22.83 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.783 -0.821 . . . . 71.12 108.783 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -134.99 123.6 23.57 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.176 0.99 . . . . 74.31 109.732 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.33 13.66 70.85 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.171 0.415 . . . . 71.11 113.491 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.13 -28.31 15.25 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 112.027 -0.429 . . . . 63.4 112.027 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.5 p -85.01 120.13 26.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.246 0.618 . . . . 74.11 110.615 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -94.31 142.04 27.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.522 0.729 . . . . 73.43 110.25 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.1 m -144.68 123.26 12.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.327 1.051 . . . . 75.42 109.326 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -77.93 109.67 12.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.907 -0.775 . . . . 71.24 108.907 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 m -114.78 122.12 45.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.415 1.086 . . . . 73.12 109.53 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 10.6 m -88.95 120.09 30.05 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -104.78 136.5 44.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.562 -0.903 . . . . 74.01 108.562 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -115.27 103.06 10.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.144 -1.058 . . . . 51.12 108.144 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 106' ' ' VAL . 6.1 mp -87.71 104.39 16.5 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.249 -1.389 . . . . 74.3 107.249 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -96.66 108.0 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.359 -0.837 . . . . 74.24 109.35 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -88.82 109.09 19.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.692 0.797 . . . . 75.41 110.293 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.54 114.71 26.99 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.818 0.847 . . . . 65.4 109.268 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG23 ' A' ' 4' ' ' ILE . 3.9 m -100.58 149.62 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.694 0.798 . . . . 64.25 110.275 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.72 119.36 16.04 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.73 -1.211 . . . . 71.41 107.73 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.54 -100.58 1.82 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.946 -0.462 . . . . 71.11 111.946 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.93 -21.78 5.43 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.094 0.558 . . . . 73.54 112.165 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -114.04 158.65 20.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.058 0.456 . . . . 73.2 110.989 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 35' ' ' LEU . 16.6 mt -84.55 125.19 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.038 -0.983 . . . . 73.1 108.878 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -96.11 -43.18 7.87 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.268 0.627 . . . . 74.35 111.264 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -132.77 160.93 35.42 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.714 0.806 . . . . 74.42 110.591 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.48 120.14 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.394 -0.965 . . . . 62.44 108.394 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.7 m -100.68 104.83 16.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.259 -1.015 . . . . 74.53 108.259 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.448 HG21 ' HG ' ' A' ' 92' ' ' LEU . 46.5 t -87.29 103.99 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.631 -0.878 . . . . 72.44 108.631 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -94.5 106.38 18.36 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.593 0.757 . . . . 64.5 109.453 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -82.06 97.45 8.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.493 -0.776 . . . . 74.13 109.9 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.434 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.3 m-80 -73.8 90.38 1.87 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.53 -1.285 . . . . 75.24 107.53 170.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.51 38.35 0.17 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.391 -0.822 . . . . 64.34 111.376 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.08 67.84 0.56 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.405 -0.678 . . . . 74.44 111.405 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.9 m 75.08 -19.36 0.39 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.769 1.628 . . . . 70.1 113.826 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -87.61 82.5 7.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.469 0.652 . . . . 75.44 110.405 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.7 91.4 4.66 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.527 -1.286 . . . . 72.42 107.527 170.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -65.97 83.23 0.08 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.68 -0.859 . . . . 73.34 108.68 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -87.49 69.05 9.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.914 -1.039 . . . . 73.3 110.638 -170.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -72.72 125.2 26.95 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.805 -1.089 . . . . 63.31 109.457 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -65.22 99.86 0.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.141 0.901 . . . . 72.52 109.935 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -97.45 107.96 20.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.984 0.914 . . . . 63.14 108.584 173.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 123.749 0.819 . . . . 64.14 109.159 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.281 -0.266 . . . . 74.21 110.281 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -132.23 -85.54 0.48 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.052 0.941 . . . . 64.51 108.753 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -104.43 144.26 31.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.205 1.002 . . . . 71.52 109.701 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.27 -32.87 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.578 1.151 . . . . 71.31 112.017 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.44 -51.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.236 0.614 . . . . 65.14 109.769 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -28.33 65.44 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.447 -0.797 . . . . 64.42 111.129 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -59.04 -48.75 80.47 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.933 0.397 . . . . 73.44 110.208 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.79 83.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.543 -0.753 . . . . 71.05 111.728 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.79 -52.25 64.97 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.581 0.752 . . . . 73.44 111.475 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.55 -37.1 82.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 73.13 110.665 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.93 80.95 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.405 -1.27 . . . . 73.03 111.498 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.56 82.22 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.911 0.757 . . . . 71.03 111.891 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.85 -40.05 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.939 -1.028 . . . . 75.44 110.204 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.03 72.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.791 0.836 . . . . 64.11 112.852 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.5 mt -63.1 -40.3 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.531 0.732 . . . . 75.23 110.028 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -71.14 -33.54 70.17 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.143 0.577 . . . . 74.24 111.521 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -62.07 -40.98 97.64 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.857 0.863 . . . . 72.44 110.997 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.23 -37.52 66.37 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.972 -0.558 . . . . 75.34 110.863 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -63.13 -32.85 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.45 0.537 . . . . 74.42 112.45 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.57 -23.31 22.01 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.394 0.278 . . . . 73.41 111.234 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.14 88.27 2.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.477 0.711 . . . . 74.43 109.242 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.19 -22.53 70.59 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.337 2.691 . . . . 73.35 114.312 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -88.46 11.23 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.578 0.751 . . . . 64.43 112.722 -174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.97 114.14 26.37 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.89 -32.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.551 2.167 . . . . 73.33 113.354 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.76 -40.26 55.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.212 0.605 . . . . 65.35 111.387 -171.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.99 67.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.727 0.811 . . . . 71.23 110.993 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.19 -26.25 63.81 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.533 -0.758 . . . . 73.2 111.864 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.21 -43.17 71.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 74.53 111.323 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.3 pp -71.08 -35.4 71.84 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.583 -0.525 . . . . 72.13 109.583 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.93 -22.34 66.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.75 0.82 . . . . 74.51 112.112 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -73.46 -30.62 63.3 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.278 0.631 . . . . 64.14 110.96 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.53 -46.28 9.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.33 -0.85 . . . . 75.22 111.538 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.7 pt -101.88 -28.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 116.092 -0.504 . . . . 73.24 111.513 -169.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.491 HD13 HG22 ' A' ' 39' ' ' VAL . 3.4 mm? -108.9 -173.94 2.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.384 1.074 . . . . 71.42 109.378 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.0 m -77.77 149.15 77.14 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 122.915 0.486 . . . . 72.42 111.091 176.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.79 -25.75 81.73 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.488 2.125 . . . . 73.11 111.804 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.83 -43.64 95.59 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.222 -1.354 . . . . 74.44 110.805 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.9 t -64.39 -52.51 54.53 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 123.531 0.732 . . . . 75.21 111.131 -175.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.22 -35.86 74.38 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 120.829 0.347 . . . . 72.43 111.528 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.88 -43.49 68.3 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.216 1.006 . . . . 74.23 111.431 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -74.25 -27.31 60.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.221 0.209 . . . . 71.23 110.952 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 t -72.62 -41.76 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.028 0.531 . . . . 75.34 110.564 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -21.49 61.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.65 0.205 . . . . 75.31 111.537 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.45 -49.26 12.58 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.922 0.392 . . . . 74.12 110.077 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.7 -24.04 67.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.98 0.912 . . . . 75.21 110.63 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.25 76.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.109 1.364 . . . . 74.32 112.471 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -61.68 -22.94 65.75 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.218 -0.901 . . . . 74.42 112.625 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.38 -46.46 66.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.583 0.753 . . . . 73.24 110.581 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.35 -31.77 60.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.819 0.848 . . . . 73.12 111.347 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.25 -39.01 78.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 73.12 110.166 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -59.74 -43.3 94.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.586 0.754 . . . . 73.32 110.266 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -75.71 -29.63 59.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.073 -0.967 . . . . 73.33 111.4 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.31 35.52 76.76 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.456 0.472 . . . . 63.11 113.427 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.35 107.9 12.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.704 -0.851 . . . . 74.45 108.704 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -84.13 111.14 19.07 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 108.728 -0.842 . . . . 74.24 108.728 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.474 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 15.5 p90 -110.37 142.67 41.72 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.009 -1.478 . . . . 72.44 107.009 168.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -134.42 126.94 30.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.152 0.283 . . . . 53.34 110.252 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.23 134.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.116 0.966 . . . . 74.34 110.047 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -117.12 -54.31 2.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.526 1.13 . . . . 74.43 109.522 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -140.78 123.72 16.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 114.658 -1.155 . . . . 72.41 108.673 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.27 124.04 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.139 -1.06 . . . . 74.44 108.139 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.08 107.6 9.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.515 HG21 HG23 ' A' ' 73' ' ' VAL . 14.7 p -99.0 140.16 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.722 0.409 . . . . 74.01 110.14 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -144.27 170.74 15.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.749 0.82 . . . . 64.24 109.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.425 HG23 HG21 ' A' ' 71' ' ' VAL . 40.1 p -126.66 149.72 49.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.209 0.604 . . . . 74.05 110.756 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -135.95 95.6 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.46 -1.311 . . . . 70.0 107.46 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.91 -101.34 1.1 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.207 -1.157 . . . . 54.0 110.207 -166.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -119.02 -7.67 10.34 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.777 0.831 . . . . 74.44 110.594 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 95' ' ' GLU . 22.1 m -87.88 114.79 24.84 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.24 -0.652 . . . . 75.53 109.24 -174.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 66' ' ' THR . 24.3 t -87.03 132.24 32.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 115.674 -0.693 . . . . 74.34 109.422 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -118.79 117.52 29.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.192 0.997 . . . . 71.21 108.634 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.515 HG23 HG21 ' A' ' 64' ' ' VAL . 46.3 t -100.35 103.18 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 73.14 109.647 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.9 m -90.65 105.42 17.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.679 -0.859 . . . . 72.24 108.679 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.54 126.51 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.679 0.792 . . . . 72.31 110.694 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.03 120.48 23.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.179 0.991 . . . . 73.05 109.783 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.39 119.1 35.14 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.374 -0.972 . . . . 75.13 108.374 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -88.46 103.41 15.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.211 -1.033 . . . . 74.22 108.211 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 30.3 mt-10 -88.2 126.06 34.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.32 1.048 . . . . 74.33 110.067 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.499 ' HG1' HG22 ' A' ' 85' ' ' THR . 25.3 m -115.64 107.72 15.48 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.218 -1.03 . . . . 73.44 108.218 173.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -147.51 138.14 23.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.908 0.883 . . . . 75.33 109.351 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.94 12.24 64.66 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.368 0.418 . . . . 24.53 113.846 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.94 -32.9 6.56 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 117.127 0.464 . . . . 74.44 112.421 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -84.09 144.78 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.482 0.713 . . . . 73.31 111.688 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.499 HG22 ' HG1' ' A' ' 80' ' ' THR . 23.4 m -121.47 129.98 53.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.014 0.926 . . . . 73.54 110.603 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.3 m -143.54 133.12 23.61 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.724 0.809 . . . . 53.42 110.1 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -81.25 101.52 9.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.386 -0.598 . . . . 74.23 109.386 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.1 m -101.54 122.44 43.83 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.198 0.999 . . . . 75.41 109.226 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -88.52 125.82 34.96 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.588 . . . . 65.42 109.414 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -104.65 126.08 51.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.765 -1.198 . . . . 74.4 107.765 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.22 103.59 12.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.145 -1.057 . . . . 75.45 108.145 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.98 110.48 22.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.893 -0.78 . . . . 73.15 108.893 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.41 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 59.7 ttp180 -88.89 99.76 12.65 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.94 -0.763 . . . . 74.01 108.94 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.534 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.9 m-85 -86.17 107.82 18.05 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.914 0.864 . . . . 75.44 108.687 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . 19.2 mt-10 -90.09 116.49 28.15 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.984 -1.462 . . . . 74.2 108.053 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 101' ' ' ILE . 11.3 m -85.45 144.92 8.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.358 -0.837 . . . . 72.53 110.907 -169.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.7 79.49 1.9 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.34 18.07 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.426 -0.806 . . . . 64.1 111.736 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -80.15 -4.87 54.74 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.95 0.722 . . . . 72.01 112.95 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.3 m -134.68 134.65 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.591 0.356 . . . . 73.23 110.217 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 94' ' ' PHE . 45.4 mt -77.46 132.02 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.169 -1.049 . . . . 74.35 108.169 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -119.4 -10.07 9.76 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.372 0.533 . . . . 75.1 111.617 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 14.4 mmt180 -130.02 150.4 51.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.224 0.61 . . . . 74.43 111.527 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.16 124.9 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.474 1.11 . . . . 72.02 109.466 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 87.7 m -111.92 105.07 13.4 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.651 0.78 . . . . 63.2 108.941 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.0 105.14 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.531 -0.914 . . . . 73.25 108.531 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.9 m -99.94 105.7 17.43 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.468 0.707 . . . . 75.44 109.384 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -84.03 123.63 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.65 -0.5 . . . . 74.05 109.65 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.8 OUTLIER -80.83 -1.38 42.89 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.384 0.673 . . . . 65.24 111.0 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.92 61.37 4.69 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 110.433 -1.067 . . . . 61.44 110.433 166.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.89 94.8 0.1 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.898 -1.281 . . . . 75.02 109.898 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 m -68.89 110.69 4.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.414 0.686 . . . . 63.31 110.911 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.3 mt -69.28 -45.21 70.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.189 0.996 . . . . 64.12 110.288 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.13 160.11 27.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.166 -0.925 . . . . 74.23 110.4 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -166.05 32.68 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.575 0.75 . . . . 75.32 110.935 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.63 107.34 2.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.152 -0.684 . . . . 65.44 109.152 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.46 145.53 50.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.879 0.871 . . . . 73.23 109.31 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -145.92 126.72 14.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.055 0.542 . . . . 73.34 109.701 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -78.95 168.26 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.447 0.699 . . . . 71.13 110.433 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.2 m80 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 123.203 0.601 . . . . 72.01 110.351 -178.016 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.332 0.587 . . . . 74.03 110.737 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -98.52 34.3 2.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.81 0.844 . . . . 73.14 109.482 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -95.74 18.25 13.42 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.7 1.2 . . . . 61.4 110.393 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.3 -39.82 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 126.061 1.745 . . . . 73.22 113.938 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 66' ' ' THR . 19.0 t -70.7 -54.24 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.021 0.529 . . . . 71.24 110.461 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 8.5 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.197 0.935 . . . . 73.0 111.021 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . . . -65.96 -47.43 74.65 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.232 -0.894 . . . . 72.34 110.716 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.8 78.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 72.21 111.572 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -64.75 -48.84 73.1 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.36 1.064 . . . . 74.44 110.85 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 23.1 mt-30 -67.68 -37.55 82.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.521 0.729 . . . . 73.11 110.352 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.25 97.01 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.03 0.932 . . . . 73.0 111.029 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.46 11.69 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.345 1.028 . . . . 74.43 110.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -60.33 -39.74 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 124.222 0.951 . . . . 72.3 110.597 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.18 93.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.975 0.91 . . . . 75.14 112.305 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.76 -45.8 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.881 0.873 . . . . 72.54 110.161 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.66 -34.46 75.75 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.985 0.514 . . . . 73.32 112.01 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.69 -38.07 89.76 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.551 0.532 . . . . 75.22 110.055 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.8 -38.49 76.66 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.754 0.659 . . . . 74.25 110.766 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -58.4 -36.78 74.08 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.52 0.728 . . . . 72.5 112.717 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -102.14 -16.28 16.43 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.863 0.465 . . . . 74.14 112.115 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.19 78.54 5.26 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.351 0.661 . . . . 71.31 109.354 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.54 -4.64 15.72 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.699 2.266 . . . . 74.24 112.733 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 p -77.2 -12.9 60.0 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.834 1.254 . . . . 74.35 112.062 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.78 113.12 19.91 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 122.622 0.369 . . . . 64.42 111.031 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.17 -18.11 18.64 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.845 2.363 . . . . 75.15 113.396 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.29 -44.89 24.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.152 0.581 . . . . 75.44 110.329 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.39 -50.1 74.95 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.114 -0.948 . . . . 64.1 110.841 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.411 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.4 pt20 -72.9 -23.61 60.73 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.673 -0.694 . . . . 62.42 112.129 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.19 -44.35 53.73 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.68 0.392 . . . . 75.44 111.319 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.21 -31.99 72.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.775 -0.454 . . . . 72.53 109.775 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 35' ' ' LEU . 97.7 mt -66.12 -29.36 69.65 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.814 0.845 . . . . 74.41 111.852 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.46 -31.95 71.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.709 0.804 . . . . 72.43 110.674 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -84.68 -43.27 14.5 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.282 -0.872 . . . . 72.4 111.137 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 8.8 pt -96.84 -37.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.96 0.504 . . . . 75.41 112.302 -168.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.434 HD11 HD21 ' A' ' 31' ' ' LEU . 73.6 mt -104.52 174.04 6.05 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.962 0.905 . . . . 74.01 108.912 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 102' ' ' ARG . 9.0 p -68.78 136.67 90.1 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.337 -0.616 . . . . 74.4 109.337 169.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.07 -22.64 19.57 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.143 2.562 . . . . 74.02 114.735 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -60.6 -40.4 91.68 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.193 0.997 . . . . 71.05 111.289 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.66 -54.56 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 72.33 111.268 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 28' ' ' GLN . 2.8 pp -64.06 -32.46 74.02 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.558 0.218 . . . . 74.13 111.05 -176.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.96 -34.03 75.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.14 0.976 . . . . 74.2 111.714 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -85.38 -36.56 20.64 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.801 0.44 . . . . 73.15 110.998 174.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.4 -39.88 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.458 0.703 . . . . 75.14 111.49 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -67.77 -21.93 65.23 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.335 0.654 . . . . 75.41 111.945 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -86.83 -44.8 11.44 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.059 0.943 . . . . 74.45 110.664 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -68.79 -24.39 64.41 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.224 0.609 . . . . 74.31 110.984 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.43 80.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.291 1.436 . . . . 75.22 111.557 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 97.2 mtt180 -62.25 -27.38 68.97 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.871 -1.513 . . . . 74.53 111.627 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.1 -40.49 74.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.146 0.578 . . . . 72.44 110.984 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 ' HA ' HE21 ' A' ' 53' ' ' GLN . 91.3 mt -74.92 -31.87 61.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.64 0.776 . . . . 71.1 110.738 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -65.38 -40.6 93.68 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.109 -0.951 . . . . 73.21 111.087 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 55.8 mttp -59.05 -40.87 86.42 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.437 0.695 . . . . 75.5 111.049 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 50' ' ' LEU . 46.1 mt-30 -72.3 -12.02 60.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.952 -1.022 . . . . 71.14 111.54 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.45 30.65 78.05 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.882 0.739 . . . . 75.14 113.336 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.3 mt -74.95 109.24 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.626 -0.879 . . . . 74.01 108.626 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -84.31 109.33 17.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 73.54 108.003 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.71 140.29 44.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.18 -0.674 . . . . 73.42 109.18 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -133.13 146.4 51.56 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.365 0.666 . . . . 74.23 109.775 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.32 116.03 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.724 1.265 . . . . 70.14 110.05 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -88.73 -54.92 3.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.518 0.675 . . . . 71.53 109.639 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tpm_? -139.08 127.06 22.32 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.847 -1.069 . . . . 74.14 109.13 -166.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.48 116.31 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.845 -1.169 . . . . 75.24 107.845 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.69 107.73 9.38 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.504 -0.925 . . . . 75.14 108.504 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -97.34 121.76 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.162 0.985 . . . . 74.31 109.89 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.6 m -130.23 127.79 40.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 73.35 108.563 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.476 HG21 HG22 ' A' ' 5' ' ' VAL . 32.8 p -88.4 154.44 20.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.229 0.612 . . . . 73.24 110.847 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -137.56 86.69 2.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.524 -1.287 . . . . 65.44 107.524 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.38 -101.08 0.79 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.857 -1.065 . . . . 52.42 111.918 -174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.74 -11.99 14.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.105 0.962 . . . . 72.1 111.319 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 HH11 ' A' ' 93' ' ' ARG . 44.8 m -100.98 118.95 38.0 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.618 -0.512 . . . . 62.44 109.618 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 66' ' ' THR . 46.1 t -87.5 140.91 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.808 0.843 . . . . 75.33 109.935 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -123.96 100.95 6.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.923 0.889 . . . . 75.11 108.742 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.98 106.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.449 0.7 . . . . 71.42 109.355 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -86.06 106.22 17.06 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.723 -0.843 . . . . 74.11 108.723 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.4 p -129.63 116.52 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.835 0.854 . . . . 73.12 110.602 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -97.08 139.96 32.3 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.238 1.015 . . . . 72.1 109.32 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -135.02 142.61 46.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.796 0.838 . . . . 74.42 109.085 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.0 105.8 17.85 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.269 1.033 . . . . 75.23 109.351 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.09 105.39 15.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.495 -0.775 . . . . 63.24 110.091 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.7 m -102.19 106.7 17.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.502 1.121 . . . . 74.24 108.331 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 t -148.38 140.34 23.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.111 0.965 . . . . 72.41 109.591 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.3 25.66 73.58 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.106 0.402 . . . . 75.03 114.106 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.9 83.51 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.897 -0.391 . . . . 63.45 114.026 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -116.91 139.05 51.1 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.43 0.615 . . . . 71.3 111.052 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.5 m -100.73 144.31 29.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.357 1.063 . . . . 72.32 109.522 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.4 m -143.92 114.54 7.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.78 0.832 . . . . 75.12 109.575 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.85 101.03 5.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.757 -0.831 . . . . 73.32 108.757 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.5 m -102.92 124.88 49.27 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.547 1.139 . . . . 65.41 110.098 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.9 m -94.05 116.9 29.38 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.316 0.646 . . . . 73.53 110.242 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.34 127.84 53.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.164 -1.05 . . . . 73.43 108.164 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -110.06 100.47 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.552 -1.277 . . . . 74.31 107.552 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.76 105.88 17.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.07 -1.085 . . . . 73.14 108.07 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.424 HH11 HG23 ' A' ' 70' ' ' THR . 59.1 ttp85 -91.35 99.02 12.06 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.547 -1.206 . . . . 75.45 107.989 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.2 m-85 -87.51 108.02 18.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.935 -0.765 . . . . 70.51 108.935 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 34.9 tt0 -98.16 133.15 42.99 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.442 -0.947 . . . . 73.12 108.442 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 25.6 m -84.06 142.66 13.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.166 0.508 . . . . 75.0 109.918 176.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.32 104.62 14.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.343 -1.725 . . . . 75.25 106.343 167.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.07 -100.68 1.51 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.399 -0.819 . . . . 33.15 111.293 -172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -123.88 -0.55 8.47 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.936 0.894 . . . . 60.01 112.54 -171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -139.71 150.03 44.36 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.514 0.725 . . . . 72.35 110.314 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 18.3 mt -75.52 119.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.054 0.542 . . . . 72.41 110.176 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 36' ' ' SER . 44.3 mmt-85 -131.18 14.98 5.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.042 0.937 . . . . 74.21 110.627 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 39.0 ttm105 -150.53 137.98 19.64 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 122.649 0.38 . . . . 75.53 110.114 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.96 119.7 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.271 1.028 . . . . 44.52 108.605 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 m -112.26 104.26 12.44 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.912 -1.144 . . . . 71.2 107.912 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.78 107.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.17 -0.678 . . . . 75.42 109.17 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 m -94.31 104.21 16.21 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.51 -0.922 . . . . 75.12 108.51 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -86.97 123.57 32.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.112 -1.07 . . . . 65.13 108.112 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.8 OUTLIER -68.81 160.53 30.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.414 0.685 . . . . 70.05 111.108 -176.152 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.77 116.58 1.41 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.321 -0.4 . . . . 73.13 112.567 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.14 8.12 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.135 0.398 . . . . 71.41 113.563 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 m -88.36 76.06 8.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.987 0.515 . . . . 71.25 110.388 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.57 101.97 2.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.524 0.73 . . . . 75.45 110.01 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.39 131.28 35.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.909 0.484 . . . . 74.43 109.925 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -87.77 83.45 7.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.53 0.732 . . . . 64.22 109.073 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -107.05 109.06 20.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.108 0.963 . . . . 73.23 109.016 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -135.79 159.23 42.28 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.926 0.891 . . . . 64.44 109.926 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.66 -28.42 60.84 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.866 0.466 . . . . 72.14 111.01 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -135.7 138.43 42.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.302 0.641 . . . . 74.45 110.77 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.9 p80 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 123.493 0.717 . . . . 74.44 110.482 174.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.152 -0.684 . . . . 73.45 109.152 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -84.85 -22.98 29.22 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.102 -0.703 . . . . 63.42 109.102 168.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -147.77 160.93 42.19 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.255 1.022 . . . . 73.11 110.192 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.544 HG22 HG12 ' A' ' 96' ' ' VAL . 44.5 mm -86.21 -52.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.806 1.242 . . . . 72.31 111.047 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.43 -40.93 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.835 0.854 . . . . 72.43 110.508 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.06 -56.21 23.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.157 . . . . 75.5 110.984 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.4 70.05 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.061 0.851 . . . . 72.04 111.432 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.41 -48.28 42.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.585 0.754 . . . . 73.11 111.694 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.43 -46.32 70.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.431 -0.804 . . . . 75.21 111.093 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.94 -39.78 93.28 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.638 0.775 . . . . 72.33 110.559 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HB2' HD11 ' A' ' 35' ' ' LEU . . . -58.78 -50.44 73.93 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 123.807 0.692 . . . . 63.02 111.317 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -54.72 42.74 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 124.218 0.949 . . . . 72.35 112.167 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.05 -39.78 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.88 0.872 . . . . 73.21 110.943 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.98 70.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.526 0.73 . . . . 71.12 112.617 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' HG13 ' A' ' 43' ' ' VAL . 63.6 mt -61.73 -38.39 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.501 0.72 . . . . 74.54 110.28 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.05 -34.03 61.79 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.002 0.521 . . . . 74.55 111.254 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.07 -21.39 64.08 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.249 0.62 . . . . 74.33 111.38 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.13 -36.28 21.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.386 0.274 . . . . 71.34 110.59 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.602 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 41.0 m0 -63.46 -27.32 69.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.64 -27.5 21.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.099 0.56 . . . . 71.43 111.467 173.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -158.43 93.41 1.99 Allowed Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.398 0.679 . . . . 73.44 109.75 -177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -16.83 56.12 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.543 2.829 . . . . 71.5 113.857 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 p -97.04 11.71 35.18 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.908 0.883 . . . . 74.35 111.454 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.45 114.59 29.29 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 109.177 -0.675 . . . . 65.33 109.177 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.25 -33.24 11.62 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.411 2.074 . . . . 74.55 112.531 -168.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.86 -48.28 59.44 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.482 0.713 . . . . 71.53 111.114 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -58.76 -50.84 72.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.631 0.772 . . . . 73.33 111.587 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.51 -29.98 62.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.412 0.523 . . . . 72.1 112.412 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.44 -36.64 71.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.813 0.279 . . . . 75.55 111.313 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.5 pp -70.61 -34.53 72.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 75.22 109.602 175.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 85.6 mt -66.67 -22.51 66.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.751 0.821 . . . . 74.54 111.716 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.29 -29.87 61.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.964 0.506 . . . . 71.12 110.477 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.27 -42.84 9.11 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.769 0.828 . . . . 75.52 111.803 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 30' ' ' LEU . 19.8 pt -95.12 -21.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.843 0.457 . . . . 75.42 111.519 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 11' ' ' ALA . 44.3 mt -122.84 -176.63 3.45 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.933 -0.766 . . . . 74.51 108.933 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -75.97 148.08 81.25 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.319 0.648 . . . . 73.11 110.514 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.26 -20.27 46.47 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.97 2.447 . . . . 73.05 113.044 171.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.26 -40.05 89.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.398 1.079 . . . . 73.5 111.237 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG11 HD12 ' A' ' 35' ' ' LEU . 57.3 t -64.05 -51.45 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.798 0.439 . . . . 74.02 111.065 -173.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.64 -27.88 69.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.77 0.319 . . . . 72.02 111.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.81 -28.76 55.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.16 0.984 . . . . 73.34 112.252 -175.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 39' ' ' VAL . 29.3 pt20 -85.45 -33.06 21.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 110.088 -0.338 . . . . 65.11 110.088 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 15' ' ' ILE . 55.1 t -65.75 -41.95 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.834 0.854 . . . . 75.53 111.209 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -63.47 -22.61 66.98 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.037 0.535 . . . . 74.44 111.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -80.33 -48.41 13.02 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.549 0.74 . . . . 73.31 110.398 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.74 -19.85 64.36 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.046 0.939 . . . . 74.32 111.805 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -53.72 -56.72 14.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.554 1.142 . . . . 64.41 112.824 173.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -18.28 65.24 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.641 0.588 . . . . 74.44 112.379 -173.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.67 -51.94 50.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.721 -0.474 . . . . 70.41 109.721 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -78.4 -33.52 48.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.669 0.787 . . . . 73.33 110.954 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.43 -38.19 84.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.228 1.011 . . . . 75.32 111.091 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.53 -42.49 95.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.4 0.68 . . . . 73.51 110.221 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -65.79 -24.2 66.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.241 -0.89 . . . . 75.03 110.703 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.77 33.73 45.69 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.958 -0.564 . . . . 74.02 111.995 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 80' ' ' THR . 65.8 mt -73.49 110.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.678 0.791 . . . . 72.02 109.668 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -89.88 107.67 19.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.525 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 18.5 p90 -112.24 123.96 51.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.581 -0.896 . . . . 73.11 108.581 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -111.47 130.39 55.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.246 0.618 . . . . 74.44 109.364 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.25 108.53 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.043 -0.725 . . . . 75.25 109.043 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HD3' ' HB2' ' A' ' 78' ' ' GLU . 31.3 mmmt -78.03 -45.74 22.86 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.873 0.869 . . . . 71.5 109.775 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -167.48 125.34 1.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.812 0.845 . . . . 74.21 109.768 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.07 109.82 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.736 0.814 . . . . 62.13 110.173 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -104.86 143.01 33.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 74.32 108.852 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -140.92 125.74 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.02 0.928 . . . . 72.45 109.881 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -140.24 139.2 35.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.058 0.943 . . . . 71.35 109.459 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.8 p -89.51 157.74 17.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.357 0.663 . . . . 64.25 111.547 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -160.84 84.78 0.68 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.403 1.081 . . . . 74.3 109.282 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.36 -116.49 8.84 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.831 -0.622 . . . . 70.21 113.445 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.22 11.88 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.276 0.63 . . . . 73.02 111.247 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.91 155.29 50.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.446 0.698 . . . . 74.25 109.773 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -137.33 120.25 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.699 0.799 . . . . 74.31 109.319 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.04 109.57 21.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.276 1.03 . . . . 75.32 109.648 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.22 105.73 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.998 -0.742 . . . . 73.1 108.998 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.6 m -96.28 102.32 14.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.871 -1.159 . . . . 71.44 107.871 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.73 113.82 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.966 0.907 . . . . 71.34 109.159 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.24 126.17 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.894 0.877 . . . . 73.31 108.923 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.84 163.24 16.48 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.886 0.874 . . . . 71.53 108.783 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 32.6 tt0 -122.65 101.69 7.62 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.701 -1.222 . . . . 74.35 107.701 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 31.6 mt-10 -86.66 139.98 30.25 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.281 1.032 . . . . 73.42 110.15 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 11.9 m -119.62 102.94 8.98 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.31 108.55 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 t -118.2 120.39 37.54 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.998 0.919 . . . . 73.13 110.079 -173.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.52 -93.46 0.46 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.769 -0.651 . . . . 62.25 112.602 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -141.44 19.16 2.63 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.24 0.447 . . . . 64.24 112.072 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.9 p -124.01 145.37 49.24 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.183 0.993 . . . . 64.13 108.99 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 m -116.39 104.27 11.29 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.181 -1.044 . . . . 73.24 108.181 177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.0 m -102.02 119.19 38.39 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.48 1.112 . . . . 75.21 109.399 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 28.5 t-20 -77.68 101.2 6.51 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.296 -1.002 . . . . 73.42 108.296 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.0 m -113.05 124.25 52.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.241 1.016 . . . . 74.55 109.884 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 109' ' ' ASN . 27.5 m -87.01 141.02 28.97 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.276 -0.639 . . . . 74.23 109.276 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -119.28 127.13 52.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.554 1.142 . . . . 74.35 108.72 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -105.7 103.21 12.67 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.232 -1.025 . . . . 71.51 108.232 176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.46 105.2 17.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 70.25 108.015 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 36.3 ttm-85 -100.0 108.64 20.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.188 -0.914 . . . . 64.1 108.659 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.465 ' HB3' HG12 ' A' ' 101' ' ' ILE . 94.8 m-85 -99.85 111.73 24.03 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.925 0.89 . . . . 71.2 110.943 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 103' ' ' ARG . 7.3 mp0 -80.14 112.21 17.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.742 -0.836 . . . . 72.13 108.742 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 2.0 m -83.19 141.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.752 0.821 . . . . 74.44 109.69 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -140.82 117.0 10.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.411 -0.959 . . . . 71.44 108.411 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.34 -99.21 1.43 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.632 -0.587 . . . . 72.34 111.632 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -122.26 -16.96 7.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.089 0.955 . . . . 73.11 110.997 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -140.38 165.22 28.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.706 0.402 . . . . 74.42 110.573 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 2.6 mp -76.98 134.12 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.101 0.56 . . . . 70.11 109.81 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -123.47 5.57 8.99 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.35 1.06 . . . . 74.21 111.602 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 21.3 tpt180 -154.67 129.79 9.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.772 -0.455 . . . . 73.42 109.772 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.92 149.3 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.072 0.949 . . . . 74.41 109.322 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.8 m -131.17 106.79 8.57 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.351 -0.981 . . . . 74.01 108.351 171.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.77 105.04 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.725 -0.843 . . . . 75.35 108.725 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -116.17 105.78 12.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.54 0.736 . . . . 72.31 109.068 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -73.1 105.06 4.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.637 -0.875 . . . . 70.02 108.637 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 24.7 t-20 -60.89 98.33 0.07 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.686 0.794 . . . . 70.04 110.292 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.2 -106.84 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.283 -1.326 . . . . 75.55 110.062 -175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.49 -50.4 4.22 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 117.298 0.549 . . . . 74.24 112.786 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -67.51 127.53 33.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.97 0.908 . . . . 72.35 110.588 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.86 -24.55 63.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.131 0.972 . . . . 60.1 110.586 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.03 99.22 1.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.444 0.697 . . . . 72.22 109.467 172.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -90.0 12.91 16.18 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.121 0.968 . . . . 73.2 111.627 -173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -117.67 115.81 25.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.133 0.573 . . . . 75.2 109.599 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.61 -35.34 18.12 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.818 -0.808 . . . . 74.15 108.818 168.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -64.49 111.05 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.648 1.179 . . . . 71.4 110.243 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -80.07 164.59 23.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.906 0.882 . . . . 74.33 110.527 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.891 -0.781 . . . . 75.34 108.891 176.673 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.842 -0.059 . . . . 64.32 110.842 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 47.19 26.14 0.63 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 126.763 2.025 . . . . 71.21 113.671 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -81.52 75.53 8.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.394 -0.965 . . . . 62.4 108.394 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -74.02 -34.19 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.117 0.967 . . . . 70.32 112.121 -168.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.26 -42.24 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.454 0.702 . . . . 72.53 109.537 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.49 -35.94 70.95 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.026 -0.988 . . . . 74.33 110.412 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 34' ' ' ILE . . . -64.27 -40.67 96.44 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.244 0.618 . . . . 75.45 110.447 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.66 76.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.747 0.819 . . . . 64.23 110.956 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HG3' HG22 ' A' ' 64' ' ' VAL . 87.2 tttt -63.13 -56.88 13.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.455 -0.793 . . . . 70.35 110.504 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -67.41 -23.2 65.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.047 0.539 . . . . 75.11 111.077 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -49.4 64.58 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 123.721 0.638 . . . . 60.3 110.115 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.11 83.25 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.173 0.921 . . . . 73.43 110.906 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.402 HG22 HE21 ' A' ' 17' ' ' GLN . 74.1 mt -61.51 -40.24 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.327 1.051 . . . . 72.23 111.085 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.7 61.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.403 0.681 . . . . 74.44 111.983 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.02 -37.47 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.485 0.714 . . . . 75.21 109.239 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -73.11 -35.16 66.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.09 0.556 . . . . 73.3 111.054 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.402 HE21 HG22 ' A' ' 13' ' ' ILE . 77.1 mt-30 -61.43 -37.39 83.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.354 0.662 . . . . 74.23 110.464 174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 70.0 mt -73.26 -40.82 64.3 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 123.759 0.662 . . . . 75.13 110.532 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -59.69 -27.8 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.421 0.526 . . . . 71.23 112.421 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HB2' ' HZ1' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.08 -14.33 17.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.169 0.588 . . . . 73.14 111.815 175.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -159.58 89.9 1.93 Allowed Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 123.42 0.688 . . . . 73.14 110.381 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' HE21 ' A' ' 51' ' ' GLN . 37.6 Cg_endo -62.32 -22.33 73.95 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.374 2.716 . . . . 64.41 113.193 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -92.16 11.48 25.4 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.66 0.784 . . . . 74.2 111.809 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.11 110.73 8.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.048 -0.723 . . . . 75.0 109.048 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.78 -38.54 23.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.468 2.112 . . . . 71.34 113.104 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.61 -40.16 73.32 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.31 0.644 . . . . 74.52 111.644 -172.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -61.74 -56.85 15.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.025 0.828 . . . . 74.21 110.783 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.9 -24.64 66.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.507 0.723 . . . . 75.3 111.661 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.45 -46.83 65.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.809 0.443 . . . . 63.41 111.254 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.93 -30.56 67.99 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 110.288 -0.264 . . . . 72.21 110.288 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.477 HD22 HD12 ' A' ' 35' ' ' LEU . 83.2 mt -66.99 -28.19 68.05 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.424 0.69 . . . . 75.4 111.571 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -71.52 -25.39 62.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.999 0.428 . . . . 74.31 110.109 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -85.62 -41.3 15.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.636 0.774 . . . . 74.45 111.598 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 7' ' ' ALA . 9.4 pt -103.64 -17.32 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.123 0.569 . . . . 75.54 112.23 -170.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.477 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -123.43 174.61 7.26 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.026 0.93 . . . . 73.01 108.681 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.533 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.8 m -68.98 141.89 92.65 Favored Pre-proline 0 CA--C 1.561 1.404 0 N-CA-C 109.949 -0.389 . . . . 41.2 109.949 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.36 -20.01 14.29 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.997 2.464 . . . . 73.41 114.514 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.08 -37.23 66.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 74.42 111.796 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -64.03 -41.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.843 0.857 . . . . 64.42 111.386 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.59 -28.02 60.73 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.943 0.402 . . . . 74.12 111.358 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.32 -27.89 62.72 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.872 -1.058 . . . . 62.43 111.224 -172.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.65 -32.72 23.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.746 0.418 . . . . 74.41 111.077 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.21 -40.21 88.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 123.337 0.655 . . . . 72.22 110.758 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -67.59 -24.89 65.54 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.597 0.56 . . . . 74.53 111.535 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.29 -48.44 14.13 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.487 0.715 . . . . 73.34 110.255 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -62.63 -28.06 69.65 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.507 1.123 . . . . 71.35 110.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.05 -35.29 80.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.302 -1.317 . . . . 75.4 112.65 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -65.62 -27.46 68.41 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.665 0.786 . . . . 75.04 111.469 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.3 -48.67 32.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.678 0.791 . . . . 72.44 109.894 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.03 -30.3 69.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.839 0.856 . . . . 72.03 110.859 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.402 HE21 ' HD2' ' A' ' 22' ' ' PRO . 4.8 tp-100 -66.61 -47.35 72.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.03 1.332 . . . . 75.34 109.677 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.69 -31.58 72.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.241 -0.89 . . . . 72.4 110.845 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 -25.62 39.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.512 0.725 . . . . 73.12 110.877 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.34 40.31 80.59 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.377 0.423 . . . . 70.41 113.179 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.13 110.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.266 0.626 . . . . 75.21 109.396 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -94.55 106.63 18.62 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 7.3 p90 -112.38 143.07 44.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.534 0.734 . . . . 74.13 109.253 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -130.23 129.03 42.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.978 0.511 . . . . 71.33 109.767 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.94 101.37 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.551 0.741 . . . . 65.44 109.245 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.53 -27.27 19.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.971 0.908 . . . . 75.31 110.332 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.8 tpp180 -145.29 146.79 31.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.164 -1.05 . . . . 75.42 108.164 176.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.58 118.62 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.598 0.759 . . . . 74.32 109.013 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.97 105.76 10.6 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.96 -1.126 . . . . 71.4 107.96 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 73' ' ' VAL . 84.6 t -99.9 108.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.567 -1.272 . . . . 70.51 107.567 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -124.37 126.1 45.42 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.337 -0.616 . . . . 65.35 109.337 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.555 HG23 HG22 ' A' ' 71' ' ' VAL . 1.4 m -89.45 113.18 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.587 -0.894 . . . . 71.34 108.587 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -110.02 91.59 3.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.781 1.232 . . . . 54.54 107.812 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.7 -110.06 3.17 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 114.869 -1.06 . . . . 73.11 112.101 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.76 23.75 13.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.585 0.754 . . . . 65.24 110.379 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.6 m -134.88 122.6 22.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.157 0.583 . . . . 75.44 110.285 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 66' ' ' THR . 30.0 t -88.68 111.1 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.046 0.538 . . . . 71.33 109.606 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -97.94 104.59 16.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.704 0.802 . . . . 70.32 109.427 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 64' ' ' VAL . 78.0 t -89.29 103.68 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.203 -0.666 . . . . 70.31 109.203 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.9 m -99.02 103.3 15.23 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.0 -1.111 . . . . 63.24 108.0 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.05 128.9 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.441 0.696 . . . . 72.44 110.214 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 6.9 tp10 -92.77 111.96 23.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.08 1.352 . . . . 73.15 109.548 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 4.9 mp -109.51 118.81 37.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.605 -0.887 . . . . 73.22 108.605 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 26.1 tt0 -88.24 101.61 14.01 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.173 -1.418 . . . . 64.23 107.173 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 28.0 mt-10 -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.344 1.058 . . . . 73.34 110.588 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.3 m -125.05 111.09 14.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.861 -1.162 . . . . 70.3 107.861 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.9 t -132.36 131.25 41.69 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.483 -0.932 . . . . 73.52 108.483 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.6 -78.56 0.47 Allowed Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.48 -0.648 . . . . 65.3 111.48 -172.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.91 10.68 0.11 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 123.529 0.585 . . . . 72.14 111.959 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.4 p -98.67 126.91 44.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.077 0.951 . . . . 64.32 109.636 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.4 m -116.44 108.33 15.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.74 0.816 . . . . 73.03 110.181 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.0 m -131.74 139.53 48.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.012 0.925 . . . . 70.21 110.395 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 18.2 m120 -77.69 115.72 17.67 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.128 0.571 . . . . 72.12 109.597 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -116.65 121.39 41.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.304 1.042 . . . . 55.22 108.644 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -88.99 122.76 32.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.976 -0.379 . . . . 75.05 109.976 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -106.84 126.07 51.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.895 -0.779 . . . . 75.12 108.895 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.8 103.4 12.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.987 -1.116 . . . . 64.54 107.987 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.13 106.68 18.71 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.701 -1.222 . . . . 71.21 107.701 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 39.5 ttm180 -93.3 99.93 12.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.26 1.024 . . . . 74.22 110.113 -175.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.42 109.67 20.96 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.746 0.819 . . . . 72.44 110.157 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 40.5 tt0 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.248 -0.649 . . . . 74.3 109.248 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.94 149.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.461 0.704 . . . . 74.33 110.134 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -154.58 103.3 2.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 53.12 108.81 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 -118.39 5.04 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.748 -0.541 . . . . 60.44 111.748 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.37 20.37 13.65 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 71.34 109.832 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -139.22 168.44 19.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.305 1.042 . . . . 75.54 109.199 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.469 ' HB ' HD21 ' A' ' 35' ' ' LEU . 65.1 mt -108.17 127.78 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.979 0.912 . . . . 72.42 108.726 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -115.06 5.46 14.94 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.257 0.623 . . . . 74.14 112.435 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.8 ttp85 -153.53 134.91 14.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 110.576 -0.157 . . . . 73.53 110.576 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 129.68 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.289 1.036 . . . . 73.32 109.056 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.3 m -116.68 104.61 11.55 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.522 -0.918 . . . . 74.22 108.522 176.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.37 117.28 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.773 -0.825 . . . . 64.31 108.773 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 m -117.66 106.3 12.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.911 0.484 . . . . 75.54 109.812 -171.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.12 122.46 25.65 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.131 0.572 . . . . 74.11 109.536 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -112.7 143.57 43.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.041 . . . . 75.04 109.21 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.75 -124.78 0.87 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.468 -0.653 . . . . 74.24 111.468 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.6 -103.52 1.2 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.814 -0.514 . . . . 74.23 111.814 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -126.63 6.94 6.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.05 0.94 . . . . 65.13 110.594 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.17 65.21 1.49 Allowed 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.647 1.179 . . . . 74.11 110.718 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.68 82.8 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.952 -1.022 . . . . 74.02 111.171 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -143.21 154.46 43.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.429 0.692 . . . . 75.02 109.762 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -155.37 27.57 0.4 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.347 1.059 . . . . 75.44 108.673 173.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -68.4 98.7 0.86 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.5 -0.773 . . . . 64.32 109.178 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -97.97 120.49 38.46 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.333 -0.849 . . . . 71.25 109.364 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -153.79 105.0 2.74 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.429 0.692 . . . . 65.53 109.225 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 33.4 p80 . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 109.278 -0.638 . . . . 73.43 109.278 171.377 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.495 0.664 . . . . 73.22 109.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.492 HG21 HG11 ' A' ' 96' ' ' VAL . 46.8 mm -71.37 -32.91 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.955 -1.02 . . . . 72.21 110.533 -174.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.25 -46.55 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.458 0.703 . . . . 64.31 110.02 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -46.51 83.4 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.55 109.218 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.92 79.16 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.033 -0.985 . . . . 74.13 111.596 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.12 -36.32 74.73 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.05 0.54 . . . . 64.43 111.242 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.516 ' HB2' HG11 ' A' ' 64' ' ' VAL . 81.3 tttt -60.44 -55.39 34.06 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 123.837 0.711 . . . . 54.11 109.58 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.8 -35.9 75.63 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.983 -1.008 . . . . 70.43 111.148 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -65.11 -49.12 71.2 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 124.142 0.901 . . . . 74.41 110.693 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.68 -52.62 64.37 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 123.993 0.808 . . . . 73.11 110.854 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.439 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 59.2 mt -62.01 -39.95 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 123.965 0.791 . . . . 44.31 110.323 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.24 75.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.605 0.762 . . . . 54.33 112.142 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.37 -43.43 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.316 0.646 . . . . 64.45 109.866 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.16 -29.99 69.0 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.849 0.46 . . . . 74.23 111.303 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 26.7 mt-30 -66.93 -33.58 75.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.862 0.465 . . . . 75.22 110.47 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.3 mt -73.42 -35.71 65.86 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.235 0.335 . . . . 70.22 110.936 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -62.86 -31.04 71.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.691 0.397 . . . . 72.13 111.896 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -92.75 -30.6 15.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.022 0.529 . . . . 63.43 110.904 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -158.39 87.37 2.36 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 123.461 0.705 . . . . 74.11 109.787 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.07 -3.66 12.67 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.266 2.644 . . . . 55.33 113.959 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -95.83 7.5 46.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.112 0.965 . . . . 64.31 111.498 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.53 118.07 47.18 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.66 -0.686 . . . . 61.13 109.927 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.88 -39.33 20.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.831 2.354 . . . . 73.32 113.009 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.77 -47.61 58.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.049 0.54 . . . . 72.43 110.089 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.65 -56.28 23.9 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 114.723 -1.126 . . . . 34.43 111.304 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.24 -34.93 77.46 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.094 0.558 . . . . 75.43 111.418 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.36 -51.79 27.3 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.132 0.573 . . . . 75.11 110.748 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -63.11 -38.7 92.22 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.815 0.697 . . . . 73.21 109.827 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.81 -35.87 77.6 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.79 0.836 . . . . 64.2 111.265 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -73.08 -28.87 62.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.074 0.55 . . . . 54.2 110.75 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -81.86 -41.94 20.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 72.25 111.628 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 30' ' ' LEU . 9.8 pt -100.16 -38.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.04 0.536 . . . . 64.14 112.29 -169.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD13 HG11 ' A' ' 39' ' ' VAL . 45.6 mt -98.45 178.24 5.09 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.092 -0.707 . . . . 63.34 109.092 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.563 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.0 m -68.67 144.83 96.55 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.205 -0.452 . . . . 63.0 110.347 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' A' ' 40' ' ' LEU . 36.1 Cg_exo -59.54 -22.79 68.25 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.698 2.265 . . . . 75.12 112.456 173.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.43 -37.16 86.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.452 1.101 . . . . 74.3 110.903 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.9 t -67.8 -49.97 64.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 123.475 0.71 . . . . 62.11 111.344 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 pp -59.9 -33.76 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 120.832 0.348 . . . . 71.13 110.396 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 30.2 t70 -71.68 -51.62 22.08 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.042 -0.981 . . . . 71.14 110.167 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -62.94 -32.89 74.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.244 0.218 . . . . 51.44 111.348 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.43 -49.18 79.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 CA-C-O 118.982 -0.532 . . . . 74.35 110.401 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -67.1 -31.3 71.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.464 0.477 . . . . 74.11 111.843 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 16.5 mm-40 -62.5 -51.8 66.01 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.319 0.581 . . . . 74.43 110.104 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 44.1 m80 -72.97 -24.34 60.77 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.954 -1.021 . . . . 71.23 111.278 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.95 93.19 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.175 0.99 . . . . 74.43 110.926 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.2 -34.95 77.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.406 -0.816 . . . . 63.11 110.825 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.68 -39.26 62.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.732 0.813 . . . . 72.23 111.099 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 84.7 mt -74.5 -29.97 61.63 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.758 . . . . 72.45 110.654 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -69.49 -39.05 77.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.835 0.854 . . . . 72.3 109.912 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -75.18 -24.65 57.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.771 0.828 . . . . 73.2 110.876 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.88 -36.5 80.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.09 30.43 31.34 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.528 -0.76 . . . . 62.24 111.99 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.85 98.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 109.073 -0.714 . . . . 74.31 109.073 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -84.02 109.57 17.76 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.45 -1.315 . . . . 71.43 107.45 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.0 p90 -111.08 161.45 15.9 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.283 -1.006 . . . . 64.11 108.283 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.53 113.13 7.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.844 -1.169 . . . . 73.2 107.844 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.25 108.42 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.112 0.965 . . . . 63.14 110.133 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -91.59 -50.87 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.147 0.579 . . . . 72.35 111.189 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -137.35 134.56 36.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.892 . . . . 74.52 109.037 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -125.77 118.54 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.809 -1.182 . . . . 74.03 107.809 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.78 107.5 9.71 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.874 -0.788 . . . . 73.24 108.874 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' VAL . 7.4 p -103.61 134.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.995 0.518 . . . . 61.03 109.763 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -149.53 166.18 29.97 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.1 0.96 . . . . 65.24 109.085 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 p -96.67 151.78 19.29 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.325 0.583 . . . . 73.2 110.297 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.32 83.07 1.81 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 106.492 -1.67 . . . . 65.24 106.492 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.91 -115.05 7.12 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.493 -1.23 . . . . 43.35 111.377 -168.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -96.11 -14.66 22.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.101 0.561 . . . . 73.31 110.765 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 m -96.58 121.44 38.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.595 0.758 . . . . 70.55 109.642 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.7 p -89.31 126.57 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 120.981 0.42 . . . . 73.21 110.187 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 72' ' ' ASN . 0.9 OUTLIER -107.64 130.6 54.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.467 0.707 . . . . 70.44 109.939 -177.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 64' ' ' VAL . 21.7 t -112.05 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.999 -0.741 . . . . 65.04 108.999 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -89.39 104.59 17.13 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.646 -0.872 . . . . 75.03 108.646 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.32 120.33 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.837 0.855 . . . . 73.02 109.709 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -89.83 127.94 36.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.766 0.826 . . . . 74.42 108.992 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -127.63 140.5 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.216 0.606 . . . . 72.21 109.393 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -89.42 112.13 23.18 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.021 -1.103 . . . . 70.15 108.021 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.7 mt-10 -101.38 114.83 29.18 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.309 0.643 . . . . 64.14 109.44 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m -87.75 103.28 15.47 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.066 -1.087 . . . . 64.4 108.066 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -140.12 133.88 30.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.74 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.75 16.16 74.11 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.708 -0.678 . . . . 75.45 113.358 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.53 84.55 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.048 0.356 . . . . 73.44 113.185 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -108.4 121.75 45.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.585 0.754 . . . . 71.31 110.371 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.6 m -87.69 116.89 26.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.535 -0.913 . . . . 73.41 108.535 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.3 t -127.22 152.86 46.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.34 0.656 . . . . 73.03 109.749 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -80.06 133.11 36.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.56 -0.533 . . . . 53.33 109.56 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 m -142.59 111.13 6.18 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.779 -1.193 . . . . 72.03 107.779 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -91.02 121.78 33.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.218 0.607 . . . . 70.32 109.562 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.58 125.85 49.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -109.93 102.32 11.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.728 -1.212 . . . . 73.35 107.728 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.1 mp -89.08 105.72 17.97 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.292 -1.373 . . . . 75.55 107.292 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 15.3 ttt180 -101.16 97.64 8.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.713 -1.217 . . . . 73.25 107.713 -170.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' ILE . 99.1 m-85 -88.49 109.48 20.08 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.445 0.698 . . . . 74.21 109.596 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 6.5 tm-20 -86.86 119.37 27.01 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.449 -1.315 . . . . 74.31 107.449 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 101' ' ' ILE . 3.0 m -97.08 150.93 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.091 0.956 . . . . 71.34 111.646 -168.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.12 99.93 4.41 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.385 1.074 . . . . 74.02 109.089 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.37 -99.47 0.73 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.662 -0.699 . . . . 74.13 112.734 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -107.76 -20.62 13.15 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.567 0.747 . . . . 74.55 110.849 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -128.04 153.31 46.92 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.654 0.782 . . . . 73.01 110.662 -170.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 94' ' ' PHE . 72.6 mt -95.1 130.75 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.878 0.871 . . . . 71.25 109.588 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 9.5 mmt180 -102.62 -35.36 8.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.099 0.56 . . . . 74.1 111.288 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.9 mtt85 -127.51 145.18 50.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.794 -0.639 . . . . 54.53 109.592 -167.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.84 123.7 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.226 1.011 . . . . 74.24 108.952 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 12.6 m -109.25 103.22 12.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.255 -1.017 . . . . 73.24 108.255 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.12 106.53 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.413 -0.958 . . . . 72.4 108.413 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.1 m -100.26 105.03 16.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.375 0.67 . . . . 74.11 109.334 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -87.49 92.04 8.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.92 0.488 . . . . 62.42 109.734 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 124.214 1.006 . . . . 73.31 110.123 176.517 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 112.976 0.732 . . . . 73.34 112.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.448 HG21 HG11 ' A' ' 96' ' ' VAL . 47.2 mm -72.8 -29.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.638 1.175 . . . . 75.53 111.957 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.98 -56.56 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 71.02 110.703 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.97 -34.5 69.0 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.802 -0.636 . . . . 61.52 110.804 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -57.25 -50.65 72.23 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.549 0.531 . . . . 72.12 110.455 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.98 -32.07 68.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.505 0.722 . . . . 55.33 112.37 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.18 -58.37 8.62 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.719 0.637 . . . . 71.34 110.154 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.92 -30.27 71.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.997 0.919 . . . . 65.14 111.141 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -62.61 -51.65 66.45 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 124.188 0.93 . . . . 74.13 110.531 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -59.43 -44.18 92.94 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 124.394 1.059 . . . . 72.44 112.357 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 62' ' ' VAL . 42.4 mt -66.73 -42.27 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.556 0.743 . . . . 62.11 109.965 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.3 -28.02 68.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.714 0.805 . . . . 74.12 112.051 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -60.89 -45.72 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.749 0.82 . . . . 74.44 109.909 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 42.3 m-85 -76.68 -29.43 56.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.276 -0.42 . . . . 73.35 112.011 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -60.59 -39.16 87.07 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.796 0.685 . . . . 74.21 110.054 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.6 -38.44 59.03 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.82 0.7 . . . . 65.1 111.176 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.539 ' HH2' HG11 ' A' ' 106' ' ' VAL . 28.2 m0 -62.88 -31.1 72.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.767 0.654 . . . . 71.01 112.767 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -95.97 -19.09 19.77 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.613 0.365 . . . . 64.23 111.204 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -158.04 88.33 2.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.412 0.685 . . . . 75.34 109.982 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.49 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.115 2.543 . . . . 64.15 113.242 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -91.56 10.66 27.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.271 1.028 . . . . 64.14 111.396 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.08 111.19 16.55 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 109.32 -0.622 . . . . 74.13 109.32 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 -44.85 7.03 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.651 2.234 . . . . 74.4 113.007 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.56 -27.72 58.71 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.274 0.472 . . . . 70.01 112.274 -171.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -62.85 -57.83 9.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.813 0.445 . . . . 73.53 110.532 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -66.66 -26.41 67.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.318 0.647 . . . . 64.21 111.937 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -67.09 -46.44 74.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.168 0.987 . . . . 74.42 110.987 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 4.2 pp -70.86 -34.27 71.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.796 -0.184 . . . . 73.31 110.719 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 93.1 mt -61.1 -28.93 69.44 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.667 0.787 . . . . 53.04 111.141 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.34 -24.95 63.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.932 0.893 . . . . 63.13 111.287 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -93.35 -44.81 8.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.666 0.786 . . . . 53.22 110.525 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 35' ' ' LEU . 11.8 pt -94.67 -30.45 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.435 0.694 . . . . 44.15 112.321 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD11 ' HB1' ' A' ' 11' ' ' ALA . 68.6 mt -110.21 175.14 5.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.324 0.65 . . . . 63.23 109.977 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.6 m -73.74 144.4 82.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.31 -0.859 . . . . 72.15 109.369 170.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 88.9 Cg_exo -52.16 -30.44 41.32 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 123.706 2.937 . . . . 73.14 114.285 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.9 -32.34 71.91 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.475 0.71 . . . . 73.11 111.482 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 36' ' ' SER . 40.4 t -70.29 -41.47 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.605 0.762 . . . . 54.14 110.987 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' PRO . 4.1 pp -72.57 -31.33 65.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.749 0.309 . . . . 53.42 110.76 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.6 t70 -65.28 -50.02 67.32 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.23 -0.896 . . . . 71.23 110.783 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.95 -32.52 72.96 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.286 0.366 . . . . 71.2 111.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 15' ' ' ILE . 47.0 t -63.38 -54.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.558 0.743 . . . . 71.24 111.219 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -67.14 -21.51 65.82 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.572 0.582 . . . . 75.44 112.572 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 12.1 mm-40 -80.35 -39.8 27.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.842 0.457 . . . . 60.04 111.344 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -73.92 -22.09 59.81 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.132 0.573 . . . . 75.24 110.698 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.68 94.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.96 1.304 . . . . 74.1 111.791 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.19 -20.96 65.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.498 -1.228 . . . . 61.22 112.024 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.98 -59.27 4.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.637 0.375 . . . . 75.41 110.219 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.31 -29.89 70.96 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.053 0.941 . . . . 72.32 111.443 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -59.51 -51.14 71.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.622 1.169 . . . . 52.23 110.672 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.62 -26.9 55.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.517 0.727 . . . . 61.41 111.885 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -74.39 -24.08 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.338 0.655 . . . . 72.25 110.07 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.19 23.96 77.15 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.469 -0.787 . . . . 61.22 113.309 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.4 mt -71.84 103.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.459 -0.941 . . . . 75.43 108.459 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -79.68 124.13 28.28 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.855 -0.794 . . . . 71.31 108.855 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.53 168.2 20.29 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.583 -0.895 . . . . 73.52 108.583 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -148.77 139.26 22.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 74.21 109.187 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 p -70.43 108.6 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.951 0.901 . . . . 71.54 109.363 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -95.53 -39.54 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.437 0.695 . . . . 73.34 111.909 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -151.07 134.29 16.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.617 0.367 . . . . 62.33 110.242 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 13' ' ' ILE . 41.0 t -125.94 116.16 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.879 0.872 . . . . 71.24 109.453 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -127.49 110.45 12.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.243 -1.021 . . . . 72.43 108.243 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 73' ' ' VAL . 2.7 p -96.55 114.45 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.251 0.62 . . . . 73.12 109.991 -173.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.9 m -109.19 135.85 49.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.765 1.226 . . . . 54.11 110.064 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 p -91.92 113.2 25.41 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.195 -0.668 . . . . 55.42 109.195 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.29 87.3 2.51 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.527 -0.916 . . . . 72.24 108.527 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.84 -123.13 12.62 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.361 -0.836 . . . . 54.31 111.139 -172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.34 -16.46 31.01 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.171 0.588 . . . . 61.54 110.538 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 95' ' ' GLU . 9.8 m -96.3 125.61 40.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.444 0.698 . . . . 75.01 109.473 -172.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 94' ' ' PHE . 6.5 p -95.54 115.57 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.746 0.784 . . . . 74.42 110.792 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -102.38 104.63 15.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.911 0.884 . . . . 65.44 109.117 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 64' ' ' VAL . 53.3 t -88.8 105.77 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.524 -0.547 . . . . 51.25 109.524 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.0 m -86.41 105.46 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.793 -0.817 . . . . 74.32 108.793 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.1 p -122.02 120.73 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.793 0.837 . . . . 71.11 110.759 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -86.42 129.31 34.9 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.913 0.885 . . . . 71.12 109.65 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.07 137.2 55.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.595 0.758 . . . . 62.21 109.02 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.46 105.49 17.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.183 -1.043 . . . . 74.41 108.183 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -97.36 115.16 27.19 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.428 0.691 . . . . 64.41 111.068 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -90.64 104.42 17.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.02 0.928 . . . . 44.31 108.673 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -124.57 122.22 36.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.263 1.025 . . . . 74.23 109.461 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.72 -88.18 0.36 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.19 0.424 . . . . 74.42 112.653 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.74 13.15 1.74 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.381 0.515 . . . . 73.31 112.256 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.6 p -116.67 139.66 50.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.826 0.851 . . . . 73.33 109.605 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -120.93 119.25 32.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.843 -1.169 . . . . 75.52 107.843 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.9 m -142.19 143.27 32.86 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.948 0.499 . . . . 74.22 110.151 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.64 102.96 8.27 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.723 0.809 . . . . 73.23 109.73 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.8 m -99.83 120.74 40.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.487 1.115 . . . . 74.02 108.743 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 m -89.41 127.52 35.84 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.448 -0.575 . . . . 70.25 109.448 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -107.44 126.5 52.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.653 -1.24 . . . . 75.42 107.653 170.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -108.56 103.28 12.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.509 -0.922 . . . . 65.41 108.509 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 12' ' ' ALA . 60.3 mt -90.0 104.71 17.25 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.373 1.069 . . . . 64.33 109.52 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 49.8 ttt85 -93.76 98.93 11.42 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.133 -0.691 . . . . 74.24 109.133 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.585 ' HB2' HG13 ' A' ' 71' ' ' VAL . 86.7 m-85 -87.52 116.49 25.67 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 9.2 tp10 -87.93 131.45 34.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 122.72 0.408 . . . . 55.04 110.114 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 101' ' ' ILE . 5.9 m -103.82 149.66 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.952 0.901 . . . . 54.35 110.32 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.456 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 17.3 t70 -141.38 111.08 6.51 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.599 -1.259 . . . . 61.03 107.599 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.96 -110.5 3.06 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.697 -0.683 . . . . 34.41 112.446 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -113.12 -6.26 13.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.113 0.965 . . . . 63.2 112.263 -171.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -135.82 165.66 25.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.064 0.546 . . . . 73.05 110.754 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 96' ' ' VAL . 71.0 mt -93.53 132.35 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.058 0.943 . . . . 64.32 109.3 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HE ' ' HB3' ' A' ' 97' ' ' ASP . 21.0 mmt180 -102.98 -28.43 12.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 73.51 111.182 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 48.9 ttt180 -145.53 154.12 41.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.69 0.396 . . . . 73.43 110.955 -166.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 39' ' ' VAL . 7.4 p -132.95 138.18 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 70.24 108.579 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.2 m -113.86 112.47 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.446 -0.946 . . . . 70.03 108.446 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HH2' ' A' ' 19' ' ' TRP . 47.8 t -86.92 104.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.045 -0.724 . . . . 73.33 109.045 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -103.84 105.84 16.17 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.9 -0.778 . . . . 61.33 108.9 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.22 95.62 6.99 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.179 -1.045 . . . . 72.22 108.179 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 . . . . . 0 CA--C 1.547 0.837 0 CA-C-N 114.982 -1.008 . . . . 64.14 109.41 -177.35 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 121.277 0.561 . . . . 63.14 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.136 1.374 . . . . 63.54 112.478 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 66' ' ' THR . 40.6 t -59.88 -57.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.663 0.785 . . . . 74.51 110.12 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.72 -37.04 83.89 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.825 -1.08 . . . . 74.12 111.203 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.07 81.82 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.56 0.538 . . . . 50.0 111.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.95 95.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.886 -0.597 . . . . 54.32 111.528 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.2 -47.01 72.16 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.926 0.491 . . . . 73.32 111.664 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.58 -34.03 77.29 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.348 1.059 . . . . 75.25 110.783 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.75 81.63 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.101 -0.954 . . . . 72.24 110.755 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.24 82.42 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.257 0.973 . . . . 52.12 110.785 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 70.3 mt -59.29 -44.13 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 O-C-N 124.39 1.056 . . . . 73.14 109.799 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.06 77.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.157 0.983 . . . . 70.2 113.077 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.84 -39.75 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 73.04 109.974 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -76.7 -28.2 55.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.985 0.514 . . . . 74.24 111.807 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 95.6 mt-30 -68.81 -27.43 65.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.064 0.546 . . . . 74.21 110.559 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 69.1 mt -79.99 -43.76 21.42 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.833 0.453 . . . . 50.41 110.252 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -62.23 -25.03 67.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.939 0.718 . . . . 71.35 112.939 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -82.87 -33.24 27.06 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.133 0.492 . . . . 63.54 110.747 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -158.02 93.04 2.11 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.331 1.052 . . . . 73.04 108.289 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' A' ' 48' ' ' ARG . 19.1 Cg_endo -56.41 -27.12 66.35 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 123.559 2.84 . . . . 73.35 113.947 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -84.8 15.01 4.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.404 0.682 . . . . 72.02 111.85 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.55 111.05 8.23 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.94 -38.95 6.71 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.412 2.074 . . . . 73.44 112.593 -173.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.91 -41.41 95.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.61 0.764 . . . . 75.04 111.245 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.03 8.85 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.216 0.947 . . . . 74.01 111.76 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -70.62 -26.59 63.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.055 -0.521 . . . . 72.31 112.383 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.83 -40.25 63.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.922 0.489 . . . . 62.02 110.707 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 2.3 pp -70.68 -31.84 68.88 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 110.056 -0.35 . . . . 73.31 110.056 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.834 0.854 . . . . 73.23 111.524 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.98 -29.45 64.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.914 0.486 . . . . 64.15 110.647 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 26.3 mtpp -80.48 -42.84 21.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.973 0.909 . . . . 74.15 111.431 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.507 HG13 HD23 ' A' ' 35' ' ' LEU . 16.9 pt -107.22 -36.13 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.61 0.596 . . . . 60.11 112.61 -168.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 34' ' ' ILE . 2.3 mm? -99.43 179.23 4.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.996 0.918 . . . . 64.42 110.801 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -80.85 146.52 59.95 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 115.046 -0.979 . . . . 75.44 110.356 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -31.35 92.48 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.371 2.714 . . . . 53.34 114.031 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.62 -38.95 92.76 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.676 0.79 . . . . 74.21 111.153 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.97 -53.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.691 0.796 . . . . 64.45 111.437 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.51 -32.12 72.99 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.569 0.224 . . . . 72.12 111.035 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 18.2 t70 -71.27 -49.85 38.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 124.16 0.913 . . . . 74.33 110.893 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.59 -38.38 89.33 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.29 0.236 . . . . 71.42 111.449 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.2 -45.09 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.223 0.609 . . . . 61.23 111.477 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.0 ptm180 -72.57 -25.99 61.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.518 0.327 . . . . 75.22 111.228 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 53.8 mt-10 -69.8 -46.32 65.98 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.212 0.605 . . . . 75.55 110.933 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.37 -34.35 78.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.843 -0.617 . . . . 71.11 110.035 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -64.15 -31.44 72.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.493 1.117 . . . . 64.34 112.222 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HA ' ' HG3' ' A' ' 22' ' ' PRO . 70.4 mtp180 -63.28 -36.68 84.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.369 0.668 . . . . 45.43 110.31 174.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -74.6 -34.44 62.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.759 -0.655 . . . . 64.44 110.69 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 55' ' ' ILE . 74.9 mt -74.26 -23.68 59.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.381 0.672 . . . . 63.02 110.707 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -70.44 -43.09 70.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.179 0.992 . . . . 75.42 109.898 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.26 -41.85 94.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.722 0.809 . . . . 72.33 110.855 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.14 -29.26 62.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.042 -0.981 . . . . 71.1 111.022 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.98 46.41 59.44 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.556 0.535 . . . . 72.45 112.766 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 50' ' ' LEU . 58.7 mt -79.56 109.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.191 0.597 . . . . 63.24 109.933 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -91.47 119.99 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.148 -1.056 . . . . 74.32 108.148 173.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.7 158.64 39.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.107 0.963 . . . . 72.1 109.163 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.38 130.12 38.33 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.382 0.673 . . . . 73.24 109.978 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.82 121.56 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 109.573 -0.529 . . . . 63.31 109.573 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -94.38 -48.0 6.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.285 1.034 . . . . 64.12 109.711 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -138.72 139.82 38.51 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.943 -1.132 . . . . 65.13 107.943 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.33 107.53 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.299 -1.0 . . . . 55.12 108.299 171.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -118.93 151.28 38.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.445 1.098 . . . . 72.31 108.799 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.1 126.22 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 71.44 109.335 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -132.22 117.18 17.89 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.966 -0.753 . . . . 55.2 108.966 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.55 HG21 HG22 ' A' ' 5' ' ' VAL . 70.5 p -88.43 127.25 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.529 -0.545 . . . . 44.52 109.529 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -132.71 100.99 5.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.289 -1.004 . . . . 74.5 108.289 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.16 -110.55 3.56 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.933 0.771 . . . . 75.11 112.138 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -118.4 23.7 11.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.866 0.866 . . . . 74.54 110.351 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -133.18 122.09 23.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.277 0.631 . . . . 52.51 109.358 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -97.95 103.72 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.446 0.641 . . . . 71.54 110.15 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -84.04 100.86 11.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.618 1.167 . . . . 72.35 109.42 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 105.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 71.42 109.234 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -89.53 109.24 20.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.015 0.926 . . . . 73.05 109.108 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.12 116.69 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.441 0.696 . . . . 54.34 110.151 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -84.18 135.51 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.079 0.952 . . . . 74.43 109.114 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.52 141.3 41.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.424 0.69 . . . . 75.25 109.608 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.63 108.67 21.43 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.315 -0.624 . . . . 70.5 109.315 168.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.59 107.63 18.24 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.63 -0.878 . . . . 74.4 108.63 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 m -89.57 102.91 15.59 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.937 -1.505 . . . . 61.43 106.937 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 t -140.94 124.18 16.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.305 1.042 . . . . 55.31 108.797 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.48 75.32 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.688 -0.687 . . . . 71.13 112.969 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.82 -19.87 42.64 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.746 -0.474 . . . . 64.31 113.416 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.4 p -88.68 120.23 29.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.159 0.584 . . . . 74.23 110.648 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -90.88 110.26 21.49 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.358 -0.979 . . . . 75.11 108.358 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.1 m -119.49 128.74 54.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 73.4 110.519 -172.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -77.35 101.7 6.45 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.126 -0.694 . . . . 61.34 109.126 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 m -108.42 114.49 28.37 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.453 1.101 . . . . 64.5 108.319 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -88.36 122.04 31.42 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.57 -0.9 . . . . 72.32 108.57 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -102.45 129.77 49.04 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.781 -1.192 . . . . 72.34 107.781 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.45 102.07 11.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.77 104.54 16.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.779 -1.193 . . . . 73.2 107.779 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -101.56 100.74 11.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.102 -1.408 . . . . 75.21 108.225 -170.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.22 110.57 21.61 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.752 0.821 . . . . 61.01 111.559 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -79.49 99.88 7.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 101' ' ' ILE . 4.2 m -97.73 141.14 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 62.45 110.163 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.9 116.38 9.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.217 0.607 . . . . 71.42 109.935 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.88 -114.22 5.45 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.969 0.793 . . . . 72.55 112.648 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.93 -3.09 26.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.9 0.88 . . . . 71.03 112.036 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.2 t -137.46 148.79 46.36 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.136 0.493 . . . . 71.41 110.943 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.499 HG23 HG12 ' A' ' 96' ' ' VAL . 34.8 mt -89.3 121.28 39.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.287 -1.005 . . . . 75.14 108.287 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -88.03 -41.86 12.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.992 0.917 . . . . 72.41 112.26 -167.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -142.37 163.89 31.62 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.809 0.338 . . . . 74.15 110.727 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.74 117.15 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.466 1.106 . . . . 74.41 108.831 168.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.1 m -93.45 104.28 16.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.649 -0.871 . . . . 62.21 108.649 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.12 104.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.719 0.771 . . . . 71.4 109.937 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 m -95.51 110.04 22.16 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.001 0.92 . . . . 73.42 109.428 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -81.68 94.38 6.96 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.485 0.714 . . . . 61.22 109.805 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.618 0.767 . . . . 75.24 109.485 178.124 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.504 -0.184 . . . . 64.23 110.504 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -49.92 -44.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.785 1.234 . . . . 74.13 112.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.78 -46.63 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.554 1.142 . . . . 72.44 111.031 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.0 -46.42 81.46 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.713 -0.676 . . . . 73.43 110.526 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.12 -30.25 70.21 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.241 1.016 . . . . 62.12 111.404 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.18 86.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.997 0.519 . . . . 74.31 110.062 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 13' ' ' ILE . 88.2 tttt -66.38 -45.18 80.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.329 -0.851 . . . . 64.34 110.135 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -57.52 -45.3 85.17 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.136 0.974 . . . . 62.22 110.475 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.21 91.73 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 124.594 1.184 . . . . 74.42 111.04 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.27 -52.2 66.31 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.994 0.809 . . . . 64.13 111.583 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 9' ' ' LYS . 33.2 mt -60.94 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 123.853 0.721 . . . . 74.22 109.706 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.48 83.92 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.271 1.029 . . . . 71.01 112.276 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.71 -43.57 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 123.973 0.796 . . . . 74.2 110.206 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 75' ' ' VAL . 75.6 m-85 -73.73 -31.86 63.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.068 0.396 . . . . 62.21 112.068 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.647 0.592 . . . . 70.11 109.964 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 28' ' ' GLN . 81.4 mt -67.72 -48.25 67.03 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 124.192 0.933 . . . . 73.11 110.317 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -54.07 -29.4 44.18 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.843 0.857 . . . . 70.01 113.144 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 20.0 ptmt -101.97 -23.01 14.18 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.074 0.55 . . . . 73.41 112.065 174.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -149.95 83.15 6.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.403 0.681 . . . . 72.4 109.996 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 44.2 Cg_endo -71.73 -7.71 21.68 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.301 2.667 . . . . 73.41 114.597 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -78.97 -10.14 59.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 74.25 112.128 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.93 117.18 51.38 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.683 0.393 . . . . 74.41 110.276 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.49 -41.97 2.09 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.679 2.253 . . . . 73.13 113.446 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.81 -33.56 74.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.227 0.611 . . . . 71.31 112.226 -170.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.22 75.51 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.477 0.711 . . . . 62.24 110.667 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 18' ' ' LEU . 9.3 pt20 -79.2 -20.83 47.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.836 -0.62 . . . . 73.21 111.815 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -46.75 75.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.608 0.763 . . . . 72.45 110.572 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.2 pp -70.33 -31.7 69.11 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.487 0.492 . . . . 61.53 110.337 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.3 -28.89 70.32 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.663 0.785 . . . . 75.35 112.048 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -70.04 -33.87 72.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.144 0.497 . . . . 74.45 110.208 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.27 -33.92 23.91 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.859 0.863 . . . . 52.32 112.023 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 7' ' ' ALA . 10.1 pt -108.89 -33.67 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 122.954 0.502 . . . . 73.41 111.446 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 39' ' ' VAL . 3.5 mm? -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.443 1.097 . . . . 74.31 108.641 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.56 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.1 m -67.62 145.3 98.16 Favored Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 109.754 -0.461 . . . . 65.02 109.754 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.05 -18.12 56.0 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.486 2.124 . . . . 72.43 112.825 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.49 -33.86 62.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.002 0.921 . . . . 61.31 111.027 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 36' ' ' SER . 63.3 t -63.96 -41.45 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.745 0.818 . . . . 74.03 111.5 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.5 pp -60.55 -35.4 75.92 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 120.697 0.284 . . . . 71.22 111.056 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.7 t70 -72.6 -52.58 14.88 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.156 -0.929 . . . . 34.53 110.558 -175.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -61.34 -29.27 69.79 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.295 0.48 . . . . 75.34 112.295 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.9 t -71.7 -48.36 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.685 0.794 . . . . 74.24 110.868 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -73.14 -21.5 60.71 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.76 0.424 . . . . 74.41 111.926 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 mm-40 -82.73 -35.33 26.75 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 122.211 -0.305 . . . . 73.32 110.423 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -68.73 -26.58 65.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.762 0.791 . . . . 64.24 110.69 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -67.93 -38.35 82.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.601 -1.181 . . . . 62.23 111.568 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -65.22 -21.29 66.73 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.679 0.612 . . . . 65.45 111.338 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -72.03 -46.72 56.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.525 0.73 . . . . 73.11 110.628 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.85 -22.95 63.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.56 0.744 . . . . 74.31 111.176 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -71.63 -27.33 63.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.107 0.963 . . . . 64.03 111.338 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -78.61 -6.73 56.42 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.618 0.367 . . . . 63.24 111.034 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -116.69 172.56 7.15 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.117 0.967 . . . . 71.42 110.248 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.67 24.41 30.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.727 -0.67 . . . . 52.53 113.144 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 88.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-O 121.357 0.599 . . . . 74.41 109.464 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -101.46 110.36 22.35 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.185 -1.042 . . . . 73.33 108.185 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -117.34 135.56 53.76 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.486 0.715 . . . . 73.11 110.469 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.61 122.2 45.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.775 0.83 . . . . 64.25 109.882 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.67 101.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.686 -0.857 . . . . 72.23 108.686 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -77.68 -44.1 29.08 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.686 -0.688 . . . . 62.33 110.805 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 17.6 tpp85 -152.77 142.1 21.58 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.78 -1.1 . . . . 71.1 108.869 -177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.77 110.01 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.615 -0.884 . . . . 61.13 108.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.485 ' HG3' ' HD2' ' A' ' 61' ' ' ARG . 28.8 mt-10 -128.7 122.92 31.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.008 -0.738 . . . . 74.13 109.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 73' ' ' VAL . 3.7 p -96.78 135.77 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.496 1.118 . . . . 62.32 110.135 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -138.55 137.63 37.22 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.176 0.99 . . . . 63.54 109.287 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -95.44 155.82 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.046 0.538 . . . . 74.41 111.368 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 95.62 2.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.32 -1.363 . . . . 75.34 107.32 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.63 -117.08 9.41 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 111.736 -0.546 . . . . 42.41 111.736 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.87 -12.93 21.58 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.01 0.524 . . . . 62.24 111.533 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.9 m -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.982 0.513 . . . . 53.13 110.087 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 94' ' ' PHE . 7.8 p -99.73 136.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.719 0.808 . . . . 64.45 110.568 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.95 115.97 22.81 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.058 1.343 . . . . 73.21 108.883 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 64' ' ' VAL . 46.8 t -92.24 113.07 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 110.181 -0.303 . . . . 65.3 110.181 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.2 m -87.64 104.89 16.94 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.074 -1.084 . . . . 72.42 108.074 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 16' ' ' PHE . 5.3 p -119.48 122.52 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.231 1.012 . . . . 71.33 109.015 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -94.96 132.93 39.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.937 0.895 . . . . 74.54 109.305 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.57 154.91 49.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.407 0.683 . . . . 71.51 109.808 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -110.07 104.48 13.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 72.23 109.289 171.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.52 106.65 17.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.567 0.747 . . . . 63.21 110.191 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -87.85 102.93 15.17 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.886 -1.153 . . . . 63.21 107.886 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.5 t -146.95 135.82 22.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.133 0.973 . . . . 52.24 109.485 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 22.45 71.08 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.732 -0.667 . . . . 73.0 112.843 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.3 80.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.938 -0.368 . . . . 72.5 114.004 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -126.97 123.43 37.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.376 0.67 . . . . 73.3 110.959 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.6 m -88.07 115.08 25.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.308 1.043 . . . . 74.01 110.005 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.6 m -119.08 133.51 55.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.013 0.925 . . . . 72.23 110.134 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -79.21 125.43 29.45 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.974 -0.75 . . . . 54.42 108.974 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.9 m -141.96 125.17 16.41 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.671 0.788 . . . . 64.01 110.234 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -90.75 129.88 36.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.648 -0.501 . . . . 65.34 109.648 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -108.96 146.84 33.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.554 0.742 . . . . 52.21 109.166 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.3 103.66 7.29 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.066 -1.087 . . . . 72.11 108.066 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -92.77 108.49 20.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 70.31 107.912 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -90.48 99.79 12.75 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.48 -0.782 . . . . 75.3 109.329 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.6 m-85 -89.3 110.3 21.1 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.987 -0.746 . . . . 62.23 108.987 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 26.6 tt0 -92.13 127.86 37.76 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.089 -1.078 . . . . 72.2 108.089 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -85.09 142.49 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.263 0.554 . . . . 73.2 110.979 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -120.96 97.41 5.52 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.915 -1.143 . . . . 72.44 107.915 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.92 -107.08 1.86 Allowed Glycine 0 C--N 1.343 0.929 0 O-C-N 123.822 0.701 . . . . 63.02 113.241 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.63 -19.05 22.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.047 0.939 . . . . 71.41 112.053 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -132.45 167.95 19.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.669 0.787 . . . . 74.12 110.614 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 94' ' ' PHE . 50.0 mt -92.06 135.79 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.685 -0.857 . . . . 52.33 108.685 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -129.48 7.69 5.36 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.942 0.497 . . . . 74.1 111.828 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 31.2 mmt180 -144.45 146.58 32.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.999 0.519 . . . . 75.23 111.544 -175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 130.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.993 1.317 . . . . 71.52 109.333 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -127.03 105.8 8.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.417 -0.957 . . . . 72.01 108.417 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 t -86.61 106.81 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.045 -0.724 . . . . 72.2 109.045 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 m -95.57 152.12 18.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.624 -0.88 . . . . 71.22 108.624 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -129.03 138.58 51.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.351 0.66 . . . . 74.52 110.197 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 108.033 -1.099 . . . . 72.32 108.033 174.065 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.52 -0.178 . . . . 73.44 110.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.37 -39.92 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.576 1.55 . . . . 73.23 113.331 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.76 -50.31 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.545 0.738 . . . . 74.04 110.292 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.19 -30.47 64.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.547 -0.752 . . . . 73.35 110.92 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.55 69.98 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.497 0.719 . . . . 63.44 109.954 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.75 94.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.532 0.733 . . . . 70.13 111.495 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.3 -57.88 11.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.268 1.027 . . . . 63.34 111.397 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -66.96 -29.1 68.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 74.03 110.906 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.76 83.6 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 123.925 0.766 . . . . 72.5 110.934 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.47 -51.08 69.8 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.373 1.046 . . . . 42.44 110.631 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 39.9 mt -61.69 -42.79 95.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 O-C-N 124.402 1.064 . . . . 70.22 110.413 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.64 74.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.803 0.841 . . . . 75.11 112.026 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.63 -40.97 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 41.42 109.508 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 60.2 m-85 -72.16 -31.13 65.67 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.472 0.309 . . . . 62.22 111.742 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 19.4 mt-30 -66.09 -35.57 80.86 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.494 0.496 . . . . 75.11 110.407 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 -42.85 65.74 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 123.888 0.742 . . . . 65.41 109.966 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 37.6 m0 -61.11 -26.06 67.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.166 0.802 . . . . 73.15 113.166 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 17' ' ' GLN . 64.3 pttt -100.22 -21.7 15.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.791 0.436 . . . . 75.52 110.948 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -152.99 89.5 3.69 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.35 0.66 . . . . 65.15 109.56 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.71 -19.21 66.87 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.095 2.53 . . . . 53.43 113.169 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.3 p -83.13 7.9 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.049 0.939 . . . . 64.12 112.469 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.77 108.59 6.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.03 0.532 . . . . 61.12 109.934 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.74 -29.68 15.42 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.573 2.182 . . . . 74.33 113.185 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.67 -41.6 62.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.247 0.619 . . . . 60.54 110.722 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.19 61.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.816 0.846 . . . . 55.13 111.144 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -66.91 -28.77 68.58 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.713 -0.676 . . . . 74.03 111.764 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.81 -52.35 44.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.881 0.472 . . . . 73.33 110.86 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.6 pp -66.89 -31.75 72.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.192 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.04 -12.58 61.81 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.959 0.903 . . . . 73.54 112.905 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 -27.02 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.419 0.628 . . . . 62.13 109.963 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -85.47 -30.49 23.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.97 0.908 . . . . 64.45 111.181 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 30' ' ' LEU . 12.9 pt -117.77 -32.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.791 0.437 . . . . 62.51 111.538 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 39' ' ' VAL . 3.7 mm? -109.2 179.28 4.21 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.688 0.795 . . . . 64.25 109.253 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 28.7 m -76.26 152.47 83.94 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 122.772 0.429 . . . . 75.13 111.347 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.61 -23.51 65.65 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.821 2.347 . . . . 73.3 112.366 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.6 -39.94 80.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.53 1.132 . . . . 54.15 111.133 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 35' ' ' LEU . 93.5 t -65.63 -57.42 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.306 0.643 . . . . 65.55 110.651 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.4 pp -58.04 -27.04 63.23 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.34 0.496 . . . . 55.31 112.34 -176.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.78 -41.02 24.1 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.77 0.828 . . . . 73.31 110.959 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -74.46 -27.91 60.79 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.303 -0.248 . . . . 74.52 110.626 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -40.83 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.161 0.985 . . . . 65.12 110.749 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.58 -30.73 69.55 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 120.268 0.08 . . . . 71.11 111.052 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.77 -26.32 27.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.844 0.458 . . . . 75.42 111.076 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -66.49 -27.11 67.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.978 0.511 . . . . 74.03 110.365 172.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.86 91.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.92 -1.036 . . . . 70.5 111.878 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -64.71 -31.76 73.13 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.119 0.887 . . . . 65.01 111.479 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.04 -44.19 97.22 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 123.824 0.702 . . . . 71.43 110.44 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -78.42 -36.16 46.02 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.327 1.051 . . . . 73.14 111.314 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.31 -30.15 63.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.924 0.89 . . . . 64.43 110.156 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.98 -36.25 80.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.649 1.18 . . . . 62.21 110.225 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.24 -20.92 29.39 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.974 -1.012 . . . . 62.32 111.013 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.57 20.91 70.5 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.922 -0.581 . . . . 64.01 113.208 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.1 mt -82.21 100.28 5.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 123.366 0.666 . . . . 73.04 110.123 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -92.96 112.98 25.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.219 -0.66 . . . . 74.35 109.219 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 5.7 p90 -105.81 159.45 16.0 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.12 -0.696 . . . . 75.04 109.12 168.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -133.0 133.54 43.27 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.988 -0.551 . . . . 61.52 110.034 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.43 101.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.512 1.132 . . . . 73.5 109.974 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.84 -54.89 3.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.93 0.395 . . . . 73.53 111.48 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -133.16 123.43 25.65 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 109.471 -0.566 . . . . 73.14 109.471 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.54 125.6 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.043 0.937 . . . . 72.53 109.398 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.65 109.12 9.5 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.481 -0.933 . . . . 71.32 108.481 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.6 p -95.41 108.27 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.484 0.659 . . . . 72.22 109.356 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.2 p -113.18 124.97 53.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.564 0.746 . . . . 61.3 109.632 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 71' ' ' VAL . 45.5 p -88.35 154.13 20.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.826 0.45 . . . . 74.42 109.948 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -148.48 92.93 2.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.017 -1.475 . . . . 52.55 107.017 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.65 -117.69 10.39 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.986 -0.846 . . . . 75.14 110.986 -169.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -94.56 -14.06 25.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.402 0.681 . . . . 54.5 110.503 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -93.84 121.62 35.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.642 0.777 . . . . 61.53 110.411 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 48.2 t -99.66 111.64 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.232 0.613 . . . . 72.44 110.85 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -94.74 107.31 19.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.334 1.054 . . . . 74.34 108.953 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.55 103.61 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.707 -0.479 . . . . 74.11 109.707 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.2 m -86.57 106.15 17.35 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.343 1.057 . . . . 52.0 109.03 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.6 p -127.87 124.85 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.06 0.944 . . . . 61.43 110.293 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -94.82 127.14 40.61 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.971 0.908 . . . . 70.12 109.051 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.99 157.07 30.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.582 0.753 . . . . 74.42 109.259 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' THR . 40.8 mt-10 -109.22 106.52 16.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.154 -0.475 . . . . 72.3 109.852 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 23.7 mt-10 -86.02 119.81 26.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.697 0.799 . . . . 75.35 110.616 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -89.51 100.44 13.24 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.743 -1.206 . . . . 63.44 107.743 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 t -149.44 128.46 12.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.123 0.969 . . . . 63.15 110.007 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.03 69.61 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 113.835 0.294 . . . . 72.35 113.835 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.45 13.22 83.61 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.901 -0.389 . . . . 71.43 113.989 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.9 p -121.56 149.39 43.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.412 0.685 . . . . 75.51 109.937 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 m -116.61 106.15 13.23 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.364 -0.976 . . . . 65.1 108.364 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 12.0 t -110.66 139.04 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.977 0.418 . . . . 63.51 110.97 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -80.45 102.71 9.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.097 -0.705 . . . . 65.21 109.097 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -114.62 128.15 56.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.227 0.611 . . . . 52.32 109.454 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.7 m -93.43 119.12 32.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.287 0.635 . . . . 72.35 110.186 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -104.3 130.34 52.12 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.241 -1.022 . . . . 60.25 108.241 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.77 104.74 11.96 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.039 -1.097 . . . . 72.45 108.039 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -90.96 108.96 20.2 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.85 -1.167 . . . . 71.21 107.85 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 27.6 ttt180 -89.36 99.68 12.63 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.042 -0.981 . . . . 70.12 108.376 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.53 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.7 m-85 -87.82 107.65 18.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.253 -0.885 . . . . 62.04 109.053 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 108.15 20.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.471 -1.307 . . . . 74.11 107.471 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 101' ' ' ILE . 3.8 m -86.68 151.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 114.871 -1.059 . . . . 61.44 112.407 -165.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.39 103.28 5.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.696 1.198 . . . . 64.55 108.631 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.13 -108.28 2.49 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.369 -0.378 . . . . 72.34 113.279 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.33 2.42 16.5 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.826 0.85 . . . . 64.51 111.74 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 164.63 26.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.691 0.796 . . . . 43.14 109.265 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 96' ' ' VAL . 24.9 mt -101.18 107.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.605 -1.257 . . . . 73.14 107.605 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -85.25 -29.12 24.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.472 0.309 . . . . 62.23 111.624 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -130.06 142.58 50.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.36 0.664 . . . . 73.52 109.757 -164.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.02 142.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.464 0.705 . . . . 64.43 110.615 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.1 m -119.48 141.65 48.98 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.241 1.017 . . . . 72.34 108.889 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 110.09 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.48 -0.563 . . . . 42.44 109.48 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.1 m -103.39 104.86 15.0 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.561 0.744 . . . . 70.54 109.64 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.51 96.11 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.248 0.547 . . . . 71.52 109.854 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 . . . . . 0 C--O 1.244 0.775 0 C-N-CA 124.158 0.983 . . . . 74.24 109.662 175.327 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.113 -0.699 . . . . 73.43 109.113 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.619 HG23 HG11 ' A' ' 96' ' ' VAL . 36.1 mm -48.01 -47.19 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.971 1.709 . . . . 74.32 113.19 -171.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 66' ' ' THR . 45.9 t -66.12 -56.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.497 0.719 . . . . 52.14 110.759 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -74.77 -29.17 61.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.181 -0.918 . . . . 74.22 111.768 -170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.1 -45.31 77.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.411 0.684 . . . . 50.41 110.023 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -68.64 -32.72 72.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.454 0.702 . . . . 54.32 111.881 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.0 -47.8 78.88 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.554 0.742 . . . . 73.24 110.482 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.761 0.824 . . . . 74.13 111.437 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.29 86.44 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.749 0.82 . . . . 71.25 110.806 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.86 79.56 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 124.202 0.939 . . . . 61.03 111.415 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.3 -40.41 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.147 -0.933 . . . . 73.02 110.449 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.92 82.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.678 0.791 . . . . 54.02 111.665 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 56.4 mt -60.87 -41.58 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.072 0.949 . . . . 71.34 110.35 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 75' ' ' VAL . 30.6 m-85 -76.38 -31.58 58.09 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.825 0.45 . . . . 72.21 111.819 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -65.86 -32.5 74.05 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.131 0.572 . . . . 70.33 110.563 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -49.11 26.39 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.502 0.501 . . . . 75.05 110.434 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -59.42 -26.09 64.88 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.39 -29.51 14.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.54 0.336 . . . . 74.14 111.008 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -147.45 85.55 6.7 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.433 0.693 . . . . 62.45 109.137 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.07 -12.16 33.51 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.977 2.451 . . . . 54.32 112.951 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -84.98 5.01 31.01 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.222 1.009 . . . . 73.11 111.584 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -77.33 110.78 13.48 Favored Pre-proline 0 C--N 1.357 0.921 0 N-CA-C 109.53 -0.544 . . . . 75.51 109.53 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.26 -26.09 9.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.408 2.072 . . . . 70.03 112.352 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -75.28 -44.3 46.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.936 0.895 . . . . 74.44 111.118 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.42 81.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 124.273 0.983 . . . . 62.04 111.094 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.3 pt20 -75.5 -24.61 56.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.735 -0.666 . . . . 63.33 111.881 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.22 -46.26 61.56 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.027 0.531 . . . . 74.1 110.983 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.4 pp -68.01 -29.34 68.32 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.357 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.2 mt -69.23 -14.76 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 74.21 112.335 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -81.29 -30.25 34.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.266 0.555 . . . . 54.41 109.503 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -82.73 -36.97 25.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.097 0.959 . . . . 55.42 111.05 -174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 7' ' ' ALA . 12.9 pt -105.16 -35.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.309 0.643 . . . . 65.2 111.637 -173.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 34' ' ' ILE . 3.9 mm? -111.13 175.7 5.32 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.335 1.054 . . . . 74.22 109.373 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.8 m -74.11 146.23 84.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 116.036 -0.529 . . . . 75.13 110.609 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.38 -32.26 41.54 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.288 2.659 . . . . 75.53 114.031 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.49 -39.82 92.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.213 1.005 . . . . 73.3 111.457 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 36' ' ' SER . 96.0 t -70.47 -45.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.498 0.719 . . . . 71.45 111.113 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.8 pp -64.14 -30.05 71.13 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.936 0.398 . . . . 61.41 110.556 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 23.8 t70 -68.23 -56.73 7.63 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.8 -1.091 . . . . 54.33 110.06 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.42 -31.64 69.45 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 111.898 0.333 . . . . 71.23 111.898 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 54.5 t -66.25 -51.99 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.219 0.608 . . . . 70.21 110.415 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 40.4 ptt180 -69.42 -21.9 63.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 119.664 -0.208 . . . . 74.51 111.463 -176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 18.6 mm-40 -71.02 -46.25 62.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.817 0.447 . . . . 74.15 111.068 175.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -66.32 -28.95 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.052 -0.522 . . . . 75.23 110.769 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.08 93.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.043 0.937 . . . . 74.24 112.049 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 79.3 mtp180 -68.13 -23.64 64.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.689 0.796 . . . . 72.14 111.777 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.26 -47.08 12.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.842 0.857 . . . . 73.43 110.152 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.09 -20.17 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.918 0.887 . . . . 74.32 111.341 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.56 -35.04 79.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.435 1.094 . . . . 74.42 110.902 174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.73 -32.95 25.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.278 0.631 . . . . 71.04 110.875 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.84 147.34 30.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.402 0.681 . . . . 74.51 110.394 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.08 56.94 5.01 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.475 -0.33 . . . . 45.15 112.46 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.41 105.14 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.086 0.954 . . . . 71.33 108.658 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -104.72 110.37 22.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.665 -0.865 . . . . 75.31 108.665 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.71 162.3 16.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.353 0.661 . . . . 70.35 109.423 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.71 140.46 22.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.673 -0.491 . . . . 73.44 109.673 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.64 122.19 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.12 0.968 . . . . 53.52 109.436 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -106.27 -17.01 14.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.442 0.697 . . . . 63.03 111.202 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.7 ttt180 -163.45 132.97 4.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.289 0.635 . . . . 74.33 110.227 -169.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.4 t -125.26 135.29 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.293 1.037 . . . . 62.0 108.762 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.84 108.97 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.283 -1.006 . . . . 61.21 108.283 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.4 121.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 121.11 0.481 . . . . 63.03 110.11 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.7 m -141.12 135.24 30.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.972 0.909 . . . . 74.13 108.639 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.516 HG21 HG22 ' A' ' 5' ' ' VAL . 26.8 p -100.8 134.13 44.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.606 0.762 . . . . 65.51 111.218 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.426 ' HB3' HD21 ' A' ' 72' ' ' ASN . 25.1 t70 -114.87 107.79 15.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.059 1.343 . . . . 75.12 108.715 174.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.39 -108.35 2.58 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.448 -0.661 . . . . 72.45 111.448 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.62 -11.97 12.92 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.34 1.056 . . . . 55.13 109.453 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.498 HG23 ' HA ' ' A' ' 95' ' ' GLU . 44.8 m -90.28 129.74 36.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.194 0.998 . . . . 64.23 109.9 -172.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 8' ' ' ALA . 21.6 t -88.8 143.74 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.38 0.672 . . . . 73.01 110.12 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 67' ' ' ASP . 12.1 m-80 -124.34 112.53 17.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.078 -1.082 . . . . 60.32 108.078 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.5 103.71 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 109.265 -0.643 . . . . 71.14 109.265 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.7 m -87.78 104.43 16.56 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.227 -1.027 . . . . 64.2 108.227 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.5 p -119.28 121.08 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.784 0.834 . . . . 70.41 109.763 -175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.7 tp10 -83.53 114.94 21.85 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.691 -0.855 . . . . 71.04 108.691 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.2 mp -101.66 160.65 14.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.193 -1.04 . . . . 62.54 108.193 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.23 105.28 7.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.751 -1.574 . . . . 70.53 106.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -105.49 106.81 17.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.39 0.676 . . . . 53.15 110.638 -169.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -87.79 104.75 16.87 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.712 -1.218 . . . . 64.54 107.712 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 t -136.52 125.0 23.49 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.374 -0.973 . . . . 71.33 108.374 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.01 26.11 72.26 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.98 -0.554 . . . . 55.33 112.993 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.38 60.13 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.19 0.424 . . . . 54.24 113.476 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.3 m -93.28 112.31 24.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.568 0.747 . . . . 73.51 110.432 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.6 m -88.47 107.88 19.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.682 0.793 . . . . 73.5 109.21 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.9 m -126.61 125.49 42.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.448 0.699 . . . . 73.2 110.221 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -77.9 115.68 17.83 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.304 0.642 . . . . 74.33 110.122 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 m -118.58 119.72 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.627 1.171 . . . . 63.4 108.799 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 m -88.17 120.76 29.83 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.59 -0.522 . . . . 75.23 109.59 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CD1' HD13 ' A' ' 77' ' ' LEU . 11.3 m-85 -103.58 134.71 46.46 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.297 -1.371 . . . . 53.23 107.297 174.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -118.13 102.46 9.03 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.223 -1.029 . . . . 61.12 108.223 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.8 104.92 16.87 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.039 -1.097 . . . . 62.42 108.039 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -95.64 102.24 14.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.81 -0.811 . . . . 71.03 108.81 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.417 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.8 m-85 -87.47 108.86 19.22 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.674 0.79 . . . . 64.41 109.562 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 30.6 tt0 -92.81 120.94 33.68 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.471 -0.786 . . . . 75.21 109.645 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 HG23 ' A' ' 4' ' ' ILE . 4.3 m -98.11 148.09 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.35 -0.841 . . . . 64.52 110.697 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.462 ' HB2' ' HG3' ' A' ' 102' ' ' ARG . 6.7 m-20 -120.37 91.59 3.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.909 -1.145 . . . . 70.2 107.909 173.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.7 -128.19 8.36 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 114.861 -1.063 . . . . 31.24 111.946 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.4 8.8 36.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.493 0.717 . . . . 74.21 112.616 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -139.63 162.43 35.12 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.315 0.646 . . . . 64.01 110.282 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 96' ' ' VAL . 10.2 mt -95.52 140.12 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.412 -0.958 . . . . 65.34 108.412 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 36.0 mmt180 -126.9 -31.3 2.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.712 0.634 . . . . 64.52 112.712 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.8 mtt180 -130.39 161.67 30.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.528 0.331 . . . . 75.03 110.404 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.39 139.23 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.212 1.005 . . . . 60.04 109.319 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.3 m -121.28 105.16 10.29 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.567 -0.901 . . . . 33.23 108.567 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -89.29 104.3 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.813 -0.81 . . . . 71.32 108.813 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.8 m -95.73 103.78 15.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.307 -0.627 . . . . 73.32 109.307 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -85.22 95.06 9.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.605 0.762 . . . . 72.44 109.74 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.243 0.716 0 N-CA-C 108.227 -1.027 . . . . 75.02 108.227 172.793 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 108.802 -0.814 . . . . 71.54 108.802 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 96' ' ' VAL . 36.9 mm -47.69 -38.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.694 1.598 . . . . 62.13 113.842 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.2 -47.8 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.957 0.503 . . . . 62.43 110.022 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.23 -42.11 80.22 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.135 -0.939 . . . . 74.34 110.092 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -61.68 -37.96 86.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.01 0.924 . . . . 72.42 111.666 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.6 -32.61 60.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.926 0.89 . . . . 72.42 110.742 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.8 tttm -67.72 -39.32 84.31 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.325 -0.852 . . . . 74.11 110.327 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.46 -40.82 85.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.357 0.663 . . . . 64.23 110.164 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.21 86.68 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.129 0.971 . . . . 64.23 111.633 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.81 66.58 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.962 0.789 . . . . 75.04 111.61 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -70.73 -32.12 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.2 -0.909 . . . . 71.43 110.8 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.5 -32.2 70.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.125 0.57 . . . . 64.43 112.182 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -60.78 -41.09 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.502 0.721 . . . . 73.1 109.398 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.29 -30.06 61.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.217 0.607 . . . . 70.3 111.771 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.29 -35.47 79.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.412 0.685 . . . . 74.33 110.271 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.448 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 73.4 mt -73.93 -40.4 63.12 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.81 -0.632 . . . . 71.55 110.867 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -60.71 -30.35 69.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.208 0.448 . . . . 74.32 112.208 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -96.65 -21.9 17.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.201 0.6 . . . . 75.32 111.024 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -156.66 89.14 2.69 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.538 0.735 . . . . 75.41 109.219 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.27 -17.53 44.74 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.905 2.403 . . . . 74.42 113.708 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.2 p -89.48 13.55 13.53 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.588 0.755 . . . . 74.52 111.425 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.39 112.27 12.28 Favored Pre-proline 0 C--N 1.358 0.978 0 C-N-CA 123.142 0.577 . . . . 75.12 110.035 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.72 -28.78 13.51 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.704 2.269 . . . . 73.33 113.02 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.1 -41.8 49.2 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.23 0.612 . . . . 62.42 110.949 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.94 -55.72 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 53.54 110.667 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -66.95 -25.9 66.57 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.764 0.426 . . . . 74.43 111.993 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.37 -56.15 24.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.331 0.652 . . . . 74.3 110.196 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.57 -35.03 76.84 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.065 -0.516 . . . . 71.51 110.458 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 87.1 mt -62.8 -29.32 70.63 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.716 0.806 . . . . 71.13 112.176 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -71.97 -35.52 69.56 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.194 0.521 . . . . 71.44 109.811 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -79.8 -39.07 31.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.834 -1.075 . . . . 62.33 111.55 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.533 HG13 ' HG ' ' A' ' 35' ' ' LEU . 7.5 pt -96.54 -40.57 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.858 0.463 . . . . 73.13 111.956 -172.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' HG13 ' A' ' 34' ' ' ILE . 47.3 mt -100.95 -175.2 2.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.737 0.815 . . . . 72.41 109.24 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.611 ' HB2' HG23 ' A' ' 39' ' ' VAL . 11.0 m -75.98 146.21 78.67 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 109.334 -0.617 . . . . 72.22 109.334 167.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.22 -19.99 62.52 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.83 2.354 . . . . 73.02 112.452 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.98 -31.71 71.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.501 1.121 . . . . 73.14 111.339 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -69.54 -49.05 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 122.951 0.5 . . . . 64.13 110.287 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.36 -30.22 71.27 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.35 -0.241 . . . . 52.24 110.35 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.58 -40.39 84.83 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.302 1.041 . . . . 61.14 111.495 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.9 -33.06 52.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.211 0.204 . . . . 71.23 110.833 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.84 -47.63 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.415 0.686 . . . . 32.42 110.985 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 5.9 ppt_? -62.8 -29.97 71.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.741 0.417 . . . . 73.1 112.114 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.42 -47.86 58.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.757 0.423 . . . . 55.41 112.072 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -66.2 -31.24 71.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.115 0.484 . . . . 70.33 110.332 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.4 -39.57 92.34 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.714 -1.13 . . . . 63.35 111.891 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 71.9 mtp180 -67.77 -30.58 70.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.266 0.626 . . . . 71.24 111.182 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -72.77 -31.7 65.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.374 0.27 . . . . 71.23 111.069 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.23 -32.04 62.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.152 0.581 . . . . 71.02 110.742 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -70.29 -37.01 74.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.408 0.683 . . . . 74.01 110.354 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -60.8 -38.07 84.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.03 0.932 . . . . 65.14 109.816 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -90.12 176.75 6.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.012 -0.995 . . . . 75.21 110.41 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.59 33.12 6.82 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mt -77.79 101.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.996 -0.742 . . . . 72.4 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -94.09 151.85 19.2 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.671 -0.863 . . . . 54.53 108.671 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 44.1 p90 -147.67 161.77 40.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.572 0.749 . . . . 65.34 109.025 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -141.02 136.47 32.12 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.739 -0.467 . . . . 73.32 109.739 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.02 122.07 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 109.368 -0.605 . . . . 63.14 109.368 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -112.01 -44.61 3.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.355 1.062 . . . . 54.22 110.186 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -140.53 135.25 31.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.091 -0.959 . . . . 75.54 109.167 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.48 115.36 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.035 -1.098 . . . . 61.45 108.035 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -127.87 131.97 49.4 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.567 -0.901 . . . . 71.3 108.567 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG11 ' HD2' ' A' ' 9' ' ' LYS . 7.6 p -120.07 109.79 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.886 -0.783 . . . . 72.21 108.886 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.3 p -111.0 164.12 13.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.531 0.732 . . . . 54.12 109.07 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -119.96 143.15 48.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.1 110.093 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -140.23 91.55 2.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.833 -1.543 . . . . 53.42 106.833 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.56 -124.9 11.13 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.855 -1.298 . . . . 72.33 109.855 -164.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -97.51 -7.7 30.84 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.344 0.657 . . . . 64.03 110.749 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.1 m -88.29 121.54 30.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.343 -0.614 . . . . 72.02 109.343 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.1 t -86.96 136.69 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.664 0.786 . . . . 74.25 109.318 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.5 99.91 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.244 -1.021 . . . . 64.44 108.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.22 104.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.19 -0.67 . . . . 54.55 109.19 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.2 m -87.16 103.36 15.34 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.913 -1.143 . . . . 75.52 107.913 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.59 115.35 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.969 0.908 . . . . 53.22 109.166 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 37.7 tt0 -84.36 124.3 31.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.829 0.852 . . . . 74.11 109.522 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.95 119.7 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.429 0.692 . . . . 54.3 109.347 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -87.59 102.72 14.87 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.214 -1.032 . . . . 71.41 108.214 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.6 mt-10 -89.15 110.42 21.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.14 0.976 . . . . 72.44 111.452 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 45.2 m -89.77 99.88 12.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.551 -1.277 . . . . 64.44 107.551 172.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -147.55 144.65 28.66 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.422 0.689 . . . . 64.32 110.101 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.08 15.63 72.17 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.837 -0.619 . . . . 53.24 113.265 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.38 3.88 81.21 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.1 -0.278 . . . . 72.2 113.474 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -124.59 148.72 47.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.002 0.521 . . . . 64.22 110.559 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 67.3 m -102.86 106.0 16.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.144 -0.687 . . . . 74.32 109.144 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.4 m -101.95 120.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.527 1.131 . . . . 63.42 109.532 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.1 103.8 9.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.652 -0.87 . . . . 63.24 108.652 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -111.06 154.0 24.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.364 1.066 . . . . 61.0 109.744 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 29.9 m -114.53 149.1 36.97 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.113 -0.699 . . . . 60.41 109.113 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.93 131.73 47.56 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.176 1.39 . . . . 72.24 107.691 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -113.83 105.77 13.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.999 . . . . 61.41 108.304 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.1 mp -98.4 106.21 18.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -95.9 103.05 14.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.134 0.574 . . . . 63.0 109.843 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 101' ' ' ILE . 96.5 m-85 -87.18 108.49 18.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.129 0.972 . . . . 73.41 109.637 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 24.8 tt0 -99.71 124.21 44.73 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 4' ' ' ILE . 3.2 m -98.17 151.89 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.177 -0.92 . . . . 41.24 111.808 -165.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -137.98 99.23 3.84 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.525 1.13 . . . . 71.44 108.062 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.31 -107.76 2.46 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.185 -0.916 . . . . 41.24 113.023 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.25 -4.08 13.77 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.63 1.172 . . . . 64.32 110.908 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.538 HG23 ' HD3' ' A' ' 102' ' ' ARG . 5.2 t -127.98 154.1 45.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.733 0.813 . . . . 54.44 110.228 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 96' ' ' VAL . 52.3 mt -95.37 133.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.177 -1.045 . . . . 71.02 108.177 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.538 ' HD3' HG23 ' A' ' 100' ' ' THR . 22.2 mmm180 -118.19 -2.98 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.633 0.373 . . . . 61.43 111.324 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 21.9 tpt180 -143.76 133.99 24.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.508 0.723 . . . . 71.23 110.01 -172.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.74 118.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.656 -1.238 . . . . 74.24 107.656 166.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 m -97.46 103.08 14.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.877 -1.157 . . . . 74.54 107.877 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 92' ' ' LEU . 44.6 t -93.87 105.24 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.408 -0.96 . . . . 74.21 108.408 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -110.54 122.09 46.9 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.56 -0.533 . . . . 71.21 109.56 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.77 97.15 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 108.255 -1.017 . . . . 61.3 108.255 176.736 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t0 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.33 0.586 . . . . 72.2 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -76.27 -39.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.372 1.069 . . . . 71.23 111.068 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.56 -48.38 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.016 0.526 . . . . 72.54 110.979 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.94 -40.47 93.38 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.908 0.755 . . . . 72.42 110.326 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.42 90.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.021 0.825 . . . . 61.22 111.136 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.26 80.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.441 0.696 . . . . 73.21 111.613 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -72.82 -48.78 34.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 72.05 110.549 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -61.15 -42.68 98.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.055 0.942 . . . . 71.32 110.937 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.72 91.65 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.111 -0.949 . . . . 41.34 111.26 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -55.31 -51.22 67.44 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.045 0.841 . . . . 53.14 111.416 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.56 -46.72 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.425 -0.807 . . . . 70.35 110.28 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.146 0.978 . . . . 74.24 113.057 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HA ' HG11 ' A' ' 43' ' ' VAL . 57.6 mt -62.72 -43.19 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.802 0.841 . . . . 72.42 110.192 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -72.8 -33.16 66.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.553 0.341 . . . . 55.25 111.465 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.596 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 55.8 mt-30 -63.02 -37.85 88.83 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.639 0.587 . . . . 75.52 111.079 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 28' ' ' GLN . 95.6 mt -75.2 -37.24 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.768 0.667 . . . . 74.4 111.185 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.43 -29.32 70.63 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.747 0.647 . . . . 72.42 112.747 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -101.88 -15.11 16.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.825 0.45 . . . . 74.03 111.58 175.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -156.59 84.27 3.16 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 108.975 -0.75 . . . . 74.32 108.975 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 -12.93 36.76 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.142 2.562 . . . . 71.54 112.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -80.91 -5.58 57.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.446 1.098 . . . . 74.55 112.384 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.99 112.55 18.42 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 109.756 -0.461 . . . . 74.44 109.756 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.15 -34.11 5.23 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.599 2.199 . . . . 55.32 113.018 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.93 -30.83 56.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.867 0.467 . . . . 74.11 111.653 -171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.02 79.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.354 0.662 . . . . 62.31 110.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.582 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.0 pt20 -78.34 -23.94 46.76 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.09 -0.504 . . . . 63.14 111.616 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.67 -48.85 75.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 55.02 110.375 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.0 pp -66.48 -35.02 79.22 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.419 0.449 . . . . 73.44 109.951 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.15 -21.6 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.782 0.833 . . . . 72.54 112.191 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.1 -31.27 34.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.555 -0.535 . . . . 74.53 109.555 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.98 -35.09 38.0 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.22 1.008 . . . . 72.32 112.382 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.5 pt -111.26 -45.15 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.038 0.535 . . . . 64.14 111.854 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 39' ' ' VAL . 3.8 mm? -96.03 177.27 5.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.998 0.919 . . . . 71.31 108.869 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.4 m -71.65 147.01 91.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 116.321 -0.399 . . . . 64.45 110.061 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.63 -18.77 56.92 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.558 2.172 . . . . 75.51 113.21 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.07 -37.92 81.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.295 1.038 . . . . 60.42 111.18 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 35' ' ' LEU . 77.5 t -61.8 -55.57 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.749 0.656 . . . . 62.03 110.047 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.582 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.0 pp -59.73 -33.46 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.439 0.462 . . . . 62.14 111.038 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 27.5 t70 -67.55 -54.4 20.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 124.249 0.968 . . . . 75.11 110.44 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -67.28 -24.71 65.81 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.155 0.182 . . . . 74.45 111.404 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 15' ' ' ILE . 31.8 t -68.91 -52.03 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.491 0.716 . . . . 73.32 110.64 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -65.91 -20.73 66.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.576 0.35 . . . . 63.42 111.389 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 44.8 mt-10 -81.93 -35.77 28.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.406 0.682 . . . . 72.13 110.642 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -67.34 -22.29 65.6 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.223 0.609 . . . . 74.41 110.498 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.14 64.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 55.12 111.431 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -59.11 -33.14 70.51 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 124.33 1.018 . . . . 72.44 111.563 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.63 -50.87 61.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.284 0.634 . . . . 72.33 110.633 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.39 -34.26 61.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.081 -0.963 . . . . 74.32 110.682 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.06 -29.04 54.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.166 0.986 . . . . 75.32 110.848 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.43 -40.28 85.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.475 0.71 . . . . 64.2 109.847 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.8 -29.56 62.24 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.002 -0.999 . . . . 72.22 110.315 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.47 29.14 30.86 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.902 0.751 . . . . 44.11 112.81 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.43 116.47 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.743 0.817 . . . . 72.11 109.957 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -91.48 112.18 23.99 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.794 -1.188 . . . . 64.43 107.794 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -130.17 132.59 46.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.629 0.772 . . . . 54.11 109.621 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.32 135.72 51.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.152 0.581 . . . . 71.43 110.427 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.54 119.83 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.285 1.034 . . . . 74.23 109.81 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -104.89 -55.22 2.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.085 0.554 . . . . 73.3 110.409 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 ttm180 -131.9 124.77 30.17 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.753 -0.832 . . . . 75.35 108.753 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.28 116.31 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.274 -1.01 . . . . 64.2 108.274 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -113.92 108.44 17.05 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.637 -0.875 . . . . 62.23 108.637 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.88 127.18 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.381 -0.97 . . . . 71.24 108.381 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -139.61 139.83 36.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.398 0.679 . . . . 72.24 109.2 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 71' ' ' VAL . 47.3 p -97.56 116.23 29.38 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.046 0.538 . . . . 73.32 110.007 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.33 91.4 3.65 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.564 -1.273 . . . . 73.12 107.564 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.1 -119.98 7.0 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.017 -0.992 . . . . 60.11 110.905 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -101.13 -11.54 19.5 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.326 0.65 . . . . 74.33 111.082 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 m -94.39 121.51 36.0 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.516 0.726 . . . . 72.32 109.516 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 66' ' ' THR . 68.3 t -87.62 139.14 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.937 -0.764 . . . . 72.33 108.937 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -120.91 110.49 16.36 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.123 . . . . 65.12 108.171 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.12 104.11 15.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.615 -0.883 . . . . 63.45 108.615 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 78.4 m -92.72 105.58 17.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.897 -1.149 . . . . 70.33 107.897 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.6 p -118.55 124.01 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.658 0.783 . . . . 74.52 110.412 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.88 121.91 30.01 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.28 -1.007 . . . . 62.51 108.28 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.6 mp -107.45 160.65 15.48 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.337 0.655 . . . . 41.21 109.328 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -116.63 104.64 11.59 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.541 1.137 . . . . 74.22 108.153 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -100.36 102.97 14.34 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.893 -0.41 . . . . 70.23 109.893 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -89.83 104.23 16.81 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.333 -1.358 . . . . 65.31 107.333 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 t -133.73 122.9 24.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.593 0.757 . . . . 74.53 110.25 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.65 0.25 58.36 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.639 -0.709 . . . . 75.2 114.02 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.28 -36.22 3.49 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.734 0.683 . . . . 54.1 111.531 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.3 p -84.87 124.82 32.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.554 0.742 . . . . 74.31 110.914 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -93.7 106.24 18.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.698 0.799 . . . . 74.44 109.796 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 m -114.33 123.61 49.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.117 0.967 . . . . 72.31 109.002 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.57 130.21 35.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.094 -0.706 . . . . 75.3 109.094 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -127.03 125.92 42.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.077 0.951 . . . . 52.31 109.335 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -89.01 121.0 30.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.275 -0.639 . . . . 63.24 109.275 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD1' HD13 ' A' ' 77' ' ' LEU . 10.2 m-85 -102.99 133.08 48.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.261 -1.385 . . . . 70.33 107.261 173.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.34 106.1 12.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.91 -0.774 . . . . 74.15 108.91 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.0 mp -97.34 106.23 18.51 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.26 1.024 . . . . 63.33 108.384 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.599 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 76.8 ttt-85 -96.2 99.97 11.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.706 -0.85 . . . . 71.4 108.706 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.1 m-85 -85.87 107.88 17.88 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.68 -0.691 . . . . 74.55 109.418 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 38.5 tt0 -101.11 124.26 46.55 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.913 -1.04 . . . . 73.12 108.954 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 101' ' ' ILE . 29.9 m -87.27 147.46 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.562 -0.744 . . . . 72.34 111.534 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.82 99.44 6.28 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.648 -1.242 . . . . 74.5 107.648 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.67 -110.99 3.43 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.272 -0.876 . . . . 22.04 112.61 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -89.23 -16.23 31.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.924 0.89 . . . . 64.13 112.311 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -133.69 166.29 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.231 0.612 . . . . 74.44 111.156 -168.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 96' ' ' VAL . 25.1 mt -94.73 120.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 107.934 -1.136 . . . . 53.42 107.934 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -106.75 -17.22 14.28 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.044 0.538 . . . . 60.02 111.2 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 84.4 mtt85 -128.63 146.98 50.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.405 0.682 . . . . 75.32 110.889 -170.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.8 p -146.31 112.23 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 114.963 -1.017 . . . . 71.11 108.755 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 92.8 m -91.8 103.54 16.08 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.634 -0.876 . . . . 65.1 108.634 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.76 112.39 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.075 -0.713 . . . . 72.33 109.075 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.0 m -106.89 118.64 37.22 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.034 0.534 . . . . 61.33 109.825 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.75 84.04 7.7 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.826 0.85 . . . . 72.32 109.103 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 . . . . . 0 N--CA 1.478 0.953 0 CA-C-N 115.996 -0.547 . . . . 72.21 109.715 -179.578 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--O 1.211 -0.971 0 CA-C-O 119.107 -0.473 . . . . 73.03 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.454 HG23 HG11 ' A' ' 96' ' ' VAL . 46.2 mm -46.4 -46.11 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.22 1.408 . . . . 45.02 113.934 -167.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.33 -52.18 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.41 0.684 . . . . 73.12 110.551 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.02 -33.92 72.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.512 -0.767 . . . . 72.54 111.35 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.02 68.72 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 124.237 1.015 . . . . 75.35 109.945 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.14 -32.64 73.05 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.719 0.637 . . . . 74.32 111.443 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.59 -51.49 59.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.581 0.752 . . . . 74.23 110.319 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.66 -33.82 76.83 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.611 0.765 . . . . 73.33 111.163 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.13 81.69 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 124.284 0.99 . . . . 71.15 110.752 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.47 71.1 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.399 1.062 . . . . 63.04 111.256 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 mt -66.31 -38.32 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 O-C-N 124.1 0.875 . . . . 42.11 110.072 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.1 74.37 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.814 0.845 . . . . 73.21 111.858 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 43' ' ' VAL . 60.1 mt -61.65 -40.97 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.774 0.83 . . . . 60.04 109.747 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 43.4 m-85 -75.36 -29.11 59.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.774 0.43 . . . . 75.45 112.084 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.13 -38.2 90.25 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.468 0.48 . . . . 54.35 110.148 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.09 -38.78 63.78 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.691 0.619 . . . . 74.44 110.707 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.1 m0 -68.58 -22.04 64.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.825 0.676 . . . . 73.24 112.825 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -99.68 -20.86 16.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.053 0.541 . . . . 71.21 110.883 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -158.72 91.75 2.02 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 123.928 0.891 . . . . 74.55 109.96 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.11 -9.14 24.84 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.268 2.645 . . . . 72.42 113.965 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 p -90.25 0.64 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.818 0.847 . . . . 53.43 111.868 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.04 114.73 22.45 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 122.866 0.466 . . . . 74.44 110.541 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 98.2 Cg_endo -75.21 -27.38 9.74 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.51 2.14 . . . . 75.41 114.005 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.9 -34.39 24.55 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.864 0.465 . . . . 54.52 112.06 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -52.34 57.12 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.483 0.713 . . . . 62.21 110.223 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -66.39 -28.53 68.7 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.203 -0.908 . . . . 61.1 111.31 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 6.8 tm-20 -58.49 -59.04 5.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.018 0.927 . . . . 65.43 109.93 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -63.97 -33.99 76.96 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.08 0.862 . . . . 72.21 111.034 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.12 -30.1 71.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.912 0.885 . . . . 63.54 112.471 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -65.42 -27.11 68.3 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.07 0.396 . . . . 74.3 111.866 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -94.16 -36.29 12.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.987 0.915 . . . . 72.33 112.286 -171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 30' ' ' LEU . 22.0 pt -103.74 -29.08 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 122.859 0.464 . . . . 74.23 112.225 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.529 HD12 HG21 ' A' ' 39' ' ' VAL . 4.1 mm? -106.05 178.38 4.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.035 0.934 . . . . 54.24 108.592 172.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 m -84.78 149.88 54.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.049 -0.523 . . . . 74.54 109.952 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 40' ' ' LEU . 83.0 Cg_exo -50.55 -26.25 16.28 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.565 2.843 . . . . 74.15 114.668 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.93 -42.07 95.0 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.084 0.954 . . . . 72.12 111.559 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 HD12 ' A' ' 35' ' ' LEU . 88.6 t -60.83 -60.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.555 0.742 . . . . 75.11 112.056 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -61.05 -22.55 64.68 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.073 0.397 . . . . 74.14 112.073 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.29 -42.68 30.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 53.44 111.234 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.56 -27.11 62.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 110.298 -0.26 . . . . 62.41 110.298 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 HG12 ' A' ' 15' ' ' ILE . 37.7 t -65.92 -53.8 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.69 0.796 . . . . 73.44 110.151 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -63.11 -22.47 66.88 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.229 0.212 . . . . 73.21 111.03 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -74.93 -45.27 43.62 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.452 0.701 . . . . 72.52 110.484 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -71.19 -22.67 62.0 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.895 -0.593 . . . . 70.44 110.701 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.49 98.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.187 0.995 . . . . 73.22 110.898 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -66.06 -34.14 77.4 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.912 -1.04 . . . . 61.13 110.837 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.53 -48.33 79.98 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.804 0.69 . . . . 63.23 110.867 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.67 -51.8 60.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.613 -0.722 . . . . 72.31 110.752 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.77 -35.29 79.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.351 -1.295 . . . . 60.51 111.405 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -61.01 -43.08 99.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.668 1.187 . . . . 74.31 111.356 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -83.65 -15.12 50.12 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.23 -0.896 . . . . 73.11 111.256 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.32 60.19 Favored Glycine 0 C--N 1.345 1.032 0 O-C-N 123.268 0.355 . . . . 14.41 112.878 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.95 91.49 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.821 -0.807 . . . . 75.02 108.821 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -92.53 153.15 19.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.398 -0.819 . . . . 71.55 108.876 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -149.84 170.17 19.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.339 0.655 . . . . 74.14 110.49 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -141.04 138.12 33.41 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.527 -0.916 . . . . 62.13 108.527 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.92 138.22 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 123.528 0.517 . . . . 74.44 109.86 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -115.98 -42.26 3.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.776 0.83 . . . . 73.14 111.559 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttm105 -157.82 123.87 4.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.805 -0.634 . . . . 72.44 109.998 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.89 107.62 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.264 -1.013 . . . . 72.43 108.264 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.71 123.75 43.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 62.23 108.945 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.81 128.75 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.83 -0.804 . . . . 55.12 108.83 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -137.91 117.85 13.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.171 -0.677 . . . . 71.41 109.171 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 71' ' ' VAL . 22.1 p -89.79 114.83 26.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.879 0.871 . . . . 72.24 109.856 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -113.99 90.92 3.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.448 1.099 . . . . 75.22 109.096 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.76 -105.13 1.45 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.513 -0.767 . . . . 51.03 112.43 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.405 ' O ' HG22 ' A' ' 96' ' ' VAL . 73.1 m-20 -114.89 14.65 17.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.241 1.016 . . . . 60.23 110.346 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.4 m -132.01 122.61 25.79 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.348 0.659 . . . . 54.55 110.227 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 66' ' ' THR . 58.7 t -90.03 115.35 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 122.939 0.495 . . . . 62.3 109.792 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -102.31 106.82 17.67 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.617 1.167 . . . . 73.51 108.872 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.22 110.53 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.533 0.733 . . . . 71.12 109.706 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -98.4 105.3 17.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.195 -1.039 . . . . 60.45 108.195 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.4 p -124.3 127.88 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.071 0.548 . . . . 74.0 110.065 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.27 136.98 32.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.937 0.495 . . . . 72.31 109.876 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.5 141.78 48.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.852 0.861 . . . . 63.13 109.927 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.32 104.32 16.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.728 0.811 . . . . 71.03 109.905 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -86.18 107.05 17.71 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.298 0.639 . . . . 73.45 109.557 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.3 m -88.34 104.55 16.86 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.12 -1.067 . . . . 63.23 108.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -144.02 131.81 21.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.437 1.095 . . . . 71.51 108.959 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.33 26.66 73.49 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.844 -0.162 . . . . 50.31 112.863 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.84 85.71 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.49 -0.616 . . . . 42.55 114.359 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.2 t -127.47 146.02 50.64 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.643 0.721 . . . . 61.34 111.259 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 149.97 22.08 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.12 0.968 . . . . 75.03 111.104 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.2 m -137.6 122.03 18.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.269 1.027 . . . . 74.15 109.219 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.41 100.31 5.15 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.03 -1.1 . . . . 74.14 108.03 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -114.72 122.76 47.4 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.359 -0.837 . . . . 63.42 109.046 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.8 m -89.99 124.68 34.96 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.75 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -104.52 127.57 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.818 0.847 . . . . 70.22 109.024 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.63 113.62 27.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.644 -0.873 . . . . 75.5 108.644 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.31 107.36 18.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.719 -0.845 . . . . 61.4 108.719 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -91.6 100.36 13.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.255 1.022 . . . . 64.11 109.484 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.26 106.9 18.52 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.367 0.667 . . . . 74.53 109.47 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 44.0 tt0 -97.54 116.95 30.72 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.736 0.814 . . . . 74.14 108.858 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 101' ' ' ILE . 4.5 m -89.69 149.32 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.444 0.697 . . . . 75.41 110.629 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.46 119.48 15.42 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.444 -1.317 . . . . 75.22 107.444 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.14 -97.99 0.97 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.017 -0.433 . . . . 54.44 112.017 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -121.72 -17.49 7.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.885 0.874 . . . . 73.12 111.91 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.7 t -124.94 160.03 29.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.93 0.492 . . . . 73.1 111.152 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 HG12 ' A' ' 96' ' ' VAL . 27.3 mt -86.03 126.78 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.772 -0.825 . . . . 65.2 108.772 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -102.36 -29.96 11.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.531 0.733 . . . . 74.14 111.715 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -130.95 146.89 52.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.624 0.25 . . . . 62.24 111.086 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.61 107.81 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.263 1.025 . . . . 64.43 109.36 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -95.12 106.57 18.59 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.949 -0.76 . . . . 74.24 108.949 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.49 136.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 109.61 -0.515 . . . . 54.45 109.61 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -129.46 113.0 14.35 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.59 0.756 . . . . 72.41 109.796 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.31 101.79 7.36 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.316 0.647 . . . . 73.42 109.902 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 . . . . . 0 N--CA 1.47 0.543 0 C-N-CA 124.124 0.97 . . . . 65.25 108.887 177.941 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 109.692 -0.484 . . . . 72.23 109.692 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.25 -39.74 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.583 0.753 . . . . 74.41 111.725 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.27 -52.93 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.682 0.793 . . . . 63.24 111.891 -171.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -67.62 -35.7 79.43 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.686 -0.688 . . . . 71.21 110.523 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.443 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -62.8 -41.84 99.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.325 0.65 . . . . 72.52 111.293 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.65 66.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 73.41 111.008 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.58 -54.63 44.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.553 1.141 . . . . 65.31 111.054 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -64.43 -33.94 77.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.509 0.723 . . . . 75.52 110.977 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -49.42 76.11 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.008 0.818 . . . . 52.23 111.025 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.75 68.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.315 1.01 . . . . 71.13 111.504 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 51.1 mt -63.4 -40.46 89.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 124.175 0.922 . . . . 72.4 110.324 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.348 0.659 . . . . 63.02 111.334 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.3 mt -56.13 -39.32 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 72.24 110.304 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -71.12 -32.67 69.3 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.249 0.62 . . . . 53.54 111.759 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 26.8 mt-30 -63.04 -38.37 90.92 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.099 0.56 . . . . 72.24 110.519 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 3.4 mm? -66.59 -48.87 68.2 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 123.543 0.527 . . . . 75.22 109.945 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 106' ' ' VAL . 32.4 m0 -51.52 -34.33 35.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.485 0.92 . . . . 74.05 113.485 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.46 -32.24 12.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.7 0.4 . . . . 64.45 111.686 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -143.95 86.99 8.22 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 108.983 -0.747 . . . . 74.15 108.983 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.89 -15.69 50.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.979 2.453 . . . . 74.23 113.03 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.2 p -89.45 13.34 13.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.42 1.088 . . . . 62.31 112.283 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.21 110.81 26.19 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.281 -0.636 . . . . 74.52 109.281 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.16 -21.61 17.71 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.461 2.107 . . . . 53.23 113.624 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.69 -39.55 26.97 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.359 0.664 . . . . 63.43 111.444 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.19 -50.02 65.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.464 0.706 . . . . 73.03 110.748 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.541 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.6 pt20 -72.41 -19.63 61.56 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.429 -0.805 . . . . 42.41 111.505 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.49 -54.97 24.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.13 0.572 . . . . 74.31 110.592 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.26 -30.3 70.15 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.313 -0.403 . . . . 65.03 110.262 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.18 -28.4 69.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.908 0.755 . . . . 74.41 112.034 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -75.11 -26.96 59.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.317 0.58 . . . . 62.34 109.891 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -78.8 -41.26 30.84 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.915 0.886 . . . . 64.42 110.748 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.453 HG13 HD23 ' A' ' 35' ' ' LEU . 9.9 pt -103.27 -36.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.081 0.552 . . . . 73.34 112.294 -170.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 34' ' ' ILE . 3.8 mm? -103.28 -176.88 3.21 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.26 1.024 . . . . 75.24 109.477 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.409 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.7 m -81.29 145.89 56.84 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.421 -0.809 . . . . 71.22 109.878 170.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.22 -27.98 59.47 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.854 2.369 . . . . 55.32 112.484 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.62 -48.33 77.71 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.537 1.135 . . . . 75.22 111.479 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 35' ' ' LEU . 98.7 t -66.33 -51.97 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.81 0.844 . . . . 70.14 111.391 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 28' ' ' GLN . 4.0 pp -65.13 -28.66 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 120.769 0.318 . . . . 75.43 111.539 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.79 -33.21 60.13 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.511 -0.768 . . . . 62.45 110.54 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -77.62 -32.63 53.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.696 -0.483 . . . . 73.01 109.696 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.3 t -59.94 -42.73 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.442 0.697 . . . . 73.25 111.028 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -73.36 -21.49 60.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.834 0.454 . . . . 62.21 111.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.26 -50.73 13.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.295 0.638 . . . . 74.55 110.829 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -71.01 -21.3 62.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.712 0.805 . . . . 70.32 111.02 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -58.25 -44.86 88.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.725 1.21 . . . . 72.12 111.613 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 99.4 mtt180 -60.43 -35.55 76.08 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.408 -1.269 . . . . 70.24 110.689 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.69 -43.97 74.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.908 0.755 . . . . 74.33 110.3 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.97 -27.96 68.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.755 0.822 . . . . 73.21 111.207 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -79.4 -33.34 42.82 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.991 0.917 . . . . 72.54 110.089 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 94.0 mttt -67.63 -39.37 84.65 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.574 0.749 . . . . 74.5 110.315 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.18 -44.51 88.23 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.085 -0.962 . . . . 73.43 109.219 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.92 44.79 5.91 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.251 -0.886 . . . . 43.41 112.137 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -79.37 106.23 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.781 -0.822 . . . . 73.0 108.781 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -85.81 108.97 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.896 -1.15 . . . . 75.04 107.896 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.53 142.09 50.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.409 -0.589 . . . . 74.14 109.409 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.89 135.72 54.78 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.797 -0.816 . . . . 71.01 108.797 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.37 100.12 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.202 -1.036 . . . . 54.44 108.202 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.37 -49.98 8.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.47 -0.786 . . . . 74.53 110.816 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -144.5 122.65 12.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.308 -0.86 . . . . 71.1 109.682 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.65 124.76 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.623 0.769 . . . . 65.22 109.275 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.1 108.2 10.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.27 -1.011 . . . . 64.53 108.27 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 HG22 ' A' ' 73' ' ' VAL . 7.7 p -96.17 121.23 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.276 0.56 . . . . 72.21 109.541 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.1 m -129.4 141.46 51.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.165 0.986 . . . . 75.15 109.711 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -88.89 163.33 15.67 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.037 0.535 . . . . 74.43 110.939 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -158.57 74.76 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.767 -1.197 . . . . 72.01 107.767 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.84 -117.83 11.21 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.861 -0.495 . . . . 72.41 111.861 -171.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -88.31 -11.68 45.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.114 0.565 . . . . 63.43 111.023 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -97.93 156.05 16.79 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.706 1.202 . . . . 73.35 109.693 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.32 123.5 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.281 0.633 . . . . 62.32 110.296 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -99.34 112.64 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.855 0.862 . . . . 74.03 109.686 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 64' ' ' VAL . 61.5 t -91.1 105.02 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.901 -0.777 . . . . 62.22 108.901 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -86.07 104.95 16.14 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.367 -0.975 . . . . 74.42 108.367 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.16 126.82 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.995 0.518 . . . . 64.01 110.461 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.65 123.75 32.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.809 0.844 . . . . 74.04 109.381 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.69 123.15 45.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.316 -0.994 . . . . 71.43 108.316 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 34.9 tt0 -88.86 107.82 19.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.461 -0.941 . . . . 73.13 108.461 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.89 130.61 48.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.731 0.813 . . . . 64.23 110.652 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.2 m -119.52 117.68 29.04 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.158 1.383 . . . . 60.14 107.926 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -144.27 134.29 24.06 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.542 -0.91 . . . . 74.44 108.542 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.51 28.64 62.61 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.355 0.409 . . . . 71.33 113.619 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.67 -34.34 4.25 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 74.33 113.03 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -82.05 133.99 35.32 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.236 0.614 . . . . 64.14 110.612 -170.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -118.51 129.85 55.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.601 0.761 . . . . 64.22 110.334 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.1 m -143.64 136.27 27.24 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.918 0.887 . . . . 73.22 109.669 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 16.5 m120 -79.79 105.39 11.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.684 0.793 . . . . 75.5 109.956 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 m -101.03 126.53 47.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.625 1.17 . . . . 72.42 110.385 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -93.78 122.52 36.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.876 0.47 . . . . 63.12 110.795 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.8 127.54 53.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.398 0.679 . . . . 73.21 109.485 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.03 106.69 18.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.909 -1.145 . . . . 71.41 107.909 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.7 mp -95.34 106.84 18.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.09 -1.078 . . . . 74.5 108.09 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 34.1 ttt180 -98.44 99.91 11.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.942 0.897 . . . . 72.25 109.41 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.81 112.46 22.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.525 1.13 . . . . 54.04 111.007 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 31.2 tt0 -90.91 134.36 34.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.088 -0.708 . . . . 72.23 109.088 174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.44 151.42 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.304 1.042 . . . . 72.23 111.712 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.37 103.41 6.9 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.705 -1.221 . . . . 64.04 107.705 162.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.33 -105.32 2.06 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.719 -0.673 . . . . 75.11 112.072 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.64 -9.9 10.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.24 1.016 . . . . 71.44 110.912 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -110.4 148.08 32.73 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.598 0.759 . . . . 74.11 109.214 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.09 144.73 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.865 -0.791 . . . . 74.31 108.865 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -125.06 -25.57 3.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.498 0.719 . . . . 71.24 112.443 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 3.0 mpt_? -129.72 156.44 44.27 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.755 0.422 . . . . 74.43 110.299 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 109.92 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.359 1.064 . . . . 74.33 109.091 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 40.7 m -92.05 105.12 17.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.762 -0.829 . . . . 50.3 108.762 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.49 HG11 ' HH2' ' A' ' 19' ' ' TRP . 48.0 t -93.36 105.84 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 122.927 0.491 . . . . 71.11 109.742 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.6 m -100.64 113.8 26.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.524 0.729 . . . . 72.34 109.849 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -79.62 126.67 31.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.027 -0.731 . . . . 75.45 109.027 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.66 0.784 . . . . 65.42 109.589 -176.426 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.974 -0.38 . . . . 63.43 109.974 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.76 -43.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.431 1.082 . . . . 64.3 111.489 -175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.5 -46.18 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.945 0.898 . . . . 61.11 110.199 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -67.23 -33.93 76.4 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.576 -0.738 . . . . 63.34 110.521 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -65.77 -45.75 81.35 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.304 0.642 . . . . 75.04 110.513 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.26 98.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.575 0.75 . . . . 73.34 110.969 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -59.02 -56.54 20.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.258 1.023 . . . . 74.54 111.019 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.77 0.828 . . . . 73.14 111.444 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -66.44 -45.13 80.87 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 124.151 0.907 . . . . 53.1 110.628 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.12 75.16 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 124.112 0.883 . . . . 63.22 110.816 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.49 -44.85 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 124.263 0.977 . . . . 70.23 110.163 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.63 71.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.107 0.963 . . . . 34.31 112.7 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -65.07 -41.45 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.26 0.624 . . . . 75.1 110.338 175.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -74.55 -31.51 62.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.71 0.404 . . . . 63.33 111.28 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.93 -37.41 85.98 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.111 0.564 . . . . 75.05 110.341 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.79 -38.86 67.11 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 119.199 -0.429 . . . . 64.42 110.71 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.429 ' HB3' ' HZ ' ' A' ' 57' ' ' PHE . 19.6 m0 -63.61 -21.33 66.3 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.364 0.876 . . . . 75.01 113.364 -176.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -102.32 -25.21 13.74 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.676 0.39 . . . . 71.21 111.156 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -146.04 96.0 4.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 123.273 0.629 . . . . 74.14 109.966 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.88 -28.51 75.59 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.251 2.634 . . . . 74.14 112.925 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 p -92.55 22.08 4.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.901 0.88 . . . . 73.44 111.945 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.25 112.15 23.75 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.055 -0.72 . . . . 74.3 109.055 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.37 -34.45 20.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.79 2.327 . . . . 70.15 112.898 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.71 -49.1 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 74.21 110.973 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.11 -52.67 64.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 124.225 0.953 . . . . 71.54 111.105 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 40' ' ' LEU . 13.8 pt20 -68.15 -32.8 73.32 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 116.061 -0.518 . . . . 71.41 111.608 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.2 tt0 -69.87 -43.5 71.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.469 0.307 . . . . 74.15 111.098 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.6 pp -67.35 -34.01 76.42 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.826 -0.435 . . . . 74.22 109.826 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 HD12 ' A' ' 35' ' ' LEU . 85.8 mt -65.34 -30.6 71.45 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.56 0.744 . . . . 75.23 111.517 174.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -67.53 -33.85 75.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.194 0.598 . . . . 72.23 110.355 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 27.4 mtpp -80.89 -46.35 15.37 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.161 -0.927 . . . . 73.31 111.376 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 30' ' ' LEU . 13.0 pt -99.07 -35.18 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.654 0.382 . . . . 73.32 111.732 -168.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.518 HD11 ' HB1' ' A' ' 11' ' ' ALA . 28.3 mt -101.95 -170.52 1.83 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.397 -0.594 . . . . 74.1 109.397 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.586 ' HB2' HG23 ' A' ' 39' ' ' VAL . 8.9 m -73.36 138.35 78.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 115.623 -0.717 . . . . 70.32 109.504 169.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.93 -19.68 33.14 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.793 2.329 . . . . 63.41 113.501 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.78 -33.39 70.71 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.513 1.125 . . . . 75.34 111.755 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.0 t -67.07 -49.67 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.435 0.694 . . . . 74.32 111.42 -175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.5 pp -58.78 -30.8 67.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.396 0.278 . . . . 72.14 111.212 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.45 -58.93 5.05 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.714 1.206 . . . . 64.33 110.986 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.31 -30.47 71.6 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.823 0.449 . . . . 63.41 111.654 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 15' ' ' ILE . 48.9 t -67.08 -50.5 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.897 0.879 . . . . 63.3 110.651 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -73.68 -20.42 60.55 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.124 0.416 . . . . 72.31 112.124 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -85.61 -26.59 25.98 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 122.22 -0.3 . . . . 74.13 110.543 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.7 -25.31 60.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.885 0.874 . . . . 72.11 109.936 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.25 90.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.185 1.394 . . . . 70.44 112.066 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -59.89 -38.65 82.85 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.836 1.335 . . . . 74.34 111.005 -173.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -57.19 -58.84 6.46 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.233 0.958 . . . . 75.53 110.659 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.8 -34.02 76.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.509 1.124 . . . . 50.32 111.983 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -66.11 -45.11 82.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.014 0.925 . . . . 71.14 110.339 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.6 -32.56 66.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.48 0.712 . . . . 72.55 111.157 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -69.45 -18.29 63.71 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.486 0.714 . . . . 75.33 111.427 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.75 42.0 40.46 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.557 0.536 . . . . 70.42 112.203 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -111.15 96.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.211 -0.663 . . . . 64.13 109.211 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -92.05 108.11 19.7 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.192 -0.669 . . . . 70.31 109.192 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 8.7 p90 -106.3 135.49 47.7 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.174 -1.417 . . . . 63.14 107.174 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.56 135.6 47.15 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 110.007 -0.368 . . . . 73.04 110.007 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.68 125.18 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.902 1.376 . . . . 74.04 110.626 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.39 -37.93 3.91 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.731 0.813 . . . . 70.42 111.064 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 27.2 ttp85 -143.81 129.5 19.24 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.338 0.655 . . . . 75.01 109.349 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.65 128.66 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.878 0.871 . . . . 63.43 108.759 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.38 106.62 9.33 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.737 -1.208 . . . . 62.42 107.737 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.466 HG23 HG22 ' A' ' 73' ' ' VAL . 7.3 p -103.26 113.97 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.772 -0.825 . . . . 73.21 108.772 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.5 t -137.55 153.63 49.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 74.41 109.97 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 71' ' ' VAL . 34.2 p -100.75 130.16 46.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.145 0.578 . . . . 71.33 111.676 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.88 81.08 1.38 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.503 1.921 . . . . 71.33 108.437 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.44 -120.47 8.35 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.41 -0.814 . . . . 64.24 111.207 -173.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -87.38 -11.33 49.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.441 0.697 . . . . 73.15 110.639 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.4 m -89.96 156.73 18.22 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.272 1.029 . . . . 61.41 108.845 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 66' ' ' THR . 43.7 t -122.4 133.0 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.04 0.936 . . . . 74.25 109.331 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -110.56 125.83 53.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.722 0.809 . . . . 74.33 109.203 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 64' ' ' VAL . 48.7 t -97.38 104.1 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.378 -0.971 . . . . 42.05 108.378 169.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -86.75 102.22 14.05 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.515 -1.291 . . . . 61.22 107.515 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.21 123.1 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 33.44 109.89 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.0 tt0 -90.13 127.81 36.19 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.353 1.061 . . . . 73.02 109.444 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.49 143.68 51.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.288 0.635 . . . . 75.33 109.847 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -91.61 108.75 20.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.178 -0.675 . . . . 74.31 109.178 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 24.9 mt-10 -87.25 103.18 15.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.075 0.55 . . . . 74.11 109.666 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.7 m -93.96 106.14 18.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 74.42 109.465 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -145.59 118.55 8.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.346 1.058 . . . . 75.54 109.24 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.73 23.14 62.8 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.514 0.565 . . . . 23.34 114.514 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.03 -22.64 34.48 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.964 0.316 . . . . 75.1 112.901 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.2 m -83.69 124.52 30.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.561 0.745 . . . . 64.21 109.833 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 m -126.92 110.37 12.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.445 -0.946 . . . . 61.34 108.445 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.9 m -125.9 136.11 52.68 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.955 0.902 . . . . 64.32 109.976 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.93 100.58 6.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.833 -1.173 . . . . 55.32 107.833 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.2 m -105.29 132.63 51.24 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.927 -1.033 . . . . 73.22 108.985 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -89.39 122.89 33.04 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.427 -0.583 . . . . 75.22 109.427 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -104.8 126.77 52.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.164 -1.05 . . . . 63.43 108.164 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -113.79 103.9 11.66 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.103 -1.073 . . . . 74.32 108.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 106' ' ' VAL . 5.7 mp -98.38 107.07 19.44 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.117 -1.068 . . . . 75.23 108.117 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -90.45 98.74 11.95 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.075 -0.713 . . . . 60.25 109.075 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.618 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.4 m-85 -89.54 109.92 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.492 1.117 . . . . 73.11 109.284 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 28.2 tt0 -107.63 131.59 54.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.616 -0.513 . . . . 72.34 109.616 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 101' ' ' ILE . 11.0 m -84.35 151.84 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.83 1.252 . . . . 63.44 111.115 -168.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.8 98.38 3.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.215 -1.032 . . . . 72.41 108.215 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.82 2.18 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.021 -0.831 . . . . 34.42 111.021 -174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.68 -5.25 12.71 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.977 0.911 . . . . 70.34 111.17 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.6 t -127.44 143.86 51.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.68 . . . . 74.42 110.282 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 94' ' ' PHE . 73.4 mt -87.9 109.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.671 0.788 . . . . 73.22 109.361 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -103.27 6.16 37.93 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.209 0.448 . . . . 64.31 112.209 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 90.0 mtt180 -133.21 141.91 48.31 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.349 0.66 . . . . 73.4 110.903 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.96 134.68 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 63.32 108.504 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.4 m -132.02 106.56 8.1 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.094 -0.706 . . . . 71.41 109.094 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 92' ' ' LEU . 37.6 t -90.04 119.03 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.924 0.49 . . . . 71.32 109.798 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.6 m -113.31 106.88 15.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.504 0.722 . . . . 73.23 110.374 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -77.93 103.83 8.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.39 -0.967 . . . . 62.3 108.39 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 . . . . . 0 N--CA 1.473 0.693 0 C-N-CA 123.539 0.735 . . . . 64.3 109.588 -178.942 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 119.722 -0.18 . . . . 45.1 110.97 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -51.59 -41.1 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 125.401 1.481 . . . . 52.13 114.111 -166.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.34 -51.9 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.457 0.703 . . . . 73.13 110.678 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.71 -30.1 71.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.437 0.695 . . . . 70.14 110.344 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.68 71.18 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.848 1.259 . . . . 64.52 109.87 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.78 82.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.528 0.731 . . . . 71.34 111.495 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.479 ' HG3' HG11 ' A' ' 62' ' ' VAL . 39.6 tttm -63.68 -51.66 64.13 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.028 -0.987 . . . . 74.42 111.796 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -72.64 -24.7 61.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.348 0.259 . . . . 64.45 111.317 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.04 -45.12 86.7 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 123.533 0.733 . . . . 53.03 110.237 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.64 -54.37 46.9 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.475 1.109 . . . . 72.12 110.746 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.45 HG12 HG11 ' A' ' 59' ' ' VAL . 57.0 mt -59.89 -41.67 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.086 0.866 . . . . 72.34 110.854 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.71 88.52 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.959 0.904 . . . . 63.13 111.58 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.514 ' HA ' HG11 ' A' ' 43' ' ' VAL . 45.6 mt -61.22 -37.23 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 124.064 0.853 . . . . 54.01 110.496 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.27 -29.9 34.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.792 0.437 . . . . 73.34 111.497 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -66.73 -35.2 79.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.355 0.662 . . . . 74.33 110.276 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.15 -47.22 59.07 Favored 'General case' 0 C--O 1.213 -0.816 0 O-C-N 123.669 0.606 . . . . 73.0 110.17 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.489 ' HB3' HD12 ' A' ' 50' ' ' LEU . 29.1 m0 -57.1 -26.67 60.85 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.105 0.78 . . . . 72.23 113.105 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -101.36 -16.18 16.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.807 0.443 . . . . 71.41 111.963 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -156.17 89.54 2.79 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 123.996 0.918 . . . . 75.54 109.352 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 23.6 Cg_endo -59.77 -23.1 70.71 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.883 3.055 . . . . 74.03 113.633 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.4 p -81.17 -2.22 47.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.15 0.98 . . . . 62.54 112.341 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.95 113.49 13.54 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 122.919 0.487 . . . . 73.23 109.873 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.51 -28.26 4.54 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.363 2.042 . . . . 61.43 112.766 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -70.03 -41.02 74.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.47 0.708 . . . . 73.13 111.183 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -51.41 49.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.897 -1.047 . . . . 62.01 111.116 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -68.41 -28.37 67.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.118 -0.492 . . . . 72.22 112.056 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.28 -47.26 62.02 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.254 0.346 . . . . 62.3 110.874 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -65.76 -33.34 75.65 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 110.175 -0.306 . . . . 74.53 110.175 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.96 -28.88 70.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.731 0.813 . . . . 71.1 111.722 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -69.39 -41.63 76.21 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.435 0.636 . . . . 70.31 109.613 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -73.98 -22.62 59.55 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.606 -1.179 . . . . 74.35 112.215 -171.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.0 pt -118.09 -51.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.315 0.507 . . . . 75.25 112.337 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.416 HD23 HG13 ' A' ' 34' ' ' ILE . 3.1 mm? -82.14 166.43 19.68 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 54.35 108.206 173.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -61.79 142.7 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 109.77 -0.456 . . . . 75.4 109.77 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.84 -11.42 14.85 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.746 2.297 . . . . 72.14 113.444 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.86 -37.12 73.07 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.735 0.814 . . . . 53.54 110.816 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.0 -37.54 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.253 1.021 . . . . 61.51 112.202 -171.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.35 -31.54 72.19 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.784 0.265 . . . . 71.04 110.905 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.22 -57.34 6.9 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 124.457 1.098 . . . . 41.25 109.991 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 12.1 pt20 -58.79 -30.44 67.59 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.035 0.534 . . . . 60.23 111.993 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 15' ' ' ILE . 67.6 t -75.44 -49.8 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.127 0.971 . . . . 54.22 111.913 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -67.67 -24.96 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.745 0.307 . . . . 74.01 111.344 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -86.14 -25.57 25.67 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.825 0.45 . . . . 52.11 110.984 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 5.5 t60 -67.0 -29.29 69.09 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.913 0.885 . . . . 72.3 109.544 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -59.03 -39.6 82.44 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.107 1.363 . . . . 63.21 112.667 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 75.3 mtp180 -58.43 -32.04 68.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.031 0.932 . . . . 73.03 111.293 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.22 -51.66 62.59 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.166 0.986 . . . . 50.43 110.907 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.515 HD22 HD12 ' A' ' 55' ' ' ILE . 53.0 mt -73.6 -17.69 61.14 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.307 -0.86 . . . . 75.33 111.317 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -72.61 -42.73 64.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.177 0.991 . . . . 74.41 109.625 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 73.6 mmtt -61.62 -42.62 99.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 123.739 0.649 . . . . 74.44 109.611 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -72.53 -28.52 62.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.231 -1.349 . . . . 73.32 111.732 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.12 40.71 95.13 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.729 0.643 . . . . 54.2 113.087 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.515 HD12 HD22 ' A' ' 50' ' ' LEU . 59.3 mt -78.62 114.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.883 0.473 . . . . 60.15 109.865 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -90.64 112.92 24.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.485 -0.931 . . . . 70.44 108.485 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.2 134.38 20.51 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.428 0.558 . . . . 72.01 111.164 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.875 0.87 . . . . 72.02 109.645 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 13' ' ' ILE . 49.4 t -77.18 120.62 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.394 1.077 . . . . 72.51 109.755 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.19 -54.5 2.6 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.431 0.692 . . . . 64.25 111.376 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 8.6 tpp85 -132.59 127.27 34.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.442 -0.948 . . . . 70.14 108.442 -173.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 9' ' ' LYS . 38.3 t -123.0 109.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.723 -0.843 . . . . 72.2 108.723 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -119.79 108.39 14.33 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.632 -0.877 . . . . 61.03 108.632 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -105.34 109.95 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.085 0.954 . . . . 65.32 109.687 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -123.83 142.55 51.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.913 0.885 . . . . 40.14 109.742 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.1 p -93.42 124.05 37.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.657 0.383 . . . . 70.03 110.369 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -113.51 98.24 6.95 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.228 -1.027 . . . . 72.35 108.228 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.191 -1.164 . . . . 73.42 110.191 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.45 -15.21 15.08 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.358 0.663 . . . . 72.03 110.332 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.0 m -93.35 117.06 29.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.922 0.489 . . . . 53.5 109.761 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.0 p -88.68 128.9 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.189 0.596 . . . . 71.34 110.377 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.63 113.35 25.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.782 1.233 . . . . 72.33 109.363 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.57 104.48 15.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.292 -0.632 . . . . 63.1 109.292 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.9 m -86.29 104.8 16.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.019 -1.104 . . . . 71.22 108.019 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.1 p -127.61 115.35 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.337 0.655 . . . . 72.12 111.391 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.59 132.43 35.3 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.206 -0.906 . . . . 70.1 109.573 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.24 135.17 54.43 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.001 0.92 . . . . 74.41 108.679 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 85' ' ' THR . 33.4 tt0 -93.96 102.14 14.22 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -95.35 112.88 24.52 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.482 1.113 . . . . 74.12 109.593 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -87.67 102.97 15.15 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.766 -1.198 . . . . 72.31 107.766 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -134.83 134.98 41.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.952 -1.129 . . . . 71.35 107.952 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.11 65.57 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.091 0.245 . . . . 71.3 112.553 -172.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.27 59.53 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 123.206 0.431 . . . . 60.42 113.5 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.2 p -96.66 151.01 20.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.905 0.882 . . . . 71.41 111.093 -173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.526 HG23 ' HG3' ' A' ' 78' ' ' GLU . 89.4 m -85.38 115.85 23.36 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.093 0.957 . . . . 74.41 109.125 177.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.6 m -121.42 111.02 16.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.714 -0.847 . . . . 62.42 108.714 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -90.37 102.7 15.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.487 -0.931 . . . . 71.55 108.487 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.6 m -111.46 126.11 54.6 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.627 0.771 . . . . 74.22 109.261 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -91.73 120.89 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.456 -0.572 . . . . 74.14 109.456 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.2 127.69 49.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.768 -1.567 . . . . 75.14 106.768 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.26 102.08 10.52 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.987 -1.116 . . . . 70.35 107.987 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.4 mp -90.74 106.58 18.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 50.6 ttp180 -91.67 98.46 11.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.731 -1.122 . . . . 73.35 108.175 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.578 ' HB3' HG21 ' A' ' 101' ' ' ILE . 98.7 m-85 -88.53 107.75 19.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 1.6 tm-20 -90.89 125.95 35.9 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.882 -1.525 . . . . 74.33 106.882 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.4 HG12 HG12 ' A' ' 101' ' ' ILE . 19.8 m -104.13 148.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.177 0.991 . . . . 75.12 111.676 -163.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.7 92.45 2.75 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.691 1.196 . . . . 75.01 109.007 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.62 -102.42 1.29 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.468 -0.787 . . . . 65.15 111.53 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.5 -10.06 13.75 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.078 0.951 . . . . 73.4 111.037 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -108.17 166.73 10.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.274 0.63 . . . . 71.25 109.565 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 94' ' ' PHE . 54.1 mt -115.52 120.29 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 107.637 -1.245 . . . . 63.44 107.637 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -88.26 -30.92 19.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.176 0.19 . . . . 73.32 111.153 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 65.2 mtt180 -129.42 147.73 51.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.904 0.481 . . . . 74.14 110.904 -164.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.67 110.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 64.34 109.051 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 25.9 m -95.39 104.67 16.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.667 -0.864 . . . . 54.44 108.667 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG22 ' HG ' ' A' ' 92' ' ' LEU . 40.9 t -85.55 102.41 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.669 -1.234 . . . . 70.15 107.669 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 m -99.26 109.31 21.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.096 -0.705 . . . . 71.41 109.096 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.37 106.56 12.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.593 0.757 . . . . 74.4 110.374 -174.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.611 1.164 . . . . 61.3 108.54 176.666 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.623 -0.51 . . . . 74.43 109.623 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.31 -50.15 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.884 0.874 . . . . 73.11 110.999 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.39 -36.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.205 -0.907 . . . . 63.34 110.295 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.14 -35.57 80.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.919 -0.582 . . . . 60.21 110.869 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.731 0.412 . . . . 75.15 110.211 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.38 90.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.702 -0.681 . . . . 73.21 111.699 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.29 -46.79 69.39 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.471 -0.786 . . . . 41.55 111.285 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -63.83 -41.77 97.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.448 0.699 . . . . 73.11 110.666 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.34 97.86 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 123.666 0.604 . . . . 72.25 111.29 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.51 -53.71 54.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.032 0.833 . . . . 63.13 111.156 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 70.1 mt -61.96 -43.68 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.363 -0.835 . . . . 74.13 110.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 30' ' ' LEU . . . -63.96 -37.56 87.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.588 0.755 . . . . 72.13 112.454 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.14 -37.59 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.841 0.856 . . . . 71.53 109.985 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -74.52 -35.01 63.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.257 0.623 . . . . 71.11 111.818 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 8.3 mm-40 -63.35 -37.29 86.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.526 -0.546 . . . . 71.31 109.526 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.7 mt -71.48 -41.84 68.82 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.36 -0.836 . . . . 74.11 110.891 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -59.29 -34.57 72.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.87 0.693 . . . . 74.02 112.87 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -96.91 -15.99 20.9 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.606 0.362 . . . . 74.43 111.547 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -157.82 84.36 2.76 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.579 0.752 . . . . 74.45 109.145 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.18 -13.51 32.43 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.275 2.65 . . . . 70.4 114.135 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 p -89.43 9.68 25.44 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.717 0.807 . . . . 54.21 112.284 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.1 109.79 4.99 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.166 0.586 . . . . 74.12 110.056 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.67 -37.62 16.0 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.555 2.17 . . . . 74.32 112.979 -171.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.06 -42.73 69.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.791 0.836 . . . . 73.31 111.697 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.11 -54.97 29.59 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.548 0.739 . . . . 63.31 111.564 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -62.81 -32.87 74.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.756 -0.657 . . . . 74.12 111.6 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.9 -46.28 72.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.106 0.563 . . . . 52.23 112.129 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 14' ' ' ALA . 4.2 pp -69.64 -27.31 64.94 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 120.842 0.353 . . . . 52.35 110.422 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 mt -69.18 -18.63 63.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.011 0.925 . . . . 72.24 112.61 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -73.96 -29.05 61.79 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.082 0.401 . . . . 73.04 110.483 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.08 -42.21 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 72.01 111.654 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 20.0 pt -103.97 -31.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 112.326 0.491 . . . . 54.24 112.326 -172.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 39' ' ' VAL . 3.2 mm? -112.78 -179.35 3.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.111 0.964 . . . . 72.33 109.208 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB2' HG23 ' A' ' 39' ' ' VAL . 50.7 m -84.67 143.29 40.69 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 73.42 109.941 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.94 -32.22 37.19 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.298 2.665 . . . . 75.12 113.185 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.43 -47.99 77.93 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.115 0.966 . . . . 53.22 111.856 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.1 t -63.02 -52.32 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.199 -0.91 . . . . 71.33 111.259 -173.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.97 -28.18 69.91 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.187 0.44 . . . . 65.1 112.187 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -58.81 5.08 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 124.156 0.91 . . . . 64.05 110.073 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.16 -21.11 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.039 -0.528 . . . . 72.04 111.414 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.36 -50.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.725 0.41 . . . . 53.41 110.071 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 4.7 ppt_? -71.06 -21.0 62.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.757 0.281 . . . . 74.41 111.757 -177.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -73.22 -49.21 29.16 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.704 0.401 . . . . 70.51 111.498 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -67.89 -21.84 65.13 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.045 0.538 . . . . 63.13 111.111 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.0 -37.7 88.52 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.234 1.013 . . . . 63.15 111.853 174.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 61.9 mtp180 -62.86 -27.38 69.3 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.57 0.748 . . . . 70.43 110.555 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -47.62 60.61 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.897 -0.592 . . . . 72.43 110.253 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.86 -33.23 75.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.628 0.771 . . . . 62.31 111.361 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -62.82 -44.71 95.43 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.019 0.928 . . . . 74.52 109.702 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.82 -31.59 69.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.994 -1.003 . . . . 75.12 111.056 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -77.48 -15.59 59.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.445 0.698 . . . . 75.54 111.198 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.38 30.1 74.91 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.59 0.556 . . . . 45.01 113.469 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.62 99.18 4.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 109.588 -0.523 . . . . 74.53 109.588 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -81.33 109.62 16.01 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 107.591 -1.263 . . . . 74.34 107.591 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.66 162.88 14.72 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.596 -0.89 . . . . 74.51 108.596 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.12 130.33 20.85 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.781 -0.452 . . . . 71.43 109.781 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.6 t -68.04 135.58 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 123.967 0.792 . . . . 74.32 109.81 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -117.62 -51.97 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.582 1.153 . . . . 74.43 110.345 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HE ' ' A' ' 61' ' ' ARG . 2.0 tpm_? -142.07 123.83 15.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.157 -0.929 . . . . 74.34 108.913 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.25 112.81 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.231 -0.655 . . . . 75.24 109.231 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.05 146.64 44.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.951 -1.129 . . . . 72.42 107.951 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.547 HG23 HG22 ' A' ' 73' ' ' VAL . 5.7 p -135.45 108.81 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.052 -0.721 . . . . 62.34 109.052 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.8 m -118.38 128.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.328 1.051 . . . . 51.11 109.399 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.4 p -88.64 162.6 16.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.116 0.566 . . . . 64.01 110.478 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -160.6 92.15 0.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.335 1.054 . . . . 64.33 108.218 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.95 9.95 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.609 -0.55 . . . . 70.25 111.827 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -91.76 -10.88 38.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 74.21 111.224 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.2 m -101.6 140.54 35.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.571 0.749 . . . . 72.41 110.605 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 94' ' ' PHE . 2.9 p -121.76 116.67 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.561 0.696 . . . . 70.13 110.142 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -96.26 108.4 20.88 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.448 1.099 . . . . 73.23 109.154 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 64' ' ' VAL . 59.2 t -88.52 107.12 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.667 -0.864 . . . . 75.21 108.667 177.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -95.89 105.25 17.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.96 -1.126 . . . . 54.43 107.96 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.52 125.49 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.517 0.727 . . . . 75.43 110.45 -170.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.7 123.66 31.34 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.257 0.623 . . . . 73.4 110.061 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.15 122.41 37.0 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.285 -1.006 . . . . 64.32 108.285 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.3 116.73 27.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.293 0.568 . . . . 55.53 109.78 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.89 105.0 17.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.154 0.982 . . . . 72.41 111.416 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -90.78 103.13 15.87 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.651 1.181 . . . . 52.52 108.744 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.0 t -138.53 137.22 36.87 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.34 0.656 . . . . 62.3 109.557 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.77 22.12 67.95 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.918 -0.583 . . . . 52.15 113.018 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.9 -33.72 5.06 Favored Glycine 0 C--N 1.354 1.569 0 C-N-CA 122.848 0.261 . . . . 44.21 112.988 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -84.57 135.6 34.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.532 0.733 . . . . 75.11 111.486 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -107.88 145.95 33.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.706 0.802 . . . . 71.03 110.034 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.8 m -143.63 123.87 13.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.489 0.715 . . . . 43.45 109.082 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.97 102.13 6.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.077 -0.712 . . . . 64.25 109.077 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.9 m -107.68 131.63 54.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.967 0.907 . . . . 51.05 110.118 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -95.47 120.14 35.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.311 0.644 . . . . 63.45 109.435 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -102.9 126.37 50.03 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.989 0.915 . . . . 72.34 108.822 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.53 104.27 13.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.723 -0.843 . . . . 71.3 108.723 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.7 mp -91.83 107.38 19.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.285 -1.006 . . . . 74.24 108.285 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -91.74 97.43 11.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.481 -0.781 . . . . 71.41 109.583 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.59 ' HB2' HG13 ' A' ' 71' ' ' VAL . 97.5 m-85 -91.14 117.4 29.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.517 0.727 . . . . 74.45 110.16 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 28.3 tt0 -101.48 121.19 41.5 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.682 -0.858 . . . . 63.12 108.682 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.592 HG12 HG12 ' A' ' 101' ' ' ILE . 10.0 m -86.37 140.17 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.913 -0.403 . . . . 74.53 109.913 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -134.56 117.45 16.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.237 -1.394 . . . . 63.01 107.237 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -114.32 3.99 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.691 -0.964 . . . . 71.22 110.691 -168.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -113.95 -19.15 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.236 0.614 . . . . 71.32 112.097 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -112.14 161.86 16.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.227 0.611 . . . . 72.15 110.675 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.592 HG12 HG12 ' A' ' 96' ' ' VAL . 52.4 mt -82.31 128.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.797 -0.816 . . . . 72.03 108.797 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -114.56 -14.52 12.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.409 0.684 . . . . 74.35 112.32 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 9.8 tpt180 -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.474 0.309 . . . . 75.0 110.505 -172.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.82 139.95 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.986 0.914 . . . . 50.3 109.162 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -134.62 104.62 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.581 -0.896 . . . . 30.02 108.581 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.72 132.02 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.014 0.526 . . . . 72.52 109.722 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.4 m -120.47 116.22 25.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.652 0.781 . . . . 64.14 109.212 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -80.3 105.26 11.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.774 0.83 . . . . 62.13 109.467 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 124.441 1.096 . . . . 73.33 110.566 -175.977 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 109.713 -0.477 . . . . 74.3 109.713 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 96' ' ' VAL . 34.3 mm -64.33 -43.65 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.423 1.089 . . . . 71.44 112.84 -169.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.5 -52.43 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.563 0.745 . . . . 65.1 109.554 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -69.93 -26.48 64.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.053 -1.43 . . . . 75.24 111.583 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.81 -57.39 8.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.619 0.767 . . . . 74.11 109.667 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.31 76.75 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.28 0.988 . . . . 65.41 111.883 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.75 -58.8 7.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.953 0.901 . . . . 60.11 110.694 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -69.82 -22.26 63.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.709 0.804 . . . . 75.31 111.67 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.3 -45.38 69.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.039 0.935 . . . . 71.01 110.571 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.561 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -59.18 -46.72 87.66 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.294 0.996 . . . . 74.45 110.672 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 62' ' ' VAL . 41.7 mt -61.39 -42.31 93.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 O-C-N 124.404 1.065 . . . . 73.04 110.165 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.87 68.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.165 0.986 . . . . 70.42 112.62 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.405 ' HA ' HG11 ' A' ' 43' ' ' VAL . 46.5 mt -63.21 -42.52 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.595 0.758 . . . . 54.24 109.826 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 92' ' ' LEU . 30.4 m-85 -69.96 -37.27 75.77 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.728 -0.669 . . . . 74.31 111.547 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.438 HE21 HG22 ' A' ' 13' ' ' ILE . 68.8 mt-30 -61.67 -38.49 87.94 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.759 0.662 . . . . 75.12 110.909 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 44' ' ' ARG . 75.6 mt -70.0 -40.45 75.28 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.582 0.552 . . . . 72.11 110.487 174.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HB3' HD12 ' A' ' 50' ' ' LEU . 39.5 m0 -64.87 -31.03 72.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 112.906 0.706 . . . . 74.42 112.906 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -98.52 -20.69 16.92 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.045 0.538 . . . . 72.14 111.537 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.27 85.14 3.17 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 123.786 0.835 . . . . 72.41 108.808 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.84 -19.87 69.8 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.45 2.1 . . . . 52.12 113.289 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -81.04 2.41 27.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.689 0.796 . . . . 73.51 112.635 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.86 111.48 6.5 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 122.878 0.471 . . . . 73.05 109.764 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.7 -31.58 8.4 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.347 2.032 . . . . 70.31 112.733 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.12 -39.42 65.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.343 0.657 . . . . 74.41 110.958 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -56.4 18.75 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 124.118 0.967 . . . . 72.45 110.937 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.44 -32.61 74.32 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.779 -0.646 . . . . 71.13 111.306 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.09 -56.71 16.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.515 0.726 . . . . 72.44 111.296 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -62.82 -31.73 72.78 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 123.759 0.662 . . . . 74.11 110.606 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -66.95 -26.03 66.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.552 0.741 . . . . 71.54 112.073 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.854 0.752 . . . . 63.22 110.516 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.77 -16.03 31.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.028 0.931 . . . . 74.3 111.501 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 30' ' ' LEU . 16.2 pt -124.56 -45.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.405 0.52 . . . . 70.54 112.405 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 39' ' ' VAL . 3.8 mm? -95.15 172.46 8.11 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.037 0.935 . . . . 64.11 109.26 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 39' ' ' VAL . 21.0 m -83.25 143.52 45.28 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.464 -0.789 . . . . 71.13 110.041 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.71 -31.88 52.62 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.046 3.164 . . . . 65.21 114.049 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.34 -48.03 77.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.779 0.832 . . . . 75.04 111.619 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 HD12 ' A' ' 35' ' ' LEU . 42.2 t -63.19 -39.48 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 72.24 111.516 -171.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.07 -27.57 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.472 0.177 . . . . 61.13 111.064 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 17.5 t70 -73.68 -44.81 55.62 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.71 0.631 . . . . 75.05 110.405 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.88 -32.71 74.03 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.593 0.357 . . . . 73.51 110.892 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 15' ' ' ILE . 25.1 t -63.52 -51.56 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 70.11 111.263 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB3' HD13 ' A' ' 18' ' ' LEU . 3.3 ptm180 -69.29 -17.27 63.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.058 0.543 . . . . 73.14 111.914 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 51.3 mt-10 -84.26 -35.26 23.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.433 0.693 . . . . 75.22 111.511 171.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -73.34 -17.76 61.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.476 0.711 . . . . 71.43 110.801 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.79 67.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.595 1.158 . . . . 73.22 111.673 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -56.1 -34.82 66.39 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 124.348 1.03 . . . . 64.54 111.507 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -65.19 -55.04 20.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.969 0.507 . . . . 73.35 111.04 -175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 19' ' ' TRP . 88.4 mt -71.39 -34.39 70.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.255 0.622 . . . . 74.51 111.35 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.46 -45.63 68.59 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.725 0.81 . . . . 74.11 111.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.01 -40.79 97.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.116 0.967 . . . . 63.45 111.134 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -75.72 -19.72 58.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.735 -0.666 . . . . 62.22 111.938 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.43 28.76 57.15 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.293 0.371 . . . . 51.02 113.44 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.62 104.97 9.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.602 0.761 . . . . 75.34 109.76 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -82.66 111.25 18.44 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.645 -0.872 . . . . 73.44 108.645 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 43.4 p90 -108.53 144.77 35.75 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.487 -1.301 . . . . 72.3 107.487 168.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -121.56 121.02 36.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.995 -0.743 . . . . 64.02 108.995 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.27 100.44 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.753 -0.832 . . . . 71.14 108.753 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -86.45 -45.19 11.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.824 0.849 . . . . 65.55 111.504 -171.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -144.87 142.29 29.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.265 -0.643 . . . . 74.41 109.265 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 13' ' ' ILE . 93.1 t -125.18 128.73 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.264 -1.013 . . . . 61.34 108.264 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.2 123.73 40.91 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.933 -1.136 . . . . 64.14 107.933 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.31 126.42 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 109.467 -0.568 . . . . 64.31 109.467 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.7 m -132.56 122.3 24.59 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.554 0.742 . . . . 72.41 109.544 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -88.57 121.52 31.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.449 0.7 . . . . 44.11 109.983 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -125.96 89.28 3.0 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.176 0.991 . . . . 71.14 108.337 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.81 -121.46 7.85 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.022 -0.831 . . . . 44.42 111.022 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -98.54 -9.94 24.21 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.127 0.571 . . . . 74.52 110.294 170.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.6 m -96.49 111.16 23.37 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.334 0.654 . . . . 75.45 109.698 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.07 109.31 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.247 0.546 . . . . 71.51 110.225 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.22 103.93 13.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.601 1.16 . . . . 71.33 108.616 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.94 105.34 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.121 0.486 . . . . 53.4 109.85 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -86.04 105.13 16.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.28 1.032 . . . . 71.22 109.691 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.75 123.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.721 0.809 . . . . 72.4 109.878 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -85.61 117.68 24.66 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.282 0.633 . . . . 73.23 109.304 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.68 163.06 13.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.783 -0.821 . . . . 73.41 108.783 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -136.52 102.55 4.98 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.938 -1.504 . . . . 64.43 106.938 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.2 mt-10 -94.14 106.51 18.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.963 0.905 . . . . 75.41 110.46 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -93.92 106.41 18.39 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.737 0.815 . . . . 60.13 109.173 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -132.95 132.48 42.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.805 0.842 . . . . 75.24 109.621 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.16 13.26 61.9 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.089 0.396 . . . . 74.24 114.089 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.07 -32.97 6.83 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.78 -0.455 . . . . 72.43 112.881 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -84.09 150.18 25.73 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.216 0.508 . . . . 75.31 110.862 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.9 m -118.28 134.02 55.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.881 0.872 . . . . 54.11 109.959 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 m -138.52 122.11 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.475 1.11 . . . . 72.23 109.257 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -76.6 119.65 20.71 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.097 -0.705 . . . . 73.32 109.097 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.9 m -129.86 123.26 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.88 0.872 . . . . 64.4 109.5 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.0 m -87.67 128.86 35.29 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.534 -0.543 . . . . 72.32 109.534 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -109.75 125.38 52.63 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.32 -1.363 . . . . 73.43 107.32 168.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -106.57 104.69 14.44 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.061 -1.088 . . . . 72.25 108.061 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 12' ' ' ALA . 4.3 mp -90.88 105.29 17.73 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.565 -1.272 . . . . 71.44 107.565 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -93.71 99.13 11.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.883 0.873 . . . . 74.43 108.846 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.96 108.16 19.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.189 0.996 . . . . 74.25 110.136 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 29.2 tt0 -90.92 113.99 26.35 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.902 -0.777 . . . . 61.22 108.902 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.616 HG12 HG12 ' A' ' 101' ' ' ILE . 4.1 m -83.48 148.82 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.095 -0.705 . . . . 52.45 109.095 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -141.97 96.53 2.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.117 -1.068 . . . . 74.2 108.117 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 -124.07 6.7 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.402 -0.679 . . . . 73.43 111.402 -173.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -89.87 -21.31 22.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.491 0.717 . . . . 74.3 111.689 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -121.87 157.59 30.82 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.33 0.652 . . . . 75.53 110.795 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 96' ' ' VAL . 28.6 mt -90.55 115.47 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 72.2 108.689 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 36' ' ' SER . 28.6 mmt180 -89.35 -28.21 19.96 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.534 0.734 . . . . 75.44 111.104 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 29.5 mtt180 -130.85 135.9 48.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.929 0.492 . . . . 75.52 110.948 -163.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.95 142.94 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.263 1.025 . . . . 73.15 109.01 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -127.8 105.43 8.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.254 -1.017 . . . . 62.42 108.254 172.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.35 104.17 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.896 -1.15 . . . . 63.22 107.896 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -104.36 104.51 14.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.894 0.477 . . . . 50.24 109.952 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.76 98.48 2.41 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.542 -0.91 . . . . 71.34 108.542 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 62.32 112.037 -174.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.147 -0.316 . . . . 74.14 110.147 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -74.67 -31.67 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.846 0.859 . . . . 71.11 112.096 -174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -59.05 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.423 0.689 . . . . 73.45 110.754 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.31 -19.1 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.294 -0.412 . . . . 73.02 111.099 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -48.15 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.271 -0.64 . . . . 75.12 109.271 170.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.24 78.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.08 -0.964 . . . . 71.52 112.066 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.64 -53.25 57.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.681 0.792 . . . . 63.2 110.829 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.37 -30.55 70.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 72.51 111.053 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -61.88 -51.18 69.22 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 123.801 0.688 . . . . 74.35 110.693 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.51 57.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 124.068 0.855 . . . . 61.03 110.91 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.0 mt -57.61 -43.03 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.089 0.956 . . . . 72.43 110.987 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.43 72.9 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.253 0.621 . . . . 75.12 112.229 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.26 -40.91 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.843 0.857 . . . . 64.11 109.896 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 66.3 m-85 -79.55 -25.65 41.6 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.851 0.46 . . . . 74.23 112.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -67.85 -34.65 77.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.134 0.573 . . . . 73.24 109.858 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.3 mt -74.59 -46.02 41.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.005 -0.543 . . . . 70.15 110.179 172.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.0 m0 -61.48 -17.96 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.865 0.691 . . . . 62.53 112.865 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -102.4 -24.56 13.84 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 122.904 0.482 . . . . 72.34 111.599 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -157.55 87.36 2.59 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.724 0.81 . . . . 74.44 109.693 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.54 -17.56 53.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.226 2.617 . . . . 54.44 113.348 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -79.69 -4.39 51.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.823 0.849 . . . . 62.54 112.693 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.48 120.42 79.72 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 109.475 -0.565 . . . . 73.44 109.475 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.98 -30.39 7.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.234 1.956 . . . . 63.22 113.301 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.05 -26.31 27.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.198 0.599 . . . . 75.22 112.305 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.91 -48.01 55.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.36 0.664 . . . . 61.31 109.483 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.16 -27.36 63.49 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.73 -0.668 . . . . 71.41 111.895 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.27 -55.31 36.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.791 0.837 . . . . 74.52 111.733 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 4.1 pp -64.13 -28.18 69.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.929 0.768 . . . . 61.51 111.282 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD22 HD12 ' A' ' 35' ' ' LEU . 96.7 mt -67.56 -28.29 67.66 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.923 0.889 . . . . 70.23 112.258 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -65.88 -37.99 87.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.327 0.584 . . . . 75.34 110.517 173.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 50.0 mtpt -77.02 -39.35 50.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.686 -1.143 . . . . 60.44 111.281 -170.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 35' ' ' LEU . 16.2 pt -102.41 -32.77 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.365 0.666 . . . . 72.14 112.325 -171.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 34' ' ' ILE . 75.3 mt -116.34 -179.36 3.65 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.897 0.879 . . . . 75.41 110.453 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -74.27 152.85 88.18 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 115.349 -0.841 . . . . 54.32 111.371 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.76 -30.65 93.2 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.022 2.482 . . . . 73.13 112.588 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.1 -38.16 78.88 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.967 1.307 . . . . 55.34 112.49 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 35' ' ' LEU . 57.5 t -68.24 -56.15 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.489 -0.778 . . . . 64.12 110.163 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -25.55 67.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.53 0.332 . . . . 72.12 111.528 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.55 -49.28 66.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.068 . . . . 71.42 110.488 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.06 -32.25 64.92 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.208 -0.451 . . . . 75.33 111.366 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.17 -47.48 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.067 0.947 . . . . 52.12 111.2 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -70.74 -23.31 62.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.153 0.427 . . . . 72.12 112.153 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.81 -51.51 12.43 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.435 0.694 . . . . 65.12 110.504 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.414 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 83.0 t60 -63.22 -27.25 69.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.019 -0.991 . . . . 62.24 110.836 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -61.87 -45.67 92.77 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.747 1.219 . . . . 74.35 111.495 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 96.5 mtt180 -61.51 -38.43 87.35 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.816 -1.084 . . . . 63.21 110.581 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.31 -46.76 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.147 0.579 . . . . 62.4 111.607 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 71.5 mt -64.03 -35.42 80.66 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.354 0.662 . . . . 73.24 110.479 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -62.56 -46.3 89.01 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.226 -0.897 . . . . 74.23 110.695 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 7.6 mtpm? -62.17 -41.03 97.93 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.331 0.652 . . . . 73.2 110.769 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -75.43 -19.76 59.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.3 -0.864 . . . . 74.31 111.4 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.25 38.14 19.22 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.188 0.305 . . . . 63.44 112.963 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.2 mt -90.55 89.56 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.06 0.944 . . . . 71.22 108.453 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -92.84 111.54 23.18 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 53.7 p90 -134.69 152.35 51.7 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.864 0.465 . . . . 75.3 110.327 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.79 142.06 51.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.173 0.589 . . . . 75.42 109.577 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.69 110.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.801 1.241 . . . . 73.14 109.077 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.56 -29.38 12.74 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.743 0.417 . . . . 72.21 112.022 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.03 131.72 33.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.198 0.599 . . . . 74.32 109.806 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.63 117.3 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.262 -1.014 . . . . 74.21 108.262 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.4 108.01 8.89 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.782 -0.821 . . . . 74.42 108.782 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.07 115.54 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.158 0.583 . . . . 64.44 109.557 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -130.19 128.3 41.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.78 0.832 . . . . 43.13 108.831 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -88.07 144.66 26.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.14 0.576 . . . . 61.32 109.642 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -131.9 90.09 2.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.517 -1.29 . . . . 54.32 107.517 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.93 -122.4 19.25 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.013 -0.994 . . . . 54.42 111.231 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -91.45 -7.73 49.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.506 0.723 . . . . 75.44 111.858 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.1 m -111.43 115.81 29.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.02 0.528 . . . . 74.42 109.835 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -92.74 131.02 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.599 0.76 . . . . 73.11 111.121 -175.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -103.79 110.47 22.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.993 1.317 . . . . 74.21 109.448 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.11 104.53 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.67 -0.863 . . . . 71.3 108.67 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -86.68 105.42 16.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.263 -1.014 . . . . 74.52 108.263 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 16' ' ' PHE . 7.6 p -114.59 134.55 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.327 1.051 . . . . 42.24 108.603 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.4 123.78 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.774 -0.824 . . . . 61.24 108.774 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.82 161.78 24.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.082 0.953 . . . . 73.5 109.865 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.0 10.95 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 27.6 mt-10 -87.25 104.13 16.09 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.685 0.794 . . . . 63.23 110.685 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -89.17 102.99 15.64 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.498 -0.927 . . . . 73.11 108.498 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -141.54 136.45 31.15 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.314 1.046 . . . . 64.21 109.14 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.64 12.26 80.53 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.817 -0.629 . . . . 53.14 111.968 -170.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.22 -22.89 27.24 Favored Glycine 0 C--N 1.356 1.64 0 C-N-CA 123.496 0.569 . . . . 61.22 112.914 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 p -94.11 134.51 36.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.811 0.844 . . . . 65.42 111.269 -175.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.6 m -87.99 124.17 33.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.163 0.985 . . . . 74.22 110.118 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -120.97 116.42 25.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.456 1.102 . . . . 72.22 108.821 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -78.28 116.85 19.01 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.203 -0.665 . . . . 72.23 109.203 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -131.63 134.69 46.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.709 1.204 . . . . 73.12 109.883 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 m -97.67 145.6 26.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.273 0.629 . . . . 73.33 109.774 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -126.89 128.48 46.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.672 1.189 . . . . 62.41 108.007 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.95 104.25 16.26 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 71.35 108.252 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.19 106.04 18.23 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.226 -1.398 . . . . 64.33 107.226 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -102.1 97.91 8.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.678 0.791 . . . . 71.01 109.206 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HB3' HG21 ' A' ' 101' ' ' ILE . 90.8 m-85 -89.25 111.29 22.06 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.853 0.861 . . . . 72.04 109.899 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 38.5 tt0 -96.01 132.58 41.21 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.224 -0.658 . . . . 62.44 109.224 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.75 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.813 0.845 . . . . 74.34 111.343 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 102' ' ' ARG . 31.4 t70 -132.15 101.4 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.335 -1.358 . . . . 73.52 107.335 171.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.98 -99.42 0.94 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.328 -0.709 . . . . 75.2 111.328 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.17 -17.51 8.9 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.563 0.745 . . . . 74.33 111.123 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.0 m -113.91 133.96 55.12 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.24 0.616 . . . . 74.41 110.266 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.521 HG21 ' HB3' ' A' ' 94' ' ' PHE . 74.2 mt -73.6 116.83 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.784 0.834 . . . . 75.32 109.12 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 97' ' ' ASP . 32.0 mmt180 -105.72 -7.68 18.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.242 0.617 . . . . 73.42 111.369 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.9 ttt180 -136.0 139.07 42.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.766 0.426 . . . . 75.34 110.658 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.27 130.69 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.219 1.008 . . . . 55.14 109.187 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.7 m -110.34 104.52 13.32 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.044 -1.095 . . . . 75.31 108.044 172.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.91 104.61 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.249 -1.019 . . . . 64.03 108.249 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 m -103.84 112.92 26.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.361 0.664 . . . . 74.52 109.617 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 103.43 4.57 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.808 -1.182 . . . . 72.41 107.808 171.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.242 0.66 0 C-N-CA 123.846 0.859 . . . . 65.34 110.832 -177.229 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.156 0.503 . . . . 62.02 109.646 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.573 HG21 HG11 ' A' ' 96' ' ' VAL . 47.4 mm -74.51 -22.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.263 1.025 . . . . 72.14 111.709 -172.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 66' ' ' THR . 21.8 t -61.31 -55.84 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.466 -0.568 . . . . 71.42 109.466 176.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.97 -32.56 65.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.061 -0.972 . . . . 71.1 111.884 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 4' ' ' ILE . . . -62.73 -52.33 63.67 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.529 0.518 . . . . 44.43 110.404 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.72 67.49 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.549 0.74 . . . . 50.54 111.839 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.67 -55.68 21.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.396 0.678 . . . . 73.13 110.45 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -63.91 -32.59 74.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.864 0.866 . . . . 74.3 111.239 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.39 86.26 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 124.014 0.821 . . . . 63.1 111.143 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.77 92.47 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.97 0.793 . . . . 34.33 111.179 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 69.4 mt -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 124.291 0.994 . . . . 70.54 109.692 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.91 -29.99 71.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.041 0.936 . . . . 74.15 112.432 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.93 -41.15 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.538 0.735 . . . . 72.14 109.81 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE2' HG11 ' A' ' 75' ' ' VAL . 51.7 m-85 -72.4 -35.21 68.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.73 0.412 . . . . 74.42 111.332 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 20.3 mm-40 -61.31 -37.43 83.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.868 0.73 . . . . 73.13 110.15 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.45 -45.13 32.69 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 123.634 0.584 . . . . 73.1 110.926 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -54.21 -31.62 53.61 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.387 0.675 . . . . 74.54 112.731 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -101.89 -19.05 15.43 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.889 0.475 . . . . 73.51 112.103 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.66 81.91 6.32 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.254 -0.647 . . . . 55.12 109.254 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.43 -11.89 33.42 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.135 2.557 . . . . 71.4 112.948 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -80.94 -2.29 47.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.591 1.156 . . . . 72.14 112.687 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -76.31 107.68 4.96 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 119.183 -0.437 . . . . 75.22 110.09 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -31.14 24.68 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.764 2.31 . . . . 61.41 113.359 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -77.64 -34.83 53.1 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.187 0.595 . . . . 75.34 111.592 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.95 -45.69 73.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.299 0.64 . . . . 53.42 110.401 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -75.36 -20.92 58.72 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.66 -0.7 . . . . 74.1 111.628 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.05 -51.35 39.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.356 0.662 . . . . 75.33 110.896 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.7 pp -65.67 -37.68 87.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.668 -0.493 . . . . 74.02 109.668 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.96 -28.59 69.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.488 0.715 . . . . 73.01 111.571 173.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.31 -24.32 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.932 0.493 . . . . 73.13 111.209 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -97.18 -24.68 15.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.047 0.939 . . . . 71.35 112.254 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 30' ' ' LEU . 8.2 pt -121.82 -26.58 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 112.898 0.703 . . . . 70.43 112.898 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.44 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.5 mm? -102.65 172.34 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.265 0.626 . . . . 71.01 110.389 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.5 m -79.31 143.79 60.93 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 114.854 -1.066 . . . . 72.25 110.238 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.71 -31.03 18.1 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.657 2.905 . . . . 64.23 114.632 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -66.56 -36.97 83.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.148 0.579 . . . . 61.44 111.382 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 36' ' ' SER . 93.5 t -67.51 -57.35 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.656 0.782 . . . . 73.0 110.696 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.89 -28.44 66.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.667 0.387 . . . . 75.32 111.301 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.98 -54.96 10.91 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 124.527 1.142 . . . . 74.21 110.559 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 1.1 pp0? -61.64 -25.92 67.67 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.308 0.243 . . . . 73.42 111.604 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 39' ' ' VAL . 72.5 t -70.48 -53.08 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.7 0.8 . . . . 73.5 111.02 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -67.34 -22.49 65.59 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.025 0.38 . . . . 75.23 112.025 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -81.07 -45.26 16.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.853 0.461 . . . . 71.42 110.455 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.96 -26.01 68.39 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.396 0.678 . . . . 61.24 111.052 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.63 97.1 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.795 1.238 . . . . 75.42 112.333 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -65.8 -28.43 69.0 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.945 0.778 . . . . 73.42 111.439 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.84 -41.81 67.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.966 0.907 . . . . 73.33 110.867 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -76.81 -28.16 55.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.454 0.701 . . . . 64.14 110.989 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -72.85 -35.17 67.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.462 1.105 . . . . 72.42 110.422 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.62 -40.91 98.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 71.13 109.785 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -84.87 178.01 7.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.167 -0.924 . . . . 70.42 110.643 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.24 33.42 6.59 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.699 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.96 89.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 109.127 -0.694 . . . . 71.44 109.127 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -83.3 136.31 34.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.177 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 140.3 24.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.503 -0.555 . . . . 71.42 109.503 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.13 130.96 39.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.227 1.011 . . . . 72.41 109.618 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.49 102.34 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 54.4 109.686 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -84.27 -35.19 23.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.654 0.782 . . . . 63.21 110.886 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 58.5 ttt180 -155.56 125.41 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.913 -0.773 . . . . 74.45 108.913 -173.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.92 125.94 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 74.33 109.856 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.03 125.36 24.83 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.518 1.127 . . . . 71.42 108.953 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.33 134.99 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.328 0.651 . . . . 75.02 110.687 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.6 m -145.67 130.67 18.28 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.084 0.954 . . . . 51.11 108.969 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.512 HG22 HG22 ' A' ' 71' ' ' VAL . 71.8 p -88.31 149.17 23.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.6 0.36 . . . . 71.24 110.425 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -129.97 96.11 4.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.444 -1.317 . . . . 71.35 107.444 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.05 -102.08 0.95 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.992 -0.843 . . . . 65.12 110.992 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -115.49 -13.48 11.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.972 0.909 . . . . 73.45 110.373 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.9 m -97.15 119.33 35.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.606 0.763 . . . . 75.45 109.568 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 66' ' ' THR . 23.4 t -87.93 144.48 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.676 0.79 . . . . 72.14 110.456 -170.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -124.31 102.48 7.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.59 1.156 . . . . 73.14 108.903 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.13 103.21 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.079 -0.711 . . . . 72.23 109.079 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.3 m -89.53 112.38 23.54 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.322 1.049 . . . . 73.01 109.026 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' HE2' ' A' ' 16' ' ' PHE . 3.9 p -132.91 119.26 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.367 0.667 . . . . 63.41 110.771 -172.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.5 tp10 -80.2 129.91 34.84 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.323 1.049 . . . . 75.21 109.143 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.41 HD13 ' HD1' ' A' ' 90' ' ' TYR . 5.8 mp -125.1 142.01 51.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.236 0.614 . . . . 53.12 109.686 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.96 108.64 21.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.439 -1.319 . . . . 73.42 107.439 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -104.54 105.74 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.173 0.589 . . . . 71.44 111.162 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -93.25 111.24 22.83 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.783 -0.821 . . . . 71.12 108.783 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -134.99 123.6 23.57 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.176 0.99 . . . . 70.03 109.732 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.33 13.66 70.85 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.171 0.415 . . . . 71.11 113.491 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.13 -28.31 15.25 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 112.027 -0.429 . . . . 30.24 112.027 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.5 p -85.01 120.13 26.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.246 0.618 . . . . 74.11 110.615 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -94.31 142.04 27.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.522 0.729 . . . . 73.43 110.25 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.1 m -144.68 123.26 12.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.327 1.051 . . . . 75.42 109.326 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -77.93 109.67 12.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.907 -0.775 . . . . 71.24 108.907 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 m -114.78 122.12 45.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.415 1.086 . . . . 15.44 109.53 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 10.6 m -88.95 120.09 30.05 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.2 -0.667 . . . . 53.33 109.2 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HD1' HD13 ' A' ' 77' ' ' LEU . 89.9 m-85 -104.78 136.5 44.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 174.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -115.27 103.06 10.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.144 -1.058 . . . . 51.12 108.144 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.1 mp -87.71 104.39 16.5 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.249 -1.389 . . . . 73.2 107.249 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -96.66 108.0 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.359 -0.837 . . . . 62.42 109.35 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.409 ' HB3' HG21 ' A' ' 101' ' ' ILE . 80.0 m-85 -88.82 109.09 19.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.692 0.797 . . . . 71.03 110.293 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 37.4 tt0 -90.54 114.71 26.99 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.818 0.847 . . . . 63.22 109.268 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 4' ' ' ILE . 3.9 m -100.58 149.62 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.694 0.798 . . . . 61.33 110.275 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.72 119.36 16.04 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.73 -1.211 . . . . 71.41 107.73 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.54 -100.58 1.82 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.946 -0.462 . . . . 25.15 111.946 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.93 -21.78 5.43 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.094 0.558 . . . . 73.54 112.165 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -114.04 158.65 20.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.058 0.456 . . . . 71.12 110.989 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 96' ' ' VAL . 16.6 mt -84.55 125.19 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.038 -0.983 . . . . 71.33 108.878 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -96.11 -43.18 7.87 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.268 0.627 . . . . 73.42 111.264 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 87.1 mtt180 -132.77 160.93 35.42 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.714 0.806 . . . . 74.42 110.591 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.48 120.14 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.394 -0.965 . . . . 61.15 108.394 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.7 m -100.68 104.83 16.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.259 -1.015 . . . . 74.53 108.259 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 92' ' ' LEU . 46.5 t -87.29 103.99 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.631 -0.878 . . . . 72.05 108.631 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -94.5 106.38 18.36 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.593 0.757 . . . . 64.5 109.453 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -82.06 97.45 8.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.493 -0.776 . . . . 74.13 109.9 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.3 m-80 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 107.53 -1.285 . . . . 71.23 107.53 170.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.701 -0.481 . . . . 71.52 109.701 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.27 -32.87 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.578 1.151 . . . . 71.31 112.017 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.44 -51.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.236 0.614 . . . . 65.14 109.769 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -28.33 65.44 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.447 -0.797 . . . . 64.42 111.129 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -59.04 -48.75 80.47 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.933 0.397 . . . . 72.52 110.208 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.79 83.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.543 -0.753 . . . . 63.34 111.728 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.79 -52.25 64.97 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.581 0.752 . . . . 73.44 111.475 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.55 -37.1 82.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 73.13 110.665 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.93 80.95 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.405 -1.27 . . . . 53.31 111.498 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.56 82.22 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.911 0.757 . . . . 71.03 111.891 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 HE21 ' A' ' 17' ' ' GLN . 55.8 mt -64.85 -40.05 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.939 -1.028 . . . . 61.04 110.204 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.03 72.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.791 0.836 . . . . 64.11 112.852 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.5 mt -63.1 -40.3 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.531 0.732 . . . . 42.53 110.028 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -71.14 -33.54 70.17 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.143 0.577 . . . . 74.24 111.521 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.475 HE21 HG22 ' A' ' 13' ' ' ILE . 80.1 mt-30 -62.07 -40.98 97.64 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.857 0.863 . . . . 72.44 110.997 175.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.23 -37.52 66.37 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.972 -0.558 . . . . 75.34 110.863 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -63.13 -32.85 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.45 0.537 . . . . 73.4 112.45 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.57 -23.31 22.01 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.394 0.278 . . . . 73.41 111.234 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -158.14 88.27 2.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.477 0.711 . . . . 74.43 109.242 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.19 -22.53 70.59 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.337 2.691 . . . . 73.35 114.312 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -88.46 11.23 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.578 0.751 . . . . 52.15 112.722 -174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.97 114.14 26.37 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.89 -32.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.551 2.167 . . . . 73.33 113.354 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.76 -40.26 55.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.212 0.605 . . . . 65.35 111.387 -171.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.99 67.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.727 0.811 . . . . 71.23 110.993 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.429 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -70.19 -26.25 63.81 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.533 -0.758 . . . . 71.32 111.864 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.21 -43.17 71.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 74.53 111.323 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.472 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.3 pp -71.08 -35.4 71.84 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.583 -0.525 . . . . 72.13 109.583 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.93 -22.34 66.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.75 0.82 . . . . 74.51 112.112 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -73.46 -30.62 63.3 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.278 0.631 . . . . 60.1 110.96 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.53 -46.28 9.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.33 -0.85 . . . . 73.23 111.538 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.7 pt -101.88 -28.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 116.092 -0.504 . . . . 73.24 111.513 -169.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 39' ' ' VAL . 3.4 mm? -108.9 -173.94 2.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.384 1.074 . . . . 53.45 109.378 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.0 m -77.77 149.15 77.14 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 122.915 0.486 . . . . 72.42 111.091 176.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.79 -25.75 81.73 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.488 2.125 . . . . 73.11 111.804 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.83 -43.64 95.59 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.222 -1.354 . . . . 73.45 110.805 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.9 t -64.39 -52.51 54.53 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 123.531 0.732 . . . . 65.52 111.131 -175.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.0 pp -59.22 -35.86 74.38 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 120.829 0.347 . . . . 61.41 111.528 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.88 -43.49 68.3 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.216 1.006 . . . . 74.23 111.431 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -74.25 -27.31 60.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.221 0.209 . . . . 64.0 110.952 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 t -72.62 -41.76 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.028 0.531 . . . . 75.34 110.564 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -21.49 61.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.65 0.205 . . . . 74.44 111.537 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.45 -49.26 12.58 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.922 0.392 . . . . 74.12 110.077 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.7 -24.04 67.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.98 0.912 . . . . 75.21 110.63 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.25 76.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.109 1.364 . . . . 74.32 112.471 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -61.68 -22.94 65.75 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.218 -0.901 . . . . 74.11 112.625 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.38 -46.46 66.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.583 0.753 . . . . 73.24 110.581 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.35 -31.77 60.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.819 0.848 . . . . 51.13 111.347 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.25 -39.01 78.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 65.34 110.166 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -59.74 -43.3 94.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.586 0.754 . . . . 73.32 110.266 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -75.71 -29.63 59.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.073 -0.967 . . . . 73.33 111.4 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.31 35.52 76.76 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.456 0.472 . . . . 63.11 113.427 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.35 107.9 12.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.704 -0.851 . . . . 72.13 108.704 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -84.13 111.14 19.07 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 108.728 -0.842 . . . . 62.35 108.728 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.495 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 15.5 p90 -110.37 142.67 41.72 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.009 -1.478 . . . . 72.44 107.009 168.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -134.42 126.94 30.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.152 0.283 . . . . 53.34 110.252 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.23 134.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.116 0.966 . . . . 71.34 110.047 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -117.12 -54.31 2.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.526 1.13 . . . . 54.01 109.522 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -140.78 123.72 16.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 114.658 -1.155 . . . . 72.41 108.673 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.27 124.04 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.139 -1.06 . . . . 74.44 108.139 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.08 107.6 9.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 73' ' ' VAL . 14.7 p -99.0 140.16 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.722 0.409 . . . . 65.34 110.14 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -144.27 170.74 15.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.749 0.82 . . . . 42.21 109.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 71' ' ' VAL . 40.1 p -126.66 149.72 49.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.209 0.604 . . . . 73.34 110.756 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -135.95 95.6 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.46 -1.311 . . . . 65.04 107.46 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.91 -101.34 1.1 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.207 -1.157 . . . . 54.0 110.207 -166.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -119.02 -7.67 10.34 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.777 0.831 . . . . 74.44 110.594 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 95' ' ' GLU . 22.1 m -87.88 114.79 24.84 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.24 -0.652 . . . . 60.01 109.24 -174.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 66' ' ' THR . 24.3 t -87.03 132.24 32.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 115.674 -0.693 . . . . 71.14 109.422 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -118.79 117.52 29.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.192 0.997 . . . . 54.51 108.634 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 64' ' ' VAL . 46.3 t -100.35 103.18 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 73.14 109.647 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.9 m -90.65 105.42 17.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.679 -0.859 . . . . 72.24 108.679 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.54 126.51 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.679 0.792 . . . . 61.13 110.694 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.03 120.48 23.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.179 0.991 . . . . 73.05 109.783 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.1 mp -115.39 119.1 35.14 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.374 -0.972 . . . . 65.04 108.374 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -88.46 103.41 15.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.211 -1.033 . . . . 61.04 108.211 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 30.3 mt-10 -88.2 126.06 34.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.32 1.048 . . . . 74.33 110.067 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.3 m -115.64 107.72 15.48 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.218 -1.03 . . . . 50.44 108.218 173.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -147.51 138.14 23.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.908 0.883 . . . . 75.33 109.351 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.94 12.24 64.66 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.368 0.418 . . . . 24.34 113.846 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.94 -32.9 6.56 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 117.127 0.464 . . . . 61.15 112.421 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -84.09 144.78 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.482 0.713 . . . . 52.43 111.688 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 129.98 53.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.014 0.926 . . . . 73.33 110.603 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.3 m -143.54 133.12 23.61 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.724 0.809 . . . . 53.42 110.1 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -81.25 101.52 9.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.386 -0.598 . . . . 65.11 109.386 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.1 m -101.54 122.44 43.83 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.198 0.999 . . . . 75.41 109.226 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -88.52 125.82 34.96 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.588 . . . . 65.42 109.414 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CD1' HD13 ' A' ' 77' ' ' LEU . 18.6 m-85 -104.65 126.08 51.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.765 -1.198 . . . . 74.4 107.765 173.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.22 103.59 12.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.145 -1.057 . . . . 72.54 108.145 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.98 110.48 22.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.893 -0.78 . . . . 45.01 108.893 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 59.7 ttp180 -88.89 99.76 12.65 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.94 -0.763 . . . . 74.01 108.94 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.9 m-85 -86.17 107.82 18.05 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.914 0.864 . . . . 75.44 108.687 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . 19.2 mt-10 -90.09 116.49 28.15 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.984 -1.462 . . . . 74.02 108.053 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 101' ' ' ILE . 11.3 m -85.45 144.92 8.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.358 -0.837 . . . . 62.33 110.907 -169.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.7 79.49 1.9 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.34 18.07 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.426 -0.806 . . . . 55.31 111.736 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -80.15 -4.87 54.74 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.95 0.722 . . . . 72.01 112.95 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.3 m -134.68 134.65 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.591 0.356 . . . . 52.33 110.217 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HB3' ' A' ' 94' ' ' PHE . 45.4 mt -77.46 132.02 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.169 -1.049 . . . . 73.21 108.169 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -119.4 -10.07 9.76 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.372 0.533 . . . . 74.53 111.617 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.636 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 14.4 mmt180 -130.02 150.4 51.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.224 0.61 . . . . 74.43 111.527 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.16 124.9 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.474 1.11 . . . . 72.02 109.466 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 87.7 m -111.92 105.07 13.4 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.651 0.78 . . . . 63.2 108.941 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.0 105.14 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.531 -0.914 . . . . 72.05 108.531 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.9 m -99.94 105.7 17.43 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.468 0.707 . . . . 72.23 109.384 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -84.03 123.63 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.65 -0.5 . . . . 74.05 109.65 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 123.384 0.673 . . . . 65.24 111.0 179.909 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 110.393 -0.225 . . . . 61.4 110.393 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.3 -39.82 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 126.061 1.745 . . . . 73.22 113.938 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 66' ' ' THR . 19.0 t -70.7 -54.24 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.021 0.529 . . . . 62.33 110.461 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 8.5 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.197 0.935 . . . . 41.23 111.021 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -65.96 -47.43 74.65 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.232 -0.894 . . . . 42.4 110.716 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.8 78.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 72.21 111.572 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -64.75 -48.84 73.1 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.36 1.064 . . . . 71.41 110.85 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 23.1 mt-30 -67.68 -37.55 82.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.521 0.729 . . . . 72.13 110.352 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.25 97.01 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.03 0.932 . . . . 73.0 111.029 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.46 11.69 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.345 1.028 . . . . 63.02 110.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -60.33 -39.74 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 124.222 0.951 . . . . 72.3 110.597 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.18 93.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.975 0.91 . . . . 75.14 112.305 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.76 -45.8 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.881 0.873 . . . . 72.54 110.161 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.66 -34.46 75.75 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.985 0.514 . . . . 73.25 112.01 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -64.69 -38.07 89.76 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.551 0.532 . . . . 64.32 110.055 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.8 -38.49 76.66 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.754 0.659 . . . . 42.22 110.766 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -58.4 -36.78 74.08 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.52 0.728 . . . . 72.5 112.717 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -102.14 -16.28 16.43 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.863 0.465 . . . . 52.12 112.115 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.19 78.54 5.26 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.351 0.661 . . . . 51.02 109.354 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.54 -4.64 15.72 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.699 2.266 . . . . 74.24 112.733 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 p -77.2 -12.9 60.0 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.834 1.254 . . . . 74.35 112.062 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.78 113.12 19.91 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 122.622 0.369 . . . . 64.42 111.031 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.17 -18.11 18.64 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.845 2.363 . . . . 63.24 113.396 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.29 -44.89 24.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.152 0.581 . . . . 75.44 110.329 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.39 -50.1 74.95 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.114 -0.948 . . . . 64.1 110.841 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.412 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.4 pt20 -72.9 -23.61 60.73 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.673 -0.694 . . . . 62.42 112.129 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.19 -44.35 53.73 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.68 0.392 . . . . 75.33 111.319 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.21 -31.99 72.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.775 -0.454 . . . . 72.53 109.775 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 35' ' ' LEU . 97.7 mt -66.12 -29.36 69.65 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.814 0.845 . . . . 63.22 111.852 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.46 -31.95 71.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.709 0.804 . . . . 72.43 110.674 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -84.68 -43.27 14.5 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.282 -0.872 . . . . 61.2 111.137 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 8.8 pt -96.84 -37.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.96 0.504 . . . . 71.44 112.302 -168.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -104.52 174.04 6.05 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.962 0.905 . . . . 72.11 108.912 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 102' ' ' ARG . 9.0 p -68.78 136.67 90.1 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.337 -0.616 . . . . 73.14 109.337 169.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.07 -22.64 19.57 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.143 2.562 . . . . 73.13 114.735 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -60.6 -40.4 91.68 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.193 0.997 . . . . 71.05 111.289 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.66 -54.56 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 63.14 111.268 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 28' ' ' GLN . 2.8 pp -64.06 -32.46 74.02 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.558 0.218 . . . . 65.13 111.05 -176.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.96 -34.03 75.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.14 0.976 . . . . 74.2 111.714 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -85.38 -36.56 20.64 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.801 0.44 . . . . 63.43 110.998 174.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.4 -39.88 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.458 0.703 . . . . 61.43 111.49 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -67.77 -21.93 65.23 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.335 0.654 . . . . 75.34 111.945 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -86.83 -44.8 11.44 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.059 0.943 . . . . 74.45 110.664 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -68.79 -24.39 64.41 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.224 0.609 . . . . 74.31 110.984 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.43 80.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.291 1.436 . . . . 71.01 111.557 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 97.2 mtt180 -62.25 -27.38 68.97 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.871 -1.513 . . . . 74.03 111.627 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.1 -40.49 74.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.146 0.578 . . . . 64.11 110.984 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -74.92 -31.87 61.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.64 0.776 . . . . 71.1 110.738 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.38 -40.6 93.68 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.109 -0.951 . . . . 61.21 111.087 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 55.8 mttp -59.05 -40.87 86.42 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.437 0.695 . . . . 75.5 111.049 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -72.3 -12.02 60.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.952 -1.022 . . . . 71.14 111.54 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.45 30.65 78.05 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.882 0.739 . . . . 75.14 113.336 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.3 mt -74.95 109.24 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.626 -0.879 . . . . 74.01 108.626 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -84.31 109.33 17.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 73.54 108.003 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 44.2 p90 -135.71 140.29 44.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.18 -0.674 . . . . 73.42 109.18 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -133.13 146.4 51.56 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.365 0.666 . . . . 74.23 109.775 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.32 116.03 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.724 1.265 . . . . 70.14 110.05 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -88.73 -54.92 3.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.518 0.675 . . . . 71.53 109.639 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tpm_? -139.08 127.06 22.32 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.847 -1.069 . . . . 74.14 109.13 -166.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.48 116.31 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.845 -1.169 . . . . 72.55 107.845 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.69 107.73 9.38 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.504 -0.925 . . . . 75.14 108.504 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -97.34 121.76 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.162 0.985 . . . . 74.31 109.89 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.6 m -130.23 127.79 40.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 65.33 108.563 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.5 HG21 HG22 ' A' ' 5' ' ' VAL . 32.8 p -88.4 154.44 20.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.229 0.612 . . . . 73.24 110.847 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -137.56 86.69 2.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.524 -1.287 . . . . 63.22 107.524 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.38 -101.08 0.79 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.857 -1.065 . . . . 52.42 111.918 -174.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.74 -11.99 14.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.105 0.962 . . . . 71.4 111.319 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.42 HG21 HH11 ' A' ' 93' ' ' ARG . 44.8 m -100.98 118.95 38.0 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.618 -0.512 . . . . 62.44 109.618 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 46.1 t -87.5 140.91 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.808 0.843 . . . . 74.21 109.935 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -123.96 100.95 6.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.923 0.889 . . . . 75.11 108.742 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.98 106.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.449 0.7 . . . . 71.42 109.355 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -86.06 106.22 17.06 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.723 -0.843 . . . . 74.11 108.723 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.4 p -129.63 116.52 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.835 0.854 . . . . 73.12 110.602 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -97.08 139.96 32.3 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.238 1.015 . . . . 71.13 109.32 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -135.02 142.61 46.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.796 0.838 . . . . 73.12 109.085 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -93.0 105.8 17.85 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.269 1.033 . . . . 64.51 109.351 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.09 105.39 15.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.495 -0.775 . . . . 63.24 110.091 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.7 m -102.19 106.7 17.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.502 1.121 . . . . 74.24 108.331 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 t -148.38 140.34 23.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.111 0.965 . . . . 60.13 109.591 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.3 25.66 73.58 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.106 0.402 . . . . 75.03 114.106 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.9 83.51 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.897 -0.391 . . . . 53.33 114.026 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -116.91 139.05 51.1 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.43 0.615 . . . . 71.3 111.052 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.5 m -100.73 144.31 29.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.357 1.063 . . . . 64.34 109.522 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.4 m -143.92 114.54 7.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.78 0.832 . . . . 64.21 109.575 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.85 101.03 5.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.757 -0.831 . . . . 73.32 108.757 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.5 m -102.92 124.88 49.27 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.547 1.139 . . . . 55.13 110.098 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.9 m -94.05 116.9 29.38 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.316 0.646 . . . . 71.21 110.242 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.34 127.84 53.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.164 -1.05 . . . . 73.43 108.164 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -110.06 100.47 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.552 -1.277 . . . . 60.42 107.552 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.76 105.88 17.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.07 -1.085 . . . . 72.51 108.07 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.42 HH11 HG21 ' A' ' 70' ' ' THR . 59.1 ttp85 -91.35 99.02 12.06 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.547 -1.206 . . . . 75.45 107.989 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 101' ' ' ILE . 88.2 m-85 -87.51 108.02 18.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.935 -0.765 . . . . 70.51 108.935 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 34.9 tt0 -98.16 133.15 42.99 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.442 -0.947 . . . . 72.13 108.442 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 25.6 m -84.06 142.66 13.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.166 0.508 . . . . 72.31 109.918 176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.32 104.62 14.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.343 -1.725 . . . . 75.25 106.343 167.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.07 -100.68 1.51 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.399 -0.819 . . . . 23.53 111.293 -172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -123.88 -0.55 8.47 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.936 0.894 . . . . 60.01 112.54 -171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -139.71 150.03 44.36 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.514 0.725 . . . . 70.12 110.314 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 18.3 mt -75.52 119.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.054 0.542 . . . . 72.41 110.176 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 36' ' ' SER . 44.3 mmt-85 -131.18 14.98 5.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.042 0.937 . . . . 44.14 110.627 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 39.0 ttm105 -150.53 137.98 19.64 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 122.649 0.38 . . . . 63.44 110.114 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.96 119.7 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.271 1.028 . . . . 44.52 108.605 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 m -112.26 104.26 12.44 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.912 -1.144 . . . . 71.2 107.912 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.78 107.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.17 -0.678 . . . . 75.42 109.17 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 m -94.31 104.21 16.21 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.51 -0.922 . . . . 71.51 108.51 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -86.97 123.57 32.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.112 -1.07 . . . . 65.13 108.112 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 123.414 0.685 . . . . 70.05 111.108 -176.152 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 110.192 -0.299 . . . . 73.11 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.614 HG23 HG11 ' A' ' 96' ' ' VAL . 44.5 mm -86.21 -52.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.806 1.242 . . . . 71.21 111.047 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.43 -40.93 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.835 0.854 . . . . 71.13 110.508 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.06 -56.21 23.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.157 . . . . 75.5 110.984 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.4 70.05 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.061 0.851 . . . . 53.43 111.432 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -72.41 -48.28 42.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.585 0.754 . . . . 71.3 111.694 177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.43 -46.32 70.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.431 -0.804 . . . . 64.24 111.093 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.94 -39.78 93.28 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.638 0.775 . . . . 61.33 110.559 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.616 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -58.78 -50.44 73.93 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 123.807 0.692 . . . . 62.12 111.317 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -54.72 42.74 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 124.218 0.949 . . . . 50.52 112.167 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.05 -39.78 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.88 0.872 . . . . 73.21 110.943 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.98 70.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.526 0.73 . . . . 71.12 112.617 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 63.6 mt -61.73 -38.39 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.501 0.72 . . . . 74.3 110.28 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.05 -34.03 61.79 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.002 0.521 . . . . 74.24 111.254 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.07 -21.39 64.08 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.249 0.62 . . . . 74.33 111.38 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.13 -36.28 21.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.386 0.274 . . . . 71.34 110.59 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 41.0 m0 -63.46 -27.32 69.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.64 -27.5 21.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.099 0.56 . . . . 64.34 111.467 173.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -158.43 93.41 1.99 Allowed Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.398 0.679 . . . . 73.44 109.75 -177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -16.83 56.12 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.543 2.829 . . . . 71.31 113.857 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 p -97.04 11.71 35.18 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.908 0.883 . . . . 74.35 111.454 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.45 114.59 29.29 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 109.177 -0.675 . . . . 65.12 109.177 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.25 -33.24 11.62 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.411 2.074 . . . . 71.35 112.531 -168.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.86 -48.28 59.44 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.482 0.713 . . . . 71.53 111.114 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -58.76 -50.84 72.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.631 0.772 . . . . 62.14 111.587 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.51 -29.98 62.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.412 0.523 . . . . 61.21 112.412 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.44 -36.64 71.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.813 0.279 . . . . 74.54 111.313 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.5 pp -70.61 -34.53 72.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 75.13 109.602 175.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 35' ' ' LEU . 85.6 mt -66.67 -22.51 66.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.751 0.821 . . . . 64.52 111.716 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.29 -29.87 61.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.964 0.506 . . . . 60.32 110.477 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.27 -42.84 9.11 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.769 0.828 . . . . 73.23 111.803 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 30' ' ' LEU . 19.8 pt -95.12 -21.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.843 0.457 . . . . 62.33 111.519 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.616 HD11 ' HB1' ' A' ' 11' ' ' ALA . 44.3 mt -122.84 -176.63 3.45 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.933 -0.766 . . . . 73.43 108.933 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -75.97 148.08 81.25 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.319 0.648 . . . . 73.11 110.514 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.26 -20.27 46.47 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.97 2.447 . . . . 73.05 113.044 171.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.26 -40.05 89.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.398 1.079 . . . . 73.5 111.237 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG11 HD13 ' A' ' 35' ' ' LEU . 57.3 t -64.05 -51.45 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.798 0.439 . . . . 74.02 111.065 -173.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.64 -27.88 69.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.77 0.319 . . . . 72.02 111.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.81 -28.76 55.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.16 0.984 . . . . 73.34 112.252 -175.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -85.45 -33.06 21.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 110.088 -0.338 . . . . 65.11 110.088 174.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 55.1 t -65.75 -41.95 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.834 0.854 . . . . 74.11 111.209 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -63.47 -22.61 66.98 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.037 0.535 . . . . 74.34 111.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -80.33 -48.41 13.02 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.549 0.74 . . . . 73.31 110.398 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.74 -19.85 64.36 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.046 0.939 . . . . 74.32 111.805 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -53.72 -56.72 14.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.554 1.142 . . . . 63.25 112.824 173.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -18.28 65.24 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.641 0.588 . . . . 64.31 112.379 -173.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.67 -51.94 50.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.721 -0.474 . . . . 63.52 109.721 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -78.4 -33.52 48.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.669 0.787 . . . . 73.33 110.954 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -67.43 -38.19 84.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.228 1.011 . . . . 72.02 111.091 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.53 -42.49 95.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.4 0.68 . . . . 73.41 110.221 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -65.79 -24.2 66.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.241 -0.89 . . . . 75.03 110.703 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.77 33.73 45.69 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.958 -0.564 . . . . 65.22 111.995 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 65.8 mt -73.49 110.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.678 0.791 . . . . 72.02 109.668 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -89.88 107.67 19.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.524 -1.287 . . . . 72.12 107.524 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 18.5 p90 -112.24 123.96 51.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.581 -0.896 . . . . 73.11 108.581 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -111.47 130.39 55.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.246 0.618 . . . . 71.42 109.364 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.25 108.53 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.043 -0.725 . . . . 63.25 109.043 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' A' ' 78' ' ' GLU . 31.3 mmmt -78.03 -45.74 22.86 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.873 0.869 . . . . 65.32 109.775 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -167.48 125.34 1.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.812 0.845 . . . . 72.51 109.768 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.07 109.82 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.736 0.814 . . . . 54.34 110.173 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -104.86 143.01 33.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 72.01 108.852 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' VAL . 2.9 p -140.92 125.74 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.02 0.928 . . . . 72.45 109.881 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -140.24 139.2 35.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.058 0.943 . . . . 71.35 109.459 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.8 p -89.51 157.74 17.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.357 0.663 . . . . 60.34 111.547 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -160.84 84.78 0.68 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.403 1.081 . . . . 74.3 109.282 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.36 -116.49 8.84 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.831 -0.622 . . . . 70.21 113.445 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.22 11.88 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.276 0.63 . . . . 54.11 111.247 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.91 155.29 50.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.446 0.698 . . . . 74.25 109.773 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -137.33 120.25 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.699 0.799 . . . . 70.43 109.319 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.04 109.57 21.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.276 1.03 . . . . 75.32 109.648 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 64' ' ' VAL . 48.2 t -98.22 105.73 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.998 -0.742 . . . . 62.12 108.998 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.6 m -96.28 102.32 14.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.871 -1.159 . . . . 64.42 107.871 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.73 113.82 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.966 0.907 . . . . 71.34 109.159 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.24 126.17 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.894 0.877 . . . . 73.31 108.923 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.84 163.24 16.48 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.886 0.874 . . . . 53.21 108.783 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 32.6 tt0 -122.65 101.69 7.62 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.701 -1.222 . . . . 74.1 107.701 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 31.6 mt-10 -86.66 139.98 30.25 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.281 1.032 . . . . 73.42 110.15 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 11.9 m -119.62 102.94 8.98 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 73.22 108.55 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 t -118.2 120.39 37.54 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.998 0.919 . . . . 62.13 110.079 -173.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.52 -93.46 0.46 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.769 -0.651 . . . . 61.14 112.602 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -141.44 19.16 2.63 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.24 0.447 . . . . 64.24 112.072 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.9 p -124.01 145.37 49.24 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.183 0.993 . . . . 64.13 108.99 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 m -116.39 104.27 11.29 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.181 -1.044 . . . . 63.23 108.181 177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.0 m -102.02 119.19 38.39 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.48 1.112 . . . . 75.21 109.399 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 28.5 t-20 -77.68 101.2 6.51 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.296 -1.002 . . . . 73.42 108.296 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.0 m -113.05 124.25 52.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.241 1.016 . . . . 74.55 109.884 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 109' ' ' ASN . 27.5 m -87.01 141.02 28.97 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.276 -0.639 . . . . 74.23 109.276 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -119.28 127.13 52.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.554 1.142 . . . . 74.11 108.72 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -105.7 103.21 12.67 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.232 -1.025 . . . . 34.1 108.232 176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.46 105.2 17.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 53.15 108.015 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 36.3 ttm-85 -100.0 108.64 20.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.188 -0.914 . . . . 62.01 108.659 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HB3' HG12 ' A' ' 101' ' ' ILE . 94.8 m-85 -99.85 111.73 24.03 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.925 0.89 . . . . 71.2 110.943 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 103' ' ' ARG . 7.3 mp0 -80.14 112.21 17.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.742 -0.836 . . . . 72.13 108.742 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 4' ' ' ILE . 2.0 m -83.19 141.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.752 0.821 . . . . 61.12 109.69 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -140.82 117.0 10.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.411 -0.959 . . . . 71.44 108.411 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.34 -99.21 1.43 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.632 -0.587 . . . . 71.41 111.632 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -122.26 -16.96 7.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.089 0.955 . . . . 73.11 110.997 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -140.38 165.22 28.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.706 0.402 . . . . 74.42 110.573 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 96' ' ' VAL . 2.6 mp -76.98 134.12 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.101 0.56 . . . . 70.11 109.81 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -123.47 5.57 8.99 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.35 1.06 . . . . 74.21 111.602 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 21.3 tpt180 -154.67 129.79 9.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.772 -0.455 . . . . 73.42 109.772 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.92 149.3 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.072 0.949 . . . . 74.41 109.322 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.8 m -131.17 106.79 8.57 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.351 -0.981 . . . . 62.33 108.351 171.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.77 105.04 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.725 -0.843 . . . . 61.31 108.725 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -116.17 105.78 12.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.54 0.736 . . . . 72.31 109.068 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -73.1 105.06 4.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.637 -0.875 . . . . 61.13 108.637 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 24.7 t-20 . . . . . 0 CA--C 1.55 0.955 0 C-N-CA 123.686 0.794 . . . . 70.04 110.292 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 108.394 -0.965 . . . . 62.4 108.394 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 HG12 ' A' ' 96' ' ' VAL . 43.5 mm -74.02 -34.19 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.117 0.967 . . . . 60.22 112.121 -168.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.26 -42.24 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.454 0.702 . . . . 63.34 109.537 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.49 -35.94 70.95 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.026 -0.988 . . . . 74.33 110.412 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -64.27 -40.67 96.44 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.244 0.618 . . . . 75.45 110.447 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.66 76.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.747 0.819 . . . . 64.23 110.956 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 64' ' ' VAL . 87.2 tttt -63.13 -56.88 13.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.455 -0.793 . . . . 63.13 110.504 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.41 -23.2 65.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.047 0.539 . . . . 64.14 111.077 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -49.4 64.58 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 123.721 0.638 . . . . 50.12 110.115 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.11 83.25 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.173 0.921 . . . . 71.15 110.906 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HE21 ' A' ' 17' ' ' GLN . 74.1 mt -61.51 -40.24 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.327 1.051 . . . . 72.23 111.085 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.7 61.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.403 0.681 . . . . 62.11 111.983 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.02 -37.47 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.485 0.714 . . . . 75.21 109.239 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -73.11 -35.16 66.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.09 0.556 . . . . 73.3 111.054 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.483 HE21 HG22 ' A' ' 13' ' ' ILE . 77.1 mt-30 -61.43 -37.39 83.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.354 0.662 . . . . 74.23 110.464 174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 mt -73.26 -40.82 64.3 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 123.759 0.662 . . . . 64.1 110.532 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -59.69 -27.8 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.421 0.526 . . . . 71.23 112.421 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 -14.33 17.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.169 0.588 . . . . 71.45 111.815 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -159.58 89.9 1.93 Allowed Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 123.42 0.688 . . . . 72.5 110.381 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.32 -22.33 73.95 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.374 2.716 . . . . 52.44 113.193 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -92.16 11.48 25.4 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.66 0.784 . . . . 74.2 111.809 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.11 110.73 8.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.048 -0.723 . . . . 75.0 109.048 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.78 -38.54 23.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.468 2.112 . . . . 71.34 113.104 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.61 -40.16 73.32 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.31 0.644 . . . . 74.52 111.644 -172.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -61.74 -56.85 15.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.025 0.828 . . . . 63.44 110.783 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.9 -24.64 66.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.507 0.723 . . . . 75.3 111.661 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.45 -46.83 65.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.809 0.443 . . . . 55.35 111.254 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.93 -30.56 67.99 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 110.288 -0.264 . . . . 64.24 110.288 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 35' ' ' LEU . 83.2 mt -66.99 -28.19 68.05 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.424 0.69 . . . . 55.43 111.571 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -71.52 -25.39 62.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.999 0.428 . . . . 74.31 110.109 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -85.62 -41.3 15.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.636 0.774 . . . . 70.25 111.598 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 7' ' ' ALA . 9.4 pt -103.64 -17.32 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.123 0.569 . . . . 63.21 112.23 -170.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -123.43 174.61 7.26 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.026 0.93 . . . . 60.1 108.681 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.8 m -68.98 141.89 92.65 Favored Pre-proline 0 CA--C 1.561 1.404 0 N-CA-C 109.949 -0.389 . . . . 41.2 109.949 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.36 -20.01 14.29 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.997 2.464 . . . . 73.03 114.514 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.08 -37.23 66.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 72.33 111.796 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -64.03 -41.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.843 0.857 . . . . 62.4 111.386 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.59 -28.02 60.73 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.943 0.402 . . . . 43.51 111.358 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.32 -27.89 62.72 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.872 -1.058 . . . . 53.2 111.224 -172.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.65 -32.72 23.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.746 0.418 . . . . 74.41 111.077 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' VAL . 55.3 t -64.21 -40.21 88.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 123.337 0.655 . . . . 72.22 110.758 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -67.59 -24.89 65.54 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.597 0.56 . . . . 74.53 111.535 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.29 -48.44 14.13 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.487 0.715 . . . . 73.34 110.255 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -62.63 -28.06 69.65 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.507 1.123 . . . . 71.35 110.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.05 -35.29 80.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.302 -1.317 . . . . 75.4 112.65 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -65.62 -27.46 68.41 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.665 0.786 . . . . 75.04 111.469 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.3 -48.67 32.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.678 0.791 . . . . 72.44 109.894 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.03 -30.3 69.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.839 0.856 . . . . 72.02 110.859 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -66.61 -47.35 72.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.03 1.332 . . . . 75.34 109.677 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.69 -31.58 72.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.241 -0.89 . . . . 65.41 110.845 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.15 -25.62 39.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.512 0.725 . . . . 62.22 110.877 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.34 40.31 80.59 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.377 0.423 . . . . 62.31 113.179 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.13 110.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.266 0.626 . . . . 73.5 109.396 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -94.55 106.63 18.62 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.099 -0.704 . . . . 63.23 109.099 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 7.3 p90 -112.38 143.07 44.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.534 0.734 . . . . 74.13 109.253 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -130.23 129.03 42.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.978 0.511 . . . . 71.33 109.767 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.94 101.37 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.551 0.741 . . . . 63.11 109.245 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.53 -27.27 19.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.971 0.908 . . . . 75.31 110.332 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.8 tpp180 -145.29 146.79 31.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.164 -1.05 . . . . 75.42 108.164 176.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.58 118.62 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.598 0.759 . . . . 74.32 109.013 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.97 105.76 10.6 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.96 -1.126 . . . . 71.04 107.96 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 73' ' ' VAL . 84.6 t -99.9 108.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.567 -1.272 . . . . 53.33 107.567 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -124.37 126.1 45.42 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.337 -0.616 . . . . 61.12 109.337 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 HG22 ' A' ' 71' ' ' VAL . 1.4 m -89.45 113.18 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.587 -0.894 . . . . 71.34 108.587 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -110.02 91.59 3.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.781 1.232 . . . . 54.54 107.812 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.7 -110.06 3.17 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 114.869 -1.06 . . . . 73.11 112.101 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.76 23.75 13.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.585 0.754 . . . . 51.51 110.379 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.6 m -134.88 122.6 22.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.157 0.583 . . . . 75.44 110.285 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 66' ' ' THR . 30.0 t -88.68 111.1 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.046 0.538 . . . . 71.33 109.606 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -97.94 104.59 16.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.704 0.802 . . . . 64.3 109.427 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 64' ' ' VAL . 78.0 t -89.29 103.68 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.203 -0.666 . . . . 70.31 109.203 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.9 m -99.02 103.3 15.23 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.0 -1.111 . . . . 63.24 108.0 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.05 128.9 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.441 0.696 . . . . 72.44 110.214 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 6.9 tp10 -92.77 111.96 23.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.08 1.352 . . . . 73.15 109.548 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 4.9 mp -109.51 118.81 37.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.605 -0.887 . . . . 60.11 108.605 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 26.1 tt0 -88.24 101.61 14.01 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.173 -1.418 . . . . 64.23 107.173 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 28.0 mt-10 -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.344 1.058 . . . . 73.34 110.588 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.3 m -125.05 111.09 14.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.861 -1.162 . . . . 70.3 107.861 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.9 t -132.36 131.25 41.69 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.483 -0.932 . . . . 73.52 108.483 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.6 -78.56 0.47 Allowed Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.48 -0.648 . . . . 65.3 111.48 -172.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.91 10.68 0.11 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 123.529 0.585 . . . . 72.14 111.959 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.4 p -98.67 126.91 44.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.077 0.951 . . . . 64.32 109.636 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.4 m -116.44 108.33 15.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.74 0.816 . . . . 64.13 110.181 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.0 m -131.74 139.53 48.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.012 0.925 . . . . 70.21 110.395 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 51.6 m-80 -77.69 115.72 17.67 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.128 0.571 . . . . 72.12 109.597 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -116.65 121.39 41.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.304 1.042 . . . . 52.32 108.644 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 19.1 m -88.99 122.76 32.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.976 -0.379 . . . . 75.05 109.976 -176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -106.84 126.07 51.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.895 -0.779 . . . . 75.12 108.895 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.8 103.4 12.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.987 -1.116 . . . . 62.53 107.987 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.13 106.68 18.71 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.701 -1.222 . . . . 54.01 107.701 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 39.5 ttm180 -93.3 99.93 12.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.26 1.024 . . . . 74.22 110.113 -175.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.429 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.1 m-85 -91.42 109.67 20.96 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.746 0.819 . . . . 72.44 110.157 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 40.5 tt0 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.248 -0.649 . . . . 74.3 109.248 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.429 HG12 HG21 ' A' ' 4' ' ' ILE . 2.3 m -84.94 149.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.461 0.704 . . . . 73.41 110.134 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -154.58 103.3 2.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 53.12 108.81 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 -118.39 5.04 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.748 -0.541 . . . . 60.44 111.748 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.37 20.37 13.65 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 71.23 109.832 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -139.22 168.44 19.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.305 1.042 . . . . 75.54 109.199 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 35' ' ' LEU . 65.1 mt -108.17 127.78 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.979 0.912 . . . . 71.32 108.726 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -115.06 5.46 14.94 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.257 0.623 . . . . 73.31 112.435 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.8 ttp85 -153.53 134.91 14.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 110.576 -0.157 . . . . 63.53 110.576 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 129.68 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.289 1.036 . . . . 64.11 109.056 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.3 m -116.68 104.61 11.55 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.522 -0.918 . . . . 72.21 108.522 176.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.37 117.28 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.773 -0.825 . . . . 64.31 108.773 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 m -117.66 106.3 12.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.911 0.484 . . . . 74.31 109.812 -171.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.12 122.46 25.65 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.131 0.572 . . . . 74.11 109.536 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.7 m-80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.041 . . . . 75.04 109.21 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.937 0.399 . . . . 61.24 110.754 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -99.1 -6.1 28.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.58 0.752 . . . . 74.12 109.232 164.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.41 57.58 4.36 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.023 1.329 . . . . 73.22 109.877 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.492 HG21 HG11 ' A' ' 96' ' ' VAL . 46.8 mm -71.37 -32.91 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.955 -1.02 . . . . 72.21 110.533 -174.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.25 -46.55 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.458 0.703 . . . . 64.31 110.02 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -46.51 83.4 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.55 109.218 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.92 79.16 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.033 -0.985 . . . . 74.13 111.596 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.12 -36.32 74.73 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.05 0.54 . . . . 64.43 111.242 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.516 ' HB2' HG11 ' A' ' 64' ' ' VAL . 81.3 tttt -60.44 -55.39 34.06 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 123.837 0.711 . . . . 54.11 109.58 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.8 -35.9 75.63 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.983 -1.008 . . . . 70.43 111.148 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -65.11 -49.12 71.2 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 124.142 0.901 . . . . 74.41 110.693 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.68 -52.62 64.37 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 123.993 0.808 . . . . 73.11 110.854 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.439 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 59.2 mt -62.01 -39.95 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 123.965 0.791 . . . . 44.31 110.323 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.24 75.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.605 0.762 . . . . 54.33 112.142 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.37 -43.43 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.316 0.646 . . . . 64.45 109.866 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.16 -29.99 69.0 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.849 0.46 . . . . 74.23 111.303 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 26.7 mt-30 -66.93 -33.58 75.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.862 0.465 . . . . 75.22 110.47 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.3 mt -73.42 -35.71 65.86 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.235 0.335 . . . . 70.22 110.936 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -62.86 -31.04 71.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.691 0.397 . . . . 72.13 111.896 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -92.75 -30.6 15.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.022 0.529 . . . . 63.43 110.904 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -158.39 87.37 2.36 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 123.461 0.705 . . . . 74.11 109.787 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.07 -3.66 12.67 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.266 2.644 . . . . 55.33 113.959 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -95.83 7.5 46.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.112 0.965 . . . . 64.31 111.498 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.53 118.07 47.18 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.66 -0.686 . . . . 61.13 109.927 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.88 -39.33 20.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.831 2.354 . . . . 73.32 113.009 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.77 -47.61 58.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.049 0.54 . . . . 72.43 110.089 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.65 -56.28 23.9 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 114.723 -1.126 . . . . 34.43 111.304 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.24 -34.93 77.46 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.094 0.558 . . . . 75.43 111.418 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.36 -51.79 27.3 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.132 0.573 . . . . 75.11 110.748 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -63.11 -38.7 92.22 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.815 0.697 . . . . 73.21 109.827 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.81 -35.87 77.6 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.79 0.836 . . . . 64.2 111.265 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -73.08 -28.87 62.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.074 0.55 . . . . 54.2 110.75 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -81.86 -41.94 20.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 72.25 111.628 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 30' ' ' LEU . 9.8 pt -100.16 -38.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.04 0.536 . . . . 64.14 112.29 -169.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD13 HG11 ' A' ' 39' ' ' VAL . 45.6 mt -98.45 178.24 5.09 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.092 -0.707 . . . . 63.34 109.092 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.563 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.0 m -68.67 144.83 96.55 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.205 -0.452 . . . . 63.0 110.347 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' A' ' 40' ' ' LEU . 36.1 Cg_exo -59.54 -22.79 68.25 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.698 2.265 . . . . 75.12 112.456 173.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.43 -37.16 86.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.452 1.101 . . . . 74.3 110.903 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.9 t -67.8 -49.97 64.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 123.475 0.71 . . . . 62.11 111.344 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 pp -59.9 -33.76 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 120.832 0.348 . . . . 71.13 110.396 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 30.2 t70 -71.68 -51.62 22.08 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.042 -0.981 . . . . 71.14 110.167 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -62.94 -32.89 74.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.244 0.218 . . . . 51.44 111.348 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.43 -49.18 79.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 CA-C-O 118.982 -0.532 . . . . 74.35 110.401 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -67.1 -31.3 71.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.464 0.477 . . . . 74.11 111.843 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 16.5 mm-40 -62.5 -51.8 66.01 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.319 0.581 . . . . 74.43 110.104 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 44.1 m80 -72.97 -24.34 60.77 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.954 -1.021 . . . . 71.23 111.278 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.95 93.19 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.175 0.99 . . . . 74.43 110.926 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.2 -34.95 77.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.406 -0.816 . . . . 63.11 110.825 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.68 -39.26 62.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.732 0.813 . . . . 72.23 111.099 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 84.7 mt -74.5 -29.97 61.63 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.758 . . . . 72.45 110.654 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -69.49 -39.05 77.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.835 0.854 . . . . 72.3 109.912 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -75.18 -24.65 57.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.771 0.828 . . . . 73.2 110.876 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.88 -36.5 80.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.09 30.43 31.34 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.528 -0.76 . . . . 62.24 111.99 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.85 98.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 109.073 -0.714 . . . . 74.31 109.073 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -84.02 109.57 17.76 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.45 -1.315 . . . . 71.43 107.45 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.0 p90 -111.08 161.45 15.9 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.283 -1.006 . . . . 64.11 108.283 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.53 113.13 7.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.844 -1.169 . . . . 73.2 107.844 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.25 108.42 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.112 0.965 . . . . 63.14 110.133 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -91.59 -50.87 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.147 0.579 . . . . 72.35 111.189 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -137.35 134.56 36.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.892 . . . . 74.52 109.037 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -125.77 118.54 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.809 -1.182 . . . . 74.03 107.809 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.78 107.5 9.71 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.874 -0.788 . . . . 73.24 108.874 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' VAL . 7.4 p -103.61 134.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.995 0.518 . . . . 61.03 109.763 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -149.53 166.18 29.97 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.1 0.96 . . . . 65.24 109.085 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 p -96.67 151.78 19.29 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.325 0.583 . . . . 73.2 110.297 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.32 83.07 1.81 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 106.492 -1.67 . . . . 65.24 106.492 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.91 -115.05 7.12 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.493 -1.23 . . . . 43.35 111.377 -168.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -96.11 -14.66 22.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.101 0.561 . . . . 73.31 110.765 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 m -96.58 121.44 38.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.595 0.758 . . . . 70.55 109.642 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.7 p -89.31 126.57 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 120.981 0.42 . . . . 73.21 110.187 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 72' ' ' ASN . 0.9 OUTLIER -107.64 130.6 54.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.467 0.707 . . . . 70.44 109.939 -177.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 64' ' ' VAL . 21.7 t -112.05 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.999 -0.741 . . . . 65.04 108.999 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -89.39 104.59 17.13 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.646 -0.872 . . . . 75.03 108.646 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.32 120.33 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.837 0.855 . . . . 73.02 109.709 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -89.83 127.94 36.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.766 0.826 . . . . 74.42 108.992 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -127.63 140.5 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.216 0.606 . . . . 72.21 109.393 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -89.42 112.13 23.18 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.021 -1.103 . . . . 70.15 108.021 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.7 mt-10 -101.38 114.83 29.18 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.309 0.643 . . . . 64.14 109.44 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m -87.75 103.28 15.47 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.066 -1.087 . . . . 64.4 108.066 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -140.12 133.88 30.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.74 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.75 16.16 74.11 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.708 -0.678 . . . . 75.45 113.358 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.53 84.55 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.048 0.356 . . . . 73.44 113.185 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -108.4 121.75 45.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.585 0.754 . . . . 71.31 110.371 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.6 m -87.69 116.89 26.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.535 -0.913 . . . . 73.41 108.535 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.3 t -127.22 152.86 46.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.34 0.656 . . . . 73.03 109.749 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -80.06 133.11 36.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.56 -0.533 . . . . 53.33 109.56 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 m -142.59 111.13 6.18 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.779 -1.193 . . . . 72.03 107.779 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -91.02 121.78 33.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.218 0.607 . . . . 70.32 109.562 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.58 125.85 49.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -109.93 102.32 11.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.728 -1.212 . . . . 73.35 107.728 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.1 mp -89.08 105.72 17.97 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.292 -1.373 . . . . 75.55 107.292 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 15.3 ttt180 -101.16 97.64 8.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.713 -1.217 . . . . 73.25 107.713 -170.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' ILE . 99.1 m-85 -88.49 109.48 20.08 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.445 0.698 . . . . 74.21 109.596 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 6.5 tm-20 -86.86 119.37 27.01 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.449 -1.315 . . . . 74.31 107.449 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 101' ' ' ILE . 3.0 m -97.08 150.93 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.091 0.956 . . . . 71.34 111.646 -168.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.12 99.93 4.41 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.385 1.074 . . . . 74.02 109.089 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.37 -99.47 0.73 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.662 -0.699 . . . . 74.13 112.734 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -107.76 -20.62 13.15 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.567 0.747 . . . . 74.55 110.849 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -128.04 153.31 46.92 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.654 0.782 . . . . 73.01 110.662 -170.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 94' ' ' PHE . 72.6 mt -95.1 130.75 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.878 0.871 . . . . 71.25 109.588 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 9.5 mmt180 -102.62 -35.36 8.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.099 0.56 . . . . 74.1 111.288 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.9 mtt85 -127.51 145.18 50.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.794 -0.639 . . . . 54.53 109.592 -167.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.84 123.7 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.226 1.011 . . . . 74.24 108.952 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 12.6 m -109.25 103.22 12.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.255 -1.017 . . . . 73.24 108.255 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.12 106.53 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.413 -0.958 . . . . 72.4 108.413 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.1 m -100.26 105.03 16.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.375 0.67 . . . . 74.11 109.334 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -87.49 92.04 8.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.92 0.488 . . . . 62.42 109.734 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -96.38 163.12 13.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.214 1.006 . . . . 73.31 110.123 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.49 101.05 0.18 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.238 -1.145 . . . . 44.43 110.238 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.49 167.49 35.13 Favored Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.868 -0.493 . . . . 72.34 111.868 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.0 m -90.52 82.08 5.89 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.469 0.652 . . . . 64.31 111.077 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.66 -16.43 14.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.947 0.899 . . . . 71.21 109.432 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -167.09 1.27 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.818 1.247 . . . . 74.31 112.283 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -128.62 97.51 4.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.849 0.86 . . . . 61.13 109.862 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 46.28 65.08 1.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.357 1.863 . . . . 71.35 112.584 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -70.52 117.66 12.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.611 -0.722 . . . . 75.21 109.918 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -64.09 113.24 3.39 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.431 -0.952 . . . . 70.35 108.431 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.31 -87.08 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.652 0.381 . . . . 62.24 110.572 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 -168.728 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 108.481 -0.933 . . . . 75.41 108.481 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -168.1 -177.24 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.067 -1.086 . . . . 73.42 108.067 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -42.64 119.03 1.34 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.247 1.419 . . . . 73.34 112.976 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.448 HG21 HG11 ' A' ' 96' ' ' VAL . 47.2 mm -72.8 -29.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.638 1.175 . . . . 75.53 111.957 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.98 -56.56 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 71.02 110.703 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.97 -34.5 69.0 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.802 -0.636 . . . . 61.52 110.804 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -57.25 -50.65 72.23 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.549 0.531 . . . . 72.12 110.455 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.98 -32.07 68.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.505 0.722 . . . . 55.33 112.37 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.18 -58.37 8.62 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.719 0.637 . . . . 71.34 110.154 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.92 -30.27 71.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.997 0.919 . . . . 65.14 111.141 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -62.61 -51.65 66.45 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 124.188 0.93 . . . . 74.13 110.531 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -59.43 -44.18 92.94 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 124.394 1.059 . . . . 72.44 112.357 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 62' ' ' VAL . 42.4 mt -66.73 -42.27 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.556 0.743 . . . . 62.11 109.965 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.3 -28.02 68.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.714 0.805 . . . . 74.12 112.051 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -60.89 -45.72 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.749 0.82 . . . . 74.44 109.909 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 42.3 m-85 -76.68 -29.43 56.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.276 -0.42 . . . . 73.35 112.011 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -60.59 -39.16 87.07 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.796 0.685 . . . . 74.21 110.054 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.6 -38.44 59.03 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.82 0.7 . . . . 65.1 111.176 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.539 ' HH2' HG11 ' A' ' 106' ' ' VAL . 28.2 m0 -62.88 -31.1 72.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.767 0.654 . . . . 71.01 112.767 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -95.97 -19.09 19.77 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.613 0.365 . . . . 64.23 111.204 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -158.04 88.33 2.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.412 0.685 . . . . 75.34 109.982 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.49 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.115 2.543 . . . . 64.15 113.242 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -91.56 10.66 27.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.271 1.028 . . . . 64.14 111.396 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.08 111.19 16.55 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 109.32 -0.622 . . . . 74.13 109.32 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 -44.85 7.03 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.651 2.234 . . . . 74.4 113.007 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.56 -27.72 58.71 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.274 0.472 . . . . 70.01 112.274 -171.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -62.85 -57.83 9.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.813 0.445 . . . . 73.53 110.532 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -66.66 -26.41 67.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.318 0.647 . . . . 64.21 111.937 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -67.09 -46.44 74.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.168 0.987 . . . . 74.42 110.987 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 4.2 pp -70.86 -34.27 71.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.796 -0.184 . . . . 73.31 110.719 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 93.1 mt -61.1 -28.93 69.44 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.667 0.787 . . . . 53.04 111.141 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.34 -24.95 63.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.932 0.893 . . . . 63.13 111.287 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -93.35 -44.81 8.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.666 0.786 . . . . 53.22 110.525 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 35' ' ' LEU . 11.8 pt -94.67 -30.45 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.435 0.694 . . . . 44.15 112.321 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD11 ' HB1' ' A' ' 11' ' ' ALA . 68.6 mt -110.21 175.14 5.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.324 0.65 . . . . 63.23 109.977 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.6 m -73.74 144.4 82.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.31 -0.859 . . . . 72.15 109.369 170.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 88.9 Cg_exo -52.16 -30.44 41.32 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 123.706 2.937 . . . . 73.14 114.285 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.9 -32.34 71.91 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.475 0.71 . . . . 73.11 111.482 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 36' ' ' SER . 40.4 t -70.29 -41.47 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.605 0.762 . . . . 54.14 110.987 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' PRO . 4.1 pp -72.57 -31.33 65.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.749 0.309 . . . . 53.42 110.76 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.6 t70 -65.28 -50.02 67.32 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.23 -0.896 . . . . 71.23 110.783 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.95 -32.52 72.96 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.286 0.366 . . . . 71.2 111.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 15' ' ' ILE . 47.0 t -63.38 -54.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.558 0.743 . . . . 71.24 111.219 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -67.14 -21.51 65.82 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.572 0.582 . . . . 75.44 112.572 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 12.1 mm-40 -80.35 -39.8 27.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.842 0.457 . . . . 60.04 111.344 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -73.92 -22.09 59.81 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.132 0.573 . . . . 75.24 110.698 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.68 94.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.96 1.304 . . . . 74.1 111.791 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.19 -20.96 65.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.498 -1.228 . . . . 61.22 112.024 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.98 -59.27 4.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.637 0.375 . . . . 75.41 110.219 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.31 -29.89 70.96 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.053 0.941 . . . . 72.32 111.443 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -59.51 -51.14 71.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.622 1.169 . . . . 52.23 110.672 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.62 -26.9 55.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.517 0.727 . . . . 61.41 111.885 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -74.39 -24.08 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.338 0.655 . . . . 72.25 110.07 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.19 23.96 77.15 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.469 -0.787 . . . . 61.22 113.309 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.4 mt -71.84 103.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.459 -0.941 . . . . 75.43 108.459 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -79.68 124.13 28.28 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.855 -0.794 . . . . 71.31 108.855 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.53 168.2 20.29 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.583 -0.895 . . . . 73.52 108.583 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -148.77 139.26 22.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 74.21 109.187 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 p -70.43 108.6 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.951 0.901 . . . . 71.54 109.363 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -95.53 -39.54 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.437 0.695 . . . . 73.34 111.909 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -151.07 134.29 16.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.617 0.367 . . . . 62.33 110.242 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 13' ' ' ILE . 41.0 t -125.94 116.16 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.879 0.872 . . . . 71.24 109.453 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -127.49 110.45 12.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.243 -1.021 . . . . 72.43 108.243 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 73' ' ' VAL . 2.7 p -96.55 114.45 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.251 0.62 . . . . 73.12 109.991 -173.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.9 m -109.19 135.85 49.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.765 1.226 . . . . 54.11 110.064 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 p -91.92 113.2 25.41 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.195 -0.668 . . . . 55.42 109.195 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.29 87.3 2.51 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.527 -0.916 . . . . 72.24 108.527 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.84 -123.13 12.62 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.361 -0.836 . . . . 54.31 111.139 -172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.34 -16.46 31.01 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.171 0.588 . . . . 61.54 110.538 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 95' ' ' GLU . 9.8 m -96.3 125.61 40.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.444 0.698 . . . . 75.01 109.473 -172.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 94' ' ' PHE . 6.5 p -95.54 115.57 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.746 0.784 . . . . 74.42 110.792 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -102.38 104.63 15.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.911 0.884 . . . . 65.44 109.117 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 64' ' ' VAL . 53.3 t -88.8 105.77 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.524 -0.547 . . . . 51.25 109.524 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.0 m -86.41 105.46 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.793 -0.817 . . . . 74.32 108.793 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.1 p -122.02 120.73 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.793 0.837 . . . . 71.11 110.759 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -86.42 129.31 34.9 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.913 0.885 . . . . 71.12 109.65 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.07 137.2 55.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.595 0.758 . . . . 62.21 109.02 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.46 105.49 17.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.183 -1.043 . . . . 74.41 108.183 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -97.36 115.16 27.19 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.428 0.691 . . . . 64.41 111.068 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -90.64 104.42 17.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.02 0.928 . . . . 44.31 108.673 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -124.57 122.22 36.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.263 1.025 . . . . 74.23 109.461 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.72 -88.18 0.36 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.19 0.424 . . . . 74.42 112.653 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.74 13.15 1.74 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.381 0.515 . . . . 73.31 112.256 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.6 p -116.67 139.66 50.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.826 0.851 . . . . 73.33 109.605 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -120.93 119.25 32.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.843 -1.169 . . . . 75.52 107.843 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.9 m -142.19 143.27 32.86 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.948 0.499 . . . . 74.22 110.151 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.64 102.96 8.27 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.723 0.809 . . . . 73.23 109.73 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.8 m -99.83 120.74 40.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.487 1.115 . . . . 74.02 108.743 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 m -89.41 127.52 35.84 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.448 -0.575 . . . . 70.25 109.448 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -107.44 126.5 52.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.653 -1.24 . . . . 75.42 107.653 170.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -108.56 103.28 12.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.509 -0.922 . . . . 65.41 108.509 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 12' ' ' ALA . 60.3 mt -90.0 104.71 17.25 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.373 1.069 . . . . 64.33 109.52 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 49.8 ttt85 -93.76 98.93 11.42 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.133 -0.691 . . . . 74.24 109.133 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.585 ' HB2' HG13 ' A' ' 71' ' ' VAL . 86.7 m-85 -87.52 116.49 25.67 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 9.2 tp10 -87.93 131.45 34.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 122.72 0.408 . . . . 55.04 110.114 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 101' ' ' ILE . 5.9 m -103.82 149.66 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.952 0.901 . . . . 54.35 110.32 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.456 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 17.3 t70 -141.38 111.08 6.51 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.599 -1.259 . . . . 61.03 107.599 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.96 -110.5 3.06 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.697 -0.683 . . . . 34.41 112.446 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -113.12 -6.26 13.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.113 0.965 . . . . 63.2 112.263 -171.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -135.82 165.66 25.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.064 0.546 . . . . 73.05 110.754 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 96' ' ' VAL . 71.0 mt -93.53 132.35 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.058 0.943 . . . . 64.32 109.3 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HE ' ' HB3' ' A' ' 97' ' ' ASP . 21.0 mmt180 -102.98 -28.43 12.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 73.51 111.182 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 48.9 ttt180 -145.53 154.12 41.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.69 0.396 . . . . 73.43 110.955 -166.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 39' ' ' VAL . 7.4 p -132.95 138.18 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 70.24 108.579 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.2 m -113.86 112.47 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.446 -0.946 . . . . 70.03 108.446 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HH2' ' A' ' 19' ' ' TRP . 47.8 t -86.92 104.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.045 -0.724 . . . . 73.33 109.045 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -103.84 105.84 16.17 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.9 -0.778 . . . . 61.33 108.9 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.22 95.62 6.99 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.179 -1.045 . . . . 72.22 108.179 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -69.7 113.77 7.28 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.982 -1.008 . . . . 64.14 109.41 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.21 -46.33 0.2 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.161 -0.775 . . . . 50.31 111.161 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.13 138.44 22.72 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.188 -0.765 . . . . 74.43 111.188 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -63.86 115.82 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.358 0.663 . . . . 61.4 110.689 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.34 -30.78 71.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.2 1.0 . . . . 61.32 110.548 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.45 155.79 20.87 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.047 0.939 . . . . 75.13 110.239 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -134.28 113.32 11.84 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.375 1.07 . . . . 55.04 108.248 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -132.64 144.38 50.31 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.056 0.542 . . . . 73.44 111.374 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -165.67 141.53 5.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.89 1.276 . . . . 75.4 108.678 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -84.0 -4.54 58.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.066 0.765 . . . . 75.41 113.066 -166.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.9 m170 74.69 -65.37 0.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.091 1.356 . . . . 73.33 110.674 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.892 -0.781 . . . . 60.42 108.892 173.372 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tpt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.404 -0.591 . . . . 75.34 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.85 -21.05 55.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.131 0.572 . . . . 73.51 111.501 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.3 73.01 5.93 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.66 0.784 . . . . 63.14 109.515 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.136 1.374 . . . . 63.54 112.478 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 66' ' ' THR . 40.6 t -59.88 -57.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.663 0.785 . . . . 74.51 110.12 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.72 -37.04 83.89 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.825 -1.08 . . . . 74.12 111.203 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.07 81.82 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.56 0.538 . . . . 50.0 111.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.95 95.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.886 -0.597 . . . . 54.32 111.528 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.2 -47.01 72.16 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.926 0.491 . . . . 73.32 111.664 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.58 -34.03 77.29 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.348 1.059 . . . . 75.25 110.783 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.75 81.63 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.101 -0.954 . . . . 72.24 110.755 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.24 82.42 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.257 0.973 . . . . 52.12 110.785 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 70.3 mt -59.29 -44.13 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 O-C-N 124.39 1.056 . . . . 73.14 109.799 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.06 77.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.157 0.983 . . . . 70.2 113.077 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.84 -39.75 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 73.04 109.974 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -76.7 -28.2 55.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.985 0.514 . . . . 74.24 111.807 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 95.6 mt-30 -68.81 -27.43 65.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.064 0.546 . . . . 74.21 110.559 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 69.1 mt -79.99 -43.76 21.42 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.833 0.453 . . . . 50.41 110.252 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -62.23 -25.03 67.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.939 0.718 . . . . 71.35 112.939 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -82.87 -33.24 27.06 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.133 0.492 . . . . 63.54 110.747 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -158.02 93.04 2.11 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.331 1.052 . . . . 73.04 108.289 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' A' ' 48' ' ' ARG . 19.1 Cg_endo -56.41 -27.12 66.35 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 123.559 2.84 . . . . 73.35 113.947 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -84.8 15.01 4.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.404 0.682 . . . . 72.02 111.85 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.55 111.05 8.23 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.94 -38.95 6.71 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.412 2.074 . . . . 73.44 112.593 -173.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.91 -41.41 95.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.61 0.764 . . . . 75.04 111.245 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.03 8.85 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.216 0.947 . . . . 74.01 111.76 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -70.62 -26.59 63.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.055 -0.521 . . . . 72.31 112.383 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.83 -40.25 63.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.922 0.489 . . . . 62.02 110.707 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 2.3 pp -70.68 -31.84 68.88 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 110.056 -0.35 . . . . 73.31 110.056 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.834 0.854 . . . . 73.23 111.524 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.98 -29.45 64.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.914 0.486 . . . . 64.15 110.647 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 26.3 mtpp -80.48 -42.84 21.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.973 0.909 . . . . 74.15 111.431 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.507 HG13 HD23 ' A' ' 35' ' ' LEU . 16.9 pt -107.22 -36.13 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.61 0.596 . . . . 60.11 112.61 -168.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 34' ' ' ILE . 2.3 mm? -99.43 179.23 4.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.996 0.918 . . . . 64.42 110.801 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -80.85 146.52 59.95 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 115.046 -0.979 . . . . 75.44 110.356 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -31.35 92.48 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.371 2.714 . . . . 53.34 114.031 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.62 -38.95 92.76 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.676 0.79 . . . . 74.21 111.153 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.97 -53.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.691 0.796 . . . . 64.45 111.437 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.51 -32.12 72.99 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.569 0.224 . . . . 72.12 111.035 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 18.2 t70 -71.27 -49.85 38.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 124.16 0.913 . . . . 74.33 110.893 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.59 -38.38 89.33 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.29 0.236 . . . . 71.42 111.449 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.2 -45.09 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.223 0.609 . . . . 61.23 111.477 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.0 ptm180 -72.57 -25.99 61.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.518 0.327 . . . . 75.22 111.228 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 53.8 mt-10 -69.8 -46.32 65.98 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.212 0.605 . . . . 75.55 110.933 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.37 -34.35 78.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.843 -0.617 . . . . 71.11 110.035 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -64.15 -31.44 72.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.493 1.117 . . . . 64.34 112.222 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HA ' ' HG3' ' A' ' 22' ' ' PRO . 70.4 mtp180 -63.28 -36.68 84.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.369 0.668 . . . . 45.43 110.31 174.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -74.6 -34.44 62.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.759 -0.655 . . . . 64.44 110.69 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 55' ' ' ILE . 74.9 mt -74.26 -23.68 59.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.381 0.672 . . . . 63.02 110.707 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -70.44 -43.09 70.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.179 0.992 . . . . 75.42 109.898 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.26 -41.85 94.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.722 0.809 . . . . 72.33 110.855 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.14 -29.26 62.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.042 -0.981 . . . . 71.1 111.022 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.98 46.41 59.44 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.556 0.535 . . . . 72.45 112.766 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 50' ' ' LEU . 58.7 mt -79.56 109.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.191 0.597 . . . . 63.24 109.933 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -91.47 119.99 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.148 -1.056 . . . . 74.32 108.148 173.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.7 158.64 39.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.107 0.963 . . . . 72.1 109.163 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.38 130.12 38.33 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.382 0.673 . . . . 73.24 109.978 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.82 121.56 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 109.573 -0.529 . . . . 63.31 109.573 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -94.38 -48.0 6.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.285 1.034 . . . . 64.12 109.711 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -138.72 139.82 38.51 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.943 -1.132 . . . . 65.13 107.943 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.33 107.53 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.299 -1.0 . . . . 55.12 108.299 171.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -118.93 151.28 38.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.445 1.098 . . . . 72.31 108.799 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.1 126.22 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 71.44 109.335 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -132.22 117.18 17.89 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.966 -0.753 . . . . 55.2 108.966 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.55 HG21 HG22 ' A' ' 5' ' ' VAL . 70.5 p -88.43 127.25 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.529 -0.545 . . . . 44.52 109.529 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -132.71 100.99 5.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.289 -1.004 . . . . 74.5 108.289 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.16 -110.55 3.56 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.933 0.771 . . . . 75.11 112.138 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -118.4 23.7 11.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.866 0.866 . . . . 74.54 110.351 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -133.18 122.09 23.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.277 0.631 . . . . 52.51 109.358 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -97.95 103.72 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.446 0.641 . . . . 71.54 110.15 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -84.04 100.86 11.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.618 1.167 . . . . 72.35 109.42 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 105.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 71.42 109.234 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -89.53 109.24 20.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.015 0.926 . . . . 73.05 109.108 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.12 116.69 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.441 0.696 . . . . 54.34 110.151 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -84.18 135.51 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.079 0.952 . . . . 74.43 109.114 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.52 141.3 41.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.424 0.69 . . . . 75.25 109.608 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.63 108.67 21.43 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.315 -0.624 . . . . 70.5 109.315 168.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.59 107.63 18.24 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.63 -0.878 . . . . 74.4 108.63 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 m -89.57 102.91 15.59 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.937 -1.505 . . . . 61.43 106.937 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 t -140.94 124.18 16.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.305 1.042 . . . . 55.31 108.797 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.48 75.32 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.688 -0.687 . . . . 71.13 112.969 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.82 -19.87 42.64 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.746 -0.474 . . . . 64.31 113.416 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.4 p -88.68 120.23 29.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.159 0.584 . . . . 74.23 110.648 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -90.88 110.26 21.49 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.358 -0.979 . . . . 75.11 108.358 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.1 m -119.49 128.74 54.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 73.4 110.519 -172.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -77.35 101.7 6.45 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.126 -0.694 . . . . 61.34 109.126 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 m -108.42 114.49 28.37 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.453 1.101 . . . . 64.5 108.319 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -88.36 122.04 31.42 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.57 -0.9 . . . . 72.32 108.57 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -102.45 129.77 49.04 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.781 -1.192 . . . . 72.34 107.781 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.45 102.07 11.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.77 104.54 16.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.779 -1.193 . . . . 73.2 107.779 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -101.56 100.74 11.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.102 -1.408 . . . . 75.21 108.225 -170.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.22 110.57 21.61 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.752 0.821 . . . . 61.01 111.559 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -79.49 99.88 7.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 101' ' ' ILE . 4.2 m -97.73 141.14 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 62.45 110.163 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.9 116.38 9.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.217 0.607 . . . . 71.42 109.935 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.88 -114.22 5.45 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.969 0.793 . . . . 72.55 112.648 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.93 -3.09 26.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.9 0.88 . . . . 71.03 112.036 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.2 t -137.46 148.79 46.36 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.136 0.493 . . . . 71.41 110.943 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.499 HG23 HG12 ' A' ' 96' ' ' VAL . 34.8 mt -89.3 121.28 39.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.287 -1.005 . . . . 75.14 108.287 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -88.03 -41.86 12.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.992 0.917 . . . . 72.41 112.26 -167.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -142.37 163.89 31.62 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.809 0.338 . . . . 74.15 110.727 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.74 117.15 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.466 1.106 . . . . 74.41 108.831 168.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.1 m -93.45 104.28 16.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.649 -0.871 . . . . 62.21 108.649 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.12 104.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.719 0.771 . . . . 71.4 109.937 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 m -95.51 110.04 22.16 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.001 0.92 . . . . 73.42 109.428 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -81.68 94.38 6.96 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.485 0.714 . . . . 61.22 109.805 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -92.29 95.97 10.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.618 0.767 . . . . 75.24 109.485 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.34 15.21 60.43 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 115.962 -0.563 . . . . 71.12 113.035 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.03 -147.14 11.5 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.476 -0.65 . . . . 54.21 111.476 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.0 m -151.49 142.14 22.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.392 0.677 . . . . 62.14 110.01 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -102.76 -9.32 20.09 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.022 0.929 . . . . 74.31 110.739 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.12 135.17 51.73 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.47 0.708 . . . . 75.24 111.355 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -103.6 18.36 22.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.147 0.979 . . . . 65.1 109.521 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -61.53 -54.92 36.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.714 1.206 . . . . 70.31 110.766 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -67.82 -38.91 83.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.012 0.525 . . . . 64.12 111.15 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.37 -3.83 51.16 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.64 0.776 . . . . 74.45 111.653 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.1 t60 72.01 -67.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.938 1.295 . . . . 73.44 110.394 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.82 -1.178 . . . . 64.13 107.82 174.916 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 107.822 -1.177 . . . . 71.2 107.822 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -111.95 17.04 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.39 1.076 . . . . 65.13 111.019 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.39 32.41 4.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.029 0.532 . . . . 64.23 110.504 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -49.92 -44.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.785 1.234 . . . . 74.13 112.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.78 -46.63 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.554 1.142 . . . . 72.44 111.031 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.0 -46.42 81.46 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.713 -0.676 . . . . 73.43 110.526 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.12 -30.25 70.21 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.241 1.016 . . . . 62.12 111.404 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.18 86.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.997 0.519 . . . . 74.31 110.062 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 13' ' ' ILE . 88.2 tttt -66.38 -45.18 80.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.329 -0.851 . . . . 64.34 110.135 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -57.52 -45.3 85.17 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.136 0.974 . . . . 62.22 110.475 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.21 91.73 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 124.594 1.184 . . . . 74.42 111.04 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.27 -52.2 66.31 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.994 0.809 . . . . 64.13 111.583 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 9' ' ' LYS . 33.2 mt -60.94 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 123.853 0.721 . . . . 74.22 109.706 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.48 83.92 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.271 1.029 . . . . 71.01 112.276 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.71 -43.57 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 123.973 0.796 . . . . 74.2 110.206 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 75' ' ' VAL . 75.6 m-85 -73.73 -31.86 63.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.068 0.396 . . . . 62.21 112.068 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.647 0.592 . . . . 70.11 109.964 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 28' ' ' GLN . 81.4 mt -67.72 -48.25 67.03 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 124.192 0.933 . . . . 73.11 110.317 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -54.07 -29.4 44.18 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.843 0.857 . . . . 70.01 113.144 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 20.0 ptmt -101.97 -23.01 14.18 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.074 0.55 . . . . 73.41 112.065 174.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -149.95 83.15 6.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.403 0.681 . . . . 72.4 109.996 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 44.2 Cg_endo -71.73 -7.71 21.68 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.301 2.667 . . . . 73.41 114.597 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -78.97 -10.14 59.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 74.25 112.128 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.93 117.18 51.38 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.683 0.393 . . . . 74.41 110.276 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.49 -41.97 2.09 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.679 2.253 . . . . 73.13 113.446 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.81 -33.56 74.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.227 0.611 . . . . 71.31 112.226 -170.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.22 75.51 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.477 0.711 . . . . 62.24 110.667 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 18' ' ' LEU . 9.3 pt20 -79.2 -20.83 47.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.836 -0.62 . . . . 73.21 111.815 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -46.75 75.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.608 0.763 . . . . 72.45 110.572 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.407 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.2 pp -70.33 -31.7 69.11 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.487 0.492 . . . . 61.53 110.337 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.3 -28.89 70.32 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.663 0.785 . . . . 75.35 112.048 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -70.04 -33.87 72.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.144 0.497 . . . . 74.45 110.208 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.27 -33.92 23.91 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.859 0.863 . . . . 52.32 112.023 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 7' ' ' ALA . 10.1 pt -108.89 -33.67 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 122.954 0.502 . . . . 73.41 111.446 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 39' ' ' VAL . 3.5 mm? -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.443 1.097 . . . . 74.31 108.641 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.56 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.1 m -67.62 145.3 98.16 Favored Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 109.754 -0.461 . . . . 65.02 109.754 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.05 -18.12 56.0 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.486 2.124 . . . . 72.43 112.825 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.49 -33.86 62.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.002 0.921 . . . . 61.31 111.027 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 36' ' ' SER . 63.3 t -63.96 -41.45 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.745 0.818 . . . . 74.03 111.5 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.5 pp -60.55 -35.4 75.92 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 120.697 0.284 . . . . 71.22 111.056 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.7 t70 -72.6 -52.58 14.88 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.156 -0.929 . . . . 34.53 110.558 -175.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -61.34 -29.27 69.79 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.295 0.48 . . . . 75.34 112.295 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.9 t -71.7 -48.36 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.685 0.794 . . . . 74.24 110.868 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -73.14 -21.5 60.71 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.76 0.424 . . . . 74.41 111.926 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 mm-40 -82.73 -35.33 26.75 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 122.211 -0.305 . . . . 73.32 110.423 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -68.73 -26.58 65.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.762 0.791 . . . . 64.24 110.69 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -67.93 -38.35 82.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.601 -1.181 . . . . 62.23 111.568 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -65.22 -21.29 66.73 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.679 0.612 . . . . 65.45 111.338 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -72.03 -46.72 56.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.525 0.73 . . . . 73.11 110.628 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.85 -22.95 63.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.56 0.744 . . . . 74.31 111.176 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -71.63 -27.33 63.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.107 0.963 . . . . 64.03 111.338 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -78.61 -6.73 56.42 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.618 0.367 . . . . 63.24 111.034 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -116.69 172.56 7.15 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.117 0.967 . . . . 71.42 110.248 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.67 24.41 30.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.727 -0.67 . . . . 52.53 113.144 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 88.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-O 121.357 0.599 . . . . 74.41 109.464 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -101.46 110.36 22.35 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.185 -1.042 . . . . 73.33 108.185 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -117.34 135.56 53.76 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.486 0.715 . . . . 73.11 110.469 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.61 122.2 45.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.775 0.83 . . . . 64.25 109.882 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.67 101.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.686 -0.857 . . . . 72.23 108.686 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -77.68 -44.1 29.08 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.686 -0.688 . . . . 62.33 110.805 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 17.6 tpp85 -152.77 142.1 21.58 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.78 -1.1 . . . . 71.1 108.869 -177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.77 110.01 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.615 -0.884 . . . . 61.13 108.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.485 ' HG3' ' HD2' ' A' ' 61' ' ' ARG . 28.8 mt-10 -128.7 122.92 31.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.008 -0.738 . . . . 74.13 109.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 73' ' ' VAL . 3.7 p -96.78 135.77 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.496 1.118 . . . . 62.32 110.135 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -138.55 137.63 37.22 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.176 0.99 . . . . 63.54 109.287 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -95.44 155.82 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.046 0.538 . . . . 74.41 111.368 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 95.62 2.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.32 -1.363 . . . . 75.34 107.32 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.63 -117.08 9.41 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 111.736 -0.546 . . . . 42.41 111.736 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.87 -12.93 21.58 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.01 0.524 . . . . 62.24 111.533 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.9 m -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.982 0.513 . . . . 53.13 110.087 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 94' ' ' PHE . 7.8 p -99.73 136.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.719 0.808 . . . . 64.45 110.568 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.95 115.97 22.81 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.058 1.343 . . . . 73.21 108.883 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 64' ' ' VAL . 46.8 t -92.24 113.07 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 110.181 -0.303 . . . . 65.3 110.181 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.2 m -87.64 104.89 16.94 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.074 -1.084 . . . . 72.42 108.074 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 16' ' ' PHE . 5.3 p -119.48 122.52 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.231 1.012 . . . . 71.33 109.015 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -94.96 132.93 39.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.937 0.895 . . . . 74.54 109.305 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.57 154.91 49.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.407 0.683 . . . . 71.51 109.808 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -110.07 104.48 13.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 72.23 109.289 171.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.52 106.65 17.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.567 0.747 . . . . 63.21 110.191 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -87.85 102.93 15.17 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.886 -1.153 . . . . 63.21 107.886 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.5 t -146.95 135.82 22.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.133 0.973 . . . . 52.24 109.485 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 22.45 71.08 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.732 -0.667 . . . . 73.0 112.843 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.3 80.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.938 -0.368 . . . . 72.5 114.004 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -126.97 123.43 37.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.376 0.67 . . . . 73.3 110.959 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.6 m -88.07 115.08 25.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.308 1.043 . . . . 74.01 110.005 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.6 m -119.08 133.51 55.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.013 0.925 . . . . 72.23 110.134 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -79.21 125.43 29.45 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.974 -0.75 . . . . 54.42 108.974 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.9 m -141.96 125.17 16.41 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.671 0.788 . . . . 64.01 110.234 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -90.75 129.88 36.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.648 -0.501 . . . . 65.34 109.648 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -108.96 146.84 33.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.554 0.742 . . . . 52.21 109.166 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.3 103.66 7.29 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.066 -1.087 . . . . 72.11 108.066 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -92.77 108.49 20.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 70.31 107.912 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -90.48 99.79 12.75 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.48 -0.782 . . . . 75.3 109.329 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.6 m-85 -89.3 110.3 21.1 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.987 -0.746 . . . . 62.23 108.987 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 26.6 tt0 -92.13 127.86 37.76 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.089 -1.078 . . . . 72.2 108.089 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -85.09 142.49 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.263 0.554 . . . . 73.2 110.979 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -120.96 97.41 5.52 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.915 -1.143 . . . . 72.44 107.915 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.92 -107.08 1.86 Allowed Glycine 0 C--N 1.343 0.929 0 O-C-N 123.822 0.701 . . . . 63.02 113.241 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.63 -19.05 22.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.047 0.939 . . . . 71.41 112.053 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -132.45 167.95 19.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.669 0.787 . . . . 74.12 110.614 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 94' ' ' PHE . 50.0 mt -92.06 135.79 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.685 -0.857 . . . . 52.33 108.685 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -129.48 7.69 5.36 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.942 0.497 . . . . 74.1 111.828 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 31.2 mmt180 -144.45 146.58 32.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.999 0.519 . . . . 75.23 111.544 -175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 130.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.993 1.317 . . . . 71.52 109.333 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -127.03 105.8 8.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.417 -0.957 . . . . 72.01 108.417 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 t -86.61 106.81 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.045 -0.724 . . . . 72.2 109.045 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 m -95.57 152.12 18.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.624 -0.88 . . . . 71.22 108.624 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -129.03 138.58 51.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.351 0.66 . . . . 74.52 110.197 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.55 83.09 2.24 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.033 -1.099 . . . . 72.32 108.033 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.9 56.9 3.33 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.636 -0.711 . . . . 14.31 111.518 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.3 157.47 9.51 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.683 -0.567 . . . . 54.42 111.683 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 51.0 m -151.29 131.84 13.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.054 0.942 . . . . 73.42 109.356 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.19 -40.85 51.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.274 0.629 . . . . 75.41 109.517 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.28 134.23 54.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.039 0.936 . . . . 55.02 109.314 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -167.81 139.0 2.91 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.172 -1.048 . . . . 61.34 108.172 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -58.32 112.64 1.63 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 54.52 109.307 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.17 68.79 3.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.087 0.955 . . . . 44.32 111.547 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -94.35 -34.42 12.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.008 0.923 . . . . 71.03 109.047 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -86.95 23.15 1.82 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.554 1.142 . . . . 73.22 110.49 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 124.768 1.227 . . . . 70.23 108.948 -165.463 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HE1' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 107.756 -1.202 . . . . 73.33 107.756 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 19.7 19.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.885 0.874 . . . . 75.44 111.365 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 15.3 m-20 -91.83 26.72 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.885 0.474 . . . . 73.44 110.52 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.37 -39.92 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.576 1.55 . . . . 73.23 113.331 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.76 -50.31 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.545 0.738 . . . . 74.04 110.292 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.19 -30.47 64.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.547 -0.752 . . . . 73.35 110.92 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.55 69.98 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.497 0.719 . . . . 63.44 109.954 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.75 94.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.532 0.733 . . . . 70.13 111.495 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.3 -57.88 11.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.268 1.027 . . . . 63.34 111.397 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -66.96 -29.1 68.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 74.03 110.906 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.76 83.6 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 123.925 0.766 . . . . 72.5 110.934 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.47 -51.08 69.8 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.373 1.046 . . . . 42.44 110.631 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 39.9 mt -61.69 -42.79 95.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 O-C-N 124.402 1.064 . . . . 70.22 110.413 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.64 74.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.803 0.841 . . . . 75.11 112.026 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.63 -40.97 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 41.42 109.508 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 60.2 m-85 -72.16 -31.13 65.67 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.472 0.309 . . . . 62.22 111.742 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 19.4 mt-30 -66.09 -35.57 80.86 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.494 0.496 . . . . 75.11 110.407 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 -42.85 65.74 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 123.888 0.742 . . . . 65.41 109.966 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 37.6 m0 -61.11 -26.06 67.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.166 0.802 . . . . 73.15 113.166 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 17' ' ' GLN . 64.3 pttt -100.22 -21.7 15.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.791 0.436 . . . . 75.52 110.948 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -152.99 89.5 3.69 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.35 0.66 . . . . 65.15 109.56 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.71 -19.21 66.87 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.095 2.53 . . . . 53.43 113.169 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.3 p -83.13 7.9 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.049 0.939 . . . . 64.12 112.469 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.77 108.59 6.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.03 0.532 . . . . 61.12 109.934 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.74 -29.68 15.42 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.573 2.182 . . . . 74.33 113.185 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.67 -41.6 62.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.247 0.619 . . . . 60.54 110.722 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.19 61.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.816 0.846 . . . . 55.13 111.144 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -66.91 -28.77 68.58 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.713 -0.676 . . . . 74.03 111.764 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.81 -52.35 44.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.881 0.472 . . . . 73.33 110.86 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.6 pp -66.89 -31.75 72.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.192 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.04 -12.58 61.81 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.959 0.903 . . . . 73.54 112.905 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 -27.02 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.419 0.628 . . . . 62.13 109.963 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -85.47 -30.49 23.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.97 0.908 . . . . 64.45 111.181 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 30' ' ' LEU . 12.9 pt -117.77 -32.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.791 0.437 . . . . 62.51 111.538 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 39' ' ' VAL . 3.7 mm? -109.2 179.28 4.21 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.688 0.795 . . . . 64.25 109.253 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 28.7 m -76.26 152.47 83.94 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 122.772 0.429 . . . . 75.13 111.347 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.61 -23.51 65.65 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.821 2.347 . . . . 73.3 112.366 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.6 -39.94 80.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.53 1.132 . . . . 54.15 111.133 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 35' ' ' LEU . 93.5 t -65.63 -57.42 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.306 0.643 . . . . 65.55 110.651 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.4 pp -58.04 -27.04 63.23 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.34 0.496 . . . . 55.31 112.34 -176.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.78 -41.02 24.1 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.77 0.828 . . . . 73.31 110.959 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -74.46 -27.91 60.79 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.303 -0.248 . . . . 74.52 110.626 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -40.83 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.161 0.985 . . . . 65.12 110.749 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.58 -30.73 69.55 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 120.268 0.08 . . . . 71.11 111.052 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.77 -26.32 27.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.844 0.458 . . . . 75.42 111.076 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -66.49 -27.11 67.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.978 0.511 . . . . 74.03 110.365 172.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.86 91.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.92 -1.036 . . . . 70.5 111.878 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -64.71 -31.76 73.13 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.119 0.887 . . . . 65.01 111.479 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.04 -44.19 97.22 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 123.824 0.702 . . . . 71.43 110.44 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -78.42 -36.16 46.02 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.327 1.051 . . . . 73.14 111.314 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.31 -30.15 63.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.924 0.89 . . . . 64.43 110.156 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.98 -36.25 80.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.649 1.18 . . . . 62.21 110.225 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.24 -20.92 29.39 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.974 -1.012 . . . . 62.32 111.013 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.57 20.91 70.5 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.922 -0.581 . . . . 64.01 113.208 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.1 mt -82.21 100.28 5.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 123.366 0.666 . . . . 73.04 110.123 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -92.96 112.98 25.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.219 -0.66 . . . . 74.35 109.219 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 5.7 p90 -105.81 159.45 16.0 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.12 -0.696 . . . . 75.04 109.12 168.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -133.0 133.54 43.27 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.988 -0.551 . . . . 61.52 110.034 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.43 101.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.512 1.132 . . . . 73.5 109.974 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.84 -54.89 3.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.93 0.395 . . . . 73.53 111.48 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -133.16 123.43 25.65 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 109.471 -0.566 . . . . 73.14 109.471 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.54 125.6 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.043 0.937 . . . . 72.53 109.398 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.65 109.12 9.5 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.481 -0.933 . . . . 71.32 108.481 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.6 p -95.41 108.27 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.484 0.659 . . . . 72.22 109.356 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.2 p -113.18 124.97 53.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.564 0.746 . . . . 61.3 109.632 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 71' ' ' VAL . 45.5 p -88.35 154.13 20.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.826 0.45 . . . . 74.42 109.948 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -148.48 92.93 2.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.017 -1.475 . . . . 52.55 107.017 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.65 -117.69 10.39 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.986 -0.846 . . . . 75.14 110.986 -169.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -94.56 -14.06 25.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.402 0.681 . . . . 54.5 110.503 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -93.84 121.62 35.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.642 0.777 . . . . 61.53 110.411 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 48.2 t -99.66 111.64 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.232 0.613 . . . . 72.44 110.85 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -94.74 107.31 19.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.334 1.054 . . . . 74.34 108.953 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.55 103.61 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.707 -0.479 . . . . 74.11 109.707 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.2 m -86.57 106.15 17.35 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.343 1.057 . . . . 52.0 109.03 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.6 p -127.87 124.85 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.06 0.944 . . . . 61.43 110.293 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -94.82 127.14 40.61 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.971 0.908 . . . . 70.12 109.051 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.99 157.07 30.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.582 0.753 . . . . 74.42 109.259 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' THR . 40.8 mt-10 -109.22 106.52 16.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.154 -0.475 . . . . 72.3 109.852 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 23.7 mt-10 -86.02 119.81 26.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.697 0.799 . . . . 75.35 110.616 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -89.51 100.44 13.24 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.743 -1.206 . . . . 63.44 107.743 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 t -149.44 128.46 12.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.123 0.969 . . . . 63.15 110.007 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.03 69.61 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 113.835 0.294 . . . . 72.35 113.835 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.45 13.22 83.61 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.901 -0.389 . . . . 71.43 113.989 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.9 p -121.56 149.39 43.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.412 0.685 . . . . 75.51 109.937 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 m -116.61 106.15 13.23 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.364 -0.976 . . . . 65.1 108.364 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 12.0 t -110.66 139.04 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.977 0.418 . . . . 63.51 110.97 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -80.45 102.71 9.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.097 -0.705 . . . . 65.21 109.097 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -114.62 128.15 56.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.227 0.611 . . . . 52.32 109.454 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.7 m -93.43 119.12 32.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.287 0.635 . . . . 72.35 110.186 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -104.3 130.34 52.12 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.241 -1.022 . . . . 60.25 108.241 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.77 104.74 11.96 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.039 -1.097 . . . . 72.45 108.039 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -90.96 108.96 20.2 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.85 -1.167 . . . . 71.21 107.85 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 27.6 ttt180 -89.36 99.68 12.63 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.042 -0.981 . . . . 70.12 108.376 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.53 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.7 m-85 -87.82 107.65 18.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.253 -0.885 . . . . 62.04 109.053 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 108.15 20.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.471 -1.307 . . . . 74.11 107.471 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 101' ' ' ILE . 3.8 m -86.68 151.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 114.871 -1.059 . . . . 61.44 112.407 -165.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.39 103.28 5.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.696 1.198 . . . . 64.55 108.631 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.13 -108.28 2.49 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.369 -0.378 . . . . 72.34 113.279 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.33 2.42 16.5 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.826 0.85 . . . . 64.51 111.74 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 164.63 26.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.691 0.796 . . . . 43.14 109.265 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 96' ' ' VAL . 24.9 mt -101.18 107.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.605 -1.257 . . . . 73.14 107.605 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -85.25 -29.12 24.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.472 0.309 . . . . 62.23 111.624 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -130.06 142.58 50.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.36 0.664 . . . . 73.52 109.757 -164.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.02 142.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.464 0.705 . . . . 64.43 110.615 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.1 m -119.48 141.65 48.98 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.241 1.017 . . . . 72.34 108.889 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 110.09 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.48 -0.563 . . . . 42.44 109.48 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.1 m -103.39 104.86 15.0 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.561 0.744 . . . . 70.54 109.64 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.51 96.11 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.248 0.547 . . . . 71.52 109.854 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -81.37 86.61 6.25 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.158 0.983 . . . . 74.24 109.662 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.71 -22.6 28.08 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.558 -0.746 . . . . 51.34 111.509 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.66 90.25 0.53 Allowed Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.357 -0.697 . . . . 71.31 111.357 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.6 m -89.05 31.16 0.88 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.711 0.804 . . . . 71.24 111.652 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.82 -2.55 54.93 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.605 0.762 . . . . 64.42 112.057 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -80.71 -175.01 5.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.682 0.793 . . . . 62.13 111.261 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -124.27 92.43 3.66 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.082 0.953 . . . . 74.43 108.639 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -66.3 -58.9 4.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.101 0.561 . . . . 44.42 109.555 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -86.65 77.63 9.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.824 -1.176 . . . . 63.23 107.824 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -76.14 94.13 3.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.37 0.668 . . . . 70.11 110.321 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -73.8 140.46 45.85 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.394 -0.821 . . . . 72.03 110.956 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 . . . . . 0 C--O 1.251 1.136 0 N-CA-C 108.117 -1.068 . . . . 72.41 108.117 171.713 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.472 0.653 . . . . 70.43 111.036 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -130.96 0.55 4.25 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.631 1.173 . . . . 74.2 108.249 167.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.72 70.2 10.3 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 124.536 1.135 . . . . 73.43 109.113 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.619 HG23 HG11 ' A' ' 96' ' ' VAL . 36.1 mm -48.01 -47.19 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.971 1.709 . . . . 74.32 113.19 -171.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 66' ' ' THR . 45.9 t -66.12 -56.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.497 0.719 . . . . 52.14 110.759 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -74.77 -29.17 61.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.181 -0.918 . . . . 74.22 111.768 -170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.1 -45.31 77.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.411 0.684 . . . . 50.41 110.023 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -68.64 -32.72 72.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.454 0.702 . . . . 54.32 111.881 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.0 -47.8 78.88 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.554 0.742 . . . . 73.24 110.482 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.761 0.824 . . . . 74.13 111.437 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.29 86.44 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.749 0.82 . . . . 71.25 110.806 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.86 79.56 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 124.202 0.939 . . . . 61.03 111.415 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.3 -40.41 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.147 -0.933 . . . . 73.02 110.449 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.92 82.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.678 0.791 . . . . 54.02 111.665 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 56.4 mt -60.87 -41.58 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.072 0.949 . . . . 71.34 110.35 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 75' ' ' VAL . 30.6 m-85 -76.38 -31.58 58.09 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.825 0.45 . . . . 72.21 111.819 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -65.86 -32.5 74.05 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.131 0.572 . . . . 70.33 110.563 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -49.11 26.39 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.502 0.501 . . . . 75.05 110.434 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -59.42 -26.09 64.88 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.39 -29.51 14.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.54 0.336 . . . . 74.14 111.008 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -147.45 85.55 6.7 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.433 0.693 . . . . 62.45 109.137 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.07 -12.16 33.51 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.977 2.451 . . . . 54.32 112.951 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -84.98 5.01 31.01 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.222 1.009 . . . . 73.11 111.584 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -77.33 110.78 13.48 Favored Pre-proline 0 C--N 1.357 0.921 0 N-CA-C 109.53 -0.544 . . . . 75.51 109.53 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.26 -26.09 9.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.408 2.072 . . . . 70.03 112.352 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -75.28 -44.3 46.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.936 0.895 . . . . 74.44 111.118 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.42 81.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 124.273 0.983 . . . . 62.04 111.094 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.3 pt20 -75.5 -24.61 56.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.735 -0.666 . . . . 63.33 111.881 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.22 -46.26 61.56 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.027 0.531 . . . . 74.1 110.983 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.4 pp -68.01 -29.34 68.32 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.357 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.2 mt -69.23 -14.76 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 74.21 112.335 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -81.29 -30.25 34.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.266 0.555 . . . . 54.41 109.503 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -82.73 -36.97 25.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.097 0.959 . . . . 55.42 111.05 -174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 7' ' ' ALA . 12.9 pt -105.16 -35.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.309 0.643 . . . . 65.2 111.637 -173.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 34' ' ' ILE . 3.9 mm? -111.13 175.7 5.32 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.335 1.054 . . . . 74.22 109.373 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.8 m -74.11 146.23 84.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 116.036 -0.529 . . . . 75.13 110.609 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.38 -32.26 41.54 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.288 2.659 . . . . 75.53 114.031 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.49 -39.82 92.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.213 1.005 . . . . 73.3 111.457 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 36' ' ' SER . 96.0 t -70.47 -45.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.498 0.719 . . . . 71.45 111.113 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.8 pp -64.14 -30.05 71.13 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.936 0.398 . . . . 61.41 110.556 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 23.8 t70 -68.23 -56.73 7.63 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.8 -1.091 . . . . 54.33 110.06 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.42 -31.64 69.45 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 111.898 0.333 . . . . 71.23 111.898 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 54.5 t -66.25 -51.99 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.219 0.608 . . . . 70.21 110.415 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 40.4 ptt180 -69.42 -21.9 63.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 119.664 -0.208 . . . . 74.51 111.463 -176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 18.6 mm-40 -71.02 -46.25 62.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.817 0.447 . . . . 74.15 111.068 175.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -66.32 -28.95 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.052 -0.522 . . . . 75.23 110.769 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.08 93.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.043 0.937 . . . . 74.24 112.049 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 79.3 mtp180 -68.13 -23.64 64.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.689 0.796 . . . . 72.14 111.777 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.26 -47.08 12.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.842 0.857 . . . . 73.43 110.152 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.09 -20.17 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.918 0.887 . . . . 74.32 111.341 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.56 -35.04 79.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.435 1.094 . . . . 74.42 110.902 174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.73 -32.95 25.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.278 0.631 . . . . 71.04 110.875 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.84 147.34 30.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.402 0.681 . . . . 74.51 110.394 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.08 56.94 5.01 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.475 -0.33 . . . . 45.15 112.46 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.41 105.14 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.086 0.954 . . . . 71.33 108.658 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -104.72 110.37 22.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.665 -0.865 . . . . 75.31 108.665 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.71 162.3 16.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.353 0.661 . . . . 70.35 109.423 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.71 140.46 22.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.673 -0.491 . . . . 73.44 109.673 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.64 122.19 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.12 0.968 . . . . 53.52 109.436 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -106.27 -17.01 14.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.442 0.697 . . . . 63.03 111.202 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.7 ttt180 -163.45 132.97 4.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.289 0.635 . . . . 74.33 110.227 -169.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.4 t -125.26 135.29 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.293 1.037 . . . . 62.0 108.762 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.84 108.97 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.283 -1.006 . . . . 61.21 108.283 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.4 121.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 121.11 0.481 . . . . 63.03 110.11 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.7 m -141.12 135.24 30.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.972 0.909 . . . . 74.13 108.639 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.516 HG21 HG22 ' A' ' 5' ' ' VAL . 26.8 p -100.8 134.13 44.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.606 0.762 . . . . 65.51 111.218 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.426 ' HB3' HD21 ' A' ' 72' ' ' ASN . 25.1 t70 -114.87 107.79 15.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.059 1.343 . . . . 75.12 108.715 174.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.39 -108.35 2.58 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.448 -0.661 . . . . 72.45 111.448 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.62 -11.97 12.92 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.34 1.056 . . . . 55.13 109.453 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.498 HG23 ' HA ' ' A' ' 95' ' ' GLU . 44.8 m -90.28 129.74 36.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.194 0.998 . . . . 64.23 109.9 -172.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 8' ' ' ALA . 21.6 t -88.8 143.74 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.38 0.672 . . . . 73.01 110.12 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 67' ' ' ASP . 12.1 m-80 -124.34 112.53 17.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.078 -1.082 . . . . 60.32 108.078 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.5 103.71 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 109.265 -0.643 . . . . 71.14 109.265 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.7 m -87.78 104.43 16.56 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.227 -1.027 . . . . 64.2 108.227 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.5 p -119.28 121.08 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.784 0.834 . . . . 70.41 109.763 -175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.7 tp10 -83.53 114.94 21.85 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.691 -0.855 . . . . 71.04 108.691 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.2 mp -101.66 160.65 14.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.193 -1.04 . . . . 62.54 108.193 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.23 105.28 7.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.751 -1.574 . . . . 70.53 106.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -105.49 106.81 17.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.39 0.676 . . . . 53.15 110.638 -169.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -87.79 104.75 16.87 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.712 -1.218 . . . . 64.54 107.712 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 t -136.52 125.0 23.49 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.374 -0.973 . . . . 71.33 108.374 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.01 26.11 72.26 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.98 -0.554 . . . . 55.33 112.993 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.38 60.13 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.19 0.424 . . . . 54.24 113.476 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.3 m -93.28 112.31 24.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.568 0.747 . . . . 73.51 110.432 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.6 m -88.47 107.88 19.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.682 0.793 . . . . 73.5 109.21 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.9 m -126.61 125.49 42.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.448 0.699 . . . . 73.2 110.221 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -77.9 115.68 17.83 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.304 0.642 . . . . 74.33 110.122 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 110' ' ' GLY . 39.6 m -118.58 119.72 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.627 1.171 . . . . 63.4 108.799 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 m -88.17 120.76 29.83 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.59 -0.522 . . . . 75.23 109.59 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CD1' HD13 ' A' ' 77' ' ' LEU . 11.3 m-85 -103.58 134.71 46.46 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.297 -1.371 . . . . 53.23 107.297 174.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -118.13 102.46 9.03 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.223 -1.029 . . . . 61.12 108.223 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.8 104.92 16.87 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.039 -1.097 . . . . 62.42 108.039 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -95.64 102.24 14.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.81 -0.811 . . . . 71.03 108.81 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.417 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.8 m-85 -87.47 108.86 19.22 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.674 0.79 . . . . 64.41 109.562 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 30.6 tt0 -92.81 120.94 33.68 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.471 -0.786 . . . . 75.21 109.645 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 HG23 ' A' ' 4' ' ' ILE . 4.3 m -98.11 148.09 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.35 -0.841 . . . . 64.52 110.697 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.462 ' HB2' ' HG3' ' A' ' 102' ' ' ARG . 6.7 m-20 -120.37 91.59 3.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.909 -1.145 . . . . 70.2 107.909 173.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.7 -128.19 8.36 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 114.861 -1.063 . . . . 31.24 111.946 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.4 8.8 36.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.493 0.717 . . . . 74.21 112.616 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -139.63 162.43 35.12 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.315 0.646 . . . . 64.01 110.282 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 96' ' ' VAL . 10.2 mt -95.52 140.12 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.412 -0.958 . . . . 65.34 108.412 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 36.0 mmt180 -126.9 -31.3 2.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.712 0.634 . . . . 64.52 112.712 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.8 mtt180 -130.39 161.67 30.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.528 0.331 . . . . 75.03 110.404 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.39 139.23 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.212 1.005 . . . . 60.04 109.319 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.3 m -121.28 105.16 10.29 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.567 -0.901 . . . . 33.23 108.567 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -89.29 104.3 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.813 -0.81 . . . . 71.32 108.813 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.8 m -95.73 103.78 15.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.307 -0.627 . . . . 73.32 109.307 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -85.22 95.06 9.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.605 0.762 . . . . 72.44 109.74 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -77.79 93.61 4.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.227 -1.027 . . . . 75.02 108.227 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 88' ' ' THR . . . -79.94 57.97 4.56 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.724 -0.671 . . . . 71.34 111.915 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.81 145.28 4.13 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.513 -1.035 . . . . 64.13 110.513 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 t -107.35 170.75 7.78 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.56 0.744 . . . . 71.34 110.407 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -76.72 -14.01 59.98 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.712 -0.677 . . . . 73.02 110.515 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.67 109.58 2.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.345 1.058 . . . . 73.43 110.172 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -138.57 160.93 38.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.392 0.677 . . . . 74.2 109.801 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -104.34 -71.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.832 -0.803 . . . . 73.21 108.832 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -148.97 -167.26 2.78 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.334 1.053 . . . . 74.53 109.672 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.3 m80 66.08 43.49 2.9 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 124.183 0.993 . . . . 73.32 110.116 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -60.49 -31.33 70.37 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.095 0.958 . . . . 72.33 111.351 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.0 p80 . . . . . 0 C--O 1.251 1.141 0 N-CA-C 108.852 -0.796 . . . . 75.31 108.852 172.483 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.678 ' SD ' HG22 ' A' ' 34' ' ' ILE . 8.6 ptm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.919 -0.4 . . . . 74.41 109.919 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -77.35 74.12 3.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.481 1.112 . . . . 73.34 110.755 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -172.47 35.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.332 1.453 . . . . 71.54 108.802 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 96' ' ' VAL . 36.9 mm -47.69 -38.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.694 1.598 . . . . 62.13 113.842 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.2 -47.8 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.957 0.503 . . . . 62.43 110.022 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.23 -42.11 80.22 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.135 -0.939 . . . . 74.34 110.092 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -61.68 -37.96 86.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.01 0.924 . . . . 72.42 111.666 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.6 -32.61 60.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.926 0.89 . . . . 72.42 110.742 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.8 tttm -67.72 -39.32 84.31 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.325 -0.852 . . . . 74.11 110.327 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.46 -40.82 85.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.357 0.663 . . . . 64.23 110.164 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.21 86.68 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.129 0.971 . . . . 64.23 111.633 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.81 66.58 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.962 0.789 . . . . 75.04 111.61 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -70.73 -32.12 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.2 -0.909 . . . . 71.43 110.8 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.5 -32.2 70.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.125 0.57 . . . . 64.43 112.182 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -60.78 -41.09 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.502 0.721 . . . . 73.1 109.398 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.29 -30.06 61.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.217 0.607 . . . . 70.3 111.771 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.29 -35.47 79.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.412 0.685 . . . . 74.33 110.271 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 73.4 mt -73.93 -40.4 63.12 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.81 -0.632 . . . . 71.55 110.867 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -60.71 -30.35 69.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.208 0.448 . . . . 74.32 112.208 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -96.65 -21.9 17.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.201 0.6 . . . . 75.32 111.024 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -156.66 89.14 2.69 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.538 0.735 . . . . 75.41 109.219 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.27 -17.53 44.74 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.905 2.403 . . . . 74.42 113.708 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.2 p -89.48 13.55 13.53 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.588 0.755 . . . . 74.52 111.425 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.39 112.27 12.28 Favored Pre-proline 0 C--N 1.358 0.978 0 C-N-CA 123.142 0.577 . . . . 75.12 110.035 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.72 -28.78 13.51 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.704 2.269 . . . . 73.33 113.02 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.1 -41.8 49.2 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.23 0.612 . . . . 62.42 110.949 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.94 -55.72 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 53.54 110.667 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -66.95 -25.9 66.57 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.764 0.426 . . . . 74.43 111.993 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.37 -56.15 24.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.331 0.652 . . . . 74.3 110.196 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.57 -35.03 76.84 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.065 -0.516 . . . . 71.51 110.458 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 87.1 mt -62.8 -29.32 70.63 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.716 0.806 . . . . 71.13 112.176 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -71.97 -35.52 69.56 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.194 0.521 . . . . 71.44 109.811 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -79.8 -39.07 31.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.834 -1.075 . . . . 62.33 111.55 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 1' ' ' MET . 7.5 pt -96.54 -40.57 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.858 0.463 . . . . 73.13 111.956 -172.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' HG13 ' A' ' 34' ' ' ILE . 47.3 mt -100.95 -175.2 2.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.737 0.815 . . . . 72.41 109.24 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.611 ' HB2' HG23 ' A' ' 39' ' ' VAL . 11.0 m -75.98 146.21 78.67 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 109.334 -0.617 . . . . 72.22 109.334 167.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.22 -19.99 62.52 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.83 2.354 . . . . 73.02 112.452 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.98 -31.71 71.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.501 1.121 . . . . 73.14 111.339 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -69.54 -49.05 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 122.951 0.5 . . . . 64.13 110.287 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.36 -30.22 71.27 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.35 -0.241 . . . . 52.24 110.35 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.58 -40.39 84.83 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.302 1.041 . . . . 61.14 111.495 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.9 -33.06 52.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.211 0.204 . . . . 71.23 110.833 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.84 -47.63 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.415 0.686 . . . . 32.42 110.985 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 5.9 ppt_? -62.8 -29.97 71.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.741 0.417 . . . . 73.1 112.114 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.42 -47.86 58.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.757 0.423 . . . . 55.41 112.072 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -66.2 -31.24 71.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.115 0.484 . . . . 70.33 110.332 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.4 -39.57 92.34 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.714 -1.13 . . . . 63.35 111.891 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 71.9 mtp180 -67.77 -30.58 70.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.266 0.626 . . . . 71.24 111.182 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -72.77 -31.7 65.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.374 0.27 . . . . 71.23 111.069 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.23 -32.04 62.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.152 0.581 . . . . 71.02 110.742 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -70.29 -37.01 74.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.408 0.683 . . . . 74.01 110.354 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -60.8 -38.07 84.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.03 0.932 . . . . 65.14 109.816 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -90.12 176.75 6.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.012 -0.995 . . . . 75.21 110.41 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.59 33.12 6.82 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mt -77.79 101.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.996 -0.742 . . . . 72.4 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -94.09 151.85 19.2 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.671 -0.863 . . . . 54.53 108.671 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 44.1 p90 -147.67 161.77 40.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.572 0.749 . . . . 65.34 109.025 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -141.02 136.47 32.12 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.739 -0.467 . . . . 73.32 109.739 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.02 122.07 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 109.368 -0.605 . . . . 63.14 109.368 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -112.01 -44.61 3.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.355 1.062 . . . . 54.22 110.186 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -140.53 135.25 31.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.091 -0.959 . . . . 75.54 109.167 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.48 115.36 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.035 -1.098 . . . . 61.45 108.035 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -127.87 131.97 49.4 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.567 -0.901 . . . . 71.3 108.567 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG11 ' HD2' ' A' ' 9' ' ' LYS . 7.6 p -120.07 109.79 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.886 -0.783 . . . . 72.21 108.886 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.3 p -111.0 164.12 13.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.531 0.732 . . . . 54.12 109.07 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -119.96 143.15 48.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.1 110.093 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -140.23 91.55 2.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.833 -1.543 . . . . 53.42 106.833 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.56 -124.9 11.13 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.855 -1.298 . . . . 72.33 109.855 -164.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -97.51 -7.7 30.84 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.344 0.657 . . . . 64.03 110.749 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.1 m -88.29 121.54 30.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.343 -0.614 . . . . 72.02 109.343 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.1 t -86.96 136.69 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.664 0.786 . . . . 74.25 109.318 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.5 99.91 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.244 -1.021 . . . . 64.44 108.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.22 104.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.19 -0.67 . . . . 54.55 109.19 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.2 m -87.16 103.36 15.34 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.913 -1.143 . . . . 75.52 107.913 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.59 115.35 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.969 0.908 . . . . 53.22 109.166 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 37.7 tt0 -84.36 124.3 31.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.829 0.852 . . . . 74.11 109.522 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.95 119.7 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.429 0.692 . . . . 54.3 109.347 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -87.59 102.72 14.87 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.214 -1.032 . . . . 71.41 108.214 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.6 mt-10 -89.15 110.42 21.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.14 0.976 . . . . 72.44 111.452 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 45.2 m -89.77 99.88 12.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.551 -1.277 . . . . 64.44 107.551 172.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -147.55 144.65 28.66 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.422 0.689 . . . . 64.32 110.101 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.08 15.63 72.17 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.837 -0.619 . . . . 53.24 113.265 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.38 3.88 81.21 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.1 -0.278 . . . . 72.2 113.474 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -124.59 148.72 47.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.002 0.521 . . . . 64.22 110.559 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 67.3 m -102.86 106.0 16.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.144 -0.687 . . . . 74.32 109.144 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.4 m -101.95 120.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.527 1.131 . . . . 63.42 109.532 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.1 103.8 9.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.652 -0.87 . . . . 63.24 108.652 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -111.06 154.0 24.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.364 1.066 . . . . 61.0 109.744 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 29.9 m -114.53 149.1 36.97 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.113 -0.699 . . . . 60.41 109.113 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.93 131.73 47.56 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.176 1.39 . . . . 72.24 107.691 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -113.83 105.77 13.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.999 . . . . 61.41 108.304 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.1 mp -98.4 106.21 18.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -95.9 103.05 14.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.134 0.574 . . . . 63.0 109.843 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 101' ' ' ILE . 96.5 m-85 -87.18 108.49 18.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.129 0.972 . . . . 73.41 109.637 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 24.8 tt0 -99.71 124.21 44.73 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 4' ' ' ILE . 3.2 m -98.17 151.89 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.177 -0.92 . . . . 41.24 111.808 -165.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -137.98 99.23 3.84 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.525 1.13 . . . . 71.44 108.062 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.31 -107.76 2.46 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.185 -0.916 . . . . 41.24 113.023 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.25 -4.08 13.77 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.63 1.172 . . . . 64.32 110.908 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.538 HG23 ' HD3' ' A' ' 102' ' ' ARG . 5.2 t -127.98 154.1 45.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.733 0.813 . . . . 54.44 110.228 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 96' ' ' VAL . 52.3 mt -95.37 133.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.177 -1.045 . . . . 71.02 108.177 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.538 ' HD3' HG23 ' A' ' 100' ' ' THR . 22.2 mmm180 -118.19 -2.98 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.633 0.373 . . . . 61.43 111.324 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 21.9 tpt180 -143.76 133.99 24.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.508 0.723 . . . . 71.23 110.01 -172.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.74 118.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.656 -1.238 . . . . 74.24 107.656 166.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 m -97.46 103.08 14.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.877 -1.157 . . . . 74.54 107.877 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 92' ' ' LEU . 44.6 t -93.87 105.24 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.408 -0.96 . . . . 74.21 108.408 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -110.54 122.09 46.9 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.56 -0.533 . . . . 71.21 109.56 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.77 97.15 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.29 78.16 8.1 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.255 -1.017 . . . . 61.3 108.255 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.77 39.51 2.87 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.822 -1.081 . . . . 71.41 111.376 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.68 63.89 0.09 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.568 -0.613 . . . . 73.24 111.568 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.8 m -73.02 114.53 11.28 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.425 0.69 . . . . 74.23 110.449 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.455 HD13 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -105.42 1.64 27.93 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.462 0.705 . . . . 72.4 112.357 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.98 87.66 1.84 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.008 0.523 . . . . 71.44 111.463 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -116.9 107.85 15.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.39 -1.337 . . . . 75.12 107.39 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 52.7 t60 64.37 4.91 2.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.288 1.035 . . . . 74.04 111.143 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -81.6 70.06 8.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.894 0.878 . . . . 54.21 111.02 -170.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 168.72 127.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.53 2.332 . . . . 74.21 106.865 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -79.47 79.86 5.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.195 -0.668 . . . . 64.24 109.195 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.3 t60 . . . . . 0 C--O 1.257 1.467 0 N-CA-C 107.413 -1.328 . . . . 74.21 107.413 179.657 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HG3' ' HA ' ' A' ' 34' ' ' ILE . 13.2 tmm? . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 108.025 -1.102 . . . . 73.11 108.025 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.2 139.28 50.07 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.406 0.682 . . . . 53.03 110.323 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t0 65.59 101.88 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.314 1.446 . . . . 72.2 110.839 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -76.27 -39.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.372 1.069 . . . . 71.23 111.068 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.56 -48.38 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.016 0.526 . . . . 72.54 110.979 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.94 -40.47 93.38 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.908 0.755 . . . . 72.42 110.326 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.42 90.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.021 0.825 . . . . 61.22 111.136 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.26 80.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.441 0.696 . . . . 73.21 111.613 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -72.82 -48.78 34.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 72.05 110.549 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -61.15 -42.68 98.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.055 0.942 . . . . 71.32 110.937 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.72 91.65 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.111 -0.949 . . . . 41.34 111.26 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -55.31 -51.22 67.44 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.045 0.841 . . . . 53.14 111.416 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.56 -46.72 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.425 -0.807 . . . . 70.35 110.28 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.146 0.978 . . . . 74.24 113.057 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HA ' HG11 ' A' ' 43' ' ' VAL . 57.6 mt -62.72 -43.19 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.802 0.841 . . . . 72.42 110.192 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -72.8 -33.16 66.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.553 0.341 . . . . 55.25 111.465 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.596 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 55.8 mt-30 -63.02 -37.85 88.83 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.639 0.587 . . . . 75.52 111.079 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 28' ' ' GLN . 95.6 mt -75.2 -37.24 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.768 0.667 . . . . 74.4 111.185 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.43 -29.32 70.63 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.747 0.647 . . . . 72.42 112.747 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -101.88 -15.11 16.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.825 0.45 . . . . 74.03 111.58 175.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -156.59 84.27 3.16 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 108.975 -0.75 . . . . 74.32 108.975 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 -12.93 36.76 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.142 2.562 . . . . 71.54 112.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -80.91 -5.58 57.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.446 1.098 . . . . 74.55 112.384 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.99 112.55 18.42 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 109.756 -0.461 . . . . 74.44 109.756 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.15 -34.11 5.23 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.599 2.199 . . . . 55.32 113.018 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.93 -30.83 56.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.867 0.467 . . . . 74.11 111.653 -171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.02 79.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.354 0.662 . . . . 62.31 110.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.582 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.0 pt20 -78.34 -23.94 46.76 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.09 -0.504 . . . . 63.14 111.616 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.67 -48.85 75.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 55.02 110.375 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.0 pp -66.48 -35.02 79.22 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.419 0.449 . . . . 73.44 109.951 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.15 -21.6 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.782 0.833 . . . . 72.54 112.191 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.1 -31.27 34.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.555 -0.535 . . . . 74.53 109.555 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.98 -35.09 38.0 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.22 1.008 . . . . 72.32 112.382 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.5 pt -111.26 -45.15 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.038 0.535 . . . . 64.14 111.854 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 39' ' ' VAL . 3.8 mm? -96.03 177.27 5.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.998 0.919 . . . . 71.31 108.869 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.4 m -71.65 147.01 91.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 116.321 -0.399 . . . . 64.45 110.061 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.63 -18.77 56.92 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.558 2.172 . . . . 75.51 113.21 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.07 -37.92 81.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.295 1.038 . . . . 60.42 111.18 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 35' ' ' LEU . 77.5 t -61.8 -55.57 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.749 0.656 . . . . 62.03 110.047 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.582 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.0 pp -59.73 -33.46 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.439 0.462 . . . . 62.14 111.038 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 27.5 t70 -67.55 -54.4 20.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 124.249 0.968 . . . . 75.11 110.44 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -67.28 -24.71 65.81 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.155 0.182 . . . . 74.45 111.404 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 15' ' ' ILE . 31.8 t -68.91 -52.03 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.491 0.716 . . . . 73.32 110.64 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -65.91 -20.73 66.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.576 0.35 . . . . 63.42 111.389 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 44.8 mt-10 -81.93 -35.77 28.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.406 0.682 . . . . 72.13 110.642 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -67.34 -22.29 65.6 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.223 0.609 . . . . 74.41 110.498 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.14 64.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 55.12 111.431 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -59.11 -33.14 70.51 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 124.33 1.018 . . . . 72.44 111.563 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.63 -50.87 61.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.284 0.634 . . . . 72.33 110.633 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.39 -34.26 61.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.081 -0.963 . . . . 74.32 110.682 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.06 -29.04 54.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.166 0.986 . . . . 75.32 110.848 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.43 -40.28 85.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.475 0.71 . . . . 64.2 109.847 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.8 -29.56 62.24 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.002 -0.999 . . . . 72.22 110.315 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.47 29.14 30.86 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.902 0.751 . . . . 44.11 112.81 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.43 116.47 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.743 0.817 . . . . 72.11 109.957 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -91.48 112.18 23.99 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.794 -1.188 . . . . 64.43 107.794 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -130.17 132.59 46.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.629 0.772 . . . . 54.11 109.621 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.32 135.72 51.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.152 0.581 . . . . 71.43 110.427 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.54 119.83 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.285 1.034 . . . . 74.23 109.81 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -104.89 -55.22 2.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.085 0.554 . . . . 73.3 110.409 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 ttm180 -131.9 124.77 30.17 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.753 -0.832 . . . . 75.35 108.753 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.28 116.31 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.274 -1.01 . . . . 64.2 108.274 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -113.92 108.44 17.05 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.637 -0.875 . . . . 62.23 108.637 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.88 127.18 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.381 -0.97 . . . . 71.24 108.381 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -139.61 139.83 36.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.398 0.679 . . . . 72.24 109.2 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 71' ' ' VAL . 47.3 p -97.56 116.23 29.38 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.046 0.538 . . . . 73.32 110.007 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.33 91.4 3.65 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.564 -1.273 . . . . 73.12 107.564 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.1 -119.98 7.0 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.017 -0.992 . . . . 60.11 110.905 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -101.13 -11.54 19.5 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.326 0.65 . . . . 74.33 111.082 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 m -94.39 121.51 36.0 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.516 0.726 . . . . 72.32 109.516 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 66' ' ' THR . 68.3 t -87.62 139.14 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.937 -0.764 . . . . 72.33 108.937 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -120.91 110.49 16.36 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.123 . . . . 65.12 108.171 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.12 104.11 15.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.615 -0.883 . . . . 63.45 108.615 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 78.4 m -92.72 105.58 17.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.897 -1.149 . . . . 70.33 107.897 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.6 p -118.55 124.01 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.658 0.783 . . . . 74.52 110.412 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.88 121.91 30.01 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.28 -1.007 . . . . 62.51 108.28 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.6 mp -107.45 160.65 15.48 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.337 0.655 . . . . 41.21 109.328 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -116.63 104.64 11.59 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.541 1.137 . . . . 74.22 108.153 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -100.36 102.97 14.34 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.893 -0.41 . . . . 70.23 109.893 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -89.83 104.23 16.81 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.333 -1.358 . . . . 65.31 107.333 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 t -133.73 122.9 24.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.593 0.757 . . . . 74.53 110.25 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.65 0.25 58.36 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.639 -0.709 . . . . 75.2 114.02 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.28 -36.22 3.49 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.734 0.683 . . . . 54.1 111.531 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.3 p -84.87 124.82 32.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.554 0.742 . . . . 74.31 110.914 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -93.7 106.24 18.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.698 0.799 . . . . 74.44 109.796 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 m -114.33 123.61 49.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.117 0.967 . . . . 72.31 109.002 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.57 130.21 35.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.094 -0.706 . . . . 75.3 109.094 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -127.03 125.92 42.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.077 0.951 . . . . 52.31 109.335 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -89.01 121.0 30.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.275 -0.639 . . . . 63.24 109.275 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD1' HD13 ' A' ' 77' ' ' LEU . 10.2 m-85 -102.99 133.08 48.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.261 -1.385 . . . . 70.33 107.261 173.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.34 106.1 12.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.91 -0.774 . . . . 74.15 108.91 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.0 mp -97.34 106.23 18.51 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.26 1.024 . . . . 63.33 108.384 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.599 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 76.8 ttt-85 -96.2 99.97 11.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.706 -0.85 . . . . 71.4 108.706 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.1 m-85 -85.87 107.88 17.88 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.68 -0.691 . . . . 74.55 109.418 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 38.5 tt0 -101.11 124.26 46.55 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.913 -1.04 . . . . 73.12 108.954 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 101' ' ' ILE . 29.9 m -87.27 147.46 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.562 -0.744 . . . . 72.34 111.534 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.82 99.44 6.28 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.648 -1.242 . . . . 74.5 107.648 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.67 -110.99 3.43 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.272 -0.876 . . . . 22.04 112.61 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -89.23 -16.23 31.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.924 0.89 . . . . 64.13 112.311 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -133.69 166.29 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.231 0.612 . . . . 74.44 111.156 -168.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 96' ' ' VAL . 25.1 mt -94.73 120.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 107.934 -1.136 . . . . 53.42 107.934 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -106.75 -17.22 14.28 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.044 0.538 . . . . 60.02 111.2 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 84.4 mtt85 -128.63 146.98 50.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.405 0.682 . . . . 75.32 110.889 -170.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.8 p -146.31 112.23 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 114.963 -1.017 . . . . 71.11 108.755 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 92.8 m -91.8 103.54 16.08 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.634 -0.876 . . . . 65.1 108.634 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.76 112.39 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.075 -0.713 . . . . 72.33 109.075 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.0 m -106.89 118.64 37.22 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.034 0.534 . . . . 61.33 109.825 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.75 84.04 7.7 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.826 0.85 . . . . 72.32 109.103 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -77.25 95.2 4.27 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.996 -0.547 . . . . 72.21 109.715 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.45 ' H ' HD23 ' A' ' 113' ' ' LEU . . . -169.82 92.18 0.1 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.276 -0.875 . . . . 55.3 110.928 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.36 -127.64 5.54 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.209 -0.756 . . . . 60.33 111.209 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -86.94 32.02 0.69 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.77 0.828 . . . . 61.14 111.748 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 110' ' ' GLY . 3.4 mm? -88.7 29.05 1.05 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.952 0.901 . . . . 62.31 111.354 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -60.31 130.7 47.92 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.456 -0.942 . . . . 64.12 108.456 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -80.72 80.76 7.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.629 0.728 . . . . 72.44 110.566 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -86.93 40.68 0.92 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.975 -1.012 . . . . 73.11 110.953 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -138.44 90.5 2.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.07 -1.455 . . . . 63.34 107.07 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -144.49 162.78 35.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.562 0.745 . . . . 73.55 109.664 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -78.42 171.54 14.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.709 0.803 . . . . 70.23 111.352 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--O 1.25 1.11 0 N-CA-C 108.826 -0.805 . . . . 73.24 108.826 177.577 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.967 0.413 . . . . 64.24 110.678 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -139.95 10.0 2.38 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.903 0.881 . . . . 74.31 110.224 -175.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.24 105.42 1.73 Allowed 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 124.687 1.195 . . . . 73.03 109.825 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.454 HG23 HG11 ' A' ' 96' ' ' VAL . 46.2 mm -46.4 -46.11 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.22 1.408 . . . . 45.02 113.934 -167.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.33 -52.18 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.41 0.684 . . . . 73.12 110.551 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.02 -33.92 72.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.512 -0.767 . . . . 72.54 111.35 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.02 68.72 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 124.237 1.015 . . . . 75.35 109.945 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.14 -32.64 73.05 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.719 0.637 . . . . 74.32 111.443 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.59 -51.49 59.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.581 0.752 . . . . 74.23 110.319 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.66 -33.82 76.83 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.611 0.765 . . . . 73.33 111.163 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.13 81.69 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 124.284 0.99 . . . . 71.15 110.752 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.47 71.1 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.399 1.062 . . . . 63.04 111.256 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 mt -66.31 -38.32 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 O-C-N 124.1 0.875 . . . . 42.11 110.072 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.1 74.37 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.814 0.845 . . . . 73.21 111.858 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 43' ' ' VAL . 60.1 mt -61.65 -40.97 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.774 0.83 . . . . 60.04 109.747 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 43.4 m-85 -75.36 -29.11 59.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.774 0.43 . . . . 75.45 112.084 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.13 -38.2 90.25 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.468 0.48 . . . . 54.35 110.148 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.09 -38.78 63.78 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.691 0.619 . . . . 74.44 110.707 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.1 m0 -68.58 -22.04 64.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.825 0.676 . . . . 73.24 112.825 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -99.68 -20.86 16.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.053 0.541 . . . . 71.21 110.883 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -158.72 91.75 2.02 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 123.928 0.891 . . . . 74.55 109.96 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.11 -9.14 24.84 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.268 2.645 . . . . 72.42 113.965 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 p -90.25 0.64 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.818 0.847 . . . . 53.43 111.868 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.04 114.73 22.45 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 122.866 0.466 . . . . 74.44 110.541 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 98.2 Cg_endo -75.21 -27.38 9.74 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.51 2.14 . . . . 75.41 114.005 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.9 -34.39 24.55 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.864 0.465 . . . . 54.52 112.06 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -52.34 57.12 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.483 0.713 . . . . 62.21 110.223 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -66.39 -28.53 68.7 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.203 -0.908 . . . . 61.1 111.31 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 6.8 tm-20 -58.49 -59.04 5.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.018 0.927 . . . . 65.43 109.93 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -63.97 -33.99 76.96 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.08 0.862 . . . . 72.21 111.034 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.12 -30.1 71.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.912 0.885 . . . . 63.54 112.471 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -65.42 -27.11 68.3 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.07 0.396 . . . . 74.3 111.866 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -94.16 -36.29 12.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.987 0.915 . . . . 72.33 112.286 -171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 30' ' ' LEU . 22.0 pt -103.74 -29.08 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 122.859 0.464 . . . . 74.23 112.225 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.529 HD12 HG21 ' A' ' 39' ' ' VAL . 4.1 mm? -106.05 178.38 4.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.035 0.934 . . . . 54.24 108.592 172.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 m -84.78 149.88 54.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.049 -0.523 . . . . 74.54 109.952 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 40' ' ' LEU . 83.0 Cg_exo -50.55 -26.25 16.28 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.565 2.843 . . . . 74.15 114.668 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.93 -42.07 95.0 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.084 0.954 . . . . 72.12 111.559 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 HD12 ' A' ' 35' ' ' LEU . 88.6 t -60.83 -60.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.555 0.742 . . . . 75.11 112.056 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -61.05 -22.55 64.68 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.073 0.397 . . . . 74.14 112.073 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.29 -42.68 30.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 53.44 111.234 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.56 -27.11 62.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 110.298 -0.26 . . . . 62.41 110.298 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 HG12 ' A' ' 15' ' ' ILE . 37.7 t -65.92 -53.8 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.69 0.796 . . . . 73.44 110.151 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -63.11 -22.47 66.88 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.229 0.212 . . . . 73.21 111.03 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -74.93 -45.27 43.62 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.452 0.701 . . . . 72.52 110.484 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -71.19 -22.67 62.0 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.895 -0.593 . . . . 70.44 110.701 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.49 98.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.187 0.995 . . . . 73.22 110.898 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -66.06 -34.14 77.4 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.912 -1.04 . . . . 61.13 110.837 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.53 -48.33 79.98 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.804 0.69 . . . . 63.23 110.867 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.67 -51.8 60.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.613 -0.722 . . . . 72.31 110.752 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.77 -35.29 79.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.351 -1.295 . . . . 60.51 111.405 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -61.01 -43.08 99.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.668 1.187 . . . . 74.31 111.356 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -83.65 -15.12 50.12 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.23 -0.896 . . . . 73.11 111.256 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.32 60.19 Favored Glycine 0 C--N 1.345 1.032 0 O-C-N 123.268 0.355 . . . . 14.41 112.878 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.95 91.49 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.821 -0.807 . . . . 75.02 108.821 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -92.53 153.15 19.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.398 -0.819 . . . . 71.55 108.876 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -149.84 170.17 19.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.339 0.655 . . . . 74.14 110.49 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -141.04 138.12 33.41 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.527 -0.916 . . . . 62.13 108.527 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.92 138.22 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 123.528 0.517 . . . . 74.44 109.86 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -115.98 -42.26 3.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.776 0.83 . . . . 73.14 111.559 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttm105 -157.82 123.87 4.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.805 -0.634 . . . . 72.44 109.998 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.89 107.62 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.264 -1.013 . . . . 72.43 108.264 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.71 123.75 43.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 62.23 108.945 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.81 128.75 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.83 -0.804 . . . . 55.12 108.83 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -137.91 117.85 13.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.171 -0.677 . . . . 71.41 109.171 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 71' ' ' VAL . 22.1 p -89.79 114.83 26.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.879 0.871 . . . . 72.24 109.856 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -113.99 90.92 3.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.448 1.099 . . . . 75.22 109.096 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.76 -105.13 1.45 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.513 -0.767 . . . . 51.03 112.43 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.405 ' O ' HG22 ' A' ' 96' ' ' VAL . 73.1 m-20 -114.89 14.65 17.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.241 1.016 . . . . 60.23 110.346 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.4 m -132.01 122.61 25.79 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.348 0.659 . . . . 54.55 110.227 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 66' ' ' THR . 58.7 t -90.03 115.35 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 122.939 0.495 . . . . 62.3 109.792 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -102.31 106.82 17.67 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.617 1.167 . . . . 73.51 108.872 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.22 110.53 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.533 0.733 . . . . 71.12 109.706 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -98.4 105.3 17.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.195 -1.039 . . . . 60.45 108.195 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.4 p -124.3 127.88 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.071 0.548 . . . . 74.0 110.065 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.27 136.98 32.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.937 0.495 . . . . 72.31 109.876 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.5 141.78 48.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.852 0.861 . . . . 63.13 109.927 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.32 104.32 16.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.728 0.811 . . . . 71.03 109.905 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -86.18 107.05 17.71 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.298 0.639 . . . . 73.45 109.557 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.3 m -88.34 104.55 16.86 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.12 -1.067 . . . . 63.23 108.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -144.02 131.81 21.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.437 1.095 . . . . 71.51 108.959 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.33 26.66 73.49 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.844 -0.162 . . . . 50.31 112.863 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.84 85.71 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.49 -0.616 . . . . 42.55 114.359 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.2 t -127.47 146.02 50.64 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.643 0.721 . . . . 61.34 111.259 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 149.97 22.08 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.12 0.968 . . . . 75.03 111.104 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.2 m -137.6 122.03 18.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.269 1.027 . . . . 74.15 109.219 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.41 100.31 5.15 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.03 -1.1 . . . . 74.14 108.03 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -114.72 122.76 47.4 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.359 -0.837 . . . . 63.42 109.046 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.8 m -89.99 124.68 34.96 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.75 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -104.52 127.57 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.818 0.847 . . . . 70.22 109.024 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.63 113.62 27.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.644 -0.873 . . . . 75.5 108.644 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.31 107.36 18.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.719 -0.845 . . . . 61.4 108.719 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -91.6 100.36 13.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.255 1.022 . . . . 64.11 109.484 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.26 106.9 18.52 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.367 0.667 . . . . 74.53 109.47 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 44.0 tt0 -97.54 116.95 30.72 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.736 0.814 . . . . 74.14 108.858 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 101' ' ' ILE . 4.5 m -89.69 149.32 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.444 0.697 . . . . 75.41 110.629 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.46 119.48 15.42 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.444 -1.317 . . . . 75.22 107.444 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.14 -97.99 0.97 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.017 -0.433 . . . . 54.44 112.017 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -121.72 -17.49 7.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.885 0.874 . . . . 73.12 111.91 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.7 t -124.94 160.03 29.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.93 0.492 . . . . 73.1 111.152 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 HG12 ' A' ' 96' ' ' VAL . 27.3 mt -86.03 126.78 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.772 -0.825 . . . . 65.2 108.772 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -102.36 -29.96 11.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.531 0.733 . . . . 74.14 111.715 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -130.95 146.89 52.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.624 0.25 . . . . 62.24 111.086 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.61 107.81 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.263 1.025 . . . . 64.43 109.36 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -95.12 106.57 18.59 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.949 -0.76 . . . . 74.24 108.949 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.49 136.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 109.61 -0.515 . . . . 54.45 109.61 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -129.46 113.0 14.35 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.59 0.756 . . . . 72.41 109.796 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.31 101.79 7.36 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.316 0.647 . . . . 73.42 109.902 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -90.47 90.16 7.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.124 0.97 . . . . 65.25 108.887 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 47.25 0.11 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.128 -1.189 . . . . 63.35 110.128 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.94 78.76 0.24 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.05 -0.575 . . . . 64.23 111.719 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 m -64.46 94.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.91 0.884 . . . . 73.4 110.634 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -106.63 109.24 21.1 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.062 -0.718 . . . . 72.53 109.062 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.02 167.91 24.54 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.614 1.166 . . . . 72.51 109.783 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -154.88 102.92 2.38 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.786 -1.19 . . . . 71.11 107.786 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -114.12 122.68 47.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.374 0.67 . . . . 73.22 110.204 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -86.99 138.13 31.76 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.248 0.619 . . . . 65.3 109.592 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -75.63 104.8 6.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.849 0.46 . . . . 75.41 110.099 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -68.82 147.32 51.92 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.471 -0.786 . . . . 65.24 108.967 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 108.311 -0.996 . . . . 73.53 108.311 -178.388 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 94.8 mmm . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.509 -0.552 . . . . 75.24 109.509 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -129.39 15.9 6.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.453 0.701 . . . . 72.11 109.844 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.48 162.9 12.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.15 0.98 . . . . 72.23 109.692 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.25 -39.74 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.583 0.753 . . . . 74.41 111.725 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.27 -52.93 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.682 0.793 . . . . 63.24 111.891 -171.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -67.62 -35.7 79.43 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.686 -0.688 . . . . 71.21 110.523 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -62.8 -41.84 99.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.325 0.65 . . . . 72.52 111.293 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.65 66.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 73.41 111.008 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.58 -54.63 44.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.553 1.141 . . . . 65.31 111.054 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -64.43 -33.94 77.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.509 0.723 . . . . 75.52 110.977 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -49.42 76.11 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.008 0.818 . . . . 52.23 111.025 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.75 68.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.315 1.01 . . . . 71.13 111.504 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 51.1 mt -63.4 -40.46 89.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 124.175 0.922 . . . . 72.4 110.324 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.348 0.659 . . . . 63.02 111.334 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.3 mt -56.13 -39.32 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 72.24 110.304 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -71.12 -32.67 69.3 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.249 0.62 . . . . 53.54 111.759 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 26.8 mt-30 -63.04 -38.37 90.92 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.099 0.56 . . . . 72.24 110.519 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 3.4 mm? -66.59 -48.87 68.2 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 123.543 0.527 . . . . 75.22 109.945 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 106' ' ' VAL . 32.4 m0 -51.52 -34.33 35.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.485 0.92 . . . . 74.05 113.485 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.46 -32.24 12.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.7 0.4 . . . . 64.45 111.686 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -143.95 86.99 8.22 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 108.983 -0.747 . . . . 74.15 108.983 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.89 -15.69 50.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.979 2.453 . . . . 74.23 113.03 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.2 p -89.45 13.34 13.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.42 1.088 . . . . 62.31 112.283 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.21 110.81 26.19 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.281 -0.636 . . . . 74.52 109.281 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.16 -21.61 17.71 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.461 2.107 . . . . 53.23 113.624 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.69 -39.55 26.97 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.359 0.664 . . . . 63.43 111.444 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.19 -50.02 65.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.464 0.706 . . . . 73.03 110.748 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.541 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.6 pt20 -72.41 -19.63 61.56 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.429 -0.805 . . . . 42.41 111.505 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.49 -54.97 24.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.13 0.572 . . . . 74.31 110.592 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.26 -30.3 70.15 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.313 -0.403 . . . . 65.03 110.262 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.18 -28.4 69.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.908 0.755 . . . . 74.41 112.034 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -75.11 -26.96 59.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.317 0.58 . . . . 62.34 109.891 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -78.8 -41.26 30.84 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.915 0.886 . . . . 64.42 110.748 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.453 HG13 HD23 ' A' ' 35' ' ' LEU . 9.9 pt -103.27 -36.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.081 0.552 . . . . 73.34 112.294 -170.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 34' ' ' ILE . 3.8 mm? -103.28 -176.88 3.21 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.26 1.024 . . . . 75.24 109.477 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.409 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.7 m -81.29 145.89 56.84 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.421 -0.809 . . . . 71.22 109.878 170.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.22 -27.98 59.47 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.854 2.369 . . . . 55.32 112.484 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.62 -48.33 77.71 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.537 1.135 . . . . 75.22 111.479 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 35' ' ' LEU . 98.7 t -66.33 -51.97 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.81 0.844 . . . . 70.14 111.391 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 28' ' ' GLN . 4.0 pp -65.13 -28.66 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 120.769 0.318 . . . . 75.43 111.539 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.79 -33.21 60.13 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.511 -0.768 . . . . 62.45 110.54 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -77.62 -32.63 53.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.696 -0.483 . . . . 73.01 109.696 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.3 t -59.94 -42.73 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.442 0.697 . . . . 73.25 111.028 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -73.36 -21.49 60.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.834 0.454 . . . . 62.21 111.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.26 -50.73 13.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.295 0.638 . . . . 74.55 110.829 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -71.01 -21.3 62.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.712 0.805 . . . . 70.32 111.02 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -58.25 -44.86 88.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.725 1.21 . . . . 72.12 111.613 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 99.4 mtt180 -60.43 -35.55 76.08 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.408 -1.269 . . . . 70.24 110.689 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.69 -43.97 74.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.908 0.755 . . . . 74.33 110.3 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.97 -27.96 68.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.755 0.822 . . . . 73.21 111.207 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -79.4 -33.34 42.82 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.991 0.917 . . . . 72.54 110.089 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 94.0 mttt -67.63 -39.37 84.65 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.574 0.749 . . . . 74.5 110.315 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.18 -44.51 88.23 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.085 -0.962 . . . . 73.43 109.219 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.92 44.79 5.91 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.251 -0.886 . . . . 43.41 112.137 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -79.37 106.23 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.781 -0.822 . . . . 73.0 108.781 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -85.81 108.97 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.896 -1.15 . . . . 75.04 107.896 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.53 142.09 50.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.409 -0.589 . . . . 74.14 109.409 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.89 135.72 54.78 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.797 -0.816 . . . . 71.01 108.797 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.37 100.12 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.202 -1.036 . . . . 54.44 108.202 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.37 -49.98 8.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.47 -0.786 . . . . 74.53 110.816 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -144.5 122.65 12.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.308 -0.86 . . . . 71.1 109.682 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.65 124.76 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.623 0.769 . . . . 65.22 109.275 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.1 108.2 10.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.27 -1.011 . . . . 64.53 108.27 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 HG22 ' A' ' 73' ' ' VAL . 7.7 p -96.17 121.23 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.276 0.56 . . . . 72.21 109.541 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.1 m -129.4 141.46 51.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.165 0.986 . . . . 75.15 109.711 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -88.89 163.33 15.67 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.037 0.535 . . . . 74.43 110.939 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -158.57 74.76 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.767 -1.197 . . . . 72.01 107.767 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.84 -117.83 11.21 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.861 -0.495 . . . . 72.41 111.861 -171.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -88.31 -11.68 45.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.114 0.565 . . . . 63.43 111.023 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -97.93 156.05 16.79 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.706 1.202 . . . . 73.35 109.693 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.32 123.5 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.281 0.633 . . . . 62.32 110.296 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -99.34 112.64 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.855 0.862 . . . . 74.03 109.686 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 64' ' ' VAL . 61.5 t -91.1 105.02 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.901 -0.777 . . . . 62.22 108.901 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -86.07 104.95 16.14 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.367 -0.975 . . . . 74.42 108.367 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.16 126.82 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.995 0.518 . . . . 64.01 110.461 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.65 123.75 32.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.809 0.844 . . . . 74.04 109.381 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.69 123.15 45.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.316 -0.994 . . . . 71.43 108.316 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 34.9 tt0 -88.86 107.82 19.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.461 -0.941 . . . . 73.13 108.461 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.89 130.61 48.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.731 0.813 . . . . 64.23 110.652 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.2 m -119.52 117.68 29.04 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.158 1.383 . . . . 60.14 107.926 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -144.27 134.29 24.06 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.542 -0.91 . . . . 74.44 108.542 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.51 28.64 62.61 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.355 0.409 . . . . 71.33 113.619 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.67 -34.34 4.25 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 74.33 113.03 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -82.05 133.99 35.32 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.236 0.614 . . . . 64.14 110.612 -170.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -118.51 129.85 55.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.601 0.761 . . . . 64.22 110.334 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.1 m -143.64 136.27 27.24 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.918 0.887 . . . . 73.22 109.669 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 16.5 m120 -79.79 105.39 11.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.684 0.793 . . . . 75.5 109.956 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 m -101.03 126.53 47.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.625 1.17 . . . . 72.42 110.385 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -93.78 122.52 36.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.876 0.47 . . . . 63.12 110.795 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.8 127.54 53.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.398 0.679 . . . . 73.21 109.485 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.03 106.69 18.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.909 -1.145 . . . . 71.41 107.909 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.7 mp -95.34 106.84 18.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.09 -1.078 . . . . 74.5 108.09 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 34.1 ttt180 -98.44 99.91 11.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.942 0.897 . . . . 72.25 109.41 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.81 112.46 22.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.525 1.13 . . . . 54.04 111.007 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 31.2 tt0 -90.91 134.36 34.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.088 -0.708 . . . . 72.23 109.088 174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.44 151.42 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.304 1.042 . . . . 72.23 111.712 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.37 103.41 6.9 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.705 -1.221 . . . . 64.04 107.705 162.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.33 -105.32 2.06 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.719 -0.673 . . . . 75.11 112.072 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.64 -9.9 10.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.24 1.016 . . . . 71.44 110.912 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -110.4 148.08 32.73 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.598 0.759 . . . . 74.11 109.214 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.09 144.73 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.865 -0.791 . . . . 74.31 108.865 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -125.06 -25.57 3.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.498 0.719 . . . . 71.24 112.443 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 3.0 mpt_? -129.72 156.44 44.27 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.755 0.422 . . . . 74.43 110.299 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 109.92 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.359 1.064 . . . . 74.33 109.091 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 40.7 m -92.05 105.12 17.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.762 -0.829 . . . . 50.3 108.762 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.49 HG11 ' HH2' ' A' ' 19' ' ' TRP . 48.0 t -93.36 105.84 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 122.927 0.491 . . . . 71.11 109.742 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.6 m -100.64 113.8 26.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.524 0.729 . . . . 72.34 109.849 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -79.62 126.67 31.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.027 -0.731 . . . . 75.45 109.027 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -128.95 146.93 50.83 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.66 0.784 . . . . 65.42 109.589 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.77 -12.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.423 -0.808 . . . . 64.23 111.93 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.62 151.42 19.16 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.343 -0.303 . . . . 52.34 112.343 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -93.06 85.92 5.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.528 0.68 . . . . 51.0 110.061 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.87 4.07 53.74 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.319 0.648 . . . . 70.13 111.448 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.02 95.61 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.15 109.963 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -178.14 159.3 1.27 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.871 1.268 . . . . 73.23 109.267 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -118.38 -74.47 0.6 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.097 -0.705 . . . . 72.11 109.097 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -97.05 43.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.438 0.695 . . . . 70.23 110.437 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.1 t60 67.08 62.2 0.48 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.232 1.413 . . . . 73.51 111.88 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -80.52 -15.24 57.17 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.297 0.57 . . . . 71.34 109.867 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.07 1.348 . . . . 73.13 107.918 174.856 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.766 -0.457 . . . . 65.44 109.766 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.6 8.66 33.31 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.32 0.648 . . . . 74.43 110.079 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -60.01 112.0 1.71 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 123.701 0.8 . . . . 63.43 109.974 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.76 -43.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.431 1.082 . . . . 64.3 111.489 -175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.5 -46.18 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.945 0.898 . . . . 61.11 110.199 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -67.23 -33.93 76.4 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.576 -0.738 . . . . 63.34 110.521 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -65.77 -45.75 81.35 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.304 0.642 . . . . 75.04 110.513 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.26 98.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.575 0.75 . . . . 73.34 110.969 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -59.02 -56.54 20.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.258 1.023 . . . . 74.54 111.019 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.77 0.828 . . . . 73.14 111.444 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -66.44 -45.13 80.87 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 124.151 0.907 . . . . 53.1 110.628 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.12 75.16 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 124.112 0.883 . . . . 63.22 110.816 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.49 -44.85 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 124.263 0.977 . . . . 70.23 110.163 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.63 71.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.107 0.963 . . . . 34.31 112.7 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -65.07 -41.45 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.26 0.624 . . . . 75.1 110.338 175.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -74.55 -31.51 62.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.71 0.404 . . . . 63.33 111.28 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.93 -37.41 85.98 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.111 0.564 . . . . 75.05 110.341 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.79 -38.86 67.11 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 119.199 -0.429 . . . . 64.42 110.71 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.429 ' HB3' ' HZ ' ' A' ' 57' ' ' PHE . 19.6 m0 -63.61 -21.33 66.3 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.364 0.876 . . . . 75.01 113.364 -176.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -102.32 -25.21 13.74 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.676 0.39 . . . . 71.21 111.156 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -146.04 96.0 4.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 123.273 0.629 . . . . 74.14 109.966 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.88 -28.51 75.59 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.251 2.634 . . . . 74.14 112.925 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 p -92.55 22.08 4.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.901 0.88 . . . . 73.44 111.945 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.25 112.15 23.75 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.055 -0.72 . . . . 74.3 109.055 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.37 -34.45 20.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.79 2.327 . . . . 70.15 112.898 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.71 -49.1 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 74.21 110.973 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.11 -52.67 64.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 124.225 0.953 . . . . 71.54 111.105 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 40' ' ' LEU . 13.8 pt20 -68.15 -32.8 73.32 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 116.061 -0.518 . . . . 71.41 111.608 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.2 tt0 -69.87 -43.5 71.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.469 0.307 . . . . 74.15 111.098 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.6 pp -67.35 -34.01 76.42 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.826 -0.435 . . . . 74.22 109.826 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 HD12 ' A' ' 35' ' ' LEU . 85.8 mt -65.34 -30.6 71.45 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.56 0.744 . . . . 75.23 111.517 174.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -67.53 -33.85 75.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.194 0.598 . . . . 72.23 110.355 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 27.4 mtpp -80.89 -46.35 15.37 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.161 -0.927 . . . . 73.31 111.376 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 30' ' ' LEU . 13.0 pt -99.07 -35.18 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.654 0.382 . . . . 73.32 111.732 -168.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.518 HD11 ' HB1' ' A' ' 11' ' ' ALA . 28.3 mt -101.95 -170.52 1.83 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.397 -0.594 . . . . 74.1 109.397 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.586 ' HB2' HG23 ' A' ' 39' ' ' VAL . 8.9 m -73.36 138.35 78.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 115.623 -0.717 . . . . 70.32 109.504 169.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.93 -19.68 33.14 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.793 2.329 . . . . 63.41 113.501 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.78 -33.39 70.71 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.513 1.125 . . . . 75.34 111.755 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.0 t -67.07 -49.67 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.435 0.694 . . . . 74.32 111.42 -175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.5 pp -58.78 -30.8 67.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.396 0.278 . . . . 72.14 111.212 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.45 -58.93 5.05 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.714 1.206 . . . . 64.33 110.986 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.31 -30.47 71.6 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.823 0.449 . . . . 63.41 111.654 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 15' ' ' ILE . 48.9 t -67.08 -50.5 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.897 0.879 . . . . 63.3 110.651 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -73.68 -20.42 60.55 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.124 0.416 . . . . 72.31 112.124 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -85.61 -26.59 25.98 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 122.22 -0.3 . . . . 74.13 110.543 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.7 -25.31 60.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.885 0.874 . . . . 72.11 109.936 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.25 90.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.185 1.394 . . . . 70.44 112.066 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -59.89 -38.65 82.85 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.836 1.335 . . . . 74.34 111.005 -173.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -57.19 -58.84 6.46 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.233 0.958 . . . . 75.53 110.659 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.8 -34.02 76.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.509 1.124 . . . . 50.32 111.983 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -66.11 -45.11 82.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.014 0.925 . . . . 71.14 110.339 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.6 -32.56 66.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.48 0.712 . . . . 72.55 111.157 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -69.45 -18.29 63.71 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.486 0.714 . . . . 75.33 111.427 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.75 42.0 40.46 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.557 0.536 . . . . 70.42 112.203 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -111.15 96.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.211 -0.663 . . . . 64.13 109.211 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -92.05 108.11 19.7 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.192 -0.669 . . . . 70.31 109.192 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 8.7 p90 -106.3 135.49 47.7 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.174 -1.417 . . . . 63.14 107.174 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.56 135.6 47.15 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 110.007 -0.368 . . . . 73.04 110.007 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.68 125.18 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.902 1.376 . . . . 74.04 110.626 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.39 -37.93 3.91 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.731 0.813 . . . . 70.42 111.064 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 27.2 ttp85 -143.81 129.5 19.24 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.338 0.655 . . . . 75.01 109.349 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.65 128.66 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.878 0.871 . . . . 63.43 108.759 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.38 106.62 9.33 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.737 -1.208 . . . . 62.42 107.737 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.466 HG23 HG22 ' A' ' 73' ' ' VAL . 7.3 p -103.26 113.97 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.772 -0.825 . . . . 73.21 108.772 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.5 t -137.55 153.63 49.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 74.41 109.97 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 71' ' ' VAL . 34.2 p -100.75 130.16 46.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.145 0.578 . . . . 71.33 111.676 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.88 81.08 1.38 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.503 1.921 . . . . 71.33 108.437 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.44 -120.47 8.35 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.41 -0.814 . . . . 64.24 111.207 -173.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -87.38 -11.33 49.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.441 0.697 . . . . 73.15 110.639 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.4 m -89.96 156.73 18.22 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.272 1.029 . . . . 61.41 108.845 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 66' ' ' THR . 43.7 t -122.4 133.0 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.04 0.936 . . . . 74.25 109.331 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -110.56 125.83 53.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.722 0.809 . . . . 74.33 109.203 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 64' ' ' VAL . 48.7 t -97.38 104.1 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.378 -0.971 . . . . 42.05 108.378 169.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -86.75 102.22 14.05 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.515 -1.291 . . . . 61.22 107.515 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.21 123.1 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 33.44 109.89 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.0 tt0 -90.13 127.81 36.19 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.353 1.061 . . . . 73.02 109.444 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.49 143.68 51.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.288 0.635 . . . . 75.33 109.847 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -91.61 108.75 20.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.178 -0.675 . . . . 74.31 109.178 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 24.9 mt-10 -87.25 103.18 15.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.075 0.55 . . . . 74.11 109.666 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.7 m -93.96 106.14 18.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 74.42 109.465 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -145.59 118.55 8.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.346 1.058 . . . . 75.54 109.24 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.73 23.14 62.8 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.514 0.565 . . . . 23.34 114.514 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.03 -22.64 34.48 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.964 0.316 . . . . 75.1 112.901 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.2 m -83.69 124.52 30.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.561 0.745 . . . . 64.21 109.833 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 m -126.92 110.37 12.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.445 -0.946 . . . . 61.34 108.445 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.9 m -125.9 136.11 52.68 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.955 0.902 . . . . 64.32 109.976 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.93 100.58 6.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.833 -1.173 . . . . 55.32 107.833 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.2 m -105.29 132.63 51.24 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.927 -1.033 . . . . 73.22 108.985 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -89.39 122.89 33.04 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.427 -0.583 . . . . 75.22 109.427 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -104.8 126.77 52.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.164 -1.05 . . . . 63.43 108.164 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -113.79 103.9 11.66 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.103 -1.073 . . . . 74.32 108.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 106' ' ' VAL . 5.7 mp -98.38 107.07 19.44 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.117 -1.068 . . . . 75.23 108.117 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -90.45 98.74 11.95 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.075 -0.713 . . . . 60.25 109.075 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.618 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.4 m-85 -89.54 109.92 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.492 1.117 . . . . 73.11 109.284 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 28.2 tt0 -107.63 131.59 54.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.616 -0.513 . . . . 72.34 109.616 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 101' ' ' ILE . 11.0 m -84.35 151.84 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.83 1.252 . . . . 63.44 111.115 -168.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.8 98.38 3.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.215 -1.032 . . . . 72.41 108.215 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.82 2.18 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.021 -0.831 . . . . 34.42 111.021 -174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.68 -5.25 12.71 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.977 0.911 . . . . 70.34 111.17 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.6 t -127.44 143.86 51.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.68 . . . . 74.42 110.282 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 94' ' ' PHE . 73.4 mt -87.9 109.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.671 0.788 . . . . 73.22 109.361 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -103.27 6.16 37.93 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.209 0.448 . . . . 64.31 112.209 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 90.0 mtt180 -133.21 141.91 48.31 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.349 0.66 . . . . 73.4 110.903 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.96 134.68 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 63.32 108.504 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.4 m -132.02 106.56 8.1 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.094 -0.706 . . . . 71.41 109.094 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 92' ' ' LEU . 37.6 t -90.04 119.03 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.924 0.49 . . . . 71.32 109.798 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.6 m -113.31 106.88 15.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.504 0.722 . . . . 73.23 110.374 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -77.93 103.83 8.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.39 -0.967 . . . . 62.3 108.39 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.97 79.94 9.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.539 0.735 . . . . 64.3 109.588 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.93 -17.75 15.66 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.461 -1.245 . . . . 71.25 111.687 172.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.86 120.22 0.58 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.299 -0.72 . . . . 70.22 111.299 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 m -72.98 159.57 33.46 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.253 0.621 . . . . 74.52 110.34 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.73 -60.08 4.23 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.831 0.852 . . . . 71.4 110.217 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.68 98.89 2.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.75 0.82 . . . . 63.15 109.385 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -81.7 178.38 8.36 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.302 0.641 . . . . 74.33 110.954 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -84.93 51.75 2.24 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.036 0.922 . . . . 72.41 110.331 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -143.41 97.06 3.01 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.998 0.919 . . . . 41.43 109.385 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -89.89 113.5 25.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.879 -0.786 . . . . 73.42 108.879 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 m80 63.91 97.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.805 1.242 . . . . 62.43 111.507 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.015 -1.105 . . . . 73.24 108.015 177.471 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.633 0.254 . . . . 74.44 110.38 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -88.48 -6.61 57.51 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.018 0.927 . . . . 75.14 110.801 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.99 41.62 0.98 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.519 1.128 . . . . 45.1 110.97 -170.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -51.59 -41.1 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 125.401 1.481 . . . . 52.13 114.111 -166.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.34 -51.9 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.457 0.703 . . . . 73.13 110.678 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.71 -30.1 71.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.437 0.695 . . . . 70.14 110.344 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.68 71.18 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.848 1.259 . . . . 64.52 109.87 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.78 82.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.528 0.731 . . . . 71.34 111.495 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.479 ' HG3' HG11 ' A' ' 62' ' ' VAL . 39.6 tttm -63.68 -51.66 64.13 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.028 -0.987 . . . . 74.42 111.796 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -72.64 -24.7 61.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.348 0.259 . . . . 64.45 111.317 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.04 -45.12 86.7 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 123.533 0.733 . . . . 53.03 110.237 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.64 -54.37 46.9 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.475 1.109 . . . . 72.12 110.746 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.45 HG12 HG11 ' A' ' 59' ' ' VAL . 57.0 mt -59.89 -41.67 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.086 0.866 . . . . 72.34 110.854 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.71 88.52 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.959 0.904 . . . . 63.13 111.58 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.514 ' HA ' HG11 ' A' ' 43' ' ' VAL . 45.6 mt -61.22 -37.23 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 124.064 0.853 . . . . 54.01 110.496 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.27 -29.9 34.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.792 0.437 . . . . 73.34 111.497 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -66.73 -35.2 79.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.355 0.662 . . . . 74.33 110.276 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.15 -47.22 59.07 Favored 'General case' 0 C--O 1.213 -0.816 0 O-C-N 123.669 0.606 . . . . 73.0 110.17 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.489 ' HB3' HD12 ' A' ' 50' ' ' LEU . 29.1 m0 -57.1 -26.67 60.85 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.105 0.78 . . . . 72.23 113.105 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -101.36 -16.18 16.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.807 0.443 . . . . 71.41 111.963 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -156.17 89.54 2.79 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 123.996 0.918 . . . . 75.54 109.352 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 23.6 Cg_endo -59.77 -23.1 70.71 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.883 3.055 . . . . 74.03 113.633 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.4 p -81.17 -2.22 47.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.15 0.98 . . . . 62.54 112.341 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.95 113.49 13.54 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 122.919 0.487 . . . . 73.23 109.873 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.51 -28.26 4.54 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.363 2.042 . . . . 61.43 112.766 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -70.03 -41.02 74.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.47 0.708 . . . . 73.13 111.183 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -51.41 49.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.897 -1.047 . . . . 62.01 111.116 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -68.41 -28.37 67.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.118 -0.492 . . . . 72.22 112.056 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.28 -47.26 62.02 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.254 0.346 . . . . 62.3 110.874 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -65.76 -33.34 75.65 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 110.175 -0.306 . . . . 74.53 110.175 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.96 -28.88 70.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.731 0.813 . . . . 71.1 111.722 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -69.39 -41.63 76.21 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.435 0.636 . . . . 70.31 109.613 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -73.98 -22.62 59.55 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.606 -1.179 . . . . 74.35 112.215 -171.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.0 pt -118.09 -51.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.315 0.507 . . . . 75.25 112.337 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.416 HD23 HG13 ' A' ' 34' ' ' ILE . 3.1 mm? -82.14 166.43 19.68 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 54.35 108.206 173.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -61.79 142.7 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 109.77 -0.456 . . . . 75.4 109.77 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.84 -11.42 14.85 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.746 2.297 . . . . 72.14 113.444 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.86 -37.12 73.07 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.735 0.814 . . . . 53.54 110.816 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.0 -37.54 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.253 1.021 . . . . 61.51 112.202 -171.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.35 -31.54 72.19 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.784 0.265 . . . . 71.04 110.905 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.22 -57.34 6.9 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 124.457 1.098 . . . . 41.25 109.991 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 12.1 pt20 -58.79 -30.44 67.59 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.035 0.534 . . . . 60.23 111.993 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 15' ' ' ILE . 67.6 t -75.44 -49.8 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.127 0.971 . . . . 54.22 111.913 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -67.67 -24.96 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.745 0.307 . . . . 74.01 111.344 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -86.14 -25.57 25.67 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.825 0.45 . . . . 52.11 110.984 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 5.5 t60 -67.0 -29.29 69.09 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.913 0.885 . . . . 72.3 109.544 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -59.03 -39.6 82.44 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.107 1.363 . . . . 63.21 112.667 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 75.3 mtp180 -58.43 -32.04 68.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.031 0.932 . . . . 73.03 111.293 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.22 -51.66 62.59 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.166 0.986 . . . . 50.43 110.907 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.515 HD22 HD12 ' A' ' 55' ' ' ILE . 53.0 mt -73.6 -17.69 61.14 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.307 -0.86 . . . . 75.33 111.317 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -72.61 -42.73 64.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.177 0.991 . . . . 74.41 109.625 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 73.6 mmtt -61.62 -42.62 99.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 123.739 0.649 . . . . 74.44 109.611 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -72.53 -28.52 62.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.231 -1.349 . . . . 73.32 111.732 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.12 40.71 95.13 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.729 0.643 . . . . 54.2 113.087 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.515 HD12 HD22 ' A' ' 50' ' ' LEU . 59.3 mt -78.62 114.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.883 0.473 . . . . 60.15 109.865 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -90.64 112.92 24.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.485 -0.931 . . . . 70.44 108.485 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.2 134.38 20.51 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.428 0.558 . . . . 72.01 111.164 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.875 0.87 . . . . 72.02 109.645 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 13' ' ' ILE . 49.4 t -77.18 120.62 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.394 1.077 . . . . 72.51 109.755 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.19 -54.5 2.6 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.431 0.692 . . . . 64.25 111.376 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 8.6 tpp85 -132.59 127.27 34.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.442 -0.948 . . . . 70.14 108.442 -173.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 9' ' ' LYS . 38.3 t -123.0 109.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.723 -0.843 . . . . 72.2 108.723 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -119.79 108.39 14.33 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.632 -0.877 . . . . 61.03 108.632 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -105.34 109.95 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.085 0.954 . . . . 65.32 109.687 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -123.83 142.55 51.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.913 0.885 . . . . 40.14 109.742 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.1 p -93.42 124.05 37.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.657 0.383 . . . . 70.03 110.369 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -113.51 98.24 6.95 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.228 -1.027 . . . . 72.35 108.228 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.191 -1.164 . . . . 73.42 110.191 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.45 -15.21 15.08 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.358 0.663 . . . . 72.03 110.332 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.0 m -93.35 117.06 29.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.922 0.489 . . . . 53.5 109.761 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.0 p -88.68 128.9 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.189 0.596 . . . . 71.34 110.377 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.63 113.35 25.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.782 1.233 . . . . 72.33 109.363 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.57 104.48 15.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.292 -0.632 . . . . 63.1 109.292 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.9 m -86.29 104.8 16.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.019 -1.104 . . . . 71.22 108.019 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.1 p -127.61 115.35 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.337 0.655 . . . . 72.12 111.391 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.59 132.43 35.3 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.206 -0.906 . . . . 70.1 109.573 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.24 135.17 54.43 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.001 0.92 . . . . 74.41 108.679 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 85' ' ' THR . 33.4 tt0 -93.96 102.14 14.22 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -95.35 112.88 24.52 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.482 1.113 . . . . 74.12 109.593 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -87.67 102.97 15.15 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.766 -1.198 . . . . 72.31 107.766 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -134.83 134.98 41.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.952 -1.129 . . . . 71.35 107.952 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.11 65.57 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.091 0.245 . . . . 71.3 112.553 -172.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.27 59.53 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 123.206 0.431 . . . . 60.42 113.5 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.2 p -96.66 151.01 20.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.905 0.882 . . . . 71.41 111.093 -173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.526 HG23 ' HG3' ' A' ' 78' ' ' GLU . 89.4 m -85.38 115.85 23.36 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.093 0.957 . . . . 74.41 109.125 177.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.6 m -121.42 111.02 16.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.714 -0.847 . . . . 62.42 108.714 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -90.37 102.7 15.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.487 -0.931 . . . . 71.55 108.487 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.6 m -111.46 126.11 54.6 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.627 0.771 . . . . 74.22 109.261 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -91.73 120.89 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.456 -0.572 . . . . 74.14 109.456 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.2 127.69 49.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.768 -1.567 . . . . 75.14 106.768 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.26 102.08 10.52 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.987 -1.116 . . . . 70.35 107.987 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.4 mp -90.74 106.58 18.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 50.6 ttp180 -91.67 98.46 11.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.731 -1.122 . . . . 73.35 108.175 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.578 ' HB3' HG21 ' A' ' 101' ' ' ILE . 98.7 m-85 -88.53 107.75 19.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 1.6 tm-20 -90.89 125.95 35.9 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.882 -1.525 . . . . 74.33 106.882 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.4 HG12 HG12 ' A' ' 101' ' ' ILE . 19.8 m -104.13 148.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.177 0.991 . . . . 75.12 111.676 -163.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.7 92.45 2.75 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.691 1.196 . . . . 75.01 109.007 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.62 -102.42 1.29 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.468 -0.787 . . . . 65.15 111.53 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.5 -10.06 13.75 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.078 0.951 . . . . 73.4 111.037 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -108.17 166.73 10.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.274 0.63 . . . . 71.25 109.565 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 94' ' ' PHE . 54.1 mt -115.52 120.29 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 107.637 -1.245 . . . . 63.44 107.637 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -88.26 -30.92 19.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.176 0.19 . . . . 73.32 111.153 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 65.2 mtt180 -129.42 147.73 51.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.904 0.481 . . . . 74.14 110.904 -164.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.67 110.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 64.34 109.051 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 25.9 m -95.39 104.67 16.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.667 -0.864 . . . . 54.44 108.667 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG22 ' HG ' ' A' ' 92' ' ' LEU . 40.9 t -85.55 102.41 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.669 -1.234 . . . . 70.15 107.669 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 m -99.26 109.31 21.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.096 -0.705 . . . . 71.41 109.096 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.37 106.56 12.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.593 0.757 . . . . 74.4 110.374 -174.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -107.23 104.56 14.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.611 1.164 . . . . 61.3 108.54 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.32 -163.9 25.13 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-O 119.854 -0.414 . . . . 45.33 112.674 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.73 57.45 14.36 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.75 0.323 . . . . 41.34 112.855 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -87.52 97.67 10.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.85 0.46 . . . . 44.3 110.492 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.03 -55.1 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.244 0.545 . . . . 75.31 110.153 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 -167.95 2.14 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.574 1.15 . . . . 71.4 109.314 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 117' ' ' HIS . 59.4 m80 -136.38 121.17 18.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.411 1.084 . . . . 74.14 108.782 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -67.54 -17.14 64.55 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.563 0.745 . . . . 40.03 112.292 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 115' ' ' HIS . 82.1 m-70 -129.36 145.14 51.44 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.442 -0.948 . . . . 72.22 108.442 165.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -52.62 143.55 15.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.998 0.919 . . . . 72.54 112.158 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -67.77 120.46 14.15 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.41 0.444 . . . . 54.31 110.958 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.411 -0.959 . . . . 71.55 108.411 171.381 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.205 -0.665 . . . . 73.11 109.205 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -58.46 -56.57 20.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.162 0.985 . . . . 65.14 112.193 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -160.54 163.01 33.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.536 0.734 . . . . 74.43 109.623 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.31 -50.15 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.884 0.874 . . . . 73.11 110.999 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.39 -36.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.205 -0.907 . . . . 63.34 110.295 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.14 -35.57 80.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.919 -0.582 . . . . 60.21 110.869 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.731 0.412 . . . . 75.15 110.211 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.38 90.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.702 -0.681 . . . . 73.21 111.699 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.29 -46.79 69.39 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.471 -0.786 . . . . 41.55 111.285 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -63.83 -41.77 97.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.448 0.699 . . . . 73.11 110.666 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.34 97.86 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 123.666 0.604 . . . . 72.25 111.29 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.51 -53.71 54.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.032 0.833 . . . . 63.13 111.156 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 70.1 mt -61.96 -43.68 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.363 -0.835 . . . . 74.13 110.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 30' ' ' LEU . . . -63.96 -37.56 87.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.588 0.755 . . . . 72.13 112.454 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.14 -37.59 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.841 0.856 . . . . 71.53 109.985 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -74.52 -35.01 63.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.257 0.623 . . . . 71.11 111.818 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 8.3 mm-40 -63.35 -37.29 86.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.526 -0.546 . . . . 71.31 109.526 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.7 mt -71.48 -41.84 68.82 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.36 -0.836 . . . . 74.11 110.891 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -59.29 -34.57 72.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.87 0.693 . . . . 74.02 112.87 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -96.91 -15.99 20.9 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.606 0.362 . . . . 74.43 111.547 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -157.82 84.36 2.76 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.579 0.752 . . . . 74.45 109.145 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.18 -13.51 32.43 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.275 2.65 . . . . 70.4 114.135 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 p -89.43 9.68 25.44 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.717 0.807 . . . . 54.21 112.284 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.1 109.79 4.99 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.166 0.586 . . . . 74.12 110.056 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.67 -37.62 16.0 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.555 2.17 . . . . 74.32 112.979 -171.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.06 -42.73 69.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.791 0.836 . . . . 73.31 111.697 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.11 -54.97 29.59 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.548 0.739 . . . . 63.31 111.564 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -62.81 -32.87 74.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.756 -0.657 . . . . 74.12 111.6 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.9 -46.28 72.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.106 0.563 . . . . 52.23 112.129 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 14' ' ' ALA . 4.2 pp -69.64 -27.31 64.94 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 120.842 0.353 . . . . 52.35 110.422 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 mt -69.18 -18.63 63.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.011 0.925 . . . . 72.24 112.61 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -73.96 -29.05 61.79 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.082 0.401 . . . . 73.04 110.483 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.08 -42.21 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 72.01 111.654 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 20.0 pt -103.97 -31.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 112.326 0.491 . . . . 54.24 112.326 -172.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 39' ' ' VAL . 3.2 mm? -112.78 -179.35 3.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.111 0.964 . . . . 72.33 109.208 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB2' HG23 ' A' ' 39' ' ' VAL . 50.7 m -84.67 143.29 40.69 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 73.42 109.941 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.94 -32.22 37.19 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.298 2.665 . . . . 75.12 113.185 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.43 -47.99 77.93 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.115 0.966 . . . . 53.22 111.856 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.1 t -63.02 -52.32 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.199 -0.91 . . . . 71.33 111.259 -173.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.97 -28.18 69.91 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.187 0.44 . . . . 65.1 112.187 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -58.81 5.08 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 124.156 0.91 . . . . 64.05 110.073 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.16 -21.11 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.039 -0.528 . . . . 72.04 111.414 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.36 -50.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.725 0.41 . . . . 53.41 110.071 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 4.7 ppt_? -71.06 -21.0 62.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.757 0.281 . . . . 74.41 111.757 -177.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -73.22 -49.21 29.16 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.704 0.401 . . . . 70.51 111.498 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -67.89 -21.84 65.13 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.045 0.538 . . . . 63.13 111.111 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.0 -37.7 88.52 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.234 1.013 . . . . 63.15 111.853 174.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 61.9 mtp180 -62.86 -27.38 69.3 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.57 0.748 . . . . 70.43 110.555 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -47.62 60.61 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.897 -0.592 . . . . 72.43 110.253 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.86 -33.23 75.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.628 0.771 . . . . 62.31 111.361 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -62.82 -44.71 95.43 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.019 0.928 . . . . 74.52 109.702 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.82 -31.59 69.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.994 -1.003 . . . . 75.12 111.056 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -77.48 -15.59 59.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.445 0.698 . . . . 75.54 111.198 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.38 30.1 74.91 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.59 0.556 . . . . 45.01 113.469 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.62 99.18 4.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 109.588 -0.523 . . . . 74.53 109.588 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -81.33 109.62 16.01 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 107.591 -1.263 . . . . 74.34 107.591 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.66 162.88 14.72 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.596 -0.89 . . . . 74.51 108.596 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.12 130.33 20.85 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.781 -0.452 . . . . 71.43 109.781 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.6 t -68.04 135.58 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 123.967 0.792 . . . . 74.32 109.81 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -117.62 -51.97 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.582 1.153 . . . . 74.43 110.345 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HE ' ' A' ' 61' ' ' ARG . 2.0 tpm_? -142.07 123.83 15.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.157 -0.929 . . . . 74.34 108.913 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.25 112.81 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.231 -0.655 . . . . 75.24 109.231 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.05 146.64 44.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.951 -1.129 . . . . 72.42 107.951 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.547 HG23 HG22 ' A' ' 73' ' ' VAL . 5.7 p -135.45 108.81 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.052 -0.721 . . . . 62.34 109.052 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.8 m -118.38 128.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.328 1.051 . . . . 51.11 109.399 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.4 p -88.64 162.6 16.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.116 0.566 . . . . 64.01 110.478 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -160.6 92.15 0.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.335 1.054 . . . . 64.33 108.218 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.95 9.95 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.609 -0.55 . . . . 70.25 111.827 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -91.76 -10.88 38.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 74.21 111.224 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.2 m -101.6 140.54 35.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.571 0.749 . . . . 72.41 110.605 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 94' ' ' PHE . 2.9 p -121.76 116.67 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.561 0.696 . . . . 70.13 110.142 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -96.26 108.4 20.88 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.448 1.099 . . . . 73.23 109.154 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 64' ' ' VAL . 59.2 t -88.52 107.12 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.667 -0.864 . . . . 75.21 108.667 177.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -95.89 105.25 17.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.96 -1.126 . . . . 54.43 107.96 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.52 125.49 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.517 0.727 . . . . 75.43 110.45 -170.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.7 123.66 31.34 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.257 0.623 . . . . 73.4 110.061 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.15 122.41 37.0 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.285 -1.006 . . . . 64.32 108.285 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.3 116.73 27.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.293 0.568 . . . . 55.53 109.78 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.89 105.0 17.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.154 0.982 . . . . 72.41 111.416 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -90.78 103.13 15.87 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.651 1.181 . . . . 52.52 108.744 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.0 t -138.53 137.22 36.87 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.34 0.656 . . . . 62.3 109.557 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.77 22.12 67.95 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.918 -0.583 . . . . 52.15 113.018 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.9 -33.72 5.06 Favored Glycine 0 C--N 1.354 1.569 0 C-N-CA 122.848 0.261 . . . . 44.21 112.988 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -84.57 135.6 34.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.532 0.733 . . . . 75.11 111.486 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -107.88 145.95 33.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.706 0.802 . . . . 71.03 110.034 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.8 m -143.63 123.87 13.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.489 0.715 . . . . 43.45 109.082 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.97 102.13 6.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.077 -0.712 . . . . 64.25 109.077 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.9 m -107.68 131.63 54.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.967 0.907 . . . . 51.05 110.118 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -95.47 120.14 35.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.311 0.644 . . . . 63.45 109.435 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -102.9 126.37 50.03 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.989 0.915 . . . . 72.34 108.822 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.53 104.27 13.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.723 -0.843 . . . . 71.3 108.723 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.7 mp -91.83 107.38 19.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.285 -1.006 . . . . 74.24 108.285 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -91.74 97.43 11.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.481 -0.781 . . . . 71.41 109.583 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.59 ' HB2' HG13 ' A' ' 71' ' ' VAL . 97.5 m-85 -91.14 117.4 29.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.517 0.727 . . . . 74.45 110.16 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 28.3 tt0 -101.48 121.19 41.5 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.682 -0.858 . . . . 63.12 108.682 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.592 HG12 HG12 ' A' ' 101' ' ' ILE . 10.0 m -86.37 140.17 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.913 -0.403 . . . . 74.53 109.913 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -134.56 117.45 16.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.237 -1.394 . . . . 63.01 107.237 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -114.32 3.99 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.691 -0.964 . . . . 71.22 110.691 -168.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -113.95 -19.15 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.236 0.614 . . . . 71.32 112.097 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -112.14 161.86 16.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.227 0.611 . . . . 72.15 110.675 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.592 HG12 HG12 ' A' ' 96' ' ' VAL . 52.4 mt -82.31 128.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.797 -0.816 . . . . 72.03 108.797 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -114.56 -14.52 12.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.409 0.684 . . . . 74.35 112.32 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 9.8 tpt180 -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.474 0.309 . . . . 75.0 110.505 -172.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.82 139.95 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.986 0.914 . . . . 50.3 109.162 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -134.62 104.62 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.581 -0.896 . . . . 30.02 108.581 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.72 132.02 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.014 0.526 . . . . 72.52 109.722 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.4 m -120.47 116.22 25.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.652 0.781 . . . . 64.14 109.212 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -80.3 105.26 11.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.774 0.83 . . . . 62.13 109.467 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -115.12 109.45 18.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.441 1.096 . . . . 73.33 110.566 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.41 63.56 4.45 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 112.087 -0.405 . . . . 41.54 112.087 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.51 31.76 56.04 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 112.129 -0.388 . . . . 73.33 112.129 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 m -77.56 117.4 18.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.511 0.724 . . . . 53.33 110.221 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt 59.74 33.23 21.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.39 1.076 . . . . 74.14 111.431 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.11 139.18 58.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.677 -1.147 . . . . 63.24 108.594 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -67.29 -41.94 84.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 74.2 112.964 -163.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -97.56 123.43 41.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.362 0.601 . . . . 71.12 110.942 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -69.36 91.93 0.57 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.914 -0.773 . . . . 74.03 108.914 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -81.22 23.53 0.59 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.438 0.903 . . . . 63.54 113.438 -170.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -159.05 129.36 5.84 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.113 -0.699 . . . . 65.12 109.113 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 124.7 1.2 . . . . 70.51 108.835 175.066 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.621 ' HB2' HG22 ' A' ' 34' ' ' ILE . 60.6 mtp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.344 -0.613 . . . . 53.23 109.344 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.29 -19.38 61.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.261 1.024 . . . . 64.32 111.789 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.67 85.36 0.64 Allowed 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.452 1.101 . . . . 74.3 109.713 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 96' ' ' VAL . 34.3 mm -64.33 -43.65 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.423 1.089 . . . . 71.44 112.84 -169.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.5 -52.43 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.563 0.745 . . . . 65.1 109.554 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -69.93 -26.48 64.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.053 -1.43 . . . . 75.24 111.583 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.81 -57.39 8.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.619 0.767 . . . . 74.11 109.667 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.31 76.75 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.28 0.988 . . . . 65.41 111.883 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.75 -58.8 7.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.953 0.901 . . . . 60.11 110.694 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -69.82 -22.26 63.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.709 0.804 . . . . 75.31 111.67 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.3 -45.38 69.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.039 0.935 . . . . 71.01 110.571 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.561 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -59.18 -46.72 87.66 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.294 0.996 . . . . 74.45 110.672 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 62' ' ' VAL . 41.7 mt -61.39 -42.31 93.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 O-C-N 124.404 1.065 . . . . 73.04 110.165 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.87 68.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.165 0.986 . . . . 70.42 112.62 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.405 ' HA ' HG11 ' A' ' 43' ' ' VAL . 46.5 mt -63.21 -42.52 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.595 0.758 . . . . 54.24 109.826 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 92' ' ' LEU . 30.4 m-85 -69.96 -37.27 75.77 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.728 -0.669 . . . . 74.31 111.547 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.438 HE21 HG22 ' A' ' 13' ' ' ILE . 68.8 mt-30 -61.67 -38.49 87.94 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.759 0.662 . . . . 75.12 110.909 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 44' ' ' ARG . 75.6 mt -70.0 -40.45 75.28 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.582 0.552 . . . . 72.11 110.487 174.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HB3' HD12 ' A' ' 50' ' ' LEU . 39.5 m0 -64.87 -31.03 72.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 112.906 0.706 . . . . 74.42 112.906 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -98.52 -20.69 16.92 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.045 0.538 . . . . 72.14 111.537 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.27 85.14 3.17 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 123.786 0.835 . . . . 72.41 108.808 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.84 -19.87 69.8 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.45 2.1 . . . . 52.12 113.289 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -81.04 2.41 27.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.689 0.796 . . . . 73.51 112.635 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.86 111.48 6.5 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 122.878 0.471 . . . . 73.05 109.764 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.7 -31.58 8.4 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.347 2.032 . . . . 70.31 112.733 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.12 -39.42 65.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.343 0.657 . . . . 74.41 110.958 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -56.4 18.75 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 124.118 0.967 . . . . 72.45 110.937 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.44 -32.61 74.32 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.779 -0.646 . . . . 71.13 111.306 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.09 -56.71 16.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.515 0.726 . . . . 72.44 111.296 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -62.82 -31.73 72.78 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 123.759 0.662 . . . . 74.11 110.606 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -66.95 -26.03 66.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.552 0.741 . . . . 71.54 112.073 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.854 0.752 . . . . 63.22 110.516 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.77 -16.03 31.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.028 0.931 . . . . 74.3 111.501 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 1' ' ' MET . 16.2 pt -124.56 -45.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.405 0.52 . . . . 70.54 112.405 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 39' ' ' VAL . 3.8 mm? -95.15 172.46 8.11 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.037 0.935 . . . . 64.11 109.26 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 39' ' ' VAL . 21.0 m -83.25 143.52 45.28 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.464 -0.789 . . . . 71.13 110.041 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.71 -31.88 52.62 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.046 3.164 . . . . 65.21 114.049 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.34 -48.03 77.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.779 0.832 . . . . 75.04 111.619 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 HD12 ' A' ' 35' ' ' LEU . 42.2 t -63.19 -39.48 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 72.24 111.516 -171.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.07 -27.57 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.472 0.177 . . . . 61.13 111.064 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 17.5 t70 -73.68 -44.81 55.62 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.71 0.631 . . . . 75.05 110.405 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.88 -32.71 74.03 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.593 0.357 . . . . 73.51 110.892 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 15' ' ' ILE . 25.1 t -63.52 -51.56 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 70.11 111.263 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB3' HD13 ' A' ' 18' ' ' LEU . 3.3 ptm180 -69.29 -17.27 63.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.058 0.543 . . . . 73.14 111.914 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 51.3 mt-10 -84.26 -35.26 23.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.433 0.693 . . . . 75.22 111.511 171.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -73.34 -17.76 61.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.476 0.711 . . . . 71.43 110.801 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.79 67.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.595 1.158 . . . . 73.22 111.673 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -56.1 -34.82 66.39 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 124.348 1.03 . . . . 64.54 111.507 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -65.19 -55.04 20.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.969 0.507 . . . . 73.35 111.04 -175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 19' ' ' TRP . 88.4 mt -71.39 -34.39 70.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.255 0.622 . . . . 74.51 111.35 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.46 -45.63 68.59 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.725 0.81 . . . . 74.11 111.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.01 -40.79 97.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.116 0.967 . . . . 63.45 111.134 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -75.72 -19.72 58.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.735 -0.666 . . . . 62.22 111.938 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.43 28.76 57.15 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.293 0.371 . . . . 51.02 113.44 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.62 104.97 9.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.602 0.761 . . . . 75.34 109.76 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -82.66 111.25 18.44 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.645 -0.872 . . . . 73.44 108.645 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 43.4 p90 -108.53 144.77 35.75 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.487 -1.301 . . . . 72.3 107.487 168.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -121.56 121.02 36.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.995 -0.743 . . . . 64.02 108.995 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.27 100.44 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.753 -0.832 . . . . 71.14 108.753 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -86.45 -45.19 11.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.824 0.849 . . . . 65.55 111.504 -171.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -144.87 142.29 29.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.265 -0.643 . . . . 74.41 109.265 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 13' ' ' ILE . 93.1 t -125.18 128.73 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.264 -1.013 . . . . 61.34 108.264 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.2 123.73 40.91 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.933 -1.136 . . . . 64.14 107.933 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.31 126.42 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 109.467 -0.568 . . . . 64.31 109.467 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.7 m -132.56 122.3 24.59 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.554 0.742 . . . . 72.41 109.544 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -88.57 121.52 31.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.449 0.7 . . . . 44.11 109.983 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -125.96 89.28 3.0 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.176 0.991 . . . . 71.14 108.337 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.81 -121.46 7.85 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.022 -0.831 . . . . 44.42 111.022 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -98.54 -9.94 24.21 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.127 0.571 . . . . 74.52 110.294 170.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.6 m -96.49 111.16 23.37 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.334 0.654 . . . . 75.45 109.698 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.07 109.31 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.247 0.546 . . . . 71.51 110.225 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.22 103.93 13.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.601 1.16 . . . . 71.33 108.616 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.94 105.34 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.121 0.486 . . . . 53.4 109.85 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -86.04 105.13 16.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.28 1.032 . . . . 71.22 109.691 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.75 123.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.721 0.809 . . . . 72.4 109.878 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -85.61 117.68 24.66 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.282 0.633 . . . . 73.23 109.304 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.68 163.06 13.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.783 -0.821 . . . . 73.41 108.783 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -136.52 102.55 4.98 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.938 -1.504 . . . . 64.43 106.938 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.2 mt-10 -94.14 106.51 18.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.963 0.905 . . . . 75.41 110.46 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -93.92 106.41 18.39 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.737 0.815 . . . . 60.13 109.173 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -132.95 132.48 42.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.805 0.842 . . . . 75.24 109.621 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.16 13.26 61.9 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.089 0.396 . . . . 74.24 114.089 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.07 -32.97 6.83 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.78 -0.455 . . . . 72.43 112.881 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -84.09 150.18 25.73 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.216 0.508 . . . . 75.31 110.862 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.9 m -118.28 134.02 55.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.881 0.872 . . . . 54.11 109.959 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 m -138.52 122.11 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.475 1.11 . . . . 72.23 109.257 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -76.6 119.65 20.71 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.097 -0.705 . . . . 73.32 109.097 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.9 m -129.86 123.26 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.88 0.872 . . . . 64.4 109.5 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.0 m -87.67 128.86 35.29 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.534 -0.543 . . . . 72.32 109.534 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -109.75 125.38 52.63 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.32 -1.363 . . . . 73.43 107.32 168.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -106.57 104.69 14.44 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.061 -1.088 . . . . 72.25 108.061 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 12' ' ' ALA . 4.3 mp -90.88 105.29 17.73 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.565 -1.272 . . . . 71.44 107.565 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -93.71 99.13 11.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.883 0.873 . . . . 74.43 108.846 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.96 108.16 19.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.189 0.996 . . . . 74.25 110.136 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 29.2 tt0 -90.92 113.99 26.35 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.902 -0.777 . . . . 61.22 108.902 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.616 HG12 HG12 ' A' ' 101' ' ' ILE . 4.1 m -83.48 148.82 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.095 -0.705 . . . . 52.45 109.095 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -141.97 96.53 2.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.117 -1.068 . . . . 74.2 108.117 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 -124.07 6.7 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.402 -0.679 . . . . 73.43 111.402 -173.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -89.87 -21.31 22.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.491 0.717 . . . . 74.3 111.689 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -121.87 157.59 30.82 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.33 0.652 . . . . 75.53 110.795 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 96' ' ' VAL . 28.6 mt -90.55 115.47 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 72.2 108.689 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 36' ' ' SER . 28.6 mmt180 -89.35 -28.21 19.96 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.534 0.734 . . . . 75.44 111.104 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 29.5 mtt180 -130.85 135.9 48.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.929 0.492 . . . . 75.52 110.948 -163.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.95 142.94 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.263 1.025 . . . . 73.15 109.01 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -127.8 105.43 8.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.254 -1.017 . . . . 62.42 108.254 172.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.35 104.17 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.896 -1.15 . . . . 63.22 107.896 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -104.36 104.51 14.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.894 0.477 . . . . 50.24 109.952 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.76 98.48 2.41 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.542 -0.91 . . . . 71.34 108.542 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -60.42 133.68 56.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 62.32 112.037 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.44 -139.01 5.59 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.694 -1.362 . . . . 52.42 109.694 -173.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.37 -62.92 4.51 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 117.459 0.63 . . . . 74.4 112.341 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 t -137.1 143.86 42.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.117 0.967 . . . . 75.25 109.919 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.2 -11.0 39.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.847 0.859 . . . . 71.13 110.729 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.01 144.05 41.99 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.266 -1.013 . . . . 73.4 108.266 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -109.92 120.39 42.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.092 0.957 . . . . 74.24 108.602 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -65.42 89.98 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.911 0.862 . . . . 75.1 111.057 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -70.43 118.38 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.955 -1.021 . . . . 72.23 108.861 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -81.78 127.23 32.75 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.447 0.699 . . . . 73.44 110.002 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -59.01 107.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.141 0.977 . . . . 73.0 110.087 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.788 0.835 . . . . 71.13 108.825 178.222 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 107.814 -1.18 . . . . 64.11 107.814 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -58.36 -50.3 74.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.926 0.891 . . . . 70.21 111.989 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.47 104.0 16.0 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.227 0.611 . . . . 74.14 110.147 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -74.67 -31.67 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.846 0.859 . . . . 71.11 112.096 -174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -59.05 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.423 0.689 . . . . 73.45 110.754 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.31 -19.1 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.294 -0.412 . . . . 73.02 111.099 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -48.15 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.271 -0.64 . . . . 75.12 109.271 170.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.24 78.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.08 -0.964 . . . . 71.52 112.066 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.64 -53.25 57.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.681 0.792 . . . . 63.2 110.829 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.37 -30.55 70.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 72.51 111.053 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -61.88 -51.18 69.22 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 123.801 0.688 . . . . 74.35 110.693 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.51 57.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 124.068 0.855 . . . . 61.03 110.91 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.0 mt -57.61 -43.03 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.089 0.956 . . . . 72.43 110.987 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.43 72.9 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.253 0.621 . . . . 75.12 112.229 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.26 -40.91 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.843 0.857 . . . . 64.11 109.896 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 66.3 m-85 -79.55 -25.65 41.6 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.851 0.46 . . . . 74.23 112.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -67.85 -34.65 77.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.134 0.573 . . . . 73.24 109.858 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.3 mt -74.59 -46.02 41.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.005 -0.543 . . . . 70.15 110.179 172.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.0 m0 -61.48 -17.96 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.865 0.691 . . . . 62.53 112.865 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -102.4 -24.56 13.84 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 122.904 0.482 . . . . 72.34 111.599 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -157.55 87.36 2.59 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.724 0.81 . . . . 74.44 109.693 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.54 -17.56 53.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.226 2.617 . . . . 54.44 113.348 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -79.69 -4.39 51.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.823 0.849 . . . . 62.54 112.693 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.48 120.42 79.72 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 109.475 -0.565 . . . . 73.44 109.475 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.98 -30.39 7.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.234 1.956 . . . . 63.22 113.301 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.05 -26.31 27.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.198 0.599 . . . . 75.22 112.305 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.91 -48.01 55.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.36 0.664 . . . . 61.31 109.483 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.16 -27.36 63.49 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.73 -0.668 . . . . 71.41 111.895 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.27 -55.31 36.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.791 0.837 . . . . 74.52 111.733 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 4.1 pp -64.13 -28.18 69.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.929 0.768 . . . . 61.51 111.282 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD22 HD12 ' A' ' 35' ' ' LEU . 96.7 mt -67.56 -28.29 67.66 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.923 0.889 . . . . 70.23 112.258 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -65.88 -37.99 87.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.327 0.584 . . . . 75.34 110.517 173.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 50.0 mtpt -77.02 -39.35 50.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.686 -1.143 . . . . 60.44 111.281 -170.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 35' ' ' LEU . 16.2 pt -102.41 -32.77 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.365 0.666 . . . . 72.14 112.325 -171.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 34' ' ' ILE . 75.3 mt -116.34 -179.36 3.65 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.897 0.879 . . . . 75.41 110.453 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -74.27 152.85 88.18 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 115.349 -0.841 . . . . 54.32 111.371 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.76 -30.65 93.2 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.022 2.482 . . . . 73.13 112.588 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.1 -38.16 78.88 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.967 1.307 . . . . 55.34 112.49 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 35' ' ' LEU . 57.5 t -68.24 -56.15 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.489 -0.778 . . . . 64.12 110.163 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -25.55 67.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.53 0.332 . . . . 72.12 111.528 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.55 -49.28 66.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.068 . . . . 71.42 110.488 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -73.06 -32.25 64.92 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.208 -0.451 . . . . 75.33 111.366 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.17 -47.48 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.067 0.947 . . . . 52.12 111.2 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -70.74 -23.31 62.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.153 0.427 . . . . 72.12 112.153 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.81 -51.51 12.43 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.435 0.694 . . . . 65.12 110.504 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.414 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 83.0 t60 -63.22 -27.25 69.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.019 -0.991 . . . . 62.24 110.836 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -61.87 -45.67 92.77 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.747 1.219 . . . . 74.35 111.495 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 96.5 mtt180 -61.51 -38.43 87.35 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.816 -1.084 . . . . 63.21 110.581 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.31 -46.76 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.147 0.579 . . . . 62.4 111.607 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 71.5 mt -64.03 -35.42 80.66 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.354 0.662 . . . . 73.24 110.479 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -62.56 -46.3 89.01 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.226 -0.897 . . . . 74.23 110.695 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 7.6 mtpm? -62.17 -41.03 97.93 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.331 0.652 . . . . 73.2 110.769 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -75.43 -19.76 59.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.3 -0.864 . . . . 74.31 111.4 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.25 38.14 19.22 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.188 0.305 . . . . 63.44 112.963 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.2 mt -90.55 89.56 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.06 0.944 . . . . 71.22 108.453 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -92.84 111.54 23.18 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 53.7 p90 -134.69 152.35 51.7 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.864 0.465 . . . . 75.3 110.327 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.79 142.06 51.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.173 0.589 . . . . 75.42 109.577 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.69 110.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.801 1.241 . . . . 73.14 109.077 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.56 -29.38 12.74 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.743 0.417 . . . . 72.21 112.022 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.03 131.72 33.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.198 0.599 . . . . 74.32 109.806 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.63 117.3 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.262 -1.014 . . . . 74.21 108.262 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.4 108.01 8.89 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.782 -0.821 . . . . 74.42 108.782 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.07 115.54 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.158 0.583 . . . . 64.44 109.557 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -130.19 128.3 41.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.78 0.832 . . . . 43.13 108.831 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -88.07 144.66 26.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.14 0.576 . . . . 61.32 109.642 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -131.9 90.09 2.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.517 -1.29 . . . . 54.32 107.517 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.93 -122.4 19.25 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.013 -0.994 . . . . 54.42 111.231 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -91.45 -7.73 49.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.506 0.723 . . . . 75.44 111.858 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.1 m -111.43 115.81 29.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.02 0.528 . . . . 74.42 109.835 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -92.74 131.02 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.599 0.76 . . . . 73.11 111.121 -175.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -103.79 110.47 22.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.993 1.317 . . . . 74.21 109.448 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.11 104.53 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.67 -0.863 . . . . 71.3 108.67 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -86.68 105.42 16.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.263 -1.014 . . . . 74.52 108.263 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 16' ' ' PHE . 7.6 p -114.59 134.55 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.327 1.051 . . . . 42.24 108.603 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.4 123.78 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.774 -0.824 . . . . 61.24 108.774 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.82 161.78 24.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.082 0.953 . . . . 73.5 109.865 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.0 10.95 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 27.6 mt-10 -87.25 104.13 16.09 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.685 0.794 . . . . 63.23 110.685 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -89.17 102.99 15.64 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.498 -0.927 . . . . 73.11 108.498 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -141.54 136.45 31.15 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.314 1.046 . . . . 64.21 109.14 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.64 12.26 80.53 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.817 -0.629 . . . . 53.14 111.968 -170.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.22 -22.89 27.24 Favored Glycine 0 C--N 1.356 1.64 0 C-N-CA 123.496 0.569 . . . . 61.22 112.914 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 p -94.11 134.51 36.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.811 0.844 . . . . 65.42 111.269 -175.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.6 m -87.99 124.17 33.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.163 0.985 . . . . 74.22 110.118 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -120.97 116.42 25.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.456 1.102 . . . . 72.22 108.821 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -78.28 116.85 19.01 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.203 -0.665 . . . . 72.23 109.203 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.0 m -131.63 134.69 46.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.709 1.204 . . . . 73.12 109.883 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 m -97.67 145.6 26.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.273 0.629 . . . . 73.33 109.774 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -126.89 128.48 46.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.672 1.189 . . . . 62.41 108.007 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.95 104.25 16.26 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 71.35 108.252 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.19 106.04 18.23 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.226 -1.398 . . . . 64.33 107.226 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -102.1 97.91 8.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.678 0.791 . . . . 71.01 109.206 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HB3' HG21 ' A' ' 101' ' ' ILE . 90.8 m-85 -89.25 111.29 22.06 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.853 0.861 . . . . 72.04 109.899 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 38.5 tt0 -96.01 132.58 41.21 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.224 -0.658 . . . . 62.44 109.224 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.75 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.813 0.845 . . . . 74.34 111.343 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 102' ' ' ARG . 31.4 t70 -132.15 101.4 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.335 -1.358 . . . . 73.52 107.335 171.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.98 -99.42 0.94 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.328 -0.709 . . . . 75.2 111.328 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.17 -17.51 8.9 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.563 0.745 . . . . 74.33 111.123 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.0 m -113.91 133.96 55.12 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.24 0.616 . . . . 74.41 110.266 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.521 HG21 ' HB3' ' A' ' 94' ' ' PHE . 74.2 mt -73.6 116.83 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.784 0.834 . . . . 75.32 109.12 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 97' ' ' ASP . 32.0 mmt180 -105.72 -7.68 18.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.242 0.617 . . . . 73.42 111.369 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.9 ttt180 -136.0 139.07 42.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.766 0.426 . . . . 75.34 110.658 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.27 130.69 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.219 1.008 . . . . 55.14 109.187 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.7 m -110.34 104.52 13.32 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.044 -1.095 . . . . 75.31 108.044 172.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.91 104.61 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.249 -1.019 . . . . 64.03 108.249 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 m -103.84 112.92 26.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.361 0.664 . . . . 74.52 109.617 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 103.43 4.57 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.808 -1.182 . . . . 72.41 107.808 171.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -68.73 131.47 45.22 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.846 0.859 . . . . 65.34 110.832 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.28 -64.99 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.951 -0.86 . . . . 45.22 110.951 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.58 162.28 11.17 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.04 0.352 . . . . 60.2 112.455 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 t -75.97 133.14 40.53 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.253 1.021 . . . . 63.31 109.88 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.12 -27.12 48.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.607 0.763 . . . . 71.32 110.197 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.75 167.18 19.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.303 1.041 . . . . 53.33 110.39 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -133.18 124.48 27.54 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.988 0.915 . . . . 72.21 108.645 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -138.4 6.32 2.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.659 0.784 . . . . 62.43 111.533 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -70.84 -20.48 62.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.098 0.559 . . . . 65.02 111.221 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -117.77 135.57 53.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.066 -1.087 . . . . 73.32 108.066 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -68.31 99.44 0.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.99 0.516 . . . . 52.23 109.772 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.7 p80 . . . . . 0 CA--C 1.553 1.094 0 C-N-CA 123.288 0.635 . . . . 74.3 109.377 177.234 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.432 0.158 . . . . 70.33 110.651 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.29 -6.41 58.86 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 72.23 111.151 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.7 71.39 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.228 1.011 . . . . 62.02 109.646 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.573 HG21 HG11 ' A' ' 96' ' ' VAL . 47.4 mm -74.51 -22.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.263 1.025 . . . . 72.14 111.709 -172.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 66' ' ' THR . 21.8 t -61.31 -55.84 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.466 -0.568 . . . . 71.42 109.466 176.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.97 -32.56 65.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.061 -0.972 . . . . 71.1 111.884 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 4' ' ' ILE . . . -62.73 -52.33 63.67 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.529 0.518 . . . . 44.43 110.404 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.72 67.49 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.549 0.74 . . . . 50.54 111.839 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.67 -55.68 21.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.396 0.678 . . . . 73.13 110.45 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -63.91 -32.59 74.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.864 0.866 . . . . 74.3 111.239 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.39 86.26 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 124.014 0.821 . . . . 63.1 111.143 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.77 92.47 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.97 0.793 . . . . 34.33 111.179 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 69.4 mt -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 124.291 0.994 . . . . 70.54 109.692 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.91 -29.99 71.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.041 0.936 . . . . 74.15 112.432 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.93 -41.15 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.538 0.735 . . . . 72.14 109.81 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE2' HG11 ' A' ' 75' ' ' VAL . 51.7 m-85 -72.4 -35.21 68.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.73 0.412 . . . . 74.42 111.332 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 20.3 mm-40 -61.31 -37.43 83.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.868 0.73 . . . . 73.13 110.15 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.45 -45.13 32.69 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 123.634 0.584 . . . . 73.1 110.926 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -54.21 -31.62 53.61 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.387 0.675 . . . . 74.54 112.731 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -101.89 -19.05 15.43 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.889 0.475 . . . . 73.51 112.103 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.66 81.91 6.32 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.254 -0.647 . . . . 55.12 109.254 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.43 -11.89 33.42 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.135 2.557 . . . . 71.4 112.948 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -80.94 -2.29 47.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.591 1.156 . . . . 72.14 112.687 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -76.31 107.68 4.96 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 119.183 -0.437 . . . . 75.22 110.09 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -31.14 24.68 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.764 2.31 . . . . 61.41 113.359 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -77.64 -34.83 53.1 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.187 0.595 . . . . 75.34 111.592 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.95 -45.69 73.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.299 0.64 . . . . 53.42 110.401 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -75.36 -20.92 58.72 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.66 -0.7 . . . . 74.1 111.628 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.05 -51.35 39.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.356 0.662 . . . . 75.33 110.896 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.7 pp -65.67 -37.68 87.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.668 -0.493 . . . . 74.02 109.668 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.96 -28.59 69.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.488 0.715 . . . . 73.01 111.571 173.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.31 -24.32 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.932 0.493 . . . . 73.13 111.209 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -97.18 -24.68 15.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.047 0.939 . . . . 71.35 112.254 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 30' ' ' LEU . 8.2 pt -121.82 -26.58 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 112.898 0.703 . . . . 70.43 112.898 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.5 mm? -102.65 172.34 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.265 0.626 . . . . 71.01 110.389 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.5 m -79.31 143.79 60.93 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 114.854 -1.066 . . . . 72.25 110.238 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.71 -31.03 18.1 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.657 2.905 . . . . 64.23 114.632 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -66.56 -36.97 83.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.148 0.579 . . . . 61.44 111.382 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 36' ' ' SER . 93.5 t -67.51 -57.35 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.656 0.782 . . . . 73.0 110.696 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.89 -28.44 66.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.667 0.387 . . . . 75.32 111.301 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.98 -54.96 10.91 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 124.527 1.142 . . . . 74.21 110.559 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 1.1 pp0? -61.64 -25.92 67.67 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.308 0.243 . . . . 73.42 111.604 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 39' ' ' VAL . 72.5 t -70.48 -53.08 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.7 0.8 . . . . 73.5 111.02 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -67.34 -22.49 65.59 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.025 0.38 . . . . 75.23 112.025 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -81.07 -45.26 16.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.853 0.461 . . . . 71.42 110.455 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.96 -26.01 68.39 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.396 0.678 . . . . 61.24 111.052 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.63 97.1 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.795 1.238 . . . . 75.42 112.333 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -65.8 -28.43 69.0 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.945 0.778 . . . . 73.42 111.439 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.84 -41.81 67.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.966 0.907 . . . . 73.33 110.867 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -76.81 -28.16 55.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.454 0.701 . . . . 64.14 110.989 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -72.85 -35.17 67.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.462 1.105 . . . . 72.42 110.422 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.62 -40.91 98.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 71.13 109.785 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -84.87 178.01 7.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.167 -0.924 . . . . 70.42 110.643 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.24 33.42 6.59 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.699 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.96 89.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 109.127 -0.694 . . . . 71.44 109.127 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -83.3 136.31 34.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.177 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 140.3 24.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.503 -0.555 . . . . 71.42 109.503 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.13 130.96 39.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.227 1.011 . . . . 72.41 109.618 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.49 102.34 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 54.4 109.686 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -84.27 -35.19 23.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.654 0.782 . . . . 63.21 110.886 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 58.5 ttt180 -155.56 125.41 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.913 -0.773 . . . . 74.45 108.913 -173.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.92 125.94 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 74.33 109.856 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.03 125.36 24.83 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.518 1.127 . . . . 71.42 108.953 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.33 134.99 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.328 0.651 . . . . 75.02 110.687 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.6 m -145.67 130.67 18.28 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.084 0.954 . . . . 51.11 108.969 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.512 HG22 HG22 ' A' ' 71' ' ' VAL . 71.8 p -88.31 149.17 23.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.6 0.36 . . . . 71.24 110.425 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -129.97 96.11 4.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.444 -1.317 . . . . 71.35 107.444 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.05 -102.08 0.95 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.992 -0.843 . . . . 65.12 110.992 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -115.49 -13.48 11.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.972 0.909 . . . . 73.45 110.373 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.9 m -97.15 119.33 35.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.606 0.763 . . . . 75.45 109.568 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 66' ' ' THR . 23.4 t -87.93 144.48 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.676 0.79 . . . . 72.14 110.456 -170.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -124.31 102.48 7.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.59 1.156 . . . . 73.14 108.903 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.13 103.21 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.079 -0.711 . . . . 72.23 109.079 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.3 m -89.53 112.38 23.54 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.322 1.049 . . . . 73.01 109.026 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' HE2' ' A' ' 16' ' ' PHE . 3.9 p -132.91 119.26 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.367 0.667 . . . . 63.41 110.771 -172.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.5 tp10 -80.2 129.91 34.84 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.323 1.049 . . . . 75.21 109.143 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.41 HD13 ' HD1' ' A' ' 90' ' ' TYR . 5.8 mp -125.1 142.01 51.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.236 0.614 . . . . 53.12 109.686 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.96 108.64 21.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.439 -1.319 . . . . 73.42 107.439 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -104.54 105.74 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.173 0.589 . . . . 71.44 111.162 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -93.25 111.24 22.83 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.783 -0.821 . . . . 71.12 108.783 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -134.99 123.6 23.57 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.176 0.99 . . . . 70.03 109.732 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.33 13.66 70.85 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.171 0.415 . . . . 71.11 113.491 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.13 -28.31 15.25 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 112.027 -0.429 . . . . 30.24 112.027 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.5 p -85.01 120.13 26.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.246 0.618 . . . . 74.11 110.615 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -94.31 142.04 27.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.522 0.729 . . . . 73.43 110.25 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.1 m -144.68 123.26 12.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.327 1.051 . . . . 75.42 109.326 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -77.93 109.67 12.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.907 -0.775 . . . . 71.24 108.907 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 m -114.78 122.12 45.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.415 1.086 . . . . 15.44 109.53 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 10.6 m -88.95 120.09 30.05 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.2 -0.667 . . . . 53.33 109.2 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HD1' HD13 ' A' ' 77' ' ' LEU . 89.9 m-85 -104.78 136.5 44.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 174.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -115.27 103.06 10.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.144 -1.058 . . . . 51.12 108.144 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.1 mp -87.71 104.39 16.5 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.249 -1.389 . . . . 73.2 107.249 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -96.66 108.0 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.359 -0.837 . . . . 62.42 109.35 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.409 ' HB3' HG21 ' A' ' 101' ' ' ILE . 80.0 m-85 -88.82 109.09 19.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.692 0.797 . . . . 71.03 110.293 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 37.4 tt0 -90.54 114.71 26.99 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.818 0.847 . . . . 63.22 109.268 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 4' ' ' ILE . 3.9 m -100.58 149.62 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.694 0.798 . . . . 61.33 110.275 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.72 119.36 16.04 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.73 -1.211 . . . . 71.41 107.73 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.54 -100.58 1.82 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.946 -0.462 . . . . 25.15 111.946 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.93 -21.78 5.43 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.094 0.558 . . . . 73.54 112.165 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -114.04 158.65 20.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.058 0.456 . . . . 71.12 110.989 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 96' ' ' VAL . 16.6 mt -84.55 125.19 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.038 -0.983 . . . . 71.33 108.878 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -96.11 -43.18 7.87 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.268 0.627 . . . . 73.42 111.264 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 87.1 mtt180 -132.77 160.93 35.42 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.714 0.806 . . . . 74.42 110.591 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.48 120.14 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.394 -0.965 . . . . 61.15 108.394 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.7 m -100.68 104.83 16.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.259 -1.015 . . . . 74.53 108.259 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 92' ' ' LEU . 46.5 t -87.29 103.99 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.631 -0.878 . . . . 72.05 108.631 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -94.5 106.38 18.36 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.593 0.757 . . . . 64.5 109.453 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -82.06 97.45 8.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.493 -0.776 . . . . 74.13 109.9 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.3 m-80 -73.8 90.38 1.87 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.53 -1.285 . . . . 71.23 107.53 170.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.51 38.35 0.17 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.391 -0.822 . . . . 64.34 111.376 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.08 67.84 0.56 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.405 -0.678 . . . . 50.42 111.405 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.9 m 75.08 -19.36 0.39 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.769 1.628 . . . . 70.1 113.826 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -87.61 82.5 7.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.469 0.652 . . . . 75.44 110.405 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.7 91.4 4.66 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.527 -1.286 . . . . 71.34 107.527 170.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -65.97 83.23 0.08 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.68 -0.859 . . . . 73.34 108.68 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -87.49 69.05 9.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.914 -1.039 . . . . 73.3 110.638 -170.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -72.72 125.2 26.95 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.805 -1.089 . . . . 63.31 109.457 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -65.22 99.86 0.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.141 0.901 . . . . 61.24 109.935 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -97.45 107.96 20.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.984 0.914 . . . . 60.2 108.584 173.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 123.749 0.819 . . . . 64.14 109.159 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.281 -0.266 . . . . 73.21 110.281 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -132.23 -85.54 0.48 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.052 0.941 . . . . 64.51 108.753 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -104.43 144.26 31.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.205 1.002 . . . . 71.52 109.701 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.27 -32.87 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.578 1.151 . . . . 71.31 112.017 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.44 -51.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.236 0.614 . . . . 65.14 109.769 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -28.33 65.44 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.447 -0.797 . . . . 64.42 111.129 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -59.04 -48.75 80.47 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.933 0.397 . . . . 72.52 110.208 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.79 83.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.543 -0.753 . . . . 63.34 111.728 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.79 -52.25 64.97 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.581 0.752 . . . . 73.44 111.475 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.55 -37.1 82.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 73.13 110.665 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.93 80.95 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.405 -1.27 . . . . 53.31 111.498 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.56 82.22 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.911 0.757 . . . . 71.03 111.891 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 HE21 ' A' ' 17' ' ' GLN . 55.8 mt -64.85 -40.05 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.939 -1.028 . . . . 61.04 110.204 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.03 72.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.791 0.836 . . . . 64.11 112.852 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.5 mt -63.1 -40.3 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.531 0.732 . . . . 42.53 110.028 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -71.14 -33.54 70.17 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.143 0.577 . . . . 74.24 111.521 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.475 HE21 HG22 ' A' ' 13' ' ' ILE . 80.1 mt-30 -62.07 -40.98 97.64 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.857 0.863 . . . . 72.44 110.997 175.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.23 -37.52 66.37 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.972 -0.558 . . . . 75.34 110.863 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -63.13 -32.85 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.45 0.537 . . . . 73.4 112.45 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.57 -23.31 22.01 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.394 0.278 . . . . 73.41 111.234 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -158.14 88.27 2.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.477 0.711 . . . . 74.43 109.242 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.19 -22.53 70.59 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.337 2.691 . . . . 73.35 114.312 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -88.46 11.23 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.578 0.751 . . . . 52.15 112.722 -174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.97 114.14 26.37 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.89 -32.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.551 2.167 . . . . 73.33 113.354 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.76 -40.26 55.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.212 0.605 . . . . 65.35 111.387 -171.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.99 67.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.727 0.811 . . . . 71.23 110.993 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -70.19 -26.25 63.81 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.533 -0.758 . . . . 71.32 111.864 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.21 -43.17 71.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 74.53 111.323 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.472 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.3 pp -71.08 -35.4 71.84 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.583 -0.525 . . . . 72.13 109.583 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.93 -22.34 66.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.75 0.82 . . . . 74.51 112.112 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -73.46 -30.62 63.3 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.278 0.631 . . . . 60.1 110.96 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.53 -46.28 9.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.33 -0.85 . . . . 73.23 111.538 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.7 pt -101.88 -28.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 116.092 -0.504 . . . . 73.24 111.513 -169.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 39' ' ' VAL . 3.4 mm? -108.9 -173.94 2.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.384 1.074 . . . . 53.45 109.378 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.0 m -77.77 149.15 77.14 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 122.915 0.486 . . . . 72.42 111.091 176.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.79 -25.75 81.73 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.488 2.125 . . . . 73.11 111.804 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.83 -43.64 95.59 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.222 -1.354 . . . . 73.45 110.805 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.9 t -64.39 -52.51 54.53 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 123.531 0.732 . . . . 65.52 111.131 -175.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.0 pp -59.22 -35.86 74.38 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 120.829 0.347 . . . . 61.41 111.528 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.88 -43.49 68.3 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.216 1.006 . . . . 74.23 111.431 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -74.25 -27.31 60.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.221 0.209 . . . . 64.0 110.952 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 t -72.62 -41.76 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.028 0.531 . . . . 75.34 110.564 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -21.49 61.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.65 0.205 . . . . 74.44 111.537 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.45 -49.26 12.58 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.922 0.392 . . . . 74.12 110.077 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.7 -24.04 67.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.98 0.912 . . . . 75.21 110.63 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.25 76.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.109 1.364 . . . . 74.32 112.471 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -61.68 -22.94 65.75 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.218 -0.901 . . . . 74.11 112.625 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.38 -46.46 66.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.583 0.753 . . . . 73.24 110.581 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.35 -31.77 60.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.819 0.848 . . . . 51.13 111.347 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.25 -39.01 78.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 65.34 110.166 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -59.74 -43.3 94.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.586 0.754 . . . . 73.32 110.266 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -75.71 -29.63 59.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.073 -0.967 . . . . 73.33 111.4 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.31 35.52 76.76 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.456 0.472 . . . . 63.11 113.427 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.35 107.9 12.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.704 -0.851 . . . . 72.13 108.704 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -84.13 111.14 19.07 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 108.728 -0.842 . . . . 62.35 108.728 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.495 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 15.5 p90 -110.37 142.67 41.72 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.009 -1.478 . . . . 72.44 107.009 168.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -134.42 126.94 30.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.152 0.283 . . . . 53.34 110.252 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.23 134.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.116 0.966 . . . . 71.34 110.047 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -117.12 -54.31 2.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.526 1.13 . . . . 54.01 109.522 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -140.78 123.72 16.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 114.658 -1.155 . . . . 72.41 108.673 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.27 124.04 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.139 -1.06 . . . . 74.44 108.139 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.08 107.6 9.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 73' ' ' VAL . 14.7 p -99.0 140.16 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.722 0.409 . . . . 65.34 110.14 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -144.27 170.74 15.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.749 0.82 . . . . 42.21 109.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 71' ' ' VAL . 40.1 p -126.66 149.72 49.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.209 0.604 . . . . 73.34 110.756 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -135.95 95.6 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.46 -1.311 . . . . 65.04 107.46 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.91 -101.34 1.1 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.207 -1.157 . . . . 54.0 110.207 -166.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -119.02 -7.67 10.34 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.777 0.831 . . . . 74.44 110.594 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 95' ' ' GLU . 22.1 m -87.88 114.79 24.84 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.24 -0.652 . . . . 60.01 109.24 -174.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 66' ' ' THR . 24.3 t -87.03 132.24 32.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 115.674 -0.693 . . . . 71.14 109.422 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -118.79 117.52 29.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.192 0.997 . . . . 54.51 108.634 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 64' ' ' VAL . 46.3 t -100.35 103.18 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 73.14 109.647 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.9 m -90.65 105.42 17.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.679 -0.859 . . . . 72.24 108.679 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.54 126.51 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.679 0.792 . . . . 61.13 110.694 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.03 120.48 23.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.179 0.991 . . . . 73.05 109.783 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.1 mp -115.39 119.1 35.14 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.374 -0.972 . . . . 65.04 108.374 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -88.46 103.41 15.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.211 -1.033 . . . . 61.04 108.211 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 30.3 mt-10 -88.2 126.06 34.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.32 1.048 . . . . 74.33 110.067 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.3 m -115.64 107.72 15.48 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.218 -1.03 . . . . 50.44 108.218 173.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -147.51 138.14 23.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.908 0.883 . . . . 75.33 109.351 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.94 12.24 64.66 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.368 0.418 . . . . 24.34 113.846 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.94 -32.9 6.56 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 117.127 0.464 . . . . 61.15 112.421 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -84.09 144.78 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.482 0.713 . . . . 52.43 111.688 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 129.98 53.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.014 0.926 . . . . 73.33 110.603 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.3 m -143.54 133.12 23.61 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.724 0.809 . . . . 53.42 110.1 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -81.25 101.52 9.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.386 -0.598 . . . . 65.11 109.386 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.1 m -101.54 122.44 43.83 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.198 0.999 . . . . 75.41 109.226 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -88.52 125.82 34.96 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.588 . . . . 65.42 109.414 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CD1' HD13 ' A' ' 77' ' ' LEU . 18.6 m-85 -104.65 126.08 51.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.765 -1.198 . . . . 74.4 107.765 173.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.22 103.59 12.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.145 -1.057 . . . . 72.54 108.145 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.98 110.48 22.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.893 -0.78 . . . . 45.01 108.893 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 59.7 ttp180 -88.89 99.76 12.65 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.94 -0.763 . . . . 74.01 108.94 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.9 m-85 -86.17 107.82 18.05 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.914 0.864 . . . . 75.44 108.687 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . 19.2 mt-10 -90.09 116.49 28.15 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.984 -1.462 . . . . 74.02 108.053 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 101' ' ' ILE . 11.3 m -85.45 144.92 8.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.358 -0.837 . . . . 62.33 110.907 -169.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.7 79.49 1.9 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.34 18.07 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.426 -0.806 . . . . 55.31 111.736 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -80.15 -4.87 54.74 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.95 0.722 . . . . 72.01 112.95 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.3 m -134.68 134.65 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.591 0.356 . . . . 52.33 110.217 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HB3' ' A' ' 94' ' ' PHE . 45.4 mt -77.46 132.02 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.169 -1.049 . . . . 73.21 108.169 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -119.4 -10.07 9.76 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.372 0.533 . . . . 74.53 111.617 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.636 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 14.4 mmt180 -130.02 150.4 51.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.224 0.61 . . . . 74.43 111.527 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.16 124.9 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.474 1.11 . . . . 72.02 109.466 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 87.7 m -111.92 105.07 13.4 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.651 0.78 . . . . 63.2 108.941 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.0 105.14 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.531 -0.914 . . . . 72.05 108.531 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.9 m -99.94 105.7 17.43 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.468 0.707 . . . . 72.23 109.384 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.434 ' HG2' ' H ' ' A' ' 110' ' ' GLY . 51.6 tt0 -84.03 123.63 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.65 -0.5 . . . . 74.05 109.65 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.83 -1.38 42.89 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.384 0.673 . . . . 65.24 111.0 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' H ' ' HG2' ' A' ' 108' ' ' GLN . . . -84.92 61.37 4.69 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 110.433 -1.067 . . . . 54.11 110.433 166.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.89 94.8 0.1 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.898 -1.281 . . . . 75.02 109.898 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 m -68.89 110.69 4.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.414 0.686 . . . . 33.12 110.911 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.3 mt -69.28 -45.21 70.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.189 0.996 . . . . 63.34 110.288 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.13 160.11 27.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.166 -0.925 . . . . 73.43 110.4 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -166.05 32.68 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.575 0.75 . . . . 75.32 110.935 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.63 107.34 2.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.152 -0.684 . . . . 65.44 109.152 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.46 145.53 50.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.879 0.871 . . . . 73.23 109.31 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -145.92 126.72 14.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.055 0.542 . . . . 62.42 109.701 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -78.95 168.26 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.447 0.699 . . . . 61.24 110.433 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.2 m80 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 123.203 0.601 . . . . 71.43 110.351 -178.016 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.332 0.587 . . . . 74.03 110.737 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -98.52 34.3 2.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.81 0.844 . . . . 70.22 109.482 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -95.74 18.25 13.42 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.7 1.2 . . . . 61.4 110.393 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.3 -39.82 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 126.061 1.745 . . . . 73.22 113.938 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 66' ' ' THR . 19.0 t -70.7 -54.24 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.021 0.529 . . . . 62.33 110.461 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 8.5 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.197 0.935 . . . . 41.23 111.021 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -65.96 -47.43 74.65 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.232 -0.894 . . . . 42.4 110.716 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.8 78.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 72.21 111.572 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -64.75 -48.84 73.1 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.36 1.064 . . . . 71.41 110.85 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 23.1 mt-30 -67.68 -37.55 82.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.521 0.729 . . . . 72.13 110.352 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.25 97.01 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.03 0.932 . . . . 73.0 111.029 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.46 11.69 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.345 1.028 . . . . 63.02 110.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -60.33 -39.74 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 124.222 0.951 . . . . 72.3 110.597 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.18 93.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.975 0.91 . . . . 75.14 112.305 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.76 -45.8 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.881 0.873 . . . . 72.54 110.161 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.66 -34.46 75.75 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.985 0.514 . . . . 73.25 112.01 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -64.69 -38.07 89.76 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.551 0.532 . . . . 64.32 110.055 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.8 -38.49 76.66 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.754 0.659 . . . . 42.22 110.766 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -58.4 -36.78 74.08 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.52 0.728 . . . . 72.5 112.717 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -102.14 -16.28 16.43 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.863 0.465 . . . . 52.12 112.115 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.19 78.54 5.26 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.351 0.661 . . . . 51.02 109.354 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.54 -4.64 15.72 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.699 2.266 . . . . 74.24 112.733 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 p -77.2 -12.9 60.0 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.834 1.254 . . . . 74.35 112.062 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.78 113.12 19.91 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 122.622 0.369 . . . . 64.42 111.031 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.17 -18.11 18.64 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.845 2.363 . . . . 63.24 113.396 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.29 -44.89 24.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.152 0.581 . . . . 75.44 110.329 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.39 -50.1 74.95 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.114 -0.948 . . . . 64.1 110.841 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.4 pt20 -72.9 -23.61 60.73 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.673 -0.694 . . . . 62.42 112.129 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.19 -44.35 53.73 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.68 0.392 . . . . 75.33 111.319 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.21 -31.99 72.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.775 -0.454 . . . . 72.53 109.775 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 35' ' ' LEU . 97.7 mt -66.12 -29.36 69.65 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.814 0.845 . . . . 63.22 111.852 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.46 -31.95 71.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.709 0.804 . . . . 72.43 110.674 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -84.68 -43.27 14.5 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.282 -0.872 . . . . 61.2 111.137 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 8.8 pt -96.84 -37.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.96 0.504 . . . . 71.44 112.302 -168.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -104.52 174.04 6.05 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.962 0.905 . . . . 72.11 108.912 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 102' ' ' ARG . 9.0 p -68.78 136.67 90.1 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.337 -0.616 . . . . 73.14 109.337 169.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.07 -22.64 19.57 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.143 2.562 . . . . 73.13 114.735 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -60.6 -40.4 91.68 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.193 0.997 . . . . 71.05 111.289 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.66 -54.56 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 63.14 111.268 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 28' ' ' GLN . 2.8 pp -64.06 -32.46 74.02 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.558 0.218 . . . . 65.13 111.05 -176.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.96 -34.03 75.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.14 0.976 . . . . 74.2 111.714 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -85.38 -36.56 20.64 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.801 0.44 . . . . 63.43 110.998 174.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.4 -39.88 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.458 0.703 . . . . 61.43 111.49 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -67.77 -21.93 65.23 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.335 0.654 . . . . 75.34 111.945 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -86.83 -44.8 11.44 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.059 0.943 . . . . 74.45 110.664 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -68.79 -24.39 64.41 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.224 0.609 . . . . 74.31 110.984 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.43 80.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.291 1.436 . . . . 71.01 111.557 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 97.2 mtt180 -62.25 -27.38 68.97 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.871 -1.513 . . . . 74.03 111.627 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.1 -40.49 74.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.146 0.578 . . . . 64.11 110.984 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.3 mt -74.92 -31.87 61.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.64 0.776 . . . . 71.1 110.738 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.38 -40.6 93.68 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.109 -0.951 . . . . 61.21 111.087 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 55.8 mttp -59.05 -40.87 86.42 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.437 0.695 . . . . 75.5 111.049 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -72.3 -12.02 60.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.952 -1.022 . . . . 71.14 111.54 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.45 30.65 78.05 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.882 0.739 . . . . 75.14 113.336 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.3 mt -74.95 109.24 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.626 -0.879 . . . . 74.01 108.626 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -84.31 109.33 17.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 73.54 108.003 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 44.2 p90 -135.71 140.29 44.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.18 -0.674 . . . . 73.42 109.18 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -133.13 146.4 51.56 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.365 0.666 . . . . 74.23 109.775 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.32 116.03 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.724 1.265 . . . . 70.14 110.05 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -88.73 -54.92 3.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.518 0.675 . . . . 71.53 109.639 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tpm_? -139.08 127.06 22.32 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.847 -1.069 . . . . 74.14 109.13 -166.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.48 116.31 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.845 -1.169 . . . . 72.55 107.845 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.69 107.73 9.38 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.504 -0.925 . . . . 75.14 108.504 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -97.34 121.76 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.162 0.985 . . . . 74.31 109.89 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.6 m -130.23 127.79 40.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 65.33 108.563 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.5 HG21 HG22 ' A' ' 5' ' ' VAL . 32.8 p -88.4 154.44 20.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.229 0.612 . . . . 73.24 110.847 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -137.56 86.69 2.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.524 -1.287 . . . . 63.22 107.524 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.38 -101.08 0.79 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.857 -1.065 . . . . 52.42 111.918 -174.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.74 -11.99 14.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.105 0.962 . . . . 71.4 111.319 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.42 HG21 HH11 ' A' ' 93' ' ' ARG . 44.8 m -100.98 118.95 38.0 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.618 -0.512 . . . . 62.44 109.618 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 46.1 t -87.5 140.91 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.808 0.843 . . . . 74.21 109.935 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -123.96 100.95 6.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.923 0.889 . . . . 75.11 108.742 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.98 106.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.449 0.7 . . . . 71.42 109.355 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -86.06 106.22 17.06 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.723 -0.843 . . . . 74.11 108.723 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.4 p -129.63 116.52 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.835 0.854 . . . . 73.12 110.602 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -97.08 139.96 32.3 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.238 1.015 . . . . 71.13 109.32 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -135.02 142.61 46.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.796 0.838 . . . . 73.12 109.085 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -93.0 105.8 17.85 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.269 1.033 . . . . 64.51 109.351 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.09 105.39 15.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.495 -0.775 . . . . 63.24 110.091 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.7 m -102.19 106.7 17.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.502 1.121 . . . . 74.24 108.331 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 t -148.38 140.34 23.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.111 0.965 . . . . 60.13 109.591 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.3 25.66 73.58 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.106 0.402 . . . . 75.03 114.106 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.9 83.51 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.897 -0.391 . . . . 53.33 114.026 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -116.91 139.05 51.1 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.43 0.615 . . . . 71.3 111.052 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.5 m -100.73 144.31 29.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.357 1.063 . . . . 64.34 109.522 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.4 m -143.92 114.54 7.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.78 0.832 . . . . 64.21 109.575 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.85 101.03 5.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.757 -0.831 . . . . 73.32 108.757 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.5 m -102.92 124.88 49.27 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.547 1.139 . . . . 55.13 110.098 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.9 m -94.05 116.9 29.38 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.316 0.646 . . . . 71.21 110.242 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.34 127.84 53.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.164 -1.05 . . . . 73.43 108.164 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -110.06 100.47 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.552 -1.277 . . . . 60.42 107.552 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.76 105.88 17.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.07 -1.085 . . . . 72.51 108.07 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.42 HH11 HG21 ' A' ' 70' ' ' THR . 59.1 ttp85 -91.35 99.02 12.06 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.547 -1.206 . . . . 75.45 107.989 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 101' ' ' ILE . 88.2 m-85 -87.51 108.02 18.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.935 -0.765 . . . . 70.51 108.935 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 34.9 tt0 -98.16 133.15 42.99 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.442 -0.947 . . . . 72.13 108.442 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 25.6 m -84.06 142.66 13.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.166 0.508 . . . . 72.31 109.918 176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.32 104.62 14.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.343 -1.725 . . . . 75.25 106.343 167.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.07 -100.68 1.51 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.399 -0.819 . . . . 23.53 111.293 -172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -123.88 -0.55 8.47 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.936 0.894 . . . . 60.01 112.54 -171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -139.71 150.03 44.36 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.514 0.725 . . . . 70.12 110.314 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 18.3 mt -75.52 119.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.054 0.542 . . . . 72.41 110.176 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 36' ' ' SER . 44.3 mmt-85 -131.18 14.98 5.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.042 0.937 . . . . 44.14 110.627 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 39.0 ttm105 -150.53 137.98 19.64 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 122.649 0.38 . . . . 63.44 110.114 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.96 119.7 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.271 1.028 . . . . 44.52 108.605 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 m -112.26 104.26 12.44 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.912 -1.144 . . . . 71.2 107.912 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.78 107.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.17 -0.678 . . . . 75.42 109.17 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 m -94.31 104.21 16.21 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.51 -0.922 . . . . 71.51 108.51 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -86.97 123.57 32.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.112 -1.07 . . . . 65.13 108.112 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -68.81 160.53 30.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.414 0.685 . . . . 70.05 111.108 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.77 116.58 1.41 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.321 -0.4 . . . . 73.13 112.567 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.14 8.12 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.135 0.398 . . . . 71.41 113.563 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 m -88.36 76.06 8.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.987 0.515 . . . . 71.25 110.388 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.57 101.97 2.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.524 0.73 . . . . 75.45 110.01 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.39 131.28 35.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.909 0.484 . . . . 74.43 109.925 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -87.77 83.45 7.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.53 0.732 . . . . 64.22 109.073 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -107.05 109.06 20.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.108 0.963 . . . . 73.03 109.016 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -135.79 159.23 42.28 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.926 0.891 . . . . 64.44 109.926 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.66 -28.42 60.84 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.866 0.466 . . . . 71.23 111.01 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -135.7 138.43 42.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.302 0.641 . . . . 74.45 110.77 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.9 p80 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 123.493 0.717 . . . . 74.44 110.482 174.902 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.152 -0.684 . . . . 73.45 109.152 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -84.85 -22.98 29.22 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.102 -0.703 . . . . 60.4 109.102 168.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -147.77 160.93 42.19 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.255 1.022 . . . . 73.11 110.192 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.614 HG23 HG11 ' A' ' 96' ' ' VAL . 44.5 mm -86.21 -52.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.806 1.242 . . . . 71.21 111.047 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.43 -40.93 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.835 0.854 . . . . 71.13 110.508 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.06 -56.21 23.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.157 . . . . 75.5 110.984 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.4 70.05 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.061 0.851 . . . . 53.43 111.432 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -72.41 -48.28 42.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.585 0.754 . . . . 71.3 111.694 177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.43 -46.32 70.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.431 -0.804 . . . . 64.24 111.093 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.94 -39.78 93.28 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.638 0.775 . . . . 61.33 110.559 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.616 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -58.78 -50.44 73.93 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 123.807 0.692 . . . . 62.12 111.317 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -54.72 42.74 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 124.218 0.949 . . . . 50.52 112.167 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.05 -39.78 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.88 0.872 . . . . 73.21 110.943 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.98 70.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.526 0.73 . . . . 71.12 112.617 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 63.6 mt -61.73 -38.39 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.501 0.72 . . . . 74.3 110.28 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.05 -34.03 61.79 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.002 0.521 . . . . 74.24 111.254 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.07 -21.39 64.08 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.249 0.62 . . . . 74.33 111.38 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.13 -36.28 21.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.386 0.274 . . . . 71.34 110.59 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 41.0 m0 -63.46 -27.32 69.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.64 -27.5 21.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.099 0.56 . . . . 64.34 111.467 173.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -158.43 93.41 1.99 Allowed Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.398 0.679 . . . . 73.44 109.75 -177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -16.83 56.12 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.543 2.829 . . . . 71.31 113.857 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 p -97.04 11.71 35.18 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.908 0.883 . . . . 74.35 111.454 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.45 114.59 29.29 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 109.177 -0.675 . . . . 65.12 109.177 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.25 -33.24 11.62 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.411 2.074 . . . . 71.35 112.531 -168.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.86 -48.28 59.44 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.482 0.713 . . . . 71.53 111.114 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -58.76 -50.84 72.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.631 0.772 . . . . 62.14 111.587 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.51 -29.98 62.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.412 0.523 . . . . 61.21 112.412 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.44 -36.64 71.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.813 0.279 . . . . 74.54 111.313 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.5 pp -70.61 -34.53 72.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 75.13 109.602 175.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 35' ' ' LEU . 85.6 mt -66.67 -22.51 66.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.751 0.821 . . . . 64.52 111.716 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.29 -29.87 61.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.964 0.506 . . . . 60.32 110.477 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.27 -42.84 9.11 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.769 0.828 . . . . 73.23 111.803 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 30' ' ' LEU . 19.8 pt -95.12 -21.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.843 0.457 . . . . 62.33 111.519 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.616 HD11 ' HB1' ' A' ' 11' ' ' ALA . 44.3 mt -122.84 -176.63 3.45 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.933 -0.766 . . . . 73.43 108.933 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -75.97 148.08 81.25 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.319 0.648 . . . . 73.11 110.514 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.26 -20.27 46.47 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.97 2.447 . . . . 73.05 113.044 171.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.26 -40.05 89.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.398 1.079 . . . . 73.5 111.237 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG11 HD13 ' A' ' 35' ' ' LEU . 57.3 t -64.05 -51.45 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.798 0.439 . . . . 74.02 111.065 -173.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.64 -27.88 69.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.77 0.319 . . . . 72.02 111.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.81 -28.76 55.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.16 0.984 . . . . 73.34 112.252 -175.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -85.45 -33.06 21.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 110.088 -0.338 . . . . 65.11 110.088 174.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 55.1 t -65.75 -41.95 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.834 0.854 . . . . 74.11 111.209 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -63.47 -22.61 66.98 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.037 0.535 . . . . 74.34 111.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -80.33 -48.41 13.02 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.549 0.74 . . . . 73.31 110.398 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.74 -19.85 64.36 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.046 0.939 . . . . 74.32 111.805 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -53.72 -56.72 14.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.554 1.142 . . . . 63.25 112.824 173.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -18.28 65.24 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.641 0.588 . . . . 64.31 112.379 -173.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.67 -51.94 50.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.721 -0.474 . . . . 63.52 109.721 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -78.4 -33.52 48.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.669 0.787 . . . . 73.33 110.954 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -67.43 -38.19 84.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.228 1.011 . . . . 72.02 111.091 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.53 -42.49 95.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.4 0.68 . . . . 73.41 110.221 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -65.79 -24.2 66.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.241 -0.89 . . . . 75.03 110.703 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.77 33.73 45.69 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.958 -0.564 . . . . 65.22 111.995 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 65.8 mt -73.49 110.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.678 0.791 . . . . 72.02 109.668 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -89.88 107.67 19.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.524 -1.287 . . . . 72.12 107.524 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 18.5 p90 -112.24 123.96 51.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.581 -0.896 . . . . 73.11 108.581 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -111.47 130.39 55.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.246 0.618 . . . . 71.42 109.364 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.25 108.53 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.043 -0.725 . . . . 63.25 109.043 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' A' ' 78' ' ' GLU . 31.3 mmmt -78.03 -45.74 22.86 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.873 0.869 . . . . 65.32 109.775 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -167.48 125.34 1.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.812 0.845 . . . . 72.51 109.768 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.07 109.82 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.736 0.814 . . . . 54.34 110.173 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -104.86 143.01 33.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 72.01 108.852 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' VAL . 2.9 p -140.92 125.74 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.02 0.928 . . . . 72.45 109.881 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -140.24 139.2 35.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.058 0.943 . . . . 71.35 109.459 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.8 p -89.51 157.74 17.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.357 0.663 . . . . 60.34 111.547 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -160.84 84.78 0.68 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.403 1.081 . . . . 74.3 109.282 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.36 -116.49 8.84 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.831 -0.622 . . . . 70.21 113.445 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.22 11.88 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.276 0.63 . . . . 54.11 111.247 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.91 155.29 50.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.446 0.698 . . . . 74.25 109.773 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -137.33 120.25 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.699 0.799 . . . . 70.43 109.319 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.04 109.57 21.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.276 1.03 . . . . 75.32 109.648 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 64' ' ' VAL . 48.2 t -98.22 105.73 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.998 -0.742 . . . . 62.12 108.998 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.6 m -96.28 102.32 14.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.871 -1.159 . . . . 64.42 107.871 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.73 113.82 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.966 0.907 . . . . 71.34 109.159 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.24 126.17 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.894 0.877 . . . . 73.31 108.923 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.84 163.24 16.48 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.886 0.874 . . . . 53.21 108.783 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 32.6 tt0 -122.65 101.69 7.62 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.701 -1.222 . . . . 74.1 107.701 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 31.6 mt-10 -86.66 139.98 30.25 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.281 1.032 . . . . 73.42 110.15 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 11.9 m -119.62 102.94 8.98 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 73.22 108.55 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 t -118.2 120.39 37.54 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.998 0.919 . . . . 62.13 110.079 -173.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.52 -93.46 0.46 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.769 -0.651 . . . . 61.14 112.602 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -141.44 19.16 2.63 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.24 0.447 . . . . 64.24 112.072 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.9 p -124.01 145.37 49.24 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.183 0.993 . . . . 64.13 108.99 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 m -116.39 104.27 11.29 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.181 -1.044 . . . . 63.23 108.181 177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.0 m -102.02 119.19 38.39 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.48 1.112 . . . . 75.21 109.399 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 28.5 t-20 -77.68 101.2 6.51 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.296 -1.002 . . . . 73.42 108.296 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.0 m -113.05 124.25 52.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.241 1.016 . . . . 74.55 109.884 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 109' ' ' ASN . 27.5 m -87.01 141.02 28.97 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.276 -0.639 . . . . 74.23 109.276 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -119.28 127.13 52.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.554 1.142 . . . . 74.11 108.72 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -105.7 103.21 12.67 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.232 -1.025 . . . . 34.1 108.232 176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.46 105.2 17.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 53.15 108.015 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 36.3 ttm-85 -100.0 108.64 20.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.188 -0.914 . . . . 62.01 108.659 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HB3' HG12 ' A' ' 101' ' ' ILE . 94.8 m-85 -99.85 111.73 24.03 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.925 0.89 . . . . 71.2 110.943 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 103' ' ' ARG . 7.3 mp0 -80.14 112.21 17.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.742 -0.836 . . . . 72.13 108.742 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 4' ' ' ILE . 2.0 m -83.19 141.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.752 0.821 . . . . 61.12 109.69 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -140.82 117.0 10.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.411 -0.959 . . . . 71.44 108.411 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.34 -99.21 1.43 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.632 -0.587 . . . . 71.41 111.632 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -122.26 -16.96 7.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.089 0.955 . . . . 73.11 110.997 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -140.38 165.22 28.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.706 0.402 . . . . 74.42 110.573 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 96' ' ' VAL . 2.6 mp -76.98 134.12 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.101 0.56 . . . . 70.11 109.81 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -123.47 5.57 8.99 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.35 1.06 . . . . 74.21 111.602 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 21.3 tpt180 -154.67 129.79 9.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.772 -0.455 . . . . 73.42 109.772 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.92 149.3 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.072 0.949 . . . . 74.41 109.322 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.8 m -131.17 106.79 8.57 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.351 -0.981 . . . . 62.33 108.351 171.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.77 105.04 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.725 -0.843 . . . . 61.31 108.725 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -116.17 105.78 12.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.54 0.736 . . . . 72.31 109.068 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -73.1 105.06 4.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.637 -0.875 . . . . 61.13 108.637 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 24.7 t-20 -60.89 98.33 0.07 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.686 0.794 . . . . 70.04 110.292 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.2 -106.84 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.283 -1.326 . . . . 75.55 110.062 -175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.49 -50.4 4.22 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 117.298 0.549 . . . . 74.24 112.786 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -67.51 127.53 33.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.97 0.908 . . . . 72.35 110.588 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.86 -24.55 63.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.131 0.972 . . . . 53.24 110.586 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.03 99.22 1.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.444 0.697 . . . . 71.41 109.467 172.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -90.0 12.91 16.18 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.121 0.968 . . . . 73.2 111.627 -173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -117.67 115.81 25.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.133 0.573 . . . . 75.2 109.599 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.61 -35.34 18.12 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.818 -0.808 . . . . 74.15 108.818 168.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -64.49 111.05 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.648 1.179 . . . . 71.4 110.243 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -80.07 164.59 23.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.906 0.882 . . . . 63.4 110.527 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.891 -0.781 . . . . 75.34 108.891 176.673 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.842 -0.059 . . . . 54.22 110.842 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 47.19 26.14 0.63 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 126.763 2.025 . . . . 71.21 113.671 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -81.52 75.53 8.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.394 -0.965 . . . . 62.4 108.394 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 HG12 ' A' ' 96' ' ' VAL . 43.5 mm -74.02 -34.19 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.117 0.967 . . . . 60.22 112.121 -168.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.26 -42.24 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.454 0.702 . . . . 63.34 109.537 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.49 -35.94 70.95 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.026 -0.988 . . . . 74.33 110.412 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -64.27 -40.67 96.44 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.244 0.618 . . . . 75.45 110.447 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.66 76.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.747 0.819 . . . . 64.23 110.956 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 64' ' ' VAL . 87.2 tttt -63.13 -56.88 13.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.455 -0.793 . . . . 63.13 110.504 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.41 -23.2 65.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.047 0.539 . . . . 64.14 111.077 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -49.4 64.58 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 123.721 0.638 . . . . 50.12 110.115 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.11 83.25 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.173 0.921 . . . . 71.15 110.906 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HE21 ' A' ' 17' ' ' GLN . 74.1 mt -61.51 -40.24 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.327 1.051 . . . . 72.23 111.085 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.7 61.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.403 0.681 . . . . 62.11 111.983 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.02 -37.47 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.485 0.714 . . . . 75.21 109.239 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -73.11 -35.16 66.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.09 0.556 . . . . 73.3 111.054 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.483 HE21 HG22 ' A' ' 13' ' ' ILE . 77.1 mt-30 -61.43 -37.39 83.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.354 0.662 . . . . 74.23 110.464 174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 mt -73.26 -40.82 64.3 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 123.759 0.662 . . . . 64.1 110.532 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -59.69 -27.8 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.421 0.526 . . . . 71.23 112.421 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 -14.33 17.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.169 0.588 . . . . 71.45 111.815 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -159.58 89.9 1.93 Allowed Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 123.42 0.688 . . . . 72.5 110.381 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.32 -22.33 73.95 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.374 2.716 . . . . 52.44 113.193 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -92.16 11.48 25.4 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.66 0.784 . . . . 74.2 111.809 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.11 110.73 8.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.048 -0.723 . . . . 75.0 109.048 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.78 -38.54 23.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.468 2.112 . . . . 71.34 113.104 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.61 -40.16 73.32 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.31 0.644 . . . . 74.52 111.644 -172.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -61.74 -56.85 15.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.025 0.828 . . . . 63.44 110.783 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.9 -24.64 66.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.507 0.723 . . . . 75.3 111.661 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.45 -46.83 65.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.809 0.443 . . . . 55.35 111.254 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.93 -30.56 67.99 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 110.288 -0.264 . . . . 64.24 110.288 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 35' ' ' LEU . 83.2 mt -66.99 -28.19 68.05 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.424 0.69 . . . . 55.43 111.571 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -71.52 -25.39 62.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.999 0.428 . . . . 74.31 110.109 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -85.62 -41.3 15.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.636 0.774 . . . . 70.25 111.598 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 7' ' ' ALA . 9.4 pt -103.64 -17.32 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.123 0.569 . . . . 63.21 112.23 -170.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -123.43 174.61 7.26 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.026 0.93 . . . . 60.1 108.681 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.8 m -68.98 141.89 92.65 Favored Pre-proline 0 CA--C 1.561 1.404 0 N-CA-C 109.949 -0.389 . . . . 41.2 109.949 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.36 -20.01 14.29 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.997 2.464 . . . . 73.03 114.514 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.08 -37.23 66.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 72.33 111.796 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -64.03 -41.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.843 0.857 . . . . 62.4 111.386 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.59 -28.02 60.73 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.943 0.402 . . . . 43.51 111.358 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.32 -27.89 62.72 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.872 -1.058 . . . . 53.2 111.224 -172.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.65 -32.72 23.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.746 0.418 . . . . 74.41 111.077 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' VAL . 55.3 t -64.21 -40.21 88.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 123.337 0.655 . . . . 72.22 110.758 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -67.59 -24.89 65.54 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.597 0.56 . . . . 74.53 111.535 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.29 -48.44 14.13 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.487 0.715 . . . . 73.34 110.255 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -62.63 -28.06 69.65 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.507 1.123 . . . . 71.35 110.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.05 -35.29 80.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.302 -1.317 . . . . 75.4 112.65 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -65.62 -27.46 68.41 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.665 0.786 . . . . 75.04 111.469 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.3 -48.67 32.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.678 0.791 . . . . 72.44 109.894 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.03 -30.3 69.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.839 0.856 . . . . 72.02 110.859 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -66.61 -47.35 72.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.03 1.332 . . . . 75.34 109.677 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.69 -31.58 72.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.241 -0.89 . . . . 65.41 110.845 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.15 -25.62 39.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.512 0.725 . . . . 62.22 110.877 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.34 40.31 80.59 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.377 0.423 . . . . 62.31 113.179 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.13 110.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.266 0.626 . . . . 73.5 109.396 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -94.55 106.63 18.62 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.099 -0.704 . . . . 63.23 109.099 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 7.3 p90 -112.38 143.07 44.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.534 0.734 . . . . 74.13 109.253 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -130.23 129.03 42.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.978 0.511 . . . . 71.33 109.767 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.94 101.37 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.551 0.741 . . . . 63.11 109.245 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.53 -27.27 19.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.971 0.908 . . . . 75.31 110.332 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.8 tpp180 -145.29 146.79 31.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.164 -1.05 . . . . 75.42 108.164 176.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.58 118.62 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.598 0.759 . . . . 74.32 109.013 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.97 105.76 10.6 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.96 -1.126 . . . . 71.04 107.96 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 73' ' ' VAL . 84.6 t -99.9 108.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.567 -1.272 . . . . 53.33 107.567 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -124.37 126.1 45.42 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.337 -0.616 . . . . 61.12 109.337 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 HG22 ' A' ' 71' ' ' VAL . 1.4 m -89.45 113.18 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.587 -0.894 . . . . 71.34 108.587 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -110.02 91.59 3.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.781 1.232 . . . . 54.54 107.812 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.7 -110.06 3.17 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 114.869 -1.06 . . . . 73.11 112.101 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.76 23.75 13.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.585 0.754 . . . . 51.51 110.379 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.6 m -134.88 122.6 22.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.157 0.583 . . . . 75.44 110.285 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 66' ' ' THR . 30.0 t -88.68 111.1 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.046 0.538 . . . . 71.33 109.606 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -97.94 104.59 16.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.704 0.802 . . . . 64.3 109.427 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 64' ' ' VAL . 78.0 t -89.29 103.68 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.203 -0.666 . . . . 70.31 109.203 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.9 m -99.02 103.3 15.23 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.0 -1.111 . . . . 63.24 108.0 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.05 128.9 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.441 0.696 . . . . 72.44 110.214 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 6.9 tp10 -92.77 111.96 23.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.08 1.352 . . . . 73.15 109.548 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 4.9 mp -109.51 118.81 37.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.605 -0.887 . . . . 60.11 108.605 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 26.1 tt0 -88.24 101.61 14.01 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.173 -1.418 . . . . 64.23 107.173 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 28.0 mt-10 -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.344 1.058 . . . . 73.34 110.588 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.3 m -125.05 111.09 14.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.861 -1.162 . . . . 70.3 107.861 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.9 t -132.36 131.25 41.69 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.483 -0.932 . . . . 73.52 108.483 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.6 -78.56 0.47 Allowed Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.48 -0.648 . . . . 65.3 111.48 -172.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.91 10.68 0.11 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 123.529 0.585 . . . . 72.14 111.959 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.4 p -98.67 126.91 44.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.077 0.951 . . . . 64.32 109.636 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.4 m -116.44 108.33 15.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.74 0.816 . . . . 64.13 110.181 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.0 m -131.74 139.53 48.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.012 0.925 . . . . 70.21 110.395 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 51.6 m-80 -77.69 115.72 17.67 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.128 0.571 . . . . 72.12 109.597 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -116.65 121.39 41.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.304 1.042 . . . . 52.32 108.644 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 19.1 m -88.99 122.76 32.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.976 -0.379 . . . . 75.05 109.976 -176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -106.84 126.07 51.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.895 -0.779 . . . . 75.12 108.895 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.8 103.4 12.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.987 -1.116 . . . . 62.53 107.987 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.13 106.68 18.71 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.701 -1.222 . . . . 54.01 107.701 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 39.5 ttm180 -93.3 99.93 12.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.26 1.024 . . . . 74.22 110.113 -175.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.429 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.1 m-85 -91.42 109.67 20.96 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.746 0.819 . . . . 72.44 110.157 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 40.5 tt0 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.248 -0.649 . . . . 74.3 109.248 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.429 HG12 HG21 ' A' ' 4' ' ' ILE . 2.3 m -84.94 149.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.461 0.704 . . . . 73.41 110.134 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -154.58 103.3 2.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 53.12 108.81 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 -118.39 5.04 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.748 -0.541 . . . . 60.44 111.748 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.37 20.37 13.65 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 71.23 109.832 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -139.22 168.44 19.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.305 1.042 . . . . 75.54 109.199 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 35' ' ' LEU . 65.1 mt -108.17 127.78 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.979 0.912 . . . . 71.32 108.726 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -115.06 5.46 14.94 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.257 0.623 . . . . 73.31 112.435 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.8 ttp85 -153.53 134.91 14.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 110.576 -0.157 . . . . 63.53 110.576 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 129.68 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.289 1.036 . . . . 64.11 109.056 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.3 m -116.68 104.61 11.55 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.522 -0.918 . . . . 72.21 108.522 176.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.37 117.28 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.773 -0.825 . . . . 64.31 108.773 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 m -117.66 106.3 12.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.911 0.484 . . . . 74.31 109.812 -171.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.12 122.46 25.65 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.131 0.572 . . . . 74.11 109.536 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.7 m-80 -112.7 143.57 43.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.041 . . . . 75.04 109.21 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.75 -124.78 0.87 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.468 -0.653 . . . . 53.44 111.468 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.6 -103.52 1.2 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.814 -0.514 . . . . 74.23 111.814 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -126.63 6.94 6.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.05 0.94 . . . . 61.41 110.594 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.17 65.21 1.49 Allowed 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.647 1.179 . . . . 74.11 110.718 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.68 82.8 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.952 -1.022 . . . . 74.02 111.171 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -143.21 154.46 43.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.429 0.692 . . . . 75.02 109.762 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -155.37 27.57 0.4 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.347 1.059 . . . . 75.44 108.673 173.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -68.4 98.7 0.86 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.5 -0.773 . . . . 62.43 109.178 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -97.97 120.49 38.46 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.333 -0.849 . . . . 71.25 109.364 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -153.79 105.0 2.74 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.429 0.692 . . . . 65.53 109.225 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 33.4 p80 . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 109.278 -0.638 . . . . 73.43 109.278 171.377 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.495 0.664 . . . . 73.22 109.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.492 HG21 HG11 ' A' ' 96' ' ' VAL . 46.8 mm -71.37 -32.91 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.955 -1.02 . . . . 72.21 110.533 -174.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.25 -46.55 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.458 0.703 . . . . 64.31 110.02 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -46.51 83.4 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.55 109.218 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.92 79.16 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.033 -0.985 . . . . 74.13 111.596 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.12 -36.32 74.73 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.05 0.54 . . . . 64.43 111.242 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.516 ' HB2' HG11 ' A' ' 64' ' ' VAL . 81.3 tttt -60.44 -55.39 34.06 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 123.837 0.711 . . . . 54.11 109.58 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.8 -35.9 75.63 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.983 -1.008 . . . . 70.43 111.148 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -65.11 -49.12 71.2 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 124.142 0.901 . . . . 74.41 110.693 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.68 -52.62 64.37 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 123.993 0.808 . . . . 73.11 110.854 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.479 HG22 HE21 ' A' ' 17' ' ' GLN . 59.2 mt -62.01 -39.95 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 123.965 0.791 . . . . 44.31 110.323 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.24 75.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.605 0.762 . . . . 54.33 112.142 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.37 -43.43 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.316 0.646 . . . . 64.45 109.866 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.16 -29.99 69.0 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.849 0.46 . . . . 74.23 111.303 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.479 HE21 HG22 ' A' ' 13' ' ' ILE . 78.2 mt-30 -66.93 -33.58 75.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.862 0.465 . . . . 75.22 110.47 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.3 mt -73.42 -35.71 65.86 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.235 0.335 . . . . 70.22 110.936 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -62.86 -31.04 71.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.691 0.397 . . . . 72.13 111.896 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -92.75 -30.6 15.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.022 0.529 . . . . 63.43 110.904 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.39 87.37 2.36 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 123.461 0.705 . . . . 74.11 109.787 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.07 -3.66 12.67 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.266 2.644 . . . . 55.33 113.959 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -95.83 7.5 46.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.112 0.965 . . . . 64.31 111.498 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.53 118.07 47.18 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.66 -0.686 . . . . 61.13 109.927 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.88 -39.33 20.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.831 2.354 . . . . 73.32 113.009 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.77 -47.61 58.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.049 0.54 . . . . 72.43 110.089 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.65 -56.28 23.9 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 114.723 -1.126 . . . . 34.43 111.304 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.24 -34.93 77.46 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.094 0.558 . . . . 75.43 111.418 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.36 -51.79 27.3 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.132 0.573 . . . . 75.11 110.748 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -63.11 -38.7 92.22 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.815 0.697 . . . . 73.21 109.827 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.81 -35.87 77.6 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.79 0.836 . . . . 64.2 111.265 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -73.08 -28.87 62.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.074 0.55 . . . . 54.2 110.75 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -81.86 -41.94 20.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 72.25 111.628 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 30' ' ' LEU . 9.8 pt -100.16 -38.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.04 0.536 . . . . 64.14 112.29 -169.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD13 HG11 ' A' ' 39' ' ' VAL . 45.6 mt -98.45 178.24 5.09 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.092 -0.707 . . . . 63.34 109.092 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.563 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.0 m -68.67 144.83 96.55 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.205 -0.452 . . . . 63.0 110.347 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' A' ' 40' ' ' LEU . 36.1 Cg_exo -59.54 -22.79 68.25 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.698 2.265 . . . . 75.12 112.456 173.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.43 -37.16 86.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.452 1.101 . . . . 74.3 110.903 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.9 t -67.8 -49.97 64.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 123.475 0.71 . . . . 62.11 111.344 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 pp -59.9 -33.76 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 120.832 0.348 . . . . 71.13 110.396 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 30.2 t70 -71.68 -51.62 22.08 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.042 -0.981 . . . . 71.14 110.167 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -62.94 -32.89 74.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.244 0.218 . . . . 51.44 111.348 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.43 -49.18 79.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 CA-C-O 118.982 -0.532 . . . . 74.35 110.401 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -67.1 -31.3 71.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.464 0.477 . . . . 74.11 111.843 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 16.5 mm-40 -62.5 -51.8 66.01 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.319 0.581 . . . . 74.43 110.104 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 44.1 m80 -72.97 -24.34 60.77 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.954 -1.021 . . . . 71.23 111.278 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.95 93.19 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.175 0.99 . . . . 74.43 110.926 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.2 -34.95 77.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.406 -0.816 . . . . 63.11 110.825 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.68 -39.26 62.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.732 0.813 . . . . 72.23 111.099 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 84.7 mt -74.5 -29.97 61.63 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.758 . . . . 72.45 110.654 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -69.49 -39.05 77.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.835 0.854 . . . . 72.3 109.912 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -75.18 -24.65 57.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.771 0.828 . . . . 73.2 110.876 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.88 -36.5 80.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.09 30.43 31.34 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.528 -0.76 . . . . 62.24 111.99 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.85 98.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 109.073 -0.714 . . . . 74.31 109.073 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -84.02 109.57 17.76 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.45 -1.315 . . . . 71.43 107.45 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.0 p90 -111.08 161.45 15.9 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.283 -1.006 . . . . 64.11 108.283 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.53 113.13 7.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.844 -1.169 . . . . 73.2 107.844 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.25 108.42 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.112 0.965 . . . . 63.14 110.133 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -91.59 -50.87 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.147 0.579 . . . . 72.35 111.189 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -137.35 134.56 36.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.892 . . . . 74.52 109.037 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -125.77 118.54 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.809 -1.182 . . . . 74.03 107.809 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.78 107.5 9.71 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.874 -0.788 . . . . 73.24 108.874 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' VAL . 7.4 p -103.61 134.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.995 0.518 . . . . 61.03 109.763 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -149.53 166.18 29.97 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.1 0.96 . . . . 65.24 109.085 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 p -96.67 151.78 19.29 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.325 0.583 . . . . 73.2 110.297 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.32 83.07 1.81 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 106.492 -1.67 . . . . 65.24 106.492 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.91 -115.05 7.12 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.493 -1.23 . . . . 43.35 111.377 -168.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -96.11 -14.66 22.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.101 0.561 . . . . 73.31 110.765 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 m -96.58 121.44 38.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.595 0.758 . . . . 70.55 109.642 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.7 p -89.31 126.57 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 120.981 0.42 . . . . 73.21 110.187 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 72' ' ' ASN . 0.9 OUTLIER -107.64 130.6 54.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.467 0.707 . . . . 70.44 109.939 -177.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 64' ' ' VAL . 21.7 t -112.05 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.999 -0.741 . . . . 65.04 108.999 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -89.39 104.59 17.13 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.646 -0.872 . . . . 75.03 108.646 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.32 120.33 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.837 0.855 . . . . 73.02 109.709 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -89.83 127.94 36.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.766 0.826 . . . . 74.42 108.992 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -127.63 140.5 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.216 0.606 . . . . 72.21 109.393 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -89.42 112.13 23.18 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.021 -1.103 . . . . 70.15 108.021 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.7 mt-10 -101.38 114.83 29.18 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.309 0.643 . . . . 64.14 109.44 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m -87.75 103.28 15.47 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.066 -1.087 . . . . 64.4 108.066 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -140.12 133.88 30.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.74 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.75 16.16 74.11 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.708 -0.678 . . . . 75.45 113.358 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.53 84.55 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.048 0.356 . . . . 73.44 113.185 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -108.4 121.75 45.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.585 0.754 . . . . 71.31 110.371 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.6 m -87.69 116.89 26.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.535 -0.913 . . . . 73.41 108.535 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.3 t -127.22 152.86 46.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.34 0.656 . . . . 73.03 109.749 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -80.06 133.11 36.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.56 -0.533 . . . . 53.33 109.56 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 m -142.59 111.13 6.18 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.779 -1.193 . . . . 72.03 107.779 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -91.02 121.78 33.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.218 0.607 . . . . 70.32 109.562 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.58 125.85 49.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -109.93 102.32 11.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.728 -1.212 . . . . 73.35 107.728 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.1 mp -89.08 105.72 17.97 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.292 -1.373 . . . . 75.55 107.292 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 15.3 ttt180 -101.16 97.64 8.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.713 -1.217 . . . . 73.25 107.713 -170.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' ILE . 99.1 m-85 -88.49 109.48 20.08 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.445 0.698 . . . . 74.21 109.596 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 6.5 tm-20 -86.86 119.37 27.01 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.449 -1.315 . . . . 74.31 107.449 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 101' ' ' ILE . 3.0 m -97.08 150.93 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.091 0.956 . . . . 71.34 111.646 -168.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.12 99.93 4.41 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.385 1.074 . . . . 74.02 109.089 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.37 -99.47 0.73 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.662 -0.699 . . . . 74.13 112.734 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -107.76 -20.62 13.15 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.567 0.747 . . . . 74.55 110.849 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -128.04 153.31 46.92 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.654 0.782 . . . . 73.01 110.662 -170.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 94' ' ' PHE . 72.6 mt -95.1 130.75 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.878 0.871 . . . . 71.25 109.588 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 9.5 mmt180 -102.62 -35.36 8.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.099 0.56 . . . . 74.1 111.288 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.9 mtt85 -127.51 145.18 50.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.794 -0.639 . . . . 54.53 109.592 -167.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.84 123.7 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.226 1.011 . . . . 74.24 108.952 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 12.6 m -109.25 103.22 12.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.255 -1.017 . . . . 73.24 108.255 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.12 106.53 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.413 -0.958 . . . . 72.4 108.413 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.1 m -100.26 105.03 16.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.375 0.67 . . . . 74.11 109.334 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -87.49 92.04 8.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.92 0.488 . . . . 62.42 109.734 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 124.214 1.006 . . . . 73.31 110.123 176.517 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 112.976 0.732 . . . . 73.34 112.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.448 HG21 HG11 ' A' ' 96' ' ' VAL . 47.2 mm -72.8 -29.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.638 1.175 . . . . 75.53 111.957 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.98 -56.56 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 71.02 110.703 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.97 -34.5 69.0 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.802 -0.636 . . . . 61.52 110.804 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -57.25 -50.65 72.23 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.549 0.531 . . . . 72.12 110.455 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.98 -32.07 68.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.505 0.722 . . . . 55.33 112.37 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.18 -58.37 8.62 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.719 0.637 . . . . 71.34 110.154 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.92 -30.27 71.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.997 0.919 . . . . 65.14 111.141 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -62.61 -51.65 66.45 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 124.188 0.93 . . . . 74.13 110.531 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -59.43 -44.18 92.94 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 124.394 1.059 . . . . 72.44 112.357 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.454 HG22 HE21 ' A' ' 17' ' ' GLN . 42.4 mt -66.73 -42.27 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.556 0.743 . . . . 62.11 109.965 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.3 -28.02 68.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.714 0.805 . . . . 74.12 112.051 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -60.89 -45.72 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.749 0.82 . . . . 74.44 109.909 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 42.3 m-85 -76.68 -29.43 56.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.276 -0.42 . . . . 73.35 112.011 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.454 HE21 HG22 ' A' ' 13' ' ' ILE . 76.6 mt-30 -60.59 -39.16 87.07 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.796 0.685 . . . . 74.21 110.054 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.6 -38.44 59.03 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.82 0.7 . . . . 65.1 111.176 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.539 ' HH2' HG11 ' A' ' 106' ' ' VAL . 28.2 m0 -62.88 -31.1 72.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.767 0.654 . . . . 71.01 112.767 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -95.97 -19.09 19.77 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.613 0.365 . . . . 64.23 111.204 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.442 HD22 ' HB2' ' A' ' 24' ' ' ASP . 6.7 t30 -158.04 88.33 2.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.412 0.685 . . . . 75.34 109.982 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.49 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.115 2.543 . . . . 64.15 113.242 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -91.56 10.66 27.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.271 1.028 . . . . 64.14 111.396 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.442 ' HB2' HD22 ' A' ' 21' ' ' ASN . 12.9 t70 -78.08 111.19 16.55 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 109.32 -0.622 . . . . 74.13 109.32 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 -44.85 7.03 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.651 2.234 . . . . 74.4 113.007 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.56 -27.72 58.71 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.274 0.472 . . . . 70.01 112.274 -171.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -62.85 -57.83 9.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.813 0.445 . . . . 73.53 110.532 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -66.66 -26.41 67.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.318 0.647 . . . . 64.21 111.937 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -67.09 -46.44 74.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.168 0.987 . . . . 74.42 110.987 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 4.2 pp -70.86 -34.27 71.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.796 -0.184 . . . . 73.31 110.719 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 93.1 mt -61.1 -28.93 69.44 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.667 0.787 . . . . 53.04 111.141 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.34 -24.95 63.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.932 0.893 . . . . 63.13 111.287 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -93.35 -44.81 8.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.666 0.786 . . . . 53.22 110.525 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 35' ' ' LEU . 11.8 pt -94.67 -30.45 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.435 0.694 . . . . 44.15 112.321 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD11 ' HB1' ' A' ' 11' ' ' ALA . 68.6 mt -110.21 175.14 5.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.324 0.65 . . . . 63.23 109.977 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.6 m -73.74 144.4 82.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.31 -0.859 . . . . 72.15 109.369 170.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 88.9 Cg_exo -52.16 -30.44 41.32 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 123.706 2.937 . . . . 73.14 114.285 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.9 -32.34 71.91 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.475 0.71 . . . . 73.11 111.482 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 36' ' ' SER . 40.4 t -70.29 -41.47 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.605 0.762 . . . . 54.14 110.987 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' PRO . 4.1 pp -72.57 -31.33 65.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.749 0.309 . . . . 53.42 110.76 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.6 t70 -65.28 -50.02 67.32 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.23 -0.896 . . . . 71.23 110.783 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.95 -32.52 72.96 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.286 0.366 . . . . 71.2 111.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 15' ' ' ILE . 47.0 t -63.38 -54.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.558 0.743 . . . . 71.24 111.219 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -67.14 -21.51 65.82 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.572 0.582 . . . . 75.44 112.572 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 12.1 mm-40 -80.35 -39.8 27.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.842 0.457 . . . . 60.04 111.344 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -73.92 -22.09 59.81 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.132 0.573 . . . . 75.24 110.698 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.68 94.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.96 1.304 . . . . 74.1 111.791 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.19 -20.96 65.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.498 -1.228 . . . . 61.22 112.024 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.98 -59.27 4.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.637 0.375 . . . . 75.41 110.219 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.31 -29.89 70.96 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.053 0.941 . . . . 72.32 111.443 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -59.51 -51.14 71.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.622 1.169 . . . . 52.23 110.672 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.62 -26.9 55.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.517 0.727 . . . . 61.41 111.885 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -74.39 -24.08 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.338 0.655 . . . . 72.25 110.07 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.19 23.96 77.15 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.469 -0.787 . . . . 61.22 113.309 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.4 mt -71.84 103.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.459 -0.941 . . . . 75.43 108.459 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -79.68 124.13 28.28 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.855 -0.794 . . . . 71.31 108.855 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.53 168.2 20.29 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.583 -0.895 . . . . 73.52 108.583 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -148.77 139.26 22.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 74.21 109.187 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 p -70.43 108.6 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.951 0.901 . . . . 71.54 109.363 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -95.53 -39.54 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.437 0.695 . . . . 73.34 111.909 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -151.07 134.29 16.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.617 0.367 . . . . 62.33 110.242 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 13' ' ' ILE . 41.0 t -125.94 116.16 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.879 0.872 . . . . 71.24 109.453 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -127.49 110.45 12.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.243 -1.021 . . . . 72.43 108.243 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 73' ' ' VAL . 2.7 p -96.55 114.45 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.251 0.62 . . . . 73.12 109.991 -173.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.9 m -109.19 135.85 49.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.765 1.226 . . . . 54.11 110.064 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 p -91.92 113.2 25.41 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.195 -0.668 . . . . 55.42 109.195 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.29 87.3 2.51 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.527 -0.916 . . . . 72.24 108.527 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.84 -123.13 12.62 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.361 -0.836 . . . . 54.31 111.139 -172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.34 -16.46 31.01 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.171 0.588 . . . . 61.54 110.538 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 95' ' ' GLU . 9.8 m -96.3 125.61 40.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.444 0.698 . . . . 75.01 109.473 -172.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 94' ' ' PHE . 6.5 p -95.54 115.57 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.746 0.784 . . . . 74.42 110.792 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -102.38 104.63 15.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.911 0.884 . . . . 65.44 109.117 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 64' ' ' VAL . 53.3 t -88.8 105.77 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.524 -0.547 . . . . 51.25 109.524 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.0 m -86.41 105.46 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.793 -0.817 . . . . 74.32 108.793 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.1 p -122.02 120.73 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.793 0.837 . . . . 71.11 110.759 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -86.42 129.31 34.9 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.913 0.885 . . . . 71.12 109.65 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.07 137.2 55.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.595 0.758 . . . . 62.21 109.02 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.46 105.49 17.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.183 -1.043 . . . . 74.41 108.183 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -97.36 115.16 27.19 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.428 0.691 . . . . 64.41 111.068 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -90.64 104.42 17.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.02 0.928 . . . . 44.31 108.673 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -124.57 122.22 36.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.263 1.025 . . . . 74.23 109.461 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.72 -88.18 0.36 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.19 0.424 . . . . 74.42 112.653 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.74 13.15 1.74 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.381 0.515 . . . . 73.31 112.256 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.6 p -116.67 139.66 50.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.826 0.851 . . . . 73.33 109.605 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -120.93 119.25 32.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.843 -1.169 . . . . 75.52 107.843 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.9 m -142.19 143.27 32.86 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.948 0.499 . . . . 74.22 110.151 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.64 102.96 8.27 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.723 0.809 . . . . 73.23 109.73 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.8 m -99.83 120.74 40.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.487 1.115 . . . . 74.02 108.743 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 m -89.41 127.52 35.84 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.448 -0.575 . . . . 70.25 109.448 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -107.44 126.5 52.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.653 -1.24 . . . . 75.42 107.653 170.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -108.56 103.28 12.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.509 -0.922 . . . . 65.41 108.509 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 12' ' ' ALA . 60.3 mt -90.0 104.71 17.25 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.373 1.069 . . . . 64.33 109.52 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 49.8 ttt85 -93.76 98.93 11.42 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.133 -0.691 . . . . 74.24 109.133 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.585 ' HB2' HG13 ' A' ' 71' ' ' VAL . 86.7 m-85 -87.52 116.49 25.67 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 9.2 tp10 -87.93 131.45 34.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 122.72 0.408 . . . . 55.04 110.114 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 101' ' ' ILE . 5.9 m -103.82 149.66 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.952 0.901 . . . . 54.35 110.32 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.456 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 17.3 t70 -141.38 111.08 6.51 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.599 -1.259 . . . . 61.03 107.599 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.96 -110.5 3.06 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.697 -0.683 . . . . 34.41 112.446 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -113.12 -6.26 13.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.113 0.965 . . . . 63.2 112.263 -171.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -135.82 165.66 25.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.064 0.546 . . . . 73.05 110.754 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 96' ' ' VAL . 71.0 mt -93.53 132.35 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.058 0.943 . . . . 64.32 109.3 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HE ' ' HB3' ' A' ' 97' ' ' ASP . 21.0 mmt180 -102.98 -28.43 12.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 73.51 111.182 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 48.9 ttt180 -145.53 154.12 41.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.69 0.396 . . . . 73.43 110.955 -166.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 39' ' ' VAL . 7.4 p -132.95 138.18 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 70.24 108.579 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.2 m -113.86 112.47 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.446 -0.946 . . . . 70.03 108.446 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HH2' ' A' ' 19' ' ' TRP . 47.8 t -86.92 104.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.045 -0.724 . . . . 73.33 109.045 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -103.84 105.84 16.17 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.9 -0.778 . . . . 61.33 108.9 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -81.22 95.62 6.99 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.179 -1.045 . . . . 72.22 108.179 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 . . . . . 0 CA--C 1.547 0.837 0 CA-C-N 114.982 -1.008 . . . . 64.14 109.41 -177.35 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 121.277 0.561 . . . . 63.14 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.136 1.374 . . . . 63.54 112.478 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 66' ' ' THR . 40.6 t -59.88 -57.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.663 0.785 . . . . 74.51 110.12 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.72 -37.04 83.89 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.825 -1.08 . . . . 74.12 111.203 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.07 81.82 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.56 0.538 . . . . 50.0 111.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.95 95.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.886 -0.597 . . . . 54.32 111.528 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.2 -47.01 72.16 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.926 0.491 . . . . 73.32 111.664 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.58 -34.03 77.29 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.348 1.059 . . . . 75.25 110.783 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.75 81.63 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.101 -0.954 . . . . 72.24 110.755 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.24 82.42 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.257 0.973 . . . . 52.12 110.785 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 70.3 mt -59.29 -44.13 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 O-C-N 124.39 1.056 . . . . 73.14 109.799 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.06 77.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.157 0.983 . . . . 70.2 113.077 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.84 -39.75 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 73.04 109.974 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -76.7 -28.2 55.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.985 0.514 . . . . 74.24 111.807 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 95.6 mt-30 -68.81 -27.43 65.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.064 0.546 . . . . 74.21 110.559 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 69.1 mt -79.99 -43.76 21.42 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.833 0.453 . . . . 50.41 110.252 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -62.23 -25.03 67.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.939 0.718 . . . . 71.35 112.939 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -82.87 -33.24 27.06 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.133 0.492 . . . . 63.54 110.747 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -158.02 93.04 2.11 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.331 1.052 . . . . 73.04 108.289 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' A' ' 48' ' ' ARG . 19.1 Cg_endo -56.41 -27.12 66.35 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 123.559 2.84 . . . . 73.35 113.947 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -84.8 15.01 4.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.404 0.682 . . . . 72.02 111.85 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.55 111.05 8.23 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.94 -38.95 6.71 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.412 2.074 . . . . 73.44 112.593 -173.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.91 -41.41 95.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.61 0.764 . . . . 75.04 111.245 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.03 8.85 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.216 0.947 . . . . 74.01 111.76 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -70.62 -26.59 63.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.055 -0.521 . . . . 72.31 112.383 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.83 -40.25 63.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.922 0.489 . . . . 62.02 110.707 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 2.3 pp -70.68 -31.84 68.88 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 110.056 -0.35 . . . . 73.31 110.056 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.834 0.854 . . . . 73.23 111.524 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.98 -29.45 64.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.914 0.486 . . . . 64.15 110.647 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 26.3 mtpp -80.48 -42.84 21.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.973 0.909 . . . . 74.15 111.431 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.507 HG13 HD23 ' A' ' 35' ' ' LEU . 16.9 pt -107.22 -36.13 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.61 0.596 . . . . 60.11 112.61 -168.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 34' ' ' ILE . 2.3 mm? -99.43 179.23 4.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.996 0.918 . . . . 64.42 110.801 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -80.85 146.52 59.95 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 115.046 -0.979 . . . . 75.44 110.356 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -31.35 92.48 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.371 2.714 . . . . 53.34 114.031 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.62 -38.95 92.76 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.676 0.79 . . . . 74.21 111.153 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' HE21 ' A' ' 42' ' ' GLN . 71.5 t -61.97 -53.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.691 0.796 . . . . 64.45 111.437 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.51 -32.12 72.99 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.569 0.224 . . . . 72.12 111.035 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 18.2 t70 -71.27 -49.85 38.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 124.16 0.913 . . . . 74.33 110.893 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 39' ' ' VAL . 22.0 pt20 -65.59 -38.38 89.33 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.29 0.236 . . . . 71.42 111.449 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.2 -45.09 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.223 0.609 . . . . 61.23 111.477 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.0 ptm180 -72.57 -25.99 61.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.518 0.327 . . . . 75.22 111.228 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 53.8 mt-10 -69.8 -46.32 65.98 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.212 0.605 . . . . 75.55 110.933 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.37 -34.35 78.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.843 -0.617 . . . . 71.11 110.035 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -64.15 -31.44 72.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.493 1.117 . . . . 64.34 112.222 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HA ' ' HG3' ' A' ' 22' ' ' PRO . 70.4 mtp180 -63.28 -36.68 84.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.369 0.668 . . . . 45.43 110.31 174.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -74.6 -34.44 62.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.759 -0.655 . . . . 64.44 110.69 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 55' ' ' ILE . 74.9 mt -74.26 -23.68 59.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.381 0.672 . . . . 63.02 110.707 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.44 -43.09 70.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.179 0.992 . . . . 75.42 109.898 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.26 -41.85 94.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.722 0.809 . . . . 72.33 110.855 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' NE2' HD23 ' A' ' 50' ' ' LEU . 48.3 mt-30 -73.14 -29.26 62.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.042 -0.981 . . . . 71.1 111.022 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.98 46.41 59.44 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.556 0.535 . . . . 72.45 112.766 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 50' ' ' LEU . 58.7 mt -79.56 109.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.191 0.597 . . . . 63.24 109.933 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -91.47 119.99 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.148 -1.056 . . . . 74.32 108.148 173.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.7 158.64 39.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.107 0.963 . . . . 72.1 109.163 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.38 130.12 38.33 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.382 0.673 . . . . 73.24 109.978 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.82 121.56 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 109.573 -0.529 . . . . 63.31 109.573 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -94.38 -48.0 6.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.285 1.034 . . . . 64.12 109.711 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -138.72 139.82 38.51 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.943 -1.132 . . . . 65.13 107.943 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.33 107.53 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.299 -1.0 . . . . 55.12 108.299 171.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -118.93 151.28 38.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.445 1.098 . . . . 72.31 108.799 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.1 126.22 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 71.44 109.335 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -132.22 117.18 17.89 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.966 -0.753 . . . . 55.2 108.966 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.55 HG21 HG22 ' A' ' 5' ' ' VAL . 70.5 p -88.43 127.25 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.529 -0.545 . . . . 44.52 109.529 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -132.71 100.99 5.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.289 -1.004 . . . . 74.5 108.289 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.16 -110.55 3.56 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.933 0.771 . . . . 75.11 112.138 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -118.4 23.7 11.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.866 0.866 . . . . 74.54 110.351 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -133.18 122.09 23.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.277 0.631 . . . . 52.51 109.358 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -97.95 103.72 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.446 0.641 . . . . 71.54 110.15 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -84.04 100.86 11.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.618 1.167 . . . . 72.35 109.42 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 105.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 71.42 109.234 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -89.53 109.24 20.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.015 0.926 . . . . 73.05 109.108 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.12 116.69 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.441 0.696 . . . . 54.34 110.151 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -84.18 135.51 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.079 0.952 . . . . 74.43 109.114 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.52 141.3 41.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.424 0.69 . . . . 75.25 109.608 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.63 108.67 21.43 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.315 -0.624 . . . . 70.5 109.315 168.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.59 107.63 18.24 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.63 -0.878 . . . . 74.4 108.63 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 m -89.57 102.91 15.59 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.937 -1.505 . . . . 61.43 106.937 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 t -140.94 124.18 16.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.305 1.042 . . . . 55.31 108.797 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.48 75.32 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.688 -0.687 . . . . 71.13 112.969 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.82 -19.87 42.64 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.746 -0.474 . . . . 64.31 113.416 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.4 p -88.68 120.23 29.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.159 0.584 . . . . 74.23 110.648 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -90.88 110.26 21.49 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.358 -0.979 . . . . 75.11 108.358 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.1 m -119.49 128.74 54.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 73.4 110.519 -172.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -77.35 101.7 6.45 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.126 -0.694 . . . . 61.34 109.126 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 m -108.42 114.49 28.37 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.453 1.101 . . . . 64.5 108.319 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -88.36 122.04 31.42 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.57 -0.9 . . . . 72.32 108.57 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -102.45 129.77 49.04 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.781 -1.192 . . . . 72.34 107.781 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.45 102.07 11.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.77 104.54 16.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.779 -1.193 . . . . 73.2 107.779 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -101.56 100.74 11.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.102 -1.408 . . . . 75.21 108.225 -170.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.22 110.57 21.61 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.752 0.821 . . . . 61.01 111.559 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -79.49 99.88 7.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 101' ' ' ILE . 4.2 m -97.73 141.14 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 62.45 110.163 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.9 116.38 9.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.217 0.607 . . . . 71.42 109.935 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.88 -114.22 5.45 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.969 0.793 . . . . 72.55 112.648 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.93 -3.09 26.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.9 0.88 . . . . 71.03 112.036 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.2 t -137.46 148.79 46.36 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.136 0.493 . . . . 71.41 110.943 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.499 HG23 HG12 ' A' ' 96' ' ' VAL . 34.8 mt -89.3 121.28 39.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.287 -1.005 . . . . 75.14 108.287 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -88.03 -41.86 12.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.992 0.917 . . . . 72.41 112.26 -167.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -142.37 163.89 31.62 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.809 0.338 . . . . 74.15 110.727 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.74 117.15 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.466 1.106 . . . . 74.41 108.831 168.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.1 m -93.45 104.28 16.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.649 -0.871 . . . . 62.21 108.649 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.12 104.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.719 0.771 . . . . 71.4 109.937 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 m -95.51 110.04 22.16 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.001 0.92 . . . . 73.42 109.428 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -81.68 94.38 6.96 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.485 0.714 . . . . 61.22 109.805 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.618 0.767 . . . . 75.24 109.485 178.124 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.504 -0.184 . . . . 64.23 110.504 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -49.92 -44.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.785 1.234 . . . . 74.13 112.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.78 -46.63 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.554 1.142 . . . . 72.44 111.031 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.0 -46.42 81.46 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.713 -0.676 . . . . 73.43 110.526 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.12 -30.25 70.21 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.241 1.016 . . . . 62.12 111.404 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.18 86.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.997 0.519 . . . . 74.31 110.062 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 13' ' ' ILE . 88.2 tttt -66.38 -45.18 80.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.329 -0.851 . . . . 64.34 110.135 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -57.52 -45.3 85.17 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.136 0.974 . . . . 62.22 110.475 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.21 91.73 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 124.594 1.184 . . . . 74.42 111.04 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.27 -52.2 66.31 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.994 0.809 . . . . 64.13 111.583 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.533 HG22 HE21 ' A' ' 17' ' ' GLN . 33.2 mt -60.94 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 123.853 0.721 . . . . 74.22 109.706 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.48 83.92 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.271 1.029 . . . . 71.01 112.276 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.71 -43.57 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 123.973 0.796 . . . . 74.2 110.206 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 75' ' ' VAL . 75.6 m-85 -73.73 -31.86 63.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.068 0.396 . . . . 62.21 112.068 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.533 HE21 HG22 ' A' ' 13' ' ' ILE . 78.4 mt-30 -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.647 0.592 . . . . 70.11 109.964 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 28' ' ' GLN . 81.4 mt -67.72 -48.25 67.03 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 124.192 0.933 . . . . 73.11 110.317 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -54.07 -29.4 44.18 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.843 0.857 . . . . 70.01 113.144 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 20.0 ptmt -101.97 -23.01 14.18 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.074 0.55 . . . . 73.41 112.065 174.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -149.95 83.15 6.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.403 0.681 . . . . 72.4 109.996 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 44.2 Cg_endo -71.73 -7.71 21.68 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.301 2.667 . . . . 73.41 114.597 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -78.97 -10.14 59.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 74.25 112.128 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.93 117.18 51.38 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.683 0.393 . . . . 74.41 110.276 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.49 -41.97 2.09 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.679 2.253 . . . . 73.13 113.446 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.81 -33.56 74.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.227 0.611 . . . . 71.31 112.226 -170.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.22 75.51 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.477 0.711 . . . . 62.24 110.667 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 18' ' ' LEU . 9.3 pt20 -79.2 -20.83 47.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.836 -0.62 . . . . 73.21 111.815 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -46.75 75.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.608 0.763 . . . . 72.45 110.572 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.2 pp -70.33 -31.7 69.11 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.487 0.492 . . . . 61.53 110.337 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.3 -28.89 70.32 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.663 0.785 . . . . 75.35 112.048 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -70.04 -33.87 72.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.144 0.497 . . . . 74.45 110.208 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.27 -33.92 23.91 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.859 0.863 . . . . 52.32 112.023 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 7' ' ' ALA . 10.1 pt -108.89 -33.67 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 122.954 0.502 . . . . 73.41 111.446 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 39' ' ' VAL . 3.5 mm? -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.443 1.097 . . . . 74.31 108.641 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.56 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.1 m -67.62 145.3 98.16 Favored Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 109.754 -0.461 . . . . 65.02 109.754 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.05 -18.12 56.0 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.486 2.124 . . . . 72.43 112.825 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.49 -33.86 62.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.002 0.921 . . . . 61.31 111.027 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 36' ' ' SER . 63.3 t -63.96 -41.45 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.745 0.818 . . . . 74.03 111.5 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.5 pp -60.55 -35.4 75.92 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 120.697 0.284 . . . . 71.22 111.056 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.7 t70 -72.6 -52.58 14.88 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.156 -0.929 . . . . 34.53 110.558 -175.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -61.34 -29.27 69.79 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.295 0.48 . . . . 75.34 112.295 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.9 t -71.7 -48.36 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.685 0.794 . . . . 74.24 110.868 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -73.14 -21.5 60.71 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.76 0.424 . . . . 74.41 111.926 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 mm-40 -82.73 -35.33 26.75 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 122.211 -0.305 . . . . 73.32 110.423 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -68.73 -26.58 65.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.762 0.791 . . . . 64.24 110.69 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -67.93 -38.35 82.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.601 -1.181 . . . . 62.23 111.568 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -65.22 -21.29 66.73 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.679 0.612 . . . . 65.45 111.338 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -72.03 -46.72 56.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.525 0.73 . . . . 73.11 110.628 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.85 -22.95 63.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.56 0.744 . . . . 74.31 111.176 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.63 -27.33 63.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.107 0.963 . . . . 64.03 111.338 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -78.61 -6.73 56.42 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.618 0.367 . . . . 63.24 111.034 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -116.69 172.56 7.15 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.117 0.967 . . . . 71.42 110.248 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.67 24.41 30.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.727 -0.67 . . . . 52.53 113.144 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 88.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-O 121.357 0.599 . . . . 74.41 109.464 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -101.46 110.36 22.35 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.185 -1.042 . . . . 73.33 108.185 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -117.34 135.56 53.76 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.486 0.715 . . . . 73.11 110.469 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.61 122.2 45.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.775 0.83 . . . . 64.25 109.882 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.67 101.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.686 -0.857 . . . . 72.23 108.686 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -77.68 -44.1 29.08 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.686 -0.688 . . . . 62.33 110.805 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 17.6 tpp85 -152.77 142.1 21.58 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.78 -1.1 . . . . 71.1 108.869 -177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.77 110.01 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.615 -0.884 . . . . 61.13 108.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.485 ' HG3' ' HD2' ' A' ' 61' ' ' ARG . 28.8 mt-10 -128.7 122.92 31.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.008 -0.738 . . . . 74.13 109.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 73' ' ' VAL . 3.7 p -96.78 135.77 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.496 1.118 . . . . 62.32 110.135 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -138.55 137.63 37.22 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.176 0.99 . . . . 63.54 109.287 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -95.44 155.82 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.046 0.538 . . . . 74.41 111.368 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 95.62 2.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.32 -1.363 . . . . 75.34 107.32 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.63 -117.08 9.41 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 111.736 -0.546 . . . . 42.41 111.736 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.87 -12.93 21.58 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.01 0.524 . . . . 62.24 111.533 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.9 m -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.982 0.513 . . . . 53.13 110.087 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 94' ' ' PHE . 7.8 p -99.73 136.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.719 0.808 . . . . 64.45 110.568 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.95 115.97 22.81 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.058 1.343 . . . . 73.21 108.883 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 64' ' ' VAL . 46.8 t -92.24 113.07 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 110.181 -0.303 . . . . 65.3 110.181 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.2 m -87.64 104.89 16.94 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.074 -1.084 . . . . 72.42 108.074 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 16' ' ' PHE . 5.3 p -119.48 122.52 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.231 1.012 . . . . 71.33 109.015 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -94.96 132.93 39.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.937 0.895 . . . . 74.54 109.305 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.57 154.91 49.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.407 0.683 . . . . 71.51 109.808 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -110.07 104.48 13.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 72.23 109.289 171.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.52 106.65 17.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.567 0.747 . . . . 63.21 110.191 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -87.85 102.93 15.17 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.886 -1.153 . . . . 63.21 107.886 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.5 t -146.95 135.82 22.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.133 0.973 . . . . 52.24 109.485 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 22.45 71.08 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.732 -0.667 . . . . 73.0 112.843 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.3 80.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.938 -0.368 . . . . 72.5 114.004 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -126.97 123.43 37.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.376 0.67 . . . . 73.3 110.959 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.6 m -88.07 115.08 25.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.308 1.043 . . . . 74.01 110.005 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.6 m -119.08 133.51 55.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.013 0.925 . . . . 72.23 110.134 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -79.21 125.43 29.45 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.974 -0.75 . . . . 54.42 108.974 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.9 m -141.96 125.17 16.41 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.671 0.788 . . . . 64.01 110.234 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -90.75 129.88 36.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.648 -0.501 . . . . 65.34 109.648 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -108.96 146.84 33.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.554 0.742 . . . . 52.21 109.166 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.3 103.66 7.29 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.066 -1.087 . . . . 72.11 108.066 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -92.77 108.49 20.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 70.31 107.912 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -90.48 99.79 12.75 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.48 -0.782 . . . . 75.3 109.329 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.6 m-85 -89.3 110.3 21.1 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.987 -0.746 . . . . 62.23 108.987 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 26.6 tt0 -92.13 127.86 37.76 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.089 -1.078 . . . . 72.2 108.089 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -85.09 142.49 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.263 0.554 . . . . 73.2 110.979 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -120.96 97.41 5.52 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.915 -1.143 . . . . 72.44 107.915 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.92 -107.08 1.86 Allowed Glycine 0 C--N 1.343 0.929 0 O-C-N 123.822 0.701 . . . . 63.02 113.241 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.63 -19.05 22.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.047 0.939 . . . . 71.41 112.053 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -132.45 167.95 19.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.669 0.787 . . . . 74.12 110.614 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 94' ' ' PHE . 50.0 mt -92.06 135.79 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.685 -0.857 . . . . 52.33 108.685 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -129.48 7.69 5.36 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.942 0.497 . . . . 74.1 111.828 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 31.2 mmt180 -144.45 146.58 32.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.999 0.519 . . . . 75.23 111.544 -175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 130.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.993 1.317 . . . . 71.52 109.333 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -127.03 105.8 8.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.417 -0.957 . . . . 72.01 108.417 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 t -86.61 106.81 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.045 -0.724 . . . . 72.2 109.045 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 m -95.57 152.12 18.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.624 -0.88 . . . . 71.22 108.624 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -129.03 138.58 51.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.351 0.66 . . . . 74.52 110.197 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 108.033 -1.099 . . . . 72.32 108.033 174.065 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.52 -0.178 . . . . 73.44 110.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.37 -39.92 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.576 1.55 . . . . 73.23 113.331 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.76 -50.31 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.545 0.738 . . . . 74.04 110.292 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.19 -30.47 64.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.547 -0.752 . . . . 73.35 110.92 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.55 69.98 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.497 0.719 . . . . 63.44 109.954 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.75 94.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.532 0.733 . . . . 70.13 111.495 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.3 -57.88 11.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.268 1.027 . . . . 63.34 111.397 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -66.96 -29.1 68.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 74.03 110.906 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.76 83.6 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 123.925 0.766 . . . . 72.5 110.934 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.47 -51.08 69.8 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.373 1.046 . . . . 42.44 110.631 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.447 HG22 HE21 ' A' ' 17' ' ' GLN . 39.9 mt -61.69 -42.79 95.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 O-C-N 124.402 1.064 . . . . 70.22 110.413 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.64 74.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.803 0.841 . . . . 75.11 112.026 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.63 -40.97 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 41.42 109.508 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 60.2 m-85 -72.16 -31.13 65.67 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.472 0.309 . . . . 62.22 111.742 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 68.9 mt-30 -66.09 -35.57 80.86 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.494 0.496 . . . . 75.11 110.407 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 -42.85 65.74 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 123.888 0.742 . . . . 65.41 109.966 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 37.6 m0 -61.11 -26.06 67.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.166 0.802 . . . . 73.15 113.166 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 17' ' ' GLN . 64.3 pttt -100.22 -21.7 15.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.791 0.436 . . . . 75.52 110.948 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -152.99 89.5 3.69 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.35 0.66 . . . . 65.15 109.56 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.71 -19.21 66.87 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.095 2.53 . . . . 53.43 113.169 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.3 p -83.13 7.9 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.049 0.939 . . . . 64.12 112.469 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.77 108.59 6.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.03 0.532 . . . . 61.12 109.934 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.74 -29.68 15.42 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.573 2.182 . . . . 74.33 113.185 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.67 -41.6 62.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.247 0.619 . . . . 60.54 110.722 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.19 61.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.816 0.846 . . . . 55.13 111.144 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -66.91 -28.77 68.58 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.713 -0.676 . . . . 74.03 111.764 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.81 -52.35 44.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.881 0.472 . . . . 73.33 110.86 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.6 pp -66.89 -31.75 72.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.192 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.04 -12.58 61.81 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.959 0.903 . . . . 73.54 112.905 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 -27.02 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.419 0.628 . . . . 62.13 109.963 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -85.47 -30.49 23.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.97 0.908 . . . . 64.45 111.181 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 30' ' ' LEU . 12.9 pt -117.77 -32.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.791 0.437 . . . . 62.51 111.538 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 39' ' ' VAL . 3.7 mm? -109.2 179.28 4.21 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.688 0.795 . . . . 64.25 109.253 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 28.7 m -76.26 152.47 83.94 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 122.772 0.429 . . . . 75.13 111.347 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.61 -23.51 65.65 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.821 2.347 . . . . 73.3 112.366 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.6 -39.94 80.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.53 1.132 . . . . 54.15 111.133 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 35' ' ' LEU . 93.5 t -65.63 -57.42 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.306 0.643 . . . . 65.55 110.651 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.4 pp -58.04 -27.04 63.23 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.34 0.496 . . . . 55.31 112.34 -176.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.78 -41.02 24.1 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.77 0.828 . . . . 73.31 110.959 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -74.46 -27.91 60.79 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.303 -0.248 . . . . 74.52 110.626 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -40.83 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.161 0.985 . . . . 65.12 110.749 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.58 -30.73 69.55 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 120.268 0.08 . . . . 71.11 111.052 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.77 -26.32 27.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.844 0.458 . . . . 75.42 111.076 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -66.49 -27.11 67.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.978 0.511 . . . . 74.03 110.365 172.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.86 91.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.92 -1.036 . . . . 70.5 111.878 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -64.71 -31.76 73.13 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.119 0.887 . . . . 65.01 111.479 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.04 -44.19 97.22 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 123.824 0.702 . . . . 71.43 110.44 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -78.42 -36.16 46.02 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.327 1.051 . . . . 73.14 111.314 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.31 -30.15 63.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.924 0.89 . . . . 64.43 110.156 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.98 -36.25 80.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.649 1.18 . . . . 62.21 110.225 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.24 -20.92 29.39 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.974 -1.012 . . . . 62.32 111.013 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.57 20.91 70.5 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.922 -0.581 . . . . 64.01 113.208 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.1 mt -82.21 100.28 5.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 123.366 0.666 . . . . 73.04 110.123 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -92.96 112.98 25.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.219 -0.66 . . . . 74.35 109.219 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 5.7 p90 -105.81 159.45 16.0 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.12 -0.696 . . . . 75.04 109.12 168.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -133.0 133.54 43.27 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.988 -0.551 . . . . 61.52 110.034 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.43 101.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.512 1.132 . . . . 73.5 109.974 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.84 -54.89 3.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.93 0.395 . . . . 73.53 111.48 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -133.16 123.43 25.65 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 109.471 -0.566 . . . . 73.14 109.471 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.54 125.6 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.043 0.937 . . . . 72.53 109.398 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.65 109.12 9.5 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.481 -0.933 . . . . 71.32 108.481 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.6 p -95.41 108.27 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.484 0.659 . . . . 72.22 109.356 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.2 p -113.18 124.97 53.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.564 0.746 . . . . 61.3 109.632 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 71' ' ' VAL . 45.5 p -88.35 154.13 20.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.826 0.45 . . . . 74.42 109.948 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -148.48 92.93 2.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.017 -1.475 . . . . 52.55 107.017 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.65 -117.69 10.39 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.986 -0.846 . . . . 75.14 110.986 -169.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -94.56 -14.06 25.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.402 0.681 . . . . 54.5 110.503 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -93.84 121.62 35.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.642 0.777 . . . . 61.53 110.411 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 48.2 t -99.66 111.64 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.232 0.613 . . . . 72.44 110.85 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -94.74 107.31 19.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.334 1.054 . . . . 74.34 108.953 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.55 103.61 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.707 -0.479 . . . . 74.11 109.707 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.2 m -86.57 106.15 17.35 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.343 1.057 . . . . 52.0 109.03 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.6 p -127.87 124.85 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.06 0.944 . . . . 61.43 110.293 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -94.82 127.14 40.61 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.971 0.908 . . . . 70.12 109.051 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.99 157.07 30.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.582 0.753 . . . . 74.42 109.259 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' THR . 40.8 mt-10 -109.22 106.52 16.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.154 -0.475 . . . . 72.3 109.852 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 23.7 mt-10 -86.02 119.81 26.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.697 0.799 . . . . 75.35 110.616 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -89.51 100.44 13.24 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.743 -1.206 . . . . 63.44 107.743 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 t -149.44 128.46 12.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.123 0.969 . . . . 63.15 110.007 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.03 69.61 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 113.835 0.294 . . . . 72.35 113.835 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.45 13.22 83.61 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.901 -0.389 . . . . 71.43 113.989 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.9 p -121.56 149.39 43.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.412 0.685 . . . . 75.51 109.937 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 m -116.61 106.15 13.23 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.364 -0.976 . . . . 65.1 108.364 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 12.0 t -110.66 139.04 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.977 0.418 . . . . 63.51 110.97 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -80.45 102.71 9.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.097 -0.705 . . . . 65.21 109.097 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -114.62 128.15 56.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.227 0.611 . . . . 52.32 109.454 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.7 m -93.43 119.12 32.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.287 0.635 . . . . 72.35 110.186 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -104.3 130.34 52.12 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.241 -1.022 . . . . 60.25 108.241 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.77 104.74 11.96 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.039 -1.097 . . . . 72.45 108.039 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -90.96 108.96 20.2 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.85 -1.167 . . . . 71.21 107.85 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 27.6 ttt180 -89.36 99.68 12.63 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.042 -0.981 . . . . 70.12 108.376 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.53 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.7 m-85 -87.82 107.65 18.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.253 -0.885 . . . . 62.04 109.053 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 108.15 20.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.471 -1.307 . . . . 74.11 107.471 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 101' ' ' ILE . 3.8 m -86.68 151.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 114.871 -1.059 . . . . 61.44 112.407 -165.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.39 103.28 5.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.696 1.198 . . . . 64.55 108.631 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.13 -108.28 2.49 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.369 -0.378 . . . . 72.34 113.279 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.33 2.42 16.5 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.826 0.85 . . . . 64.51 111.74 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 164.63 26.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.691 0.796 . . . . 43.14 109.265 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 96' ' ' VAL . 24.9 mt -101.18 107.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.605 -1.257 . . . . 73.14 107.605 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -85.25 -29.12 24.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.472 0.309 . . . . 62.23 111.624 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -130.06 142.58 50.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.36 0.664 . . . . 73.52 109.757 -164.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.02 142.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.464 0.705 . . . . 64.43 110.615 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.1 m -119.48 141.65 48.98 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.241 1.017 . . . . 72.34 108.889 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 110.09 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.48 -0.563 . . . . 42.44 109.48 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.1 m -103.39 104.86 15.0 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.561 0.744 . . . . 70.54 109.64 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.51 96.11 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.248 0.547 . . . . 71.52 109.854 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 . . . . . 0 C--O 1.244 0.775 0 C-N-CA 124.158 0.983 . . . . 74.24 109.662 175.327 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.113 -0.699 . . . . 73.43 109.113 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.619 HG23 HG11 ' A' ' 96' ' ' VAL . 36.1 mm -48.01 -47.19 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.971 1.709 . . . . 74.32 113.19 -171.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 66' ' ' THR . 45.9 t -66.12 -56.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.497 0.719 . . . . 52.14 110.759 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -74.77 -29.17 61.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.181 -0.918 . . . . 74.22 111.768 -170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.1 -45.31 77.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.411 0.684 . . . . 50.41 110.023 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -68.64 -32.72 72.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.454 0.702 . . . . 54.32 111.881 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.0 -47.8 78.88 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.554 0.742 . . . . 73.24 110.482 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.761 0.824 . . . . 74.13 111.437 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.29 86.44 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.749 0.82 . . . . 71.25 110.806 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.86 79.56 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 124.202 0.939 . . . . 61.03 111.415 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.3 -40.41 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.147 -0.933 . . . . 73.02 110.449 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.92 82.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.678 0.791 . . . . 54.02 111.665 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 56.4 mt -60.87 -41.58 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.072 0.949 . . . . 71.34 110.35 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 75' ' ' VAL . 30.6 m-85 -76.38 -31.58 58.09 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.825 0.45 . . . . 72.21 111.819 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.86 -32.5 74.05 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.131 0.572 . . . . 70.33 110.563 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -49.11 26.39 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.502 0.501 . . . . 75.05 110.434 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -59.42 -26.09 64.88 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.39 -29.51 14.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.54 0.336 . . . . 74.14 111.008 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.45 HD22 ' HB2' ' A' ' 24' ' ' ASP . 5.4 t30 -147.45 85.55 6.7 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.433 0.693 . . . . 62.45 109.137 -172.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.07 -12.16 33.51 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.977 2.451 . . . . 54.32 112.951 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -84.98 5.01 31.01 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.222 1.009 . . . . 73.11 111.584 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' HB2' HD22 ' A' ' 21' ' ' ASN . 8.0 t70 -77.33 110.78 13.48 Favored Pre-proline 0 C--N 1.357 0.921 0 N-CA-C 109.53 -0.544 . . . . 75.51 109.53 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.26 -26.09 9.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.408 2.072 . . . . 70.03 112.352 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -75.28 -44.3 46.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.936 0.895 . . . . 74.44 111.118 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.42 81.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 124.273 0.983 . . . . 62.04 111.094 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.3 pt20 -75.5 -24.61 56.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.735 -0.666 . . . . 63.33 111.881 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.22 -46.26 61.56 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.027 0.531 . . . . 74.1 110.983 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.4 pp -68.01 -29.34 68.32 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.357 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.2 mt -69.23 -14.76 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 74.21 112.335 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -81.29 -30.25 34.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.266 0.555 . . . . 54.41 109.503 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -82.73 -36.97 25.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.097 0.959 . . . . 55.42 111.05 -174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 7' ' ' ALA . 12.9 pt -105.16 -35.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.309 0.643 . . . . 65.2 111.637 -173.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 34' ' ' ILE . 3.9 mm? -111.13 175.7 5.32 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.335 1.054 . . . . 74.22 109.373 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.8 m -74.11 146.23 84.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 116.036 -0.529 . . . . 75.13 110.609 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.38 -32.26 41.54 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.288 2.659 . . . . 75.53 114.031 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.49 -39.82 92.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.213 1.005 . . . . 73.3 111.457 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 36' ' ' SER . 96.0 t -70.47 -45.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.498 0.719 . . . . 71.45 111.113 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.8 pp -64.14 -30.05 71.13 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.936 0.398 . . . . 61.41 110.556 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 23.8 t70 -68.23 -56.73 7.63 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.8 -1.091 . . . . 54.33 110.06 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.42 -31.64 69.45 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 111.898 0.333 . . . . 71.23 111.898 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 54.5 t -66.25 -51.99 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.219 0.608 . . . . 70.21 110.415 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 40.4 ptt180 -69.42 -21.9 63.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 119.664 -0.208 . . . . 74.51 111.463 -176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 18.6 mm-40 -71.02 -46.25 62.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.817 0.447 . . . . 74.15 111.068 175.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -66.32 -28.95 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.052 -0.522 . . . . 75.23 110.769 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.08 93.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.043 0.937 . . . . 74.24 112.049 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 79.3 mtp180 -68.13 -23.64 64.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.689 0.796 . . . . 72.14 111.777 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.26 -47.08 12.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.842 0.857 . . . . 73.43 110.152 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD23 ' NE2' ' A' ' 53' ' ' GLN . 89.8 mt -67.09 -20.17 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.918 0.887 . . . . 74.32 111.341 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.56 -35.04 79.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.435 1.094 . . . . 74.42 110.902 174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.73 -32.95 25.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.278 0.631 . . . . 71.04 110.875 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.47 ' NE2' HD23 ' A' ' 50' ' ' LEU . 47.8 mt-30 -80.84 147.34 30.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.402 0.681 . . . . 74.51 110.394 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.08 56.94 5.01 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.475 -0.33 . . . . 45.15 112.46 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.41 105.14 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.086 0.954 . . . . 71.33 108.658 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -104.72 110.37 22.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.665 -0.865 . . . . 75.31 108.665 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.71 162.3 16.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.353 0.661 . . . . 70.35 109.423 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.71 140.46 22.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.673 -0.491 . . . . 73.44 109.673 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.64 122.19 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.12 0.968 . . . . 53.52 109.436 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -106.27 -17.01 14.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.442 0.697 . . . . 63.03 111.202 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.7 ttt180 -163.45 132.97 4.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.289 0.635 . . . . 74.33 110.227 -169.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.4 t -125.26 135.29 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.293 1.037 . . . . 62.0 108.762 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.84 108.97 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.283 -1.006 . . . . 61.21 108.283 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.4 121.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 121.11 0.481 . . . . 63.03 110.11 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.7 m -141.12 135.24 30.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.972 0.909 . . . . 74.13 108.639 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.516 HG21 HG22 ' A' ' 5' ' ' VAL . 26.8 p -100.8 134.13 44.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.606 0.762 . . . . 65.51 111.218 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.426 ' HB3' HD21 ' A' ' 72' ' ' ASN . 25.1 t70 -114.87 107.79 15.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.059 1.343 . . . . 75.12 108.715 174.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.39 -108.35 2.58 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.448 -0.661 . . . . 72.45 111.448 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.62 -11.97 12.92 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.34 1.056 . . . . 55.13 109.453 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.498 HG23 ' HA ' ' A' ' 95' ' ' GLU . 44.8 m -90.28 129.74 36.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.194 0.998 . . . . 64.23 109.9 -172.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 8' ' ' ALA . 21.6 t -88.8 143.74 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.38 0.672 . . . . 73.01 110.12 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 67' ' ' ASP . 12.1 m-80 -124.34 112.53 17.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.078 -1.082 . . . . 60.32 108.078 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.5 103.71 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 109.265 -0.643 . . . . 71.14 109.265 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.7 m -87.78 104.43 16.56 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.227 -1.027 . . . . 64.2 108.227 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.5 p -119.28 121.08 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.784 0.834 . . . . 70.41 109.763 -175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.7 tp10 -83.53 114.94 21.85 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.691 -0.855 . . . . 71.04 108.691 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.2 mp -101.66 160.65 14.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.193 -1.04 . . . . 62.54 108.193 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.23 105.28 7.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.751 -1.574 . . . . 70.53 106.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -105.49 106.81 17.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.39 0.676 . . . . 53.15 110.638 -169.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -87.79 104.75 16.87 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.712 -1.218 . . . . 64.54 107.712 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 t -136.52 125.0 23.49 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.374 -0.973 . . . . 71.33 108.374 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.01 26.11 72.26 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.98 -0.554 . . . . 55.33 112.993 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.38 60.13 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.19 0.424 . . . . 54.24 113.476 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.3 m -93.28 112.31 24.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.568 0.747 . . . . 73.51 110.432 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.6 m -88.47 107.88 19.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.682 0.793 . . . . 73.5 109.21 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.9 m -126.61 125.49 42.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.448 0.699 . . . . 73.2 110.221 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -77.9 115.68 17.83 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.304 0.642 . . . . 74.33 110.122 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 m -118.58 119.72 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.627 1.171 . . . . 63.4 108.799 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 m -88.17 120.76 29.83 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.59 -0.522 . . . . 75.23 109.59 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CD1' HD13 ' A' ' 77' ' ' LEU . 11.3 m-85 -103.58 134.71 46.46 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.297 -1.371 . . . . 53.23 107.297 174.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -118.13 102.46 9.03 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.223 -1.029 . . . . 61.12 108.223 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.8 104.92 16.87 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.039 -1.097 . . . . 62.42 108.039 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -95.64 102.24 14.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.81 -0.811 . . . . 71.03 108.81 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.417 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.8 m-85 -87.47 108.86 19.22 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.674 0.79 . . . . 64.41 109.562 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 30.6 tt0 -92.81 120.94 33.68 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.471 -0.786 . . . . 75.21 109.645 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 HG23 ' A' ' 4' ' ' ILE . 4.3 m -98.11 148.09 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.35 -0.841 . . . . 64.52 110.697 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.462 ' HB2' ' HG3' ' A' ' 102' ' ' ARG . 6.7 m-20 -120.37 91.59 3.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.909 -1.145 . . . . 70.2 107.909 173.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.7 -128.19 8.36 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 114.861 -1.063 . . . . 31.24 111.946 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.4 8.8 36.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.493 0.717 . . . . 74.21 112.616 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -139.63 162.43 35.12 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.315 0.646 . . . . 64.01 110.282 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 96' ' ' VAL . 10.2 mt -95.52 140.12 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.412 -0.958 . . . . 65.34 108.412 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 36.0 mmt180 -126.9 -31.3 2.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.712 0.634 . . . . 64.52 112.712 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.8 mtt180 -130.39 161.67 30.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.528 0.331 . . . . 75.03 110.404 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.39 139.23 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.212 1.005 . . . . 60.04 109.319 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.3 m -121.28 105.16 10.29 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.567 -0.901 . . . . 33.23 108.567 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -89.29 104.3 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.813 -0.81 . . . . 71.32 108.813 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.8 m -95.73 103.78 15.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.307 -0.627 . . . . 73.32 109.307 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -85.22 95.06 9.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.605 0.762 . . . . 72.44 109.74 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.243 0.716 0 N-CA-C 108.227 -1.027 . . . . 75.02 108.227 172.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 108.802 -0.814 . . . . 71.54 108.802 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 96' ' ' VAL . 36.9 mm -47.69 -38.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.694 1.598 . . . . 62.13 113.842 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.2 -47.8 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.957 0.503 . . . . 62.43 110.022 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.23 -42.11 80.22 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.135 -0.939 . . . . 74.34 110.092 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -61.68 -37.96 86.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.01 0.924 . . . . 72.42 111.666 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.6 -32.61 60.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.926 0.89 . . . . 72.42 110.742 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.8 tttm -67.72 -39.32 84.31 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.325 -0.852 . . . . 74.11 110.327 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.46 -40.82 85.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.357 0.663 . . . . 64.23 110.164 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.21 86.68 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.129 0.971 . . . . 64.23 111.633 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.81 66.58 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.962 0.789 . . . . 75.04 111.61 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -70.73 -32.12 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.2 -0.909 . . . . 71.43 110.8 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.5 -32.2 70.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.125 0.57 . . . . 64.43 112.182 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -60.78 -41.09 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.502 0.721 . . . . 73.1 109.398 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.29 -30.06 61.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.217 0.607 . . . . 70.3 111.771 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.29 -35.47 79.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.412 0.685 . . . . 74.33 110.271 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.448 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 73.4 mt -73.93 -40.4 63.12 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.81 -0.632 . . . . 71.55 110.867 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -60.71 -30.35 69.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.208 0.448 . . . . 74.32 112.208 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -96.65 -21.9 17.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.201 0.6 . . . . 75.32 111.024 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.66 89.14 2.69 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.538 0.735 . . . . 75.41 109.219 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.27 -17.53 44.74 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.905 2.403 . . . . 74.42 113.708 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.2 p -89.48 13.55 13.53 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.588 0.755 . . . . 74.52 111.425 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.39 112.27 12.28 Favored Pre-proline 0 C--N 1.358 0.978 0 C-N-CA 123.142 0.577 . . . . 75.12 110.035 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.72 -28.78 13.51 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.704 2.269 . . . . 73.33 113.02 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.1 -41.8 49.2 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.23 0.612 . . . . 62.42 110.949 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.94 -55.72 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 53.54 110.667 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -66.95 -25.9 66.57 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.764 0.426 . . . . 74.43 111.993 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.37 -56.15 24.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.331 0.652 . . . . 74.3 110.196 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.57 -35.03 76.84 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.065 -0.516 . . . . 71.51 110.458 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 87.1 mt -62.8 -29.32 70.63 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.716 0.806 . . . . 71.13 112.176 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -71.97 -35.52 69.56 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.194 0.521 . . . . 71.44 109.811 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -79.8 -39.07 31.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.834 -1.075 . . . . 62.33 111.55 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.533 HG13 ' HG ' ' A' ' 35' ' ' LEU . 7.5 pt -96.54 -40.57 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.858 0.463 . . . . 73.13 111.956 -172.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' HG13 ' A' ' 34' ' ' ILE . 47.3 mt -100.95 -175.2 2.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.737 0.815 . . . . 72.41 109.24 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.611 ' HB2' HG23 ' A' ' 39' ' ' VAL . 11.0 m -75.98 146.21 78.67 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 109.334 -0.617 . . . . 72.22 109.334 167.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.22 -19.99 62.52 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.83 2.354 . . . . 73.02 112.452 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.98 -31.71 71.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.501 1.121 . . . . 73.14 111.339 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -69.54 -49.05 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 122.951 0.5 . . . . 64.13 110.287 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.36 -30.22 71.27 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.35 -0.241 . . . . 52.24 110.35 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.58 -40.39 84.83 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.302 1.041 . . . . 61.14 111.495 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.9 -33.06 52.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.211 0.204 . . . . 71.23 110.833 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.84 -47.63 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.415 0.686 . . . . 32.42 110.985 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 5.9 ppt_? -62.8 -29.97 71.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.741 0.417 . . . . 73.1 112.114 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.42 -47.86 58.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.757 0.423 . . . . 55.41 112.072 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -66.2 -31.24 71.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.115 0.484 . . . . 70.33 110.332 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.4 -39.57 92.34 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.714 -1.13 . . . . 63.35 111.891 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 71.9 mtp180 -67.77 -30.58 70.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.266 0.626 . . . . 71.24 111.182 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -72.77 -31.7 65.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.374 0.27 . . . . 71.23 111.069 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.23 -32.04 62.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.152 0.581 . . . . 71.02 110.742 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -70.29 -37.01 74.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.408 0.683 . . . . 74.01 110.354 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -60.8 -38.07 84.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.03 0.932 . . . . 65.14 109.816 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -90.12 176.75 6.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.012 -0.995 . . . . 75.21 110.41 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.59 33.12 6.82 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mt -77.79 101.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.996 -0.742 . . . . 72.4 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -94.09 151.85 19.2 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.671 -0.863 . . . . 54.53 108.671 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 44.1 p90 -147.67 161.77 40.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.572 0.749 . . . . 65.34 109.025 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -141.02 136.47 32.12 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.739 -0.467 . . . . 73.32 109.739 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.02 122.07 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 109.368 -0.605 . . . . 63.14 109.368 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -112.01 -44.61 3.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.355 1.062 . . . . 54.22 110.186 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -140.53 135.25 31.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.091 -0.959 . . . . 75.54 109.167 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.48 115.36 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.035 -1.098 . . . . 61.45 108.035 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -127.87 131.97 49.4 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.567 -0.901 . . . . 71.3 108.567 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG11 ' HD2' ' A' ' 9' ' ' LYS . 7.6 p -120.07 109.79 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.886 -0.783 . . . . 72.21 108.886 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.3 p -111.0 164.12 13.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.531 0.732 . . . . 54.12 109.07 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -119.96 143.15 48.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.1 110.093 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.48 ' HB3' ' ND2' ' A' ' 72' ' ' ASN . 5.0 t70 -140.23 91.55 2.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.833 -1.543 . . . . 53.42 106.833 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.56 -124.9 11.13 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.855 -1.298 . . . . 72.33 109.855 -164.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -97.51 -7.7 30.84 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.344 0.657 . . . . 64.03 110.749 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.1 m -88.29 121.54 30.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.343 -0.614 . . . . 72.02 109.343 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.1 t -86.96 136.69 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.664 0.786 . . . . 74.25 109.318 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 67' ' ' ASP . 9.0 m-80 -119.5 99.91 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.244 -1.021 . . . . 64.44 108.244 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.22 104.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.19 -0.67 . . . . 54.55 109.19 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.2 m -87.16 103.36 15.34 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.913 -1.143 . . . . 75.52 107.913 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.59 115.35 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.969 0.908 . . . . 53.22 109.166 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 37.7 tt0 -84.36 124.3 31.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.829 0.852 . . . . 74.11 109.522 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.95 119.7 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.429 0.692 . . . . 54.3 109.347 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -87.59 102.72 14.87 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.214 -1.032 . . . . 71.41 108.214 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.6 mt-10 -89.15 110.42 21.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.14 0.976 . . . . 72.44 111.452 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 45.2 m -89.77 99.88 12.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.551 -1.277 . . . . 64.44 107.551 172.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -147.55 144.65 28.66 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.422 0.689 . . . . 64.32 110.101 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.08 15.63 72.17 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.837 -0.619 . . . . 53.24 113.265 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.38 3.88 81.21 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.1 -0.278 . . . . 72.2 113.474 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -124.59 148.72 47.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.002 0.521 . . . . 64.22 110.559 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 67.3 m -102.86 106.0 16.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.144 -0.687 . . . . 74.32 109.144 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.4 m -101.95 120.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.527 1.131 . . . . 63.42 109.532 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.1 103.8 9.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.652 -0.87 . . . . 63.24 108.652 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -111.06 154.0 24.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.364 1.066 . . . . 61.0 109.744 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 29.9 m -114.53 149.1 36.97 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.113 -0.699 . . . . 60.41 109.113 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.93 131.73 47.56 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.176 1.39 . . . . 72.24 107.691 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -113.83 105.77 13.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.999 . . . . 61.41 108.304 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.1 mp -98.4 106.21 18.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -95.9 103.05 14.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.134 0.574 . . . . 63.0 109.843 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 101' ' ' ILE . 96.5 m-85 -87.18 108.49 18.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.129 0.972 . . . . 73.41 109.637 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 24.8 tt0 -99.71 124.21 44.73 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 4' ' ' ILE . 3.2 m -98.17 151.89 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.177 -0.92 . . . . 41.24 111.808 -165.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -137.98 99.23 3.84 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.525 1.13 . . . . 71.44 108.062 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.31 -107.76 2.46 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.185 -0.916 . . . . 41.24 113.023 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.25 -4.08 13.77 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.63 1.172 . . . . 64.32 110.908 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.538 HG23 ' HD3' ' A' ' 102' ' ' ARG . 5.2 t -127.98 154.1 45.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.733 0.813 . . . . 54.44 110.228 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 96' ' ' VAL . 52.3 mt -95.37 133.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.177 -1.045 . . . . 71.02 108.177 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.538 ' HD3' HG23 ' A' ' 100' ' ' THR . 22.2 mmm180 -118.19 -2.98 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.633 0.373 . . . . 61.43 111.324 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 21.9 tpt180 -143.76 133.99 24.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.508 0.723 . . . . 71.23 110.01 -172.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.74 118.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.656 -1.238 . . . . 74.24 107.656 166.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 m -97.46 103.08 14.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.877 -1.157 . . . . 74.54 107.877 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 92' ' ' LEU . 44.6 t -93.87 105.24 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.408 -0.96 . . . . 74.21 108.408 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -110.54 122.09 46.9 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.56 -0.533 . . . . 71.21 109.56 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.77 97.15 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 108.255 -1.017 . . . . 61.3 108.255 176.736 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t0 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.33 0.586 . . . . 72.2 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -76.27 -39.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.372 1.069 . . . . 71.23 111.068 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.56 -48.38 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.016 0.526 . . . . 72.54 110.979 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.94 -40.47 93.38 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.908 0.755 . . . . 72.42 110.326 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.42 90.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.021 0.825 . . . . 61.22 111.136 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.26 80.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.441 0.696 . . . . 73.21 111.613 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -72.82 -48.78 34.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 72.05 110.549 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -61.15 -42.68 98.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.055 0.942 . . . . 71.32 110.937 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.72 91.65 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.111 -0.949 . . . . 41.34 111.26 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -55.31 -51.22 67.44 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.045 0.841 . . . . 53.14 111.416 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.56 -46.72 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.425 -0.807 . . . . 70.35 110.28 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.146 0.978 . . . . 74.24 113.057 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HA ' HG11 ' A' ' 43' ' ' VAL . 57.6 mt -62.72 -43.19 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.802 0.841 . . . . 72.42 110.192 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -72.8 -33.16 66.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.553 0.341 . . . . 55.25 111.465 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.596 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 49.7 mt-30 -63.02 -37.85 88.83 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.639 0.587 . . . . 75.52 111.079 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 28' ' ' GLN . 95.6 mt -75.2 -37.24 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.768 0.667 . . . . 74.4 111.185 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.43 -29.32 70.63 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.747 0.647 . . . . 72.42 112.747 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -101.88 -15.11 16.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.825 0.45 . . . . 74.03 111.58 175.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 24' ' ' ASP . 4.9 t30 -156.59 84.27 3.16 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 108.975 -0.75 . . . . 74.32 108.975 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 -12.93 36.76 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.142 2.562 . . . . 71.54 112.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -80.91 -5.58 57.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.446 1.098 . . . . 74.55 112.384 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' HB2' HD22 ' A' ' 21' ' ' ASN . 10.5 t70 -74.99 112.55 18.42 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 109.756 -0.461 . . . . 74.44 109.756 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.15 -34.11 5.23 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.599 2.199 . . . . 55.32 113.018 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.93 -30.83 56.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.867 0.467 . . . . 74.11 111.653 -171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.02 79.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.354 0.662 . . . . 62.31 110.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.582 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.0 pt20 -78.34 -23.94 46.76 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.09 -0.504 . . . . 63.14 111.616 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.67 -48.85 75.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 55.02 110.375 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.0 pp -66.48 -35.02 79.22 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.419 0.449 . . . . 73.44 109.951 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.15 -21.6 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.782 0.833 . . . . 72.54 112.191 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.1 -31.27 34.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.555 -0.535 . . . . 74.53 109.555 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.98 -35.09 38.0 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.22 1.008 . . . . 72.32 112.382 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.5 pt -111.26 -45.15 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.038 0.535 . . . . 64.14 111.854 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 39' ' ' VAL . 3.8 mm? -96.03 177.27 5.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.998 0.919 . . . . 71.31 108.869 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.4 m -71.65 147.01 91.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 116.321 -0.399 . . . . 64.45 110.061 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.63 -18.77 56.92 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.558 2.172 . . . . 75.51 113.21 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.07 -37.92 81.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.295 1.038 . . . . 60.42 111.18 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 35' ' ' LEU . 77.5 t -61.8 -55.57 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.749 0.656 . . . . 62.03 110.047 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.582 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.0 pp -59.73 -33.46 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.439 0.462 . . . . 62.14 111.038 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 27.5 t70 -67.55 -54.4 20.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 124.249 0.968 . . . . 75.11 110.44 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -67.28 -24.71 65.81 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.155 0.182 . . . . 74.45 111.404 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 15' ' ' ILE . 31.8 t -68.91 -52.03 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.491 0.716 . . . . 73.32 110.64 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -65.91 -20.73 66.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.576 0.35 . . . . 63.42 111.389 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 44.8 mt-10 -81.93 -35.77 28.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.406 0.682 . . . . 72.13 110.642 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -67.34 -22.29 65.6 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.223 0.609 . . . . 74.41 110.498 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.14 64.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 55.12 111.431 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -59.11 -33.14 70.51 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 124.33 1.018 . . . . 72.44 111.563 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.63 -50.87 61.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.284 0.634 . . . . 72.33 110.633 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.39 -34.26 61.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.081 -0.963 . . . . 74.32 110.682 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.06 -29.04 54.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.166 0.986 . . . . 75.32 110.848 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.43 -40.28 85.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.475 0.71 . . . . 64.2 109.847 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.8 -29.56 62.24 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.002 -0.999 . . . . 72.22 110.315 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.47 29.14 30.86 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.902 0.751 . . . . 44.11 112.81 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.43 116.47 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.743 0.817 . . . . 72.11 109.957 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -91.48 112.18 23.99 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.794 -1.188 . . . . 64.43 107.794 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -130.17 132.59 46.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.629 0.772 . . . . 54.11 109.621 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.32 135.72 51.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.152 0.581 . . . . 71.43 110.427 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.54 119.83 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.285 1.034 . . . . 74.23 109.81 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -104.89 -55.22 2.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.085 0.554 . . . . 73.3 110.409 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 ttm180 -131.9 124.77 30.17 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.753 -0.832 . . . . 75.35 108.753 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.28 116.31 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.274 -1.01 . . . . 64.2 108.274 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -113.92 108.44 17.05 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.637 -0.875 . . . . 62.23 108.637 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.88 127.18 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.381 -0.97 . . . . 71.24 108.381 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -139.61 139.83 36.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.398 0.679 . . . . 72.24 109.2 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 71' ' ' VAL . 47.3 p -97.56 116.23 29.38 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.046 0.538 . . . . 73.32 110.007 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.33 91.4 3.65 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.564 -1.273 . . . . 73.12 107.564 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.1 -119.98 7.0 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.017 -0.992 . . . . 60.11 110.905 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -101.13 -11.54 19.5 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.326 0.65 . . . . 74.33 111.082 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 m -94.39 121.51 36.0 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.516 0.726 . . . . 72.32 109.516 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 66' ' ' THR . 68.3 t -87.62 139.14 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.937 -0.764 . . . . 72.33 108.937 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -120.91 110.49 16.36 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.123 . . . . 65.12 108.171 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.12 104.11 15.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.615 -0.883 . . . . 63.45 108.615 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 78.4 m -92.72 105.58 17.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.897 -1.149 . . . . 70.33 107.897 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.6 p -118.55 124.01 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.658 0.783 . . . . 74.52 110.412 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.88 121.91 30.01 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.28 -1.007 . . . . 62.51 108.28 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.6 mp -107.45 160.65 15.48 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.337 0.655 . . . . 41.21 109.328 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -116.63 104.64 11.59 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.541 1.137 . . . . 74.22 108.153 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -100.36 102.97 14.34 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.893 -0.41 . . . . 70.23 109.893 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -89.83 104.23 16.81 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.333 -1.358 . . . . 65.31 107.333 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 t -133.73 122.9 24.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.593 0.757 . . . . 74.53 110.25 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.65 0.25 58.36 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.639 -0.709 . . . . 75.2 114.02 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.28 -36.22 3.49 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.734 0.683 . . . . 54.1 111.531 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.3 p -84.87 124.82 32.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.554 0.742 . . . . 74.31 110.914 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -93.7 106.24 18.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.698 0.799 . . . . 74.44 109.796 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 m -114.33 123.61 49.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.117 0.967 . . . . 72.31 109.002 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.57 130.21 35.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.094 -0.706 . . . . 75.3 109.094 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -127.03 125.92 42.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.077 0.951 . . . . 52.31 109.335 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -89.01 121.0 30.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.275 -0.639 . . . . 63.24 109.275 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD1' HD13 ' A' ' 77' ' ' LEU . 10.2 m-85 -102.99 133.08 48.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.261 -1.385 . . . . 70.33 107.261 173.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.34 106.1 12.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.91 -0.774 . . . . 74.15 108.91 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.0 mp -97.34 106.23 18.51 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.26 1.024 . . . . 63.33 108.384 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.599 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 76.8 ttt-85 -96.2 99.97 11.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.706 -0.85 . . . . 71.4 108.706 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.1 m-85 -85.87 107.88 17.88 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.68 -0.691 . . . . 74.55 109.418 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 38.5 tt0 -101.11 124.26 46.55 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.913 -1.04 . . . . 73.12 108.954 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 101' ' ' ILE . 29.9 m -87.27 147.46 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.562 -0.744 . . . . 72.34 111.534 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.82 99.44 6.28 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.648 -1.242 . . . . 74.5 107.648 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.67 -110.99 3.43 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.272 -0.876 . . . . 22.04 112.61 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -89.23 -16.23 31.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.924 0.89 . . . . 64.13 112.311 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -133.69 166.29 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.231 0.612 . . . . 74.44 111.156 -168.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 96' ' ' VAL . 25.1 mt -94.73 120.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 107.934 -1.136 . . . . 53.42 107.934 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -106.75 -17.22 14.28 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.044 0.538 . . . . 60.02 111.2 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 84.4 mtt85 -128.63 146.98 50.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.405 0.682 . . . . 75.32 110.889 -170.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.8 p -146.31 112.23 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 114.963 -1.017 . . . . 71.11 108.755 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 92.8 m -91.8 103.54 16.08 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.634 -0.876 . . . . 65.1 108.634 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.76 112.39 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.075 -0.713 . . . . 72.33 109.075 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.0 m -106.89 118.64 37.22 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.034 0.534 . . . . 61.33 109.825 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.75 84.04 7.7 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.826 0.85 . . . . 72.32 109.103 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 . . . . . 0 N--CA 1.478 0.953 0 CA-C-N 115.996 -0.547 . . . . 72.21 109.715 -179.578 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--O 1.211 -0.971 0 CA-C-O 119.107 -0.473 . . . . 73.03 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.454 HG23 HG11 ' A' ' 96' ' ' VAL . 46.2 mm -46.4 -46.11 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.22 1.408 . . . . 45.02 113.934 -167.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.33 -52.18 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.41 0.684 . . . . 73.12 110.551 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.02 -33.92 72.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.512 -0.767 . . . . 72.54 111.35 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.02 68.72 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 124.237 1.015 . . . . 75.35 109.945 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.14 -32.64 73.05 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.719 0.637 . . . . 74.32 111.443 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.59 -51.49 59.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.581 0.752 . . . . 74.23 110.319 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.66 -33.82 76.83 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.611 0.765 . . . . 73.33 111.163 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.13 81.69 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 124.284 0.99 . . . . 71.15 110.752 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.47 71.1 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.399 1.062 . . . . 63.04 111.256 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG22 HE21 ' A' ' 17' ' ' GLN . 28.8 mt -66.31 -38.32 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 O-C-N 124.1 0.875 . . . . 42.11 110.072 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.1 74.37 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.814 0.845 . . . . 73.21 111.858 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 43' ' ' VAL . 60.1 mt -61.65 -40.97 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.774 0.83 . . . . 60.04 109.747 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 43.4 m-85 -75.36 -29.11 59.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.774 0.43 . . . . 75.45 112.084 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.534 HE21 HG22 ' A' ' 13' ' ' ILE . 72.7 mt-30 -63.13 -38.2 90.25 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.468 0.48 . . . . 54.35 110.148 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.09 -38.78 63.78 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.691 0.619 . . . . 74.44 110.707 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.1 m0 -68.58 -22.04 64.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.825 0.676 . . . . 73.24 112.825 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -99.68 -20.86 16.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.053 0.541 . . . . 71.21 110.883 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 24' ' ' ASP . 7.6 t30 -158.72 91.75 2.02 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 123.928 0.891 . . . . 74.55 109.96 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.11 -9.14 24.84 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.268 2.645 . . . . 72.42 113.965 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 p -90.25 0.64 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.818 0.847 . . . . 53.43 111.868 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' HB2' HD22 ' A' ' 21' ' ' ASN . 12.3 t70 -68.04 114.73 22.45 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 122.866 0.466 . . . . 74.44 110.541 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 98.2 Cg_endo -75.21 -27.38 9.74 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.51 2.14 . . . . 75.41 114.005 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.9 -34.39 24.55 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.864 0.465 . . . . 54.52 112.06 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -52.34 57.12 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.483 0.713 . . . . 62.21 110.223 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -66.39 -28.53 68.7 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.203 -0.908 . . . . 61.1 111.31 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 6.8 tm-20 -58.49 -59.04 5.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.018 0.927 . . . . 65.43 109.93 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -63.97 -33.99 76.96 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.08 0.862 . . . . 72.21 111.034 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.12 -30.1 71.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.912 0.885 . . . . 63.54 112.471 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -65.42 -27.11 68.3 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.07 0.396 . . . . 74.3 111.866 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -94.16 -36.29 12.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.987 0.915 . . . . 72.33 112.286 -171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 30' ' ' LEU . 22.0 pt -103.74 -29.08 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 122.859 0.464 . . . . 74.23 112.225 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.529 HD12 HG21 ' A' ' 39' ' ' VAL . 4.1 mm? -106.05 178.38 4.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.035 0.934 . . . . 54.24 108.592 172.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 m -84.78 149.88 54.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.049 -0.523 . . . . 74.54 109.952 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 40' ' ' LEU . 83.0 Cg_exo -50.55 -26.25 16.28 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.565 2.843 . . . . 74.15 114.668 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.93 -42.07 95.0 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.084 0.954 . . . . 72.12 111.559 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 HD12 ' A' ' 35' ' ' LEU . 88.6 t -60.83 -60.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.555 0.742 . . . . 75.11 112.056 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -61.05 -22.55 64.68 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.073 0.397 . . . . 74.14 112.073 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.29 -42.68 30.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 53.44 111.234 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 39' ' ' VAL . 28.3 pt20 -71.56 -27.11 62.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 110.298 -0.26 . . . . 62.41 110.298 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 HG12 ' A' ' 15' ' ' ILE . 37.7 t -65.92 -53.8 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.69 0.796 . . . . 73.44 110.151 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -63.11 -22.47 66.88 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.229 0.212 . . . . 73.21 111.03 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -74.93 -45.27 43.62 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.452 0.701 . . . . 72.52 110.484 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -71.19 -22.67 62.0 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.895 -0.593 . . . . 70.44 110.701 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.49 98.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.187 0.995 . . . . 73.22 110.898 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -66.06 -34.14 77.4 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.912 -1.04 . . . . 61.13 110.837 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.53 -48.33 79.98 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.804 0.69 . . . . 63.23 110.867 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.67 -51.8 60.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.613 -0.722 . . . . 72.31 110.752 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.77 -35.29 79.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.351 -1.295 . . . . 60.51 111.405 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -61.01 -43.08 99.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.668 1.187 . . . . 74.31 111.356 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -83.65 -15.12 50.12 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.23 -0.896 . . . . 73.11 111.256 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.32 60.19 Favored Glycine 0 C--N 1.345 1.032 0 O-C-N 123.268 0.355 . . . . 14.41 112.878 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.95 91.49 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.821 -0.807 . . . . 75.02 108.821 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -92.53 153.15 19.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.398 -0.819 . . . . 71.55 108.876 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -149.84 170.17 19.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.339 0.655 . . . . 74.14 110.49 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -141.04 138.12 33.41 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.527 -0.916 . . . . 62.13 108.527 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.92 138.22 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 123.528 0.517 . . . . 74.44 109.86 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -115.98 -42.26 3.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.776 0.83 . . . . 73.14 111.559 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttm105 -157.82 123.87 4.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.805 -0.634 . . . . 72.44 109.998 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.89 107.62 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.264 -1.013 . . . . 72.43 108.264 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.71 123.75 43.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 62.23 108.945 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.81 128.75 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.83 -0.804 . . . . 55.12 108.83 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -137.91 117.85 13.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.171 -0.677 . . . . 71.41 109.171 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 71' ' ' VAL . 22.1 p -89.79 114.83 26.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.879 0.871 . . . . 72.24 109.856 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -113.99 90.92 3.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.448 1.099 . . . . 75.22 109.096 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.76 -105.13 1.45 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.513 -0.767 . . . . 51.03 112.43 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.405 ' O ' HG22 ' A' ' 96' ' ' VAL . 73.1 m-20 -114.89 14.65 17.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.241 1.016 . . . . 60.23 110.346 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.4 m -132.01 122.61 25.79 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.348 0.659 . . . . 54.55 110.227 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 66' ' ' THR . 58.7 t -90.03 115.35 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 122.939 0.495 . . . . 62.3 109.792 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -102.31 106.82 17.67 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.617 1.167 . . . . 73.51 108.872 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.22 110.53 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.533 0.733 . . . . 71.12 109.706 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -98.4 105.3 17.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.195 -1.039 . . . . 60.45 108.195 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.4 p -124.3 127.88 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.071 0.548 . . . . 74.0 110.065 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.27 136.98 32.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.937 0.495 . . . . 72.31 109.876 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.5 141.78 48.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.852 0.861 . . . . 63.13 109.927 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.32 104.32 16.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.728 0.811 . . . . 71.03 109.905 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -86.18 107.05 17.71 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.298 0.639 . . . . 73.45 109.557 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.3 m -88.34 104.55 16.86 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.12 -1.067 . . . . 63.23 108.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -144.02 131.81 21.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.437 1.095 . . . . 71.51 108.959 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.33 26.66 73.49 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.844 -0.162 . . . . 50.31 112.863 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.84 85.71 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.49 -0.616 . . . . 42.55 114.359 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.2 t -127.47 146.02 50.64 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.643 0.721 . . . . 61.34 111.259 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 149.97 22.08 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.12 0.968 . . . . 75.03 111.104 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.2 m -137.6 122.03 18.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.269 1.027 . . . . 74.15 109.219 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.41 100.31 5.15 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.03 -1.1 . . . . 74.14 108.03 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -114.72 122.76 47.4 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.359 -0.837 . . . . 63.42 109.046 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.8 m -89.99 124.68 34.96 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.75 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -104.52 127.57 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.818 0.847 . . . . 70.22 109.024 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.63 113.62 27.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.644 -0.873 . . . . 75.5 108.644 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.31 107.36 18.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.719 -0.845 . . . . 61.4 108.719 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -91.6 100.36 13.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.255 1.022 . . . . 64.11 109.484 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.26 106.9 18.52 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.367 0.667 . . . . 74.53 109.47 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 44.0 tt0 -97.54 116.95 30.72 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.736 0.814 . . . . 74.14 108.858 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 101' ' ' ILE . 4.5 m -89.69 149.32 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.444 0.697 . . . . 75.41 110.629 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.46 119.48 15.42 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.444 -1.317 . . . . 75.22 107.444 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.14 -97.99 0.97 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.017 -0.433 . . . . 54.44 112.017 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -121.72 -17.49 7.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.885 0.874 . . . . 73.12 111.91 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.7 t -124.94 160.03 29.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.93 0.492 . . . . 73.1 111.152 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 HG12 ' A' ' 96' ' ' VAL . 27.3 mt -86.03 126.78 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.772 -0.825 . . . . 65.2 108.772 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -102.36 -29.96 11.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.531 0.733 . . . . 74.14 111.715 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -130.95 146.89 52.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.624 0.25 . . . . 62.24 111.086 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.61 107.81 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.263 1.025 . . . . 64.43 109.36 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -95.12 106.57 18.59 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.949 -0.76 . . . . 74.24 108.949 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.49 136.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 109.61 -0.515 . . . . 54.45 109.61 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -129.46 113.0 14.35 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.59 0.756 . . . . 72.41 109.796 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.31 101.79 7.36 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.316 0.647 . . . . 73.42 109.902 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 . . . . . 0 N--CA 1.47 0.543 0 C-N-CA 124.124 0.97 . . . . 65.25 108.887 177.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 109.692 -0.484 . . . . 72.23 109.692 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.25 -39.74 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.583 0.753 . . . . 74.41 111.725 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.27 -52.93 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.682 0.793 . . . . 63.24 111.891 -171.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -67.62 -35.7 79.43 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.686 -0.688 . . . . 71.21 110.523 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.443 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -62.8 -41.84 99.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.325 0.65 . . . . 72.52 111.293 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.65 66.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 73.41 111.008 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.58 -54.63 44.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.553 1.141 . . . . 65.31 111.054 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -64.43 -33.94 77.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.509 0.723 . . . . 75.52 110.977 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -49.42 76.11 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.008 0.818 . . . . 52.23 111.025 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.75 68.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.315 1.01 . . . . 71.13 111.504 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.492 HG22 HE21 ' A' ' 17' ' ' GLN . 51.1 mt -63.4 -40.46 89.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 124.175 0.922 . . . . 72.4 110.324 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.348 0.659 . . . . 63.02 111.334 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.3 mt -56.13 -39.32 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 72.24 110.304 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -71.12 -32.67 69.3 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.249 0.62 . . . . 53.54 111.759 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.492 HE21 HG22 ' A' ' 13' ' ' ILE . 71.8 mt-30 -63.04 -38.37 90.92 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.099 0.56 . . . . 72.24 110.519 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 3.4 mm? -66.59 -48.87 68.2 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 123.543 0.527 . . . . 75.22 109.945 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 106' ' ' VAL . 32.4 m0 -51.52 -34.33 35.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.485 0.92 . . . . 74.05 113.485 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.46 -32.24 12.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.7 0.4 . . . . 64.45 111.686 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.454 HD22 ' HB2' ' A' ' 24' ' ' ASP . 7.2 t30 -143.95 86.99 8.22 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 108.983 -0.747 . . . . 74.15 108.983 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.89 -15.69 50.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.979 2.453 . . . . 74.23 113.03 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.2 p -89.45 13.34 13.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.42 1.088 . . . . 62.31 112.283 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' HD22 ' A' ' 21' ' ' ASN . 17.2 t70 -83.21 110.81 26.19 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.281 -0.636 . . . . 74.52 109.281 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.16 -21.61 17.71 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.461 2.107 . . . . 53.23 113.624 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.69 -39.55 26.97 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.359 0.664 . . . . 63.43 111.444 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.19 -50.02 65.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.464 0.706 . . . . 73.03 110.748 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.541 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.6 pt20 -72.41 -19.63 61.56 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.429 -0.805 . . . . 42.41 111.505 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.49 -54.97 24.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.13 0.572 . . . . 74.31 110.592 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.26 -30.3 70.15 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.313 -0.403 . . . . 65.03 110.262 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.18 -28.4 69.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.908 0.755 . . . . 74.41 112.034 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -75.11 -26.96 59.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.317 0.58 . . . . 62.34 109.891 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -78.8 -41.26 30.84 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.915 0.886 . . . . 64.42 110.748 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.453 HG13 HD23 ' A' ' 35' ' ' LEU . 9.9 pt -103.27 -36.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.081 0.552 . . . . 73.34 112.294 -170.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 34' ' ' ILE . 3.8 mm? -103.28 -176.88 3.21 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.26 1.024 . . . . 75.24 109.477 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.409 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.7 m -81.29 145.89 56.84 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.421 -0.809 . . . . 71.22 109.878 170.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.22 -27.98 59.47 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.854 2.369 . . . . 55.32 112.484 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.62 -48.33 77.71 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.537 1.135 . . . . 75.22 111.479 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 35' ' ' LEU . 98.7 t -66.33 -51.97 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.81 0.844 . . . . 70.14 111.391 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 28' ' ' GLN . 4.0 pp -65.13 -28.66 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 120.769 0.318 . . . . 75.43 111.539 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.79 -33.21 60.13 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.511 -0.768 . . . . 62.45 110.54 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -77.62 -32.63 53.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.696 -0.483 . . . . 73.01 109.696 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.3 t -59.94 -42.73 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.442 0.697 . . . . 73.25 111.028 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -73.36 -21.49 60.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.834 0.454 . . . . 62.21 111.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.26 -50.73 13.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.295 0.638 . . . . 74.55 110.829 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -71.01 -21.3 62.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.712 0.805 . . . . 70.32 111.02 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -58.25 -44.86 88.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.725 1.21 . . . . 72.12 111.613 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 99.4 mtt180 -60.43 -35.55 76.08 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.408 -1.269 . . . . 70.24 110.689 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.69 -43.97 74.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.908 0.755 . . . . 74.33 110.3 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.97 -27.96 68.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.755 0.822 . . . . 73.21 111.207 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -79.4 -33.34 42.82 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.991 0.917 . . . . 72.54 110.089 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 94.0 mttt -67.63 -39.37 84.65 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.574 0.749 . . . . 74.5 110.315 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.18 -44.51 88.23 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.085 -0.962 . . . . 73.43 109.219 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.92 44.79 5.91 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.251 -0.886 . . . . 43.41 112.137 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -79.37 106.23 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.781 -0.822 . . . . 73.0 108.781 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -85.81 108.97 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.896 -1.15 . . . . 75.04 107.896 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.53 142.09 50.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.409 -0.589 . . . . 74.14 109.409 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.89 135.72 54.78 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.797 -0.816 . . . . 71.01 108.797 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.37 100.12 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.202 -1.036 . . . . 54.44 108.202 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.37 -49.98 8.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.47 -0.786 . . . . 74.53 110.816 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -144.5 122.65 12.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.308 -0.86 . . . . 71.1 109.682 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.65 124.76 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.623 0.769 . . . . 65.22 109.275 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.1 108.2 10.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.27 -1.011 . . . . 64.53 108.27 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 HG22 ' A' ' 73' ' ' VAL . 7.7 p -96.17 121.23 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.276 0.56 . . . . 72.21 109.541 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.1 m -129.4 141.46 51.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.165 0.986 . . . . 75.15 109.711 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -88.89 163.33 15.67 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.037 0.535 . . . . 74.43 110.939 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -158.57 74.76 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.767 -1.197 . . . . 72.01 107.767 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.84 -117.83 11.21 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.861 -0.495 . . . . 72.41 111.861 -171.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -88.31 -11.68 45.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.114 0.565 . . . . 63.43 111.023 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -97.93 156.05 16.79 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.706 1.202 . . . . 73.35 109.693 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.32 123.5 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.281 0.633 . . . . 62.32 110.296 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -99.34 112.64 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.855 0.862 . . . . 74.03 109.686 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 64' ' ' VAL . 61.5 t -91.1 105.02 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.901 -0.777 . . . . 62.22 108.901 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -86.07 104.95 16.14 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.367 -0.975 . . . . 74.42 108.367 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.16 126.82 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.995 0.518 . . . . 64.01 110.461 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.65 123.75 32.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.809 0.844 . . . . 74.04 109.381 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.69 123.15 45.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.316 -0.994 . . . . 71.43 108.316 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 34.9 tt0 -88.86 107.82 19.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.461 -0.941 . . . . 73.13 108.461 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.89 130.61 48.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.731 0.813 . . . . 64.23 110.652 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.2 m -119.52 117.68 29.04 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.158 1.383 . . . . 60.14 107.926 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -144.27 134.29 24.06 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.542 -0.91 . . . . 74.44 108.542 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.51 28.64 62.61 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.355 0.409 . . . . 71.33 113.619 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.67 -34.34 4.25 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 74.33 113.03 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -82.05 133.99 35.32 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.236 0.614 . . . . 64.14 110.612 -170.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -118.51 129.85 55.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.601 0.761 . . . . 64.22 110.334 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.1 m -143.64 136.27 27.24 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.918 0.887 . . . . 73.22 109.669 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 16.5 m120 -79.79 105.39 11.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.684 0.793 . . . . 75.5 109.956 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 m -101.03 126.53 47.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.625 1.17 . . . . 72.42 110.385 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -93.78 122.52 36.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.876 0.47 . . . . 63.12 110.795 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.8 127.54 53.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.398 0.679 . . . . 73.21 109.485 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.03 106.69 18.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.909 -1.145 . . . . 71.41 107.909 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.7 mp -95.34 106.84 18.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.09 -1.078 . . . . 74.5 108.09 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 34.1 ttt180 -98.44 99.91 11.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.942 0.897 . . . . 72.25 109.41 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.81 112.46 22.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.525 1.13 . . . . 54.04 111.007 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 31.2 tt0 -90.91 134.36 34.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.088 -0.708 . . . . 72.23 109.088 174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.44 151.42 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.304 1.042 . . . . 72.23 111.712 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.37 103.41 6.9 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.705 -1.221 . . . . 64.04 107.705 162.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.33 -105.32 2.06 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.719 -0.673 . . . . 75.11 112.072 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.64 -9.9 10.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.24 1.016 . . . . 71.44 110.912 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -110.4 148.08 32.73 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.598 0.759 . . . . 74.11 109.214 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.09 144.73 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.865 -0.791 . . . . 74.31 108.865 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -125.06 -25.57 3.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.498 0.719 . . . . 71.24 112.443 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 3.0 mpt_? -129.72 156.44 44.27 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.755 0.422 . . . . 74.43 110.299 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 109.92 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.359 1.064 . . . . 74.33 109.091 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 40.7 m -92.05 105.12 17.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.762 -0.829 . . . . 50.3 108.762 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.49 HG11 ' HH2' ' A' ' 19' ' ' TRP . 48.0 t -93.36 105.84 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 122.927 0.491 . . . . 71.11 109.742 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.6 m -100.64 113.8 26.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.524 0.729 . . . . 72.34 109.849 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -79.62 126.67 31.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.027 -0.731 . . . . 75.45 109.027 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.66 0.784 . . . . 65.42 109.589 -176.426 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.974 -0.38 . . . . 63.43 109.974 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.76 -43.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.431 1.082 . . . . 64.3 111.489 -175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.5 -46.18 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.945 0.898 . . . . 61.11 110.199 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -67.23 -33.93 76.4 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.576 -0.738 . . . . 63.34 110.521 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -65.77 -45.75 81.35 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.304 0.642 . . . . 75.04 110.513 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.26 98.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.575 0.75 . . . . 73.34 110.969 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -59.02 -56.54 20.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.258 1.023 . . . . 74.54 111.019 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.77 0.828 . . . . 73.14 111.444 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -66.44 -45.13 80.87 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 124.151 0.907 . . . . 53.1 110.628 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.12 75.16 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 124.112 0.883 . . . . 63.22 110.816 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.49 -44.85 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 124.263 0.977 . . . . 70.23 110.163 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.63 71.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.107 0.963 . . . . 34.31 112.7 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -65.07 -41.45 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.26 0.624 . . . . 75.1 110.338 175.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -74.55 -31.51 62.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.71 0.404 . . . . 63.33 111.28 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.93 -37.41 85.98 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.111 0.564 . . . . 75.05 110.341 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.79 -38.86 67.11 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 119.199 -0.429 . . . . 64.42 110.71 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.429 ' HB3' ' HZ ' ' A' ' 57' ' ' PHE . 19.6 m0 -63.61 -21.33 66.3 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.364 0.876 . . . . 75.01 113.364 -176.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -102.32 -25.21 13.74 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.676 0.39 . . . . 71.21 111.156 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -146.04 96.0 4.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 123.273 0.629 . . . . 74.14 109.966 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.88 -28.51 75.59 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.251 2.634 . . . . 74.14 112.925 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 p -92.55 22.08 4.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.901 0.88 . . . . 73.44 111.945 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.25 112.15 23.75 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.055 -0.72 . . . . 74.3 109.055 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.37 -34.45 20.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.79 2.327 . . . . 70.15 112.898 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.71 -49.1 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 74.21 110.973 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.11 -52.67 64.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 124.225 0.953 . . . . 71.54 111.105 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.9 pt20 -68.15 -32.8 73.32 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 116.061 -0.518 . . . . 71.41 111.608 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.2 tt0 -69.87 -43.5 71.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.469 0.307 . . . . 74.15 111.098 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.6 pp -67.35 -34.01 76.42 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.826 -0.435 . . . . 74.22 109.826 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 HD12 ' A' ' 35' ' ' LEU . 85.8 mt -65.34 -30.6 71.45 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.56 0.744 . . . . 75.23 111.517 174.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -67.53 -33.85 75.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.194 0.598 . . . . 72.23 110.355 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 27.4 mtpp -80.89 -46.35 15.37 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.161 -0.927 . . . . 73.31 111.376 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 30' ' ' LEU . 13.0 pt -99.07 -35.18 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.654 0.382 . . . . 73.32 111.732 -168.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.518 HD11 ' HB1' ' A' ' 11' ' ' ALA . 28.3 mt -101.95 -170.52 1.83 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.397 -0.594 . . . . 74.1 109.397 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.586 ' HB2' HG23 ' A' ' 39' ' ' VAL . 8.9 m -73.36 138.35 78.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 115.623 -0.717 . . . . 70.32 109.504 169.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.93 -19.68 33.14 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.793 2.329 . . . . 63.41 113.501 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.78 -33.39 70.71 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.513 1.125 . . . . 75.34 111.755 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.0 t -67.07 -49.67 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.435 0.694 . . . . 74.32 111.42 -175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.5 pp -58.78 -30.8 67.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.396 0.278 . . . . 72.14 111.212 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.45 -58.93 5.05 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.714 1.206 . . . . 64.33 110.986 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.31 -30.47 71.6 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.823 0.449 . . . . 63.41 111.654 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 15' ' ' ILE . 48.9 t -67.08 -50.5 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.897 0.879 . . . . 63.3 110.651 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -73.68 -20.42 60.55 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.124 0.416 . . . . 72.31 112.124 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -85.61 -26.59 25.98 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 122.22 -0.3 . . . . 74.13 110.543 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.7 -25.31 60.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.885 0.874 . . . . 72.11 109.936 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.25 90.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.185 1.394 . . . . 70.44 112.066 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -59.89 -38.65 82.85 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.836 1.335 . . . . 74.34 111.005 -173.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -57.19 -58.84 6.46 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.233 0.958 . . . . 75.53 110.659 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.8 -34.02 76.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.509 1.124 . . . . 50.32 111.983 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -66.11 -45.11 82.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.014 0.925 . . . . 71.14 110.339 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.6 -32.56 66.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.48 0.712 . . . . 72.55 111.157 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -69.45 -18.29 63.71 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.486 0.714 . . . . 75.33 111.427 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.75 42.0 40.46 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.557 0.536 . . . . 70.42 112.203 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -111.15 96.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.211 -0.663 . . . . 64.13 109.211 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -92.05 108.11 19.7 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.192 -0.669 . . . . 70.31 109.192 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 8.7 p90 -106.3 135.49 47.7 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.174 -1.417 . . . . 63.14 107.174 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.56 135.6 47.15 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 110.007 -0.368 . . . . 73.04 110.007 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.68 125.18 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.902 1.376 . . . . 74.04 110.626 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.39 -37.93 3.91 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.731 0.813 . . . . 70.42 111.064 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 27.2 ttp85 -143.81 129.5 19.24 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.338 0.655 . . . . 75.01 109.349 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.65 128.66 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.878 0.871 . . . . 63.43 108.759 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.38 106.62 9.33 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.737 -1.208 . . . . 62.42 107.737 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.466 HG23 HG22 ' A' ' 73' ' ' VAL . 7.3 p -103.26 113.97 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.772 -0.825 . . . . 73.21 108.772 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.5 t -137.55 153.63 49.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 74.41 109.97 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 71' ' ' VAL . 34.2 p -100.75 130.16 46.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.145 0.578 . . . . 71.33 111.676 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.88 81.08 1.38 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.503 1.921 . . . . 71.33 108.437 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.44 -120.47 8.35 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.41 -0.814 . . . . 64.24 111.207 -173.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -87.38 -11.33 49.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.441 0.697 . . . . 73.15 110.639 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.4 m -89.96 156.73 18.22 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.272 1.029 . . . . 61.41 108.845 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 66' ' ' THR . 43.7 t -122.4 133.0 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.04 0.936 . . . . 74.25 109.331 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -110.56 125.83 53.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.722 0.809 . . . . 74.33 109.203 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 64' ' ' VAL . 48.7 t -97.38 104.1 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.378 -0.971 . . . . 42.05 108.378 169.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -86.75 102.22 14.05 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.515 -1.291 . . . . 61.22 107.515 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.21 123.1 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 33.44 109.89 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.0 tt0 -90.13 127.81 36.19 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.353 1.061 . . . . 73.02 109.444 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.49 143.68 51.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.288 0.635 . . . . 75.33 109.847 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -91.61 108.75 20.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.178 -0.675 . . . . 74.31 109.178 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 24.9 mt-10 -87.25 103.18 15.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.075 0.55 . . . . 74.11 109.666 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.7 m -93.96 106.14 18.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 74.42 109.465 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -145.59 118.55 8.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.346 1.058 . . . . 75.54 109.24 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.73 23.14 62.8 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.514 0.565 . . . . 23.34 114.514 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.03 -22.64 34.48 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.964 0.316 . . . . 75.1 112.901 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.2 m -83.69 124.52 30.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.561 0.745 . . . . 64.21 109.833 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 m -126.92 110.37 12.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.445 -0.946 . . . . 61.34 108.445 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.9 m -125.9 136.11 52.68 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.955 0.902 . . . . 64.32 109.976 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.93 100.58 6.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.833 -1.173 . . . . 55.32 107.833 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.2 m -105.29 132.63 51.24 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.927 -1.033 . . . . 73.22 108.985 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -89.39 122.89 33.04 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.427 -0.583 . . . . 75.22 109.427 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -104.8 126.77 52.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.164 -1.05 . . . . 63.43 108.164 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -113.79 103.9 11.66 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.103 -1.073 . . . . 74.32 108.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 106' ' ' VAL . 5.7 mp -98.38 107.07 19.44 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.117 -1.068 . . . . 75.23 108.117 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -90.45 98.74 11.95 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.075 -0.713 . . . . 60.25 109.075 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.618 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.4 m-85 -89.54 109.92 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.492 1.117 . . . . 73.11 109.284 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 28.2 tt0 -107.63 131.59 54.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.616 -0.513 . . . . 72.34 109.616 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 101' ' ' ILE . 11.0 m -84.35 151.84 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.83 1.252 . . . . 63.44 111.115 -168.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.8 98.38 3.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.215 -1.032 . . . . 72.41 108.215 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.82 2.18 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.021 -0.831 . . . . 34.42 111.021 -174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.68 -5.25 12.71 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.977 0.911 . . . . 70.34 111.17 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.6 t -127.44 143.86 51.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.68 . . . . 74.42 110.282 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 94' ' ' PHE . 73.4 mt -87.9 109.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.671 0.788 . . . . 73.22 109.361 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -103.27 6.16 37.93 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.209 0.448 . . . . 64.31 112.209 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 90.0 mtt180 -133.21 141.91 48.31 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.349 0.66 . . . . 73.4 110.903 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.96 134.68 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 63.32 108.504 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.4 m -132.02 106.56 8.1 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.094 -0.706 . . . . 71.41 109.094 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 92' ' ' LEU . 37.6 t -90.04 119.03 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.924 0.49 . . . . 71.32 109.798 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.6 m -113.31 106.88 15.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.504 0.722 . . . . 73.23 110.374 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -77.93 103.83 8.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.39 -0.967 . . . . 62.3 108.39 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 . . . . . 0 N--CA 1.473 0.693 0 C-N-CA 123.539 0.735 . . . . 64.3 109.588 -178.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 119.722 -0.18 . . . . 45.1 110.97 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -51.59 -41.1 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 125.401 1.481 . . . . 52.13 114.111 -166.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.34 -51.9 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.457 0.703 . . . . 73.13 110.678 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.71 -30.1 71.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.437 0.695 . . . . 70.14 110.344 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.68 71.18 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.848 1.259 . . . . 64.52 109.87 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.78 82.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.528 0.731 . . . . 71.34 111.495 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.479 ' HG3' HG11 ' A' ' 62' ' ' VAL . 39.6 tttm -63.68 -51.66 64.13 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.028 -0.987 . . . . 74.42 111.796 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.403 HE21 HD13 ' A' ' 30' ' ' LEU . 20.0 pt20 -72.64 -24.7 61.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.348 0.259 . . . . 64.45 111.317 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.04 -45.12 86.7 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 123.533 0.733 . . . . 53.03 110.237 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.64 -54.37 46.9 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.475 1.109 . . . . 72.12 110.746 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.45 HG12 HG11 ' A' ' 59' ' ' VAL . 57.0 mt -59.89 -41.67 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.086 0.866 . . . . 72.34 110.854 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.71 88.52 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.959 0.904 . . . . 63.13 111.58 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.514 ' HA ' HG11 ' A' ' 43' ' ' VAL . 45.6 mt -61.22 -37.23 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 124.064 0.853 . . . . 54.01 110.496 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.27 -29.9 34.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.792 0.437 . . . . 73.34 111.497 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -66.73 -35.2 79.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.355 0.662 . . . . 74.33 110.276 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.15 -47.22 59.07 Favored 'General case' 0 C--O 1.213 -0.816 0 O-C-N 123.669 0.606 . . . . 73.0 110.17 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.489 ' HB3' HD12 ' A' ' 50' ' ' LEU . 29.1 m0 -57.1 -26.67 60.85 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.105 0.78 . . . . 72.23 113.105 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -101.36 -16.18 16.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.807 0.443 . . . . 71.41 111.963 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.469 HD22 ' HB2' ' A' ' 24' ' ' ASP . 7.8 t30 -156.17 89.54 2.79 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 123.996 0.918 . . . . 75.54 109.352 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 23.6 Cg_endo -59.77 -23.1 70.71 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.883 3.055 . . . . 74.03 113.633 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.4 p -81.17 -2.22 47.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.15 0.98 . . . . 62.54 112.341 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' HB2' HD22 ' A' ' 21' ' ' ASN . 10.2 t70 -66.95 113.49 13.54 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 122.919 0.487 . . . . 73.23 109.873 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.51 -28.26 4.54 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.363 2.042 . . . . 61.43 112.766 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -70.03 -41.02 74.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.47 0.708 . . . . 73.13 111.183 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -51.41 49.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.897 -1.047 . . . . 62.01 111.116 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -68.41 -28.37 67.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.118 -0.492 . . . . 72.22 112.056 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.28 -47.26 62.02 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.254 0.346 . . . . 62.3 110.874 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -65.76 -33.34 75.65 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 110.175 -0.306 . . . . 74.53 110.175 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.96 -28.88 70.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.731 0.813 . . . . 71.1 111.722 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -69.39 -41.63 76.21 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.435 0.636 . . . . 70.31 109.613 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -73.98 -22.62 59.55 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.606 -1.179 . . . . 74.35 112.215 -171.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.0 pt -118.09 -51.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.315 0.507 . . . . 75.25 112.337 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.416 HD23 HG13 ' A' ' 34' ' ' ILE . 3.1 mm? -82.14 166.43 19.68 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 54.35 108.206 173.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -61.79 142.7 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 109.77 -0.456 . . . . 75.4 109.77 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.84 -11.42 14.85 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.746 2.297 . . . . 72.14 113.444 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.86 -37.12 73.07 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.735 0.814 . . . . 53.54 110.816 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.0 -37.54 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.253 1.021 . . . . 61.51 112.202 -171.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.35 -31.54 72.19 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.784 0.265 . . . . 71.04 110.905 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.22 -57.34 6.9 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 124.457 1.098 . . . . 41.25 109.991 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 12.1 pt20 -58.79 -30.44 67.59 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.035 0.534 . . . . 60.23 111.993 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 15' ' ' ILE . 67.6 t -75.44 -49.8 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.127 0.971 . . . . 54.22 111.913 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -67.67 -24.96 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.745 0.307 . . . . 74.01 111.344 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -86.14 -25.57 25.67 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.825 0.45 . . . . 52.11 110.984 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 5.5 t60 -67.0 -29.29 69.09 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.913 0.885 . . . . 72.3 109.544 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -59.03 -39.6 82.44 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.107 1.363 . . . . 63.21 112.667 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 75.3 mtp180 -58.43 -32.04 68.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.031 0.932 . . . . 73.03 111.293 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.22 -51.66 62.59 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.166 0.986 . . . . 50.43 110.907 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.515 HD22 HD12 ' A' ' 55' ' ' ILE . 53.0 mt -73.6 -17.69 61.14 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.307 -0.86 . . . . 75.33 111.317 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -72.61 -42.73 64.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.177 0.991 . . . . 74.41 109.625 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 73.6 mmtt -61.62 -42.62 99.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 123.739 0.649 . . . . 74.44 109.611 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' NE2' HD23 ' A' ' 50' ' ' LEU . 50.9 mt-30 -72.53 -28.52 62.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.231 -1.349 . . . . 73.32 111.732 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.12 40.71 95.13 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.729 0.643 . . . . 54.2 113.087 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.515 HD12 HD22 ' A' ' 50' ' ' LEU . 59.3 mt -78.62 114.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.883 0.473 . . . . 60.15 109.865 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -90.64 112.92 24.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.485 -0.931 . . . . 70.44 108.485 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.2 134.38 20.51 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.428 0.558 . . . . 72.01 111.164 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.875 0.87 . . . . 72.02 109.645 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 13' ' ' ILE . 49.4 t -77.18 120.62 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.394 1.077 . . . . 72.51 109.755 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.19 -54.5 2.6 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.431 0.692 . . . . 64.25 111.376 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 8.6 tpp85 -132.59 127.27 34.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.442 -0.948 . . . . 70.14 108.442 -173.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 9' ' ' LYS . 38.3 t -123.0 109.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.723 -0.843 . . . . 72.2 108.723 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -119.79 108.39 14.33 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.632 -0.877 . . . . 61.03 108.632 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -105.34 109.95 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.085 0.954 . . . . 65.32 109.687 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -123.83 142.55 51.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.913 0.885 . . . . 40.14 109.742 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.1 p -93.42 124.05 37.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.657 0.383 . . . . 70.03 110.369 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -113.51 98.24 6.95 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.228 -1.027 . . . . 72.35 108.228 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.191 -1.164 . . . . 73.42 110.191 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.45 -15.21 15.08 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.358 0.663 . . . . 72.03 110.332 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.0 m -93.35 117.06 29.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.922 0.489 . . . . 53.5 109.761 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.0 p -88.68 128.9 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.189 0.596 . . . . 71.34 110.377 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.63 113.35 25.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.782 1.233 . . . . 72.33 109.363 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.57 104.48 15.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.292 -0.632 . . . . 63.1 109.292 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.9 m -86.29 104.8 16.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.019 -1.104 . . . . 71.22 108.019 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.1 p -127.61 115.35 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.337 0.655 . . . . 72.12 111.391 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.59 132.43 35.3 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.206 -0.906 . . . . 70.1 109.573 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.24 135.17 54.43 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.001 0.92 . . . . 74.41 108.679 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 85' ' ' THR . 33.4 tt0 -93.96 102.14 14.22 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -95.35 112.88 24.52 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.482 1.113 . . . . 74.12 109.593 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -87.67 102.97 15.15 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.766 -1.198 . . . . 72.31 107.766 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -134.83 134.98 41.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.952 -1.129 . . . . 71.35 107.952 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.11 65.57 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.091 0.245 . . . . 71.3 112.553 -172.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.27 59.53 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 123.206 0.431 . . . . 60.42 113.5 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.2 p -96.66 151.01 20.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.905 0.882 . . . . 71.41 111.093 -173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.526 HG23 ' HG3' ' A' ' 78' ' ' GLU . 89.4 m -85.38 115.85 23.36 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.093 0.957 . . . . 74.41 109.125 177.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.6 m -121.42 111.02 16.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.714 -0.847 . . . . 62.42 108.714 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -90.37 102.7 15.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.487 -0.931 . . . . 71.55 108.487 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.6 m -111.46 126.11 54.6 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.627 0.771 . . . . 74.22 109.261 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -91.73 120.89 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.456 -0.572 . . . . 74.14 109.456 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.2 127.69 49.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.768 -1.567 . . . . 75.14 106.768 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.26 102.08 10.52 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.987 -1.116 . . . . 70.35 107.987 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.4 mp -90.74 106.58 18.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 50.6 ttp180 -91.67 98.46 11.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.731 -1.122 . . . . 73.35 108.175 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.578 ' HB3' HG21 ' A' ' 101' ' ' ILE . 98.7 m-85 -88.53 107.75 19.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 1.6 tm-20 -90.89 125.95 35.9 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.882 -1.525 . . . . 74.33 106.882 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.4 HG12 HG12 ' A' ' 101' ' ' ILE . 19.8 m -104.13 148.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.177 0.991 . . . . 75.12 111.676 -163.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.7 92.45 2.75 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.691 1.196 . . . . 75.01 109.007 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.62 -102.42 1.29 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.468 -0.787 . . . . 65.15 111.53 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.5 -10.06 13.75 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.078 0.951 . . . . 73.4 111.037 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -108.17 166.73 10.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.274 0.63 . . . . 71.25 109.565 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 94' ' ' PHE . 54.1 mt -115.52 120.29 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 107.637 -1.245 . . . . 63.44 107.637 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -88.26 -30.92 19.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.176 0.19 . . . . 73.32 111.153 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 65.2 mtt180 -129.42 147.73 51.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.904 0.481 . . . . 74.14 110.904 -164.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.67 110.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 64.34 109.051 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 25.9 m -95.39 104.67 16.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.667 -0.864 . . . . 54.44 108.667 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG22 ' HG ' ' A' ' 92' ' ' LEU . 40.9 t -85.55 102.41 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.669 -1.234 . . . . 70.15 107.669 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 m -99.26 109.31 21.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.096 -0.705 . . . . 71.41 109.096 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.37 106.56 12.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.593 0.757 . . . . 74.4 110.374 -174.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.611 1.164 . . . . 61.3 108.54 176.666 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.623 -0.51 . . . . 74.43 109.623 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.31 -50.15 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.884 0.874 . . . . 73.11 110.999 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.39 -36.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.205 -0.907 . . . . 63.34 110.295 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.14 -35.57 80.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.919 -0.582 . . . . 60.21 110.869 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.731 0.412 . . . . 75.15 110.211 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.38 90.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.702 -0.681 . . . . 73.21 111.699 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.29 -46.79 69.39 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.471 -0.786 . . . . 41.55 111.285 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -63.83 -41.77 97.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.448 0.699 . . . . 73.11 110.666 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.34 97.86 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 123.666 0.604 . . . . 72.25 111.29 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.51 -53.71 54.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.032 0.833 . . . . 63.13 111.156 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 70.1 mt -61.96 -43.68 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.363 -0.835 . . . . 74.13 110.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 30' ' ' LEU . . . -63.96 -37.56 87.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.588 0.755 . . . . 72.13 112.454 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.14 -37.59 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.841 0.856 . . . . 71.53 109.985 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -74.52 -35.01 63.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.257 0.623 . . . . 71.11 111.818 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 8.3 mm-40 -63.35 -37.29 86.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.526 -0.546 . . . . 71.31 109.526 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.7 mt -71.48 -41.84 68.82 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.36 -0.836 . . . . 74.11 110.891 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -59.29 -34.57 72.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.87 0.693 . . . . 74.02 112.87 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -96.91 -15.99 20.9 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.606 0.362 . . . . 74.43 111.547 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.82 84.36 2.76 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.579 0.752 . . . . 74.45 109.145 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' HE21 ' A' ' 51' ' ' GLN . 29.1 Cg_endo -62.18 -13.51 32.43 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.275 2.65 . . . . 70.4 114.135 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 p -89.43 9.68 25.44 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.717 0.807 . . . . 54.21 112.284 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.1 109.79 4.99 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.166 0.586 . . . . 74.12 110.056 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.67 -37.62 16.0 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.555 2.17 . . . . 74.32 112.979 -171.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.06 -42.73 69.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.791 0.836 . . . . 73.31 111.697 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.11 -54.97 29.59 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.548 0.739 . . . . 63.31 111.564 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -62.81 -32.87 74.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.756 -0.657 . . . . 74.12 111.6 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.9 -46.28 72.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.106 0.563 . . . . 52.23 112.129 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 14' ' ' ALA . 4.2 pp -69.64 -27.31 64.94 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 120.842 0.353 . . . . 52.35 110.422 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 mt -69.18 -18.63 63.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.011 0.925 . . . . 72.24 112.61 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -73.96 -29.05 61.79 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.082 0.401 . . . . 73.04 110.483 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.08 -42.21 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 72.01 111.654 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 20.0 pt -103.97 -31.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 112.326 0.491 . . . . 54.24 112.326 -172.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 39' ' ' VAL . 3.2 mm? -112.78 -179.35 3.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.111 0.964 . . . . 72.33 109.208 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB2' HG23 ' A' ' 39' ' ' VAL . 50.7 m -84.67 143.29 40.69 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 73.42 109.941 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.94 -32.22 37.19 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.298 2.665 . . . . 75.12 113.185 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.43 -47.99 77.93 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.115 0.966 . . . . 53.22 111.856 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.1 t -63.02 -52.32 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.199 -0.91 . . . . 71.33 111.259 -173.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.97 -28.18 69.91 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.187 0.44 . . . . 65.1 112.187 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -58.81 5.08 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 124.156 0.91 . . . . 64.05 110.073 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 39' ' ' VAL . 26.8 pt20 -69.16 -21.11 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.039 -0.528 . . . . 72.04 111.414 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.36 -50.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.725 0.41 . . . . 53.41 110.071 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 4.7 ppt_? -71.06 -21.0 62.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.757 0.281 . . . . 74.41 111.757 -177.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -73.22 -49.21 29.16 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.704 0.401 . . . . 70.51 111.498 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -67.89 -21.84 65.13 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.045 0.538 . . . . 63.13 111.111 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.0 -37.7 88.52 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.234 1.013 . . . . 63.15 111.853 174.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 61.9 mtp180 -62.86 -27.38 69.3 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.57 0.748 . . . . 70.43 110.555 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -47.62 60.61 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.897 -0.592 . . . . 72.43 110.253 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD23 ' NE2' ' A' ' 53' ' ' GLN . 92.8 mt -65.86 -33.23 75.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.628 0.771 . . . . 62.31 111.361 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.422 HE21 ' HD2' ' A' ' 22' ' ' PRO . 6.1 tp-100 -62.82 -44.71 95.43 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.019 0.928 . . . . 74.52 109.702 175.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.82 -31.59 69.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.994 -1.003 . . . . 75.12 111.056 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.409 ' NE2' HD23 ' A' ' 50' ' ' LEU . 49.8 mt-30 -77.48 -15.59 59.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.445 0.698 . . . . 75.54 111.198 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.38 30.1 74.91 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.59 0.556 . . . . 45.01 113.469 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.62 99.18 4.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 109.588 -0.523 . . . . 74.53 109.588 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -81.33 109.62 16.01 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 107.591 -1.263 . . . . 74.34 107.591 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.66 162.88 14.72 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.596 -0.89 . . . . 74.51 108.596 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.12 130.33 20.85 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.781 -0.452 . . . . 71.43 109.781 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.6 t -68.04 135.58 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 123.967 0.792 . . . . 74.32 109.81 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -117.62 -51.97 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.582 1.153 . . . . 74.43 110.345 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HE ' ' A' ' 61' ' ' ARG . 2.0 tpm_? -142.07 123.83 15.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.157 -0.929 . . . . 74.34 108.913 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.25 112.81 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.231 -0.655 . . . . 75.24 109.231 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.05 146.64 44.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.951 -1.129 . . . . 72.42 107.951 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.547 HG23 HG22 ' A' ' 73' ' ' VAL . 5.7 p -135.45 108.81 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.052 -0.721 . . . . 62.34 109.052 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.8 m -118.38 128.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.328 1.051 . . . . 51.11 109.399 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.4 p -88.64 162.6 16.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.116 0.566 . . . . 64.01 110.478 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -160.6 92.15 0.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.335 1.054 . . . . 64.33 108.218 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.95 9.95 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.609 -0.55 . . . . 70.25 111.827 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -91.76 -10.88 38.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 74.21 111.224 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.2 m -101.6 140.54 35.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.571 0.749 . . . . 72.41 110.605 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 94' ' ' PHE . 2.9 p -121.76 116.67 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.561 0.696 . . . . 70.13 110.142 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -96.26 108.4 20.88 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.448 1.099 . . . . 73.23 109.154 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 64' ' ' VAL . 59.2 t -88.52 107.12 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.667 -0.864 . . . . 75.21 108.667 177.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -95.89 105.25 17.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.96 -1.126 . . . . 54.43 107.96 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.52 125.49 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.517 0.727 . . . . 75.43 110.45 -170.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.7 123.66 31.34 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.257 0.623 . . . . 73.4 110.061 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.15 122.41 37.0 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.285 -1.006 . . . . 64.32 108.285 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.3 116.73 27.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.293 0.568 . . . . 55.53 109.78 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.89 105.0 17.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.154 0.982 . . . . 72.41 111.416 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -90.78 103.13 15.87 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.651 1.181 . . . . 52.52 108.744 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.0 t -138.53 137.22 36.87 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.34 0.656 . . . . 62.3 109.557 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.77 22.12 67.95 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.918 -0.583 . . . . 52.15 113.018 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.9 -33.72 5.06 Favored Glycine 0 C--N 1.354 1.569 0 C-N-CA 122.848 0.261 . . . . 44.21 112.988 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -84.57 135.6 34.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.532 0.733 . . . . 75.11 111.486 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -107.88 145.95 33.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.706 0.802 . . . . 71.03 110.034 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.8 m -143.63 123.87 13.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.489 0.715 . . . . 43.45 109.082 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.97 102.13 6.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.077 -0.712 . . . . 64.25 109.077 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.9 m -107.68 131.63 54.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.967 0.907 . . . . 51.05 110.118 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -95.47 120.14 35.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.311 0.644 . . . . 63.45 109.435 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -102.9 126.37 50.03 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.989 0.915 . . . . 72.34 108.822 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.53 104.27 13.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.723 -0.843 . . . . 71.3 108.723 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.7 mp -91.83 107.38 19.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.285 -1.006 . . . . 74.24 108.285 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -91.74 97.43 11.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.481 -0.781 . . . . 71.41 109.583 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.59 ' HB2' HG13 ' A' ' 71' ' ' VAL . 97.5 m-85 -91.14 117.4 29.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.517 0.727 . . . . 74.45 110.16 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 28.3 tt0 -101.48 121.19 41.5 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.682 -0.858 . . . . 63.12 108.682 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.592 HG12 HG12 ' A' ' 101' ' ' ILE . 10.0 m -86.37 140.17 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.913 -0.403 . . . . 74.53 109.913 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -134.56 117.45 16.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.237 -1.394 . . . . 63.01 107.237 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -114.32 3.99 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.691 -0.964 . . . . 71.22 110.691 -168.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -113.95 -19.15 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.236 0.614 . . . . 71.32 112.097 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -112.14 161.86 16.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.227 0.611 . . . . 72.15 110.675 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.592 HG12 HG12 ' A' ' 96' ' ' VAL . 52.4 mt -82.31 128.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.797 -0.816 . . . . 72.03 108.797 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -114.56 -14.52 12.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.409 0.684 . . . . 74.35 112.32 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 9.8 tpt180 -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.474 0.309 . . . . 75.0 110.505 -172.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.82 139.95 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.986 0.914 . . . . 50.3 109.162 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -134.62 104.62 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.581 -0.896 . . . . 30.02 108.581 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.72 132.02 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.014 0.526 . . . . 72.52 109.722 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.4 m -120.47 116.22 25.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.652 0.781 . . . . 64.14 109.212 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -80.3 105.26 11.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.774 0.83 . . . . 62.13 109.467 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 124.441 1.096 . . . . 73.33 110.566 -175.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 109.713 -0.477 . . . . 74.3 109.713 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 96' ' ' VAL . 34.3 mm -64.33 -43.65 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.423 1.089 . . . . 71.44 112.84 -169.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.5 -52.43 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.563 0.745 . . . . 65.1 109.554 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -69.93 -26.48 64.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.053 -1.43 . . . . 75.24 111.583 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.81 -57.39 8.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.619 0.767 . . . . 74.11 109.667 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.31 76.75 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.28 0.988 . . . . 65.41 111.883 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.75 -58.8 7.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.953 0.901 . . . . 60.11 110.694 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -69.82 -22.26 63.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.709 0.804 . . . . 75.31 111.67 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.3 -45.38 69.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.039 0.935 . . . . 71.01 110.571 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.561 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -59.18 -46.72 87.66 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.294 0.996 . . . . 74.45 110.672 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 62' ' ' VAL . 41.7 mt -61.39 -42.31 93.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 O-C-N 124.404 1.065 . . . . 73.04 110.165 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.87 68.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.165 0.986 . . . . 70.42 112.62 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.405 ' HA ' HG11 ' A' ' 43' ' ' VAL . 46.5 mt -63.21 -42.52 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.595 0.758 . . . . 54.24 109.826 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 92' ' ' LEU . 30.4 m-85 -69.96 -37.27 75.77 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.728 -0.669 . . . . 74.31 111.547 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.438 HE21 HG22 ' A' ' 13' ' ' ILE . 68.8 mt-30 -61.67 -38.49 87.94 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.759 0.662 . . . . 75.12 110.909 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 44' ' ' ARG . 75.6 mt -70.0 -40.45 75.28 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.582 0.552 . . . . 72.11 110.487 174.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HB3' HD12 ' A' ' 50' ' ' LEU . 39.5 m0 -64.87 -31.03 72.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 112.906 0.706 . . . . 74.42 112.906 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -98.52 -20.69 16.92 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.045 0.538 . . . . 72.14 111.537 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -156.27 85.14 3.17 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 123.786 0.835 . . . . 72.41 108.808 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.84 -19.87 69.8 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.45 2.1 . . . . 52.12 113.289 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -81.04 2.41 27.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.689 0.796 . . . . 73.51 112.635 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.86 111.48 6.5 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 122.878 0.471 . . . . 73.05 109.764 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.7 -31.58 8.4 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.347 2.032 . . . . 70.31 112.733 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.12 -39.42 65.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.343 0.657 . . . . 74.41 110.958 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -56.4 18.75 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 124.118 0.967 . . . . 72.45 110.937 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.44 -32.61 74.32 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.779 -0.646 . . . . 71.13 111.306 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.09 -56.71 16.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.515 0.726 . . . . 72.44 111.296 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -62.82 -31.73 72.78 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 123.759 0.662 . . . . 74.11 110.606 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -66.95 -26.03 66.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.552 0.741 . . . . 71.54 112.073 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.854 0.752 . . . . 63.22 110.516 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.77 -16.03 31.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.028 0.931 . . . . 74.3 111.501 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 30' ' ' LEU . 16.2 pt -124.56 -45.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.405 0.52 . . . . 70.54 112.405 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 39' ' ' VAL . 3.8 mm? -95.15 172.46 8.11 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.037 0.935 . . . . 64.11 109.26 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 39' ' ' VAL . 21.0 m -83.25 143.52 45.28 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.464 -0.789 . . . . 71.13 110.041 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.71 -31.88 52.62 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.046 3.164 . . . . 65.21 114.049 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.34 -48.03 77.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.779 0.832 . . . . 75.04 111.619 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 HD12 ' A' ' 35' ' ' LEU . 42.2 t -63.19 -39.48 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 72.24 111.516 -171.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.07 -27.57 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.472 0.177 . . . . 61.13 111.064 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 17.5 t70 -73.68 -44.81 55.62 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.71 0.631 . . . . 75.05 110.405 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.88 -32.71 74.03 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.593 0.357 . . . . 73.51 110.892 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 15' ' ' ILE . 25.1 t -63.52 -51.56 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 70.11 111.263 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB3' HD13 ' A' ' 18' ' ' LEU . 3.3 ptm180 -69.29 -17.27 63.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.058 0.543 . . . . 73.14 111.914 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 51.3 mt-10 -84.26 -35.26 23.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.433 0.693 . . . . 75.22 111.511 171.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -73.34 -17.76 61.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.476 0.711 . . . . 71.43 110.801 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.79 67.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.595 1.158 . . . . 73.22 111.673 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -56.1 -34.82 66.39 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 124.348 1.03 . . . . 64.54 111.507 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -65.19 -55.04 20.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.969 0.507 . . . . 73.35 111.04 -175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 19' ' ' TRP . 88.4 mt -71.39 -34.39 70.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.255 0.622 . . . . 74.51 111.35 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.46 -45.63 68.59 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.725 0.81 . . . . 74.11 111.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.01 -40.79 97.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.116 0.967 . . . . 63.45 111.134 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -75.72 -19.72 58.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.735 -0.666 . . . . 62.22 111.938 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.43 28.76 57.15 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.293 0.371 . . . . 51.02 113.44 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.62 104.97 9.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.602 0.761 . . . . 75.34 109.76 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -82.66 111.25 18.44 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.645 -0.872 . . . . 73.44 108.645 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 43.4 p90 -108.53 144.77 35.75 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.487 -1.301 . . . . 72.3 107.487 168.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -121.56 121.02 36.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.995 -0.743 . . . . 64.02 108.995 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.27 100.44 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.753 -0.832 . . . . 71.14 108.753 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -86.45 -45.19 11.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.824 0.849 . . . . 65.55 111.504 -171.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -144.87 142.29 29.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.265 -0.643 . . . . 74.41 109.265 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 13' ' ' ILE . 93.1 t -125.18 128.73 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.264 -1.013 . . . . 61.34 108.264 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.2 123.73 40.91 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.933 -1.136 . . . . 64.14 107.933 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.31 126.42 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 109.467 -0.568 . . . . 64.31 109.467 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.7 m -132.56 122.3 24.59 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.554 0.742 . . . . 72.41 109.544 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -88.57 121.52 31.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.449 0.7 . . . . 44.11 109.983 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -125.96 89.28 3.0 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.176 0.991 . . . . 71.14 108.337 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.81 -121.46 7.85 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.022 -0.831 . . . . 44.42 111.022 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -98.54 -9.94 24.21 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.127 0.571 . . . . 74.52 110.294 170.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.6 m -96.49 111.16 23.37 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.334 0.654 . . . . 75.45 109.698 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.07 109.31 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.247 0.546 . . . . 71.51 110.225 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.486 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -84.22 103.93 13.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.601 1.16 . . . . 71.33 108.616 177.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.94 105.34 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.121 0.486 . . . . 53.4 109.85 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -86.04 105.13 16.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.28 1.032 . . . . 71.22 109.691 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.75 123.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.721 0.809 . . . . 72.4 109.878 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -85.61 117.68 24.66 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.282 0.633 . . . . 73.23 109.304 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.68 163.06 13.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.783 -0.821 . . . . 73.41 108.783 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -136.52 102.55 4.98 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.938 -1.504 . . . . 64.43 106.938 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.2 mt-10 -94.14 106.51 18.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.963 0.905 . . . . 75.41 110.46 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -93.92 106.41 18.39 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.737 0.815 . . . . 60.13 109.173 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -132.95 132.48 42.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.805 0.842 . . . . 75.24 109.621 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.16 13.26 61.9 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.089 0.396 . . . . 74.24 114.089 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.07 -32.97 6.83 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.78 -0.455 . . . . 72.43 112.881 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -84.09 150.18 25.73 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.216 0.508 . . . . 75.31 110.862 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.9 m -118.28 134.02 55.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.881 0.872 . . . . 54.11 109.959 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 m -138.52 122.11 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.475 1.11 . . . . 72.23 109.257 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -76.6 119.65 20.71 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.097 -0.705 . . . . 73.32 109.097 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.448 HG21 HE21 ' A' ' 108' ' ' GLN . 32.9 m -129.86 123.26 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.88 0.872 . . . . 64.4 109.5 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.0 m -87.67 128.86 35.29 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.534 -0.543 . . . . 72.32 109.534 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -109.75 125.38 52.63 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.32 -1.363 . . . . 73.43 107.32 168.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HB2' HD21 ' A' ' 109' ' ' ASN . 2.9 tt0 -106.57 104.69 14.44 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.061 -1.088 . . . . 72.25 108.061 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 12' ' ' ALA . 4.3 mp -90.88 105.29 17.73 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.565 -1.272 . . . . 71.44 107.565 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -93.71 99.13 11.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.883 0.873 . . . . 74.43 108.846 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.96 108.16 19.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.189 0.996 . . . . 74.25 110.136 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 29.2 tt0 -90.92 113.99 26.35 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.902 -0.777 . . . . 61.22 108.902 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.616 HG12 HG12 ' A' ' 101' ' ' ILE . 4.1 m -83.48 148.82 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.095 -0.705 . . . . 52.45 109.095 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -141.97 96.53 2.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.117 -1.068 . . . . 74.2 108.117 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 -124.07 6.7 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.402 -0.679 . . . . 73.43 111.402 -173.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -89.87 -21.31 22.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.491 0.717 . . . . 74.3 111.689 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -121.87 157.59 30.82 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.33 0.652 . . . . 75.53 110.795 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 96' ' ' VAL . 28.6 mt -90.55 115.47 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 72.2 108.689 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 36' ' ' SER . 28.6 mmt180 -89.35 -28.21 19.96 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.534 0.734 . . . . 75.44 111.104 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 29.5 mtt180 -130.85 135.9 48.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.929 0.492 . . . . 75.52 110.948 -163.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.95 142.94 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.263 1.025 . . . . 73.15 109.01 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -127.8 105.43 8.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.254 -1.017 . . . . 62.42 108.254 172.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.35 104.17 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.896 -1.15 . . . . 63.22 107.896 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -104.36 104.51 14.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.894 0.477 . . . . 50.24 109.952 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.448 HE21 HG21 ' A' ' 88' ' ' THR . 59.1 tt0 -72.76 98.48 2.41 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.542 -0.91 . . . . 71.34 108.542 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 91' ' ' GLU . 42.7 m-80 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 62.32 112.037 -174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.147 -0.316 . . . . 74.14 110.147 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -74.67 -31.67 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.846 0.859 . . . . 71.11 112.096 -174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -59.05 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.423 0.689 . . . . 73.45 110.754 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.31 -19.1 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.294 -0.412 . . . . 73.02 111.099 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -48.15 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.271 -0.64 . . . . 75.12 109.271 170.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.24 78.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.08 -0.964 . . . . 71.52 112.066 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.64 -53.25 57.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.681 0.792 . . . . 63.2 110.829 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.37 -30.55 70.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 72.51 111.053 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -61.88 -51.18 69.22 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 123.801 0.688 . . . . 74.35 110.693 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.51 57.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 124.068 0.855 . . . . 61.03 110.91 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.0 mt -57.61 -43.03 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.089 0.956 . . . . 72.43 110.987 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.43 72.9 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.253 0.621 . . . . 75.12 112.229 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.26 -40.91 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.843 0.857 . . . . 64.11 109.896 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 66.3 m-85 -79.55 -25.65 41.6 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.851 0.46 . . . . 74.23 112.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -67.85 -34.65 77.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.134 0.573 . . . . 73.24 109.858 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.3 mt -74.59 -46.02 41.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.005 -0.543 . . . . 70.15 110.179 172.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.0 m0 -61.48 -17.96 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.865 0.691 . . . . 62.53 112.865 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -102.4 -24.56 13.84 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 122.904 0.482 . . . . 72.34 111.599 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.481 HD22 ' HB2' ' A' ' 24' ' ' ASP . 8.1 t30 -157.55 87.36 2.59 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.724 0.81 . . . . 74.44 109.693 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.54 -17.56 53.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.226 2.617 . . . . 54.44 113.348 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -79.69 -4.39 51.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.823 0.849 . . . . 62.54 112.693 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HB2' HD22 ' A' ' 21' ' ' ASN . 12.4 t70 -71.48 120.42 79.72 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 109.475 -0.565 . . . . 73.44 109.475 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.98 -30.39 7.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.234 1.956 . . . . 63.22 113.301 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.05 -26.31 27.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.198 0.599 . . . . 75.22 112.305 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.91 -48.01 55.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.36 0.664 . . . . 61.31 109.483 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.16 -27.36 63.49 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.73 -0.668 . . . . 71.41 111.895 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.27 -55.31 36.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.791 0.837 . . . . 74.52 111.733 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 4.1 pp -64.13 -28.18 69.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.929 0.768 . . . . 61.51 111.282 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD22 HD12 ' A' ' 35' ' ' LEU . 96.7 mt -67.56 -28.29 67.66 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.923 0.889 . . . . 70.23 112.258 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -65.88 -37.99 87.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.327 0.584 . . . . 75.34 110.517 173.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 50.0 mtpt -77.02 -39.35 50.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.686 -1.143 . . . . 60.44 111.281 -170.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 35' ' ' LEU . 16.2 pt -102.41 -32.77 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.365 0.666 . . . . 72.14 112.325 -171.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 34' ' ' ILE . 75.3 mt -116.34 -179.36 3.65 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.897 0.879 . . . . 75.41 110.453 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -74.27 152.85 88.18 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 115.349 -0.841 . . . . 54.32 111.371 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.76 -30.65 93.2 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.022 2.482 . . . . 73.13 112.588 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.1 -38.16 78.88 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.967 1.307 . . . . 55.34 112.49 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 35' ' ' LEU . 57.5 t -68.24 -56.15 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.489 -0.778 . . . . 64.12 110.163 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -25.55 67.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.53 0.332 . . . . 72.12 111.528 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.55 -49.28 66.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.068 . . . . 71.42 110.488 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -73.06 -32.25 64.92 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.208 -0.451 . . . . 75.33 111.366 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.17 -47.48 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.067 0.947 . . . . 52.12 111.2 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -70.74 -23.31 62.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.153 0.427 . . . . 72.12 112.153 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.81 -51.51 12.43 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.435 0.694 . . . . 65.12 110.504 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.414 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 83.0 t60 -63.22 -27.25 69.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.019 -0.991 . . . . 62.24 110.836 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -61.87 -45.67 92.77 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.747 1.219 . . . . 74.35 111.495 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 96.5 mtt180 -61.51 -38.43 87.35 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.816 -1.084 . . . . 63.21 110.581 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.31 -46.76 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.147 0.579 . . . . 62.4 111.607 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 71.5 mt -64.03 -35.42 80.66 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.354 0.662 . . . . 73.24 110.479 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -62.56 -46.3 89.01 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.226 -0.897 . . . . 74.23 110.695 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 7.6 mtpm? -62.17 -41.03 97.93 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.331 0.652 . . . . 73.2 110.769 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -75.43 -19.76 59.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.3 -0.864 . . . . 74.31 111.4 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.25 38.14 19.22 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.188 0.305 . . . . 63.44 112.963 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.2 mt -90.55 89.56 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.06 0.944 . . . . 71.22 108.453 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -92.84 111.54 23.18 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 53.7 p90 -134.69 152.35 51.7 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.864 0.465 . . . . 75.3 110.327 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.79 142.06 51.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.173 0.589 . . . . 75.42 109.577 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.69 110.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.801 1.241 . . . . 73.14 109.077 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.56 -29.38 12.74 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.743 0.417 . . . . 72.21 112.022 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.03 131.72 33.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.198 0.599 . . . . 74.32 109.806 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.63 117.3 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.262 -1.014 . . . . 74.21 108.262 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.4 108.01 8.89 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.782 -0.821 . . . . 74.42 108.782 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.07 115.54 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.158 0.583 . . . . 64.44 109.557 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -130.19 128.3 41.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.78 0.832 . . . . 43.13 108.831 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -88.07 144.66 26.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.14 0.576 . . . . 61.32 109.642 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -131.9 90.09 2.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.517 -1.29 . . . . 54.32 107.517 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.93 -122.4 19.25 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.013 -0.994 . . . . 54.42 111.231 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -91.45 -7.73 49.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.506 0.723 . . . . 75.44 111.858 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.1 m -111.43 115.81 29.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.02 0.528 . . . . 74.42 109.835 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -92.74 131.02 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.599 0.76 . . . . 73.11 111.121 -175.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -103.79 110.47 22.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.993 1.317 . . . . 74.21 109.448 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.11 104.53 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.67 -0.863 . . . . 71.3 108.67 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -86.68 105.42 16.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.263 -1.014 . . . . 74.52 108.263 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 16' ' ' PHE . 7.6 p -114.59 134.55 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.327 1.051 . . . . 42.24 108.603 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.4 123.78 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.774 -0.824 . . . . 61.24 108.774 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.82 161.78 24.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.082 0.953 . . . . 73.5 109.865 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.0 10.95 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 27.6 mt-10 -87.25 104.13 16.09 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.685 0.794 . . . . 63.23 110.685 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -89.17 102.99 15.64 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.498 -0.927 . . . . 73.11 108.498 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -141.54 136.45 31.15 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.314 1.046 . . . . 64.21 109.14 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.64 12.26 80.53 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.817 -0.629 . . . . 53.14 111.968 -170.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.22 -22.89 27.24 Favored Glycine 0 C--N 1.356 1.64 0 C-N-CA 123.496 0.569 . . . . 61.22 112.914 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 p -94.11 134.51 36.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.811 0.844 . . . . 65.42 111.269 -175.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.6 m -87.99 124.17 33.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.163 0.985 . . . . 74.22 110.118 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -120.97 116.42 25.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.456 1.102 . . . . 72.22 108.821 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -78.28 116.85 19.01 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.203 -0.665 . . . . 72.23 109.203 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.426 HG21 HE21 ' A' ' 108' ' ' GLN . 77.0 m -131.63 134.69 46.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.709 1.204 . . . . 73.12 109.883 -173.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 m -97.67 145.6 26.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.273 0.629 . . . . 73.33 109.774 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -126.89 128.48 46.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.672 1.189 . . . . 62.41 108.007 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.95 104.25 16.26 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 71.35 108.252 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.19 106.04 18.23 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.226 -1.398 . . . . 64.33 107.226 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -102.1 97.91 8.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.678 0.791 . . . . 71.01 109.206 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HB3' HG21 ' A' ' 101' ' ' ILE . 90.8 m-85 -89.25 111.29 22.06 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.853 0.861 . . . . 72.04 109.899 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 38.5 tt0 -96.01 132.58 41.21 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.224 -0.658 . . . . 62.44 109.224 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.75 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.813 0.845 . . . . 74.34 111.343 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 102' ' ' ARG . 31.4 t70 -132.15 101.4 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.335 -1.358 . . . . 73.52 107.335 171.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.98 -99.42 0.94 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.328 -0.709 . . . . 75.2 111.328 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.17 -17.51 8.9 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.563 0.745 . . . . 74.33 111.123 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.0 m -113.91 133.96 55.12 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.24 0.616 . . . . 74.41 110.266 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.521 HG21 ' HB3' ' A' ' 94' ' ' PHE . 74.2 mt -73.6 116.83 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.784 0.834 . . . . 75.32 109.12 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 97' ' ' ASP . 32.0 mmt180 -105.72 -7.68 18.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.242 0.617 . . . . 73.42 111.369 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.9 ttt180 -136.0 139.07 42.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.766 0.426 . . . . 75.34 110.658 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.27 130.69 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.219 1.008 . . . . 55.14 109.187 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.7 m -110.34 104.52 13.32 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.044 -1.095 . . . . 75.31 108.044 172.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.91 104.61 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.249 -1.019 . . . . 64.03 108.249 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 m -103.84 112.92 26.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.361 0.664 . . . . 74.52 109.617 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.426 HE21 HG21 ' A' ' 88' ' ' THR . 60.5 tt0 -74.13 103.43 4.57 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.808 -1.182 . . . . 72.41 107.808 171.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.242 0.66 0 C-N-CA 123.846 0.859 . . . . 65.34 110.832 -177.229 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.156 0.503 . . . . 62.02 109.646 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.573 HG21 HG11 ' A' ' 96' ' ' VAL . 47.4 mm -74.51 -22.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.263 1.025 . . . . 72.14 111.709 -172.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 66' ' ' THR . 21.8 t -61.31 -55.84 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.466 -0.568 . . . . 71.42 109.466 176.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.97 -32.56 65.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.061 -0.972 . . . . 71.1 111.884 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 4' ' ' ILE . . . -62.73 -52.33 63.67 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.529 0.518 . . . . 44.43 110.404 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.72 67.49 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.549 0.74 . . . . 50.54 111.839 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.67 -55.68 21.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.396 0.678 . . . . 73.13 110.45 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -63.91 -32.59 74.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.864 0.866 . . . . 74.3 111.239 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.39 86.26 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 124.014 0.821 . . . . 63.1 111.143 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.77 92.47 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.97 0.793 . . . . 34.33 111.179 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 69.4 mt -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 124.291 0.994 . . . . 70.54 109.692 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.91 -29.99 71.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.041 0.936 . . . . 74.15 112.432 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.93 -41.15 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.538 0.735 . . . . 72.14 109.81 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE2' HG11 ' A' ' 75' ' ' VAL . 51.7 m-85 -72.4 -35.21 68.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.73 0.412 . . . . 74.42 111.332 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 20.3 mm-40 -61.31 -37.43 83.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.868 0.73 . . . . 73.13 110.15 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.45 -45.13 32.69 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 123.634 0.584 . . . . 73.1 110.926 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -54.21 -31.62 53.61 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.387 0.675 . . . . 74.54 112.731 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -101.89 -19.05 15.43 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.889 0.475 . . . . 73.51 112.103 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.45 HD22 ' HB2' ' A' ' 24' ' ' ASP . 4.8 t30 -150.66 81.91 6.32 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.254 -0.647 . . . . 55.12 109.254 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.43 -11.89 33.42 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.135 2.557 . . . . 71.4 112.948 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -80.94 -2.29 47.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.591 1.156 . . . . 72.14 112.687 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' HB2' HD22 ' A' ' 21' ' ' ASN . 9.3 t70 -76.31 107.68 4.96 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 119.183 -0.437 . . . . 75.22 110.09 -177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -31.14 24.68 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.764 2.31 . . . . 61.41 113.359 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -77.64 -34.83 53.1 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.187 0.595 . . . . 75.34 111.592 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.95 -45.69 73.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.299 0.64 . . . . 53.42 110.401 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -75.36 -20.92 58.72 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.66 -0.7 . . . . 74.1 111.628 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.05 -51.35 39.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.356 0.662 . . . . 75.33 110.896 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.7 pp -65.67 -37.68 87.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.668 -0.493 . . . . 74.02 109.668 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.96 -28.59 69.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.488 0.715 . . . . 73.01 111.571 173.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.31 -24.32 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.932 0.493 . . . . 73.13 111.209 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -97.18 -24.68 15.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.047 0.939 . . . . 71.35 112.254 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 30' ' ' LEU . 8.2 pt -121.82 -26.58 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 112.898 0.703 . . . . 70.43 112.898 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.44 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.5 mm? -102.65 172.34 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.265 0.626 . . . . 71.01 110.389 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.5 m -79.31 143.79 60.93 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 114.854 -1.066 . . . . 72.25 110.238 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.71 -31.03 18.1 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.657 2.905 . . . . 64.23 114.632 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -66.56 -36.97 83.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.148 0.579 . . . . 61.44 111.382 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 36' ' ' SER . 93.5 t -67.51 -57.35 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.656 0.782 . . . . 73.0 110.696 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.89 -28.44 66.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.667 0.387 . . . . 75.32 111.301 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.98 -54.96 10.91 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 124.527 1.142 . . . . 74.21 110.559 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 1.1 pp0? -61.64 -25.92 67.67 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.308 0.243 . . . . 73.42 111.604 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 39' ' ' VAL . 72.5 t -70.48 -53.08 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.7 0.8 . . . . 73.5 111.02 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -67.34 -22.49 65.59 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.025 0.38 . . . . 75.23 112.025 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -81.07 -45.26 16.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.853 0.461 . . . . 71.42 110.455 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.96 -26.01 68.39 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.396 0.678 . . . . 61.24 111.052 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.63 97.1 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.795 1.238 . . . . 75.42 112.333 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -65.8 -28.43 69.0 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.945 0.778 . . . . 73.42 111.439 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.84 -41.81 67.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.966 0.907 . . . . 73.33 110.867 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -76.81 -28.16 55.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.454 0.701 . . . . 64.14 110.989 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.85 -35.17 67.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.462 1.105 . . . . 72.42 110.422 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.62 -40.91 98.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 71.13 109.785 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -84.87 178.01 7.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.167 -0.924 . . . . 70.42 110.643 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.24 33.42 6.59 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.699 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.96 89.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 109.127 -0.694 . . . . 71.44 109.127 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -83.3 136.31 34.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.177 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 140.3 24.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.503 -0.555 . . . . 71.42 109.503 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.13 130.96 39.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.227 1.011 . . . . 72.41 109.618 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.49 102.34 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 54.4 109.686 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -84.27 -35.19 23.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.654 0.782 . . . . 63.21 110.886 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 58.5 ttt180 -155.56 125.41 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.913 -0.773 . . . . 74.45 108.913 -173.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.92 125.94 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 74.33 109.856 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.03 125.36 24.83 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.518 1.127 . . . . 71.42 108.953 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.33 134.99 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.328 0.651 . . . . 75.02 110.687 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.6 m -145.67 130.67 18.28 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.084 0.954 . . . . 51.11 108.969 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.512 HG22 HG22 ' A' ' 71' ' ' VAL . 71.8 p -88.31 149.17 23.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.6 0.36 . . . . 71.24 110.425 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -129.97 96.11 4.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.444 -1.317 . . . . 71.35 107.444 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.05 -102.08 0.95 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.992 -0.843 . . . . 65.12 110.992 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -115.49 -13.48 11.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.972 0.909 . . . . 73.45 110.373 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.9 m -97.15 119.33 35.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.606 0.763 . . . . 75.45 109.568 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 66' ' ' THR . 23.4 t -87.93 144.48 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.676 0.79 . . . . 72.14 110.456 -170.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -124.31 102.48 7.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.59 1.156 . . . . 73.14 108.903 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.13 103.21 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.079 -0.711 . . . . 72.23 109.079 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.3 m -89.53 112.38 23.54 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.322 1.049 . . . . 73.01 109.026 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' HE2' ' A' ' 16' ' ' PHE . 3.9 p -132.91 119.26 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.367 0.667 . . . . 63.41 110.771 -172.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.5 tp10 -80.2 129.91 34.84 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.323 1.049 . . . . 75.21 109.143 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.41 HD13 ' HD1' ' A' ' 90' ' ' TYR . 5.8 mp -125.1 142.01 51.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.236 0.614 . . . . 53.12 109.686 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.96 108.64 21.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.439 -1.319 . . . . 73.42 107.439 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -104.54 105.74 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.173 0.589 . . . . 71.44 111.162 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -93.25 111.24 22.83 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.783 -0.821 . . . . 71.12 108.783 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -134.99 123.6 23.57 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.176 0.99 . . . . 70.03 109.732 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.33 13.66 70.85 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.171 0.415 . . . . 71.11 113.491 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.13 -28.31 15.25 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 112.027 -0.429 . . . . 30.24 112.027 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.5 p -85.01 120.13 26.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.246 0.618 . . . . 74.11 110.615 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -94.31 142.04 27.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.522 0.729 . . . . 73.43 110.25 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.1 m -144.68 123.26 12.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.327 1.051 . . . . 75.42 109.326 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -77.93 109.67 12.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.907 -0.775 . . . . 71.24 108.907 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 m -114.78 122.12 45.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.415 1.086 . . . . 15.44 109.53 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 10.6 m -88.95 120.09 30.05 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.2 -0.667 . . . . 53.33 109.2 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HD1' HD13 ' A' ' 77' ' ' LEU . 89.9 m-85 -104.78 136.5 44.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 174.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -115.27 103.06 10.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.144 -1.058 . . . . 51.12 108.144 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.1 mp -87.71 104.39 16.5 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.249 -1.389 . . . . 73.2 107.249 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -96.66 108.0 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.359 -0.837 . . . . 62.42 109.35 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.409 ' HB3' HG21 ' A' ' 101' ' ' ILE . 80.0 m-85 -88.82 109.09 19.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.692 0.797 . . . . 71.03 110.293 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 37.4 tt0 -90.54 114.71 26.99 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.818 0.847 . . . . 63.22 109.268 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 4' ' ' ILE . 3.9 m -100.58 149.62 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.694 0.798 . . . . 61.33 110.275 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.72 119.36 16.04 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.73 -1.211 . . . . 71.41 107.73 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.54 -100.58 1.82 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.946 -0.462 . . . . 25.15 111.946 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.93 -21.78 5.43 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.094 0.558 . . . . 73.54 112.165 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -114.04 158.65 20.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.058 0.456 . . . . 71.12 110.989 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 96' ' ' VAL . 16.6 mt -84.55 125.19 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.038 -0.983 . . . . 71.33 108.878 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -96.11 -43.18 7.87 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.268 0.627 . . . . 73.42 111.264 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 87.1 mtt180 -132.77 160.93 35.42 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.714 0.806 . . . . 74.42 110.591 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.48 120.14 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.394 -0.965 . . . . 61.15 108.394 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.7 m -100.68 104.83 16.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.259 -1.015 . . . . 74.53 108.259 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 92' ' ' LEU . 46.5 t -87.29 103.99 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.631 -0.878 . . . . 72.05 108.631 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -94.5 106.38 18.36 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.593 0.757 . . . . 64.5 109.453 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -82.06 97.45 8.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.493 -0.776 . . . . 74.13 109.9 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.3 m-80 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 107.53 -1.285 . . . . 71.23 107.53 170.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.701 -0.481 . . . . 71.52 109.701 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.27 -32.87 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.578 1.151 . . . . 71.31 112.017 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.44 -51.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.236 0.614 . . . . 65.14 109.769 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -28.33 65.44 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.447 -0.797 . . . . 64.42 111.129 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -59.04 -48.75 80.47 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.933 0.397 . . . . 72.52 110.208 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.79 83.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.543 -0.753 . . . . 63.34 111.728 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.79 -52.25 64.97 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.581 0.752 . . . . 73.44 111.475 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.55 -37.1 82.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 73.13 110.665 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.93 80.95 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.405 -1.27 . . . . 53.31 111.498 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.56 82.22 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.911 0.757 . . . . 71.03 111.891 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 HE21 ' A' ' 17' ' ' GLN . 55.8 mt -64.85 -40.05 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.939 -1.028 . . . . 61.04 110.204 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.03 72.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.791 0.836 . . . . 64.11 112.852 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.5 mt -63.1 -40.3 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.531 0.732 . . . . 42.53 110.028 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -71.14 -33.54 70.17 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.143 0.577 . . . . 74.24 111.521 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.475 HE21 HG22 ' A' ' 13' ' ' ILE . 80.1 mt-30 -62.07 -40.98 97.64 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.857 0.863 . . . . 72.44 110.997 175.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.23 -37.52 66.37 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.972 -0.558 . . . . 75.34 110.863 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -63.13 -32.85 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.45 0.537 . . . . 73.4 112.45 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.57 -23.31 22.01 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.394 0.278 . . . . 73.41 111.234 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.14 88.27 2.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.477 0.711 . . . . 74.43 109.242 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.19 -22.53 70.59 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.337 2.691 . . . . 73.35 114.312 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -88.46 11.23 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.578 0.751 . . . . 52.15 112.722 -174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.97 114.14 26.37 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.89 -32.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.551 2.167 . . . . 73.33 113.354 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.76 -40.26 55.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.212 0.605 . . . . 65.35 111.387 -171.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.99 67.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.727 0.811 . . . . 71.23 110.993 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.429 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -70.19 -26.25 63.81 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.533 -0.758 . . . . 71.32 111.864 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.21 -43.17 71.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 74.53 111.323 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.472 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.3 pp -71.08 -35.4 71.84 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.583 -0.525 . . . . 72.13 109.583 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.93 -22.34 66.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.75 0.82 . . . . 74.51 112.112 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -73.46 -30.62 63.3 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.278 0.631 . . . . 60.1 110.96 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.53 -46.28 9.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.33 -0.85 . . . . 73.23 111.538 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.7 pt -101.88 -28.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 116.092 -0.504 . . . . 73.24 111.513 -169.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 39' ' ' VAL . 3.4 mm? -108.9 -173.94 2.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.384 1.074 . . . . 53.45 109.378 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.0 m -77.77 149.15 77.14 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 122.915 0.486 . . . . 72.42 111.091 176.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.79 -25.75 81.73 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.488 2.125 . . . . 73.11 111.804 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.83 -43.64 95.59 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.222 -1.354 . . . . 73.45 110.805 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.9 t -64.39 -52.51 54.53 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 123.531 0.732 . . . . 65.52 111.131 -175.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.0 pp -59.22 -35.86 74.38 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 120.829 0.347 . . . . 61.41 111.528 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.88 -43.49 68.3 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.216 1.006 . . . . 74.23 111.431 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -74.25 -27.31 60.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.221 0.209 . . . . 64.0 110.952 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 t -72.62 -41.76 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.028 0.531 . . . . 75.34 110.564 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -21.49 61.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.65 0.205 . . . . 74.44 111.537 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.45 -49.26 12.58 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.922 0.392 . . . . 74.12 110.077 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.7 -24.04 67.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.98 0.912 . . . . 75.21 110.63 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.25 76.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.109 1.364 . . . . 74.32 112.471 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -61.68 -22.94 65.75 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.218 -0.901 . . . . 74.11 112.625 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.38 -46.46 66.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.583 0.753 . . . . 73.24 110.581 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.35 -31.77 60.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.819 0.848 . . . . 51.13 111.347 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.25 -39.01 78.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 65.34 110.166 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -59.74 -43.3 94.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.586 0.754 . . . . 73.32 110.266 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -75.71 -29.63 59.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.073 -0.967 . . . . 73.33 111.4 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.31 35.52 76.76 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.456 0.472 . . . . 63.11 113.427 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.35 107.9 12.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.704 -0.851 . . . . 72.13 108.704 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -84.13 111.14 19.07 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 108.728 -0.842 . . . . 62.35 108.728 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.495 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 15.5 p90 -110.37 142.67 41.72 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.009 -1.478 . . . . 72.44 107.009 168.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -134.42 126.94 30.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.152 0.283 . . . . 53.34 110.252 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.23 134.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.116 0.966 . . . . 71.34 110.047 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -117.12 -54.31 2.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.526 1.13 . . . . 54.01 109.522 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -140.78 123.72 16.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 114.658 -1.155 . . . . 72.41 108.673 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.27 124.04 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.139 -1.06 . . . . 74.44 108.139 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.08 107.6 9.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 73' ' ' VAL . 14.7 p -99.0 140.16 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.722 0.409 . . . . 65.34 110.14 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -144.27 170.74 15.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.749 0.82 . . . . 42.21 109.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 71' ' ' VAL . 40.1 p -126.66 149.72 49.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.209 0.604 . . . . 73.34 110.756 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -135.95 95.6 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.46 -1.311 . . . . 65.04 107.46 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.91 -101.34 1.1 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.207 -1.157 . . . . 54.0 110.207 -166.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -119.02 -7.67 10.34 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.777 0.831 . . . . 74.44 110.594 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 95' ' ' GLU . 22.1 m -87.88 114.79 24.84 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.24 -0.652 . . . . 60.01 109.24 -174.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 66' ' ' THR . 24.3 t -87.03 132.24 32.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 115.674 -0.693 . . . . 71.14 109.422 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -118.79 117.52 29.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.192 0.997 . . . . 54.51 108.634 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 64' ' ' VAL . 46.3 t -100.35 103.18 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 73.14 109.647 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.9 m -90.65 105.42 17.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.679 -0.859 . . . . 72.24 108.679 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.54 126.51 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.679 0.792 . . . . 61.13 110.694 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.03 120.48 23.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.179 0.991 . . . . 73.05 109.783 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.1 mp -115.39 119.1 35.14 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.374 -0.972 . . . . 65.04 108.374 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -88.46 103.41 15.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.211 -1.033 . . . . 61.04 108.211 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 30.3 mt-10 -88.2 126.06 34.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.32 1.048 . . . . 74.33 110.067 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.3 m -115.64 107.72 15.48 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.218 -1.03 . . . . 50.44 108.218 173.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -147.51 138.14 23.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.908 0.883 . . . . 75.33 109.351 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.94 12.24 64.66 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.368 0.418 . . . . 24.34 113.846 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.94 -32.9 6.56 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 117.127 0.464 . . . . 61.15 112.421 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -84.09 144.78 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.482 0.713 . . . . 52.43 111.688 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 129.98 53.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.014 0.926 . . . . 73.33 110.603 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.3 m -143.54 133.12 23.61 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.724 0.809 . . . . 53.42 110.1 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -81.25 101.52 9.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.386 -0.598 . . . . 65.11 109.386 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.1 m -101.54 122.44 43.83 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.198 0.999 . . . . 75.41 109.226 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -88.52 125.82 34.96 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.588 . . . . 65.42 109.414 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CD1' HD13 ' A' ' 77' ' ' LEU . 18.6 m-85 -104.65 126.08 51.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.765 -1.198 . . . . 74.4 107.765 173.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.22 103.59 12.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.145 -1.057 . . . . 72.54 108.145 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.98 110.48 22.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.893 -0.78 . . . . 45.01 108.893 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 59.7 ttp180 -88.89 99.76 12.65 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.94 -0.763 . . . . 74.01 108.94 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.9 m-85 -86.17 107.82 18.05 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.914 0.864 . . . . 75.44 108.687 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . 19.2 mt-10 -90.09 116.49 28.15 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.984 -1.462 . . . . 74.02 108.053 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 101' ' ' ILE . 11.3 m -85.45 144.92 8.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.358 -0.837 . . . . 62.33 110.907 -169.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.7 79.49 1.9 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.34 18.07 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.426 -0.806 . . . . 55.31 111.736 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -80.15 -4.87 54.74 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.95 0.722 . . . . 72.01 112.95 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.3 m -134.68 134.65 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.591 0.356 . . . . 52.33 110.217 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HB3' ' A' ' 94' ' ' PHE . 45.4 mt -77.46 132.02 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.169 -1.049 . . . . 73.21 108.169 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -119.4 -10.07 9.76 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.372 0.533 . . . . 74.53 111.617 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.636 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 14.4 mmt180 -130.02 150.4 51.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.224 0.61 . . . . 74.43 111.527 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.16 124.9 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.474 1.11 . . . . 72.02 109.466 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 87.7 m -111.92 105.07 13.4 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.651 0.78 . . . . 63.2 108.941 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.0 105.14 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.531 -0.914 . . . . 72.05 108.531 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.9 m -99.94 105.7 17.43 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.468 0.707 . . . . 72.23 109.384 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -84.03 123.63 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.65 -0.5 . . . . 74.05 109.65 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 123.384 0.673 . . . . 65.24 111.0 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 110.393 -0.225 . . . . 61.4 110.393 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.3 -39.82 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 126.061 1.745 . . . . 73.22 113.938 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 66' ' ' THR . 19.0 t -70.7 -54.24 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.021 0.529 . . . . 62.33 110.461 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 8.5 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.197 0.935 . . . . 41.23 111.021 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -65.96 -47.43 74.65 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.232 -0.894 . . . . 42.4 110.716 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.8 78.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 72.21 111.572 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -64.75 -48.84 73.1 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.36 1.064 . . . . 71.41 110.85 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 23.1 mt-30 -67.68 -37.55 82.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.521 0.729 . . . . 72.13 110.352 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.25 97.01 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.03 0.932 . . . . 73.0 111.029 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.46 11.69 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.345 1.028 . . . . 63.02 110.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -60.33 -39.74 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 124.222 0.951 . . . . 72.3 110.597 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.18 93.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.975 0.91 . . . . 75.14 112.305 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.76 -45.8 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.881 0.873 . . . . 72.54 110.161 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.66 -34.46 75.75 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.985 0.514 . . . . 73.25 112.01 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.69 -38.07 89.76 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.551 0.532 . . . . 64.32 110.055 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.8 -38.49 76.66 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.754 0.659 . . . . 42.22 110.766 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -58.4 -36.78 74.08 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.52 0.728 . . . . 72.5 112.717 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -102.14 -16.28 16.43 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.863 0.465 . . . . 52.12 112.115 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.453 HD22 ' HB2' ' A' ' 24' ' ' ASP . 5.9 t30 -154.19 78.54 5.26 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.351 0.661 . . . . 51.02 109.354 -174.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.54 -4.64 15.72 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.699 2.266 . . . . 74.24 112.733 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 p -77.2 -12.9 60.0 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.834 1.254 . . . . 74.35 112.062 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' HB2' HD22 ' A' ' 21' ' ' ASN . 22.0 t70 -73.78 113.12 19.91 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 122.622 0.369 . . . . 64.42 111.031 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.17 -18.11 18.64 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.845 2.363 . . . . 63.24 113.396 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.29 -44.89 24.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.152 0.581 . . . . 75.44 110.329 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.39 -50.1 74.95 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.114 -0.948 . . . . 64.1 110.841 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.412 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.4 pt20 -72.9 -23.61 60.73 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.673 -0.694 . . . . 62.42 112.129 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.19 -44.35 53.73 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.68 0.392 . . . . 75.33 111.319 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.21 -31.99 72.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.775 -0.454 . . . . 72.53 109.775 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 35' ' ' LEU . 97.7 mt -66.12 -29.36 69.65 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.814 0.845 . . . . 63.22 111.852 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.46 -31.95 71.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.709 0.804 . . . . 72.43 110.674 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -84.68 -43.27 14.5 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.282 -0.872 . . . . 61.2 111.137 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 8.8 pt -96.84 -37.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.96 0.504 . . . . 71.44 112.302 -168.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -104.52 174.04 6.05 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.962 0.905 . . . . 72.11 108.912 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 102' ' ' ARG . 9.0 p -68.78 136.67 90.1 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.337 -0.616 . . . . 73.14 109.337 169.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.07 -22.64 19.57 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.143 2.562 . . . . 73.13 114.735 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -60.6 -40.4 91.68 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.193 0.997 . . . . 71.05 111.289 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.66 -54.56 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 63.14 111.268 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 28' ' ' GLN . 2.8 pp -64.06 -32.46 74.02 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.558 0.218 . . . . 65.13 111.05 -176.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.96 -34.03 75.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.14 0.976 . . . . 74.2 111.714 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -85.38 -36.56 20.64 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.801 0.44 . . . . 63.43 110.998 174.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.4 -39.88 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.458 0.703 . . . . 61.43 111.49 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -67.77 -21.93 65.23 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.335 0.654 . . . . 75.34 111.945 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -86.83 -44.8 11.44 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.059 0.943 . . . . 74.45 110.664 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -68.79 -24.39 64.41 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.224 0.609 . . . . 74.31 110.984 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.43 80.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.291 1.436 . . . . 71.01 111.557 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 97.2 mtt180 -62.25 -27.38 68.97 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.871 -1.513 . . . . 74.03 111.627 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.1 -40.49 74.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.146 0.578 . . . . 64.11 110.984 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.423 ' HA ' HE21 ' A' ' 53' ' ' GLN . 91.3 mt -74.92 -31.87 61.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.64 0.776 . . . . 71.1 110.738 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -65.38 -40.6 93.68 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.109 -0.951 . . . . 61.21 111.087 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 55.8 mttp -59.05 -40.87 86.42 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.437 0.695 . . . . 75.5 111.049 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 50' ' ' LEU . 46.1 mt-30 -72.3 -12.02 60.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.952 -1.022 . . . . 71.14 111.54 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.45 30.65 78.05 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.882 0.739 . . . . 75.14 113.336 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.3 mt -74.95 109.24 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.626 -0.879 . . . . 74.01 108.626 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -84.31 109.33 17.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 73.54 108.003 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 44.2 p90 -135.71 140.29 44.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.18 -0.674 . . . . 73.42 109.18 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -133.13 146.4 51.56 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.365 0.666 . . . . 74.23 109.775 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.32 116.03 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.724 1.265 . . . . 70.14 110.05 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -88.73 -54.92 3.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.518 0.675 . . . . 71.53 109.639 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tpm_? -139.08 127.06 22.32 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.847 -1.069 . . . . 74.14 109.13 -166.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.48 116.31 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.845 -1.169 . . . . 72.55 107.845 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.69 107.73 9.38 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.504 -0.925 . . . . 75.14 108.504 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -97.34 121.76 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.162 0.985 . . . . 74.31 109.89 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.6 m -130.23 127.79 40.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 65.33 108.563 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.5 HG21 HG22 ' A' ' 5' ' ' VAL . 32.8 p -88.4 154.44 20.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.229 0.612 . . . . 73.24 110.847 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -137.56 86.69 2.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.524 -1.287 . . . . 63.22 107.524 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.38 -101.08 0.79 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.857 -1.065 . . . . 52.42 111.918 -174.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.74 -11.99 14.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.105 0.962 . . . . 71.4 111.319 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.42 HG21 HH11 ' A' ' 93' ' ' ARG . 44.8 m -100.98 118.95 38.0 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.618 -0.512 . . . . 62.44 109.618 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 46.1 t -87.5 140.91 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.808 0.843 . . . . 74.21 109.935 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -123.96 100.95 6.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.923 0.889 . . . . 75.11 108.742 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.98 106.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.449 0.7 . . . . 71.42 109.355 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -86.06 106.22 17.06 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.723 -0.843 . . . . 74.11 108.723 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.4 p -129.63 116.52 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.835 0.854 . . . . 73.12 110.602 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -97.08 139.96 32.3 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.238 1.015 . . . . 71.13 109.32 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -135.02 142.61 46.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.796 0.838 . . . . 73.12 109.085 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -93.0 105.8 17.85 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.269 1.033 . . . . 64.51 109.351 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.09 105.39 15.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.495 -0.775 . . . . 63.24 110.091 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.7 m -102.19 106.7 17.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.502 1.121 . . . . 74.24 108.331 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 t -148.38 140.34 23.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.111 0.965 . . . . 60.13 109.591 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.3 25.66 73.58 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.106 0.402 . . . . 75.03 114.106 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.9 83.51 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.897 -0.391 . . . . 53.33 114.026 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -116.91 139.05 51.1 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.43 0.615 . . . . 71.3 111.052 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.5 m -100.73 144.31 29.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.357 1.063 . . . . 64.34 109.522 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.4 m -143.92 114.54 7.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.78 0.832 . . . . 64.21 109.575 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.85 101.03 5.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.757 -0.831 . . . . 73.32 108.757 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.5 m -102.92 124.88 49.27 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.547 1.139 . . . . 55.13 110.098 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.9 m -94.05 116.9 29.38 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.316 0.646 . . . . 71.21 110.242 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.34 127.84 53.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.164 -1.05 . . . . 73.43 108.164 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -110.06 100.47 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.552 -1.277 . . . . 60.42 107.552 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.76 105.88 17.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.07 -1.085 . . . . 72.51 108.07 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.42 HH11 HG21 ' A' ' 70' ' ' THR . 59.1 ttp85 -91.35 99.02 12.06 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.547 -1.206 . . . . 75.45 107.989 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 101' ' ' ILE . 88.2 m-85 -87.51 108.02 18.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.935 -0.765 . . . . 70.51 108.935 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 34.9 tt0 -98.16 133.15 42.99 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.442 -0.947 . . . . 72.13 108.442 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 25.6 m -84.06 142.66 13.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.166 0.508 . . . . 72.31 109.918 176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.32 104.62 14.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.343 -1.725 . . . . 75.25 106.343 167.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.07 -100.68 1.51 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.399 -0.819 . . . . 23.53 111.293 -172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -123.88 -0.55 8.47 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.936 0.894 . . . . 60.01 112.54 -171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -139.71 150.03 44.36 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.514 0.725 . . . . 70.12 110.314 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 18.3 mt -75.52 119.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.054 0.542 . . . . 72.41 110.176 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 36' ' ' SER . 44.3 mmt-85 -131.18 14.98 5.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.042 0.937 . . . . 44.14 110.627 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 39.0 ttm105 -150.53 137.98 19.64 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 122.649 0.38 . . . . 63.44 110.114 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.96 119.7 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.271 1.028 . . . . 44.52 108.605 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 m -112.26 104.26 12.44 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.912 -1.144 . . . . 71.2 107.912 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.78 107.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.17 -0.678 . . . . 75.42 109.17 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 m -94.31 104.21 16.21 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.51 -0.922 . . . . 71.51 108.51 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -86.97 123.57 32.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.112 -1.07 . . . . 65.13 108.112 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 123.414 0.685 . . . . 70.05 111.108 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.244 0.807 0 N-CA-C 110.192 -0.299 . . . . 73.11 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.614 HG23 HG11 ' A' ' 96' ' ' VAL . 44.5 mm -86.21 -52.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.806 1.242 . . . . 71.21 111.047 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.43 -40.93 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.835 0.854 . . . . 71.13 110.508 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.06 -56.21 23.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.157 . . . . 75.5 110.984 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.4 70.05 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.061 0.851 . . . . 53.43 111.432 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -72.41 -48.28 42.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.585 0.754 . . . . 71.3 111.694 177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.43 -46.32 70.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.431 -0.804 . . . . 64.24 111.093 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.94 -39.78 93.28 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.638 0.775 . . . . 61.33 110.559 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.616 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -58.78 -50.44 73.93 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 123.807 0.692 . . . . 62.12 111.317 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -54.72 42.74 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 124.218 0.949 . . . . 50.52 112.167 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.05 -39.78 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.88 0.872 . . . . 73.21 110.943 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.98 70.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.526 0.73 . . . . 71.12 112.617 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 63.6 mt -61.73 -38.39 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.501 0.72 . . . . 74.3 110.28 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.05 -34.03 61.79 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.002 0.521 . . . . 74.24 111.254 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.07 -21.39 64.08 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.249 0.62 . . . . 74.33 111.38 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.13 -36.28 21.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.386 0.274 . . . . 71.34 110.59 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 41.0 m0 -63.46 -27.32 69.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.64 -27.5 21.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.099 0.56 . . . . 64.34 111.467 173.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -158.43 93.41 1.99 Allowed Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.398 0.679 . . . . 73.44 109.75 -177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HD2' HE22 ' A' ' 51' ' ' GLN . 39.9 Cg_endo -65.36 -16.83 56.12 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.543 2.829 . . . . 71.31 113.857 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 p -97.04 11.71 35.18 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.908 0.883 . . . . 74.35 111.454 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.45 114.59 29.29 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 109.177 -0.675 . . . . 65.12 109.177 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.25 -33.24 11.62 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.411 2.074 . . . . 71.35 112.531 -168.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.86 -48.28 59.44 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.482 0.713 . . . . 71.53 111.114 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -58.76 -50.84 72.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.631 0.772 . . . . 62.14 111.587 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.51 -29.98 62.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.412 0.523 . . . . 61.21 112.412 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.44 -36.64 71.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.813 0.279 . . . . 74.54 111.313 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.5 pp -70.61 -34.53 72.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 75.13 109.602 175.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 35' ' ' LEU . 85.6 mt -66.67 -22.51 66.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.751 0.821 . . . . 64.52 111.716 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.29 -29.87 61.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.964 0.506 . . . . 60.32 110.477 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.27 -42.84 9.11 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.769 0.828 . . . . 73.23 111.803 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 30' ' ' LEU . 19.8 pt -95.12 -21.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.843 0.457 . . . . 62.33 111.519 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.616 HD11 ' HB1' ' A' ' 11' ' ' ALA . 44.3 mt -122.84 -176.63 3.45 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.933 -0.766 . . . . 73.43 108.933 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -75.97 148.08 81.25 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.319 0.648 . . . . 73.11 110.514 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.26 -20.27 46.47 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.97 2.447 . . . . 73.05 113.044 171.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.26 -40.05 89.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.398 1.079 . . . . 73.5 111.237 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG11 HD13 ' A' ' 35' ' ' LEU . 57.3 t -64.05 -51.45 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.798 0.439 . . . . 74.02 111.065 -173.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.64 -27.88 69.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.77 0.319 . . . . 72.02 111.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.81 -28.76 55.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.16 0.984 . . . . 73.34 112.252 -175.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 39' ' ' VAL . 29.3 pt20 -85.45 -33.06 21.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 110.088 -0.338 . . . . 65.11 110.088 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 55.1 t -65.75 -41.95 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.834 0.854 . . . . 74.11 111.209 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -63.47 -22.61 66.98 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.037 0.535 . . . . 74.34 111.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -80.33 -48.41 13.02 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.549 0.74 . . . . 73.31 110.398 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.74 -19.85 64.36 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.046 0.939 . . . . 74.32 111.805 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -53.72 -56.72 14.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.554 1.142 . . . . 63.25 112.824 173.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -18.28 65.24 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.641 0.588 . . . . 64.31 112.379 -173.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.67 -51.94 50.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.721 -0.474 . . . . 63.52 109.721 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -78.4 -33.52 48.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.669 0.787 . . . . 73.33 110.954 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.437 HE22 ' HD2' ' A' ' 22' ' ' PRO . 35.6 tt0 -67.43 -38.19 84.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.228 1.011 . . . . 72.02 111.091 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.53 -42.49 95.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.4 0.68 . . . . 73.41 110.221 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -65.79 -24.2 66.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.241 -0.89 . . . . 75.03 110.703 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.77 33.73 45.69 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.958 -0.564 . . . . 65.22 111.995 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 65.8 mt -73.49 110.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.678 0.791 . . . . 72.02 109.668 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -89.88 107.67 19.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.524 -1.287 . . . . 72.12 107.524 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 18.5 p90 -112.24 123.96 51.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.581 -0.896 . . . . 73.11 108.581 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -111.47 130.39 55.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.246 0.618 . . . . 71.42 109.364 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.25 108.53 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.043 -0.725 . . . . 63.25 109.043 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' A' ' 78' ' ' GLU . 31.3 mmmt -78.03 -45.74 22.86 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.873 0.869 . . . . 65.32 109.775 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -167.48 125.34 1.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.812 0.845 . . . . 72.51 109.768 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.07 109.82 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.736 0.814 . . . . 54.34 110.173 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -104.86 143.01 33.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 72.01 108.852 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' VAL . 2.9 p -140.92 125.74 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.02 0.928 . . . . 72.45 109.881 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -140.24 139.2 35.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.058 0.943 . . . . 71.35 109.459 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.8 p -89.51 157.74 17.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.357 0.663 . . . . 60.34 111.547 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -160.84 84.78 0.68 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.403 1.081 . . . . 74.3 109.282 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.36 -116.49 8.84 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.831 -0.622 . . . . 70.21 113.445 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.22 11.88 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.276 0.63 . . . . 54.11 111.247 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.91 155.29 50.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.446 0.698 . . . . 74.25 109.773 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -137.33 120.25 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.699 0.799 . . . . 70.43 109.319 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.04 109.57 21.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.276 1.03 . . . . 75.32 109.648 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 64' ' ' VAL . 48.2 t -98.22 105.73 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.998 -0.742 . . . . 62.12 108.998 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.6 m -96.28 102.32 14.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.871 -1.159 . . . . 64.42 107.871 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.73 113.82 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.966 0.907 . . . . 71.34 109.159 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.24 126.17 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.894 0.877 . . . . 73.31 108.923 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.84 163.24 16.48 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.886 0.874 . . . . 53.21 108.783 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 32.6 tt0 -122.65 101.69 7.62 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.701 -1.222 . . . . 74.1 107.701 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 31.6 mt-10 -86.66 139.98 30.25 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.281 1.032 . . . . 73.42 110.15 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 11.9 m -119.62 102.94 8.98 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 73.22 108.55 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 t -118.2 120.39 37.54 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.998 0.919 . . . . 62.13 110.079 -173.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.52 -93.46 0.46 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.769 -0.651 . . . . 61.14 112.602 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -141.44 19.16 2.63 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.24 0.447 . . . . 64.24 112.072 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.9 p -124.01 145.37 49.24 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.183 0.993 . . . . 64.13 108.99 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 m -116.39 104.27 11.29 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.181 -1.044 . . . . 63.23 108.181 177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.0 m -102.02 119.19 38.39 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.48 1.112 . . . . 75.21 109.399 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 28.5 t-20 -77.68 101.2 6.51 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.296 -1.002 . . . . 73.42 108.296 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.0 m -113.05 124.25 52.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.241 1.016 . . . . 74.55 109.884 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 109' ' ' ASN . 27.5 m -87.01 141.02 28.97 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.276 -0.639 . . . . 74.23 109.276 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -119.28 127.13 52.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.554 1.142 . . . . 74.11 108.72 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -105.7 103.21 12.67 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.232 -1.025 . . . . 34.1 108.232 176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.46 105.2 17.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 53.15 108.015 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 36.3 ttm-85 -100.0 108.64 20.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.188 -0.914 . . . . 62.01 108.659 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HB3' HG12 ' A' ' 101' ' ' ILE . 94.8 m-85 -99.85 111.73 24.03 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.925 0.89 . . . . 71.2 110.943 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 103' ' ' ARG . 7.3 mp0 -80.14 112.21 17.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.742 -0.836 . . . . 72.13 108.742 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 4' ' ' ILE . 2.0 m -83.19 141.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.752 0.821 . . . . 61.12 109.69 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -140.82 117.0 10.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.411 -0.959 . . . . 71.44 108.411 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.34 -99.21 1.43 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.632 -0.587 . . . . 71.41 111.632 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -122.26 -16.96 7.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.089 0.955 . . . . 73.11 110.997 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -140.38 165.22 28.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.706 0.402 . . . . 74.42 110.573 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 96' ' ' VAL . 2.6 mp -76.98 134.12 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.101 0.56 . . . . 70.11 109.81 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -123.47 5.57 8.99 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.35 1.06 . . . . 74.21 111.602 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 21.3 tpt180 -154.67 129.79 9.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.772 -0.455 . . . . 73.42 109.772 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.92 149.3 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.072 0.949 . . . . 74.41 109.322 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.8 m -131.17 106.79 8.57 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.351 -0.981 . . . . 62.33 108.351 171.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.77 105.04 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.725 -0.843 . . . . 61.31 108.725 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -116.17 105.78 12.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.54 0.736 . . . . 72.31 109.068 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -73.1 105.06 4.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.637 -0.875 . . . . 61.13 108.637 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 24.7 t-20 . . . . . 0 CA--C 1.55 0.955 0 C-N-CA 123.686 0.794 . . . . 70.04 110.292 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 108.394 -0.965 . . . . 62.4 108.394 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 HG12 ' A' ' 96' ' ' VAL . 43.5 mm -74.02 -34.19 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.117 0.967 . . . . 60.22 112.121 -168.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.26 -42.24 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.454 0.702 . . . . 63.34 109.537 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.49 -35.94 70.95 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.026 -0.988 . . . . 74.33 110.412 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -64.27 -40.67 96.44 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.244 0.618 . . . . 75.45 110.447 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.66 76.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.747 0.819 . . . . 64.23 110.956 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 64' ' ' VAL . 87.2 tttt -63.13 -56.88 13.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.455 -0.793 . . . . 63.13 110.504 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.406 HE21 HD13 ' A' ' 30' ' ' LEU . 21.2 pt20 -67.41 -23.2 65.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.047 0.539 . . . . 64.14 111.077 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -49.4 64.58 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 123.721 0.638 . . . . 50.12 110.115 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.11 83.25 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.173 0.921 . . . . 71.15 110.906 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HE21 ' A' ' 17' ' ' GLN . 74.1 mt -61.51 -40.24 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.327 1.051 . . . . 72.23 111.085 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.7 61.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.403 0.681 . . . . 62.11 111.983 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.02 -37.47 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.485 0.714 . . . . 75.21 109.239 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -73.11 -35.16 66.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.09 0.556 . . . . 73.3 111.054 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.483 HE21 HG22 ' A' ' 13' ' ' ILE . 77.1 mt-30 -61.43 -37.39 83.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.354 0.662 . . . . 74.23 110.464 174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 mt -73.26 -40.82 64.3 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 123.759 0.662 . . . . 64.1 110.532 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -59.69 -27.8 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.421 0.526 . . . . 71.23 112.421 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 -14.33 17.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.169 0.588 . . . . 71.45 111.815 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -159.58 89.9 1.93 Allowed Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 123.42 0.688 . . . . 72.5 110.381 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HD2' HE21 ' A' ' 51' ' ' GLN . 37.6 Cg_endo -62.32 -22.33 73.95 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.374 2.716 . . . . 52.44 113.193 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -92.16 11.48 25.4 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.66 0.784 . . . . 74.2 111.809 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.11 110.73 8.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.048 -0.723 . . . . 75.0 109.048 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.78 -38.54 23.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.468 2.112 . . . . 71.34 113.104 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.61 -40.16 73.32 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.31 0.644 . . . . 74.52 111.644 -172.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -61.74 -56.85 15.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.025 0.828 . . . . 63.44 110.783 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.9 -24.64 66.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.507 0.723 . . . . 75.3 111.661 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.45 -46.83 65.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.809 0.443 . . . . 55.35 111.254 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.406 HD13 HE21 ' A' ' 10' ' ' GLN . 4.3 pp -69.93 -30.56 67.99 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 110.288 -0.264 . . . . 64.24 110.288 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 35' ' ' LEU . 83.2 mt -66.99 -28.19 68.05 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.424 0.69 . . . . 55.43 111.571 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -71.52 -25.39 62.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.999 0.428 . . . . 74.31 110.109 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -85.62 -41.3 15.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.636 0.774 . . . . 70.25 111.598 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 7' ' ' ALA . 9.4 pt -103.64 -17.32 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.123 0.569 . . . . 63.21 112.23 -170.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -123.43 174.61 7.26 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.026 0.93 . . . . 60.1 108.681 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.8 m -68.98 141.89 92.65 Favored Pre-proline 0 CA--C 1.561 1.404 0 N-CA-C 109.949 -0.389 . . . . 41.2 109.949 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.36 -20.01 14.29 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.997 2.464 . . . . 73.03 114.514 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.08 -37.23 66.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 72.33 111.796 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -64.03 -41.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.843 0.857 . . . . 62.4 111.386 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.59 -28.02 60.73 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.943 0.402 . . . . 43.51 111.358 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.32 -27.89 62.72 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.872 -1.058 . . . . 53.2 111.224 -172.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.65 -32.72 23.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.746 0.418 . . . . 74.41 111.077 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' VAL . 55.3 t -64.21 -40.21 88.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 123.337 0.655 . . . . 72.22 110.758 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -67.59 -24.89 65.54 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.597 0.56 . . . . 74.53 111.535 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.29 -48.44 14.13 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.487 0.715 . . . . 73.34 110.255 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -62.63 -28.06 69.65 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.507 1.123 . . . . 71.35 110.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.05 -35.29 80.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.302 -1.317 . . . . 75.4 112.65 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -65.62 -27.46 68.41 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.665 0.786 . . . . 75.04 111.469 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.3 -48.67 32.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.678 0.791 . . . . 72.44 109.894 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.03 -30.3 69.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.839 0.856 . . . . 72.02 110.859 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.498 HE21 ' HD2' ' A' ' 22' ' ' PRO . 4.8 tp-100 -66.61 -47.35 72.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.03 1.332 . . . . 75.34 109.677 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.69 -31.58 72.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.241 -0.89 . . . . 65.41 110.845 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 -25.62 39.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.512 0.725 . . . . 62.22 110.877 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.34 40.31 80.59 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.377 0.423 . . . . 62.31 113.179 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.13 110.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.266 0.626 . . . . 73.5 109.396 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -94.55 106.63 18.62 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.099 -0.704 . . . . 63.23 109.099 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 7.3 p90 -112.38 143.07 44.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.534 0.734 . . . . 74.13 109.253 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -130.23 129.03 42.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.978 0.511 . . . . 71.33 109.767 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.94 101.37 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.551 0.741 . . . . 63.11 109.245 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.53 -27.27 19.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.971 0.908 . . . . 75.31 110.332 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.8 tpp180 -145.29 146.79 31.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.164 -1.05 . . . . 75.42 108.164 176.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.58 118.62 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.598 0.759 . . . . 74.32 109.013 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.97 105.76 10.6 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.96 -1.126 . . . . 71.04 107.96 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 73' ' ' VAL . 84.6 t -99.9 108.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.567 -1.272 . . . . 53.33 107.567 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -124.37 126.1 45.42 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.337 -0.616 . . . . 61.12 109.337 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 HG22 ' A' ' 71' ' ' VAL . 1.4 m -89.45 113.18 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.587 -0.894 . . . . 71.34 108.587 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -110.02 91.59 3.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.781 1.232 . . . . 54.54 107.812 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.7 -110.06 3.17 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 114.869 -1.06 . . . . 73.11 112.101 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.76 23.75 13.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.585 0.754 . . . . 51.51 110.379 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.6 m -134.88 122.6 22.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.157 0.583 . . . . 75.44 110.285 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 66' ' ' THR . 30.0 t -88.68 111.1 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.046 0.538 . . . . 71.33 109.606 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -97.94 104.59 16.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.704 0.802 . . . . 64.3 109.427 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 64' ' ' VAL . 78.0 t -89.29 103.68 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.203 -0.666 . . . . 70.31 109.203 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.9 m -99.02 103.3 15.23 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.0 -1.111 . . . . 63.24 108.0 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.05 128.9 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.441 0.696 . . . . 72.44 110.214 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 6.9 tp10 -92.77 111.96 23.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.08 1.352 . . . . 73.15 109.548 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 4.9 mp -109.51 118.81 37.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.605 -0.887 . . . . 60.11 108.605 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 26.1 tt0 -88.24 101.61 14.01 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.173 -1.418 . . . . 64.23 107.173 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 28.0 mt-10 -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.344 1.058 . . . . 73.34 110.588 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.3 m -125.05 111.09 14.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.861 -1.162 . . . . 70.3 107.861 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.9 t -132.36 131.25 41.69 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.483 -0.932 . . . . 73.52 108.483 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.6 -78.56 0.47 Allowed Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.48 -0.648 . . . . 65.3 111.48 -172.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.91 10.68 0.11 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 123.529 0.585 . . . . 72.14 111.959 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.4 p -98.67 126.91 44.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.077 0.951 . . . . 64.32 109.636 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.4 m -116.44 108.33 15.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.74 0.816 . . . . 64.13 110.181 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.0 m -131.74 139.53 48.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.012 0.925 . . . . 70.21 110.395 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 18.2 m120 -77.69 115.72 17.67 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.128 0.571 . . . . 72.12 109.597 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -116.65 121.39 41.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.304 1.042 . . . . 52.32 108.644 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 19.1 m -88.99 122.76 32.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.976 -0.379 . . . . 75.05 109.976 -176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -106.84 126.07 51.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.895 -0.779 . . . . 75.12 108.895 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.8 103.4 12.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.987 -1.116 . . . . 62.53 107.987 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.13 106.68 18.71 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.701 -1.222 . . . . 54.01 107.701 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 39.5 ttm180 -93.3 99.93 12.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.26 1.024 . . . . 74.22 110.113 -175.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.429 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.1 m-85 -91.42 109.67 20.96 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.746 0.819 . . . . 72.44 110.157 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 40.5 tt0 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.248 -0.649 . . . . 74.3 109.248 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.429 HG12 HG21 ' A' ' 4' ' ' ILE . 2.3 m -84.94 149.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.461 0.704 . . . . 73.41 110.134 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -154.58 103.3 2.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 53.12 108.81 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 -118.39 5.04 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.748 -0.541 . . . . 60.44 111.748 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.37 20.37 13.65 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 71.23 109.832 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -139.22 168.44 19.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.305 1.042 . . . . 75.54 109.199 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 35' ' ' LEU . 65.1 mt -108.17 127.78 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.979 0.912 . . . . 71.32 108.726 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -115.06 5.46 14.94 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.257 0.623 . . . . 73.31 112.435 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.8 ttp85 -153.53 134.91 14.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 110.576 -0.157 . . . . 63.53 110.576 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 129.68 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.289 1.036 . . . . 64.11 109.056 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.3 m -116.68 104.61 11.55 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.522 -0.918 . . . . 72.21 108.522 176.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.37 117.28 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.773 -0.825 . . . . 64.31 108.773 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 m -117.66 106.3 12.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.911 0.484 . . . . 74.31 109.812 -171.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.12 122.46 25.65 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.131 0.572 . . . . 74.11 109.536 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.7 m-80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.041 . . . . 75.04 109.21 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.937 0.399 . . . . 61.24 110.754 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -99.1 -6.1 28.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.58 0.752 . . . . 74.12 109.232 164.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.41 57.58 4.36 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.023 1.329 . . . . 73.22 109.877 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.492 HG21 HG11 ' A' ' 96' ' ' VAL . 46.8 mm -71.37 -32.91 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.955 -1.02 . . . . 72.21 110.533 -174.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.25 -46.55 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.458 0.703 . . . . 64.31 110.02 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -46.51 83.4 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.55 109.218 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.92 79.16 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.033 -0.985 . . . . 74.13 111.596 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.12 -36.32 74.73 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.05 0.54 . . . . 64.43 111.242 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.516 ' HB2' HG11 ' A' ' 64' ' ' VAL . 81.3 tttt -60.44 -55.39 34.06 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 123.837 0.711 . . . . 54.11 109.58 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.8 -35.9 75.63 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.983 -1.008 . . . . 70.43 111.148 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -65.11 -49.12 71.2 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 124.142 0.901 . . . . 74.41 110.693 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.68 -52.62 64.37 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 123.993 0.808 . . . . 73.11 110.854 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.479 HG22 HE21 ' A' ' 17' ' ' GLN . 59.2 mt -62.01 -39.95 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 123.965 0.791 . . . . 44.31 110.323 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.24 75.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.605 0.762 . . . . 54.33 112.142 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.37 -43.43 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.316 0.646 . . . . 64.45 109.866 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.16 -29.99 69.0 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.849 0.46 . . . . 74.23 111.303 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.479 HE21 HG22 ' A' ' 13' ' ' ILE . 78.2 mt-30 -66.93 -33.58 75.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.862 0.465 . . . . 75.22 110.47 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.3 mt -73.42 -35.71 65.86 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.235 0.335 . . . . 70.22 110.936 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -62.86 -31.04 71.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.691 0.397 . . . . 72.13 111.896 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -92.75 -30.6 15.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.022 0.529 . . . . 63.43 110.904 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.39 87.37 2.36 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 123.461 0.705 . . . . 74.11 109.787 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.07 -3.66 12.67 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.266 2.644 . . . . 55.33 113.959 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -95.83 7.5 46.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.112 0.965 . . . . 64.31 111.498 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.53 118.07 47.18 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.66 -0.686 . . . . 61.13 109.927 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.88 -39.33 20.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.831 2.354 . . . . 73.32 113.009 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.77 -47.61 58.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.049 0.54 . . . . 72.43 110.089 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.65 -56.28 23.9 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 114.723 -1.126 . . . . 34.43 111.304 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.24 -34.93 77.46 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.094 0.558 . . . . 75.43 111.418 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.36 -51.79 27.3 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.132 0.573 . . . . 75.11 110.748 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -63.11 -38.7 92.22 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 123.815 0.697 . . . . 73.21 109.827 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.81 -35.87 77.6 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.79 0.836 . . . . 64.2 111.265 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -73.08 -28.87 62.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.074 0.55 . . . . 54.2 110.75 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -81.86 -41.94 20.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 72.25 111.628 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 30' ' ' LEU . 9.8 pt -100.16 -38.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.04 0.536 . . . . 64.14 112.29 -169.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD13 HG11 ' A' ' 39' ' ' VAL . 45.6 mt -98.45 178.24 5.09 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.092 -0.707 . . . . 63.34 109.092 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.563 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.0 m -68.67 144.83 96.55 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.205 -0.452 . . . . 63.0 110.347 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' A' ' 40' ' ' LEU . 36.1 Cg_exo -59.54 -22.79 68.25 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.698 2.265 . . . . 75.12 112.456 173.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.43 -37.16 86.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.452 1.101 . . . . 74.3 110.903 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.9 t -67.8 -49.97 64.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 123.475 0.71 . . . . 62.11 111.344 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 pp -59.9 -33.76 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 120.832 0.348 . . . . 71.13 110.396 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 30.2 t70 -71.68 -51.62 22.08 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.042 -0.981 . . . . 71.14 110.167 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -62.94 -32.89 74.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.244 0.218 . . . . 51.44 111.348 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.43 -49.18 79.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 CA-C-O 118.982 -0.532 . . . . 74.35 110.401 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -67.1 -31.3 71.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.464 0.477 . . . . 74.11 111.843 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 16.5 mm-40 -62.5 -51.8 66.01 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.319 0.581 . . . . 74.43 110.104 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 44.1 m80 -72.97 -24.34 60.77 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.954 -1.021 . . . . 71.23 111.278 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.95 93.19 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.175 0.99 . . . . 74.43 110.926 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.2 -34.95 77.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.406 -0.816 . . . . 63.11 110.825 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.68 -39.26 62.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.732 0.813 . . . . 72.23 111.099 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 84.7 mt -74.5 -29.97 61.63 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.596 0.758 . . . . 72.45 110.654 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -69.49 -39.05 77.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.835 0.854 . . . . 72.3 109.912 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -75.18 -24.65 57.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.771 0.828 . . . . 73.2 110.876 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.88 -36.5 80.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.09 30.43 31.34 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.528 -0.76 . . . . 62.24 111.99 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.85 98.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 109.073 -0.714 . . . . 74.31 109.073 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -84.02 109.57 17.76 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.45 -1.315 . . . . 71.43 107.45 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.0 p90 -111.08 161.45 15.9 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.283 -1.006 . . . . 64.11 108.283 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.53 113.13 7.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.844 -1.169 . . . . 73.2 107.844 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.25 108.42 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.112 0.965 . . . . 63.14 110.133 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -91.59 -50.87 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.147 0.579 . . . . 72.35 111.189 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -137.35 134.56 36.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.892 . . . . 74.52 109.037 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -125.77 118.54 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.809 -1.182 . . . . 74.03 107.809 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.78 107.5 9.71 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.874 -0.788 . . . . 73.24 108.874 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 73' ' ' VAL . 7.4 p -103.61 134.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.995 0.518 . . . . 61.03 109.763 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -149.53 166.18 29.97 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.1 0.96 . . . . 65.24 109.085 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 p -96.67 151.78 19.29 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.325 0.583 . . . . 73.2 110.297 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.32 83.07 1.81 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 106.492 -1.67 . . . . 65.24 106.492 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.91 -115.05 7.12 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.493 -1.23 . . . . 43.35 111.377 -168.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -96.11 -14.66 22.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.101 0.561 . . . . 73.31 110.765 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 m -96.58 121.44 38.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.595 0.758 . . . . 70.55 109.642 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.7 p -89.31 126.57 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 120.981 0.42 . . . . 73.21 110.187 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 72' ' ' ASN . 0.9 OUTLIER -107.64 130.6 54.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.467 0.707 . . . . 70.44 109.939 -177.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.537 HG22 HG23 ' A' ' 64' ' ' VAL . 21.7 t -112.05 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.999 -0.741 . . . . 65.04 108.999 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -89.39 104.59 17.13 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.646 -0.872 . . . . 75.03 108.646 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.32 120.33 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.837 0.855 . . . . 73.02 109.709 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -89.83 127.94 36.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.766 0.826 . . . . 74.42 108.992 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -127.63 140.5 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.216 0.606 . . . . 72.21 109.393 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -89.42 112.13 23.18 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.021 -1.103 . . . . 70.15 108.021 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.7 mt-10 -101.38 114.83 29.18 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.309 0.643 . . . . 64.14 109.44 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m -87.75 103.28 15.47 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.066 -1.087 . . . . 64.4 108.066 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -140.12 133.88 30.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.035 -0.984 . . . . 74.23 108.74 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.75 16.16 74.11 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.708 -0.678 . . . . 75.45 113.358 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.53 84.55 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.048 0.356 . . . . 73.44 113.185 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -108.4 121.75 45.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.585 0.754 . . . . 71.31 110.371 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.6 m -87.69 116.89 26.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.535 -0.913 . . . . 73.41 108.535 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.3 t -127.22 152.86 46.83 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.34 0.656 . . . . 73.03 109.749 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -80.06 133.11 36.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.56 -0.533 . . . . 53.33 109.56 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.6 m -142.59 111.13 6.18 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.779 -1.193 . . . . 72.03 107.779 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -91.02 121.78 33.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.218 0.607 . . . . 70.32 109.562 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.58 125.85 49.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -109.93 102.32 11.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.728 -1.212 . . . . 73.35 107.728 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.1 mp -89.08 105.72 17.97 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.292 -1.373 . . . . 75.55 107.292 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 15.3 ttt180 -101.16 97.64 8.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.713 -1.217 . . . . 73.25 107.713 -170.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' ILE . 99.1 m-85 -88.49 109.48 20.08 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.445 0.698 . . . . 74.21 109.596 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 6.5 tm-20 -86.86 119.37 27.01 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.449 -1.315 . . . . 74.31 107.449 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 101' ' ' ILE . 3.0 m -97.08 150.93 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.091 0.956 . . . . 71.34 111.646 -168.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.12 99.93 4.41 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.385 1.074 . . . . 74.02 109.089 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.37 -99.47 0.73 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.662 -0.699 . . . . 74.13 112.734 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -107.76 -20.62 13.15 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.567 0.747 . . . . 74.55 110.849 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -128.04 153.31 46.92 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.654 0.782 . . . . 73.01 110.662 -170.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 94' ' ' PHE . 72.6 mt -95.1 130.75 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.878 0.871 . . . . 71.25 109.588 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 9.5 mmt180 -102.62 -35.36 8.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.099 0.56 . . . . 74.1 111.288 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.9 mtt85 -127.51 145.18 50.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.794 -0.639 . . . . 54.53 109.592 -167.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.84 123.7 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.226 1.011 . . . . 74.24 108.952 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 12.6 m -109.25 103.22 12.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.255 -1.017 . . . . 73.24 108.255 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.12 106.53 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.413 -0.958 . . . . 72.4 108.413 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.1 m -100.26 105.03 16.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.375 0.67 . . . . 74.11 109.334 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -87.49 92.04 8.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.92 0.488 . . . . 62.42 109.734 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -96.38 163.12 13.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.214 1.006 . . . . 73.31 110.123 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.49 101.05 0.18 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.238 -1.145 . . . . 44.43 110.238 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.49 167.49 35.13 Favored Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.868 -0.493 . . . . 72.34 111.868 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.0 m -90.52 82.08 5.89 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.469 0.652 . . . . 64.31 111.077 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.66 -16.43 14.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.947 0.899 . . . . 71.21 109.432 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -167.09 1.27 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.818 1.247 . . . . 74.31 112.283 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -128.62 97.51 4.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.849 0.86 . . . . 61.13 109.862 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 46.28 65.08 1.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.357 1.863 . . . . 71.35 112.584 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -70.52 117.66 12.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.611 -0.722 . . . . 75.21 109.918 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -64.09 113.24 3.39 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.431 -0.952 . . . . 70.35 108.431 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.31 -87.08 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.652 0.381 . . . . 62.24 110.572 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 -168.728 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 108.481 -0.933 . . . . 75.41 108.481 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -168.1 -177.24 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.067 -1.086 . . . . 73.42 108.067 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -42.64 119.03 1.34 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.247 1.419 . . . . 73.34 112.976 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.448 HG21 HG11 ' A' ' 96' ' ' VAL . 47.2 mm -72.8 -29.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.638 1.175 . . . . 75.53 111.957 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.98 -56.56 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 71.02 110.703 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.97 -34.5 69.0 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.802 -0.636 . . . . 61.52 110.804 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -57.25 -50.65 72.23 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.549 0.531 . . . . 72.12 110.455 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.98 -32.07 68.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.505 0.722 . . . . 55.33 112.37 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.18 -58.37 8.62 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.719 0.637 . . . . 71.34 110.154 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.92 -30.27 71.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.997 0.919 . . . . 65.14 111.141 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -62.61 -51.65 66.45 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 124.188 0.93 . . . . 74.13 110.531 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -59.43 -44.18 92.94 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 124.394 1.059 . . . . 72.44 112.357 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.454 HG22 HE21 ' A' ' 17' ' ' GLN . 42.4 mt -66.73 -42.27 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.556 0.743 . . . . 62.11 109.965 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.3 -28.02 68.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.714 0.805 . . . . 74.12 112.051 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -60.89 -45.72 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.749 0.82 . . . . 74.44 109.909 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 42.3 m-85 -76.68 -29.43 56.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.276 -0.42 . . . . 73.35 112.011 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.454 HE21 HG22 ' A' ' 13' ' ' ILE . 76.6 mt-30 -60.59 -39.16 87.07 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.796 0.685 . . . . 74.21 110.054 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.6 -38.44 59.03 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.82 0.7 . . . . 65.1 111.176 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.539 ' HH2' HG11 ' A' ' 106' ' ' VAL . 28.2 m0 -62.88 -31.1 72.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.767 0.654 . . . . 71.01 112.767 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -95.97 -19.09 19.77 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.613 0.365 . . . . 64.23 111.204 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.442 HD22 ' HB2' ' A' ' 24' ' ' ASP . 6.7 t30 -158.04 88.33 2.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.412 0.685 . . . . 75.34 109.982 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.49 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.115 2.543 . . . . 64.15 113.242 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -91.56 10.66 27.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.271 1.028 . . . . 64.14 111.396 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.442 ' HB2' HD22 ' A' ' 21' ' ' ASN . 12.9 t70 -78.08 111.19 16.55 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 109.32 -0.622 . . . . 74.13 109.32 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 -44.85 7.03 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.651 2.234 . . . . 74.4 113.007 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.56 -27.72 58.71 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.274 0.472 . . . . 70.01 112.274 -171.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -62.85 -57.83 9.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.813 0.445 . . . . 73.53 110.532 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -66.66 -26.41 67.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.318 0.647 . . . . 64.21 111.937 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -67.09 -46.44 74.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.168 0.987 . . . . 74.42 110.987 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 4.2 pp -70.86 -34.27 71.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.796 -0.184 . . . . 73.31 110.719 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 93.1 mt -61.1 -28.93 69.44 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.667 0.787 . . . . 53.04 111.141 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.34 -24.95 63.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.932 0.893 . . . . 63.13 111.287 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -93.35 -44.81 8.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.666 0.786 . . . . 53.22 110.525 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 35' ' ' LEU . 11.8 pt -94.67 -30.45 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.435 0.694 . . . . 44.15 112.321 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD11 ' HB1' ' A' ' 11' ' ' ALA . 68.6 mt -110.21 175.14 5.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.324 0.65 . . . . 63.23 109.977 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.6 m -73.74 144.4 82.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.31 -0.859 . . . . 72.15 109.369 170.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 88.9 Cg_exo -52.16 -30.44 41.32 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 123.706 2.937 . . . . 73.14 114.285 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.9 -32.34 71.91 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.475 0.71 . . . . 73.11 111.482 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.557 HG23 ' HB2' ' A' ' 36' ' ' SER . 40.4 t -70.29 -41.47 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.605 0.762 . . . . 54.14 110.987 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' PRO . 4.1 pp -72.57 -31.33 65.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.749 0.309 . . . . 53.42 110.76 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.6 t70 -65.28 -50.02 67.32 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.23 -0.896 . . . . 71.23 110.783 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.95 -32.52 72.96 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.286 0.366 . . . . 71.2 111.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 15' ' ' ILE . 47.0 t -63.38 -54.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.558 0.743 . . . . 71.24 111.219 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -67.14 -21.51 65.82 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.572 0.582 . . . . 75.44 112.572 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 12.1 mm-40 -80.35 -39.8 27.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.842 0.457 . . . . 60.04 111.344 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -73.92 -22.09 59.81 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.132 0.573 . . . . 75.24 110.698 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.68 94.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.96 1.304 . . . . 74.1 111.791 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.19 -20.96 65.8 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.498 -1.228 . . . . 61.22 112.024 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.98 -59.27 4.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.637 0.375 . . . . 75.41 110.219 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.31 -29.89 70.96 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.053 0.941 . . . . 72.32 111.443 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -59.51 -51.14 71.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.622 1.169 . . . . 52.23 110.672 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -76.62 -26.9 55.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.517 0.727 . . . . 61.41 111.885 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -74.39 -24.08 59.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.338 0.655 . . . . 72.25 110.07 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.19 23.96 77.15 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.469 -0.787 . . . . 61.22 113.309 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.4 mt -71.84 103.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.459 -0.941 . . . . 75.43 108.459 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -79.68 124.13 28.28 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.855 -0.794 . . . . 71.31 108.855 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.53 168.2 20.29 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.583 -0.895 . . . . 73.52 108.583 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -148.77 139.26 22.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 74.21 109.187 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 p -70.43 108.6 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.951 0.901 . . . . 71.54 109.363 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -95.53 -39.54 9.9 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.437 0.695 . . . . 73.34 111.909 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -151.07 134.29 16.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.617 0.367 . . . . 62.33 110.242 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 13' ' ' ILE . 41.0 t -125.94 116.16 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.879 0.872 . . . . 71.24 109.453 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -127.49 110.45 12.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.243 -1.021 . . . . 72.43 108.243 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 73' ' ' VAL . 2.7 p -96.55 114.45 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.251 0.62 . . . . 73.12 109.991 -173.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.9 m -109.19 135.85 49.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.765 1.226 . . . . 54.11 110.064 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.5 p -91.92 113.2 25.41 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.195 -0.668 . . . . 55.42 109.195 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.29 87.3 2.51 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.527 -0.916 . . . . 72.24 108.527 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.84 -123.13 12.62 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.361 -0.836 . . . . 54.31 111.139 -172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.34 -16.46 31.01 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.171 0.588 . . . . 61.54 110.538 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 95' ' ' GLU . 9.8 m -96.3 125.61 40.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.444 0.698 . . . . 75.01 109.473 -172.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 94' ' ' PHE . 6.5 p -95.54 115.57 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-O 121.746 0.784 . . . . 74.42 110.792 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -102.38 104.63 15.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.911 0.884 . . . . 65.44 109.117 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 64' ' ' VAL . 53.3 t -88.8 105.77 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.524 -0.547 . . . . 51.25 109.524 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.0 m -86.41 105.46 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.793 -0.817 . . . . 74.32 108.793 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.1 p -122.02 120.73 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.793 0.837 . . . . 71.11 110.759 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -86.42 129.31 34.9 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.913 0.885 . . . . 71.12 109.65 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.07 137.2 55.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.595 0.758 . . . . 62.21 109.02 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.46 105.49 17.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.183 -1.043 . . . . 74.41 108.183 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -97.36 115.16 27.19 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.428 0.691 . . . . 64.41 111.068 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -90.64 104.42 17.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.02 0.928 . . . . 44.31 108.673 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -124.57 122.22 36.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.263 1.025 . . . . 74.23 109.461 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.72 -88.18 0.36 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.19 0.424 . . . . 74.42 112.653 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.74 13.15 1.74 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.381 0.515 . . . . 73.31 112.256 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.6 p -116.67 139.66 50.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.826 0.851 . . . . 73.33 109.605 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -120.93 119.25 32.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.843 -1.169 . . . . 75.52 107.843 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.9 m -142.19 143.27 32.86 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.948 0.499 . . . . 74.22 110.151 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.64 102.96 8.27 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.723 0.809 . . . . 73.23 109.73 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.8 m -99.83 120.74 40.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.487 1.115 . . . . 74.02 108.743 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 m -89.41 127.52 35.84 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.448 -0.575 . . . . 70.25 109.448 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -107.44 126.5 52.58 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.653 -1.24 . . . . 75.42 107.653 170.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -108.56 103.28 12.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.509 -0.922 . . . . 65.41 108.509 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 12' ' ' ALA . 60.3 mt -90.0 104.71 17.25 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.373 1.069 . . . . 64.33 109.52 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 49.8 ttt85 -93.76 98.93 11.42 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.133 -0.691 . . . . 74.24 109.133 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.585 ' HB2' HG13 ' A' ' 71' ' ' VAL . 86.7 m-85 -87.52 116.49 25.67 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 9.2 tp10 -87.93 131.45 34.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 122.72 0.408 . . . . 55.04 110.114 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 101' ' ' ILE . 5.9 m -103.82 149.66 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.952 0.901 . . . . 54.35 110.32 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.456 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 17.3 t70 -141.38 111.08 6.51 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.599 -1.259 . . . . 61.03 107.599 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.96 -110.5 3.06 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.697 -0.683 . . . . 34.41 112.446 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -113.12 -6.26 13.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.113 0.965 . . . . 63.2 112.263 -171.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -135.82 165.66 25.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.064 0.546 . . . . 73.05 110.754 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 96' ' ' VAL . 71.0 mt -93.53 132.35 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.058 0.943 . . . . 64.32 109.3 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HE ' ' HB3' ' A' ' 97' ' ' ASP . 21.0 mmt180 -102.98 -28.43 12.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 73.51 111.182 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 48.9 ttt180 -145.53 154.12 41.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.69 0.396 . . . . 73.43 110.955 -166.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 39' ' ' VAL . 7.4 p -132.95 138.18 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 70.24 108.579 167.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.2 m -113.86 112.47 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.446 -0.946 . . . . 70.03 108.446 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HH2' ' A' ' 19' ' ' TRP . 47.8 t -86.92 104.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.045 -0.724 . . . . 73.33 109.045 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -103.84 105.84 16.17 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.9 -0.778 . . . . 61.33 108.9 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -81.22 95.62 6.99 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.179 -1.045 . . . . 72.22 108.179 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -69.7 113.77 7.28 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.982 -1.008 . . . . 64.14 109.41 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.21 -46.33 0.2 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.161 -0.775 . . . . 50.31 111.161 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.13 138.44 22.72 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.188 -0.765 . . . . 74.43 111.188 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -63.86 115.82 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.358 0.663 . . . . 61.4 110.689 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.34 -30.78 71.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.2 1.0 . . . . 61.32 110.548 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.45 155.79 20.87 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.047 0.939 . . . . 75.13 110.239 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -134.28 113.32 11.84 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.375 1.07 . . . . 55.04 108.248 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -132.64 144.38 50.31 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.056 0.542 . . . . 73.44 111.374 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -165.67 141.53 5.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.89 1.276 . . . . 75.4 108.678 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -84.0 -4.54 58.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.066 0.765 . . . . 75.41 113.066 -166.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.9 m170 74.69 -65.37 0.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.091 1.356 . . . . 73.33 110.674 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.892 -0.781 . . . . 60.42 108.892 173.372 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tpt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.404 -0.591 . . . . 75.34 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.85 -21.05 55.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.131 0.572 . . . . 73.51 111.501 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.3 73.01 5.93 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.66 0.784 . . . . 63.14 109.515 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.136 1.374 . . . . 63.54 112.478 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.55 HG22 HG21 ' A' ' 66' ' ' THR . 40.6 t -59.88 -57.32 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.663 0.785 . . . . 74.51 110.12 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.72 -37.04 83.89 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.825 -1.08 . . . . 74.12 111.203 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.07 81.82 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.56 0.538 . . . . 50.0 111.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.95 95.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.886 -0.597 . . . . 54.32 111.528 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.2 -47.01 72.16 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.926 0.491 . . . . 73.32 111.664 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.58 -34.03 77.29 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.348 1.059 . . . . 75.25 110.783 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.75 81.63 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.101 -0.954 . . . . 72.24 110.755 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.24 82.42 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.257 0.973 . . . . 52.12 110.785 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 70.3 mt -59.29 -44.13 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 O-C-N 124.39 1.056 . . . . 73.14 109.799 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.06 77.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.157 0.983 . . . . 70.2 113.077 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.84 -39.75 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 73.04 109.974 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -76.7 -28.2 55.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.985 0.514 . . . . 74.24 111.807 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 13' ' ' ILE . 95.6 mt-30 -68.81 -27.43 65.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.064 0.546 . . . . 74.21 110.559 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 69.1 mt -79.99 -43.76 21.42 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.833 0.453 . . . . 50.41 110.252 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -62.23 -25.03 67.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.939 0.718 . . . . 71.35 112.939 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -82.87 -33.24 27.06 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.133 0.492 . . . . 63.54 110.747 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -158.02 93.04 2.11 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.331 1.052 . . . . 73.04 108.289 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' A' ' 48' ' ' ARG . 19.1 Cg_endo -56.41 -27.12 66.35 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 123.559 2.84 . . . . 73.35 113.947 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -84.8 15.01 4.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.404 0.682 . . . . 72.02 111.85 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.55 111.05 8.23 Favored Pre-proline 0 N--CA 1.478 0.951 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.94 -38.95 6.71 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.412 2.074 . . . . 73.44 112.593 -173.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.91 -41.41 95.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.61 0.764 . . . . 75.04 111.245 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.03 8.85 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.216 0.947 . . . . 74.01 111.76 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -70.62 -26.59 63.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.055 -0.521 . . . . 72.31 112.383 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.83 -40.25 63.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.922 0.489 . . . . 62.02 110.707 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 2.3 pp -70.68 -31.84 68.88 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 110.056 -0.35 . . . . 73.31 110.056 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.834 0.854 . . . . 73.23 111.524 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.98 -29.45 64.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.914 0.486 . . . . 64.15 110.647 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 26.3 mtpp -80.48 -42.84 21.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.973 0.909 . . . . 74.15 111.431 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.507 HG13 HD23 ' A' ' 35' ' ' LEU . 16.9 pt -107.22 -36.13 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.61 0.596 . . . . 60.11 112.61 -168.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 34' ' ' ILE . 2.3 mm? -99.43 179.23 4.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.996 0.918 . . . . 64.42 110.801 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -80.85 146.52 59.95 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-N 115.046 -0.979 . . . . 75.44 110.356 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -31.35 92.48 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.371 2.714 . . . . 53.34 114.031 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.62 -38.95 92.76 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.676 0.79 . . . . 74.21 111.153 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' HE21 ' A' ' 42' ' ' GLN . 71.5 t -61.97 -53.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.691 0.796 . . . . 64.45 111.437 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.51 -32.12 72.99 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.569 0.224 . . . . 72.12 111.035 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 18.2 t70 -71.27 -49.85 38.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 124.16 0.913 . . . . 74.33 110.893 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 39' ' ' VAL . 22.0 pt20 -65.59 -38.38 89.33 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.29 0.236 . . . . 71.42 111.449 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.2 -45.09 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.223 0.609 . . . . 61.23 111.477 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.0 ptm180 -72.57 -25.99 61.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.518 0.327 . . . . 75.22 111.228 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 53.8 mt-10 -69.8 -46.32 65.98 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.212 0.605 . . . . 75.55 110.933 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.37 -34.35 78.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.843 -0.617 . . . . 71.11 110.035 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -64.15 -31.44 72.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.493 1.117 . . . . 64.34 112.222 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HA ' ' HG3' ' A' ' 22' ' ' PRO . 70.4 mtp180 -63.28 -36.68 84.49 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.369 0.668 . . . . 45.43 110.31 174.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -74.6 -34.44 62.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.759 -0.655 . . . . 64.44 110.69 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 55' ' ' ILE . 74.9 mt -74.26 -23.68 59.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.381 0.672 . . . . 63.02 110.707 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.44 -43.09 70.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.179 0.992 . . . . 75.42 109.898 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.26 -41.85 94.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.722 0.809 . . . . 72.33 110.855 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' NE2' HD23 ' A' ' 50' ' ' LEU . 48.3 mt-30 -73.14 -29.26 62.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.042 -0.981 . . . . 71.1 111.022 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.98 46.41 59.44 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.556 0.535 . . . . 72.45 112.766 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 50' ' ' LEU . 58.7 mt -79.56 109.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.191 0.597 . . . . 63.24 109.933 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -91.47 119.99 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.148 -1.056 . . . . 74.32 108.148 173.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.7 158.64 39.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.107 0.963 . . . . 72.1 109.163 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.38 130.12 38.33 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.382 0.673 . . . . 73.24 109.978 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.82 121.56 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 109.573 -0.529 . . . . 63.31 109.573 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -94.38 -48.0 6.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.285 1.034 . . . . 64.12 109.711 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 tpp85 -138.72 139.82 38.51 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.943 -1.132 . . . . 65.13 107.943 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.33 107.53 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.299 -1.0 . . . . 55.12 108.299 171.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -118.93 151.28 38.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.445 1.098 . . . . 72.31 108.799 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.1 126.22 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 71.44 109.335 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -132.22 117.18 17.89 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.966 -0.753 . . . . 55.2 108.966 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.55 HG21 HG22 ' A' ' 5' ' ' VAL . 70.5 p -88.43 127.25 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.529 -0.545 . . . . 44.52 109.529 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -132.71 100.99 5.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.289 -1.004 . . . . 74.5 108.289 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.16 -110.55 3.56 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.933 0.771 . . . . 75.11 112.138 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -118.4 23.7 11.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.866 0.866 . . . . 74.54 110.351 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -133.18 122.09 23.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.277 0.631 . . . . 52.51 109.358 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -97.95 103.72 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.446 0.641 . . . . 71.54 110.15 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -84.04 100.86 11.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.618 1.167 . . . . 72.35 109.42 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -89.94 105.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 71.42 109.234 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -89.53 109.24 20.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.015 0.926 . . . . 73.05 109.108 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.12 116.69 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.441 0.696 . . . . 54.34 110.151 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -84.18 135.51 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.079 0.952 . . . . 74.43 109.114 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.52 141.3 41.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.424 0.69 . . . . 75.25 109.608 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.63 108.67 21.43 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.315 -0.624 . . . . 70.5 109.315 168.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.59 107.63 18.24 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.63 -0.878 . . . . 74.4 108.63 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 m -89.57 102.91 15.59 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.937 -1.505 . . . . 61.43 106.937 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 t -140.94 124.18 16.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.305 1.042 . . . . 55.31 108.797 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.48 75.32 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.688 -0.687 . . . . 71.13 112.969 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.82 -19.87 42.64 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.746 -0.474 . . . . 64.31 113.416 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.4 p -88.68 120.23 29.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.159 0.584 . . . . 74.23 110.648 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -90.88 110.26 21.49 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.358 -0.979 . . . . 75.11 108.358 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.1 m -119.49 128.74 54.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 73.4 110.519 -172.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -77.35 101.7 6.45 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.126 -0.694 . . . . 61.34 109.126 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 m -108.42 114.49 28.37 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.453 1.101 . . . . 64.5 108.319 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -88.36 122.04 31.42 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.57 -0.9 . . . . 72.32 108.57 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -102.45 129.77 49.04 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.781 -1.192 . . . . 72.34 107.781 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.45 102.07 11.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.77 104.54 16.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.779 -1.193 . . . . 73.2 107.779 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -101.56 100.74 11.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.102 -1.408 . . . . 75.21 108.225 -170.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.22 110.57 21.61 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.752 0.821 . . . . 61.01 111.559 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -79.49 99.88 7.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 101' ' ' ILE . 4.2 m -97.73 141.14 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 62.45 110.163 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.9 116.38 9.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.217 0.607 . . . . 71.42 109.935 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.88 -114.22 5.45 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.969 0.793 . . . . 72.55 112.648 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.93 -3.09 26.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.9 0.88 . . . . 71.03 112.036 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.2 t -137.46 148.79 46.36 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.136 0.493 . . . . 71.41 110.943 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.499 HG23 HG12 ' A' ' 96' ' ' VAL . 34.8 mt -89.3 121.28 39.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.287 -1.005 . . . . 75.14 108.287 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -88.03 -41.86 12.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.992 0.917 . . . . 72.41 112.26 -167.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -142.37 163.89 31.62 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.809 0.338 . . . . 74.15 110.727 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.74 117.15 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.466 1.106 . . . . 74.41 108.831 168.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.1 m -93.45 104.28 16.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.649 -0.871 . . . . 62.21 108.649 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.12 104.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.719 0.771 . . . . 71.4 109.937 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 m -95.51 110.04 22.16 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.001 0.92 . . . . 73.42 109.428 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -81.68 94.38 6.96 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.485 0.714 . . . . 61.22 109.805 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -92.29 95.97 10.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.618 0.767 . . . . 75.24 109.485 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.34 15.21 60.43 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 115.962 -0.563 . . . . 71.12 113.035 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.03 -147.14 11.5 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.476 -0.65 . . . . 54.21 111.476 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.0 m -151.49 142.14 22.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.392 0.677 . . . . 62.14 110.01 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -102.76 -9.32 20.09 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.022 0.929 . . . . 74.31 110.739 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.12 135.17 51.73 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.47 0.708 . . . . 75.24 111.355 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -103.6 18.36 22.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.147 0.979 . . . . 65.1 109.521 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -61.53 -54.92 36.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.714 1.206 . . . . 70.31 110.766 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -67.82 -38.91 83.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.012 0.525 . . . . 64.12 111.15 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -80.37 -3.83 51.16 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.64 0.776 . . . . 74.45 111.653 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.1 t60 72.01 -67.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.938 1.295 . . . . 73.44 110.394 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.82 -1.178 . . . . 64.13 107.82 174.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 107.822 -1.177 . . . . 71.2 107.822 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -111.95 17.04 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.39 1.076 . . . . 65.13 111.019 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.39 32.41 4.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.029 0.532 . . . . 64.23 110.504 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -49.92 -44.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.785 1.234 . . . . 74.13 112.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.78 -46.63 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.554 1.142 . . . . 72.44 111.031 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.0 -46.42 81.46 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.713 -0.676 . . . . 73.43 110.526 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.12 -30.25 70.21 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.241 1.016 . . . . 62.12 111.404 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.18 86.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.997 0.519 . . . . 74.31 110.062 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 13' ' ' ILE . 88.2 tttt -66.38 -45.18 80.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.329 -0.851 . . . . 64.34 110.135 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -57.52 -45.3 85.17 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.136 0.974 . . . . 62.22 110.475 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.21 91.73 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 124.594 1.184 . . . . 74.42 111.04 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -60.27 -52.2 66.31 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.994 0.809 . . . . 64.13 111.583 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.533 HG22 HE21 ' A' ' 17' ' ' GLN . 33.2 mt -60.94 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 123.853 0.721 . . . . 74.22 109.706 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.48 83.92 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.271 1.029 . . . . 71.01 112.276 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.71 -43.57 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 123.973 0.796 . . . . 74.2 110.206 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 75' ' ' VAL . 75.6 m-85 -73.73 -31.86 63.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.068 0.396 . . . . 62.21 112.068 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.533 HE21 HG22 ' A' ' 13' ' ' ILE . 78.4 mt-30 -60.03 -42.83 95.22 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.647 0.592 . . . . 70.11 109.964 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 28' ' ' GLN . 81.4 mt -67.72 -48.25 67.03 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 124.192 0.933 . . . . 73.11 110.317 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -54.07 -29.4 44.18 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.843 0.857 . . . . 70.01 113.144 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 20.0 ptmt -101.97 -23.01 14.18 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.074 0.55 . . . . 73.41 112.065 174.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -149.95 83.15 6.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.403 0.681 . . . . 72.4 109.996 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 44.2 Cg_endo -71.73 -7.71 21.68 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.301 2.667 . . . . 73.41 114.597 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -78.97 -10.14 59.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 74.25 112.128 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.93 117.18 51.38 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.683 0.393 . . . . 74.41 110.276 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.49 -41.97 2.09 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.679 2.253 . . . . 73.13 113.446 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.81 -33.56 74.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.227 0.611 . . . . 71.31 112.226 -170.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.22 75.51 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.477 0.711 . . . . 62.24 110.667 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 18' ' ' LEU . 9.3 pt20 -79.2 -20.83 47.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.836 -0.62 . . . . 73.21 111.815 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -46.75 75.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.608 0.763 . . . . 72.45 110.572 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.407 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.2 pp -70.33 -31.7 69.11 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.487 0.492 . . . . 61.53 110.337 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.3 -28.89 70.32 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.663 0.785 . . . . 75.35 112.048 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -70.04 -33.87 72.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.144 0.497 . . . . 74.45 110.208 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.27 -33.92 23.91 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.859 0.863 . . . . 52.32 112.023 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 7' ' ' ALA . 10.1 pt -108.89 -33.67 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 122.954 0.502 . . . . 73.41 111.446 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 39' ' ' VAL . 3.5 mm? -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.443 1.097 . . . . 74.31 108.641 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.56 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.1 m -67.62 145.3 98.16 Favored Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 109.754 -0.461 . . . . 65.02 109.754 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.05 -18.12 56.0 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.486 2.124 . . . . 72.43 112.825 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.49 -33.86 62.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.002 0.921 . . . . 61.31 111.027 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 36' ' ' SER . 63.3 t -63.96 -41.45 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.745 0.818 . . . . 74.03 111.5 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.5 pp -60.55 -35.4 75.92 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 120.697 0.284 . . . . 71.22 111.056 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.7 t70 -72.6 -52.58 14.88 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.156 -0.929 . . . . 34.53 110.558 -175.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -61.34 -29.27 69.79 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.295 0.48 . . . . 75.34 112.295 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.9 t -71.7 -48.36 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.685 0.794 . . . . 74.24 110.868 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -73.14 -21.5 60.71 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.76 0.424 . . . . 74.41 111.926 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 mm-40 -82.73 -35.33 26.75 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 122.211 -0.305 . . . . 73.32 110.423 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -68.73 -26.58 65.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.762 0.791 . . . . 64.24 110.69 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -67.93 -38.35 82.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.601 -1.181 . . . . 62.23 111.568 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -65.22 -21.29 66.73 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 123.679 0.612 . . . . 65.45 111.338 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -72.03 -46.72 56.02 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.525 0.73 . . . . 73.11 110.628 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.85 -22.95 63.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.56 0.744 . . . . 74.31 111.176 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.63 -27.33 63.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.107 0.963 . . . . 64.03 111.338 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -78.61 -6.73 56.42 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.618 0.367 . . . . 63.24 111.034 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -116.69 172.56 7.15 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.117 0.967 . . . . 71.42 110.248 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.67 24.41 30.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.727 -0.67 . . . . 52.53 113.144 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 88.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.995 0 CA-C-O 121.357 0.599 . . . . 74.41 109.464 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -101.46 110.36 22.35 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.185 -1.042 . . . . 73.33 108.185 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -117.34 135.56 53.76 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.486 0.715 . . . . 73.11 110.469 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.61 122.2 45.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.775 0.83 . . . . 64.25 109.882 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.67 101.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.686 -0.857 . . . . 72.23 108.686 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -77.68 -44.1 29.08 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.686 -0.688 . . . . 62.33 110.805 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 17.6 tpp85 -152.77 142.1 21.58 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.78 -1.1 . . . . 71.1 108.869 -177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.77 110.01 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.615 -0.884 . . . . 61.13 108.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.485 ' HG3' ' HD2' ' A' ' 61' ' ' ARG . 28.8 mt-10 -128.7 122.92 31.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.008 -0.738 . . . . 74.13 109.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 73' ' ' VAL . 3.7 p -96.78 135.77 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.496 1.118 . . . . 62.32 110.135 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -138.55 137.63 37.22 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.176 0.99 . . . . 63.54 109.287 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -95.44 155.82 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.046 0.538 . . . . 74.41 111.368 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 95.62 2.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.32 -1.363 . . . . 75.34 107.32 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.63 -117.08 9.41 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 111.736 -0.546 . . . . 42.41 111.736 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.87 -12.93 21.58 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.01 0.524 . . . . 62.24 111.533 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.9 m -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.982 0.513 . . . . 53.13 110.087 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 94' ' ' PHE . 7.8 p -99.73 136.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.719 0.808 . . . . 64.45 110.568 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.95 115.97 22.81 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.058 1.343 . . . . 73.21 108.883 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 64' ' ' VAL . 46.8 t -92.24 113.07 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 110.181 -0.303 . . . . 65.3 110.181 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.2 m -87.64 104.89 16.94 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.074 -1.084 . . . . 72.42 108.074 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 16' ' ' PHE . 5.3 p -119.48 122.52 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.231 1.012 . . . . 71.33 109.015 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -94.96 132.93 39.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.937 0.895 . . . . 74.54 109.305 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.57 154.91 49.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.407 0.683 . . . . 71.51 109.808 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -110.07 104.48 13.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 72.23 109.289 171.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.52 106.65 17.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.567 0.747 . . . . 63.21 110.191 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -87.85 102.93 15.17 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.886 -1.153 . . . . 63.21 107.886 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.5 t -146.95 135.82 22.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.133 0.973 . . . . 52.24 109.485 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 22.45 71.08 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.732 -0.667 . . . . 73.0 112.843 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.3 80.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.938 -0.368 . . . . 72.5 114.004 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -126.97 123.43 37.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.376 0.67 . . . . 73.3 110.959 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.6 m -88.07 115.08 25.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.308 1.043 . . . . 74.01 110.005 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.6 m -119.08 133.51 55.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.013 0.925 . . . . 72.23 110.134 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -79.21 125.43 29.45 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.974 -0.75 . . . . 54.42 108.974 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.9 m -141.96 125.17 16.41 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.671 0.788 . . . . 64.01 110.234 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -90.75 129.88 36.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.648 -0.501 . . . . 65.34 109.648 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -108.96 146.84 33.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.554 0.742 . . . . 52.21 109.166 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.3 103.66 7.29 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.066 -1.087 . . . . 72.11 108.066 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -92.77 108.49 20.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 70.31 107.912 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -90.48 99.79 12.75 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.48 -0.782 . . . . 75.3 109.329 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.6 m-85 -89.3 110.3 21.1 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.987 -0.746 . . . . 62.23 108.987 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 26.6 tt0 -92.13 127.86 37.76 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.089 -1.078 . . . . 72.2 108.089 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -85.09 142.49 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.263 0.554 . . . . 73.2 110.979 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -120.96 97.41 5.52 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.915 -1.143 . . . . 72.44 107.915 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.92 -107.08 1.86 Allowed Glycine 0 C--N 1.343 0.929 0 O-C-N 123.822 0.701 . . . . 63.02 113.241 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.63 -19.05 22.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.047 0.939 . . . . 71.41 112.053 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -132.45 167.95 19.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.669 0.787 . . . . 74.12 110.614 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 94' ' ' PHE . 50.0 mt -92.06 135.79 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.685 -0.857 . . . . 52.33 108.685 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -129.48 7.69 5.36 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.942 0.497 . . . . 74.1 111.828 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 31.2 mmt180 -144.45 146.58 32.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.999 0.519 . . . . 75.23 111.544 -175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 130.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.993 1.317 . . . . 71.52 109.333 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -127.03 105.8 8.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.417 -0.957 . . . . 72.01 108.417 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 t -86.61 106.81 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.045 -0.724 . . . . 72.2 109.045 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 m -95.57 152.12 18.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.624 -0.88 . . . . 71.22 108.624 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -129.03 138.58 51.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.351 0.66 . . . . 74.52 110.197 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.55 83.09 2.24 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.033 -1.099 . . . . 72.32 108.033 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.9 56.9 3.33 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.636 -0.711 . . . . 14.31 111.518 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.3 157.47 9.51 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.683 -0.567 . . . . 54.42 111.683 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 51.0 m -151.29 131.84 13.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.054 0.942 . . . . 73.42 109.356 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.19 -40.85 51.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.274 0.629 . . . . 75.41 109.517 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.28 134.23 54.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.039 0.936 . . . . 55.02 109.314 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -167.81 139.0 2.91 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.172 -1.048 . . . . 61.34 108.172 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -58.32 112.64 1.63 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 54.52 109.307 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.17 68.79 3.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.087 0.955 . . . . 44.32 111.547 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -94.35 -34.42 12.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.008 0.923 . . . . 71.03 109.047 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -86.95 23.15 1.82 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.554 1.142 . . . . 73.22 110.49 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 124.768 1.227 . . . . 70.23 108.948 -165.463 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HE1' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 107.756 -1.202 . . . . 73.33 107.756 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 19.7 19.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.885 0.874 . . . . 75.44 111.365 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 15.3 m-20 -91.83 26.72 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.885 0.474 . . . . 73.44 110.52 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.37 -39.92 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.576 1.55 . . . . 73.23 113.331 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.76 -50.31 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.545 0.738 . . . . 74.04 110.292 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.19 -30.47 64.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.547 -0.752 . . . . 73.35 110.92 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.55 69.98 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.497 0.719 . . . . 63.44 109.954 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.75 94.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.532 0.733 . . . . 70.13 111.495 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.3 -57.88 11.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.268 1.027 . . . . 63.34 111.397 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -66.96 -29.1 68.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 74.03 110.906 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.76 83.6 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 123.925 0.766 . . . . 72.5 110.934 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.47 -51.08 69.8 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.373 1.046 . . . . 42.44 110.631 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.447 HG22 HE21 ' A' ' 17' ' ' GLN . 39.9 mt -61.69 -42.79 95.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 O-C-N 124.402 1.064 . . . . 70.22 110.413 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.64 74.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.803 0.841 . . . . 75.11 112.026 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.63 -40.97 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 41.42 109.508 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 60.2 m-85 -72.16 -31.13 65.67 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.472 0.309 . . . . 62.22 111.742 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 68.9 mt-30 -66.09 -35.57 80.86 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.494 0.496 . . . . 75.11 110.407 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.06 -42.85 65.74 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 123.888 0.742 . . . . 65.41 109.966 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 37.6 m0 -61.11 -26.06 67.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.166 0.802 . . . . 73.15 113.166 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 17' ' ' GLN . 64.3 pttt -100.22 -21.7 15.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.791 0.436 . . . . 75.52 110.948 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -152.99 89.5 3.69 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 123.35 0.66 . . . . 65.15 109.56 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.71 -19.21 66.87 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.095 2.53 . . . . 53.43 113.169 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.3 p -83.13 7.9 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.049 0.939 . . . . 64.12 112.469 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.77 108.59 6.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.03 0.532 . . . . 61.12 109.934 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.74 -29.68 15.42 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.573 2.182 . . . . 74.33 113.185 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.67 -41.6 62.47 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.247 0.619 . . . . 60.54 110.722 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.19 61.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.816 0.846 . . . . 55.13 111.144 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -66.91 -28.77 68.58 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.713 -0.676 . . . . 74.03 111.764 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.81 -52.35 44.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.881 0.472 . . . . 73.33 110.86 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.6 pp -66.89 -31.75 72.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.192 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.04 -12.58 61.81 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.959 0.903 . . . . 73.54 112.905 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 -27.02 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.419 0.628 . . . . 62.13 109.963 172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -85.47 -30.49 23.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.97 0.908 . . . . 64.45 111.181 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 30' ' ' LEU . 12.9 pt -117.77 -32.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.791 0.437 . . . . 62.51 111.538 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 39' ' ' VAL . 3.7 mm? -109.2 179.28 4.21 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.688 0.795 . . . . 64.25 109.253 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 28.7 m -76.26 152.47 83.94 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 122.772 0.429 . . . . 75.13 111.347 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.61 -23.51 65.65 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.821 2.347 . . . . 73.3 112.366 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.6 -39.94 80.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.53 1.132 . . . . 54.15 111.133 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 35' ' ' LEU . 93.5 t -65.63 -57.42 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.306 0.643 . . . . 65.55 110.651 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.4 pp -58.04 -27.04 63.23 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.34 0.496 . . . . 55.31 112.34 -176.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.78 -41.02 24.1 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.77 0.828 . . . . 73.31 110.959 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -74.46 -27.91 60.79 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 122.303 -0.248 . . . . 74.52 110.626 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -40.83 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.161 0.985 . . . . 65.12 110.749 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.58 -30.73 69.55 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 120.268 0.08 . . . . 71.11 111.052 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.77 -26.32 27.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.844 0.458 . . . . 75.42 111.076 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -66.49 -27.11 67.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.978 0.511 . . . . 74.03 110.365 172.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.86 91.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.92 -1.036 . . . . 70.5 111.878 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -64.71 -31.76 73.13 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.119 0.887 . . . . 65.01 111.479 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.04 -44.19 97.22 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 123.824 0.702 . . . . 71.43 110.44 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -78.42 -36.16 46.02 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.327 1.051 . . . . 73.14 111.314 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.31 -30.15 63.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.924 0.89 . . . . 64.43 110.156 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.98 -36.25 80.93 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.649 1.18 . . . . 62.21 110.225 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.24 -20.92 29.39 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.974 -1.012 . . . . 62.32 111.013 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.57 20.91 70.5 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.922 -0.581 . . . . 64.01 113.208 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.1 mt -82.21 100.28 5.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 123.366 0.666 . . . . 73.04 110.123 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -92.96 112.98 25.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.219 -0.66 . . . . 74.35 109.219 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 5.7 p90 -105.81 159.45 16.0 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.12 -0.696 . . . . 75.04 109.12 168.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -133.0 133.54 43.27 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.988 -0.551 . . . . 61.52 110.034 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.43 101.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.512 1.132 . . . . 73.5 109.974 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.84 -54.89 3.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.93 0.395 . . . . 73.53 111.48 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -133.16 123.43 25.65 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 109.471 -0.566 . . . . 73.14 109.471 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.54 125.6 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.043 0.937 . . . . 72.53 109.398 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.65 109.12 9.5 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.481 -0.933 . . . . 71.32 108.481 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.6 p -95.41 108.27 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.484 0.659 . . . . 72.22 109.356 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.2 p -113.18 124.97 53.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.564 0.746 . . . . 61.3 109.632 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 71' ' ' VAL . 45.5 p -88.35 154.13 20.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.826 0.45 . . . . 74.42 109.948 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -148.48 92.93 2.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.017 -1.475 . . . . 52.55 107.017 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.65 -117.69 10.39 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.986 -0.846 . . . . 75.14 110.986 -169.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -94.56 -14.06 25.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.402 0.681 . . . . 54.5 110.503 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -93.84 121.62 35.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.642 0.777 . . . . 61.53 110.411 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 48.2 t -99.66 111.64 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.232 0.613 . . . . 72.44 110.85 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -94.74 107.31 19.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.334 1.054 . . . . 74.34 108.953 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.55 103.61 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.707 -0.479 . . . . 74.11 109.707 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.2 m -86.57 106.15 17.35 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.343 1.057 . . . . 52.0 109.03 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.6 p -127.87 124.85 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.06 0.944 . . . . 61.43 110.293 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -94.82 127.14 40.61 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.971 0.908 . . . . 70.12 109.051 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.99 157.07 30.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.582 0.753 . . . . 74.42 109.259 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' THR . 40.8 mt-10 -109.22 106.52 16.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.154 -0.475 . . . . 72.3 109.852 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 23.7 mt-10 -86.02 119.81 26.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.697 0.799 . . . . 75.35 110.616 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -89.51 100.44 13.24 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.743 -1.206 . . . . 63.44 107.743 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 t -149.44 128.46 12.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.123 0.969 . . . . 63.15 110.007 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.03 69.61 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 113.835 0.294 . . . . 72.35 113.835 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.45 13.22 83.61 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.901 -0.389 . . . . 71.43 113.989 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.9 p -121.56 149.39 43.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.412 0.685 . . . . 75.51 109.937 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 m -116.61 106.15 13.23 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.364 -0.976 . . . . 65.1 108.364 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 12.0 t -110.66 139.04 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.977 0.418 . . . . 63.51 110.97 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -80.45 102.71 9.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.097 -0.705 . . . . 65.21 109.097 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -114.62 128.15 56.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.227 0.611 . . . . 52.32 109.454 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.7 m -93.43 119.12 32.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.287 0.635 . . . . 72.35 110.186 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -104.3 130.34 52.12 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.241 -1.022 . . . . 60.25 108.241 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -115.77 104.74 11.96 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.039 -1.097 . . . . 72.45 108.039 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 12' ' ' ALA . 6.2 mp -90.96 108.96 20.2 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.85 -1.167 . . . . 71.21 107.85 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 27.6 ttt180 -89.36 99.68 12.63 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.042 -0.981 . . . . 70.12 108.376 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.53 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.7 m-85 -87.82 107.65 18.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.253 -0.885 . . . . 62.04 109.053 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 108.15 20.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.471 -1.307 . . . . 74.11 107.471 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 101' ' ' ILE . 3.8 m -86.68 151.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 114.871 -1.059 . . . . 61.44 112.407 -165.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.39 103.28 5.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.696 1.198 . . . . 64.55 108.631 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.13 -108.28 2.49 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.369 -0.378 . . . . 72.34 113.279 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.33 2.42 16.5 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.826 0.85 . . . . 64.51 111.74 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 164.63 26.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.691 0.796 . . . . 43.14 109.265 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 96' ' ' VAL . 24.9 mt -101.18 107.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.605 -1.257 . . . . 73.14 107.605 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -85.25 -29.12 24.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.472 0.309 . . . . 62.23 111.624 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -130.06 142.58 50.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.36 0.664 . . . . 73.52 109.757 -164.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.02 142.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.464 0.705 . . . . 64.43 110.615 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 24.1 m -119.48 141.65 48.98 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.241 1.017 . . . . 72.34 108.889 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 110.09 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.48 -0.563 . . . . 42.44 109.48 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.1 m -103.39 104.86 15.0 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.561 0.744 . . . . 70.54 109.64 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.51 96.11 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.248 0.547 . . . . 71.52 109.854 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -81.37 86.61 6.25 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.158 0.983 . . . . 74.24 109.662 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.71 -22.6 28.08 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.558 -0.746 . . . . 51.34 111.509 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.66 90.25 0.53 Allowed Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.357 -0.697 . . . . 71.31 111.357 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.6 m -89.05 31.16 0.88 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.711 0.804 . . . . 71.24 111.652 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.82 -2.55 54.93 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.605 0.762 . . . . 64.42 112.057 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -80.71 -175.01 5.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.682 0.793 . . . . 62.13 111.261 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -124.27 92.43 3.66 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.082 0.953 . . . . 74.43 108.639 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -66.3 -58.9 4.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.101 0.561 . . . . 44.42 109.555 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -86.65 77.63 9.31 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.824 -1.176 . . . . 63.23 107.824 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -76.14 94.13 3.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.37 0.668 . . . . 70.11 110.321 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -73.8 140.46 45.85 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.394 -0.821 . . . . 72.03 110.956 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 . . . . . 0 C--O 1.251 1.136 0 N-CA-C 108.117 -1.068 . . . . 72.41 108.117 171.713 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.472 0.653 . . . . 70.43 111.036 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -130.96 0.55 4.25 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.631 1.173 . . . . 74.2 108.249 167.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.72 70.2 10.3 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 124.536 1.135 . . . . 73.43 109.113 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.619 HG23 HG11 ' A' ' 96' ' ' VAL . 36.1 mm -48.01 -47.19 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.971 1.709 . . . . 74.32 113.19 -171.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 66' ' ' THR . 45.9 t -66.12 -56.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.497 0.719 . . . . 52.14 110.759 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -74.77 -29.17 61.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.181 -0.918 . . . . 74.22 111.768 -170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -67.1 -45.31 77.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.411 0.684 . . . . 50.41 110.023 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -68.64 -32.72 72.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.454 0.702 . . . . 54.32 111.881 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.0 -47.8 78.88 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.554 0.742 . . . . 73.24 110.482 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.761 0.824 . . . . 74.13 111.437 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.29 86.44 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.749 0.82 . . . . 71.25 110.806 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.86 79.56 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 124.202 0.939 . . . . 61.03 111.415 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.3 -40.41 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.147 -0.933 . . . . 73.02 110.449 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.32 -35.92 82.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.678 0.791 . . . . 54.02 111.665 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 56.4 mt -60.87 -41.58 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.072 0.949 . . . . 71.34 110.35 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 75' ' ' VAL . 30.6 m-85 -76.38 -31.58 58.09 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.825 0.45 . . . . 72.21 111.819 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.86 -32.5 74.05 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.131 0.572 . . . . 70.33 110.563 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -49.11 26.39 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.502 0.501 . . . . 75.05 110.434 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -59.42 -26.09 64.88 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.39 -29.51 14.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.54 0.336 . . . . 74.14 111.008 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.45 HD22 ' HB2' ' A' ' 24' ' ' ASP . 5.4 t30 -147.45 85.55 6.7 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.433 0.693 . . . . 62.45 109.137 -172.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.07 -12.16 33.51 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.977 2.451 . . . . 54.32 112.951 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -84.98 5.01 31.01 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.222 1.009 . . . . 73.11 111.584 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' HB2' HD22 ' A' ' 21' ' ' ASN . 8.0 t70 -77.33 110.78 13.48 Favored Pre-proline 0 C--N 1.357 0.921 0 N-CA-C 109.53 -0.544 . . . . 75.51 109.53 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.26 -26.09 9.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.408 2.072 . . . . 70.03 112.352 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -75.28 -44.3 46.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.936 0.895 . . . . 74.44 111.118 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.42 81.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 124.273 0.983 . . . . 62.04 111.094 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.3 pt20 -75.5 -24.61 56.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.735 -0.666 . . . . 63.33 111.881 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.22 -46.26 61.56 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.027 0.531 . . . . 74.1 110.983 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.4 pp -68.01 -29.34 68.32 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.357 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.2 mt -69.23 -14.76 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 74.21 112.335 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -81.29 -30.25 34.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.266 0.555 . . . . 54.41 109.503 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -82.73 -36.97 25.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.097 0.959 . . . . 55.42 111.05 -174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 7' ' ' ALA . 12.9 pt -105.16 -35.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 123.309 0.643 . . . . 65.2 111.637 -173.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 34' ' ' ILE . 3.9 mm? -111.13 175.7 5.32 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.335 1.054 . . . . 74.22 109.373 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.8 m -74.11 146.23 84.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 116.036 -0.529 . . . . 75.13 110.609 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.38 -32.26 41.54 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.288 2.659 . . . . 75.53 114.031 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.49 -39.82 92.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.213 1.005 . . . . 73.3 111.457 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 36' ' ' SER . 96.0 t -70.47 -45.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.498 0.719 . . . . 71.45 111.113 -174.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 28' ' ' GLN . 2.8 pp -64.14 -30.05 71.13 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.936 0.398 . . . . 61.41 110.556 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 23.8 t70 -68.23 -56.73 7.63 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.8 -1.091 . . . . 54.33 110.06 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.42 -31.64 69.45 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 111.898 0.333 . . . . 71.23 111.898 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 54.5 t -66.25 -51.99 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.219 0.608 . . . . 70.21 110.415 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 40.4 ptt180 -69.42 -21.9 63.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 119.664 -0.208 . . . . 74.51 111.463 -176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 18.6 mm-40 -71.02 -46.25 62.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.817 0.447 . . . . 74.15 111.068 175.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -66.32 -28.95 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.052 -0.522 . . . . 75.23 110.769 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.08 93.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.043 0.937 . . . . 74.24 112.049 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 79.3 mtp180 -68.13 -23.64 64.92 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.689 0.796 . . . . 72.14 111.777 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.26 -47.08 12.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.842 0.857 . . . . 73.43 110.152 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD23 ' NE2' ' A' ' 53' ' ' GLN . 89.8 mt -67.09 -20.17 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.918 0.887 . . . . 74.32 111.341 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.56 -35.04 79.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.435 1.094 . . . . 74.42 110.902 174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.73 -32.95 25.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.278 0.631 . . . . 71.04 110.875 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.47 ' NE2' HD23 ' A' ' 50' ' ' LEU . 47.8 mt-30 -80.84 147.34 30.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.402 0.681 . . . . 74.51 110.394 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.08 56.94 5.01 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.475 -0.33 . . . . 45.15 112.46 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.41 105.14 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.086 0.954 . . . . 71.33 108.658 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -104.72 110.37 22.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.665 -0.865 . . . . 75.31 108.665 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.71 162.3 16.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.353 0.661 . . . . 70.35 109.423 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.71 140.46 22.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.673 -0.491 . . . . 73.44 109.673 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.64 122.19 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.12 0.968 . . . . 53.52 109.436 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -106.27 -17.01 14.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.442 0.697 . . . . 63.03 111.202 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.7 ttt180 -163.45 132.97 4.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.289 0.635 . . . . 74.33 110.227 -169.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.4 t -125.26 135.29 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.293 1.037 . . . . 62.0 108.762 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.84 108.97 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.283 -1.006 . . . . 61.21 108.283 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.4 121.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 121.11 0.481 . . . . 63.03 110.11 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.7 m -141.12 135.24 30.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.972 0.909 . . . . 74.13 108.639 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.516 HG21 HG22 ' A' ' 5' ' ' VAL . 26.8 p -100.8 134.13 44.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.606 0.762 . . . . 65.51 111.218 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.426 ' HB3' HD21 ' A' ' 72' ' ' ASN . 25.1 t70 -114.87 107.79 15.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.059 1.343 . . . . 75.12 108.715 174.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.39 -108.35 2.58 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.448 -0.661 . . . . 72.45 111.448 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.62 -11.97 12.92 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.34 1.056 . . . . 55.13 109.453 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.498 HG23 ' HA ' ' A' ' 95' ' ' GLU . 44.8 m -90.28 129.74 36.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.194 0.998 . . . . 64.23 109.9 -172.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 8' ' ' ALA . 21.6 t -88.8 143.74 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.38 0.672 . . . . 73.01 110.12 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 67' ' ' ASP . 12.1 m-80 -124.34 112.53 17.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.078 -1.082 . . . . 60.32 108.078 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.5 103.71 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 109.265 -0.643 . . . . 71.14 109.265 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.7 m -87.78 104.43 16.56 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.227 -1.027 . . . . 64.2 108.227 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.5 p -119.28 121.08 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.784 0.834 . . . . 70.41 109.763 -175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.7 tp10 -83.53 114.94 21.85 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.691 -0.855 . . . . 71.04 108.691 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.2 mp -101.66 160.65 14.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.193 -1.04 . . . . 62.54 108.193 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.23 105.28 7.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.751 -1.574 . . . . 70.53 106.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -105.49 106.81 17.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.39 0.676 . . . . 53.15 110.638 -169.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -87.79 104.75 16.87 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.712 -1.218 . . . . 64.54 107.712 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 t -136.52 125.0 23.49 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.374 -0.973 . . . . 71.33 108.374 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.01 26.11 72.26 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.98 -0.554 . . . . 55.33 112.993 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.38 60.13 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.19 0.424 . . . . 54.24 113.476 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.3 m -93.28 112.31 24.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.568 0.747 . . . . 73.51 110.432 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.6 m -88.47 107.88 19.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.682 0.793 . . . . 73.5 109.21 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.9 m -126.61 125.49 42.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.448 0.699 . . . . 73.2 110.221 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -77.9 115.68 17.83 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.304 0.642 . . . . 74.33 110.122 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 110' ' ' GLY . 39.6 m -118.58 119.72 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.627 1.171 . . . . 63.4 108.799 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 m -88.17 120.76 29.83 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.59 -0.522 . . . . 75.23 109.59 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CD1' HD13 ' A' ' 77' ' ' LEU . 11.3 m-85 -103.58 134.71 46.46 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.297 -1.371 . . . . 53.23 107.297 174.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -118.13 102.46 9.03 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.223 -1.029 . . . . 61.12 108.223 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.8 104.92 16.87 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.039 -1.097 . . . . 62.42 108.039 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -95.64 102.24 14.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.81 -0.811 . . . . 71.03 108.81 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.417 ' HB3' HG21 ' A' ' 101' ' ' ILE . 91.8 m-85 -87.47 108.86 19.22 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.674 0.79 . . . . 64.41 109.562 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 30.6 tt0 -92.81 120.94 33.68 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.471 -0.786 . . . . 75.21 109.645 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 HG23 ' A' ' 4' ' ' ILE . 4.3 m -98.11 148.09 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.35 -0.841 . . . . 64.52 110.697 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.462 ' HB2' ' HG3' ' A' ' 102' ' ' ARG . 6.7 m-20 -120.37 91.59 3.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.909 -1.145 . . . . 70.2 107.909 173.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.7 -128.19 8.36 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 114.861 -1.063 . . . . 31.24 111.946 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.4 8.8 36.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.493 0.717 . . . . 74.21 112.616 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -139.63 162.43 35.12 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.315 0.646 . . . . 64.01 110.282 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 96' ' ' VAL . 10.2 mt -95.52 140.12 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.412 -0.958 . . . . 65.34 108.412 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 36.0 mmt180 -126.9 -31.3 2.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.712 0.634 . . . . 64.52 112.712 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 56.8 mtt180 -130.39 161.67 30.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.528 0.331 . . . . 75.03 110.404 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.39 139.23 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.212 1.005 . . . . 60.04 109.319 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.3 m -121.28 105.16 10.29 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.567 -0.901 . . . . 33.23 108.567 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -89.29 104.3 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.813 -0.81 . . . . 71.32 108.813 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.8 m -95.73 103.78 15.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.307 -0.627 . . . . 73.32 109.307 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -85.22 95.06 9.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.605 0.762 . . . . 72.44 109.74 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.7 OUTLIER -77.79 93.61 4.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.227 -1.027 . . . . 75.02 108.227 172.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 88' ' ' THR . . . -79.94 57.97 4.56 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.724 -0.671 . . . . 71.34 111.915 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.81 145.28 4.13 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.513 -1.035 . . . . 64.13 110.513 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 t -107.35 170.75 7.78 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.56 0.744 . . . . 71.34 110.407 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -76.72 -14.01 59.98 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.712 -0.677 . . . . 73.02 110.515 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.67 109.58 2.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.345 1.058 . . . . 73.43 110.172 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -138.57 160.93 38.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.392 0.677 . . . . 74.2 109.801 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -104.34 -71.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.832 -0.803 . . . . 73.21 108.832 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -148.97 -167.26 2.78 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.334 1.053 . . . . 74.53 109.672 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.3 m80 66.08 43.49 2.9 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 124.183 0.993 . . . . 73.32 110.116 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -60.49 -31.33 70.37 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.095 0.958 . . . . 72.33 111.351 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.0 p80 . . . . . 0 C--O 1.251 1.141 0 N-CA-C 108.852 -0.796 . . . . 75.31 108.852 172.483 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.678 ' SD ' HG22 ' A' ' 34' ' ' ILE . 8.6 ptm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.919 -0.4 . . . . 74.41 109.919 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -77.35 74.12 3.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.481 1.112 . . . . 73.34 110.755 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -172.47 35.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.332 1.453 . . . . 71.54 108.802 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 96' ' ' VAL . 36.9 mm -47.69 -38.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.694 1.598 . . . . 62.13 113.842 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.2 -47.8 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.957 0.503 . . . . 62.43 110.022 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.23 -42.11 80.22 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.135 -0.939 . . . . 74.34 110.092 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -61.68 -37.96 86.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.01 0.924 . . . . 72.42 111.666 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.6 -32.61 60.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.926 0.89 . . . . 72.42 110.742 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.8 tttm -67.72 -39.32 84.31 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.325 -0.852 . . . . 74.11 110.327 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.46 -40.82 85.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.357 0.663 . . . . 64.23 110.164 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.21 86.68 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.129 0.971 . . . . 64.23 111.633 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.81 66.58 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.962 0.789 . . . . 75.04 111.61 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -70.73 -32.12 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.2 -0.909 . . . . 71.43 110.8 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.5 -32.2 70.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.125 0.57 . . . . 64.43 112.182 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -60.78 -41.09 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.502 0.721 . . . . 73.1 109.398 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.29 -30.06 61.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.217 0.607 . . . . 70.3 111.771 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.29 -35.47 79.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.412 0.685 . . . . 74.33 110.271 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 73.4 mt -73.93 -40.4 63.12 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.81 -0.632 . . . . 71.55 110.867 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -60.71 -30.35 69.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.208 0.448 . . . . 74.32 112.208 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -96.65 -21.9 17.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.201 0.6 . . . . 75.32 111.024 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.66 89.14 2.69 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.538 0.735 . . . . 75.41 109.219 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.27 -17.53 44.74 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.905 2.403 . . . . 74.42 113.708 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.2 p -89.48 13.55 13.53 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.588 0.755 . . . . 74.52 111.425 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.39 112.27 12.28 Favored Pre-proline 0 C--N 1.358 0.978 0 C-N-CA 123.142 0.577 . . . . 75.12 110.035 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.72 -28.78 13.51 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.704 2.269 . . . . 73.33 113.02 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.1 -41.8 49.2 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.23 0.612 . . . . 62.42 110.949 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.94 -55.72 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 53.54 110.667 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -66.95 -25.9 66.57 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.764 0.426 . . . . 74.43 111.993 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.37 -56.15 24.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.331 0.652 . . . . 74.3 110.196 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.57 -35.03 76.84 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.065 -0.516 . . . . 71.51 110.458 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 87.1 mt -62.8 -29.32 70.63 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.716 0.806 . . . . 71.13 112.176 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -71.97 -35.52 69.56 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.194 0.521 . . . . 71.44 109.811 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -79.8 -39.07 31.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.834 -1.075 . . . . 62.33 111.55 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 1' ' ' MET . 7.5 pt -96.54 -40.57 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.858 0.463 . . . . 73.13 111.956 -172.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' HG13 ' A' ' 34' ' ' ILE . 47.3 mt -100.95 -175.2 2.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.737 0.815 . . . . 72.41 109.24 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.611 ' HB2' HG23 ' A' ' 39' ' ' VAL . 11.0 m -75.98 146.21 78.67 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 109.334 -0.617 . . . . 72.22 109.334 167.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.22 -19.99 62.52 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.83 2.354 . . . . 73.02 112.452 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.98 -31.71 71.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.501 1.121 . . . . 73.14 111.339 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -69.54 -49.05 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 122.951 0.5 . . . . 64.13 110.287 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.36 -30.22 71.27 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.35 -0.241 . . . . 52.24 110.35 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.58 -40.39 84.83 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.302 1.041 . . . . 61.14 111.495 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.9 -33.06 52.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.211 0.204 . . . . 71.23 110.833 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.84 -47.63 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.415 0.686 . . . . 32.42 110.985 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 5.9 ppt_? -62.8 -29.97 71.12 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.741 0.417 . . . . 73.1 112.114 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.42 -47.86 58.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.757 0.423 . . . . 55.41 112.072 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -66.2 -31.24 71.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.115 0.484 . . . . 70.33 110.332 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.4 -39.57 92.34 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.714 -1.13 . . . . 63.35 111.891 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 71.9 mtp180 -67.77 -30.58 70.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.266 0.626 . . . . 71.24 111.182 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -72.77 -31.7 65.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.374 0.27 . . . . 71.23 111.069 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.23 -32.04 62.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.152 0.581 . . . . 71.02 110.742 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -70.29 -37.01 74.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.408 0.683 . . . . 74.01 110.354 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -60.8 -38.07 84.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.03 0.932 . . . . 65.14 109.816 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -90.12 176.75 6.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.012 -0.995 . . . . 75.21 110.41 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.59 33.12 6.82 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mt -77.79 101.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.996 -0.742 . . . . 72.4 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -94.09 151.85 19.2 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.671 -0.863 . . . . 54.53 108.671 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 44.1 p90 -147.67 161.77 40.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.572 0.749 . . . . 65.34 109.025 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -141.02 136.47 32.12 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.739 -0.467 . . . . 73.32 109.739 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.02 122.07 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 109.368 -0.605 . . . . 63.14 109.368 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -112.01 -44.61 3.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.355 1.062 . . . . 54.22 110.186 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -140.53 135.25 31.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.091 -0.959 . . . . 75.54 109.167 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.48 115.36 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.035 -1.098 . . . . 61.45 108.035 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -127.87 131.97 49.4 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.567 -0.901 . . . . 71.3 108.567 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG11 ' HD2' ' A' ' 9' ' ' LYS . 7.6 p -120.07 109.79 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.886 -0.783 . . . . 72.21 108.886 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.3 p -111.0 164.12 13.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.531 0.732 . . . . 54.12 109.07 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -119.96 143.15 48.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.1 110.093 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.48 ' HB3' ' ND2' ' A' ' 72' ' ' ASN . 5.0 t70 -140.23 91.55 2.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.833 -1.543 . . . . 53.42 106.833 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.56 -124.9 11.13 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.855 -1.298 . . . . 72.33 109.855 -164.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -97.51 -7.7 30.84 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.344 0.657 . . . . 64.03 110.749 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.1 m -88.29 121.54 30.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.343 -0.614 . . . . 72.02 109.343 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.1 t -86.96 136.69 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.664 0.786 . . . . 74.25 109.318 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 67' ' ' ASP . 9.0 m-80 -119.5 99.91 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.244 -1.021 . . . . 64.44 108.244 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.22 104.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.19 -0.67 . . . . 54.55 109.19 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.2 m -87.16 103.36 15.34 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.913 -1.143 . . . . 75.52 107.913 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.59 115.35 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.969 0.908 . . . . 53.22 109.166 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 37.7 tt0 -84.36 124.3 31.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.829 0.852 . . . . 74.11 109.522 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.95 119.7 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.429 0.692 . . . . 54.3 109.347 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -87.59 102.72 14.87 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.214 -1.032 . . . . 71.41 108.214 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.6 mt-10 -89.15 110.42 21.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.14 0.976 . . . . 72.44 111.452 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 45.2 m -89.77 99.88 12.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.551 -1.277 . . . . 64.44 107.551 172.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -147.55 144.65 28.66 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.422 0.689 . . . . 64.32 110.101 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.08 15.63 72.17 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.837 -0.619 . . . . 53.24 113.265 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.38 3.88 81.21 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.1 -0.278 . . . . 72.2 113.474 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -124.59 148.72 47.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.002 0.521 . . . . 64.22 110.559 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 67.3 m -102.86 106.0 16.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.144 -0.687 . . . . 74.32 109.144 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.4 m -101.95 120.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.527 1.131 . . . . 63.42 109.532 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.1 103.8 9.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.652 -0.87 . . . . 63.24 108.652 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -111.06 154.0 24.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.364 1.066 . . . . 61.0 109.744 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 29.9 m -114.53 149.1 36.97 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.113 -0.699 . . . . 60.41 109.113 171.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.93 131.73 47.56 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.176 1.39 . . . . 72.24 107.691 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -113.83 105.77 13.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.999 . . . . 61.41 108.304 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.1 mp -98.4 106.21 18.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -95.9 103.05 14.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.134 0.574 . . . . 63.0 109.843 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 101' ' ' ILE . 96.5 m-85 -87.18 108.49 18.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.129 0.972 . . . . 73.41 109.637 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 24.8 tt0 -99.71 124.21 44.73 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 4' ' ' ILE . 3.2 m -98.17 151.89 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.177 -0.92 . . . . 41.24 111.808 -165.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -137.98 99.23 3.84 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.525 1.13 . . . . 71.44 108.062 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.31 -107.76 2.46 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.185 -0.916 . . . . 41.24 113.023 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.25 -4.08 13.77 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.63 1.172 . . . . 64.32 110.908 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.538 HG23 ' HD3' ' A' ' 102' ' ' ARG . 5.2 t -127.98 154.1 45.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.733 0.813 . . . . 54.44 110.228 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 96' ' ' VAL . 52.3 mt -95.37 133.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.177 -1.045 . . . . 71.02 108.177 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.538 ' HD3' HG23 ' A' ' 100' ' ' THR . 22.2 mmm180 -118.19 -2.98 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.633 0.373 . . . . 61.43 111.324 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 21.9 tpt180 -143.76 133.99 24.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.508 0.723 . . . . 71.23 110.01 -172.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.74 118.1 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.656 -1.238 . . . . 74.24 107.656 166.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 m -97.46 103.08 14.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.877 -1.157 . . . . 74.54 107.877 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 92' ' ' LEU . 44.6 t -93.87 105.24 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.408 -0.96 . . . . 74.21 108.408 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.8 m -110.54 122.09 46.9 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.56 -0.533 . . . . 71.21 109.56 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.77 97.15 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.29 78.16 8.1 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.255 -1.017 . . . . 61.3 108.255 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.77 39.51 2.87 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.822 -1.081 . . . . 71.41 111.376 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.68 63.89 0.09 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.568 -0.613 . . . . 73.24 111.568 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.8 m -73.02 114.53 11.28 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.425 0.69 . . . . 74.23 110.449 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.455 HD13 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -105.42 1.64 27.93 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.462 0.705 . . . . 72.4 112.357 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.98 87.66 1.84 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.008 0.523 . . . . 71.44 111.463 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -116.9 107.85 15.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.39 -1.337 . . . . 75.12 107.39 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 52.7 t60 64.37 4.91 2.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.288 1.035 . . . . 74.04 111.143 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -81.6 70.06 8.4 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.894 0.878 . . . . 54.21 111.02 -170.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 168.72 127.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.53 2.332 . . . . 74.21 106.865 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -79.47 79.86 5.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.195 -0.668 . . . . 64.24 109.195 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.3 t60 . . . . . 0 C--O 1.257 1.467 0 N-CA-C 107.413 -1.328 . . . . 74.21 107.413 179.657 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HG3' ' HA ' ' A' ' 34' ' ' ILE . 13.2 tmm? . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 108.025 -1.102 . . . . 73.11 108.025 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.2 139.28 50.07 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.406 0.682 . . . . 53.03 110.323 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t0 65.59 101.88 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.314 1.446 . . . . 72.2 110.839 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -76.27 -39.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.372 1.069 . . . . 71.23 111.068 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.56 -48.38 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.016 0.526 . . . . 72.54 110.979 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.94 -40.47 93.38 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.908 0.755 . . . . 72.42 110.326 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.42 90.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.021 0.825 . . . . 61.22 111.136 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.26 80.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.441 0.696 . . . . 73.21 111.613 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -72.82 -48.78 34.95 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 72.05 110.549 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -61.15 -42.68 98.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.055 0.942 . . . . 71.32 110.937 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -42.72 91.65 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.111 -0.949 . . . . 41.34 111.26 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -55.31 -51.22 67.44 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.045 0.841 . . . . 53.14 111.416 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.56 -46.72 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.425 -0.807 . . . . 70.35 110.28 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.146 0.978 . . . . 74.24 113.057 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HA ' HG11 ' A' ' 43' ' ' VAL . 57.6 mt -62.72 -43.19 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.802 0.841 . . . . 72.42 110.192 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -72.8 -33.16 66.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.553 0.341 . . . . 55.25 111.465 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.596 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 49.7 mt-30 -63.02 -37.85 88.83 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.639 0.587 . . . . 75.52 111.079 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 28' ' ' GLN . 95.6 mt -75.2 -37.24 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.768 0.667 . . . . 74.4 111.185 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.43 -29.32 70.63 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.747 0.647 . . . . 72.42 112.747 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -101.88 -15.11 16.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.825 0.45 . . . . 74.03 111.58 175.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 24' ' ' ASP . 4.9 t30 -156.59 84.27 3.16 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 108.975 -0.75 . . . . 74.32 108.975 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 -12.93 36.76 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.142 2.562 . . . . 71.54 112.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -80.91 -5.58 57.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.446 1.098 . . . . 74.55 112.384 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' HB2' HD22 ' A' ' 21' ' ' ASN . 10.5 t70 -74.99 112.55 18.42 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 109.756 -0.461 . . . . 74.44 109.756 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.15 -34.11 5.23 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.599 2.199 . . . . 55.32 113.018 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.93 -30.83 56.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.867 0.467 . . . . 74.11 111.653 -171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.02 79.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.354 0.662 . . . . 62.31 110.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.582 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.0 pt20 -78.34 -23.94 46.76 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.09 -0.504 . . . . 63.14 111.616 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.67 -48.85 75.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 55.02 110.375 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.0 pp -66.48 -35.02 79.22 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.419 0.449 . . . . 73.44 109.951 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.15 -21.6 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.782 0.833 . . . . 72.54 112.191 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.1 -31.27 34.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.555 -0.535 . . . . 74.53 109.555 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.98 -35.09 38.0 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.22 1.008 . . . . 72.32 112.382 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.5 pt -111.26 -45.15 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.038 0.535 . . . . 64.14 111.854 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 39' ' ' VAL . 3.8 mm? -96.03 177.27 5.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.998 0.919 . . . . 71.31 108.869 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.4 m -71.65 147.01 91.82 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 116.321 -0.399 . . . . 64.45 110.061 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.63 -18.77 56.92 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.558 2.172 . . . . 75.51 113.21 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.07 -37.92 81.79 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.295 1.038 . . . . 60.42 111.18 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 35' ' ' LEU . 77.5 t -61.8 -55.57 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.749 0.656 . . . . 62.03 110.047 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.582 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.0 pp -59.73 -33.46 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.439 0.462 . . . . 62.14 111.038 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 27.5 t70 -67.55 -54.4 20.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 124.249 0.968 . . . . 75.11 110.44 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -67.28 -24.71 65.81 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.155 0.182 . . . . 74.45 111.404 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 15' ' ' ILE . 31.8 t -68.91 -52.03 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.491 0.716 . . . . 73.32 110.64 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -65.91 -20.73 66.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.576 0.35 . . . . 63.42 111.389 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 44.8 mt-10 -81.93 -35.77 28.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.406 0.682 . . . . 72.13 110.642 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -67.34 -22.29 65.6 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.223 0.609 . . . . 74.41 110.498 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.14 64.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 55.12 111.431 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -59.11 -33.14 70.51 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 124.33 1.018 . . . . 72.44 111.563 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.63 -50.87 61.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.284 0.634 . . . . 72.33 110.633 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.39 -34.26 61.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.081 -0.963 . . . . 74.32 110.682 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.06 -29.04 54.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.166 0.986 . . . . 75.32 110.848 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -67.43 -40.28 85.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.475 0.71 . . . . 64.2 109.847 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.8 -29.56 62.24 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.002 -0.999 . . . . 72.22 110.315 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.47 29.14 30.86 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.902 0.751 . . . . 44.11 112.81 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.43 116.47 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.743 0.817 . . . . 72.11 109.957 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -91.48 112.18 23.99 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.794 -1.188 . . . . 64.43 107.794 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -130.17 132.59 46.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.629 0.772 . . . . 54.11 109.621 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.32 135.72 51.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.152 0.581 . . . . 71.43 110.427 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.54 119.83 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.285 1.034 . . . . 74.23 109.81 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -104.89 -55.22 2.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.085 0.554 . . . . 73.3 110.409 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 ttm180 -131.9 124.77 30.17 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.753 -0.832 . . . . 75.35 108.753 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.28 116.31 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.274 -1.01 . . . . 64.2 108.274 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -113.92 108.44 17.05 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.637 -0.875 . . . . 62.23 108.637 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.88 127.18 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.381 -0.97 . . . . 71.24 108.381 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -139.61 139.83 36.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.398 0.679 . . . . 72.24 109.2 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 71' ' ' VAL . 47.3 p -97.56 116.23 29.38 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.046 0.538 . . . . 73.32 110.007 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.33 91.4 3.65 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.564 -1.273 . . . . 73.12 107.564 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.1 -119.98 7.0 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.017 -0.992 . . . . 60.11 110.905 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -101.13 -11.54 19.5 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.326 0.65 . . . . 74.33 111.082 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 m -94.39 121.51 36.0 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.516 0.726 . . . . 72.32 109.516 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 66' ' ' THR . 68.3 t -87.62 139.14 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.937 -0.764 . . . . 72.33 108.937 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -120.91 110.49 16.36 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.123 . . . . 65.12 108.171 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.12 104.11 15.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.615 -0.883 . . . . 63.45 108.615 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 78.4 m -92.72 105.58 17.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.897 -1.149 . . . . 70.33 107.897 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.6 p -118.55 124.01 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.658 0.783 . . . . 74.52 110.412 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.88 121.91 30.01 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.28 -1.007 . . . . 62.51 108.28 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.6 mp -107.45 160.65 15.48 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.337 0.655 . . . . 41.21 109.328 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -116.63 104.64 11.59 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.541 1.137 . . . . 74.22 108.153 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -100.36 102.97 14.34 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.893 -0.41 . . . . 70.23 109.893 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -89.83 104.23 16.81 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.333 -1.358 . . . . 65.31 107.333 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 t -133.73 122.9 24.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.593 0.757 . . . . 74.53 110.25 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.65 0.25 58.36 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.639 -0.709 . . . . 75.2 114.02 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.28 -36.22 3.49 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.734 0.683 . . . . 54.1 111.531 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.3 p -84.87 124.82 32.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.554 0.742 . . . . 74.31 110.914 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -93.7 106.24 18.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.698 0.799 . . . . 74.44 109.796 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 m -114.33 123.61 49.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.117 0.967 . . . . 72.31 109.002 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.57 130.21 35.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.094 -0.706 . . . . 75.3 109.094 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.1 m -127.03 125.92 42.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.077 0.951 . . . . 52.31 109.335 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -89.01 121.0 30.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.275 -0.639 . . . . 63.24 109.275 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD1' HD13 ' A' ' 77' ' ' LEU . 10.2 m-85 -102.99 133.08 48.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.261 -1.385 . . . . 70.33 107.261 173.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.34 106.1 12.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.91 -0.774 . . . . 74.15 108.91 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.0 mp -97.34 106.23 18.51 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.26 1.024 . . . . 63.33 108.384 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.599 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 76.8 ttt-85 -96.2 99.97 11.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.706 -0.85 . . . . 71.4 108.706 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.1 m-85 -85.87 107.88 17.88 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.68 -0.691 . . . . 74.55 109.418 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 38.5 tt0 -101.11 124.26 46.55 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.913 -1.04 . . . . 73.12 108.954 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 101' ' ' ILE . 29.9 m -87.27 147.46 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.562 -0.744 . . . . 72.34 111.534 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.82 99.44 6.28 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.648 -1.242 . . . . 74.5 107.648 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.67 -110.99 3.43 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.272 -0.876 . . . . 22.04 112.61 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -89.23 -16.23 31.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.924 0.89 . . . . 64.13 112.311 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -133.69 166.29 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.231 0.612 . . . . 74.44 111.156 -168.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 96' ' ' VAL . 25.1 mt -94.73 120.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 107.934 -1.136 . . . . 53.42 107.934 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -106.75 -17.22 14.28 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.044 0.538 . . . . 60.02 111.2 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 84.4 mtt85 -128.63 146.98 50.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.405 0.682 . . . . 75.32 110.889 -170.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.8 p -146.31 112.23 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 114.963 -1.017 . . . . 71.11 108.755 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 92.8 m -91.8 103.54 16.08 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.634 -0.876 . . . . 65.1 108.634 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.76 112.39 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.075 -0.713 . . . . 72.33 109.075 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.0 m -106.89 118.64 37.22 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.034 0.534 . . . . 61.33 109.825 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.75 84.04 7.7 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.826 0.85 . . . . 72.32 109.103 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -77.25 95.2 4.27 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.996 -0.547 . . . . 72.21 109.715 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.45 ' H ' HD23 ' A' ' 113' ' ' LEU . . . -169.82 92.18 0.1 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.276 -0.875 . . . . 55.3 110.928 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.36 -127.64 5.54 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.209 -0.756 . . . . 60.33 111.209 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -86.94 32.02 0.69 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.77 0.828 . . . . 61.14 111.748 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 110' ' ' GLY . 3.4 mm? -88.7 29.05 1.05 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.952 0.901 . . . . 62.31 111.354 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -60.31 130.7 47.92 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.456 -0.942 . . . . 64.12 108.456 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -80.72 80.76 7.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.629 0.728 . . . . 72.44 110.566 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -86.93 40.68 0.92 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.975 -1.012 . . . . 73.11 110.953 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -138.44 90.5 2.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.07 -1.455 . . . . 63.34 107.07 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -144.49 162.78 35.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.562 0.745 . . . . 73.55 109.664 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -78.42 171.54 14.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.709 0.803 . . . . 70.23 111.352 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--O 1.25 1.11 0 N-CA-C 108.826 -0.805 . . . . 73.24 108.826 177.577 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.967 0.413 . . . . 64.24 110.678 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -139.95 10.0 2.38 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.903 0.881 . . . . 74.31 110.224 -175.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.24 105.42 1.73 Allowed 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 124.687 1.195 . . . . 73.03 109.825 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.454 HG23 HG11 ' A' ' 96' ' ' VAL . 46.2 mm -46.4 -46.11 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.22 1.408 . . . . 45.02 113.934 -167.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.33 -52.18 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.41 0.684 . . . . 73.12 110.551 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.02 -33.92 72.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.512 -0.767 . . . . 72.54 111.35 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -44.02 68.72 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 124.237 1.015 . . . . 75.35 109.945 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.14 -32.64 73.05 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.719 0.637 . . . . 74.32 111.443 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.59 -51.49 59.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.581 0.752 . . . . 74.23 110.319 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -64.66 -33.82 76.83 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.611 0.765 . . . . 73.33 111.163 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.13 81.69 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 124.284 0.99 . . . . 71.15 110.752 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.47 71.1 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.399 1.062 . . . . 63.04 111.256 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG22 HE21 ' A' ' 17' ' ' GLN . 28.8 mt -66.31 -38.32 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 O-C-N 124.1 0.875 . . . . 42.11 110.072 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.1 74.37 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.814 0.845 . . . . 73.21 111.858 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 43' ' ' VAL . 60.1 mt -61.65 -40.97 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.774 0.83 . . . . 60.04 109.747 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 43.4 m-85 -75.36 -29.11 59.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.774 0.43 . . . . 75.45 112.084 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.534 HE21 HG22 ' A' ' 13' ' ' ILE . 72.7 mt-30 -63.13 -38.2 90.25 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.468 0.48 . . . . 54.35 110.148 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.09 -38.78 63.78 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.691 0.619 . . . . 74.44 110.707 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.1 m0 -68.58 -22.04 64.48 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.825 0.676 . . . . 73.24 112.825 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -99.68 -20.86 16.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.053 0.541 . . . . 71.21 110.883 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 24' ' ' ASP . 7.6 t30 -158.72 91.75 2.02 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 123.928 0.891 . . . . 74.55 109.96 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.11 -9.14 24.84 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.268 2.645 . . . . 72.42 113.965 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 p -90.25 0.64 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.818 0.847 . . . . 53.43 111.868 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' HB2' HD22 ' A' ' 21' ' ' ASN . 12.3 t70 -68.04 114.73 22.45 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 122.866 0.466 . . . . 74.44 110.541 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 98.2 Cg_endo -75.21 -27.38 9.74 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.51 2.14 . . . . 75.41 114.005 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.9 -34.39 24.55 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.864 0.465 . . . . 54.52 112.06 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -52.34 57.12 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.483 0.713 . . . . 62.21 110.223 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -66.39 -28.53 68.7 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.203 -0.908 . . . . 61.1 111.31 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 6.8 tm-20 -58.49 -59.04 5.99 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.018 0.927 . . . . 65.43 109.93 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -63.97 -33.99 76.96 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.08 0.862 . . . . 72.21 111.034 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.12 -30.1 71.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.912 0.885 . . . . 63.54 112.471 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -65.42 -27.11 68.3 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.07 0.396 . . . . 74.3 111.866 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -94.16 -36.29 12.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.987 0.915 . . . . 72.33 112.286 -171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 30' ' ' LEU . 22.0 pt -103.74 -29.08 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 122.859 0.464 . . . . 74.23 112.225 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.529 HD12 HG21 ' A' ' 39' ' ' VAL . 4.1 mm? -106.05 178.38 4.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.035 0.934 . . . . 54.24 108.592 172.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 m -84.78 149.88 54.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.049 -0.523 . . . . 74.54 109.952 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 40' ' ' LEU . 83.0 Cg_exo -50.55 -26.25 16.28 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.565 2.843 . . . . 74.15 114.668 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.93 -42.07 95.0 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.084 0.954 . . . . 72.12 111.559 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 HD12 ' A' ' 35' ' ' LEU . 88.6 t -60.83 -60.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.555 0.742 . . . . 75.11 112.056 -173.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -61.05 -22.55 64.68 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.073 0.397 . . . . 74.14 112.073 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.29 -42.68 30.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 53.44 111.234 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 39' ' ' VAL . 28.3 pt20 -71.56 -27.11 62.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 110.298 -0.26 . . . . 62.41 110.298 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 HG12 ' A' ' 15' ' ' ILE . 37.7 t -65.92 -53.8 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.69 0.796 . . . . 73.44 110.151 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -63.11 -22.47 66.88 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.229 0.212 . . . . 73.21 111.03 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -74.93 -45.27 43.62 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.452 0.701 . . . . 72.52 110.484 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -71.19 -22.67 62.0 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.895 -0.593 . . . . 70.44 110.701 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.49 98.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.187 0.995 . . . . 73.22 110.898 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -66.06 -34.14 77.4 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.912 -1.04 . . . . 61.13 110.837 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.53 -48.33 79.98 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.804 0.69 . . . . 63.23 110.867 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.67 -51.8 60.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.613 -0.722 . . . . 72.31 110.752 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.77 -35.29 79.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.351 -1.295 . . . . 60.51 111.405 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -61.01 -43.08 99.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.668 1.187 . . . . 74.31 111.356 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -83.65 -15.12 50.12 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.23 -0.896 . . . . 73.11 111.256 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.32 60.19 Favored Glycine 0 C--N 1.345 1.032 0 O-C-N 123.268 0.355 . . . . 14.41 112.878 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.95 91.49 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.821 -0.807 . . . . 75.02 108.821 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -92.53 153.15 19.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.398 -0.819 . . . . 71.55 108.876 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -149.84 170.17 19.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.339 0.655 . . . . 74.14 110.49 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -141.04 138.12 33.41 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.527 -0.916 . . . . 62.13 108.527 165.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.92 138.22 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 123.528 0.517 . . . . 74.44 109.86 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -115.98 -42.26 3.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.776 0.83 . . . . 73.14 111.559 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.0 ttm105 -157.82 123.87 4.72 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.805 -0.634 . . . . 72.44 109.998 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.89 107.62 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.264 -1.013 . . . . 72.43 108.264 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.71 123.75 43.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 62.23 108.945 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.81 128.75 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.83 -0.804 . . . . 55.12 108.83 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -137.91 117.85 13.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.171 -0.677 . . . . 71.41 109.171 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 71' ' ' VAL . 22.1 p -89.79 114.83 26.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.879 0.871 . . . . 72.24 109.856 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -113.99 90.92 3.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.448 1.099 . . . . 75.22 109.096 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.76 -105.13 1.45 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.513 -0.767 . . . . 51.03 112.43 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.405 ' O ' HG22 ' A' ' 96' ' ' VAL . 73.1 m-20 -114.89 14.65 17.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.241 1.016 . . . . 60.23 110.346 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.4 m -132.01 122.61 25.79 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.348 0.659 . . . . 54.55 110.227 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 66' ' ' THR . 58.7 t -90.03 115.35 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 122.939 0.495 . . . . 62.3 109.792 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -102.31 106.82 17.67 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.617 1.167 . . . . 73.51 108.872 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.22 110.53 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.533 0.733 . . . . 71.12 109.706 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -98.4 105.3 17.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.195 -1.039 . . . . 60.45 108.195 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 16' ' ' PHE . 2.4 p -124.3 127.88 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.071 0.548 . . . . 74.0 110.065 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.27 136.98 32.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.937 0.495 . . . . 72.31 109.876 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.5 141.78 48.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.852 0.861 . . . . 63.13 109.927 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.32 104.32 16.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.728 0.811 . . . . 71.03 109.905 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -86.18 107.05 17.71 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.298 0.639 . . . . 73.45 109.557 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.3 m -88.34 104.55 16.86 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.12 -1.067 . . . . 63.23 108.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -144.02 131.81 21.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.437 1.095 . . . . 71.51 108.959 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.33 26.66 73.49 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.844 -0.162 . . . . 50.31 112.863 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.84 85.71 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 119.49 -0.616 . . . . 42.55 114.359 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.2 t -127.47 146.02 50.64 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.643 0.721 . . . . 61.34 111.259 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 149.97 22.08 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.12 0.968 . . . . 75.03 111.104 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.2 m -137.6 122.03 18.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.269 1.027 . . . . 74.15 109.219 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.41 100.31 5.15 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.03 -1.1 . . . . 74.14 108.03 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -114.72 122.76 47.4 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.359 -0.837 . . . . 63.42 109.046 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.8 m -89.99 124.68 34.96 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.75 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -104.52 127.57 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.818 0.847 . . . . 70.22 109.024 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.63 113.62 27.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.644 -0.873 . . . . 75.5 108.644 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.31 107.36 18.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.719 -0.845 . . . . 61.4 108.719 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -91.6 100.36 13.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.255 1.022 . . . . 64.11 109.484 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.26 106.9 18.52 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.367 0.667 . . . . 74.53 109.47 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 44.0 tt0 -97.54 116.95 30.72 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.736 0.814 . . . . 74.14 108.858 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 101' ' ' ILE . 4.5 m -89.69 149.32 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.444 0.697 . . . . 75.41 110.629 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.46 119.48 15.42 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.444 -1.317 . . . . 75.22 107.444 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.14 -97.99 0.97 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.017 -0.433 . . . . 54.44 112.017 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -121.72 -17.49 7.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.885 0.874 . . . . 73.12 111.91 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.7 t -124.94 160.03 29.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.93 0.492 . . . . 73.1 111.152 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 HG12 ' A' ' 96' ' ' VAL . 27.3 mt -86.03 126.78 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.772 -0.825 . . . . 65.2 108.772 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -102.36 -29.96 11.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.531 0.733 . . . . 74.14 111.715 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -130.95 146.89 52.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.624 0.25 . . . . 62.24 111.086 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.61 107.81 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.263 1.025 . . . . 64.43 109.36 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -95.12 106.57 18.59 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.949 -0.76 . . . . 74.24 108.949 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.49 136.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 109.61 -0.515 . . . . 54.45 109.61 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -129.46 113.0 14.35 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.59 0.756 . . . . 72.41 109.796 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.31 101.79 7.36 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.316 0.647 . . . . 73.42 109.902 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -90.47 90.16 7.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.124 0.97 . . . . 65.25 108.887 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 47.25 0.11 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.128 -1.189 . . . . 63.35 110.128 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.94 78.76 0.24 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.05 -0.575 . . . . 64.23 111.719 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 m -64.46 94.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.91 0.884 . . . . 73.4 110.634 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -106.63 109.24 21.1 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.062 -0.718 . . . . 72.53 109.062 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.02 167.91 24.54 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.614 1.166 . . . . 72.51 109.783 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -154.88 102.92 2.38 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.786 -1.19 . . . . 71.11 107.786 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -114.12 122.68 47.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.374 0.67 . . . . 73.22 110.204 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -86.99 138.13 31.76 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.248 0.619 . . . . 65.3 109.592 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -75.63 104.8 6.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.849 0.46 . . . . 75.41 110.099 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -68.82 147.32 51.92 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.471 -0.786 . . . . 65.24 108.967 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 108.311 -0.996 . . . . 73.53 108.311 -178.388 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 94.8 mmm . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.509 -0.552 . . . . 75.24 109.509 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -129.39 15.9 6.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.453 0.701 . . . . 72.11 109.844 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.48 162.9 12.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.15 0.98 . . . . 72.23 109.692 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.25 -39.74 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.583 0.753 . . . . 74.41 111.725 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.27 -52.93 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.682 0.793 . . . . 63.24 111.891 -171.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -67.62 -35.7 79.43 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.686 -0.688 . . . . 71.21 110.523 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -62.8 -41.84 99.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.325 0.65 . . . . 72.52 111.293 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.65 66.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.796 0.838 . . . . 73.41 111.008 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.58 -54.63 44.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.553 1.141 . . . . 65.31 111.054 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -64.43 -33.94 77.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.509 0.723 . . . . 75.52 110.977 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -49.42 76.11 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.008 0.818 . . . . 52.23 111.025 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.75 68.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.315 1.01 . . . . 71.13 111.504 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.492 HG22 HE21 ' A' ' 17' ' ' GLN . 51.1 mt -63.4 -40.46 89.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 124.175 0.922 . . . . 72.4 110.324 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.348 0.659 . . . . 63.02 111.334 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.3 mt -56.13 -39.32 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 72.24 110.304 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -71.12 -32.67 69.3 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.249 0.62 . . . . 53.54 111.759 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.492 HE21 HG22 ' A' ' 13' ' ' ILE . 71.8 mt-30 -63.04 -38.37 90.92 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.099 0.56 . . . . 72.24 110.519 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 3.4 mm? -66.59 -48.87 68.2 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 123.543 0.527 . . . . 75.22 109.945 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 106' ' ' VAL . 32.4 m0 -51.52 -34.33 35.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.485 0.92 . . . . 74.05 113.485 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.46 -32.24 12.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.7 0.4 . . . . 64.45 111.686 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.454 HD22 ' HB2' ' A' ' 24' ' ' ASP . 7.2 t30 -143.95 86.99 8.22 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 108.983 -0.747 . . . . 74.15 108.983 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.89 -15.69 50.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.979 2.453 . . . . 74.23 113.03 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.2 p -89.45 13.34 13.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.42 1.088 . . . . 62.31 112.283 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' HD22 ' A' ' 21' ' ' ASN . 17.2 t70 -83.21 110.81 26.19 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.281 -0.636 . . . . 74.52 109.281 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.16 -21.61 17.71 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.461 2.107 . . . . 53.23 113.624 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.69 -39.55 26.97 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.359 0.664 . . . . 63.43 111.444 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.19 -50.02 65.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.464 0.706 . . . . 73.03 110.748 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.541 ' HB2' HD13 ' A' ' 40' ' ' LEU . 11.6 pt20 -72.41 -19.63 61.56 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.429 -0.805 . . . . 42.41 111.505 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.49 -54.97 24.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.13 0.572 . . . . 74.31 110.592 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.26 -30.3 70.15 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.313 -0.403 . . . . 65.03 110.262 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.4 mt -65.18 -28.4 69.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.908 0.755 . . . . 74.41 112.034 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -75.11 -26.96 59.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.317 0.58 . . . . 62.34 109.891 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -78.8 -41.26 30.84 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.915 0.886 . . . . 64.42 110.748 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.453 HG13 HD23 ' A' ' 35' ' ' LEU . 9.9 pt -103.27 -36.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.081 0.552 . . . . 73.34 112.294 -170.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 34' ' ' ILE . 3.8 mm? -103.28 -176.88 3.21 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.26 1.024 . . . . 75.24 109.477 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.409 ' HB2' HG23 ' A' ' 39' ' ' VAL . 32.7 m -81.29 145.89 56.84 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.421 -0.809 . . . . 71.22 109.878 170.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.22 -27.98 59.47 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.854 2.369 . . . . 55.32 112.484 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.62 -48.33 77.71 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.537 1.135 . . . . 75.22 111.479 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 35' ' ' LEU . 98.7 t -66.33 -51.97 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.81 0.844 . . . . 70.14 111.391 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 28' ' ' GLN . 4.0 pp -65.13 -28.66 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 120.769 0.318 . . . . 75.43 111.539 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.79 -33.21 60.13 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.511 -0.768 . . . . 62.45 110.54 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -77.62 -32.63 53.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.696 -0.483 . . . . 73.01 109.696 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.3 t -59.94 -42.73 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.442 0.697 . . . . 73.25 111.028 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -73.36 -21.49 60.51 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.834 0.454 . . . . 62.21 111.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.26 -50.73 13.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.295 0.638 . . . . 74.55 110.829 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -71.01 -21.3 62.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.712 0.805 . . . . 70.32 111.02 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -58.25 -44.86 88.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.725 1.21 . . . . 72.12 111.613 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 99.4 mtt180 -60.43 -35.55 76.08 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.408 -1.269 . . . . 70.24 110.689 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.69 -43.97 74.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.908 0.755 . . . . 74.33 110.3 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.97 -27.96 68.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.755 0.822 . . . . 73.21 111.207 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -79.4 -33.34 42.82 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.991 0.917 . . . . 72.54 110.089 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 94.0 mttt -67.63 -39.37 84.65 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.574 0.749 . . . . 74.5 110.315 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -65.18 -44.51 88.23 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.085 -0.962 . . . . 73.43 109.219 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.92 44.79 5.91 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.251 -0.886 . . . . 43.41 112.137 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -79.37 106.23 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.781 -0.822 . . . . 73.0 108.781 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -85.81 108.97 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.896 -1.15 . . . . 75.04 107.896 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.53 142.09 50.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.409 -0.589 . . . . 74.14 109.409 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.89 135.72 54.78 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.797 -0.816 . . . . 71.01 108.797 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.37 100.12 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.202 -1.036 . . . . 54.44 108.202 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -84.37 -49.98 8.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.47 -0.786 . . . . 74.53 110.816 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -144.5 122.65 12.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.308 -0.86 . . . . 71.1 109.682 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.65 124.76 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.623 0.769 . . . . 65.22 109.275 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.1 108.2 10.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.27 -1.011 . . . . 64.53 108.27 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 HG22 ' A' ' 73' ' ' VAL . 7.7 p -96.17 121.23 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.276 0.56 . . . . 72.21 109.541 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.1 m -129.4 141.46 51.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.165 0.986 . . . . 75.15 109.711 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -88.89 163.33 15.67 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.037 0.535 . . . . 74.43 110.939 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -158.57 74.76 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.767 -1.197 . . . . 72.01 107.767 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.84 -117.83 11.21 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.861 -0.495 . . . . 72.41 111.861 -171.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -88.31 -11.68 45.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.114 0.565 . . . . 63.43 111.023 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -97.93 156.05 16.79 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.706 1.202 . . . . 73.35 109.693 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.32 123.5 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.281 0.633 . . . . 62.32 110.296 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -99.34 112.64 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.855 0.862 . . . . 74.03 109.686 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 64' ' ' VAL . 61.5 t -91.1 105.02 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.901 -0.777 . . . . 62.22 108.901 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.0 m -86.07 104.95 16.14 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.367 -0.975 . . . . 74.42 108.367 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.16 126.82 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.995 0.518 . . . . 64.01 110.461 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.65 123.75 32.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.809 0.844 . . . . 74.04 109.381 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -117.69 123.15 45.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.316 -0.994 . . . . 71.43 108.316 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 34.9 tt0 -88.86 107.82 19.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.461 -0.941 . . . . 73.13 108.461 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.89 130.61 48.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.731 0.813 . . . . 64.23 110.652 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.2 m -119.52 117.68 29.04 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.158 1.383 . . . . 60.14 107.926 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -144.27 134.29 24.06 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.542 -0.91 . . . . 74.44 108.542 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.51 28.64 62.61 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.355 0.409 . . . . 71.33 113.619 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.67 -34.34 4.25 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 74.33 113.03 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -82.05 133.99 35.32 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.236 0.614 . . . . 64.14 110.612 -170.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -118.51 129.85 55.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.601 0.761 . . . . 64.22 110.334 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.1 m -143.64 136.27 27.24 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.918 0.887 . . . . 73.22 109.669 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 16.5 m120 -79.79 105.39 11.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.684 0.793 . . . . 75.5 109.956 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 m -101.03 126.53 47.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.625 1.17 . . . . 72.42 110.385 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -93.78 122.52 36.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.876 0.47 . . . . 63.12 110.795 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.8 127.54 53.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.398 0.679 . . . . 73.21 109.485 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.03 106.69 18.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.909 -1.145 . . . . 71.41 107.909 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.7 mp -95.34 106.84 18.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.09 -1.078 . . . . 74.5 108.09 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 34.1 ttt180 -98.44 99.91 11.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.942 0.897 . . . . 72.25 109.41 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.81 112.46 22.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.525 1.13 . . . . 54.04 111.007 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 31.2 tt0 -90.91 134.36 34.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.088 -0.708 . . . . 72.23 109.088 174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.44 151.42 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.304 1.042 . . . . 72.23 111.712 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -129.37 103.41 6.9 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.705 -1.221 . . . . 64.04 107.705 162.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.33 -105.32 2.06 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.719 -0.673 . . . . 75.11 112.072 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.64 -9.9 10.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.24 1.016 . . . . 71.44 110.912 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -110.4 148.08 32.73 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.598 0.759 . . . . 74.11 109.214 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.09 144.73 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.865 -0.791 . . . . 74.31 108.865 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -125.06 -25.57 3.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.498 0.719 . . . . 71.24 112.443 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 3.0 mpt_? -129.72 156.44 44.27 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.755 0.422 . . . . 74.43 110.299 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 109.92 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.359 1.064 . . . . 74.33 109.091 173.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 40.7 m -92.05 105.12 17.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.762 -0.829 . . . . 50.3 108.762 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.49 HG11 ' HH2' ' A' ' 19' ' ' TRP . 48.0 t -93.36 105.84 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 122.927 0.491 . . . . 71.11 109.742 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.6 m -100.64 113.8 26.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.524 0.729 . . . . 72.34 109.849 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -79.62 126.67 31.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.027 -0.731 . . . . 75.45 109.027 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -128.95 146.93 50.83 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.66 0.784 . . . . 65.42 109.589 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.77 -12.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.423 -0.808 . . . . 64.23 111.93 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.62 151.42 19.16 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.343 -0.303 . . . . 52.34 112.343 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -93.06 85.92 5.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.528 0.68 . . . . 51.0 110.061 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.87 4.07 53.74 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.319 0.648 . . . . 70.13 111.448 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.02 95.61 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.15 109.963 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -178.14 159.3 1.27 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.871 1.268 . . . . 73.23 109.267 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -118.38 -74.47 0.6 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.097 -0.705 . . . . 72.11 109.097 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -97.05 43.84 1.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.438 0.695 . . . . 70.23 110.437 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.1 t60 67.08 62.2 0.48 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.232 1.413 . . . . 73.51 111.88 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -80.52 -15.24 57.17 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.297 0.57 . . . . 71.34 109.867 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.07 1.348 . . . . 73.13 107.918 174.856 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.766 -0.457 . . . . 65.44 109.766 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.6 8.66 33.31 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.32 0.648 . . . . 74.43 110.079 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -60.01 112.0 1.71 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 123.701 0.8 . . . . 63.43 109.974 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.76 -43.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.431 1.082 . . . . 64.3 111.489 -175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.5 -46.18 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.945 0.898 . . . . 61.11 110.199 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -67.23 -33.93 76.4 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.576 -0.738 . . . . 63.34 110.521 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -65.77 -45.75 81.35 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.304 0.642 . . . . 75.04 110.513 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.26 98.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.575 0.75 . . . . 73.34 110.969 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -59.02 -56.54 20.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.258 1.023 . . . . 74.54 111.019 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.77 0.828 . . . . 73.14 111.444 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -66.44 -45.13 80.87 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 124.151 0.907 . . . . 53.1 110.628 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.12 75.16 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 124.112 0.883 . . . . 63.22 110.816 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.9 mt -58.49 -44.85 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 124.263 0.977 . . . . 70.23 110.163 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.63 71.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.107 0.963 . . . . 34.31 112.7 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 62.7 mt -65.07 -41.45 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.26 0.624 . . . . 75.1 110.338 175.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -74.55 -31.51 62.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.71 0.404 . . . . 63.33 111.28 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.93 -37.41 85.98 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.111 0.564 . . . . 75.05 110.341 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.79 -38.86 67.11 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 119.199 -0.429 . . . . 64.42 110.71 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.429 ' HB3' ' HZ ' ' A' ' 57' ' ' PHE . 19.6 m0 -63.61 -21.33 66.3 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.364 0.876 . . . . 75.01 113.364 -176.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -102.32 -25.21 13.74 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.676 0.39 . . . . 71.21 111.156 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -146.04 96.0 4.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 123.273 0.629 . . . . 74.14 109.966 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.88 -28.51 75.59 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.251 2.634 . . . . 74.14 112.925 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 p -92.55 22.08 4.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.901 0.88 . . . . 73.44 111.945 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.25 112.15 23.75 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.055 -0.72 . . . . 74.3 109.055 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.37 -34.45 20.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.79 2.327 . . . . 70.15 112.898 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.71 -49.1 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 74.21 110.973 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.11 -52.67 64.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 124.225 0.953 . . . . 71.54 111.105 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.9 pt20 -68.15 -32.8 73.32 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 116.061 -0.518 . . . . 71.41 111.608 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 41.2 tt0 -69.87 -43.5 71.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.469 0.307 . . . . 74.15 111.098 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.6 pp -67.35 -34.01 76.42 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.826 -0.435 . . . . 74.22 109.826 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 HD12 ' A' ' 35' ' ' LEU . 85.8 mt -65.34 -30.6 71.45 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.56 0.744 . . . . 75.23 111.517 174.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -67.53 -33.85 75.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.194 0.598 . . . . 72.23 110.355 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 27.4 mtpp -80.89 -46.35 15.37 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.161 -0.927 . . . . 73.31 111.376 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 30' ' ' LEU . 13.0 pt -99.07 -35.18 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.654 0.382 . . . . 73.32 111.732 -168.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.518 HD11 ' HB1' ' A' ' 11' ' ' ALA . 28.3 mt -101.95 -170.52 1.83 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.397 -0.594 . . . . 74.1 109.397 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.586 ' HB2' HG23 ' A' ' 39' ' ' VAL . 8.9 m -73.36 138.35 78.21 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 115.623 -0.717 . . . . 70.32 109.504 169.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.93 -19.68 33.14 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.793 2.329 . . . . 63.41 113.501 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.78 -33.39 70.71 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.513 1.125 . . . . 75.34 111.755 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.0 t -67.07 -49.67 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.435 0.694 . . . . 74.32 111.42 -175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 28' ' ' GLN . 3.5 pp -58.78 -30.8 67.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.396 0.278 . . . . 72.14 111.212 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.45 -58.93 5.05 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.714 1.206 . . . . 64.33 110.986 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.31 -30.47 71.6 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.823 0.449 . . . . 63.41 111.654 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 15' ' ' ILE . 48.9 t -67.08 -50.5 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.897 0.879 . . . . 63.3 110.651 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -73.68 -20.42 60.55 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.124 0.416 . . . . 72.31 112.124 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -85.61 -26.59 25.98 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 122.22 -0.3 . . . . 74.13 110.543 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.7 -25.31 60.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.885 0.874 . . . . 72.11 109.936 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.25 90.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.185 1.394 . . . . 70.44 112.066 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -59.89 -38.65 82.85 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.836 1.335 . . . . 74.34 111.005 -173.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -57.19 -58.84 6.46 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.233 0.958 . . . . 75.53 110.659 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.8 -34.02 76.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.509 1.124 . . . . 50.32 111.983 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -66.11 -45.11 82.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.014 0.925 . . . . 71.14 110.339 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.6 -32.56 66.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.48 0.712 . . . . 72.55 111.157 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -69.45 -18.29 63.71 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.486 0.714 . . . . 75.33 111.427 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.75 42.0 40.46 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.557 0.536 . . . . 70.42 112.203 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -111.15 96.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.211 -0.663 . . . . 64.13 109.211 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -92.05 108.11 19.7 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.192 -0.669 . . . . 70.31 109.192 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 8.7 p90 -106.3 135.49 47.7 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.174 -1.417 . . . . 63.14 107.174 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.56 135.6 47.15 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 110.007 -0.368 . . . . 73.04 110.007 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.68 125.18 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.902 1.376 . . . . 74.04 110.626 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.39 -37.93 3.91 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.731 0.813 . . . . 70.42 111.064 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 27.2 ttp85 -143.81 129.5 19.24 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.338 0.655 . . . . 75.01 109.349 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.65 128.66 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.878 0.871 . . . . 63.43 108.759 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -127.38 106.62 9.33 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.737 -1.208 . . . . 62.42 107.737 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.466 HG23 HG22 ' A' ' 73' ' ' VAL . 7.3 p -103.26 113.97 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.772 -0.825 . . . . 73.21 108.772 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.5 t -137.55 153.63 49.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 74.41 109.97 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 71' ' ' VAL . 34.2 p -100.75 130.16 46.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.145 0.578 . . . . 71.33 111.676 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.88 81.08 1.38 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.503 1.921 . . . . 71.33 108.437 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.44 -120.47 8.35 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.41 -0.814 . . . . 64.24 111.207 -173.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -87.38 -11.33 49.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.441 0.697 . . . . 73.15 110.639 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.4 m -89.96 156.73 18.22 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.272 1.029 . . . . 61.41 108.845 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 66' ' ' THR . 43.7 t -122.4 133.0 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.04 0.936 . . . . 74.25 109.331 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -110.56 125.83 53.77 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.722 0.809 . . . . 74.33 109.203 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 64' ' ' VAL . 48.7 t -97.38 104.1 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.378 -0.971 . . . . 42.05 108.378 169.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -86.75 102.22 14.05 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.515 -1.291 . . . . 61.22 107.515 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.21 123.1 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 33.44 109.89 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.0 tt0 -90.13 127.81 36.19 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.353 1.061 . . . . 73.02 109.444 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.49 143.68 51.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.288 0.635 . . . . 75.33 109.847 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -91.61 108.75 20.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.178 -0.675 . . . . 74.31 109.178 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 24.9 mt-10 -87.25 103.18 15.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.075 0.55 . . . . 74.11 109.666 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.7 m -93.96 106.14 18.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 74.42 109.465 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -145.59 118.55 8.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.346 1.058 . . . . 75.54 109.24 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.73 23.14 62.8 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.514 0.565 . . . . 23.34 114.514 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.03 -22.64 34.48 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.964 0.316 . . . . 75.1 112.901 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.2 m -83.69 124.52 30.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.561 0.745 . . . . 64.21 109.833 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 m -126.92 110.37 12.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.445 -0.946 . . . . 61.34 108.445 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.9 m -125.9 136.11 52.68 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.955 0.902 . . . . 64.32 109.976 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.93 100.58 6.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.833 -1.173 . . . . 55.32 107.833 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.2 m -105.29 132.63 51.24 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.927 -1.033 . . . . 73.22 108.985 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -89.39 122.89 33.04 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.427 -0.583 . . . . 75.22 109.427 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -104.8 126.77 52.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.164 -1.05 . . . . 63.43 108.164 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -113.79 103.9 11.66 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.103 -1.073 . . . . 74.32 108.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 106' ' ' VAL . 5.7 mp -98.38 107.07 19.44 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.117 -1.068 . . . . 75.23 108.117 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -90.45 98.74 11.95 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.075 -0.713 . . . . 60.25 109.075 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.618 ' HB3' HG21 ' A' ' 101' ' ' ILE . 93.4 m-85 -89.54 109.92 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.492 1.117 . . . . 73.11 109.284 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 28.2 tt0 -107.63 131.59 54.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.616 -0.513 . . . . 72.34 109.616 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 101' ' ' ILE . 11.0 m -84.35 151.84 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.83 1.252 . . . . 63.44 111.115 -168.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.8 98.38 3.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.215 -1.032 . . . . 72.41 108.215 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.82 2.18 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.021 -0.831 . . . . 34.42 111.021 -174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.68 -5.25 12.71 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.977 0.911 . . . . 70.34 111.17 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.6 t -127.44 143.86 51.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.68 . . . . 74.42 110.282 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 94' ' ' PHE . 73.4 mt -87.9 109.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.671 0.788 . . . . 73.22 109.361 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -103.27 6.16 37.93 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.209 0.448 . . . . 64.31 112.209 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 90.0 mtt180 -133.21 141.91 48.31 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.349 0.66 . . . . 73.4 110.903 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.96 134.68 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 63.32 108.504 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.4 m -132.02 106.56 8.1 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.094 -0.706 . . . . 71.41 109.094 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 92' ' ' LEU . 37.6 t -90.04 119.03 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.924 0.49 . . . . 71.32 109.798 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.6 m -113.31 106.88 15.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.504 0.722 . . . . 73.23 110.374 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -77.93 103.83 8.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.39 -0.967 . . . . 62.3 108.39 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.97 79.94 9.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.539 0.735 . . . . 64.3 109.588 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.93 -17.75 15.66 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.461 -1.245 . . . . 71.25 111.687 172.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.86 120.22 0.58 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.299 -0.72 . . . . 70.22 111.299 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 m -72.98 159.57 33.46 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.253 0.621 . . . . 74.52 110.34 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.73 -60.08 4.23 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.831 0.852 . . . . 71.4 110.217 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.68 98.89 2.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.75 0.82 . . . . 63.15 109.385 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -81.7 178.38 8.36 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.302 0.641 . . . . 74.33 110.954 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -84.93 51.75 2.24 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.036 0.922 . . . . 72.41 110.331 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -143.41 97.06 3.01 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.998 0.919 . . . . 41.43 109.385 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -89.89 113.5 25.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.879 -0.786 . . . . 73.42 108.879 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 m80 63.91 97.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.805 1.242 . . . . 62.43 111.507 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.015 -1.105 . . . . 73.24 108.015 177.471 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.633 0.254 . . . . 74.44 110.38 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -88.48 -6.61 57.51 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.018 0.927 . . . . 75.14 110.801 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.99 41.62 0.98 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.519 1.128 . . . . 45.1 110.97 -170.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -51.59 -41.1 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 125.401 1.481 . . . . 52.13 114.111 -166.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.34 -51.9 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.457 0.703 . . . . 73.13 110.678 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.71 -30.1 71.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.437 0.695 . . . . 70.14 110.344 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.68 71.18 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.848 1.259 . . . . 64.52 109.87 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.78 82.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.528 0.731 . . . . 71.34 111.495 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.479 ' HG3' HG11 ' A' ' 62' ' ' VAL . 39.6 tttm -63.68 -51.66 64.13 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.028 -0.987 . . . . 74.42 111.796 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.403 HE21 HD13 ' A' ' 30' ' ' LEU . 20.0 pt20 -72.64 -24.7 61.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.348 0.259 . . . . 64.45 111.317 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.04 -45.12 86.7 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 123.533 0.733 . . . . 53.03 110.237 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.64 -54.37 46.9 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.475 1.109 . . . . 72.12 110.746 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.45 HG12 HG11 ' A' ' 59' ' ' VAL . 57.0 mt -59.89 -41.67 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.086 0.866 . . . . 72.34 110.854 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.71 88.52 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.959 0.904 . . . . 63.13 111.58 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.514 ' HA ' HG11 ' A' ' 43' ' ' VAL . 45.6 mt -61.22 -37.23 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 124.064 0.853 . . . . 54.01 110.496 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.27 -29.9 34.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.792 0.437 . . . . 73.34 111.497 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -66.73 -35.2 79.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.355 0.662 . . . . 74.33 110.276 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.15 -47.22 59.07 Favored 'General case' 0 C--O 1.213 -0.816 0 O-C-N 123.669 0.606 . . . . 73.0 110.17 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.489 ' HB3' HD12 ' A' ' 50' ' ' LEU . 29.1 m0 -57.1 -26.67 60.85 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.105 0.78 . . . . 72.23 113.105 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -101.36 -16.18 16.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.807 0.443 . . . . 71.41 111.963 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.469 HD22 ' HB2' ' A' ' 24' ' ' ASP . 7.8 t30 -156.17 89.54 2.79 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 123.996 0.918 . . . . 75.54 109.352 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 23.6 Cg_endo -59.77 -23.1 70.71 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.883 3.055 . . . . 74.03 113.633 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.4 p -81.17 -2.22 47.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.15 0.98 . . . . 62.54 112.341 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' HB2' HD22 ' A' ' 21' ' ' ASN . 10.2 t70 -66.95 113.49 13.54 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 122.919 0.487 . . . . 73.23 109.873 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.51 -28.26 4.54 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.363 2.042 . . . . 61.43 112.766 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -70.03 -41.02 74.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.47 0.708 . . . . 73.13 111.183 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -51.41 49.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.897 -1.047 . . . . 62.01 111.116 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -68.41 -28.37 67.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.118 -0.492 . . . . 72.22 112.056 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.28 -47.26 62.02 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.254 0.346 . . . . 62.3 110.874 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.9 pp -65.76 -33.34 75.65 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 110.175 -0.306 . . . . 74.53 110.175 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.96 -28.88 70.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.731 0.813 . . . . 71.1 111.722 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -69.39 -41.63 76.21 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.435 0.636 . . . . 70.31 109.613 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -73.98 -22.62 59.55 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.606 -1.179 . . . . 74.35 112.215 -171.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.0 pt -118.09 -51.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.315 0.507 . . . . 75.25 112.337 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.416 HD23 HG13 ' A' ' 34' ' ' ILE . 3.1 mm? -82.14 166.43 19.68 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 54.35 108.206 173.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -61.79 142.7 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 109.77 -0.456 . . . . 75.4 109.77 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.84 -11.42 14.85 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.746 2.297 . . . . 72.14 113.444 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.86 -37.12 73.07 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.735 0.814 . . . . 53.54 110.816 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.0 -37.54 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.253 1.021 . . . . 61.51 112.202 -171.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.35 -31.54 72.19 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.784 0.265 . . . . 71.04 110.905 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.22 -57.34 6.9 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 124.457 1.098 . . . . 41.25 109.991 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 12.1 pt20 -58.79 -30.44 67.59 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.035 0.534 . . . . 60.23 111.993 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 15' ' ' ILE . 67.6 t -75.44 -49.8 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.127 0.971 . . . . 54.22 111.913 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -67.67 -24.96 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.745 0.307 . . . . 74.01 111.344 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -86.14 -25.57 25.67 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.825 0.45 . . . . 52.11 110.984 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 5.5 t60 -67.0 -29.29 69.09 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.913 0.885 . . . . 72.3 109.544 172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . . . -59.03 -39.6 82.44 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.107 1.363 . . . . 63.21 112.667 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 75.3 mtp180 -58.43 -32.04 68.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.031 0.932 . . . . 73.03 111.293 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.22 -51.66 62.59 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.166 0.986 . . . . 50.43 110.907 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.515 HD22 HD12 ' A' ' 55' ' ' ILE . 53.0 mt -73.6 -17.69 61.14 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.307 -0.86 . . . . 75.33 111.317 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -72.61 -42.73 64.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.177 0.991 . . . . 74.41 109.625 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 73.6 mmtt -61.62 -42.62 99.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 123.739 0.649 . . . . 74.44 109.611 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' NE2' HD23 ' A' ' 50' ' ' LEU . 50.9 mt-30 -72.53 -28.52 62.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.231 -1.349 . . . . 73.32 111.732 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.12 40.71 95.13 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.729 0.643 . . . . 54.2 113.087 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.515 HD12 HD22 ' A' ' 50' ' ' LEU . 59.3 mt -78.62 114.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.883 0.473 . . . . 60.15 109.865 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -90.64 112.92 24.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.485 -0.931 . . . . 70.44 108.485 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.2 134.38 20.51 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.428 0.558 . . . . 72.01 111.164 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.875 0.87 . . . . 72.02 109.645 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 13' ' ' ILE . 49.4 t -77.18 120.62 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.394 1.077 . . . . 72.51 109.755 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.19 -54.5 2.6 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.431 0.692 . . . . 64.25 111.376 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 8.6 tpp85 -132.59 127.27 34.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.442 -0.948 . . . . 70.14 108.442 -173.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 9' ' ' LYS . 38.3 t -123.0 109.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.723 -0.843 . . . . 72.2 108.723 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -119.79 108.39 14.33 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.632 -0.877 . . . . 61.03 108.632 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -105.34 109.95 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.085 0.954 . . . . 65.32 109.687 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -123.83 142.55 51.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.913 0.885 . . . . 40.14 109.742 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.1 p -93.42 124.05 37.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.657 0.383 . . . . 70.03 110.369 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -113.51 98.24 6.95 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.228 -1.027 . . . . 72.35 108.228 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.191 -1.164 . . . . 73.42 110.191 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -105.45 -15.21 15.08 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.358 0.663 . . . . 72.03 110.332 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.0 m -93.35 117.06 29.62 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.922 0.489 . . . . 53.5 109.761 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 94' ' ' PHE . 8.0 p -88.68 128.9 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.189 0.596 . . . . 71.34 110.377 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.63 113.35 25.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.782 1.233 . . . . 72.33 109.363 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.57 104.48 15.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.292 -0.632 . . . . 63.1 109.292 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.9 m -86.29 104.8 16.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.019 -1.104 . . . . 71.22 108.019 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.1 p -127.61 115.35 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.337 0.655 . . . . 72.12 111.391 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.59 132.43 35.3 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.206 -0.906 . . . . 70.1 109.573 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.24 135.17 54.43 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.001 0.92 . . . . 74.41 108.679 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 85' ' ' THR . 33.4 tt0 -93.96 102.14 14.22 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -95.35 112.88 24.52 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.482 1.113 . . . . 74.12 109.593 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -87.67 102.97 15.15 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.766 -1.198 . . . . 72.31 107.766 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -134.83 134.98 41.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.952 -1.129 . . . . 71.35 107.952 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.11 65.57 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.091 0.245 . . . . 71.3 112.553 -172.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.27 59.53 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 123.206 0.431 . . . . 60.42 113.5 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.2 p -96.66 151.01 20.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.905 0.882 . . . . 71.41 111.093 -173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.526 HG23 ' HG3' ' A' ' 78' ' ' GLU . 89.4 m -85.38 115.85 23.36 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.093 0.957 . . . . 74.41 109.125 177.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.6 m -121.42 111.02 16.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.714 -0.847 . . . . 62.42 108.714 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -90.37 102.7 15.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.487 -0.931 . . . . 71.55 108.487 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.6 m -111.46 126.11 54.6 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.627 0.771 . . . . 74.22 109.261 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -91.73 120.89 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.456 -0.572 . . . . 74.14 109.456 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.2 127.69 49.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.768 -1.567 . . . . 75.14 106.768 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.26 102.08 10.52 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.987 -1.116 . . . . 70.35 107.987 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 106' ' ' VAL . 7.4 mp -90.74 106.58 18.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 50.6 ttp180 -91.67 98.46 11.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.731 -1.122 . . . . 73.35 108.175 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.578 ' HB3' HG21 ' A' ' 101' ' ' ILE . 98.7 m-85 -88.53 107.75 19.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.999 -0.741 . . . . 71.3 108.999 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 1.6 tm-20 -90.89 125.95 35.9 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.882 -1.525 . . . . 74.33 106.882 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.4 HG12 HG12 ' A' ' 101' ' ' ILE . 19.8 m -104.13 148.85 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.177 0.991 . . . . 75.12 111.676 -163.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.7 92.45 2.75 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.691 1.196 . . . . 75.01 109.007 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.62 -102.42 1.29 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.468 -0.787 . . . . 65.15 111.53 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.5 -10.06 13.75 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.078 0.951 . . . . 73.4 111.037 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -108.17 166.73 10.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.274 0.63 . . . . 71.25 109.565 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 94' ' ' PHE . 54.1 mt -115.52 120.29 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 107.637 -1.245 . . . . 63.44 107.637 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -88.26 -30.92 19.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.176 0.19 . . . . 73.32 111.153 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 65.2 mtt180 -129.42 147.73 51.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.904 0.481 . . . . 74.14 110.904 -164.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.67 110.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 64.34 109.051 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 25.9 m -95.39 104.67 16.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.667 -0.864 . . . . 54.44 108.667 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG22 ' HG ' ' A' ' 92' ' ' LEU . 40.9 t -85.55 102.41 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.669 -1.234 . . . . 70.15 107.669 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.0 m -99.26 109.31 21.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.096 -0.705 . . . . 71.41 109.096 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.37 106.56 12.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.593 0.757 . . . . 74.4 110.374 -174.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -107.23 104.56 14.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.611 1.164 . . . . 61.3 108.54 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.32 -163.9 25.13 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-O 119.854 -0.414 . . . . 45.33 112.674 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.73 57.45 14.36 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.75 0.323 . . . . 41.34 112.855 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -87.52 97.67 10.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.85 0.46 . . . . 44.3 110.492 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.03 -55.1 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.244 0.545 . . . . 75.31 110.153 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 -167.95 2.14 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.574 1.15 . . . . 71.4 109.314 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 117' ' ' HIS . 59.4 m80 -136.38 121.17 18.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.411 1.084 . . . . 74.14 108.782 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -67.54 -17.14 64.55 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.563 0.745 . . . . 40.03 112.292 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 115' ' ' HIS . 82.1 m-70 -129.36 145.14 51.44 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.442 -0.948 . . . . 72.22 108.442 165.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -52.62 143.55 15.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.998 0.919 . . . . 72.54 112.158 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -67.77 120.46 14.15 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.41 0.444 . . . . 54.31 110.958 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.411 -0.959 . . . . 71.55 108.411 171.381 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.205 -0.665 . . . . 73.11 109.205 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -58.46 -56.57 20.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.162 0.985 . . . . 65.14 112.193 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -160.54 163.01 33.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.536 0.734 . . . . 74.43 109.623 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.31 -50.15 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.884 0.874 . . . . 73.11 110.999 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.39 -36.0 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.205 -0.907 . . . . 63.34 110.295 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.14 -35.57 80.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.919 -0.582 . . . . 60.21 110.869 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.731 0.412 . . . . 75.15 110.211 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.38 90.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.702 -0.681 . . . . 73.21 111.699 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.29 -46.79 69.39 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.471 -0.786 . . . . 41.55 111.285 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -63.83 -41.77 97.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.448 0.699 . . . . 73.11 110.666 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.34 97.86 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 123.666 0.604 . . . . 72.25 111.29 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -56.51 -53.71 54.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.032 0.833 . . . . 63.13 111.156 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 70.1 mt -61.96 -43.68 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.363 -0.835 . . . . 74.13 110.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 30' ' ' LEU . . . -63.96 -37.56 87.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.588 0.755 . . . . 72.13 112.454 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.14 -37.59 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.841 0.856 . . . . 71.53 109.985 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -74.52 -35.01 63.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.257 0.623 . . . . 71.11 111.818 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 8.3 mm-40 -63.35 -37.29 86.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.526 -0.546 . . . . 71.31 109.526 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.7 mt -71.48 -41.84 68.82 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.36 -0.836 . . . . 74.11 110.891 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -59.29 -34.57 72.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.87 0.693 . . . . 74.02 112.87 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -96.91 -15.99 20.9 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.606 0.362 . . . . 74.43 111.547 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.82 84.36 2.76 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.579 0.752 . . . . 74.45 109.145 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' HE21 ' A' ' 51' ' ' GLN . 29.1 Cg_endo -62.18 -13.51 32.43 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.275 2.65 . . . . 70.4 114.135 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 p -89.43 9.68 25.44 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.717 0.807 . . . . 54.21 112.284 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.1 109.79 4.99 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.166 0.586 . . . . 74.12 110.056 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.67 -37.62 16.0 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.555 2.17 . . . . 74.32 112.979 -171.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.06 -42.73 69.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.791 0.836 . . . . 73.31 111.697 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.11 -54.97 29.59 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.548 0.739 . . . . 63.31 111.564 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -62.81 -32.87 74.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.756 -0.657 . . . . 74.12 111.6 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.9 -46.28 72.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.106 0.563 . . . . 52.23 112.129 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 14' ' ' ALA . 4.2 pp -69.64 -27.31 64.94 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 120.842 0.353 . . . . 52.35 110.422 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 mt -69.18 -18.63 63.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.011 0.925 . . . . 72.24 112.61 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -73.96 -29.05 61.79 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.082 0.401 . . . . 73.04 110.483 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.08 -42.21 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 72.01 111.654 -174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 20.0 pt -103.97 -31.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 112.326 0.491 . . . . 54.24 112.326 -172.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 39' ' ' VAL . 3.2 mm? -112.78 -179.35 3.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.111 0.964 . . . . 72.33 109.208 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB2' HG23 ' A' ' 39' ' ' VAL . 50.7 m -84.67 143.29 40.69 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 73.42 109.941 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.94 -32.22 37.19 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.298 2.665 . . . . 75.12 113.185 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.43 -47.99 77.93 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.115 0.966 . . . . 53.22 111.856 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' SER . 91.1 t -63.02 -52.32 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.199 -0.91 . . . . 71.33 111.259 -173.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.97 -28.18 69.91 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.187 0.44 . . . . 65.1 112.187 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -58.81 5.08 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 124.156 0.91 . . . . 64.05 110.073 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 39' ' ' VAL . 26.8 pt20 -69.16 -21.11 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.039 -0.528 . . . . 72.04 111.414 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.36 -50.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.725 0.41 . . . . 53.41 110.071 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 4.7 ppt_? -71.06 -21.0 62.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.757 0.281 . . . . 74.41 111.757 -177.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -73.22 -49.21 29.16 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.704 0.401 . . . . 70.51 111.498 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -67.89 -21.84 65.13 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.045 0.538 . . . . 63.13 111.111 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.0 -37.7 88.52 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.234 1.013 . . . . 63.15 111.853 174.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 44' ' ' ARG . 61.9 mtp180 -62.86 -27.38 69.3 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.57 0.748 . . . . 70.43 110.555 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -47.62 60.61 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.897 -0.592 . . . . 72.43 110.253 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD23 ' NE2' ' A' ' 53' ' ' GLN . 92.8 mt -65.86 -33.23 75.37 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.628 0.771 . . . . 62.31 111.361 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.422 HE21 ' HD2' ' A' ' 22' ' ' PRO . 6.1 tp-100 -62.82 -44.71 95.43 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.019 0.928 . . . . 74.52 109.702 175.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.82 -31.59 69.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.994 -1.003 . . . . 75.12 111.056 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.409 ' NE2' HD23 ' A' ' 50' ' ' LEU . 49.8 mt-30 -77.48 -15.59 59.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.445 0.698 . . . . 75.54 111.198 176.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.38 30.1 74.91 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.59 0.556 . . . . 45.01 113.469 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.8 mt -80.62 99.18 4.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 109.588 -0.523 . . . . 74.53 109.588 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -81.33 109.62 16.01 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 107.591 -1.263 . . . . 74.34 107.591 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.66 162.88 14.72 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.596 -0.89 . . . . 74.51 108.596 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.12 130.33 20.85 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.781 -0.452 . . . . 71.43 109.781 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.6 t -68.04 135.58 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 123.967 0.792 . . . . 74.32 109.81 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -117.62 -51.97 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.582 1.153 . . . . 74.43 110.345 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HE ' ' A' ' 61' ' ' ARG . 2.0 tpm_? -142.07 123.83 15.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.157 -0.929 . . . . 74.34 108.913 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.25 112.81 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.231 -0.655 . . . . 75.24 109.231 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.05 146.64 44.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.951 -1.129 . . . . 72.42 107.951 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.547 HG23 HG22 ' A' ' 73' ' ' VAL . 5.7 p -135.45 108.81 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.052 -0.721 . . . . 62.34 109.052 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.8 m -118.38 128.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.328 1.051 . . . . 51.11 109.399 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.4 p -88.64 162.6 16.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.116 0.566 . . . . 64.01 110.478 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -160.6 92.15 0.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.335 1.054 . . . . 64.33 108.218 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.95 9.95 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.609 -0.55 . . . . 70.25 111.827 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -91.76 -10.88 38.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 74.21 111.224 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.2 m -101.6 140.54 35.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.571 0.749 . . . . 72.41 110.605 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 94' ' ' PHE . 2.9 p -121.76 116.67 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.561 0.696 . . . . 70.13 110.142 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -96.26 108.4 20.88 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.448 1.099 . . . . 73.23 109.154 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 64' ' ' VAL . 59.2 t -88.52 107.12 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.667 -0.864 . . . . 75.21 108.667 177.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -95.89 105.25 17.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.96 -1.126 . . . . 54.43 107.96 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.52 125.49 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.517 0.727 . . . . 75.43 110.45 -170.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.7 123.66 31.34 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.257 0.623 . . . . 73.4 110.061 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.15 122.41 37.0 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.285 -1.006 . . . . 64.32 108.285 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.3 116.73 27.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.293 0.568 . . . . 55.53 109.78 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.89 105.0 17.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.154 0.982 . . . . 72.41 111.416 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -90.78 103.13 15.87 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.651 1.181 . . . . 52.52 108.744 170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.0 t -138.53 137.22 36.87 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.34 0.656 . . . . 62.3 109.557 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.77 22.12 67.95 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.918 -0.583 . . . . 52.15 113.018 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.9 -33.72 5.06 Favored Glycine 0 C--N 1.354 1.569 0 C-N-CA 122.848 0.261 . . . . 44.21 112.988 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -84.57 135.6 34.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.532 0.733 . . . . 75.11 111.486 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -107.88 145.95 33.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.706 0.802 . . . . 71.03 110.034 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.8 m -143.63 123.87 13.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.489 0.715 . . . . 43.45 109.082 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.97 102.13 6.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.077 -0.712 . . . . 64.25 109.077 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 84.9 m -107.68 131.63 54.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.967 0.907 . . . . 51.05 110.118 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -95.47 120.14 35.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.311 0.644 . . . . 63.45 109.435 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -102.9 126.37 50.03 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.989 0.915 . . . . 72.34 108.822 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.53 104.27 13.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.723 -0.843 . . . . 71.3 108.723 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 12' ' ' ALA . 5.7 mp -91.83 107.38 19.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.285 -1.006 . . . . 74.24 108.285 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -91.74 97.43 11.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.481 -0.781 . . . . 71.41 109.583 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.59 ' HB2' HG13 ' A' ' 71' ' ' VAL . 97.5 m-85 -91.14 117.4 29.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.517 0.727 . . . . 74.45 110.16 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 28.3 tt0 -101.48 121.19 41.5 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.682 -0.858 . . . . 63.12 108.682 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.592 HG12 HG12 ' A' ' 101' ' ' ILE . 10.0 m -86.37 140.17 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.913 -0.403 . . . . 74.53 109.913 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -134.56 117.45 16.17 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.237 -1.394 . . . . 63.01 107.237 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -114.32 3.99 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.691 -0.964 . . . . 71.22 110.691 -168.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -113.95 -19.15 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.236 0.614 . . . . 71.32 112.097 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -112.14 161.86 16.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.227 0.611 . . . . 72.15 110.675 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.592 HG12 HG12 ' A' ' 96' ' ' VAL . 52.4 mt -82.31 128.36 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.797 -0.816 . . . . 72.03 108.797 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -114.56 -14.52 12.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.409 0.684 . . . . 74.35 112.32 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.665 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 9.8 tpt180 -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.474 0.309 . . . . 75.0 110.505 -172.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.82 139.95 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.986 0.914 . . . . 50.3 109.162 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -134.62 104.62 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.581 -0.896 . . . . 30.02 108.581 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.72 132.02 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.014 0.526 . . . . 72.52 109.722 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.4 m -120.47 116.22 25.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.652 0.781 . . . . 64.14 109.212 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -80.3 105.26 11.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.774 0.83 . . . . 62.13 109.467 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -115.12 109.45 18.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.441 1.096 . . . . 73.33 110.566 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.41 63.56 4.45 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 112.087 -0.405 . . . . 41.54 112.087 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.51 31.76 56.04 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 112.129 -0.388 . . . . 73.33 112.129 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 m -77.56 117.4 18.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.511 0.724 . . . . 53.33 110.221 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt 59.74 33.23 21.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.39 1.076 . . . . 74.14 111.431 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.11 139.18 58.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.677 -1.147 . . . . 63.24 108.594 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -67.29 -41.94 84.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 74.2 112.964 -163.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -97.56 123.43 41.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.362 0.601 . . . . 71.12 110.942 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -69.36 91.93 0.57 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.914 -0.773 . . . . 74.03 108.914 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -81.22 23.53 0.59 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.438 0.903 . . . . 63.54 113.438 -170.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -159.05 129.36 5.84 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.113 -0.699 . . . . 65.12 109.113 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 124.7 1.2 . . . . 70.51 108.835 175.066 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.621 ' HB2' HG22 ' A' ' 34' ' ' ILE . 60.6 mtp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.344 -0.613 . . . . 53.23 109.344 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.29 -19.38 61.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.261 1.024 . . . . 64.32 111.789 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.67 85.36 0.64 Allowed 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.452 1.101 . . . . 74.3 109.713 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 96' ' ' VAL . 34.3 mm -64.33 -43.65 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 124.423 1.089 . . . . 71.44 112.84 -169.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.5 -52.43 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.563 0.745 . . . . 65.1 109.554 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -69.93 -26.48 64.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.053 -1.43 . . . . 75.24 111.583 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.81 -57.39 8.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.619 0.767 . . . . 74.11 109.667 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.31 76.75 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.28 0.988 . . . . 65.41 111.883 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.75 -58.8 7.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.953 0.901 . . . . 60.11 110.694 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -69.82 -22.26 63.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.709 0.804 . . . . 75.31 111.67 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.3 -45.38 69.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.039 0.935 . . . . 71.01 110.571 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.561 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . -59.18 -46.72 87.66 Favored 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.294 0.996 . . . . 74.45 110.672 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 62' ' ' VAL . 41.7 mt -61.39 -42.31 93.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 O-C-N 124.404 1.065 . . . . 73.04 110.165 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.87 68.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.165 0.986 . . . . 70.42 112.62 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.405 ' HA ' HG11 ' A' ' 43' ' ' VAL . 46.5 mt -63.21 -42.52 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.595 0.758 . . . . 54.24 109.826 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 92' ' ' LEU . 30.4 m-85 -69.96 -37.27 75.77 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.728 -0.669 . . . . 74.31 111.547 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.438 HE21 HG22 ' A' ' 13' ' ' ILE . 68.8 mt-30 -61.67 -38.49 87.94 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.759 0.662 . . . . 75.12 110.909 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 44' ' ' ARG . 75.6 mt -70.0 -40.45 75.28 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.582 0.552 . . . . 72.11 110.487 174.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HB3' HD12 ' A' ' 50' ' ' LEU . 39.5 m0 -64.87 -31.03 72.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 112.906 0.706 . . . . 74.42 112.906 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -98.52 -20.69 16.92 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.045 0.538 . . . . 72.14 111.537 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -156.27 85.14 3.17 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 123.786 0.835 . . . . 72.41 108.808 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.84 -19.87 69.8 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.45 2.1 . . . . 52.12 113.289 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -81.04 2.41 27.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.689 0.796 . . . . 73.51 112.635 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.86 111.48 6.5 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 122.878 0.471 . . . . 73.05 109.764 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.7 -31.58 8.4 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.347 2.032 . . . . 70.31 112.733 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.12 -39.42 65.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.343 0.657 . . . . 74.41 110.958 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -56.4 18.75 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 124.118 0.967 . . . . 72.45 110.937 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.44 -32.61 74.32 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.779 -0.646 . . . . 71.13 111.306 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.09 -56.71 16.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.515 0.726 . . . . 72.44 111.296 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 pp -62.82 -31.73 72.78 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 123.759 0.662 . . . . 74.11 110.606 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -66.95 -26.03 66.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.552 0.741 . . . . 71.54 112.073 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.854 0.752 . . . . 63.22 110.516 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.77 -16.03 31.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.028 0.931 . . . . 74.3 111.501 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 1' ' ' MET . 16.2 pt -124.56 -45.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.405 0.52 . . . . 70.54 112.405 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 39' ' ' VAL . 3.8 mm? -95.15 172.46 8.11 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.037 0.935 . . . . 64.11 109.26 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 39' ' ' VAL . 21.0 m -83.25 143.52 45.28 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 115.464 -0.789 . . . . 71.13 110.041 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.71 -31.88 52.62 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.046 3.164 . . . . 65.21 114.049 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.34 -48.03 77.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.779 0.832 . . . . 75.04 111.619 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 HD12 ' A' ' 35' ' ' LEU . 42.2 t -63.19 -39.48 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 72.24 111.516 -171.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.07 -27.57 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.472 0.177 . . . . 61.13 111.064 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 17.5 t70 -73.68 -44.81 55.62 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.71 0.631 . . . . 75.05 110.405 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.88 -32.71 74.03 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 122.593 0.357 . . . . 73.51 110.892 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 15' ' ' ILE . 25.1 t -63.52 -51.56 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 70.11 111.263 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB3' HD13 ' A' ' 18' ' ' LEU . 3.3 ptm180 -69.29 -17.27 63.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.058 0.543 . . . . 73.14 111.914 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 51.3 mt-10 -84.26 -35.26 23.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.433 0.693 . . . . 75.22 111.511 171.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -73.34 -17.76 61.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.476 0.711 . . . . 71.43 110.801 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.79 67.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.595 1.158 . . . . 73.22 111.673 169.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -56.1 -34.82 66.39 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 124.348 1.03 . . . . 64.54 111.507 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -65.19 -55.04 20.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.969 0.507 . . . . 73.35 111.04 -175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 19' ' ' TRP . 88.4 mt -71.39 -34.39 70.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.255 0.622 . . . . 74.51 111.35 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.46 -45.63 68.59 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.725 0.81 . . . . 74.11 111.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.01 -40.79 97.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.116 0.967 . . . . 63.45 111.134 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -75.72 -19.72 58.87 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.735 -0.666 . . . . 62.22 111.938 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.43 28.76 57.15 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.293 0.371 . . . . 51.02 113.44 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.62 104.97 9.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.602 0.761 . . . . 75.34 109.76 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -82.66 111.25 18.44 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.645 -0.872 . . . . 73.44 108.645 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 43.4 p90 -108.53 144.77 35.75 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.487 -1.301 . . . . 72.3 107.487 168.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -121.56 121.02 36.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.995 -0.743 . . . . 64.02 108.995 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.27 100.44 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.753 -0.832 . . . . 71.14 108.753 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -86.45 -45.19 11.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.824 0.849 . . . . 65.55 111.504 -171.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -144.87 142.29 29.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.265 -0.643 . . . . 74.41 109.265 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 13' ' ' ILE . 93.1 t -125.18 128.73 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.264 -1.013 . . . . 61.34 108.264 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.2 123.73 40.91 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.933 -1.136 . . . . 64.14 107.933 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.31 126.42 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 109.467 -0.568 . . . . 64.31 109.467 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.7 m -132.56 122.3 24.59 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.554 0.742 . . . . 72.41 109.544 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -88.57 121.52 31.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.449 0.7 . . . . 44.11 109.983 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -125.96 89.28 3.0 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.176 0.991 . . . . 71.14 108.337 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.81 -121.46 7.85 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.022 -0.831 . . . . 44.42 111.022 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -98.54 -9.94 24.21 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.127 0.571 . . . . 74.52 110.294 170.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.6 m -96.49 111.16 23.37 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.334 0.654 . . . . 75.45 109.698 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.07 109.31 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.247 0.546 . . . . 71.51 110.225 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.486 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -84.22 103.93 13.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.601 1.16 . . . . 71.33 108.616 177.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.94 105.34 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.121 0.486 . . . . 53.4 109.85 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.1 m -86.04 105.13 16.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.28 1.032 . . . . 71.22 109.691 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.75 123.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.721 0.809 . . . . 72.4 109.878 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -85.61 117.68 24.66 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.282 0.633 . . . . 73.23 109.304 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.68 163.06 13.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.783 -0.821 . . . . 73.41 108.783 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -136.52 102.55 4.98 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.938 -1.504 . . . . 64.43 106.938 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 33.2 mt-10 -94.14 106.51 18.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.963 0.905 . . . . 75.41 110.46 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -93.92 106.41 18.39 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.737 0.815 . . . . 60.13 109.173 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -132.95 132.48 42.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.805 0.842 . . . . 75.24 109.621 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.16 13.26 61.9 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.089 0.396 . . . . 74.24 114.089 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.07 -32.97 6.83 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.78 -0.455 . . . . 72.43 112.881 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -84.09 150.18 25.73 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 117.216 0.508 . . . . 75.31 110.862 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.9 m -118.28 134.02 55.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.881 0.872 . . . . 54.11 109.959 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.9 m -138.52 122.11 17.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.475 1.11 . . . . 72.23 109.257 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -76.6 119.65 20.71 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.097 -0.705 . . . . 73.32 109.097 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.448 HG21 HE21 ' A' ' 108' ' ' GLN . 32.9 m -129.86 123.26 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.88 0.872 . . . . 64.4 109.5 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.0 m -87.67 128.86 35.29 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.534 -0.543 . . . . 72.32 109.534 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -109.75 125.38 52.63 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.32 -1.363 . . . . 73.43 107.32 168.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HB2' HD21 ' A' ' 109' ' ' ASN . 2.9 tt0 -106.57 104.69 14.44 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.061 -1.088 . . . . 72.25 108.061 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 12' ' ' ALA . 4.3 mp -90.88 105.29 17.73 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.565 -1.272 . . . . 71.44 107.565 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -93.71 99.13 11.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.883 0.873 . . . . 74.43 108.846 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.96 108.16 19.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.189 0.996 . . . . 74.25 110.136 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 29.2 tt0 -90.92 113.99 26.35 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.902 -0.777 . . . . 61.22 108.902 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.616 HG12 HG12 ' A' ' 101' ' ' ILE . 4.1 m -83.48 148.82 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.095 -0.705 . . . . 52.45 109.095 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -141.97 96.53 2.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.117 -1.068 . . . . 74.2 108.117 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 -124.07 6.7 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.402 -0.679 . . . . 73.43 111.402 -173.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -89.87 -21.31 22.59 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.491 0.717 . . . . 74.3 111.689 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -121.87 157.59 30.82 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.33 0.652 . . . . 75.53 110.795 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 96' ' ' VAL . 28.6 mt -90.55 115.47 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 72.2 108.689 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 36' ' ' SER . 28.6 mmt180 -89.35 -28.21 19.96 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.534 0.734 . . . . 75.44 111.104 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 29.5 mtt180 -130.85 135.9 48.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.929 0.492 . . . . 75.52 110.948 -163.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.95 142.94 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.263 1.025 . . . . 73.15 109.01 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -127.8 105.43 8.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.254 -1.017 . . . . 62.42 108.254 172.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.35 104.17 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.896 -1.15 . . . . 63.22 107.896 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -104.36 104.51 14.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.894 0.477 . . . . 50.24 109.952 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.448 HE21 HG21 ' A' ' 88' ' ' THR . 59.1 tt0 -72.76 98.48 2.41 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.542 -0.91 . . . . 71.34 108.542 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 91' ' ' GLU . 42.7 m-80 -60.42 133.68 56.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 62.32 112.037 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.44 -139.01 5.59 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.694 -1.362 . . . . 52.42 109.694 -173.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.37 -62.92 4.51 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 117.459 0.63 . . . . 74.4 112.341 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 t -137.1 143.86 42.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.117 0.967 . . . . 75.25 109.919 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.2 -11.0 39.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.847 0.859 . . . . 71.13 110.729 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.01 144.05 41.99 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.266 -1.013 . . . . 73.4 108.266 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -109.92 120.39 42.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.092 0.957 . . . . 74.24 108.602 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -65.42 89.98 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.911 0.862 . . . . 75.1 111.057 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -70.43 118.38 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.955 -1.021 . . . . 72.23 108.861 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -81.78 127.23 32.75 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.447 0.699 . . . . 73.44 110.002 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -59.01 107.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.141 0.977 . . . . 73.0 110.087 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.788 0.835 . . . . 71.13 108.825 178.222 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 107.814 -1.18 . . . . 64.11 107.814 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -58.36 -50.3 74.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.926 0.891 . . . . 70.21 111.989 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.47 104.0 16.0 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.227 0.611 . . . . 74.14 110.147 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -74.67 -31.67 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.846 0.859 . . . . 71.11 112.096 -174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -59.05 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.423 0.689 . . . . 73.45 110.754 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.31 -19.1 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.294 -0.412 . . . . 73.02 111.099 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -48.15 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.271 -0.64 . . . . 75.12 109.271 170.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.38 -39.24 78.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.08 -0.964 . . . . 71.52 112.066 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.64 -53.25 57.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.681 0.792 . . . . 63.2 110.829 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.37 -30.55 70.38 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 72.51 111.053 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -61.88 -51.18 69.22 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 123.801 0.688 . . . . 74.35 110.693 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.51 57.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 124.068 0.855 . . . . 61.03 110.91 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.0 mt -57.61 -43.03 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.089 0.956 . . . . 72.43 110.987 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.43 72.9 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.253 0.621 . . . . 75.12 112.229 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.26 -40.91 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.843 0.857 . . . . 64.11 109.896 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 19' ' ' TRP . 66.3 m-85 -79.55 -25.65 41.6 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.851 0.46 . . . . 74.23 112.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -67.85 -34.65 77.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.134 0.573 . . . . 73.24 109.858 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 81.3 mt -74.59 -46.02 41.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.005 -0.543 . . . . 70.15 110.179 172.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 16' ' ' PHE . 36.0 m0 -61.48 -17.96 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.865 0.691 . . . . 62.53 112.865 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -102.4 -24.56 13.84 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 122.904 0.482 . . . . 72.34 111.599 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.481 HD22 ' HB2' ' A' ' 24' ' ' ASP . 8.1 t30 -157.55 87.36 2.59 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.724 0.81 . . . . 74.44 109.693 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.54 -17.56 53.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.226 2.617 . . . . 54.44 113.348 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -79.69 -4.39 51.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.823 0.849 . . . . 62.54 112.693 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HB2' HD22 ' A' ' 21' ' ' ASN . 12.4 t70 -71.48 120.42 79.72 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 109.475 -0.565 . . . . 73.44 109.475 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.98 -30.39 7.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.234 1.956 . . . . 63.22 113.301 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.05 -26.31 27.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.198 0.599 . . . . 75.22 112.305 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.91 -48.01 55.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.36 0.664 . . . . 61.31 109.483 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.16 -27.36 63.49 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.73 -0.668 . . . . 71.41 111.895 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.27 -55.31 36.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.791 0.837 . . . . 74.52 111.733 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 4.1 pp -64.13 -28.18 69.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.929 0.768 . . . . 61.51 111.282 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD22 HD12 ' A' ' 35' ' ' LEU . 96.7 mt -67.56 -28.29 67.66 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.923 0.889 . . . . 70.23 112.258 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -65.88 -37.99 87.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.327 0.584 . . . . 75.34 110.517 173.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 50.0 mtpt -77.02 -39.35 50.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.686 -1.143 . . . . 60.44 111.281 -170.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 35' ' ' LEU . 16.2 pt -102.41 -32.77 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.365 0.666 . . . . 72.14 112.325 -171.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 34' ' ' ILE . 75.3 mt -116.34 -179.36 3.65 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.897 0.879 . . . . 75.41 110.453 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -74.27 152.85 88.18 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 115.349 -0.841 . . . . 54.32 111.371 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.76 -30.65 93.2 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.022 2.482 . . . . 73.13 112.588 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.1 -38.16 78.88 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.967 1.307 . . . . 55.34 112.49 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 35' ' ' LEU . 57.5 t -68.24 -56.15 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.489 -0.778 . . . . 64.12 110.163 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -25.55 67.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.53 0.332 . . . . 72.12 111.528 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.55 -49.28 66.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.068 . . . . 71.42 110.488 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -73.06 -32.25 64.92 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.208 -0.451 . . . . 75.33 111.366 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.17 -47.48 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.067 0.947 . . . . 52.12 111.2 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -70.74 -23.31 62.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.153 0.427 . . . . 72.12 112.153 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.81 -51.51 12.43 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.435 0.694 . . . . 65.12 110.504 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.414 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 83.0 t60 -63.22 -27.25 69.23 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.019 -0.991 . . . . 62.24 110.836 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -61.87 -45.67 92.77 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.747 1.219 . . . . 74.35 111.495 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 96.5 mtt180 -61.51 -38.43 87.35 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.816 -1.084 . . . . 63.21 110.581 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.31 -46.76 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.147 0.579 . . . . 62.4 111.607 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 46' ' ' HIS . 71.5 mt -64.03 -35.42 80.66 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.354 0.662 . . . . 73.24 110.479 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -62.56 -46.3 89.01 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.226 -0.897 . . . . 74.23 110.695 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 7.6 mtpm? -62.17 -41.03 97.93 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.331 0.652 . . . . 73.2 110.769 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -75.43 -19.76 59.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.3 -0.864 . . . . 74.31 111.4 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.25 38.14 19.22 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.188 0.305 . . . . 63.44 112.963 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.2 mt -90.55 89.56 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.06 0.944 . . . . 71.22 108.453 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -92.84 111.54 23.18 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 53.7 p90 -134.69 152.35 51.7 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.864 0.465 . . . . 75.3 110.327 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.79 142.06 51.65 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.173 0.589 . . . . 75.42 109.577 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.69 110.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.801 1.241 . . . . 73.14 109.077 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -99.56 -29.38 12.74 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.743 0.417 . . . . 72.21 112.022 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.03 131.72 33.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.198 0.599 . . . . 74.32 109.806 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.63 117.3 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.262 -1.014 . . . . 74.21 108.262 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.4 108.01 8.89 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.782 -0.821 . . . . 74.42 108.782 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.07 115.54 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.158 0.583 . . . . 64.44 109.557 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -130.19 128.3 41.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.78 0.832 . . . . 43.13 108.831 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -88.07 144.66 26.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.14 0.576 . . . . 61.32 109.642 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -131.9 90.09 2.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.517 -1.29 . . . . 54.32 107.517 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.93 -122.4 19.25 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.013 -0.994 . . . . 54.42 111.231 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -91.45 -7.73 49.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.506 0.723 . . . . 75.44 111.858 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.1 m -111.43 115.81 29.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.02 0.528 . . . . 74.42 109.835 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -92.74 131.02 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.599 0.76 . . . . 73.11 111.121 -175.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -103.79 110.47 22.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.993 1.317 . . . . 74.21 109.448 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.11 104.53 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.67 -0.863 . . . . 71.3 108.67 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -86.68 105.42 16.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.263 -1.014 . . . . 74.52 108.263 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 16' ' ' PHE . 7.6 p -114.59 134.55 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.327 1.051 . . . . 42.24 108.603 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.4 123.78 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.774 -0.824 . . . . 61.24 108.774 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.82 161.78 24.59 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.082 0.953 . . . . 73.5 109.865 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.0 10.95 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.55 -0.537 . . . . 75.31 109.55 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 27.6 mt-10 -87.25 104.13 16.09 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.685 0.794 . . . . 63.23 110.685 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -89.17 102.99 15.64 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.498 -0.927 . . . . 73.11 108.498 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -141.54 136.45 31.15 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.314 1.046 . . . . 64.21 109.14 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.64 12.26 80.53 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.817 -0.629 . . . . 53.14 111.968 -170.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.22 -22.89 27.24 Favored Glycine 0 C--N 1.356 1.64 0 C-N-CA 123.496 0.569 . . . . 61.22 112.914 -173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 p -94.11 134.51 36.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.811 0.844 . . . . 65.42 111.269 -175.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.6 m -87.99 124.17 33.45 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.163 0.985 . . . . 74.22 110.118 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -120.97 116.42 25.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.456 1.102 . . . . 72.22 108.821 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -78.28 116.85 19.01 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.203 -0.665 . . . . 72.23 109.203 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.426 HG21 HE21 ' A' ' 108' ' ' GLN . 77.0 m -131.63 134.69 46.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.709 1.204 . . . . 73.12 109.883 -173.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 m -97.67 145.6 26.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.273 0.629 . . . . 73.33 109.774 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -126.89 128.48 46.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.672 1.189 . . . . 62.41 108.007 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.95 104.25 16.26 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 71.35 108.252 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.19 106.04 18.23 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.226 -1.398 . . . . 64.33 107.226 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -102.1 97.91 8.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.678 0.791 . . . . 71.01 109.206 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HB3' HG21 ' A' ' 101' ' ' ILE . 90.8 m-85 -89.25 111.29 22.06 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.853 0.861 . . . . 72.04 109.899 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 38.5 tt0 -96.01 132.58 41.21 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.224 -0.658 . . . . 62.44 109.224 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.75 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.813 0.845 . . . . 74.34 111.343 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 102' ' ' ARG . 31.4 t70 -132.15 101.4 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.335 -1.358 . . . . 73.52 107.335 171.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.98 -99.42 0.94 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.328 -0.709 . . . . 75.2 111.328 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.17 -17.51 8.9 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.563 0.745 . . . . 74.33 111.123 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.0 m -113.91 133.96 55.12 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.24 0.616 . . . . 74.41 110.266 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.521 HG21 ' HB3' ' A' ' 94' ' ' PHE . 74.2 mt -73.6 116.83 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.784 0.834 . . . . 75.32 109.12 177.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 97' ' ' ASP . 32.0 mmt180 -105.72 -7.68 18.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.242 0.617 . . . . 73.42 111.369 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.9 ttt180 -136.0 139.07 42.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.766 0.426 . . . . 75.34 110.658 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.27 130.69 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.219 1.008 . . . . 55.14 109.187 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.7 m -110.34 104.52 13.32 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.044 -1.095 . . . . 75.31 108.044 172.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.91 104.61 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.249 -1.019 . . . . 64.03 108.249 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 m -103.84 112.92 26.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.361 0.664 . . . . 74.52 109.617 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.426 HE21 HG21 ' A' ' 88' ' ' THR . 60.5 tt0 -74.13 103.43 4.57 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.808 -1.182 . . . . 72.41 107.808 171.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -68.73 131.47 45.22 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.846 0.859 . . . . 65.34 110.832 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.28 -64.99 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.951 -0.86 . . . . 45.22 110.951 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.58 162.28 11.17 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.04 0.352 . . . . 60.2 112.455 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 t -75.97 133.14 40.53 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.253 1.021 . . . . 63.31 109.88 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.12 -27.12 48.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.607 0.763 . . . . 71.32 110.197 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.75 167.18 19.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.303 1.041 . . . . 53.33 110.39 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -133.18 124.48 27.54 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.988 0.915 . . . . 72.21 108.645 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -138.4 6.32 2.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.659 0.784 . . . . 62.43 111.533 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -70.84 -20.48 62.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.098 0.559 . . . . 65.02 111.221 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -117.77 135.57 53.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.066 -1.087 . . . . 73.32 108.066 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -68.31 99.44 0.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.99 0.516 . . . . 52.23 109.772 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.7 p80 . . . . . 0 CA--C 1.553 1.094 0 C-N-CA 123.288 0.635 . . . . 74.3 109.377 177.234 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.432 0.158 . . . . 70.33 110.651 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.29 -6.41 58.86 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 72.23 111.151 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.7 71.39 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.228 1.011 . . . . 62.02 109.646 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.573 HG21 HG11 ' A' ' 96' ' ' VAL . 47.4 mm -74.51 -22.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.263 1.025 . . . . 72.14 111.709 -172.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 66' ' ' THR . 21.8 t -61.31 -55.84 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.466 -0.568 . . . . 71.42 109.466 176.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.97 -32.56 65.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.061 -0.972 . . . . 71.1 111.884 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 4' ' ' ILE . . . -62.73 -52.33 63.67 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.529 0.518 . . . . 44.43 110.404 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.72 67.49 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.549 0.74 . . . . 50.54 111.839 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.67 -55.68 21.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.396 0.678 . . . . 73.13 110.45 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -63.91 -32.59 74.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.864 0.866 . . . . 74.3 111.239 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.39 86.26 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 124.014 0.821 . . . . 63.1 111.143 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.77 92.47 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.97 0.793 . . . . 34.33 111.179 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 69.4 mt -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 124.291 0.994 . . . . 70.54 109.692 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.91 -29.99 71.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.041 0.936 . . . . 74.15 112.432 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.93 -41.15 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.538 0.735 . . . . 72.14 109.81 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE2' HG11 ' A' ' 75' ' ' VAL . 51.7 m-85 -72.4 -35.21 68.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.73 0.412 . . . . 74.42 111.332 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 13' ' ' ILE . 20.3 mm-40 -61.31 -37.43 83.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.868 0.73 . . . . 73.13 110.15 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.45 -45.13 32.69 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 123.634 0.584 . . . . 73.1 110.926 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -54.21 -31.62 53.61 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.387 0.675 . . . . 74.54 112.731 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -101.89 -19.05 15.43 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.889 0.475 . . . . 73.51 112.103 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.45 HD22 ' HB2' ' A' ' 24' ' ' ASP . 4.8 t30 -150.66 81.91 6.32 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.254 -0.647 . . . . 55.12 109.254 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.43 -11.89 33.42 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.135 2.557 . . . . 71.4 112.948 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -80.94 -2.29 47.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.591 1.156 . . . . 72.14 112.687 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' HB2' HD22 ' A' ' 21' ' ' ASN . 9.3 t70 -76.31 107.68 4.96 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 119.183 -0.437 . . . . 75.22 110.09 -177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -31.14 24.68 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.764 2.31 . . . . 61.41 113.359 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -77.64 -34.83 53.1 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.187 0.595 . . . . 75.34 111.592 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.95 -45.69 73.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.299 0.64 . . . . 53.42 110.401 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -75.36 -20.92 58.72 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.66 -0.7 . . . . 74.1 111.628 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.05 -51.35 39.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.356 0.662 . . . . 75.33 110.896 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.7 pp -65.67 -37.68 87.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.668 -0.493 . . . . 74.02 109.668 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.96 -28.59 69.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.488 0.715 . . . . 73.01 111.571 173.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.31 -24.32 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.932 0.493 . . . . 73.13 111.209 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -97.18 -24.68 15.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.047 0.939 . . . . 71.35 112.254 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 30' ' ' LEU . 8.2 pt -121.82 -26.58 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 112.898 0.703 . . . . 70.43 112.898 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.5 mm? -102.65 172.34 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.265 0.626 . . . . 71.01 110.389 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 19.5 m -79.31 143.79 60.93 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 114.854 -1.066 . . . . 72.25 110.238 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.71 -31.03 18.1 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.657 2.905 . . . . 64.23 114.632 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -66.56 -36.97 83.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.148 0.579 . . . . 61.44 111.382 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 36' ' ' SER . 93.5 t -67.51 -57.35 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.656 0.782 . . . . 73.0 110.696 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.89 -28.44 66.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.667 0.387 . . . . 75.32 111.301 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.98 -54.96 10.91 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 124.527 1.142 . . . . 74.21 110.559 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 1.1 pp0? -61.64 -25.92 67.67 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.308 0.243 . . . . 73.42 111.604 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 39' ' ' VAL . 72.5 t -70.48 -53.08 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.7 0.8 . . . . 73.5 111.02 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -67.34 -22.49 65.59 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.025 0.38 . . . . 75.23 112.025 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -81.07 -45.26 16.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.853 0.461 . . . . 71.42 110.455 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.96 -26.01 68.39 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.396 0.678 . . . . 61.24 111.052 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.63 97.1 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.795 1.238 . . . . 75.42 112.333 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -65.8 -28.43 69.0 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.945 0.778 . . . . 73.42 111.439 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.84 -41.81 67.69 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.966 0.907 . . . . 73.33 110.867 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -76.81 -28.16 55.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.454 0.701 . . . . 64.14 110.989 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.85 -35.17 67.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.462 1.105 . . . . 72.42 110.422 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -63.62 -40.91 98.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 71.13 109.785 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -84.87 178.01 7.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.167 -0.924 . . . . 70.42 110.643 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.24 33.42 6.59 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.699 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.96 89.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 109.127 -0.694 . . . . 71.44 109.127 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -83.3 136.31 34.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.177 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 140.3 24.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.503 -0.555 . . . . 71.42 109.503 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.13 130.96 39.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.227 1.011 . . . . 72.41 109.618 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.49 102.34 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 54.4 109.686 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -84.27 -35.19 23.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.654 0.782 . . . . 63.21 110.886 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 58.5 ttt180 -155.56 125.41 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.913 -0.773 . . . . 74.45 108.913 -173.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.92 125.94 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 74.33 109.856 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.03 125.36 24.83 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.518 1.127 . . . . 71.42 108.953 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.33 134.99 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.328 0.651 . . . . 75.02 110.687 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.6 m -145.67 130.67 18.28 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.084 0.954 . . . . 51.11 108.969 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.512 HG22 HG22 ' A' ' 71' ' ' VAL . 71.8 p -88.31 149.17 23.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.6 0.36 . . . . 71.24 110.425 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -129.97 96.11 4.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.444 -1.317 . . . . 71.35 107.444 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.05 -102.08 0.95 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.992 -0.843 . . . . 65.12 110.992 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -115.49 -13.48 11.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.972 0.909 . . . . 73.45 110.373 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.9 m -97.15 119.33 35.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.606 0.763 . . . . 75.45 109.568 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 66' ' ' THR . 23.4 t -87.93 144.48 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.676 0.79 . . . . 72.14 110.456 -170.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -124.31 102.48 7.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.59 1.156 . . . . 73.14 108.903 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.13 103.21 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.079 -0.711 . . . . 72.23 109.079 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.3 m -89.53 112.38 23.54 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.322 1.049 . . . . 73.01 109.026 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' HE2' ' A' ' 16' ' ' PHE . 3.9 p -132.91 119.26 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.367 0.667 . . . . 63.41 110.771 -172.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 9.5 tp10 -80.2 129.91 34.84 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.323 1.049 . . . . 75.21 109.143 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.41 HD13 ' HD1' ' A' ' 90' ' ' TYR . 5.8 mp -125.1 142.01 51.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.236 0.614 . . . . 53.12 109.686 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.96 108.64 21.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.439 -1.319 . . . . 73.42 107.439 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -104.54 105.74 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.173 0.589 . . . . 71.44 111.162 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -93.25 111.24 22.83 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.783 -0.821 . . . . 71.12 108.783 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -134.99 123.6 23.57 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.176 0.99 . . . . 70.03 109.732 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.33 13.66 70.85 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.171 0.415 . . . . 71.11 113.491 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.13 -28.31 15.25 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 112.027 -0.429 . . . . 30.24 112.027 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.5 p -85.01 120.13 26.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.246 0.618 . . . . 74.11 110.615 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -94.31 142.04 27.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.522 0.729 . . . . 73.43 110.25 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.1 m -144.68 123.26 12.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.327 1.051 . . . . 75.42 109.326 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -77.93 109.67 12.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.907 -0.775 . . . . 71.24 108.907 173.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 m -114.78 122.12 45.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.415 1.086 . . . . 15.44 109.53 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 10.6 m -88.95 120.09 30.05 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.2 -0.667 . . . . 53.33 109.2 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HD1' HD13 ' A' ' 77' ' ' LEU . 89.9 m-85 -104.78 136.5 44.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 174.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -115.27 103.06 10.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.144 -1.058 . . . . 51.12 108.144 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 106' ' ' VAL . 6.1 mp -87.71 104.39 16.5 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.249 -1.389 . . . . 73.2 107.249 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -96.66 108.0 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.359 -0.837 . . . . 62.42 109.35 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.409 ' HB3' HG21 ' A' ' 101' ' ' ILE . 80.0 m-85 -88.82 109.09 19.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.692 0.797 . . . . 71.03 110.293 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 103' ' ' ARG . 37.4 tt0 -90.54 114.71 26.99 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.818 0.847 . . . . 63.22 109.268 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 4' ' ' ILE . 3.9 m -100.58 149.62 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.694 0.798 . . . . 61.33 110.275 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.72 119.36 16.04 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.73 -1.211 . . . . 71.41 107.73 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.54 -100.58 1.82 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.946 -0.462 . . . . 25.15 111.946 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.93 -21.78 5.43 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.094 0.558 . . . . 73.54 112.165 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -114.04 158.65 20.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.058 0.456 . . . . 71.12 110.989 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 96' ' ' VAL . 16.6 mt -84.55 125.19 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.038 -0.983 . . . . 71.33 108.878 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -96.11 -43.18 7.87 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.268 0.627 . . . . 73.42 111.264 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 87.1 mtt180 -132.77 160.93 35.42 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.714 0.806 . . . . 74.42 110.591 -171.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.48 120.14 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.394 -0.965 . . . . 61.15 108.394 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.7 m -100.68 104.83 16.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.259 -1.015 . . . . 74.53 108.259 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 92' ' ' LEU . 46.5 t -87.29 103.99 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.631 -0.878 . . . . 72.05 108.631 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -94.5 106.38 18.36 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.593 0.757 . . . . 64.5 109.453 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -82.06 97.45 8.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.493 -0.776 . . . . 74.13 109.9 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.3 m-80 -73.8 90.38 1.87 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.53 -1.285 . . . . 71.23 107.53 170.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.51 38.35 0.17 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.391 -0.822 . . . . 64.34 111.376 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.08 67.84 0.56 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.405 -0.678 . . . . 50.42 111.405 -176.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.9 m 75.08 -19.36 0.39 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.769 1.628 . . . . 70.1 113.826 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -87.61 82.5 7.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.469 0.652 . . . . 75.44 110.405 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.7 91.4 4.66 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.527 -1.286 . . . . 71.34 107.527 170.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -65.97 83.23 0.08 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.68 -0.859 . . . . 73.34 108.68 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -87.49 69.05 9.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.914 -1.039 . . . . 73.3 110.638 -170.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -72.72 125.2 26.95 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.805 -1.089 . . . . 63.31 109.457 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -65.22 99.86 0.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.141 0.901 . . . . 61.24 109.935 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -97.45 107.96 20.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.984 0.914 . . . . 60.2 108.584 173.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 123.749 0.819 . . . . 64.14 109.159 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.281 -0.266 . . . . 73.21 110.281 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -132.23 -85.54 0.48 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.052 0.941 . . . . 64.51 108.753 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -104.43 144.26 31.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.205 1.002 . . . . 71.52 109.701 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.27 -32.87 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.578 1.151 . . . . 71.31 112.017 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.44 -51.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.236 0.614 . . . . 65.14 109.769 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -28.33 65.44 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.447 -0.797 . . . . 64.42 111.129 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -59.04 -48.75 80.47 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.933 0.397 . . . . 72.52 110.208 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.79 83.71 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.543 -0.753 . . . . 63.34 111.728 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.79 -52.25 64.97 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.581 0.752 . . . . 73.44 111.475 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.55 -37.1 82.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 73.13 110.665 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.93 80.95 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.405 -1.27 . . . . 53.31 111.498 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.56 82.22 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.911 0.757 . . . . 71.03 111.891 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 HE21 ' A' ' 17' ' ' GLN . 55.8 mt -64.85 -40.05 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.939 -1.028 . . . . 61.04 110.204 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.03 72.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.791 0.836 . . . . 64.11 112.852 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.5 mt -63.1 -40.3 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.531 0.732 . . . . 42.53 110.028 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -71.14 -33.54 70.17 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.143 0.577 . . . . 74.24 111.521 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.475 HE21 HG22 ' A' ' 13' ' ' ILE . 80.1 mt-30 -62.07 -40.98 97.64 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.857 0.863 . . . . 72.44 110.997 175.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.23 -37.52 66.37 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.972 -0.558 . . . . 75.34 110.863 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -63.13 -32.85 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.45 0.537 . . . . 73.4 112.45 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.57 -23.31 22.01 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.394 0.278 . . . . 73.41 111.234 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -158.14 88.27 2.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.477 0.711 . . . . 74.43 109.242 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.19 -22.53 70.59 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.337 2.691 . . . . 73.35 114.312 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -88.46 11.23 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.578 0.751 . . . . 52.15 112.722 -174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.97 114.14 26.37 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.89 -32.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.551 2.167 . . . . 73.33 113.354 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.76 -40.26 55.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.212 0.605 . . . . 65.35 111.387 -171.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.99 67.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.727 0.811 . . . . 71.23 110.993 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.2 pt20 -70.19 -26.25 63.81 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.533 -0.758 . . . . 71.32 111.864 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.21 -43.17 71.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 74.53 111.323 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.472 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.3 pp -71.08 -35.4 71.84 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.583 -0.525 . . . . 72.13 109.583 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.93 -22.34 66.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.75 0.82 . . . . 74.51 112.112 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -73.46 -30.62 63.3 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.278 0.631 . . . . 60.1 110.96 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.53 -46.28 9.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.33 -0.85 . . . . 73.23 111.538 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.7 pt -101.88 -28.97 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 116.092 -0.504 . . . . 73.24 111.513 -169.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 39' ' ' VAL . 3.4 mm? -108.9 -173.94 2.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.384 1.074 . . . . 53.45 109.378 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB2' HG23 ' A' ' 39' ' ' VAL . 17.0 m -77.77 149.15 77.14 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 122.915 0.486 . . . . 72.42 111.091 176.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.79 -25.75 81.73 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.488 2.125 . . . . 73.11 111.804 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.83 -43.64 95.59 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.222 -1.354 . . . . 73.45 110.805 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 36' ' ' SER . 53.9 t -64.39 -52.51 54.53 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 123.531 0.732 . . . . 65.52 111.131 -175.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 28' ' ' GLN . 4.0 pp -59.22 -35.86 74.38 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 120.829 0.347 . . . . 61.41 111.528 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.88 -43.49 68.3 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.216 1.006 . . . . 74.23 111.431 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -74.25 -27.31 60.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.221 0.209 . . . . 64.0 110.952 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 t -72.62 -41.76 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.028 0.531 . . . . 75.34 110.564 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -21.49 61.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.65 0.205 . . . . 74.44 111.537 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.45 -49.26 12.58 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.922 0.392 . . . . 74.12 110.077 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.7 -24.04 67.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.98 0.912 . . . . 75.21 110.63 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.25 76.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.109 1.364 . . . . 74.32 112.471 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -61.68 -22.94 65.75 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.218 -0.901 . . . . 74.11 112.625 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.38 -46.46 66.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.583 0.753 . . . . 73.24 110.581 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.35 -31.77 60.64 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.819 0.848 . . . . 51.13 111.347 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.25 -39.01 78.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 65.34 110.166 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -59.74 -43.3 94.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.586 0.754 . . . . 73.32 110.266 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -75.71 -29.63 59.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.073 -0.967 . . . . 73.33 111.4 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.31 35.52 76.76 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.456 0.472 . . . . 63.11 113.427 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.35 107.9 12.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.704 -0.851 . . . . 72.13 108.704 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -84.13 111.14 19.07 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 108.728 -0.842 . . . . 62.35 108.728 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.495 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 15.5 p90 -110.37 142.67 41.72 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.009 -1.478 . . . . 72.44 107.009 168.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -134.42 126.94 30.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.152 0.283 . . . . 53.34 110.252 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -62.23 134.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.116 0.966 . . . . 71.34 110.047 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -117.12 -54.31 2.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.526 1.13 . . . . 54.01 109.522 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -140.78 123.72 16.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 114.658 -1.155 . . . . 72.41 108.673 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.27 124.04 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.139 -1.06 . . . . 74.44 108.139 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.08 107.6 9.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 73' ' ' VAL . 14.7 p -99.0 140.16 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.722 0.409 . . . . 65.34 110.14 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -144.27 170.74 15.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.749 0.82 . . . . 42.21 109.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 71' ' ' VAL . 40.1 p -126.66 149.72 49.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.209 0.604 . . . . 73.34 110.756 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -135.95 95.6 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.46 -1.311 . . . . 65.04 107.46 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.91 -101.34 1.1 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.207 -1.157 . . . . 54.0 110.207 -166.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -119.02 -7.67 10.34 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.777 0.831 . . . . 74.44 110.594 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 95' ' ' GLU . 22.1 m -87.88 114.79 24.84 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.24 -0.652 . . . . 60.01 109.24 -174.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 66' ' ' THR . 24.3 t -87.03 132.24 32.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 115.674 -0.693 . . . . 71.14 109.422 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -118.79 117.52 29.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.192 0.997 . . . . 54.51 108.634 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 64' ' ' VAL . 46.3 t -100.35 103.18 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 73.14 109.647 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.9 m -90.65 105.42 17.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.679 -0.859 . . . . 72.24 108.679 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.54 126.51 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.679 0.792 . . . . 61.13 110.694 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.03 120.48 23.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.179 0.991 . . . . 73.05 109.783 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 90' ' ' TYR . 6.1 mp -115.39 119.1 35.14 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.374 -0.972 . . . . 65.04 108.374 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -88.46 103.41 15.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.211 -1.033 . . . . 61.04 108.211 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 30.3 mt-10 -88.2 126.06 34.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.32 1.048 . . . . 74.33 110.067 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.3 m -115.64 107.72 15.48 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.218 -1.03 . . . . 50.44 108.218 173.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -147.51 138.14 23.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.908 0.883 . . . . 75.33 109.351 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.94 12.24 64.66 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.368 0.418 . . . . 24.34 113.846 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.94 -32.9 6.56 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 117.127 0.464 . . . . 61.15 112.421 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -84.09 144.78 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.482 0.713 . . . . 52.43 111.688 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 129.98 53.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.014 0.926 . . . . 73.33 110.603 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.3 m -143.54 133.12 23.61 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.724 0.809 . . . . 53.42 110.1 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -81.25 101.52 9.78 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.386 -0.598 . . . . 65.11 109.386 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.1 m -101.54 122.44 43.83 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.198 0.999 . . . . 75.41 109.226 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -88.52 125.82 34.96 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.588 . . . . 65.42 109.414 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CD1' HD13 ' A' ' 77' ' ' LEU . 18.6 m-85 -104.65 126.08 51.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.765 -1.198 . . . . 74.4 107.765 173.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.22 103.59 12.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.145 -1.057 . . . . 72.54 108.145 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.98 110.48 22.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.893 -0.78 . . . . 45.01 108.893 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 59.7 ttp180 -88.89 99.76 12.65 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.94 -0.763 . . . . 74.01 108.94 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.9 m-85 -86.17 107.82 18.05 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.914 0.864 . . . . 75.44 108.687 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . 19.2 mt-10 -90.09 116.49 28.15 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.984 -1.462 . . . . 74.02 108.053 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 101' ' ' ILE . 11.3 m -85.45 144.92 8.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.358 -0.837 . . . . 62.33 110.907 -169.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.7 79.49 1.9 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.34 18.07 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.426 -0.806 . . . . 55.31 111.736 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -80.15 -4.87 54.74 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.95 0.722 . . . . 72.01 112.95 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.3 m -134.68 134.65 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.591 0.356 . . . . 52.33 110.217 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HB3' ' A' ' 94' ' ' PHE . 45.4 mt -77.46 132.02 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.169 -1.049 . . . . 73.21 108.169 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -119.4 -10.07 9.76 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.372 0.533 . . . . 74.53 111.617 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.636 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 14.4 mmt180 -130.02 150.4 51.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.224 0.61 . . . . 74.43 111.527 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.16 124.9 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.474 1.11 . . . . 72.02 109.466 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 87.7 m -111.92 105.07 13.4 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.651 0.78 . . . . 63.2 108.941 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.0 105.14 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.531 -0.914 . . . . 72.05 108.531 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.9 m -99.94 105.7 17.43 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.468 0.707 . . . . 72.23 109.384 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.434 ' HG2' ' H ' ' A' ' 110' ' ' GLY . 51.6 tt0 -84.03 123.63 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.65 -0.5 . . . . 74.05 109.65 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -80.83 -1.38 42.89 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.384 0.673 . . . . 65.24 111.0 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' H ' ' HG2' ' A' ' 108' ' ' GLN . . . -84.92 61.37 4.69 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 110.433 -1.067 . . . . 54.11 110.433 166.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.89 94.8 0.1 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.898 -1.281 . . . . 75.02 109.898 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 m -68.89 110.69 4.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.414 0.686 . . . . 33.12 110.911 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.3 mt -69.28 -45.21 70.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.189 0.996 . . . . 63.34 110.288 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.13 160.11 27.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.166 -0.925 . . . . 73.43 110.4 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -166.05 32.68 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.575 0.75 . . . . 75.32 110.935 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.63 107.34 2.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.152 -0.684 . . . . 65.44 109.152 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.46 145.53 50.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.879 0.871 . . . . 73.23 109.31 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -145.92 126.72 14.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.055 0.542 . . . . 62.42 109.701 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -78.95 168.26 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.447 0.699 . . . . 61.24 110.433 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.2 m80 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 123.203 0.601 . . . . 71.43 110.351 -178.016 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.332 0.587 . . . . 74.03 110.737 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -98.52 34.3 2.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.81 0.844 . . . . 70.22 109.482 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -95.74 18.25 13.42 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.7 1.2 . . . . 61.4 110.393 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.3 -39.82 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 126.061 1.745 . . . . 73.22 113.938 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 66' ' ' THR . 19.0 t -70.7 -54.24 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.021 0.529 . . . . 62.33 110.461 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 8.5 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.197 0.935 . . . . 41.23 111.021 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' A' ' 34' ' ' ILE . . . -65.96 -47.43 74.65 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.232 -0.894 . . . . 42.4 110.716 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.8 78.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 72.21 111.572 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -64.75 -48.84 73.1 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.36 1.064 . . . . 71.41 110.85 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 23.1 mt-30 -67.68 -37.55 82.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.521 0.729 . . . . 72.13 110.352 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.25 97.01 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.03 0.932 . . . . 73.0 111.029 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.46 11.69 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.345 1.028 . . . . 63.02 110.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -60.33 -39.74 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 124.222 0.951 . . . . 72.3 110.597 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.18 93.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.975 0.91 . . . . 75.14 112.305 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.76 -45.8 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.881 0.873 . . . . 72.54 110.161 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.66 -34.46 75.75 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.985 0.514 . . . . 73.25 112.01 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.69 -38.07 89.76 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.551 0.532 . . . . 64.32 110.055 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.8 -38.49 76.66 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.754 0.659 . . . . 42.22 110.766 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -58.4 -36.78 74.08 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.52 0.728 . . . . 72.5 112.717 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -102.14 -16.28 16.43 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.863 0.465 . . . . 52.12 112.115 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.453 HD22 ' HB2' ' A' ' 24' ' ' ASP . 5.9 t30 -154.19 78.54 5.26 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.351 0.661 . . . . 51.02 109.354 -174.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.54 -4.64 15.72 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.699 2.266 . . . . 74.24 112.733 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 p -77.2 -12.9 60.0 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.834 1.254 . . . . 74.35 112.062 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' HB2' HD22 ' A' ' 21' ' ' ASN . 22.0 t70 -73.78 113.12 19.91 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 122.622 0.369 . . . . 64.42 111.031 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.17 -18.11 18.64 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.845 2.363 . . . . 63.24 113.396 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.29 -44.89 24.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.152 0.581 . . . . 75.44 110.329 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -60.39 -50.1 74.95 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 115.114 -0.948 . . . . 64.1 110.841 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' O ' HD22 ' A' ' 40' ' ' LEU . 11.4 pt20 -72.9 -23.61 60.73 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.673 -0.694 . . . . 62.42 112.129 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.19 -44.35 53.73 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.68 0.392 . . . . 75.33 111.319 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.21 -31.99 72.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.775 -0.454 . . . . 72.53 109.775 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 35' ' ' LEU . 97.7 mt -66.12 -29.36 69.65 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.814 0.845 . . . . 63.22 111.852 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.46 -31.95 71.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.709 0.804 . . . . 72.43 110.674 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -84.68 -43.27 14.5 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.282 -0.872 . . . . 61.2 111.137 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 7' ' ' ALA . 8.8 pt -96.84 -37.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.96 0.504 . . . . 71.44 112.302 -168.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -104.52 174.04 6.05 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.962 0.905 . . . . 72.11 108.912 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 102' ' ' ARG . 9.0 p -68.78 136.67 90.1 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.337 -0.616 . . . . 73.14 109.337 169.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.07 -22.64 19.57 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.143 2.562 . . . . 73.13 114.735 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -60.6 -40.4 91.68 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.193 0.997 . . . . 71.05 111.289 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.66 -54.56 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 63.14 111.268 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 28' ' ' GLN . 2.8 pp -64.06 -32.46 74.02 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.558 0.218 . . . . 65.13 111.05 -176.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.96 -34.03 75.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.14 0.976 . . . . 74.2 111.714 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -85.38 -36.56 20.64 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.801 0.44 . . . . 63.43 110.998 174.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.4 -39.88 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.458 0.703 . . . . 61.43 111.49 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -67.77 -21.93 65.23 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.335 0.654 . . . . 75.34 111.945 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -86.83 -44.8 11.44 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.059 0.943 . . . . 74.45 110.664 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -68.79 -24.39 64.41 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.224 0.609 . . . . 74.31 110.984 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.43 80.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.291 1.436 . . . . 71.01 111.557 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 97.2 mtt180 -62.25 -27.38 68.97 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.871 -1.513 . . . . 74.03 111.627 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.1 -40.49 74.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.146 0.578 . . . . 64.11 110.984 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.423 ' HA ' HE21 ' A' ' 53' ' ' GLN . 91.3 mt -74.92 -31.87 61.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.64 0.776 . . . . 71.1 110.738 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -65.38 -40.6 93.68 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.109 -0.951 . . . . 61.21 111.087 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 55.8 mttp -59.05 -40.87 86.42 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.437 0.695 . . . . 75.5 111.049 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 50' ' ' LEU . 46.1 mt-30 -72.3 -12.02 60.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.952 -1.022 . . . . 71.14 111.54 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.45 30.65 78.05 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.882 0.739 . . . . 75.14 113.336 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.3 mt -74.95 109.24 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.626 -0.879 . . . . 74.01 108.626 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -84.31 109.33 17.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 73.54 108.003 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 44.2 p90 -135.71 140.29 44.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.18 -0.674 . . . . 73.42 109.18 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -133.13 146.4 51.56 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.365 0.666 . . . . 74.23 109.775 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.32 116.03 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.724 1.265 . . . . 70.14 110.05 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -88.73 -54.92 3.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.518 0.675 . . . . 71.53 109.639 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tpm_? -139.08 127.06 22.32 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.847 -1.069 . . . . 74.14 109.13 -166.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.48 116.31 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.845 -1.169 . . . . 72.55 107.845 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.69 107.73 9.38 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.504 -0.925 . . . . 75.14 108.504 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -97.34 121.76 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.162 0.985 . . . . 74.31 109.89 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.6 m -130.23 127.79 40.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 65.33 108.563 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.5 HG21 HG22 ' A' ' 5' ' ' VAL . 32.8 p -88.4 154.44 20.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.229 0.612 . . . . 73.24 110.847 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -137.56 86.69 2.21 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.524 -1.287 . . . . 63.22 107.524 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.38 -101.08 0.79 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.857 -1.065 . . . . 52.42 111.918 -174.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.74 -11.99 14.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.105 0.962 . . . . 71.4 111.319 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.42 HG21 HH11 ' A' ' 93' ' ' ARG . 44.8 m -100.98 118.95 38.0 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.618 -0.512 . . . . 62.44 109.618 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 66' ' ' THR . 46.1 t -87.5 140.91 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.808 0.843 . . . . 74.21 109.935 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -123.96 100.95 6.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.923 0.889 . . . . 75.11 108.742 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.98 106.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.449 0.7 . . . . 71.42 109.355 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.9 m -86.06 106.22 17.06 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.723 -0.843 . . . . 74.11 108.723 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 2.4 p -129.63 116.52 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.835 0.854 . . . . 73.12 110.602 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -97.08 139.96 32.3 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.238 1.015 . . . . 71.13 109.32 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -135.02 142.61 46.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.796 0.838 . . . . 73.12 109.085 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -93.0 105.8 17.85 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.269 1.033 . . . . 64.51 109.351 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.09 105.39 15.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.495 -0.775 . . . . 63.24 110.091 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.7 m -102.19 106.7 17.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.502 1.121 . . . . 74.24 108.331 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 t -148.38 140.34 23.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.111 0.965 . . . . 60.13 109.591 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.3 25.66 73.58 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.106 0.402 . . . . 75.03 114.106 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.9 83.51 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.897 -0.391 . . . . 53.33 114.026 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -116.91 139.05 51.1 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.43 0.615 . . . . 71.3 111.052 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.5 m -100.73 144.31 29.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.357 1.063 . . . . 64.34 109.522 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.4 m -143.92 114.54 7.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.78 0.832 . . . . 64.21 109.575 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.85 101.03 5.72 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.757 -0.831 . . . . 73.32 108.757 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.5 m -102.92 124.88 49.27 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.547 1.139 . . . . 55.13 110.098 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.9 m -94.05 116.9 29.38 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.316 0.646 . . . . 71.21 110.242 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.34 127.84 53.17 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.164 -1.05 . . . . 73.43 108.164 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -110.06 100.47 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.552 -1.277 . . . . 60.42 107.552 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.76 105.88 17.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.07 -1.085 . . . . 72.51 108.07 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.42 HH11 HG21 ' A' ' 70' ' ' THR . 59.1 ttp85 -91.35 99.02 12.06 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.547 -1.206 . . . . 75.45 107.989 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 101' ' ' ILE . 88.2 m-85 -87.51 108.02 18.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.935 -0.765 . . . . 70.51 108.935 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 34.9 tt0 -98.16 133.15 42.99 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.442 -0.947 . . . . 72.13 108.442 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 25.6 m -84.06 142.66 13.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.166 0.508 . . . . 72.31 109.918 176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.32 104.62 14.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.343 -1.725 . . . . 75.25 106.343 167.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.07 -100.68 1.51 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.399 -0.819 . . . . 23.53 111.293 -172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -123.88 -0.55 8.47 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.936 0.894 . . . . 60.01 112.54 -171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -139.71 150.03 44.36 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.514 0.725 . . . . 70.12 110.314 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 18.3 mt -75.52 119.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.054 0.542 . . . . 72.41 110.176 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 36' ' ' SER . 44.3 mmt-85 -131.18 14.98 5.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.042 0.937 . . . . 44.14 110.627 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 39.0 ttm105 -150.53 137.98 19.64 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 122.649 0.38 . . . . 63.44 110.114 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.96 119.7 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.271 1.028 . . . . 44.52 108.605 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 m -112.26 104.26 12.44 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.912 -1.144 . . . . 71.2 107.912 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.78 107.31 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.17 -0.678 . . . . 75.42 109.17 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 m -94.31 104.21 16.21 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.51 -0.922 . . . . 71.51 108.51 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -86.97 123.57 32.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.112 -1.07 . . . . 65.13 108.112 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -68.81 160.53 30.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.414 0.685 . . . . 70.05 111.108 -176.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.77 116.58 1.41 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.321 -0.4 . . . . 73.13 112.567 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.14 8.12 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.135 0.398 . . . . 71.41 113.563 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 m -88.36 76.06 8.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.987 0.515 . . . . 71.25 110.388 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.57 101.97 2.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.524 0.73 . . . . 75.45 110.01 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.39 131.28 35.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.909 0.484 . . . . 74.43 109.925 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -87.77 83.45 7.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.53 0.732 . . . . 64.22 109.073 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -107.05 109.06 20.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.108 0.963 . . . . 73.03 109.016 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -135.79 159.23 42.28 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.926 0.891 . . . . 64.44 109.926 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.66 -28.42 60.84 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.866 0.466 . . . . 71.23 111.01 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -135.7 138.43 42.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.302 0.641 . . . . 74.45 110.77 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.9 p80 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 123.493 0.717 . . . . 74.44 110.482 174.902 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.152 -0.684 . . . . 73.45 109.152 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -84.85 -22.98 29.22 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.102 -0.703 . . . . 60.4 109.102 168.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -147.77 160.93 42.19 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.255 1.022 . . . . 73.11 110.192 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.614 HG23 HG11 ' A' ' 96' ' ' VAL . 44.5 mm -86.21 -52.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.806 1.242 . . . . 71.21 111.047 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.43 -40.93 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.835 0.854 . . . . 71.13 110.508 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.06 -56.21 23.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.157 . . . . 75.5 110.984 176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.4 70.05 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.061 0.851 . . . . 53.43 111.432 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -72.41 -48.28 42.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.585 0.754 . . . . 71.3 111.694 177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.43 -46.32 70.19 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.431 -0.804 . . . . 64.24 111.093 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.94 -39.78 93.28 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.638 0.775 . . . . 61.33 110.559 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.616 ' HB1' HD11 ' A' ' 35' ' ' LEU . . . -58.78 -50.44 73.93 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 123.807 0.692 . . . . 62.12 111.317 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -54.72 42.74 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 124.218 0.949 . . . . 50.52 112.167 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.05 -39.78 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.88 0.872 . . . . 73.21 110.943 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.98 70.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.526 0.73 . . . . 71.12 112.617 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' HG11 ' A' ' 43' ' ' VAL . 63.6 mt -61.73 -38.39 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 123.501 0.72 . . . . 74.3 110.28 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.05 -34.03 61.79 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.002 0.521 . . . . 74.24 111.254 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.07 -21.39 64.08 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.249 0.62 . . . . 74.33 111.38 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.13 -36.28 21.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.386 0.274 . . . . 71.34 110.59 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 41.0 m0 -63.46 -27.32 69.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.64 -27.5 21.26 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.099 0.56 . . . . 64.34 111.467 173.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -158.43 93.41 1.99 Allowed Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.398 0.679 . . . . 73.44 109.75 -177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HD2' HE22 ' A' ' 51' ' ' GLN . 39.9 Cg_endo -65.36 -16.83 56.12 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.543 2.829 . . . . 71.31 113.857 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 p -97.04 11.71 35.18 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.908 0.883 . . . . 74.35 111.454 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.45 114.59 29.29 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 109.177 -0.675 . . . . 65.12 109.177 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.25 -33.24 11.62 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.411 2.074 . . . . 71.35 112.531 -168.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.86 -48.28 59.44 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.482 0.713 . . . . 71.53 111.114 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -58.76 -50.84 72.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.631 0.772 . . . . 62.14 111.587 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.51 -29.98 62.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.412 0.523 . . . . 61.21 112.412 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.44 -36.64 71.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 117.813 0.279 . . . . 74.54 111.313 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 34' ' ' ILE . 3.5 pp -70.61 -34.53 72.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 75.13 109.602 175.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 35' ' ' LEU . 85.6 mt -66.67 -22.51 66.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.751 0.821 . . . . 64.52 111.716 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.29 -29.87 61.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.964 0.506 . . . . 60.32 110.477 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.27 -42.84 9.11 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.769 0.828 . . . . 73.23 111.803 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 30' ' ' LEU . 19.8 pt -95.12 -21.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.843 0.457 . . . . 62.33 111.519 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.616 HD11 ' HB1' ' A' ' 11' ' ' ALA . 44.3 mt -122.84 -176.63 3.45 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.933 -0.766 . . . . 73.43 108.933 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -75.97 148.08 81.25 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.319 0.648 . . . . 73.11 110.514 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.26 -20.27 46.47 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.97 2.447 . . . . 73.05 113.044 171.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.26 -40.05 89.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.398 1.079 . . . . 73.5 111.237 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG11 HD13 ' A' ' 35' ' ' LEU . 57.3 t -64.05 -51.45 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.798 0.439 . . . . 74.02 111.065 -173.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.64 -27.88 69.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.77 0.319 . . . . 72.02 111.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.81 -28.76 55.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.16 0.984 . . . . 73.34 112.252 -175.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 39' ' ' VAL . 29.3 pt20 -85.45 -33.06 21.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 110.088 -0.338 . . . . 65.11 110.088 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 15' ' ' ILE . 55.1 t -65.75 -41.95 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.834 0.854 . . . . 74.11 111.209 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -63.47 -22.61 66.98 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.037 0.535 . . . . 74.34 111.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -80.33 -48.41 13.02 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.549 0.74 . . . . 73.31 110.398 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.74 -19.85 64.36 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.046 0.939 . . . . 74.32 111.805 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . . . -53.72 -56.72 14.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.554 1.142 . . . . 63.25 112.824 173.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -18.28 65.24 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.641 0.588 . . . . 64.31 112.379 -173.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.67 -51.94 50.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.721 -0.474 . . . . 63.52 109.721 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -78.4 -33.52 48.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.669 0.787 . . . . 73.33 110.954 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.437 HE22 ' HD2' ' A' ' 22' ' ' PRO . 35.6 tt0 -67.43 -38.19 84.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.228 1.011 . . . . 72.02 111.091 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -64.53 -42.49 95.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.4 0.68 . . . . 73.41 110.221 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -65.79 -24.2 66.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.241 -0.89 . . . . 75.03 110.703 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.77 33.73 45.69 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.958 -0.564 . . . . 65.22 111.995 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 65.8 mt -73.49 110.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.678 0.791 . . . . 72.02 109.668 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -89.88 107.67 19.25 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.524 -1.287 . . . . 72.12 107.524 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 18.5 p90 -112.24 123.96 51.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.581 -0.896 . . . . 73.11 108.581 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -111.47 130.39 55.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.246 0.618 . . . . 71.42 109.364 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.25 108.53 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.043 -0.725 . . . . 63.25 109.043 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' A' ' 78' ' ' GLU . 31.3 mmmt -78.03 -45.74 22.86 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.873 0.869 . . . . 65.32 109.775 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -167.48 125.34 1.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.812 0.845 . . . . 72.51 109.768 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.07 109.82 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.736 0.814 . . . . 54.34 110.173 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -104.86 143.01 33.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 72.01 108.852 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' VAL . 2.9 p -140.92 125.74 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.02 0.928 . . . . 72.45 109.881 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -140.24 139.2 35.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.058 0.943 . . . . 71.35 109.459 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.8 p -89.51 157.74 17.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.357 0.663 . . . . 60.34 111.547 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -160.84 84.78 0.68 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.403 1.081 . . . . 74.3 109.282 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.36 -116.49 8.84 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.831 -0.622 . . . . 70.21 113.445 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.22 11.88 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.276 0.63 . . . . 54.11 111.247 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.91 155.29 50.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.446 0.698 . . . . 74.25 109.773 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 94' ' ' PHE . 3.6 p -137.33 120.25 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.699 0.799 . . . . 70.43 109.319 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.04 109.57 21.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.276 1.03 . . . . 75.32 109.648 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 64' ' ' VAL . 48.2 t -98.22 105.73 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.998 -0.742 . . . . 62.12 108.998 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.6 m -96.28 102.32 14.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.871 -1.159 . . . . 64.42 107.871 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.73 113.82 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.966 0.907 . . . . 71.34 109.159 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.24 126.17 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.894 0.877 . . . . 73.31 108.923 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.84 163.24 16.48 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.886 0.874 . . . . 53.21 108.783 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 32.6 tt0 -122.65 101.69 7.62 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.701 -1.222 . . . . 74.1 107.701 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 31.6 mt-10 -86.66 139.98 30.25 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.281 1.032 . . . . 73.42 110.15 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 11.9 m -119.62 102.94 8.98 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 73.22 108.55 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 t -118.2 120.39 37.54 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.998 0.919 . . . . 62.13 110.079 -173.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.52 -93.46 0.46 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.769 -0.651 . . . . 61.14 112.602 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -141.44 19.16 2.63 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.24 0.447 . . . . 64.24 112.072 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.9 p -124.01 145.37 49.24 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.183 0.993 . . . . 64.13 108.99 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 m -116.39 104.27 11.29 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.181 -1.044 . . . . 63.23 108.181 177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.0 m -102.02 119.19 38.39 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.48 1.112 . . . . 75.21 109.399 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 28.5 t-20 -77.68 101.2 6.51 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.296 -1.002 . . . . 73.42 108.296 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.0 m -113.05 124.25 52.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.241 1.016 . . . . 74.55 109.884 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 109' ' ' ASN . 27.5 m -87.01 141.02 28.97 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.276 -0.639 . . . . 74.23 109.276 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -119.28 127.13 52.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.554 1.142 . . . . 74.11 108.72 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -105.7 103.21 12.67 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.232 -1.025 . . . . 34.1 108.232 176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.46 105.2 17.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 53.15 108.015 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 36.3 ttm-85 -100.0 108.64 20.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.188 -0.914 . . . . 62.01 108.659 -174.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HB3' HG12 ' A' ' 101' ' ' ILE . 94.8 m-85 -99.85 111.73 24.03 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.925 0.89 . . . . 71.2 110.943 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 103' ' ' ARG . 7.3 mp0 -80.14 112.21 17.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.742 -0.836 . . . . 72.13 108.742 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 4' ' ' ILE . 2.0 m -83.19 141.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.752 0.821 . . . . 61.12 109.69 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -140.82 117.0 10.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.411 -0.959 . . . . 71.44 108.411 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.34 -99.21 1.43 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.632 -0.587 . . . . 71.41 111.632 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -122.26 -16.96 7.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.089 0.955 . . . . 73.11 110.997 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -140.38 165.22 28.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.706 0.402 . . . . 74.42 110.573 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 96' ' ' VAL . 2.6 mp -76.98 134.12 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.101 0.56 . . . . 70.11 109.81 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -123.47 5.57 8.99 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.35 1.06 . . . . 74.21 111.602 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 21.3 tpt180 -154.67 129.79 9.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.772 -0.455 . . . . 73.42 109.772 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.92 149.3 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.072 0.949 . . . . 74.41 109.322 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.8 m -131.17 106.79 8.57 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.351 -0.981 . . . . 62.33 108.351 171.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.77 105.04 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.725 -0.843 . . . . 61.31 108.725 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -116.17 105.78 12.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.54 0.736 . . . . 72.31 109.068 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -73.1 105.06 4.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.637 -0.875 . . . . 61.13 108.637 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 24.7 t-20 -60.89 98.33 0.07 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.686 0.794 . . . . 70.04 110.292 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.2 -106.84 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.283 -1.326 . . . . 75.55 110.062 -175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.49 -50.4 4.22 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 117.298 0.549 . . . . 74.24 112.786 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -67.51 127.53 33.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.97 0.908 . . . . 72.35 110.588 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.86 -24.55 63.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.131 0.972 . . . . 53.24 110.586 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.03 99.22 1.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.444 0.697 . . . . 71.41 109.467 172.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -90.0 12.91 16.18 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.121 0.968 . . . . 73.2 111.627 -173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -117.67 115.81 25.81 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.133 0.573 . . . . 75.2 109.599 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.61 -35.34 18.12 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.818 -0.808 . . . . 74.15 108.818 168.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -64.49 111.05 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.648 1.179 . . . . 71.4 110.243 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -80.07 164.59 23.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.906 0.882 . . . . 63.4 110.527 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.891 -0.781 . . . . 75.34 108.891 176.673 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.842 -0.059 . . . . 54.22 110.842 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 47.19 26.14 0.63 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 126.763 2.025 . . . . 71.21 113.671 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -81.52 75.53 8.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.394 -0.965 . . . . 62.4 108.394 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 HG12 ' A' ' 96' ' ' VAL . 43.5 mm -74.02 -34.19 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.117 0.967 . . . . 60.22 112.121 -168.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.26 -42.24 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.454 0.702 . . . . 63.34 109.537 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.49 -35.94 70.95 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.026 -0.988 . . . . 74.33 110.412 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -64.27 -40.67 96.44 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 123.244 0.618 . . . . 75.45 110.447 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.66 76.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.747 0.819 . . . . 64.23 110.956 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 64' ' ' VAL . 87.2 tttt -63.13 -56.88 13.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.455 -0.793 . . . . 63.13 110.504 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.406 HE21 HD13 ' A' ' 30' ' ' LEU . 21.2 pt20 -67.41 -23.2 65.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.047 0.539 . . . . 64.14 111.077 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -49.4 64.58 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 123.721 0.638 . . . . 50.12 110.115 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.11 83.25 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.173 0.921 . . . . 71.15 110.906 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HE21 ' A' ' 17' ' ' GLN . 74.1 mt -61.51 -40.24 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.327 1.051 . . . . 72.23 111.085 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.7 61.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.403 0.681 . . . . 62.11 111.983 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.02 -37.47 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.485 0.714 . . . . 75.21 109.239 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -73.11 -35.16 66.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.09 0.556 . . . . 73.3 111.054 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.483 HE21 HG22 ' A' ' 13' ' ' ILE . 77.1 mt-30 -61.43 -37.39 83.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.354 0.662 . . . . 74.23 110.464 174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 mt -73.26 -40.82 64.3 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 123.759 0.662 . . . . 64.1 110.532 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -59.69 -27.8 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.421 0.526 . . . . 71.23 112.421 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 -14.33 17.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.169 0.588 . . . . 71.45 111.815 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -159.58 89.9 1.93 Allowed Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 123.42 0.688 . . . . 72.5 110.381 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HD2' HE21 ' A' ' 51' ' ' GLN . 37.6 Cg_endo -62.32 -22.33 73.95 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.374 2.716 . . . . 52.44 113.193 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.1 p -92.16 11.48 25.4 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.66 0.784 . . . . 74.2 111.809 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.11 110.73 8.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.048 -0.723 . . . . 75.0 109.048 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.78 -38.54 23.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.468 2.112 . . . . 71.34 113.104 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.61 -40.16 73.32 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.31 0.644 . . . . 74.52 111.644 -172.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 31' ' ' LEU . . . -61.74 -56.85 15.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.025 0.828 . . . . 63.44 110.783 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.9 -24.64 66.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.507 0.723 . . . . 75.3 111.661 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.45 -46.83 65.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.809 0.443 . . . . 55.35 111.254 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.406 HD13 HE21 ' A' ' 10' ' ' GLN . 4.3 pp -69.93 -30.56 67.99 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 110.288 -0.264 . . . . 64.24 110.288 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 35' ' ' LEU . 83.2 mt -66.99 -28.19 68.05 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.424 0.69 . . . . 55.43 111.571 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -71.52 -25.39 62.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.999 0.428 . . . . 74.31 110.109 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -85.62 -41.3 15.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.636 0.774 . . . . 70.25 111.598 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 7' ' ' ALA . 9.4 pt -103.64 -17.32 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.123 0.569 . . . . 63.21 112.23 -170.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 31' ' ' LEU . 73.6 mt -123.43 174.61 7.26 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.026 0.93 . . . . 60.1 108.681 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.8 m -68.98 141.89 92.65 Favored Pre-proline 0 CA--C 1.561 1.404 0 N-CA-C 109.949 -0.389 . . . . 41.2 109.949 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.36 -20.01 14.29 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.997 2.464 . . . . 73.03 114.514 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.08 -37.23 66.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 72.33 111.796 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 36' ' ' SER . 97.9 t -64.03 -41.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.843 0.857 . . . . 62.4 111.386 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.59 -28.02 60.73 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.943 0.402 . . . . 43.51 111.358 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.32 -27.89 62.72 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.872 -1.058 . . . . 53.2 111.224 -172.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.65 -32.72 23.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.746 0.418 . . . . 74.41 111.077 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 39' ' ' VAL . 55.3 t -64.21 -40.21 88.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 123.337 0.655 . . . . 72.22 110.758 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -67.59 -24.89 65.54 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.597 0.56 . . . . 74.53 111.535 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.29 -48.44 14.13 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.487 0.715 . . . . 73.34 110.255 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -62.63 -28.06 69.65 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.507 1.123 . . . . 71.35 110.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -65.05 -35.29 80.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.302 -1.317 . . . . 75.4 112.65 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -65.62 -27.46 68.41 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.665 0.786 . . . . 75.04 111.469 -174.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.3 -48.67 32.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.678 0.791 . . . . 72.44 109.894 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.03 -30.3 69.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.839 0.856 . . . . 72.02 110.859 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.498 HE21 ' HD2' ' A' ' 22' ' ' PRO . 4.8 tp-100 -66.61 -47.35 72.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.03 1.332 . . . . 75.34 109.677 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.69 -31.58 72.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.241 -0.89 . . . . 65.41 110.845 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 -25.62 39.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.512 0.725 . . . . 62.22 110.877 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.34 40.31 80.59 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.377 0.423 . . . . 62.31 113.179 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.13 110.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.266 0.626 . . . . 73.5 109.396 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -94.55 106.63 18.62 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.099 -0.704 . . . . 63.23 109.099 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 7.3 p90 -112.38 143.07 44.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.534 0.734 . . . . 74.13 109.253 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -130.23 129.03 42.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.978 0.511 . . . . 71.33 109.767 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.94 101.37 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.551 0.741 . . . . 63.11 109.245 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.53 -27.27 19.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.971 0.908 . . . . 75.31 110.332 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 8.8 tpp180 -145.29 146.79 31.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.164 -1.05 . . . . 75.42 108.164 176.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.58 118.62 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.598 0.759 . . . . 74.32 109.013 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.97 105.76 10.6 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.96 -1.126 . . . . 71.04 107.96 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 73' ' ' VAL . 84.6 t -99.9 108.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.567 -1.272 . . . . 53.33 107.567 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -124.37 126.1 45.42 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.337 -0.616 . . . . 61.12 109.337 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 HG22 ' A' ' 71' ' ' VAL . 1.4 m -89.45 113.18 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.587 -0.894 . . . . 71.34 108.587 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -110.02 91.59 3.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.781 1.232 . . . . 54.54 107.812 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.7 -110.06 3.17 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 114.869 -1.06 . . . . 73.11 112.101 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.76 23.75 13.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.585 0.754 . . . . 51.51 110.379 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.6 m -134.88 122.6 22.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.157 0.583 . . . . 75.44 110.285 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 66' ' ' THR . 30.0 t -88.68 111.1 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.046 0.538 . . . . 71.33 109.606 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -97.94 104.59 16.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.704 0.802 . . . . 64.3 109.427 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 64' ' ' VAL . 78.0 t -89.29 103.68 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 109.203 -0.666 . . . . 70.31 109.203 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.9 m -99.02 103.3 15.23 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.0 -1.111 . . . . 63.24 108.0 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.05 128.9 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.441 0.696 . . . . 72.44 110.214 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 6.9 tp10 -92.77 111.96 23.75 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.08 1.352 . . . . 73.15 109.548 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 4.9 mp -109.51 118.81 37.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.605 -0.887 . . . . 60.11 108.605 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 87' ' ' ASN . 26.1 tt0 -88.24 101.61 14.01 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.173 -1.418 . . . . 64.23 107.173 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 57' ' ' PHE . 28.0 mt-10 -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.344 1.058 . . . . 73.34 110.588 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.3 m -125.05 111.09 14.96 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.861 -1.162 . . . . 70.3 107.861 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.9 t -132.36 131.25 41.69 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.483 -0.932 . . . . 73.52 108.483 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.6 -78.56 0.47 Allowed Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.48 -0.648 . . . . 65.3 111.48 -172.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.91 10.68 0.11 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 123.529 0.585 . . . . 72.14 111.959 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.4 p -98.67 126.91 44.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.077 0.951 . . . . 64.32 109.636 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.4 m -116.44 108.33 15.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.74 0.816 . . . . 64.13 110.181 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.0 m -131.74 139.53 48.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.012 0.925 . . . . 70.21 110.395 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 18.2 m120 -77.69 115.72 17.67 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.128 0.571 . . . . 72.12 109.597 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -116.65 121.39 41.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.304 1.042 . . . . 52.32 108.644 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 109' ' ' ASN . 19.1 m -88.99 122.76 32.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.976 -0.379 . . . . 75.05 109.976 -176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -106.84 126.07 51.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.895 -0.779 . . . . 75.12 108.895 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.8 103.4 12.66 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.987 -1.116 . . . . 62.53 107.987 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.13 106.68 18.71 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.701 -1.222 . . . . 54.01 107.701 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 39.5 ttm180 -93.3 99.93 12.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.26 1.024 . . . . 74.22 110.113 -175.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.429 ' HB3' HG21 ' A' ' 101' ' ' ILE . 97.1 m-85 -91.42 109.67 20.96 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.746 0.819 . . . . 72.44 110.157 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 103' ' ' ARG . 40.5 tt0 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.248 -0.649 . . . . 74.3 109.248 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.429 HG12 HG21 ' A' ' 4' ' ' ILE . 2.3 m -84.94 149.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.461 0.704 . . . . 73.41 110.134 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -154.58 103.3 2.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 53.12 108.81 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 -118.39 5.04 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.748 -0.541 . . . . 60.44 111.748 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.37 20.37 13.65 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 71.23 109.832 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t -139.22 168.44 19.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.305 1.042 . . . . 75.54 109.199 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 35' ' ' LEU . 65.1 mt -108.17 127.78 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.979 0.912 . . . . 71.32 108.726 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -115.06 5.46 14.94 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.257 0.623 . . . . 73.31 112.435 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' GLU . 68.8 ttp85 -153.53 134.91 14.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 110.576 -0.157 . . . . 63.53 110.576 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 129.68 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.289 1.036 . . . . 64.11 109.056 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 93' ' ' ARG . 16.3 m -116.68 104.61 11.55 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.522 -0.918 . . . . 72.21 108.522 176.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.37 117.28 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.773 -0.825 . . . . 64.31 108.773 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 m -117.66 106.3 12.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.911 0.484 . . . . 74.31 109.812 -171.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.12 122.46 25.65 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.131 0.572 . . . . 74.11 109.536 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.7 m-80 -112.7 143.57 43.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.041 . . . . 75.04 109.21 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.75 -124.78 0.87 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.468 -0.653 . . . . 53.44 111.468 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.6 -103.52 1.2 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.814 -0.514 . . . . 74.23 111.814 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -126.63 6.94 6.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.05 0.94 . . . . 61.41 110.594 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.17 65.21 1.49 Allowed 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.647 1.179 . . . . 74.11 110.718 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.68 82.8 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.952 -1.022 . . . . 74.02 111.171 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -143.21 154.46 43.87 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.429 0.692 . . . . 75.02 109.762 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -155.37 27.57 0.4 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.347 1.059 . . . . 75.44 108.673 173.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -68.4 98.7 0.86 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.5 -0.773 . . . . 62.43 109.178 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -97.97 120.49 38.46 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.333 -0.849 . . . . 71.25 109.364 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -153.79 105.0 2.74 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.429 0.692 . . . . 65.53 109.225 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 33.4 p80 . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 109.278 -0.638 . . . . 73.43 109.278 171.377 . . . . . . . . 0 0 . 1 stop_ save_